PT J
AU Shin, YH
   Kim, AJ
   Ro, H
   Chang, JH
   Jung, JY
   Chung, WK
   Lee, HH
AF Shin, Yong Hoon
   Kim, Ae Jin
   Ro, Han
   Chang, Jae Hyun
   Jung, Ji Yong
   Chung, Woo Kyung
   Lee, Hyun Hee
TI Concomitant Mitochondrial Diabetes and Myopathy Mistook for Complications of Immunosuppressants After Kidney Transplant
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Lactic acidosis; Maternally inherited diabetes deafness; Mitochondrial disease; Mitochondrial encephalomyopathy; Stroke-like episodes
ID hearing-loss; mellitus; mutation
AB Posttransplant diabetes mellitus, presenile deafness, and myopathy are not commonly accompanied symptoms after kidney transplant. We report the case of a 48-year-old woman with diabetes mellitus, sensorineural hearing loss, and severe myopathy without neuropathy after deceased donor kidney transplant. She had a mitochondrial DNA point mutation at position 3243 (A>G), and mitochondrial diseases such as maternally inherited diabetes deafness or mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes were suspected. Diabetes and other symptoms following kidney transplant can often be overlooked as complications of immunosuppressants taken after kidney transplant. However, in patients without a known cause of their symptoms, appropriate examinations and consultation for other diseases, including genetic diseases, should be considered.
C1 [Shin, Yong Hoon; Kim, Ae Jin; Ro, Han; Chang, Jae Hyun; Jung, Ji Yong; Chung, Woo Kyung; Lee, Hyun Hee] Gachon Univ, Coll Med, Dept Internal Med, 21,Namdong Dero,774 Beon Gil, Incheon 21565, South Korea.
C3 Gachon University
RP Lee, HH (corresponding author), Gachon Univ, Coll Med, Dept Internal Med, 21,Namdong Dero,774 Beon Gil, Incheon 21565, South Korea.
EM lhh90@gilhospital.com
CR Akinpelu OV, 2014, LARYNGOSCOPE, V124, P767, DOI 10.1002/lary.24354
   Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231
   Bamanie AH, 2011, SAUDI MED J, V32, P271
   Cho Y, 2016, MEDICINE, V95, P0, DOI 10.1097/MD.0000000000003423
   Ciorba A, 2011, J LARYNGOL OTOL, V125, P776, DOI 10.1017/S0022215111001101
   Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540
   de Laat P, 2019, CLIN KIDNEY J, V12, P840, DOI 10.1093/ckj/sfz020
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Mozaffari M, 2010, EAST MEDITERR HEALTH J, V16, P947
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Vilayur E, 2010, AM J KIDNEY DIS, V56, P661, DOI 10.1053/j.ajkd.2010.05.015
NR 13
TC 0
Z9 0
U1 0
U2 4
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
EI 2146-8427
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD JUL 15
PY 2021
VL 19
IS 7
BP 736
EP 738
DI 10.6002/ect.2020.0505
PG 3
WC Transplantation
SC Transplantation
GA TH9FA
UT WOS:000672387000016
PM 34325625
DA 2024-11-01
ER

PT J
AU Sequiera, GL
   Srivastava, A
   Alagarsamy, KN
   Rockman-Greenberg, C
   Dhingra, S
AF Sequiera, Glen Lester
   Srivastava, Abhay
   Alagarsamy, Keshav Narayan
   Rockman-Greenberg, Cheryl
   Dhingra, Sanjiv
TI Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome
SO CELLS
LA English
DT Article
DE Kearns Sayre syndrome; mitochondria; iPSC; stem cells
AB Kearns Sayre syndrome (KSS) is mitochondrial multisystem disorder with no proven effective treatment. The underlying cause for multisystem involvement is the energy deficit resulting from the load of mutant mitochondrial DNA (mtDNA), which manifests as loss of cells and tissue dysfunction. Therefore, functional organ or cellular replacement provides a promising avenue as a therapeutic option. Patient-specific induced pluripotent stem cells (iPSC) have become a handy tool to create personalized cell -based therapies. iPSC are capable of self-renewal, differentiation into all types of body cells including cardiomyocytes (CM) and neural progenitor cells (NPC). In KSS patients, mutations in mtDNA are largely found in the muscle tissue and are predominantly absent in the blood cells. Therefore, we conceptualized that peripheral blood mononuclear cells (PBMNC) from KSS patients can be reprogrammed to generate mutation free, patient specific iPSC lines that can be used as isogenic source of cell replacement therapies to treat affected organs. In the current study we generated iPSC lines from two female patients with clinical diagnosis of classic KSS. Our data demonstrate that iPSC from these KSS patients showed normal differentiation potential toward CM, NPC and fibroblasts without any mtDNA deletions over passages. Next, we also found that functional studies including ATP production, reactive oxygen species generation, lactate accumulation and mitochondrial membrane potential in iPSC, CM, NPC and fibroblasts of these KSS patients were not different from respective cells from healthy controls. PBMNCs from these KSS patients in the current study did not reproduce mtDNA mutations which were present in muscle biopsies. Furthermore, we demonstrate for the first time that this phenomenon provides opportunities to create isogenic mutation free iPSC with absent or very low level of expression of mtDNA deletion which can be banked for future cell replacement therapies in these patients as the disease progresses.
C1 [Sequiera, Glen Lester; Srivastava, Abhay; Alagarsamy, Keshav Narayan; Dhingra, Sanjiv] Univ Manitoba, Max Rady Coll Med,Rady Fac Hlth Sci, St Boniface Hosp,Dept Physiol & Pathophysiol, Albrechtsen Res Ctr,Regenerat Med Program,Inst Ca, Winnipeg, MB R2H 2A6, Canada.
   [Rockman-Greenberg, Cheryl] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Pediat & Child Hlth, Winnipeg, MB R3E 3P4, Canada.
C3 University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba
RP Dhingra, S (corresponding author), Univ Manitoba, Max Rady Coll Med,Rady Fac Hlth Sci, St Boniface Hosp,Dept Physiol & Pathophysiol, Albrechtsen Res Ctr,Regenerat Med Program,Inst Ca, Winnipeg, MB R2H 2A6, Canada.
EM gsequiera@sbrc.ca; asrivastava@sbrc.ca; kalagarsamy@sbrc.ca; cgreenberg@hsc.mb.ca; sdhingra@sbrc.ca
FU Canadian Institutes of Health Research [MOP142265]
CR Björklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   CHANNER KS, 1988, BRIT HEART J, V59, P486
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Cohen BH, 2016, MITOCHONDRIAL CASE S, V0, P43
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Deinsberger J, 2020, NPJ REGEN MED, V5, P0, DOI 10.1038/s41536-020-00100-4
   Elitt MS, 2018, HUM MOL GENET, V27, PR89, DOI 10.1093/hmg/ddy186
   Forbes TA, 2018, AM J HUM GENET, V102, P816, DOI 10.1016/j.ajhg.2018.03.014
   Gao L, 2018, CIRC RES, V123, P1313, DOI 10.1161/CIRCRESAHA.118.313094
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Holloman Conisha Mone, 2013, BMJ CASE REP, V2013, P0, DOI 10.1136/bcr-2012-007272
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Li JP, 2019, TRANSL PSYCHIAT, V9, P0, DOI 10.1038/s41398-019-0643-y
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li SS, 2018, STEM CELL REP, V10, P808, DOI 10.1016/j.stemcr.2018.01.013
   Li Y, 2017, CHEMSUSCHEM, V10, P68, DOI 10.1002/cssc.201601188
   Mahato B, 2011, MITOCHONDRION, V11, P564, DOI 10.1016/j.mito.2011.03.006
   Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368
   Margolin E, 2020, STATPEARLS, V0, P0
   Nagoshi N, 2018, CELL MOL LIFE SCI, V75, P989, DOI 10.1007/s00018-017-2676-9
   Ohashi Toya, 2012, PEDIATR ENDOCRINOL REV, V10 Suppl 1, P26
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Sequiera GL, 2020, STEM CELL RES, V48, P0, DOI 10.1016/j.scr.2020.101964
   Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001
NR 30
TC 11
Z9 11
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR 15
PY 2021
VL 10
IS 3
BP 
EP 
DI 10.3390/cells10030568
PG 15
WC Cell Biology
SC Cell Biology
GA RD4PL
UT WOS:000633462000001
PM 33807701
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Winklehner, M
AF Finsterer, Josef
   Winklehner, Michael
TI ADULT-ONSET, ISOLATED RESPIRATORY CHAIN COMPLEX-IV DEFICIENCY WITH MILD MANIFESTATIONS
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE mtDNA; mitochondrial; respiratory chain; multisystem; myopathy
ID pediatric-patients; clinical spectrum; mitochondrial; mutation
AB Isolated respiratory chain complex-IV deficiency (ICIVD) usually manifests clin-ically as an early-onset, severe, multisystem mitochondrial disorder (MID) and only rarely with mild manifestations. Here we present an adult patient with late onset ICIVD with slowly progressive, mild clinical manifestations. In a 57-years old Caucasian male with exercise-induced myalgia, muscle cramps, ptosis, and recurrent creatine-kinase (CK) elevation, muscle biopsy and biochemi-cal investigations of the left lateral vastus muscle revealed ICIVD. He additionally had developed diabetes, arterial hypertension, hyperlipidemia, retinal detachment, transient hypothyroidism, and a hearing fall. The family history was positive for diabetes, Parkinsonism, and dementia in the mother and myopathy in the brother, suggesting maternal transmission of the MID. Conclusions: ICIVD may manifest in adulthood with only mild manifestations and may take a slowly progressive course. Patients with mild hyper-CKemia and mild multisystem manifestations, including the muscle, profit from muscle biopsy and biochemical investigations.
C1 [Finsterer, Josef] Messerli Inst, Klinikum Landstr, Vienna, Austria.
   [Winklehner, Michael] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria.
C3 Medical University of Vienna
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Pillai NR, 2019, AM J MED GENET A, V179, P2138, DOI 10.1002/ajmg.a.61288
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Renkema GH, 2017, HUM GENET, V136, P759, DOI 10.1007/s00439-017-1794-7
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossmanith Walter, 2009, BMJ CASE REP, V2009, P0, DOI 10.1136/bcr.08.2008.0666
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 10
TC 1
Z9 1
U1 0
U2 1
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
EI 
J9 POL J PATHOL
JI Pol. J. Pathol.
PD JUN 15
PY 2021
VL 72
IS 2
BP 185
EP 189
DI 10.5114/PJP.2021.109523
PG 5
WC Pathology
SC Pathology
GA XM2YA
UT WOS:000728698100016
PM 34706528
DA 2024-11-01
ER

PT J
AU Lundquist, AA
   Farholt, S
   Borresen, ML
   Duno, M
   Wibrand, F
   Witting, N
   Ostergaard, E
AF Lundquist, Alberte A.
   Farholt, Stense
   Borresen, Malene L.
   Duno, Morten
   Wibrand, Flemming
   Witting, Nanna
   Ostergaard, Elsebet
TI A novel homoplasmic mt-tRNA<SUP>Glu</SUP> m.14701C&gt;T variant presenting with a partially reversible infantile respiratory chain deficiency
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Homoplasmy; Mitochondrial disorders; RIRCD; MT-TE; Mt-tRNA(Glu)
ID mitochondrial myopathy; mutation; lipomas; disease; mtdna
AB Background: Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial disorder associated with variable penetrance and partial to full remission of symptoms. Objective: To describe features of maternally related individuals with a novel variant associated with RIRCD. Materials and methods: Nine maternally related individuals aged 23 months to 64 years are described through physical examinations, muscle biopsies, histochemical and biochemical analyses, genome sequencing, and cerebral imaging. Results: A homoplasmic mitochondrial transfer ribonucleic acid for glutamic acid (mt-tRNAGlu) m.14701C>T variant was identified in eight tested individuals out of nine maternally related individuals. Two individuals presented with hypotonia, muscle weakness, feeding difficulties and lactic acidosis at age 3-4 months, and improvement around age 15-23 months with mild residual symptoms at last examination. One individual with less severe symptoms had unknown age at onset and improved around age 4-5 years. Five individuals developed lipoma on the upper back, and one adult individual developed ataxia, while one was unaffected. Conclusions: We have identified a novel homoplasmic mt-tRNAGlu m.14701C>T variant presenting with phenotypic and paraclinical features associated with RIRCD as well as ataxia and lipomas, which to our knowledge are new features associated to RIRCD.
C1 [Lundquist, Alberte A.; Duno, Morten; Wibrand, Flemming; Ostergaard, Elsebet] Copenhagen Univ Hosp, Dept Clin Genet, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   [Farholt, Stense; Borresen, Malene L.] Copenhagen Univ Hosp, Ctr Rare Dis Pediat & Adolescent Med, Rigshosp, Copenhagen, Denmark.
   [Farholt, Stense] Aarhus Univ Hosp, Ctr Rare Dis Pediat & Adolescent Med, Aarhus, Denmark.
   [Witting, Nanna] Copenhagen Univ Hosp, Copenhagen Neuromuscular Ctr, Dept Neurol, Rigshosp, Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet; Rigshospitalet; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen
RP Ostergaard, E (corresponding author), Copenhagen Univ Hosp, Dept Clin Genet, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM Elsebet.ostergaard.01@regionh.dk
CR Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   Garrison E, 2012, ARXIV12073907, V0, P0
   Guerrero JC, 2019, 1093526619860362 PED, V0, P0, DOI DOI 10.1177/1093526619860362
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   HAO HL, 1995, AM J HUM GENET, V56, P1017
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Jeppesen TD, 2017, CLIN CASE REP, V5, P2034, DOI 10.1002/ccr3.1096
   Lax NZ, 2013, J NEUROPATH EXP NEUR, V72, P164, DOI 10.1097/NEN.0b013e31828129c5
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   SALO MK, 1992, ARCH DIS CHILD, V67, P1033, DOI 10.1136/adc.67.8.1033
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0
   TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
   Wada H, 1996, BRAIN DEV-JPN, V18, P263, DOI 10.1016/0387-7604(96)00017-4
   Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 24
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT 15
PY 2021
VL 64
IS 10
BP 
EP 
DI 10.1016/j.ejmg.2021.104306
EA AUG 2021
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA UQ8NU
UT WOS:000696316400003
PM 34400372
DA 2024-11-01
ER

PT J
AU Facchinello, N
   Laquatra, C
   Locatello, L
   Beffagna, G
   Casas, RB
   Fornetto, C
   Dinarello, A
   Martorano, L
   Vettori, A
   Risato, G
   Celeghin, R
   Meneghetti, G
   Santoro, MM
   Delahodde, A
   Vanzi, F
   Rasola, A
   Dalla Valle, L
   Rasotto, MB
   Lodi, T
   Baruffini, E
   Argenton, F
   Tiso, N
AF Facchinello, Nicola
   Laquatra, Claudio
   Locatello, Lisa
   Beffagna, Giorgia
   Branas Casas, Raquel
   Fornetto, Chiara
   Dinarello, Alberto
   Martorano, Laura
   Vettori, Andrea
   Risato, Giovanni
   Celeghin, Rudy
   Meneghetti, Giacomo
   Santoro, Massimo Mattia
   Delahodde, Agnes
   Vanzi, Francesco
   Rasola, Andrea
   Dalla Valle, Luisa
   Rasotto, Maria Berica
   Lodi, Tiziana
   Baruffini, Enrico
   Argenton, Francesco
   Tiso, Natascia
TI Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish
SO CELL DEATH & DISEASE
LA English
DT Article
ID mitochondrial-dna depletion; polymerase gamma; caenorhabditis-elegans; gene
AB The DNA polymerase gamma (Polg) is a nuclear-encoded enzyme involved in DNA replication in animal mitochondria. In humans, mutations in the POLG gene underlie a set of mitochondrial diseases characterized by mitochondrial DNA (mtDNA) depletion or deletion and multiorgan defects, named POLG disorders, for which an effective therapy is still needed. By applying antisense strategies, ENU- and CRISPR/Cas9-based mutagenesis, we have generated embryonic, larval-lethal and adult-viable zebrafish Polg models. Morphological and functional characterizations detected a set of phenotypes remarkably associated to POLG disorders, including cardiac, skeletal muscle, hepatic and gonadal defects, as well as mitochondrial dysfunctions and, notably, a perturbed mitochondria-to-nucleus retrograde signaling (CREB and Hypoxia pathways). Next, taking advantage of preliminary evidence on the candidate molecule Clofilium tosylate (CLO), we tested CLO toxicity and then its efficacy in our zebrafish lines. Interestingly, at well tolerated doses, the CLO drug could successfully rescue mtDNA and Complex I respiratory activity to normal levels, even in mutant phenotypes worsened by treatment with Ethidium Bromide. In addition, the CLO drug could efficiently restore cardio-skeletal parameters and mitochondrial mass back to normal values. Altogether, these evidences point to zebrafish as a valuable vertebrate organism to faithfully phenocopy multiple defects detected in POLG patients. Moreover, this model represents an excellent platform to screen, at the whole-animal level, candidate molecules with therapeutic effects in POLG disorders.
C1 [Facchinello, Nicola; Locatello, Lisa; Beffagna, Giorgia; Dinarello, Alberto; Martorano, Laura; Risato, Giovanni; Celeghin, Rudy; Meneghetti, Giacomo; Santoro, Massimo Mattia; Dalla Valle, Luisa; Rasotto, Maria Berica; Argenton, Francesco; Tiso, Natascia] Univ Padua, Dept Biol, I-35131 Padua, Italy.
   [Laquatra, Claudio; Rasola, Andrea] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Beffagna, Giorgia; Risato, Giovanni] Univ Padua, Dept Cardiothoraco Vasc Sci & Publ Hlth, I-35128 Padua, Italy.
   [Branas Casas, Raquel] Univ Barcelona, Fac Biol, Barcelona 08028, Spain.
   [Fornetto, Chiara; Vanzi, Francesco] Univ Florence, Dept Biol, I-50019 Sesto Fiorentino, FI, Italy.
   [Fornetto, Chiara; Vanzi, Francesco] Univ Florence, LENS, I-50019 Sesto Fiorentino, FI, Italy.
   [Vettori, Andrea] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy.
   [Delahodde, Agnes] Inst Biol Integrat Cellule I2BC, F-91190 Gif Sur Yvette, France.
   [Lodi, Tiziana; Baruffini, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
C3 University of Padua; University of Padua; University of Padua; University of Barcelona; University of Florence; University of Florence; University of Verona; Universite Paris Saclay; University of Parma
RP Argenton, F (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.; Lodi, T; Baruffini, E (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
EM tiziana.lodi@unipr.it; enrico.baruffini@unipr.it; francesco.argenton@unipd.it
FU Department of Biology, University of Padova [BIRD192500]; French Muscular Dystrophy Association (AFM-Telethon) [POLYGON 18572]; Italian Association for Cancer Research (AIRC) [IG-2017-19928]; Italian Telethon Foundation [GGP15041, GGP19287]; CARIPARO grant SHoCD; Italian Ministry University Research (MIUR) [PRIN 20173ZWACS]; AIRC [IG-2017/20749]; European Research Council (ERC) Consolidator Grant-Rendox [ERC-CoG 647057]
CR Aleström P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037
   Alway SE, 2017, EXERC SPORT SCI REV, V45, P58, DOI 10.1249/JES.0000000000000101
   Artuso L, 2012, BBA-BIOENERGETICS, V1817, P1002, DOI 10.1016/j.bbabio.2012.03.019
   Becker WA, 1984, MANUAL OF QUANTITATIVE GENETICS., V0, P0
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Cannino G, 2018, FRONT ONCOL, V8, P0, DOI 10.3389/fonc.2018.00333
   da Cunha FM, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/482582
   Facchinello N, 2016, METHODS MOL BIOL, V1481, P81, DOI 10.1007/978-1-4939-6393-5_9
   Gagnon JA, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098186
   Giannelli F, 2001, AM J HUM GENET, V68, P1535, DOI 10.1086/320613
   Giuliodori A, 2018, CARDIOVASC RES, V114, P1082, DOI 10.1093/cvr/cvy057
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Korzh S, 2008, BMC DEV BIOL, V8, P0, DOI 10.1186/1471-213X-8-84
   Kumar H, 2015, MEDIAT INFLAMM, V2015, P0, DOI 10.1155/2015/584758
   Kuo CW, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18061220
   Lodi T, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00106
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Martorano L, 2019, DIS MODEL MECH, V12, P0, DOI 10.1242/dmm.037226
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Mugoni V, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51328
   PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892
   Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Schönenberger MJ, 2015, FRONT CELL DEV BIOL, V3, P0, DOI 10.3389/fcell.2015.00042
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks596
   Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Vettori A, 2017, P NATL ACAD SCI USA, V114, P9948, DOI 10.1073/pnas.1705338114
   Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003
   Zhou WQ, 2018, DIS MODEL MECH, V11, P0, DOI 10.1242/dmm.033027
NR 36
TC 15
Z9 15
U1 1
U2 10
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
EI 
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 19
PY 2021
VL 12
IS 1
BP 
EP 
DI 10.1038/s41419-020-03359-z
PG 18
WC Cell Biology
SC Cell Biology
GA PY4VZ
UT WOS:000612045000003
PM 33469036
DA 2024-11-01
ER

PT J
AU Visuttijai, K
   Hedberg-Oldfors, C
   Lindgren, U
   Nordström, S
   Elíasdóttir, O
   Lindberg, C
   Oldfors, A
AF Visuttijai, Kittichate
   Hedberg-Oldfors, Carola
   Lindgren, Ulrika
   Nordstrom, Sara
   Eliasdottir, Olof
   Lindberg, Christopher
   Oldfors, Anders
TI Progressive external ophthalmoplegia associated with novel<i>MT</i>-<i>TN</i>mutations
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
ID mitochondrial trna(asn) gene; point mutations; dna mutations; identification; deletions; muscle
AB Objectives To describe two patients with progressive external ophthalmoplegia (PEO) and mitochondrial myopathy associated with mutations in mitochondrial DNA, encoding the tRNA(Asn)gene (MT-TN), which have not previously been published with clinical descriptions. Materials & Methods Two unrelated patients with PEO were clinically examined. Muscle biopsy was performed and investigated by exome sequencing, enzyme histochemistry, and immunohistochemistry. The level of heteroplasmy was investigated in single muscle fibers and in other tissues. Results Patient 1 was a 52-year-old man with ptosis, PEO, and exercise intolerance since childhood. Muscle biopsy demonstrated mitochondrial myopathy with frequent cytochromecoxidase (COX)-deficient fibers and a heteroplasmic mutation, m.5669G>A in theMT-TNgene, resulting in a substitution of a highly conserved C to T in the T stem of tRNA(Asn). Patient 2 was a 66-year-old woman with ptosis, PEO, and exercise intolerance since many years. Muscle biopsy demonstrated mitochondrial myopathy with frequent COX-deficient fibers. She had a novel m.5702delA mutation inMT-TN, resulting in loss of a highly conserved U in the anticodon stem of tRNA(Asn). Single fiber analysis in both cases showed highly significant differences in mutation load between COX-deficient and COX-normal fibers and a high threshold level for COX deficiency. The mutations were not found in blood, urine sediment or buccal cells. Conclusion We describe twoMT-TNmutations associated with PEO and mitochondrial myopathy, and their pathogenicity was demonstrated. Together with previous reports, the results indicate thatMT-TNis a hot spot for mutations causing sporadic PEO.
C1 [Visuttijai, Kittichate; Hedberg-Oldfors, Carola; Lindgren, Ulrika; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.
   [Nordstrom, Sara; Eliasdottir, Olof; Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital
RP Oldfors, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden.
EM anders.oldfors@gu.se
FU Vetenskapsradet [2018-02821]; Swedish Research Council [2018-02821] Funding Source: Swedish Research Council; Vinnova [2018-02821] Funding Source: Vinnova
CR Alston CL, 2017, J PATHOL, V0, P139
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Dubowitz V, 2020, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   MITOMAP, 2020, HUM MIT GEN DAT, V0, P0
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pinós T, 2013, NEUROMUSCULAR DISORD, V23, P330, DOI 10.1016/j.nmd.2013.01.001
   Ronchi D, 2012, EUR J HUM GENET, V20, P357, DOI 10.1038/ejhg.2011.238
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Tarnopolsky M, 2019, MITOCHONDRION, V47, P139, DOI 10.1016/j.mito.2019.04.003
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685
NR 20
TC 12
Z9 12
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD JAN 15
PY 2021
VL 143
IS 1
BP 103
EP 108
DI 10.1111/ane.13339
EA SEP 2020
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA OZ9KK
UT WOS:000570735800001
PM 32869280
DA 2024-11-01
ER

PT J
AU Saku, T
   Takashio, S
   Tsuruta, Y
   Otsuka, Y
   Takae, M
   Kiyama, T
   Yamamoto, E
   Kaikita, K
   Hotta, T
   Matsumoto, S
   Kang, DC
   Tsujita, K
   Komohara, Y
AF Saku, Taiki
   Takashio, Seiji
   Tsuruta, Yuichiro
   Otsuka, Yasuhiro
   Takae, Masafumi
   Kiyama, Takuya
   Yamamoto, Eichiro
   Kaikita, Koichi
   Hotta, Taeko
   Matsumoto, Shinya
   Kang, Dongchon
   Tsujita, Kenichi
   Komohara, Yoshihiro
TI Comparison of electron microscopic findings and clinical presentation in three patients with mitochondrial cardiomyopathy caused by the mitochondrial DNA mutation m.3243A &gt; G
SO MEDICAL MOLECULAR MORPHOLOGY
LA English
DT Article
DE Mitochondrial cardiomyopathy; Electron microscopy; Pathology
AB Mitochondrial cardiomyopathy can be described as a condition characterized by abnormal heart-muscle structure and/or function, secondary to mutations in nuclear or mitochondrial DNA. Its severity can range from subclinical to critical conditions. We presented three cases of mitochondrial cardiomyopathy with m.3243A > G mutation and compared the clinical manifestations with the histological findings for each of these cases. All cases showed cardiac hypertrophy, juvenile-onset diabetes mellitus, and hearing loss. Case 1 (43-year-old male) showed less cardiac involvement and shorter duration of mitochondrial disease-related symptoms than case 2 (67-year-old female) and case 3 (51-year-old male), who showed the most advanced cardiac condition and longest duration from the manifestation of heart failure. The histological findings revealed that cardiomyocytes from case 1 showed no hypertrophy and mitochondrial degeneration in electron microscopy. Alternatively, cases 2 and 3 showed hypertrophy in their cardiomyocytes, and mitochondrial degeneration (e.g. onion-like lesions, swollen cristae, and lamellar bodies) was most apparent in case 3. These results suggested that mitochondrial degeneration, as evaluated by electron microscopy, might be correlated with impaired heart function in patients with mitochondrial cardiomyopathy.
C1 [Saku, Taiki; Takashio, Seiji; Tsuruta, Yuichiro; Otsuka, Yasuhiro; Takae, Masafumi; Kiyama, Takuya; Yamamoto, Eichiro; Kaikita, Koichi; Tsujita, Kenichi] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chou Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.
   [Hotta, Taeko; Matsumoto, Shinya] Kyushu Univ Hosp, Dept Clin Chem & Lab Med, Fukuoka, Japan.
   [Kang, Dongchon] Kyushu Univ, Dept Clin Chem & Lab Med, Grad Sch Med Sci, Fukuoka, Japan.
   [Komohara, Yoshihiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Chou Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.
C3 Kumamoto University; Kyushu University; Kyushu University; Kumamoto University
RP Takashio, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chou Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.; Komohara, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Chou Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.
EM s-takash@kumamoto-u.ac.jp; ycomo@kumamoto-u.ac.jp
FU Grants-in-Aid for Scientific Research [20H00530] Funding Source: KAKEN
CR Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Daghistani HM, 2019, BRIT J PHARMACOL, V176, P4340, DOI 10.1111/bph.14499
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00025
   Ikeda Y, 2015, CARDIOVASC PATHOL, V24, P128, DOI 10.1016/j.carpath.2014.10.003
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Noda N, 2019, IGAKU KENSA, V68, P596
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Takemura G, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.116.003283
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
NR 11
TC 2
Z9 2
U1 0
U2 20
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN
SN 1860-1480
EI 1860-1499
J9 MED MOL MORPHOL
JI Med. Mol. Morphol.
PD JUN 15
PY 2021
VL 54
IS 2
BP 181
EP 186
DI 10.1007/s00795-020-00268-0
EA OCT 2020
PG 6
WC Biology; Microscopy; Pathology
SC Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology
GA SF9OE
UT WOS:000584896600001
PM 33113037
DA 2024-11-01
ER

PT J
AU Montano, V
   Gruosso, F
   Simoncini, C
   Siciliano, G
   Mancuso, M
AF Montano, V
   Gruosso, F.
   Simoncini, C.
   Siciliano, G.
   Mancuso, M.
TI Clinical features of mtDNA-related syndromes in adulthood
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mitochondrial disorders; MELAS; MERRF; Primary mitochondrial myopathy
ID hereditary optic neuropathy; mitochondrial-dna mutations; progressive external ophthalmoplegia; respiratory-chain disorders; large-scale deletions; molecular diagnosis; replacement therapy; consensus statement; myoclonic epilepsy; gene-therapy
AB Mitochondrial diseases are the most common inheritable metabolic diseases, due to defects in oxidative phosphorylation. They are caused by mutations of nuclear or mitochondrial DNA in genes involved in mitochondrial function. The peculiarity of "mitochondrial DNA genetics rules" in part explains the marked phenotypic variability, the complexity of genotype-phenotype correlations and the challenge of genetic counseling. The new massive genetic sequencing technologies have changed the diagnostic approach, enhancing mitochondrial DNA-related syndromes diagnosis and often avoiding the need of a tissue biopsy. Here we present the most common phenotypes associated with a mitochondrial DNA mutation with the recent advances in diagnosis and in therapeutic perspectives.
C1 [Montano, V; Gruosso, F.; Simoncini, C.; Siciliano, G.; Mancuso, M.] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, Pisa, Italy.
C3 University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Neurol Inst, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
FU Telethon Grant [GUP09004]; Telethon-MITOCON grant [GSP16001, RF-2016-02361495]; EJPRD2019 project GENOMIT
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Barros MH, 2020, MITOCHONDRION, V50, P94, DOI 10.1016/j.mito.2019.10.008
   Berardo A, 2020, J NEUROL, V267, P823, DOI 10.1007/s00415-019-09619-z
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Brailova M, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9030694
   Bris C, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00632
   Calabrese C, 2014, BIOINFORMATICS, V30, P3115, DOI 10.1093/bioinformatics/btu483
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Carelli V, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv339
   Castellana S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005628
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Ciron J, 2018, J NEUROL SCI, V388, P94, DOI 10.1016/j.jns.2018.03.002
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   Davis Ryan L, 2018, HANDB CLIN NEUROL, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gagliardi D, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00038
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Goldstein A, 2003, GENEREVIEWS, V0, P1993
   González MD, 2020, MITOCHONDRION, V50, P88, DOI 10.1016/j.mito.2019.10.006
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   HOWELL N, 1991, AM J HUM GENET, V48, P935
   Hwang TJ, 2017, OPHTHALMOLOGY, V124, P843, DOI 10.1016/j.ophtha.2017.01.002
   Ikawa M, 2020, CURR OPIN CLIN NUTR, V23, P17, DOI 10.1097/MCO.0000000000000610
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Konovalova S, 2019, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/59269
   Kraya T, 2019, MITOCHONDRION, V44, P53, DOI 10.1016/j.mito.2017.12.012
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lim A, 2020, EUR J PAEDIATR NEURO, V24, P47, DOI 10.1016/j.ejpn.2019.12.021
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Margolin E, 2020, STATPEARLS, V0, P0
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   Mejia-Vergara AJ, 2020, CURR NEUROL NEUROSCI, V20, P0, DOI 10.1007/s11910-020-01032-8
   Meyerspeer M, 2021, NMR BIOMED, V34, P0, DOI 10.1002/nbm.4246
   Moggio Maurizio, 2014, ACTA MYOL, V33, P86
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Musumeci O, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00160
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   Niroula A, 2016, NUCLEIC ACIDS RES, V44, P2020, DOI 10.1093/nar/gkw046
   Niu FN, 2017, CNS NEUROSCI THER, V23, P686, DOI 10.1111/cns.12714
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Orsucci D, 2014, CURR MOL MED, V14, P598, DOI 10.2174/1566524014666140603100131
   Oyama M, 2020, BMC NEUROL, V20, P0, DOI 10.1186/s12883-020-01748-7
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Piccoli GB, 2012, BMC NEPHROL, V13, P0, DOI 10.1186/1471-2369-13-9
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rawle MJ, 2013, CASE REP NEUROL, V5, P204, DOI 10.1159/000357518
   Reynaud-Dulaurier R, 2020, BRAIN, V143, P1686, DOI 10.1093/brain/awaa105
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sembrano E, 1997, NEUROLOGY, V49, P1714, DOI 10.1212/WNL.49.6.1714
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Slone J, 2020, NPJ GENOM MED, V5, P0, DOI 10.1038/s41525-020-0116-5
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky M, 2003, MUSCLE NERVE, V27, P359, DOI 10.1002/mus.10330
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Ticci C, 2020, NEUROGENETICS, V21, P87, DOI 10.1007/s10048-019-00601-5
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Voet NBM, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003907.pub4
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wabbels B, 2008, OPHTHALMOLOGE, V105, P550, DOI 10.1007/s00347-007-1643-5
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Watanabe Yuka, 2009, BRAIN AND NERVE (TOKYO), V61, P309
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2000, LEBER HEREDITARY OPT, V0, P1993
   Zekonyte U, 2020, J INTERN MED, V287, P685, DOI 10.1111/joim.13055
   ZEVIANI M, 1990, AM J HUM GENET, V47, P904
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhao Q, 2020, MICRO NANO TECHNOL, V0, PP1, DOI 10.1016/C2017-0-02305-4
NR 159
TC 9
Z9 11
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2021
VL 697
IS 
BP 
EP 
DI 10.1016/j.abb.2020.108689
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA PS0LF
UT WOS:000607619400004
PM 33227288
DA 2024-11-01
ER

PT J
AU Galber, C
   Carissimi, S
   Baracca, A
   Giorgio, V
AF Galber, Chiara
   Carissimi, Stefania
   Baracca, Alessandra
   Giorgio, Valentina
TI The ATP Synthase Deficiency in Human Diseases
SO LIFE-BASEL
LA English
DT Review
DE ATP synthase; human disease; mitochondria
ID complex-v deficiency; human mitochondrial-dna; amyotrophic-lateral-sclerosis; bovine heart-mitochondria; alzheimers-disease; oxidative-phosphorylation; t8993g mutation; leigh-syndrome; infantile cardiomyopathy; pathogenic mechanism
AB Human diseases range from gene-associated to gene-non-associated disorders, including age-related diseases, neurodegenerative, neuromuscular, cardiovascular, diabetic diseases, neurocognitive disorders and cancer. Mitochondria participate to the cascades of pathogenic events leading to the onset and progression of these diseases independently of their association to mutations of genes encoding mitochondrial protein. Under physiological conditions, the mitochondrial ATP synthase provides the most energy of the cell via the oxidative phosphorylation. Alterations of oxidative phosphorylation mainly affect the tissues characterized by a high-energy metabolism, such as nervous, cardiac and skeletal muscle tissues. In this review, we focus on human diseases caused by altered expressions of ATP synthase genes of both mitochondrial and nuclear origin. Moreover, we describe the contribution of ATP synthase to the pathophysiological mechanisms of other human diseases such as cardiovascular, neurodegenerative diseases or neurocognitive disorders.
C1 [Galber, Chiara; Carissimi, Stefania; Giorgio, Valentina] CNR, Inst Neurosci, I-35121 Padua, Italy.
   [Galber, Chiara; Baracca, Alessandra; Giorgio, Valentina] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); University of Bologna
RP Giorgio, V (corresponding author), CNR, Inst Neurosci, I-35121 Padua, Italy.; Giorgio, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
EM chiara.galber@phd.unipd.it; stefania.carissimi@unipd.it; alessandra.baracca@unibo.it; valentina.giorgio4@unibo.it
FU AIRC [MFAG 2017-ID, 20316, PRIN 2017-ID]
CR ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986
   Adav SS, 2019, MOL BRAIN, V12, P0, DOI 10.1186/s13041-019-0430-y
   Ala-Rämi A, 2003, BASIC RES CARDIOL, V98, P250, DOI 10.1007/s00395-003-0413-z
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8
   Bahri H, 2020, CELL BIOL, V0, P0, DOI DOI 10.1101/2020.04.03.023861
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Beck SJ, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11483
   Boada M, 2014, MOL PSYCHIATR, V19, P682, DOI 10.1038/mp.2013.86
   Boillée S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Bosetti F, 2004, FEBS LETT, V563, P161, DOI 10.1016/S0014-5793(04)00294-7
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Braczynski AK, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/462592
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carrette O, 2006, J CHROMATOGR B, V840, P1, DOI 10.1016/j.jchromb.2006.05.019
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Cha MY, 2015, HUM MOL GENET, V24, P6492, DOI 10.1093/hmg/ddv358
   Chandrasekaran K, 1997, MOL BRAIN RES, V44, P99, DOI 10.1016/S0169-328X(96)00191-X
   Chen RM, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1679-x
   Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475
   Choi SY, 2019, NAT NEUROSCI, V22, P851, DOI 10.1038/s41593-019-0397-0
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Collinson IR, 1996, BIOCHEMISTRY-US, V35, P12640, DOI 10.1021/bi960969t
   COLLINSON IR, 1994, J MOL BIOL, V242, P408
   Comelli M, 2007, AM J PHYSIOL-HEART C, V292, PH820, DOI 10.1152/ajpheart.00366.2006
   Contessi S, 2004, BIOCHEM PHARMACOL, V67, P1843, DOI 10.1016/j.bcp.2004.02.001
   Cross HR, 2002, J MOL CELL CARDIOL, V34, P361, DOI 10.1006/jmcc.2001.1518
   DAntoni S, 2020, BIOL CHEM, V401, P497, DOI 10.1515/hsz-2019-0221
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Deng JW, 2018, P NATL ACAD SCI USA, V115, PE9678, DOI 10.1073/pnas.1806655115
   Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031
   Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177
   DILISA F, 1995, J PHYSIOL-LONDON, V486, P1
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ding BQ, 2014, AM J ALZHEIMERS DIS, V29, P526, DOI 10.1177/1533317514523487
   Diodato D, 2014, JIMD REP, V4, P71, DOI 10.1007/8904
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107
   Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003
   FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751
   Fragaki K, 2019, MOL GENET METAB REP, V21, P0, DOI 10.1016/j.ymgmr.2019.100543
   FRALIX TA, 1993, AM J PHYSIOL, V264, PC986, DOI 10.1152/ajpcell.1993.264.4.C986
   Franco LVR, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10110304
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gather C, 2020, BIOL CHEM, V401, P1199, DOI 10.1515/hsz-2020-0157
   Gauba E, 2019, NEUROBIOL DIS, V121, P138, DOI 10.1016/j.nbd.2018.09.020
   Gauba E, 2017, J ALZHEIMERS DIS, V55, P1351, DOI 10.3233/JAD-160822
   Ghezzi D, 2018, ESSAYS BIOCHEM, V62, P271, DOI 10.1042/EBC20170099
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115
   Green DW, 1998, AM J PHYSIOL-HEART C, V274, PH90, DOI 10.1152/ajpheart.1998.274.1.H90
   Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002
   Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815
   Havlícková V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   Hejzlarová K, 2014, PHYSIOL RES, V63, PS57, DOI 10.33549/physiolres.932643
   HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jolly RD, 2002, NEUROCHEM INT, V40, P565, DOI 10.1016/S0197-0186(01)00128-0
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kaludercic N, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3869610
   Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155
   Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003
   Kovalcíková J, 2019, FASEB J, V33, P14103, DOI 10.1096/fj.201900685RR
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kühlbrandt W, 2016, TRENDS BIOCHEM SCI, V41, P106, DOI 10.1016/j.tibs.2015.10.006
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669
   Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105
   Licznerski P, 2020, CELL, V182, P1170, DOI 10.1016/j.cell.2020.07.008
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Ludtmann MHR, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04422-2
   Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Martín-Maestro P, 2019, MOL NEUROBIOL, V56, P8220, DOI 10.1007/s12035-019-01665-y
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Meulemans A, 2010, J BIOL CHEM, V285, P4099, DOI 10.1074/jbc.M109.046920
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nobile V, 2020, HUM GENET, V139, P227, DOI 10.1007/s00439-019-02104-7
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Orr AL, 2019, J ALZHEIMERS DIS, V68, P991, DOI 10.3233/JAD-181184
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007
   Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027
   Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109
   Robinson RAS, 2011, NEUROSCIENCE, V177, P207, DOI 10.1016/j.neuroscience.2011.01.005
   Rouslin W, 1996, J BIOL CHEM, V271, P23638, DOI 10.1074/jbc.271.39.23638
   ROUSLIN W, 1983, J BIOL CHEM, V258, P9657
   ROUSLIN W, 1986, AM J PHYSIOL, V250, PH503, DOI 10.1152/ajpheart.1986.250.3.H503
   ROUSLIN W, 1987, AM J PHYSIOL, V252, PH622, DOI 10.1152/ajpheart.1987.252.3.H622
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHAGGER H, 1995, EUR J BIOCHEM, V227, P916, DOI 10.1111/j.1432-1033.1995.tb20219.x
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sgarbi G, 2018, BBA-BIOENERGETICS, V1859, P99, DOI 10.1016/j.bbabio.2017.10.007
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shi X, 2011, NEUROSCI LETT, V500, P87, DOI 10.1016/j.neulet.2011.06.009
   Skoczén N, 2018, BBA-BIOENERGETICS, V1859, P602, DOI 10.1016/j.bbabio.2018.05.009
   Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   STEENBERGEN C, 1993, CIRC RES, V72, P112, DOI 10.1161/01.RES.72.1.112
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004
   Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, P0, DOI 10.1371/journal.pntd.0001205
   Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x
   Tetaud E, 2014, MOL BIOL CELL, V25, P791, DOI 10.1091/mbc.E13-02-0112
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   VanderHeide RS, 1996, J MOL CELL CARDIOL, V28, P103, DOI 10.1006/jmcc.1996.0010
   Vrbacky M, 2016, HUM MOL GENET, V25, P4674, DOI 10.1093/hmg/ddw295
   Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
   Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197
   Yu HT, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00074
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhou AN, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.10180
NR 152
TC 30
Z9 30
U1 2
U2 36
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR 15
PY 2021
VL 11
IS 4
BP 
EP 
DI 10.3390/life11040325
PG 19
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA RR6RL
UT WOS:000643222600001
PM 33917760
DA 2024-11-01
ER

PT J
AU Tanaka, K
   Ueno, T
   Yoshida, M
   Shimizu, Y
   Ogawa, T
   Nishisaka, T
   Kurashige, T
   Masaki, T
AF Tanaka, Kenta
   Ueno, Toshinori
   Yoshida, Maria
   Shimizu, Yuka
   Ogawa, Takahiko
   Nishisaka, Takashi
   Kurashige, Takashi
   Masaki, Takao
TI Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report
SO CEN CASE REPORTS
LA English
DT Article
DE Maternally inherited diabetes and deafness; Mitochondrial disease; Chronic kidney disease
ID mitochondrial dysfunction; modification defect; g mutation; involvement; nucleotide; mellitus; features; japanese
AB Maternally inherited diabetes and deafness (MIDD) is a mitochondrial genetic disorder with variable clinical presentations, which can delay its diagnosis. Herein, we report the case of a 57-year-old Japanese man with MIDD who developed chronic kidney disease. He developed proteinuria long before his diabetes and deafness; at the age of 36 years, a renal biopsy showed minor glomerular abnormality and electron microscopy showed mild mitochondrial degeneration in the distal tubular epithelial cells. Twenty years later, a second renal biopsy showed nephrosclerosis with interstitial fibrosis and arteriolar hyaline thickening, despite the absence of hypertension and relatively good glycemic control. Granular swollen epithelial cells were found in the medullary collecting duct epithelium. Electron microscopy showed accumulating mitochondria in podocytes and tubular cells, leading to the diagnosis of MIDD. A muscle biopsy also showed ragged-red fibers, despite the absence of muscle weakness. Mitochondrial DNA analysis revealed an m.3243A > G mutation, and taurine supplementation was initiated. Our findings suggest that mitochondrial dysfunction is mainly associated with progressive renal damage.
C1 [Tanaka, Kenta; Ueno, Toshinori; Shimizu, Yuka; Ogawa, Takahiko] Hiroshima Prefectural Hosp, Dept Nephrol, Minami Ku, 1-5-54,Ujinakanda, Hiroshima 7348530, Japan.
   [Yoshida, Maria; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.
   [Nishisaka, Takashi] Hiroshima Prefectural Hosp, Dept Pathol, Hiroshima, Japan.
   [Kurashige, Takashi] Natl Hosp Org Kure Med Ctr, Dept Neurol, Hiroshima, Japan.
   [Kurashige, Takashi] Chugoku Canc Ctr, Hiroshima, Japan.
C3 Hiroshima University
RP Ueno, T (corresponding author), Hiroshima Prefectural Hosp, Dept Nephrol, Minami Ku, 1-5-54,Ujinakanda, Hiroshima 7348530, Japan.
EM tueno-ygc@umin.ac.jp
CR Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Granata S, 2009, BMC GENOMICS, V10, P0, DOI 10.1186/1471-2164-10-388
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Müller-Deile J, 2014, FRONT ENDOCRINOL, V5, P0, DOI 10.3389/fendo.2014.00209
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Yamagata K, 2000, NEPHROL DIAL TRANSPL, V15, P385, DOI 10.1093/ndt/15.3.385
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
NR 19
TC 6
Z9 7
U1 0
U2 1
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN
SN 2192-4449
EI 
J9 CEN CASE REP
JI CEN CASE REP.
PD MAY 15
PY 2021
VL 10
IS 2
BP 220
EP 225
DI 10.1007/s13730-020-00547-w
EA OCT 2020
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA RH7ZR
UT WOS:000582993100002
PM 33125665
DA 2024-11-01
ER

PT J
AU Bris, C
   Goudenège, D
   Desquiret-Dumas, V
   Gueguen, N
   Bannwarth, S
   Gaignard, P
   Rucheton, B
   Trimouille, A
   Allouche, S
   Rouzier, C
   Saadi, S
   Jardel, C
   Slama, A
   Barth, M
   Verny, C
   Spinazzi, M
   Cassereau, J
   Colin, E
   Armelle, M
   Pereon, Y
   Martin-Negrier, ML
   Paquis-Flucklinger, V
   Letournel, F
   Lenaers, G
   Bonneau, D
   Reynier, P
   Amati-Bonneau, P
   Procaccio, V
AF Bris, Celine
   Goudenege, David
   Desquiret-Dumas, Valerie
   Gueguen, Naig
   Bannwarth, Sylvie
   Gaignard, Pauline
   Rucheton, Benoit
   Trimouille, Aurelien
   Allouche, Stephane
   Rouzier, Cecile
   Saadi, Samira
   Jardel, Claude
   Slama, Abdel
   Barth, Magalie
   Verny, Christophe
   Spinazzi, Marco
   Cassereau, Julien
   Colin, Estelle
   Armelle, Magot
   Pereon, Yann
   Martin-Negrier, Marie Laure
   Paquis-Flucklinger, Veronique
   Letournel, Franck
   Lenaers, Guy
   Bonneau, Dominique
   Reynier, Pascal
   Amati-Bonneau, Patrizia
   Procaccio, Vincent
TI Improved detection of mitochondrial DNA instability in mitochondrial genome maintenance disorders
SO GENETICS IN MEDICINE
LA English
DT Article
ID ribosomal-rna; mutations; deletions; single
AB Purpose Diseases caused by defects in mitochondrial DNA (mtDNA) maintenance machinery, leading to mtDNA deletions, form a specific group of disorders. However, mtDNA deletions also appear during aging, interfering with those resulting from mitochondrial disorders. Methods Here, using next-generation sequencing (NGS) data processed by eKLIPse and data mining, we established criteria distinguishing age-related mtDNA rearrangements from those due to mtDNA maintenance defects. MtDNA deletion profiles from muscle and urine patient samples carrying pathogenic variants in nuclear genes involved in mtDNA maintenance (n = 40) were compared with age-matched controls (n = 90). Seventeen additional patient samples were used to validate the data mining model. Results Overall, deletion number, heteroplasmy level, deletion locations, and the presence of repeats at deletion breakpoints were significantly different between patients and controls, especially in muscle samples. The deletion number was significantly relevant in adults, while breakpoint repeat lengths surrounding deletions were discriminant in young subjects. Conclusion Altogether, eKLIPse analysis is a powerful tool for measuring the accumulation of mtDNA deletions between patients of different ages, as well as in prioritizing novel variants in genes involved in mtDNA stability.
C1 [Bris, Celine; Goudenege, David; Desquiret-Dumas, Valerie; Gueguen, Naig; Verny, Christophe; Spinazzi, Marco; Cassereau, Julien; Colin, Estelle; Lenaers, Guy; Bonneau, Dominique; Reynier, Pascal; Amati-Bonneau, Patrizia; Procaccio, Vincent] Univ Angers, Inst MitoVasc, UMR CNRS 6015, MitoLab,INSERM U1083, F-6015 Angers, France.
   [Bris, Celine; Goudenege, David; Desquiret-Dumas, Valerie; Gueguen, Naig; Barth, Magalie; Colin, Estelle; Bonneau, Dominique; Reynier, Pascal; Amati-Bonneau, Patrizia; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, Angers, France.
   [Bannwarth, Sylvie; Rouzier, Cecile; Saadi, Samira; Paquis-Flucklinger, Veronique] Univ Cote Azur, IRCAN, CNRS, INSERM,CHU Nice, Nice, France.
   [Gaignard, Pauline; Slama, Abdel] Univ Paris Saclay, CHU Bicetre, AP HP, Serv Biochim, Le Kremlin Bicetre, France.
   [Rucheton, Benoit; Jardel, Claude] GHU Pitie Salpetriere, AP HP, Dept Biochim & Genet, Paris, France.
   [Trimouille, Aurelien] CHU Bordeaux, Serv Genet Med, Bordeaux, France.
   [Allouche, Stephane] Ctr Hosp Univ, Serv Biochim, EA4650, Caen, France.
   [Armelle, Magot; Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Martin-Negrier, Marie Laure] CHU Bordeaux, Serv Pathol, Bordeaux, France.
   [Letournel, Franck] Mint, UF Neurobiol Neuropathol, UMR INSERM 1066, CNRS 6021, Angers, France.
C3 Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Nice; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite Paris Cite; Universite Paris Saclay; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CHU Bordeaux; Universite de Bordeaux; CHU de Caen NORMANDIE; Universite de Caen Normandie; Nantes Universite; CHU de Nantes; CHU Bordeaux; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers
RP Procaccio, V (corresponding author), Univ Angers, Inst MitoVasc, UMR CNRS 6015, MitoLab,INSERM U1083, F-6015 Angers, France.; Procaccio, V (corresponding author), CHU Angers, Dept Biochim & Genet, Angers, France.
EM ViProcaccio@chu-angers.fr
FU Association contre les Maladies Mitochondriales (AMMi); AFM-Telethon; Aviesan INSERM Genomic Variability Project; Angers University Hospital
CR Boucret L, 2017, HUM REPROD, V32, P2101, DOI 10.1093/humrep/dex268
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Dörrenhaus A, 2000, ARCH TOXICOL, V74, P618, DOI 10.1007/s002040000173
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Elson JL, 2015, MITOCHONDRION, V25, P17, DOI 10.1016/j.mito.2015.08.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Liu H, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067146
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Wallace DC, 2018, EMERY RIMOINS PRINCI, V0, P267
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 39
TC 6
Z9 6
U1 1
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD SEP 15
PY 2021
VL 23
IS 9
BP 1769
EP 1778
DI 10.1038/s41436-021-01206-w
EA MAY 2021
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA UW6TR
UT WOS:000654878400001
PM 34040194
DA 2024-11-01
ER

PT J
AU Dahal, S
   Raghavan, SC
AF Dahal, Sumedha
   Raghavan, Sathees C.
TI Mitochondrial genome stability in human: understanding the role of DNA repair pathways
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID base-excision-repair; strand break repair; cytochrome-c-oxidase; oxidative stress; nuclear-dna; ligase iii; homologous recombination; endonuclease-1 ape1; mtdna replication; escherichia-coli
AB Mitochondria are semiautonomous organelles in eukaryotic cells and possess their own genome that replicates independently. Mitochondria play a major role in oxidative phosphorylation due to which its genome is frequently exposed to oxidative stress. Factors including ionizing radiation, radiomimetic drugs and replication fork stalling can also result in different types of mutations in mitochondrial DNA (mtDNA) leading to genome fragility. Mitochondria from myopathies, dystonia, cancer patient samples show frequent mtDNA mutations such as point mutations, insertions and large-scale deletions that could account for mitochondria-associated disease pathogenesis. The mechanism by which such mutations arise following exposure to various DNA-damaging agents is not well understood. One of the well-studied repair pathways in mitochondria is base excision repair. Other repair pathways such as mismatch repair, homologous recombination and microhomology-mediated end joining have also been reported. Interestingly, nucleotide excision repair and classical nonhomologous DNA end joining are not detected in mitochondria. In this review, we summarize the potential causes of mitochondrial genome fragility, their implications as well as various DNA repair pathways that operate in mitochondria.
C1 [Dahal, Sumedha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.
C3 Indian Institute of Science (IISC) - Bangalore
RP Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.
EM sathees@iisc.ac.in
FU CSIR [37(1692)/17/EMR-11]; DAE [21/01/2016-BRNS/35074]; DBT-COE [BT/PR/3458/COE/34/33/2015]; IISc-DBT partnership program [BT/PR27952-INF/22/212/2018]; IISc, India
CR Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006
   Abnet CC, 2004, BMC CANCER, V4, P0, DOI 10.1186/1471-2407-4-30
   Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Almpanis A, 2018, MICROB GENOMICS, V4, P0, DOI 10.1099/mgen.0.000168
   ANDERSON CTM, 1980, NUCLEIC ACIDS RES, V8, P875
   [Anonymous], 2018, MOL CELL BIOL, V0, P0, DOI DOI 10.1128/MCB.00037-18
   Attene-Ramos MS, 2013, CHEM RES TOXICOL, V26, P1323, DOI 10.1021/tx4001754
   Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Barchiesi A, 2015, NUCLEIC ACIDS RES, V43, P5451, DOI 10.1093/nar/gkv433
   Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2
   Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008
   Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6
   Birch-Machin MA, 2010, MUTAGENESIS, V25, P101, DOI 10.1093/mutage/gep061
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544
   Canbay E, 2010, ANTICANCER RES, V30, P1359
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Carew Jennifer S, 2002, MOL CANCER, V1, P9, DOI 10.1186/1476-4598-1-9
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107
   Chen L, 2006, J UROLOGY, V175, P108, DOI 10.1016/S0022-5347(05)00042-X
   Chen M, 2011, INVEST OPHTH VIS SCI, V52, P7027, DOI 10.1167/iovs.11-7524
   Chen SM, 2013, CANCER BIOTHER RADIO, V28, P169, DOI 10.1089/cbr.2012.1266
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012757
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Coffey G, 1999, NUCLEIC ACIDS RES, V27, P3348, DOI 10.1093/nar/27.16.3348
   Dahal S, 2018, CELL MOL LIFE SCI, V75, P1641, DOI 10.1007/s00018-017-2702-y
   Dai Ji Gang, 2006, INDIAN J CANCER, V43, P20
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021
   Degli Esposti M, 2014, GENOME BIOL EVOL, V6, P3238, DOI 10.1093/gbe/evu257
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   Dmitrieva NI, 2011, AM J PHYSIOL-REG I, V301, PR632, DOI 10.1152/ajpregu.00853.2010
   Doublié S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101
   DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1
   GAaF MJ, 2003, MITOCHONDRIAL DNA DE, V0, P0
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   GOLDMANN A, 1990, ROENTGEN-BLAETTER, V43, P345
   Grasso S, 2014, DNA REPAIR, V21, P148, DOI 10.1016/j.dnarep.2014.05.006
   Gray MW, 2001, GENOME BIOL, V2, P0
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Gredilla Ricardo, 2010, J AGING RES, V2011, P257093, DOI 10.4061/2011/257093
   Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017
   Groothuizen FS, 2016, DNA REPAIR, V38, P14, DOI 10.1016/j.dnarep.2015.11.012
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942
   Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200
   Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jain S, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005976
   Javadekar SM, 2015, FEBS J, V282, P2627, DOI 10.1111/febs.13311
   Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   Kamalidehghan B, 2006, ARCH MED RES, V37, P730, DOI 10.1016/j.arcmed.2006.02.005
   Kamenisch Y, 2010, J EXP MED, V207, P379, DOI 10.1084/jem.20091834
   Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057
   Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014
   KELLY JL, 1986, J BIOL CHEM, V261, P340
   Kim JJ, 2019, CRIT REV BIOCHEM MOL, V54, P208, DOI 10.1080/10409238.2019.1620676
   Kim Yun-Jeong, 2012, CURR MOL PHARMACOL, V5, P3
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012583
   Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365
   Krwawicz J, 2007, ACTA BIOCHIM POL, V54, P413, DOI 10.18388/abp.2007_3219
   Kuznetsov NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P118, DOI 10.1134/S0006297911010123
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029
   LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lee HM, 2002, J NEUROCHEM, V80, P928, DOI 10.1046/j.0022-3042.2002.00774.x
   Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042
   Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115
   Li MX, 2008, FREE RADICAL BIO MED, V45, P592, DOI 10.1016/j.freeradbiomed.2008.05.007
   Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492
   Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1
   Li Y, 2013, MED ONCOL, V30, P0, DOI 10.1007/s12032-013-0505-z
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649
   LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425
   LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Liu VWS, 2001, CANCER RES, V61, P5998
   Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345
   Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1
   Mandal SM, 2012, J BIOL CHEM, V287, P2819, DOI 10.1074/jbc.M111.272179
   Manjunath M, 2021, CANCER REP-US, V4, P0, DOI 10.1002/cnr2.1341
   Marinc M, 2012, ECONOMICS OF BANK BANKRUPTCY LAW, V0, PP5, DOI 10.1128/ecosalplus.7.2.5
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046
   Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167
   Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200
   McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Meyer A, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00536
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495
   Moore DH, 2000, CLIN CANCER RES, V6, P602
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Morrical SW, 2015, CSH PERSPECT BIOL, V7, P0, DOI 10.1101/cshperspect.a016444
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019
   Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249
   Pandey M, 2017, JOURNAL OF RADIATION AND CANCER RESEARCH, V8, P93, DOI 10.4103/jrcr.jrcr_18_17
   Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9
   PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113
   Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Pohjoismäki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Raghavan SC, 2004, CELL CYCLE, V3, P762
   Ray U, 2020, ONCOGENE, V39, P6393, DOI 10.1038/s41388-020-01445-2
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROBBERSODL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Schärer OD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012609
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Sharma S, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.58
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Sia EA, 2000, P NATL ACAD SCI USA, V97, P250, DOI 10.1073/pnas.97.1.250
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579
   Srivastava M, 2015, CHEM BIOL, V22, P17, DOI 10.1016/j.chembiol.2014.11.013
   Srivastava N, 2007, CELL BIOCHEM FUNCT, V25, P75, DOI 10.1002/cbf.1375
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712
   Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128
   Subramani S, 2002, J CELL BIOL, V156, P415, DOI 10.1083/jcb.200112122
   Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tekel A, 2008, IN VIVO, V22, P477
   Tell G, 2002, HORM METAB RES, V34, P303, DOI 10.1055/s-2002-33258
   Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Trevors JT, 1997, ANTON LEEUW INT J G, V71, P257, DOI 10.1023/A:1000175217677
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1794, DOI 10.1016/j.bbamcr.2006.08.013
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030
   Wang D, 2004, MOL CANCER THER, V3, P679
   Wang MM, 2013, AM J OBSTET GYNECOL, V209, P0, DOI 10.1016/j.ajog.2013.07.010
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3
   WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919
   Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yang XD, 2001, EUR J CELL BIOL, V80, P126, DOI 10.1078/0171-9335-00144
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yu ZL, 2016, SEMIN CELL DEV BIOL, V54, P106, DOI 10.1016/j.semcdb.2016.03.014
   Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang YC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0128624
   Zhao YB, 2005, WORLD J GASTROENTERO, V11, P3304, DOI 10.3748/wjg.v11.i21.3304
   Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2
NR 200
TC 8
Z9 10
U1 0
U2 25
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD MAR 15
PY 2021
VL 478
IS 6
BP 1179
EP 1197
DI 10.1042/BCJ20200920
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA RA1LO
UT WOS:000631179600001
PM 33740046
DA 2024-11-01
ER

PT J
AU Baty, K
   Farrugia, ME
   Hopton, S
   Falkous, G
   Schaefer, AM
   Stewart, W
   Willison, HJ
   Reilly, MM
   Blakely, EL
   Taylor, RW
   Ng, YS
AF Baty, Karen
   Farrugia, Maria E.
   Hopton, Sila
   Falkous, Gavin
   Schaefer, Andrew M.
   Stewart, William
   Willison, Hugh J.
   Reilly, Mary M.
   Blakely, Emma L.
   Taylor, Robert W.
   Ng, Yi Shiau
TI A novel MT-CO2 variant causing cerebellar ataxia and neuropathy: The role of muscle biopsy in diagnosis and defining pathogenicity
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA; Muscle biopsy; Segregation study
ID mitochondrial-dna mutations; myopathy; patient
AB Pathogenic variants in mitochondrial DNA (mtDNA) are associated with significant clinical heterogeneity with neuromuscular involvement commonly reported. Non-syndromic presentations of mtDNA disease continue to pose a diagnostic challenge and with genomic testing still necessitating a muscle biopsy in many cases. Here we describe an adult patient who presented with progressive ataxia, neuropathy and exercise intolerance in whom the application of numerous Mendelian gene panels had failed to make a genetic diagnosis. Muscle biopsy revealed characteristic mitochondrial pathology (cytochrome c oxidase deficient, ragged-red fibers) prompting a thorough investigation of the mitochondrial genome. Two heteroplasmic MT-CO2 gene variants (NC_012920.1: m.7887G > A and m.8250G > A) were identified, necessitating single fiber segregation and familial studies - including the biopsy of the patient's clinically-unaffected mother - to demonstrate pathogenicity of the novel m.7887G > A p.(Gly101Asp) variant and establishing this as the cause of the mitochondrial biochemical defects and clinical presentation. In the era of high throughput whole exome and genome sequencing, muscle biopsy remains a key investigation in the diagnosis of patients with non-syndromic presentations of adult-onset mitochondrial disease and fully defining the pathogenicity of novel mtDNA variants. (c) 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
C1 [Baty, Karen; Hopton, Sila; Falkous, Gavin; Schaefer, Andrew M.; Blakely, Emma L.; Taylor, Robert W.; Ng, Yi Shiau] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Baty, Karen; Hopton, Sila; Falkous, Gavin; Schaefer, Andrew M.; Blakely, Emma L.; Taylor, Robert W.; Ng, Yi Shiau] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Farrugia, Maria E.] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland.
   [Schaefer, Andrew M.; Ng, Yi Shiau] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Directorate Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland.
   [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland.
   [Willison, Hugh J.] Univ Glasgow, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland.
   [Willison, Hugh J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G51 4TF, Lanark, Scotland.
   [Reilly, Mary M.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Queen Elizabeth University Hospital (QEUH); University of Glasgow; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Queen Elizabeth University Hospital (QEUH); University of Glasgow; University of Glasgow; University of Glasgow; University of London; University College London
RP Ng, YS (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM yi.ng@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; UK NHS Specialist Commissioners; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; MRC/EPSRC Molecular Pathology Node; NIHR Clinical Lectureship in Neurology [CL-2016-01-003]; NHS Research Scotland; Medical Research Council [MRC MR/S005021/1]; National Institutes of Neurological Diseases and Stroke; office of Rare Diseases [U54NS065712];  [MDA510281]; MRC [MR/K000608/1, MR/S005021/1] Funding Source: UKRI
CR Bacalhau M, 2018, NEUROMUSCULAR DISORD, V28, P350, DOI 10.1016/j.nmd.2017.11.006
   Bargiela David, 2015, CEREBELLUM ATAXIAS, V2, P16, DOI 10.1186/s40673-015-0035-x
   Beaudin M, 2019, CEREBELLUM, V18, P1098, DOI 10.1007/s12311-019-01052-2
   Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   de Silva RN, 2019, PRACT NEUROL, V19, P196, DOI 10.1136/practneurol-2018-002096
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Melberg A, 2009, EUR J MED GENET, V52, P47, DOI 10.1016/j.ejmg.2008.10.004
   Meulemans A, 2007, ARCH NEUROL-CHICAGO, V64, P1339, DOI 10.1001/archneur.64.9.1339
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Ng YS, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00024
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Renaud M, 2017, ANN NEUROL, V82, P892, DOI 10.1002/ana.25084
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossi M, 2018, MOVEMENT DISORD, V33, P1056, DOI 10.1002/mds.27415
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Swalwell H, 2008, EUR J HUM GENET, V16, P1265, DOI 10.1038/ejhg.2008.65
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Wong LJC, 2020, GENET MED, V0, P0, DOI DOI 10.1038/s41436-019-0746-0
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 35
TC 3
Z9 3
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV 15
PY 2021
VL 31
IS 11
BP 1186
EP 1193
DI 10.1016/j.nmd.2021.05.014
EA DEC 2021
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA XQ1EZ
UT WOS:000731297600010
PM 34325999
DA 2024-11-01
ER

PT J
AU McCastlain, K
   Howell, CR
   Welsh, CE
   Wang, ZM
   Wilson, CL
   Mulder, HL
   Easton, J
   Mertens, AC
   Zhang, JH
   Yasui, Y
   Hudson, MM
   Robison, LL
   Kundu, M
   Ness, KK
AF McCastlain, Kelly
   Howell, Carrie R.
   Welsh, Catherine E.
   Wang, Zhaoming
   Wilson, Carmen L.
   Mulder, Heather L.
   Easton, John
   Mertens, Ann C.
   Zhang, Jinghui
   Yasui, Yutaka
   Hudson, Melissa M.
   Robison, Leslie L.
   Kundu, Mondira
   Ness, Kirsten K.
TI The Association of Mitochondrial Copy Number With Sarcopenia in Adult Survivors of Childhood Cancer
SO JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
LA English
DT Article
ID skeletal-muscle; peripheral-blood; oxidative stress; molecular-mechanisms; read alignment; dna mutations; stem-cells; frailty; dysfunction; mass
AB Background: Adult childhood cancer survivors are at risk for frailty, including low muscle mass and weakness (sarcopenia). Using peripheral blood mitochondrial DNA copy number (mtDNAcn) as a proxy for functional mitochondria, this study describes cross-sectional associations between mtDNAcn and sarcopenia among survivors. Methods: Among 1762 adult childhood cancer survivors (51.6% male; median age = 29.4 years, interquartile range [IQR] = 23.3-36.8), with a median of 20.6 years from diagnosis (IQR = 15.2-28.2), mtDNAcn estimates were derived from whole-genome sequencing. A subset was validated by quantitative polymerase chain reaction and evaluated cross-sectionally using multivariable logistic regression for their association with sarcopenia, defined by race-, age-, and sex-specific low lean muscle mass or weak grip strength. All statistical tests were 2-sided. Results: The prevalence of sarcopenia was 27.0%, higher among female than male survivors (31.5% vs 22.9%; P < .001) and associated with age at diagnosis; 51.7% of survivors with sarcopenia were diagnosed ages 4-13 years (P = .01). Sarcopenia was most prevalent (39.0%) among central nervous system tumor survivors. Cranial radiation (odds ratio [OR] = 1.84, 95% confidence interval [CI] = 1.32 to 2.59) and alkylating agents (OR = 1.34, 95% CI = 1.04 to 1.72) increased, whereas glucocorticoids decreased odds (OR = 0.72, 95% CI = 0.56 to 0.93) of sarcopenia. mtDNAcn decreased with age (beta = -0.81, P = .002) and was higher among female survivors (beta = 9.23, P = .01) and among survivors with a C allele at mt.204 (beta = -17.9, P = .02). In adjusted models, every standard deviation decrease in mtDNAcn increased the odds of sarcopenia 20% (OR = 1.20, 95% CI = 1.07 to 1.34). Conclusions: A growing body of evidence supports peripheral blood mtDNAcn as a biomarker for adverse health outcomes; however, this study is the first to report an association between mtDNAcn and sarcopenia among childhood cancer survivors.
C1 [McCastlain, Kelly; Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA.
   [Howell, Carrie R.] Univ Alabama Birmingham, Dept Prevent Med, Birmingham, AL USA.
   [Welsh, Catherine E.] Rhodes Coll, Dept Math & Comp Sci, Memphis, TN 38112 USA.
   [Wang, Zhaoming; Mulder, Heather L.; Easton, John; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA.
   [Wang, Zhaoming; Wilson, Carmen L.; Yasui, Yutaka; Hudson, Melissa M.; Robison, Leslie L.; Ness, Kirsten K.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS 735, Memphis, TN 38105 USA.
   [Mertens, Ann C.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA.
   [Mertens, Ann C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.
C3 St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Children's Healthcare of Atlanta (CHOA); Emory University
RP Ness, KK (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS 735, Memphis, TN 38105 USA.
EM kiri.ness@stjude.org
FU National Cancer Institute at the National Institutes of Health [CA174851, CA195547, CA21765, GM132231]; American Lebanese Syrian Associated Charities; National Cancer Institute [U01CA195547] Funding Source: NIH RePORTER
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antipova VN, 2018, INT J RADIAT BIOL, V94, P282, DOI 10.1080/09553002.2018.1419299
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Barjaktarovic Z, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027811
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a008342
   Boland AM, 2016, PHYS THER, V96, P1029, DOI 10.2522/ptj.20150507
   Braun TP, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00012
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116
   Center for Mitochondrial & Epigenomic Medicine Childrens Hospital of Philadelphia, 2018, MITOMAP HUM MIT GEN, V0, P0
   Chen Y, 2007, MOL INTERV, V7, P147, DOI 10.1124/mi.7.3.6
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Crouch ML, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0181086
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013
   Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Fried LP, 2001, J GERONTOL A-BIOL, V56, PM146, DOI 10.1093/gerona/56.3.M146
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   Gawade PL, 2014, CURR PEDIATR REV, V10, P249, DOI 10.2174/1573400510666141114223827
   Gouspillou G, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep08717
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Howlader N, 2017, NATL CANC I SURVEILL, V0, P0
   Hudson MM, 2015, J CLIN ONCOL, V33, P479, DOI 10.1200/JCO.2014.57.4863
   Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875
   Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12
   Kelly TL, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007038
   Klein Gordon L, 2015, OSTEOPOROS SARCOPENIA, V1, P39, DOI 10.1016/j.afos.2015.07.008
   Knez J, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0181036
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuznetsova T, 2017, ADV EXP MED BIOL, V982, P347, DOI 10.1007/978-3-319-55330-6_19
   Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863
   LEXELL J, 1992, MUSCLE NERVE, V15, P404, DOI 10.1002/mus.880150323
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121
   Liu X, 2019, MOL PHARMACOL, V96, P408, DOI 10.1124/mol.119.116806
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001
   MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69
   MATHIOWETZ V, 1985, J HAND SURG-AM, V10A, P694, DOI 10.1016/S0363-5023(85)80210-0
   Meacham LR, 2005, CANCER-AM CANCER SOC, V103, P1730, DOI 10.1002/cncr.20960
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5
   Mkaouar-Rebai E, 2016, BIOCHEM BIOPH RES CO, V473, P578, DOI 10.1016/j.bbrc.2016.03.126
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moore AZ, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011069
   National Center for Biotechnology Information US National Library of Medicine. NCBI, 2018, DNA RNA, V0, P0
   Ness KK, 2007, PEDIATR BLOOD CANCER, V49, P975, DOI 10.1002/pbc.21091
   Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Noda A, 2018, J RADIAT RES, V59, P0, DOI 10.1093/jrr/rrx074
   Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006
   Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Porter C, 2012, J PHYSIOL-LONDON, V590, P5935, DOI 10.1113/jphysiol.2012.241083
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, P0, DOI 10.3389/fphar.2013.00049
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh AN, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-0977-6
   Sorensen JC, 2016, CANCER CHEMOTH PHARM, V78, P673, DOI 10.1007/s00280-016-3045-3
   Sousa-Victor P, 2016, MOL ASPECTS MED, V50, P109, DOI 10.1016/j.mam.2016.02.002
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trajanoska K, 2018, J BONE MINER RES, V33, P1209, DOI 10.1002/jbmr.3416
   Uhlen M, 2015, SCIENCE, V347, P0, DOI 10.1126/science.1260419
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van Brussel Marco, 2006, PEDIATR REHABIL, V9, P267, DOI 10.1080/13638490500523150
   Venegas Victor, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1907s68
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Wright Jacqueline D, 2010, NCHS DATA BRIEF, V0, P1
   Xia CY, 2017, CHINESE MED J-PEKING, V130, P2435, DOI 10.4103/0366-6999.216395
   Zhang L, 2017, INT J BIOL SCI, V13, P1152, DOI 10.7150/ijbs.20132
   Zillikens MC, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00031-7
   Zou H, 2005, J R STAT SOC B, V67, P768, DOI 10.1111/j.1467-9868.2005.00527.x
NR 88
TC 9
Z9 9
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0027-8874
EI 1460-2105
J9 JNCI-J NATL CANCER I
JI JNCI-J. Natl. Cancer Inst.
PD NOV 15
PY 2021
VL 113
IS 11
BP 1570
EP 1580
DI 10.1093/jnci/djab084
EA APR 2021
PG 11
WC Oncology
SC Oncology
GA YJ4PY
UT WOS:000744517000020
PM 33871611
DA 2024-11-01
ER

PT J
AU Imai-Okazaki, A
   Yagi, N
   Nitta, KR
   Murayama, K
   Ohtake, A
   Okazaki, Y
AF Imai-Okazaki, Atsuko
   Yagi, Nobuyasu
   Nitta, Kazuhiro R.
   Murayama, Kei
   Ohtake, Akira
   Okazaki, Yasushi
TI Clinical heterogeneity in patients with m.4412G &gt; A MT-TM mutation and different heteroplasmy levels
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA; Mitochondrial respiratory chain complex deficiencies; Mitochondrial tRNA; Clinical heterogeneity
AB The identification of the m.4412G > A MT-TM (mt-tRNA(Met)) mutation was first reported in 2019. The affected individual presented with childhood-onset seizures and myopathy and bilateral basal ganglia changes, with heteroplasmy levels in muscle as high as 90%. Here, we describe another adult-onset patient with the same mutation and additional phenotypes, including hearing impairment, cerebellar ataxia, progressive dementia, and myopathy. The 10% heteroplasmy level observed in skin fibroblasts from this patient are lower than those in the previously reported patient. Our report suggests possible clinical heterogeneity in patients with mitochondrial tRNA mutations based on heteroplasmy levels.
C1 [Imai-Okazaki, Atsuko; Nitta, Kazuhiro R.; Okazaki, Yasushi] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Diagnost & Therapeut Intractable Dis, Tokyo, Japan.
   [Yagi, Nobuyasu] Japanese Red Cross Shizuoka Hosp, Dept Neurol, Shizuoka, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan.
   [Ohtake, Akira] Saitama Med Univ, Dept Pediat & Clin Genom, Saitama, Japan.
   [Ohtake, Akira] Saitama Med Univ Hosp, Ctr Intractable Dis, Saitama, Japan.
   [Okazaki, Yasushi] RIKEN Ctr Integrat Med Sci, Lab Comprehens Genom Anal, Yokohama, Kanagawa, Japan.
C3 Juntendo University; Chiba Children's Hospital; Saitama Medical University; Saitama Medical University; RIKEN
RP Okazaki, Y (corresponding author), Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.
EM ya-okazaki@juntendo.ac.jp
FU JSPS KAKENHI [JP20K08497, JP18K15863]; MEXT-Supported Program for the Private University Research Branding Project; Japan Agency for Medical Research and Development, AMED [JP20ek0109468, JP19ek0109273, 20kk0305015h0001]; Grants-in-Aid for Scientific Research [20K08497] Funding Source: KAKEN
CR GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lim AZ, 2019, MITOCHONDRION, V47, P18, DOI 10.1016/j.mito.2019.04.007
   Russell OM, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20064-2
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2021
VL 59
IS 
BP 214
EP 215
DI 10.1016/j.mito.2021.06.001
EA JUN 2021
PG 2
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA TM4BQ
UT WOS:000675496600009
PM 34089906
DA 2024-11-01
ER

PT J
AU Hedberg-Oldfors, C
   Lindgren, U
   Basu, S
   Visuttijai, K
   Lindberg, C
   Falkenberg, M
   Lekholm, EL
   Oldfors, A
AF Hedberg-Oldfors, Carola
   Lindgren, Ulrika
   Basu, Swaraj
   Visuttijai, Kittichate
   Lindberg, Christopher
   Falkenberg, Maria
   Larsson Lekholm, Erik
   Oldfors, Anders
TI Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing
SO BRAIN PATHOLOGY
LA English
DT Article
DE inclusion body myositis; muscle disease; mitochondrial DNA; mtDNA deletions; mtDNA duplications; mtDNA rearrangements; mtDNA point mutations
ID replication machinery; point mutations; muscle; age; deletions; abnormality; inflammation
AB Muscle pathology in inclusion body myositis (IBM) typically includes inflammatory cell infiltration, muscle fibers with rimmed vacuoles and cytochrome c oxidase (COX)-deficient fibers. Previous studies have revealed clonal expansion of large mitochondrial DNA (mtDNA) deletions in the COX-deficient muscle fibers. Technical limitations have prevented complete investigations of the mtDNA deletions and other mtDNA variants. Detailed characterization by deep sequencing of mtDNA in muscle samples from 21 IBM patients and 10 age-matched controls was performed after whole genome sequencing with a mean depth of mtDNA coverage of 46,000x. Multiple large mtDNA deletions and duplications were identified in all IBM and control muscle samples. In general, the IBM muscles demonstrated a larger number of deletions and duplications with a mean heteroplasmy level of 10% (range 1%-35%) compared to controls (1%, range 0.2%-3%). There was also a small increase in the number of somatic single nucleotide variants in IBM muscle. More than 200 rearrangements were recurrent in at least two or more IBM muscles while 26 were found in both IBM and control muscles. The deletions and duplications, with a high recurrence rate, were mainly observed in three mtDNA regions, m.534-4429, m.6330-13993, and m.8636-16072, where some were flanked by repetitive sequences. The mtDNA copy number in IBM muscle was reduced to 42% of controls. Immunohistochemical and western blot analyses of IBM muscle revealed combined complex I and complex IV deficiency affecting the COX-deficient fibers. In conclusion, deep sequencing and quantitation of mtDNA variants revealed that IBM muscles had markedly increased levels of large deletions and duplications, and there were also indications of increased somatic single nucleotide variants and reduced mtDNA copy numbers compared to age-matched controls. The distribution and type of variants were similar in IBM muscle and controls indicating an accelerated aging process in IBM muscle, possibly associated with chronic inflammation.
C1 [Hedberg-Oldfors, Carola; Lindgren, Ulrika; Visuttijai, Kittichate; Oldfors, Anders] Univ Gothenburg, Dept Lab Med, Gothenburg, Sweden.
   [Lindgren, Ulrika; Lindberg, Christopher] Sahlgrens Univ Hosp, Dept Neurol, Neuromuscular Ctr, Gothenburg, Sweden.
   [Basu, Swaraj; Falkenberg, Maria; Larsson Lekholm, Erik] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
C3 University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg
RP Oldfors, A (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Lab Med, Gula Straket 8, S-41345 Gothenburg, Sweden.
EM anders.oldfors@gu.se
CR Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39
   Carpenter S, 1975, RECENT ADV MYOLOGY, V0, P374
   Catalán-García M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dahlbom K, 2019, ACTA NEUROL SCAND, V139, P177, DOI 10.1111/ane.13040
   De Paepe B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9010015
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fülöp T, 2019, GERONTOLOGY, V65, P495, DOI 10.1159/000497375
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Gupta S, 2018, RHEUM DIS CLIN N AM, V44, P393, DOI 10.1016/j.rdc.2018.03.001
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000391
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   LINDBERG C, 1994, ACTA NEUROL SCAND, V89, P123
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Maiuri AR, 2018, CANCER METAB, V6, P0, DOI 10.1186/s40170-018-0182-7
   Mastaglia FL, 2015, J CLIN NEUROSCI, V22, P6, DOI 10.1016/j.jocn.2014.09.012
   Molnar M, 1998, ACTA NEUROPATHOL, V96, P41, DOI 10.1007/s004010050858
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oldfors, 2021, MUSCLE BIOPSY PRACTI, V0, P0
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Piber D, 2019, J GERONTOL A-BIOL, V74, P1716, DOI 10.1093/gerona/glz130
   Picca A, 2018, BIOL CHEM, V399, P421, DOI 10.1515/hsz-2017-0331
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Riuzzi F, 2018, J CACHEXIA SARCOPENI, V9, P1255, DOI 10.1002/jcsm.12363
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 40
TC 20
Z9 21
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD MAY 15
PY 2021
VL 31
IS 3
BP 
EP 
DI 10.1111/bpa.12931
PG 12
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA SI9AO
UT WOS:000655121800015
PM 33354847
DA 2024-11-01
ER

PT J
AU Engvall, M
   Kawasaki, A
   Carelli, V
   Wibom, R
   Bruhn, H
   Lesko, N
   Schober, FA
   Wredenberg, A
   Wedell, A
   Träisk, F
AF Engvall, Martin
   Kawasaki, Aki
   Carelli, Valerio
   Wibom, Rolf
   Bruhn, Helene
   Lesko, Nicole
   Schober, Florian A.
   Wredenberg, Anna
   Wedell, Anna
   Traisk, Frank
TI Case Report: A Novel Mutation in the Mitochondrial <i>MT-ND5</i> Gene Is Associated With Leber Hereditary Optic Neuropathy (LHON)
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE leber hereditary optic neuropathy; optic neuropathy; MT-ND5; mitochondrial DNA; case report; complex 1; LHON
AB Leber hereditary optic neuropathy (LHON) is a mitochondrial disease causing severe bilateral visual loss, typically in young adults. The disorder is commonly caused by one of three primary point mutations in mitochondrial DNA, but a number of other rare mutations causing or associated with the clinical syndrome of LHON have been reported. The mutations in LHON are almost exclusively located in genes encoding subunits of complex I in the mitochondrial respiratory chain. Here we report two patients, a mother and her son, with the typical LHON phenotype. Genetic investigations for the three common mutations were negative, instead we found a new and previously unreported mutation in mitochondrial DNA. This homoplasmic mutation, m.13345G>A, is located in the MT-ND5 gene, encoding a core subunit in complex I in the mitochondrial respiratory chain. Investigation of the patients mitochondrial respiratory chain in muscle found a mild defect in the combined activity of complex I+III. In the literature six other mutations in the MT-ND5 gene have been associated with LHON and by this report a new putative mutation in the MT-ND5 can be added.
C1 [Engvall, Martin; Lesko, Nicole; Schober, Florian A.; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Engvall, Martin; Wibom, Rolf; Bruhn, Helene; Lesko, Nicole; Wredenberg, Anna; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Kawasaki, Aki] Univ Lausanne, Hop Ophtalm Jules Gonin, Fdn Asile Aveugles, Lausanne, Switzerland.
   [Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Bologna, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Wibom, Rolf; Bruhn, Helene; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Traisk, Frank] Karolinska Inst, St Erik Eye Hosp, Div Eye & Vis, Dept Clin Neurosci, Solna, Sweden.
   [Traisk, Frank] St Erik Eye Hosp, Dept Neuroophthalmol, Solna, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Lausanne; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; Karolinska Institutet; Karolinska Institutet
RP Träisk, F (corresponding author), Karolinska Inst, St Erik Eye Hosp, Div Eye & Vis, Dept Clin Neurosci, Solna, Sweden.; Träisk, F (corresponding author), St Erik Eye Hosp, Dept Neuroophthalmol, Solna, Sweden.
EM frank.traisk@sll.se
FU Swedish patient organisation LHON Eye Society
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   [Anonymous], 2018, MITOMAP HUMAN MITOCH, V0, P0
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Bolze A, 2020, BIORXIV, V0, P0, DOI DOI 10.1101/798264
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   La Morgia C, 2014, FRONT NEUROL, V5, P0, DOI 10.3389/fneur.2014.00141
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ponzoni L, 2020, BIOINFORMATICS, V36, P3084, DOI 10.1093/bioinformatics/btaa127
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Rosenberg T, 2016, INVEST OPHTH VIS SCI, V57, P1370, DOI 10.1167/iovs.15-18306
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sim NL, 2012, NUCLEIC ACIDS RES, V40, PW452, DOI 10.1093/nar/gks539
   Stranneheim H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1090
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
NR 31
TC 4
Z9 4
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD MAR 25
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fneur.2021.652590
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA RJ6TZ
UT WOS:000637734400001
PM 33841319
DA 2024-11-01
ER

PT J
AU Barbosa-Gouveia, S
   Vazquez-Mosquera, ME
   Gonzalez-Vioque, E
   Hermida-Ameijeiras, A
   Valverde, LL
   Armstrong-Moron, J
   Fons-Estupina, MD
   Wintjes, LT
   Kappen, A
   Rodenburg, RJ
   Couce, ML
AF Barbosa-Gouveia, Sofia
   Vazquez-Mosquera, Maria E.
   Gonzalez-Vioque, Emiliano
   Hermida-Ameijeiras, Alvaro
   Valverde, Laura L.
   Armstrong-Moron, Judith
   Fons-Estupina, Maria del Carmen
   Wintjes, Liesbeth T.
   Kappen, Antonia
   Rodenburg, Richard J.
   Couce, Maria L.
TI Characterization of a Novel Splicing Variant in Acylglycerol Kinase (AGK) Associated with Fatal Sengers Syndrome
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE acylglycerol kinase; mitochondrial dysfunction; mitochondrial ATP generation; oxidative phosphorylation machinery; Sengers syndrome
ID mitochondrial myopathy; congenital cataract; heart; cardiolipin; acid; metabolism; skeletal; subunit; muscle; gene
AB Mitochondrial functional integrity depends on protein and lipid homeostasis in the mitochondrial membranes and disturbances in their accumulation can cause disease. AGK, a mitochondrial acylglycerol kinase, is not only involved in lipid signaling but is also a component of the TIM22 complex in the inner mitochondrial membrane, which mediates the import of a subset of membrane proteins. AGK mutations can alter both phospholipid metabolism and mitochondrial protein biogenesis, contributing to the pathogenesis of Sengers syndrome. We describe the case of an infant carrying a novel homozygous AGK variant, c.518+1G>A, who was born with congenital cataracts, pielic ectasia, critical congenital dilated myocardiopathy, and hyperlactacidemia and died 20 h after birth. Using the patient's DNA, we performed targeted sequencing of 314 nuclear genes encoding respiratory chain complex subunits and proteins implicated in mitochondrial oxidative phosphorylation (OXPHOS). A decrease of 96-bp in the length of the AGK cDNA sequence was detected. Decreases in the oxygen consumption rate (OCR) and the OCR:ECAR (extracellular acidification rate) ratio in the patient's fibroblasts indicated reduced electron flow through the respiratory chain, and spectrophotometry revealed decreased activity of OXPHOS complexes I and V. We demonstrate a clear defect in mitochondrial function in the patient's fibroblasts and describe the possible molecular mechanism underlying the pathogenicity of this novel AGK variant. Experimental validation using in vitro analysis allowed an accurate characterization of the disease-causing variant.
C1 [Barbosa-Gouveia, Sofia; Vazquez-Mosquera, Maria E.; Hermida-Ameijeiras, Alvaro; Valverde, Laura L.; Couce, Maria L.] Santiago de Compostela Univ Clin Hosp, Unit Diag & Treatment Congenital Metab Dis, Dept Paediat, Santiago De Compostela 15706, Spain.
   [Barbosa-Gouveia, Sofia; Vazquez-Mosquera, Maria E.; Hermida-Ameijeiras, Alvaro; Valverde, Laura L.; Couce, Maria L.] Santiago de Compostela Univ Clin Hosp, Rare Dis Networking Biomed Res Ctr CIBERER, IDIS Hlth Res Inst Santiago de Compostela, European Reference Network Hereditary Metab Disor, Santiago De Compostela 15706, Spain.
   [Gonzalez-Vioque, Emiliano] Puerta de Hierro Majadahonda Univ Hosp, Clin Biochem Serv, Majadahonda 28222, Spain.
   [Armstrong-Moron, Judith] Hosp St Joan de Deu, Clin Genet Mol & Genet Med Sect, Esplugas de Llobregat 08950, Spain.
   [Armstrong-Moron, Judith] Inst Recerca St Joan de Deu, Esplugas de Llobregat 08950, Spain.
   [Armstrong-Moron, Judith; Fons-Estupina, Maria del Carmen] Inst Salud Carlos III ISCIII, CIBER ER Biomed Network Res Ctr Rare Dis, Madrid 28029, Spain.
   [Fons-Estupina, Maria del Carmen] St Joan de Deu Univ Hosp, Pediat Neurol Dept, Inst Recerca St Joan de Deu, Barcelona 08950, Spain.
   [Wintjes, Liesbeth T.; Kappen, Antonia] Radboud Univ Nijmegen Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, NL-6525 GA Nijmegen, Netherlands.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Radboud University Nijmegen; Radboud University Nijmegen
RP Barbosa-Gouveia, S; Couce, ML (corresponding author), Santiago de Compostela Univ Clin Hosp, Unit Diag & Treatment Congenital Metab Dis, Dept Paediat, Santiago De Compostela 15706, Spain.; Barbosa-Gouveia, S; Couce, ML (corresponding author), Santiago de Compostela Univ Clin Hosp, Rare Dis Networking Biomed Res Ctr CIBERER, IDIS Hlth Res Inst Santiago de Compostela, European Reference Network Hereditary Metab Disor, Santiago De Compostela 15706, Spain.
EM sofiabsg@gmail.com; maria.eugenia.vazquez.mosquera@sergas.es; egvioque@gmail.com; alvaro.hermida@usc.es; laura261lv@gmail.com; jarmstrong@sjdhospitalbarcelona.org; cfons@sjdhospitalbarcelona.org; liesbeth.Wintjes@radboudumc.nl; antonia.vanheck-kappen@radboudumc.nl; richard.rodenburg@radboudumc.nl; maria.luz.couce.pico@sergas.es
CR Abramowicz A, 2018, J APPL GENET, V59, P253, DOI 10.1007/s13353-018-0444-7
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Anderson AJ, 2019, OPEN BIOL, V9, P0, DOI 10.1098/rsob.190126
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Camacho C, 2009, BMC BIOINFORMATICS, V10, P0, DOI 10.1186/1471-2105-10-421
   Chu BX, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.659158
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-23
   Cowell CF, 2009, J CELL SCI, V122, P919, DOI 10.1242/jcs.041061
   Desmet FO, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkp215
   Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113
   Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Hu ZL, 2019, CELL METAB, V30, P290, DOI 10.1016/j.cmet.2019.05.016
   Jackson TD, 2021, MOL BIOL CELL, V32, P475, DOI 10.1091/mbc.E20-06-0390
   Jiang HJ, 2020, BLOOD, V136, P119, DOI 10.1182/blood.2019003851
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011
   Kang YL, 2018, SEMIN CELL DEV BIOL, V76, P142, DOI 10.1016/j.semcdb.2017.07.028
   Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014
   Kerkhofs M, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0179-0
   Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400
   Le CH, 2014, CIRC-HEART FAIL, V7, P172, DOI 10.1161/CIRCHEARTFAILURE.113.000744
   Lu YW, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00003
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Picard M, 2018, FRONT NEUROENDOCRIN, V49, P72, DOI 10.1016/j.yfrne.2018.01.001
   Qi LB, 2021, CELL RES, V31, P369, DOI 10.1038/s41422-020-00400-w
   Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945
   REIBEL DK, 1986, AM J PHYSIOL, V250, PH1, DOI 10.1152/ajpheart.1986.250.1.H1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Shen ZN, 2015, BIOMED RES INT-UK, V2015, P0, DOI 10.1155/2015/891707
   Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200
   Srere PA, 1969, METHODS IN ENZYMOLOGY, V13, P3
   Steinegger M, 2019, BMC BIOINFORMATICS, V20, P0, DOI 10.1186/s12859-019-3019-7
   Stojanovski D, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011320
   Suzuki-Hatano S, 2019, HUM GENE THER, V30, P139, DOI 10.1089/hum.2018.020
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013
NR 42
TC 7
Z9 8
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC 15
PY 2021
VL 22
IS 24
BP 
EP 
DI 10.3390/ijms222413484
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA YJ6VL
UT WOS:000744669700001
PM 34948281
DA 2024-11-01
ER

PT J
AU Hoffmann, J
   Richardson, G
   Haendeler, J
   Altschmied, J
   Andrés, V
   Spyridopoulos, I
AF Hoffmann, Jedrzej
   Richardson, Gavin
   Haendeler, Judith
   Altschmied, Joachim
   Andres, Vicente
   Spyridopoulos, Ioakim
TI Telomerase as a Therapeutic Target in Cardiovascular Disease
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Review
DE aging; atherosclerosis; cardiovascular diseases; oxidative stress; T-lymphocytes; telomerase; telomere
ID gilford progeria syndrome; coronary-artery-disease; smooth-muscle-cells; reverse-transcriptase; nuclear export; mitochondrial-dna; heart-disease; stem-cells; length; association
AB Shortened telomeres have been linked to numerous chronic diseases, most importantly coronary artery disease, but the underlying mechanisms remain ill defined. Loss-of-function mutations and deletions in telomerase both accelerate telomere shortening but do not necessarily lead to a clinical phenotype associated with atherosclerosis, questioning the causal role of telomere length in cardiac pathology. The differential extranuclear functions of the 2 main components of telomerase, telomerase reverse transcriptase and telomerase RNA component, offer important clues about the complex relationship between telomere length and cardiovascular pathology. In this review, we critically discuss relevant preclinical models, genetic disorders, and clinical studies to elucidate the impact of telomerase in cardiovascular disease and its potential role as a therapeutic target. We suggest that the antioxidative function of mitochondrial telomerase reverse transcriptase might be atheroprotective, making it a potential target for clinical trials.
C1 [Hoffmann, Jedrzej] Goethe Univ Hosp, Dept Med Cardiol, Frankfurt, Germany.
   [Richardson, Gavin] Newcastle Univ, Inst Biosci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Haendeler, Judith; Altschmied, Joachim] Med Fac, Inst Clin Chem & Aboratory Diagnost, Dusseldorf, Germany.
   [Haendeler, Judith; Altschmied, Joachim] Univ Hosp Duesseldorf, Dusseldorf, Germany.
   [Haendeler, Judith; Altschmied, Joachim] Heinrich Heine Univ Duesseldorf, Dusseldorf, Germany.
   [Altschmied, Joachim] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.
   [Andres, Vicente] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.
   [Andres, Vicente] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.
   [Spyridopoulos, Ioakim] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Spyridopoulos, Ioakim] Newcastle Upon Tyne Hosp Trust, Freeman Hosp, Cardiothorac Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Goethe University Frankfurt; Goethe University Frankfurt Hospital; Newcastle University - UK; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Newcastle University - UK; Northumbria University; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Freeman Hospital
RP Spyridopoulos, I (corresponding author), Newcastle Univ, Int Ctr Life, Translat & Clin Res Inst, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM ioakim.spyridopoulos@newcastle.ac.uk
FU Spanish Ministerio de Ciencia e Innovacion (MCIN) [PID2019-108489RB-I00]; Instituto de Salud Carlos III (ISCIII) [AC17/00067]; European Regional Development Fund (ERDF, "Una manera de hacer Europa"); Progeria Research Foundation [PRF 2019-77]; ISCIII; MCIN; Pro CNIC Foundation; British Heart Foundation [PG/18/25/33587]; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Deutsche Forschungsgemeinschaft (DFG) [SFB1116, HA2868/14-1, AL288/5-1]; TA-Science for the TACTIC trial (Telomerase Activator to Reverse Immunosenescence in Acute Coronary Syndrome); Newcastle University
CR Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
   Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Ait-Aissa K, 2018, AM J PHYSIOL-HEART C, V314, PH1053, DOI 10.1152/ajpheart.00472.2017
   Ali M, 2016, BIOCHEM BIOPH RES CO, V478, P1198, DOI 10.1016/j.bbrc.2016.08.094
   Anderson R, 2019, EMBO J, V38, P0, DOI 10.15252/embj.2018100492
   Andrés V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124
   Ashapkin VV, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00455
   Aviv A, 2012, ANNU REV MED, V63, P293, DOI 10.1146/annurev-med-050311-104846
   Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263
   Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bendix L, 2010, AGING CELL, V9, P383, DOI 10.1111/j.1474-9726.2010.00568.x
   Bennaceur K, 2014, ATHEROSCLEROSIS, V236, P312, DOI 10.1016/j.atherosclerosis.2014.07.020
   de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x
   Beyer AM, 2016, CIRC RES, V118, P856, DOI 10.1161/CIRCRESAHA.115.307918
   Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Brazvan B, 2018, BIOMED PHARMACOTHER, V102, P9, DOI 10.1016/j.biopha.2018.02.073
   Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32
   Brouilette SW, 2008, HEART, V94, P422, DOI 10.1136/hrt.2007.139675
   Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, P0, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.10.e47
   Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004
   Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528
   Daniali L, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2602
   DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518
   Donnini S, 2010, J PHARMACOL EXP THER, V332, P776, DOI 10.1124/jpet.109.159178
   Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011
   Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049
   Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400
   Fernández-Alvira JM, 2016, J AM COLL CARDIOL, V67, P2467, DOI 10.1016/j.jacc.2016.03.530
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18
   Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017
   Gizard F, 2008, CIRC RES, V103, P1155, DOI 10.1161/CIRCRESAHA.108.186205
   Gizard F, 2011, ARTERIOSCL THROM VAS, V31, P245, DOI 10.1161/ATVBAHA.110.219808
   Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102
   Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x
   Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028
   GRAY R, 1991, BONE MARROW TRANSPL, V7, P9
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3
   Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hamczyk MR, 2018, ANNU REV PHYSIOL, V80, P27, DOI 10.1146/annurev-physiol-021317-121454
   Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085
   Haycock PC, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g4227
   Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626
   Hoffmann J, 2011, FUTUR CARDIOL, V7, P789, DOI 10.2217/fca.11.55
   Hoffmann J, 2009, EXP GERONTOL, V44, P363, DOI 10.1016/j.exger.2009.02.006
   Hughes WE, 2021, ARTERIOSCL THROM VAS, V41, P446, DOI 10.1161/ATVBAHA.120.314944
   Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kimura M, 2011, NUCLEIC ACIDS RES, V39, P0, DOI 10.1093/nar/gkr235
   Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124
   Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x
   Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685
   Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013
   Lewis-McDougall FC, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12931
   Liu SC, 2005, CARDIOVASC PATHOL, V14, P232, DOI 10.1016/j.carpath.2005.05.006
   Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, P0, DOI 10.1093/nar/gku439
   Madrid AS, 2016, CLIN CHEM, V62, P1140, DOI 10.1373/clinchem.2016.258566
   Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283
   Maier R, 2020, JMIR RES PROTOC, V9, P0, DOI 10.2196/19456
   Makino N, 2015, MOL CELL BIOCHEM, V403, P1, DOI 10.1007/s11010-015-2327-0
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   McClintock B, 1941, GENETICS, V26, P234
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4
   Narducci ML, 2007, J AM COLL CARDIOL, V50, P2369, DOI 10.1016/j.jacc.2007.08.048
   Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1
   Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137
   Pérez-Rivero G, 2006, CIRCULATION, V114, P309, DOI 10.1161/CIRCULATIONAHA.105.611111
   Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683
   Poch E, 2004, FASEB J, V18, P418, DOI 10.1096/fj.03-0710fje
   Richardson GD, 2016, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/53979
   Richardson GD, 2018, ARTERIOSCL THROM VAS, V38, P1283, DOI 10.1161/ATVBAHA.117.309940
   Richardson GD, 2015, STEM CELLS DEV, V24, P1672, DOI 10.1089/scd.2014.0495
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366
   Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1
   Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628
   Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836
   Sawhney V, 2016, INT J CARDIOL, V207, P157, DOI 10.1016/j.ijcard.2016.01.066
   Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111
   Sharifi-Sanjani M, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.116.005086
   Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758
   Siland JE, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0171545
   Smith GD, 2010, PERSPECT PSYCHOL SCI, V5, P527, DOI 10.1177/1745691610383505
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Spyridopoulos I, 2008, ARTERIOSCL THROM VAS, V28, P968, DOI 10.1161/ATVBAHA.107.160846
   Spyridopoulos I, 2009, CIRCULATION, V120, P1364, DOI 10.1161/CIRCULATIONAHA.109.854299
   Staerk L, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006541
   Strazhesko ID, 2016, FRONT PHARMACOL, V7, P0, DOI 10.3389/fphar.2016.00347
   SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X
   Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5
   van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027
   Vecoli C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215508
   Walaszczyk A, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12945
   Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034
   Werner C, 2011, ATHEROSCLEROSIS, V216, P23, DOI 10.1016/j.atherosclerosis.2011.02.011
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   Werner CM, 2019, EUR HEART J, V40, P34, DOI 10.1093/eurheartj/ehy585
   Whittemore K, 2019, P NATL ACAD SCI USA, V116, P15122, DOI 10.1073/pnas.1902452116
   Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897
   Xu SW, 2019, TRENDS BIOCHEM SCI, V44, P561, DOI 10.1016/j.tibs.2019.03.010
   Yan Y, 2017, FREE RADICAL BIO MED, V109, P108, DOI 10.1016/j.freeradbiomed.2016.12.003
   Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677
   Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423
   Zurek M, 2016, GENES-BASEL, V7, P0, DOI 10.3390/genes7060029
NR 118
TC 41
Z9 44
U1 1
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1079-5642
EI 1524-4636
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD MAR 15
PY 2021
VL 41
IS 3
BP 1047
EP 1061
DI 10.1161/ATVBAHA.120.315695
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA RL9XE
UT WOS:000639315600009
PM 33504179
DA 2024-11-01
ER

PT J
AU Son, JM
   Lee, C
AF Son, Jyung Mean
   Lee, Changhan
TI Aging: All roads lead to mitochondria
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
ID permeability transition pore; life-span; oxidative stress; metabolic-regulation; dna mutations; inflammatory responses; superoxide-production; immune-responses; humanin peptide; skeletal-muscle
AB Mitochondria were described as early as 1890 as ubiquitous intracellular structures by Ernster and Schatz (1981) [1]. Since then, the accretion of knowledge in the past century has revealed much of the molecular details of mitochondria, ranging from mitochondrial origin, structure, metabolism, genetics, and signaling, and their implications in health and disease. We now know that mitochondria are remarkably multifunctional and deeply intertwined with many vital cellular processes. They are quasi-self organelles that still possess remnants of its bacterial ancestry, including an independent genome. The mitochondrial free radical theory of aging (MFRTA), which postulated that aging is a product of oxidative damage to mitochondrial DNA, provided a conceptual framework that put mitochondria on the map of aging research. However, several studies have more recently challenged the general validity of the theory, favoring novel ideas based on emerging evidence to understand how mitochondria contribute to aging and age-related diseases. One prominent topic of investigation lies on the fact that mitochondria are not only production sites for bioenergetics and macromolecules, but also regulatory hubs that communicate and coordinate many vital physiological processes at the cellular and organismal level. The bi-directional communication and coordination between the co-evolved mitochondrial and nuclear genomes is especially interesting in terms of cellular regulation. Mitochondria are dynamic and adaptive, rendering their function sensitive to cellular context. Tissues with high energy demands, such as the brain, seem to be uniquely affected by age-dependent mitochondrial dysfunction, providing a foundation for the development of novel mitochondrial-based therapeutics and diagnostics.
C1 [Son, Jyung Mean; Lee, Changhan] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
   [Lee, Changhan] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.
   [Lee, Changhan] Ajou Univ, Biomed Sci Grad Sch, Suwon 16499, South Korea.
C3 University of Southern California; University of Southern California; Ajou University
RP Lee, C (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
FU NIH [R01AG052258, R01GM136837]; American Federation for Aging Research (AFAR); Larry L. Hillblom Foundation (LLHF) fellowship
CR Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   Anderson NS, 2020, TRENDS CELL BIOL, V30, P428, DOI 10.1016/j.tcb.2020.03.001
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005
   Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012
   Baumgart M, 2016, CELL SYST, V2, P122, DOI 10.1016/j.cels.2016.01.014
   Benayoun BA, 2019, BIOESSAYS, V41, P0, DOI 10.1002/bies.201900046
   Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, PD303, DOI 10.1093/nar/gkx1030
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013
   Boyapati Ray K, 2017, F1000RES, V6, P169, DOI 10.12688/f1000research.10397.1
   Breiling A, 2015, EPIGENET CHROMATIN, V8, P0, DOI 10.1186/s13072-015-0016-6
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Carlberg C, 2018, HUMAN EPIGENOMICS, V0, PP75, DOI 10.1007/978-981-10-7614-5_5
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262
   Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00163
   Ciabattini A, 2018, SEMIN IMMUNOL, V40, P83, DOI 10.1016/j.smim.2018.10.010
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Conte M, 2020, SEMIN IMMUNOPATHOL, V42, P607, DOI 10.1007/s00281-020-00813-0
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314
   Couso JP, 2017, NAT REV MOL CELL BIO, V18, P575, DOI 10.1038/nrm.2017.58
   da Silveira WA, 2020, CELL, V183, P1185, DOI 10.1016/j.cell.2020.11.002
   DEGUCHI T, 1971, J BIOL CHEM, V246, P3175
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053
   ERNSTER L, 1981, J CELL BIOL, V91, PS227, DOI 10.1083/jcb.91.3.227s
   Fabrizio P, 2003, GENETICS, V163, P35
   Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gambardella S, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01064
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   García N, 2005, LIFE SCI, V76, P2873, DOI 10.1016/j.lfs.2004.12.012
   García N, 2007, LIFE SCI, V81, P1160, DOI 10.1016/j.lfs.2007.08.019
   Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885
   Glück S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Guo Q, 2020, DIABETOLOGIA, V63, P2675, DOI 10.1007/s00125-020-05269-3
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P454, DOI 10.1196/annals.1354.065
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Henderson VW, 2010, MENOPAUSE MITOCHONDR, V0, P77
   Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009
   Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Hummel EM, 2018, TRANSL PSYCHIAT, V8, P0, DOI 10.1038/s41398-018-0264-x
   Hunter P, 2016, EMBO REP, V17, P136, DOI 10.15252/embr.201541835
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Jambhekar A, 2019, NAT REV MOL CELL BIO, V20, P625, DOI 10.1038/s41580-019-0151-1
   Janssen JJE, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00078
   Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x
   Kang GM, 2021, CELL METAB, V33, P334, DOI 10.1016/j.cmet.2021.01.003
   Kann LM, 1998, P NATL ACAD SCI USA, V95, P2372, DOI 10.1073/pnas.95.5.2372
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276
   Khan S, 2020, J CLIN INVEST, V130, P20, DOI 10.1172/JCI129202
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kim KH, 2018, CELL METAB, V28, P516, DOI 10.1016/j.cmet.2018.06.008
   Knoop A, 2019, RAPID COMMUN MASS SP, V33, P371, DOI 10.1002/rcm.8337
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Krukowski K, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.62048
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lane N, 2015, P NATL ACAD SCI USA, V112, PE4823, DOI 10.1073/pnas.1509237112
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8060949
   Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014
   Li SC, 2015, TRENDS PHARMACOL SCI, V36, P906, DOI 10.1016/j.tips.2015.08.014
   Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lindqvist D, 2016, TRANSL PSYCHIAT, V6, P0, DOI 10.1038/tp.2016.236
   Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   LOPEZ JV, 1994, J MOL EVOL, V39, P174
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Lowes H, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00362-y
   Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008
   Lu HY, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102456
   Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80
   Makarewich CA, 2017, TRENDS CELL BIOL, V27, P685, DOI 10.1016/j.tcb.2017.04.006
   Martin I, 2009, FREE RADICAL BIO MED, V47, P803, DOI 10.1016/j.freeradbiomed.2009.06.021
   Martínez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Martire S, 2020, NAT REV MOL CELL BIO, V21, P522, DOI 10.1038/s41580-020-0262-8
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Michalak EM, 2019, NAT REV MOL CELL BIO, V20, P573, DOI 10.1038/s41580-019-0143-1
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003
   MORRIS RL, 1993, J CELL SCI, V104, P917
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Muzumdar RH, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006334
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Ng LF, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00311
   Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100
   ONeill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   Ogrodnik M, 2019, TRENDS BIOCHEM SCI, V44, P996, DOI 10.1016/j.tibs.2019.06.011
   Oishi Y, 2016, NPJ AGING MECH DIS, V2, P0, DOI 10.1038/npjamd.2016.18
   Parlakgul G, 2020, HIGH RESOLUTION 3D I, V0, P0
   Patrushev M, 2006, MITOCHONDRION, V6, P43, DOI 10.1016/j.mito.2005.12.001
   Pence BD, 2018, EXP GERONTOL, V108, P112, DOI 10.1016/j.exger.2018.04.008
   Peng Y, 2019, FRONT IMMUNOL, V10, P0
   Pérez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00441
   Picard M, 2019, CURR OPIN BEHAV SCI, V28, P142, DOI 10.1016/j.cobeha.2019.04.015
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Podlesniy P, 2018, METHODS MOL BIOL, V1768, P111, DOI 10.1007/978-1-4939-7778-9_7
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Prevost CT, 2018, CURR GENET, V64, P199, DOI 10.1007/s00294-017-0717-4
   Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rabhi N, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00304
   Raefsky SM, 2017, FREE RADICAL BIO MED, V102, P203, DOI 10.1016/j.freeradbiomed.2016.11.045
   Rath S, 2020, NUCLEIC ACIDS RES, V0, P0
   Ren ZH, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.01030
   Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001
   Reynolds JC, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20790-0
   Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273
   Riley JS, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949799
   Riley JS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201899238
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140
   Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007
   Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156
   Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025
   Shi YG, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a017947
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Sloan DB, 2018, NAT REV GENET, V19, P635, DOI 10.1038/s41576-018-0035-9
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040
   Sunnucks P, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00025
   Szczepanowska K, 2020, HUMAN MITOCHONDRIAL, V0, P221
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4
   Takihara Y, 2015, P NATL ACAD SCI USA, V112, P10515, DOI 10.1073/pnas.1509879112
   Tan JX, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.202002179
   Thevis M, 2016, RAPID COMMUN MASS SP, V30, P635, DOI 10.1002/rcm.7470
   Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3
   Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011
   Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V107, P82, DOI 10.1016/j.psyneuen.2019.05.001
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026
   TSUZUKI T, 1983, BIOCHEM BIOPH RES CO, V114, P670, DOI 10.1016/0006-291X(83)90833-1
   Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055
   Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Viña J, 2019, FREE RADICAL BIO MED, V134, P690, DOI 10.1016/j.freeradbiomed.2019.01.045
   Wang CG, 2019, P NATL ACAD SCI USA, V116, P15817, DOI 10.1073/pnas.1905924116
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wicks S, 2009, FREE RADICAL BIO MED, V46, P176, DOI 10.1016/j.freeradbiomed.2008.09.036
   Wiese M, 2020, MOL METAB, V38, P0, DOI 10.1016/j.molmet.2020.01.006
   Willemsen D, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.55794
   Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33
   Wu Z, 2019, NAT METAB, V1, P1209, DOI 10.1038/s42255-019-0150-8
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018
   Yang H, 2017, P NATL ACAD SCI USA, V114, PE4612, DOI 10.1073/pnas.1705499114
   Yao J, 2012, ADV PHARMACOL, V64, P327, DOI 10.1016/B978-0-12-394816-8.00010-6
   Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005
   Yen K, 2020, AGING-US, V12, P11185, DOI 10.18632/aging.103534
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zarse K, 2015, CELL METAB, V21, P355, DOI 10.1016/j.cmet.2015.02.013
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YQ, 2016, MECH AGEING DEV, V154, P1, DOI 10.1016/j.mad.2016.01.005
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847
NR 211
TC 40
Z9 44
U1 4
U2 37
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
EI 1096-3634
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD AUG 15
PY 2021
VL 116
IS 
BP 160
EP 168
DI 10.1016/j.semcdb.2021.02.006
EA JUL 2021
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA TK8KO
UT WOS:000674402300019
PM 33741252
DA 2024-11-01
ER

PT J
AU Bonora, E
   Chakrabarty, S
   Kellaris, G
   Tsutsumi, M
   Bianco, F
   Bergamini, C
   Ullah, F
   Isidori, F
   Liparulo, I
   Diquigiovanni, C
   Masin, L
   Rizzardi, N
   Cratere, MG
   Boschetti, E
   Papa, V
   Maresca, A
   Cenacchi, G
   Casadio, R
   Martelli, P
   Matera, I
   Ceccherini, I
   Fato, R
   Raiola, G
   Arrigo, S
   Signa, S
   Sementa, AR
   Severino, M
   Striano, P
   Fiorillo, C
   Goto, T
   Uchino, S
   Oyazato, Y
   Nakamura, H
   Mishra, SK
   Yeh, YS
   Kato, T
   Nozu, K
   Tanboon, J
   Morioka, I
   Nishino, I
   Toda, T
   Goto, Y
   Ohtake, A
   Kosaki, K
   Yamaguchi, Y
   Nonaka, I
   Iijima, K
   Mimaki, M
   Kurahashi, H
   Raams, A
   MacInnes, A
   Alders, M
   Engelen, M
   Linthorst, G
   de Koning, T
   den Dunnen, W
   Dijkstra, G
   van Spaendonck, K
   van Gent, DC
   Aronica, EM
   Picco, P
   Carelli, V
   Seri, M
   Katsanis, N
   Duijkers, FAM
   Taniguchi-Ikeda, M
   De Giorgio, R
AF Bonora, Elena
   Chakrabarty, Sanjiban
   Kellaris, Georgios
   Tsutsumi, Makiko
   Bianco, Francesca
   Bergamini, Christian
   Ullah, Farid
   Isidori, Federica
   Liparulo, Irene
   Diquigiovanni, Chiara
   Masin, Luca
   Rizzardi, Nicola
   Cratere, Mariapia Giuditta
   Boschetti, Elisa
   Papa, Valentina
   Maresca, Alessandra
   Cenacchi, Giovanna
   Casadio, Rita
   Martelli, Pierluigi
   Matera, Ivana
   Ceccherini, Isabella
   Fato, Romana
   Raiola, Giuseppe
   Arrigo, Serena
   Signa, Sara
   Sementa, Angela Rita
   Severino, Mariasavina
   Striano, Pasquale
   Fiorillo, Chiara
   Goto, Tsuyoshi
   Uchino, Shumpei
   Oyazato, Yoshinobu
   Nakamura, Hisayoshi
   Mishra, Sushil K.
   Yeh, Yu-Sheng
   Kato, Takema
   Nozu, Kandai
   Tanboon, Jantima
   Morioka, Ichiro
   Nishino, Ichizo
   Toda, Tatsushi
   Goto, Yu-ichi
   Ohtake, Akira
   Kosaki, Kenjiro
   Yamaguchi, Yoshiki
   Nonaka, Ikuya
   Iijima, Kazumoto
   Mimaki, Masakazu
   Kurahashi, Hiroki
   Raams, Anja
   MacInnes, Alyson
   Alders, Mariel
   Engelen, Marc
   Linthorst, Gabor
   de Koning, Tom
   den Dunnen, Wilfred
   Dijkstra, Gerard
   van Spaendonck, Karin
   van Gent, Dik C.
   Aronica, Eleonora M.
   Picco, Paolo
   Carelli, Valerio
   Seri, Marco
   Katsanis, Nicholas
   Duijkers, Floor A. M.
   Taniguchi-Ikeda, Mariko
   De Giorgio, Roberto
TI Biallelic variants in <i>LIG3</i> cause a novel mitochondrial neurogastrointestinal encephalomyopathy
SO BRAIN
LA English
DT Article
DE mtDNA repair; mtDNA replication; LIG3; MNGIE; CIPO
ID dna-ligase iii; progressive external ophthalmoplegia; single-nucleotide polymorphisms; repair gene; mutations; glutamine; nuclear; cells; pathophysiology; association
AB Abnormal gut motility is a feature of several mitochondrial encephalomyopathies, and mutations in genes such as TYMP and POLG, have been linked to these rare diseases. The human genome encodes three DNA ligases, of which only one, ligase III (LIG3), has a mitochondrial splice variant and is crucial for mitochondrial health. We investigated the effect of reduced LIG3 activity and resulting mitochondrial dysfunction in seven patients from three independent families, who showed the common occurrence of gut dysmotility and neurological manifestations reminiscent of mitochondrial neurogastrointestinal encephalomyopathy. DNA from these patients was subjected to whole exome sequencing. In all patients, compound heterozygous variants in a new disease gene, LIG3, were identified. All variants were predicted to have a damaging effect on the protein. The LIG3 gene encodes the only mitochondrial DNA (mtDNA) ligase and therefore plays a pivotal role in mtDNA repair and replication. In intro assays in patient-derived cells showed a decrease in LIG3 protein levels and ligase activity. We demonstrated that the LIG3 gene defects affect mtDNA maintenance, leading to mtDNA depletion without the accumulation of multiple deletions as observed in other mitochondrial disorders. This mitochondrial dysfunction is likely to cause the phenotypes observed in these patients. The most prominent and consistent clinical signs were severe gut dysmotility and neurological abnormalities, including leukoencephalopathy, epilepsy, migraine, stroke-like episodes, and neurogenic bladder. A decrease in the number of myenteric neurons, and increased fibrosis and elastin levels were the most prominent changes in the gut. Cytochrome c oxidase (COX) deficient fibres in skeletal muscle were also observed. Disruption of lig3 in zebrafish reproduced the brain alterations and impaired gut transit in uiuo. In conclusion, we identified variants in the LIG3 gene that result in a mitochondrial disease characterized by predominant gut dysmotility, encephalopathy, and neuromuscular abnormalities.
C1 [Bonora, Elena; Bianco, Francesca; Isidori, Federica; Diquigiovanni, Chiara; Cratere, Mariapia Giuditta; Boschetti, Elisa; Seri, Marco] Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci, I-40138 Bologna, Italy.
   [Chakrabarty, Sanjiban; Raams, Anja; van Gent, Dik C.] Erasmus MC, Dept Mol Genet, NL-3000 CA Rotterdam, Netherlands.
   [Kellaris, Georgios; Ullah, Farid; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.
   [Tsutsumi, Makiko; Kato, Takema; Kurahashi, Hiroki; Taniguchi-Ikeda, Mariko] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Toyoake, Aichi 4701192, Japan.
   [Bergamini, Christian; Liparulo, Irene; Masin, Luca; Rizzardi, Nicola; Fato, Romana] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy.
   [Cratere, Mariapia Giuditta] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.
   [Papa, Valentina; Cenacchi, Giovanna; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40123 Bologna, Italy.
   [Maresca, Alessandra; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, I-40139 Bologna, Italy.
   [Casadio, Rita; Martelli, Pierluigi] Univ Bologna, Dept Biol Geol Environm Sci, Biocomp Grp, I-40126 Bologna, Italy.
   [Matera, Ivana; Ceccherini, Isabella; Arrigo, Serena; Signa, Sara; Sementa, Angela Rita; Severino, Mariasavina; Striano, Pasquale; Fiorillo, Chiara; Picco, Paolo] IRCCS Ist Giannina Gaslini, I-16128 Genoa, Italy.
   [Raiola, Giuseppe] Pugliese Ciaccio Hosp, Dept Paediat, I-88100 Catanzaro, Italy.
   [Goto, Tsuyoshi; Yeh, Yu-Sheng] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji 6110011, Japan.
   [Uchino, Shumpei; Mimaki, Masakazu] Teikyo Univ, Sch Med, Dept Pediat, Tokyo 1738605, Japan.
   [Uchino, Shumpei] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1130033, Japan.
   [Oyazato, Yoshinobu] Kakogawa Cent City Hosp, Dept Pediat, Kakogawa, Hyogo 6758611, Japan.
   [Nakamura, Hisayoshi; Tanboon, Jantima; Nishino, Ichizo; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan.
   [Mishra, Sushil K.] Natl Univ Ireland, Glycosci Grp, Galway H91 CF50, Ireland.
   [Nozu, Kandai; Iijima, Kazumoto; Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan.
   [Morioka, Ichiro] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo 1738610, Japan.
   [Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1130033, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo 1878502, Japan.
   [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat & Clin Genom, Saitama 3500495, Japan.
   [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan.
   [Yamaguchi, Yoshiki] Tohoku Med & Pharmaceut Univ, Lab Pharmaceut Phys Chem, Sendai, Miyagi 9818558, Japan.
   [MacInnes, Alyson; Linthorst, Gabor] Univ Amsterdam, Dept Metab Dis, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Alders, Mariel; van Spaendonck, Karin; Duijkers, Floor A. M.] Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Engelen, Marc] Univ Amsterdam, Dept Neurol, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [de Koning, Tom] Univ Med Ctr Groningen, Dept Metab Dis, NL-9700 RB Groningen, Netherlands.
   [den Dunnen, Wilfred] Univ Med Ctr Groningen, Dept Pathol, NL-9700 RB Groningen, Netherlands.
   [Dijkstra, Gerard] Univ Med Ctr Groningen, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands.
   [Aronica, Eleonora M.] Univ Amsterdam, Dept Pathol, Amsterdam UMC, NL-1100 DD Amsterdam, Netherlands.
   [Taniguchi-Ikeda, Mariko] Fujita Hlth Univ Hosp, Dept Clin Genet, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.
   [De Giorgio, Roberto] Univ Ferrara, St Anna Hosp, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Erasmus University Rotterdam; Erasmus MC; Duke University; Fujita Health University; University of Bologna; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Genoa; IRCCS Istituto Giannina Gaslini; Kyoto University; Teikyo University; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Kobe University; Nihon University; University of Tokyo; National Center for Neurology & Psychiatry - Japan; Saitama Medical University; Keio University; Tohoku Medical & Pharmaceutical University; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Groningen; University of Groningen; University of Groningen; University of Amsterdam; Fujita Health University; University of Ferrara; Arcispedale Sant'Anna
RP Taniguchi-Ikeda, M (corresponding author), Fujita Hlth Univ Hosp, Dept Clin Genet, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.; De Giorgio, R (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, I-44124 Ferrara, Italy.; Duijkers, FAM (corresponding author), Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands.
EM f.a.duijkers@amsterdamumc.nl; mtani@fujita-hu.ac.jp; roberto.degiorgio@unife.it
FU Telethon Grant [GGP15171]; Department of General Pediatrics, Kobe University Graduate School of Medicine [K550003302]; Dutch Cancer Foundation grant [KWF11011]; Italian Ministry of Health; University of Ferrara (FAR fund); University of Ferrara (FIR fund); Grants-in-Aid for Scientific Research [21H02885, 21K07807, 21K06283, 21K19457, 23K21430, 20H00526] Funding Source: KAKEN
CR Akbari M, 2014, DNA REPAIR, V16, P44, DOI 10.1016/j.dnarep.2014.01.015
   Bergamini C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033712
   Bonora E, 2015, GASTROENTEROLOGY, V148, P771, DOI 10.1053/j.gastro.2014.12.034
   Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Carelli V, 2018, ESSAYS BIOCHEM, V62, P235, DOI 10.1042/EBC20170097
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Corral R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071211
   Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419
   Czarny P, 2017, MOL NEUROBIOL, V54, P4150, DOI 10.1007/s12035-016-9971-6
   Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002
   Di Nardo G, 2017, NEUROGASTROENT MOTIL, V29, P0, DOI 10.1111/nmo.12945
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Diquigiovanni C, 2019, FASEB J, V33, P11284, DOI 10.1096/fj.201802722R
   Diquigiovanni C, 2018, INT J CANCER, V143, P1706, DOI 10.1002/ijc.31548
   Downes TJ, 2018, J CLIN GASTROENTEROL, V52, P477, DOI 10.1097/MCG.0000000000001047
   Eales KL, 2016, ONCOGENESIS, V5, P0, DOI 10.1038/oncsis.2015.50
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, PD427, DOI 10.1093/nar/gky995
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Goldstein AM, 2016, DEV BIOL, V417, P217, DOI 10.1016/j.ydbio.2016.03.032
   Guissart C, 2018, AM J HUM GENET, V102, P744, DOI 10.1016/j.ajhg.2018.02.021
   Kanungo S, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.12.13
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kwiatkowski D, 2016, NEUROPSYCHOBIOLOGY, V73, P98, DOI 10.1159/000444643
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   Lazzeri E, 2015, J AM SOC NEPHROL, V26, P1961, DOI 10.1681/ASN.2014010057
   Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607
   Li GN, 2018, MED SCI MONITOR, V24, P5015, DOI 10.12659/MSM.907492
   Liao YH, 2017, J GENE MED, V19, P0, DOI 10.1002/jgm.2988
   Loviglio MN, 2017, AM J HUM GENET, V101, P564, DOI 10.1016/j.ajhg.2017.08.016
   Madeira F, 2019, NUCLEIC ACIDS RES, V47, PW636, DOI 10.1093/nar/gkz268
   Marjoram L, 2015, P NATL ACAD SCI USA, V112, P2770, DOI 10.1073/pnas.1424089112
   Niederriter AR, 2013, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/50338
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11
   Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528
   Pichili VBR, 2007, GLIA, V55, P801, DOI 10.1002/glia.20499
   Rao KVR, 2003, NEUROCHEM INT, V43, P517, DOI 10.1016/S0197-0186(03)00042-1
   Sanna-Cherchi S, 2017, AM J HUM GENET, V101, P789, DOI 10.1016/j.ajhg.2017.09.018
   Savojardo C, 2016, BIOINFORMATICS, V32, P2542, DOI 10.1093/bioinformatics/btw192
   Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017
   Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
NR 51
TC 29
Z9 31
U1 2
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY 15
PY 2021
VL 144
IS 
BP 1451
EP 1466
DI 10.1093/brain/awab056
EA APR 2021
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA WM2NM
UT WOS:000710927500031
PM 33855352
DA 2024-11-01
ER

PT J
AU Cao, J
   Verma, SK
   Jaworski, E
   Mohan, S
   Nagasawa, CK
   Rayavara, K
   Sooter, A
   Miller, SN
   Holcomb, RJ
   Powell, MJ
   Ji, P
   Elrod, ND
   Yildirim, E
   Wagner, EJ
   Popov, V
   Garg, NJ
   Routh, AL
   Kuyumcu-Martinez, MN
AF Cao, Jun
   Verma, Sunil K.
   Jaworski, Elizabeth
   Mohan, Stephanie
   Nagasawa, Chloe K.
   Rayavara, Kempaiah
   Sooter, Amanda
   Miller, Sierra N.
   Holcomb, Richard J.
   Powell, Mason J.
   Ji, Ping
   Elrod, Nathan D.
   Yildirim, Eda
   Wagner, Eric J.
   Popov, Vsevolod
   Garg, Nisha J.
   Routh, Andrew L.
   Kuyumcu-Martinez, Muge N.
TI RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts
SO CELL REPORTS
LA English
DT Article
ID dna elements; cell-line; heart; tropomyosin; expression; isoform; encyclopedia; mechanisms; repression; mutations
AB RBFOX2, which has a well-established role in alternative splicing, is linked to heart diseases. However, it is unclear whether RBFOX2 has other roles in RNA processing that can influence gene expression in muscle cells, contributing to heart disease. Here, we employ both 3MODIFIER LETTER PRIME-end and nanopore cDNA sequencing to reveal a previously unrecognized role for RBFOX2 in maintaining alternative polyadenylation (APA) signatures in myoblasts. RBFOX2-mediated APA modulates mRNA levels and/or isoform expression of a collection of genes, including contractile and mitochondrial genes. Depletion of RBFOX2 adversely affects mitochondrial health in myoblasts, correlating with disrupted APA of mitochondrial gene Slc25a4. Mechanistically, RBFOX2 regulation of Slc25a4 APA is mediated through consensus RBFOX2 binding motifs near the distal polyadenylation site, enforcing the use of the proximal polyadenylation site. In sum, our results unveil a role for RBFOX2 in fine-tuning expression of mitochondrial and contractile genes via APA in myoblasts relevant to heart diseases.
C1 [Cao, Jun; Verma, Sunil K.; Jaworski, Elizabeth; Mohan, Stephanie; Nagasawa, Chloe K.; Holcomb, Richard J.; Ji, Ping; Elrod, Nathan D.; Wagner, Eric J.; Routh, Andrew L.; Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Rayavara, Kempaiah; Garg, Nisha J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Sooter, Amanda; Powell, Mason J.] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA.
   [Miller, Sierra N.] Univ Texas Med Branch, Ctr Addict Res, Galveston, TX 77555 USA.
   [Yildirim, Eda] Duke Univ, Dept Cell Biol, Sch Med, Durham, NC 27708 USA.
   [Wagner, Eric J.; Routh, Andrew L.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Popov, Vsevolod] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA.
   [Cao, Jun] Harvard Med Sch, Boston Childrens Hosp, Cardiol Dept, Boston, MA 02115 USA.
   [Wagner, Eric J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.
   [Mohan, Stephanie] Univ New England, Sch Biol Sci, Biddeford, ME USA.
C3 University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Duke University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Harvard Medical School; Boston Children's Hospital; University of Rochester; University of New England - Maine
RP Kuyumcu-Martinez, MN (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Kuyumcu-Martinez, MN (corresponding author), Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA.
EM nmmartin@utmb.edu
FU UTMB Department of Biochemistry and Molecular Biology Bridging funds; National Institutes of Health/National Heart Lung Blood Institute [1R01HL135031]; UTMB John Sealy Memorial Endowment Pilot Award; American Heart Association [18POST 3399018, 20TPA35490206, 2021AHA000DIVSUP0211476]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI136031]; UTMB; National Institutes of Health [R03CA223893]; American Heart Association (AHA) [20TPA35490206] Funding Source: American Heart Association (AHA); National Institute of Allergy and Infectious Diseases [R01AI136031] Funding Source: NIH RePORTER
CR Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027
   Belanger K, 2018, BIOCHEM BIOPH RES CO, V503, P3205, DOI 10.1016/j.bbrc.2018.08.126
   Berberoglu MA, 2017, DEV BIOL, V424, P162, DOI 10.1016/j.ydbio.2017.03.004
   Cao J, 2021, J CELL MOL MED, V25, P8352, DOI 10.1111/jcmm.16795
   Cooke C, 1999, MOL CELL BIOL, V19, P4971
   Creemers EE, 2016, CIRC RES, V118, P433, DOI 10.1161/CIRCRESAHA.115.307082
   Damianov A, 2016, CELL, V165, P606, DOI 10.1016/j.cell.2016.03.040
   Davis CA, 2018, NUCLEIC ACIDS RES, V46, PD794, DOI 10.1093/nar/gkx1081
   Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111
   Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   England J, 2017, J MOL CELL CARDIOL, V106, P1, DOI 10.1016/j.yjmcc.2017.03.006
   Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025
   Gooding C, 2008, ADV EXP MED BIOL, V644, P27
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476
   Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396
   Huang SC, 2012, MOL CELL BIOL, V32, P513, DOI 10.1128/MCB.06423-11
   Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI 10.1038/NMETH.3885
   Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474
   KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X
   King MS, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000256
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, PW90, DOI 10.1093/nar/gkw377
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152
   Lin JJC, 2008, ADV EXP MED BIOL, V644, P201
   Liu XQ, 2017, NAT GENET, V49, P1152, DOI 10.1038/ng.3870
   Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244
   Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261
   MEJIAALVAREZ R, 1994, J PHYSIOL-LONDON, V478, P315, DOI 10.1113/jphysiol.1994.sp020252
   Ménard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063
   Misra C, 2020, DEV CELL, V52, P748, DOI 10.1016/j.devcel.2020.01.037
   Nimura K, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.16030
   Nutter CA, 2017, MUSCLE NERVE, V56, P744, DOI 10.1002/mus.25599
   Nutter CA, 2016, CELL REP, V15, P2200, DOI 10.1016/j.celrep.2016.05.002
   Perelman A, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.171
   Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0
   Routh A, 2019, G3-GENES GENOM GENET, V9, P1825, DOI 10.1534/g3.119.400273
   Routh A, 2017, NUCLEIC ACIDS RES, V45, P0, DOI 10.1093/nar/gkx286
   Runfola V, 2015, J CELL SCI, V128, P631, DOI 10.1242/jcs.161059
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112
   Singh RK, 2018, CELL REP, V24, P197, DOI 10.1016/j.celrep.2018.06.017
   Singh RK, 2014, MOL CELL, V55, P592, DOI 10.1016/j.molcel.2014.06.035
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sun SY, 2012, RNA, V18, P274, DOI 10.1261/rna.030486.111
   Tang AD, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15171-6
   Thomas A, 2010, J CELL BIOCHEM, V110, P875, DOI 10.1002/jcb.22599
   Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158
   van der Putten HHAGM, 2002, J ENDOCRINOL, V175, P587, DOI 10.1677/joe.0.1750587
   Verma SK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30896
   Verma SK, 2013, J BIOL CHEM, V288, P35372, DOI 10.1074/jbc.M113.507426
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Wang W, 1999, AM J PHYSIOL-HEART C, V276, PH1559, DOI 10.1152/ajpheart.1999.276.5.H1559
   Wei CL, 2015, CELL REP, V10, P1521, DOI 10.1016/j.celrep.2015.02.013
   Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005
   Wolska BM, 2003, PFLUG ARCH EUR J PHY, V446, P1, DOI 10.1007/s00424-002-0900-3
   Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 63
TC 14
Z9 16
U1 2
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
EI 
J9 CELL REP
JI Cell Reports
PD NOV 2
PY 2021
VL 37
IS 5
BP 
EP 
DI 10.1016/j.celrep.2021.109910
EA NOV 2021
PG 19
WC Cell Biology
SC Cell Biology
GA WT5YJ
UT WOS:000715939600004
PM 34731606
DA 2024-11-01
ER

PT J
AU Naess, K
   Bruhn, H
   Stranneheim, H
   Freyer, C
   Wibom, R
   Mourier, A
   Engvall, M
   Nennesmo, I
   Lesko, N
   Wredenberg, A
   Wedell, A
   von Döbeln, U
AF Naess, Karin
   Bruhn, Helene
   Stranneheim, Henrik
   Freyer, Christoph
   Wibom, Rolf
   Mourier, Arnaud
   Engvall, Martin
   Nennesmo, Inger
   Lesko, Nicole
   Wredenberg, Anna
   Wedell, Anna
   von Dobeln, Ulrika
TI Clinical Presentation, Genetic Etiology, and Coenzyme Q10 Levels in 55 Children with Combined Enzyme Deficiencies of the Mitochondrial Respiratory Chain
SO JOURNAL OF PEDIATRICS
LA English
DT Article
ID pediatric-patients; atp production; mutations; spectrum; disorders; childhood; disease; defect
AB Objectives To evaluate the clinical symptoms and biochemical findings and establish the genetic etiology in a cohort of pediatric patients with combined deficiencies of the mitochondrial respiratory chain complexes. Study design Clinical and biochemical data were collected from 55 children. All patients were subjected to sequence analysis of the entire mitochondrial genome, except when the causative mutations had been identified based on the clinical picture. Whole exome sequencing/whole genome sequencing (WES/WGS) was performed in 32 patients. Results Onset of disease was generally early in life (median age, 6 weeks). The most common symptoms were muscle weakness, hypotonia, and developmental delay/intellectual disability. Nonneurologic symptoms were frequent. Disease causing mutations were found in 20 different nuclear genes, and 7 patients had mutations in mitochondrial DNA. Causative variants were found in 18 of the 32 patients subjected to WES/WGS. Interestingly, many patients had low levels of coenzyme Q10 in muscle, irrespective of genetic cause. Conclusions Children with combined enzyme defects display a diversity of clinical symptoms with varying age of presentation. We established the genetic diagnosis in 35 of the 55 patients (64%). The high diagnostic yield was achieved by the introduction of massive parallel sequencing, which also revealed novel genes and enabled elucidation of new disease mechanisms.
C1 [Naess, Karin; Bruhn, Helene; Stranneheim, Henrik; Freyer, Christoph; Wibom, Rolf; Engvall, Martin; Lesko, Nicole; Wredenberg, Anna; Wedell, Anna; von Dobeln, Ulrika] Karolinska Univ Hosp, Ctr Inherited Metab Dis, L7 05, S-17176 Stockholm, Sweden.
   [Naess, Karin; Bruhn, Helene; Freyer, Christoph; Wibom, Rolf; Wredenberg, Anna; von Dobeln, Ulrika] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Stranneheim, Henrik; Engvall, Martin; Lesko, Nicole; Wedell, Anna] Karolinska Inst, Sci Life Lab, Dept Mol Med & Surg, Stockholm, Sweden.
   [Nennesmo, Inger] Karolinska Univ Hosp, Dept Lab Med, Clin Pathol, Stockholm, Sweden.
   [Mourier, Arnaud] CNRS UMR 5095, Bordeaux, France.
   [Mourier, Arnaud] Univ Bordeaux, EPST, IBGC UMR 5095, Bordeaux, France.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)
RP Naess, K (corresponding author), Karolinska Univ Hosp, Ctr Inherited Metab Dis, L7 05, S-17176 Stockholm, Sweden.
EM karin.naess@ki.se
FU Swedish Research Council [201601082, 2016-02179]; Karolinska Institutet, Stockholm County Council [20170022, 20100051]; Knut & Alice Wallenberg Foundation [KAW 2013.0026, KAW 2014.0293]; European Research Council under the European Union [715009]; AFM-Telethon Trampoline [AFM19613]; ANR [ANR-16-CE14-0013]; European Research Council (ERC) [715009] Funding Source: European Research Council (ERC); Agence Nationale de la Recherche (ANR) [ANR-16-CE14-0013] Funding Source: Agence Nationale de la Recherche (ANR); Swedish Research Council [2016-02179] Funding Source: Swedish Research Council
CR ALM J, 1978, ANN CLIN BIOCHEM, V15, P245, DOI 10.1177/000456327801500159
   BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808
   Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004
   CHINNERY P, 2006, COCHRANE DATABASE SY, V1, P0
   Chong JX, 2016, AM J HUM GENET, V98, P772, DOI 10.1016/j.ajhg.2016.01.016
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Das AM, 2000, EUR J PEDIATR, V159, P243, DOI 10.1007/s004310050063
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Kishita Y, 2015, AM J HUM GENET, V97, P761, DOI 10.1016/j.ajhg.2015.09.013
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013
   Liu YL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071349
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Stödberg T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9038
   Stranneheim H, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-1090
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Tuppen HAL, 2012, EUR J HUM GENET, V20, P897, DOI 10.1038/ejhg.2012.44
   van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013
   VONDOBELN U, 1993, ACTA PAEDIATR, V82, P1079, DOI 10.1111/j.1651-2227.1993.tb12818.x
   WIBOM R, 1990, AM J PHYSIOL, V259, PE204, DOI 10.1152/ajpendo.1990.259.2.E204
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
NR 38
TC 5
Z9 5
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3476
EI 1097-6833
J9 J PEDIATR-US
JI J. Pediatr.
PD JAN 15
PY 2021
VL 228
IS 
BP 240
EP +
DI 10.1016/j.jpeds.2020.08.025
PG 14
WC Pediatrics
SC Pediatrics
GA PH8OR
UT WOS:000600665200046
PM 32827528
DA 2024-11-01
ER

PT J
AU Boyer, O
   Butler-Browne, G
   Chinoy, H
   Cossu, G
   Galli, F
   Lilleker, JB
   Magli, A
   Mouly, V
   Perlingeiro, RCR
   Previtali, SC
   Sampaolesi, M
   Smeets, H
   Schoewel-Wolf, V
   Spuler, S
   Torrente, Y
   Van Tienen, F
AF Boyer, Olivier
   Butler-Browne, Gillian
   Chinoy, Hector
   Cossu, Giulio
   Galli, Francesco
   Lilleker, James B.
   Magli, Alessandro
   Mouly, Vincent
   Perlingeiro, Rita C. R.
   Previtali, Stefano C.
   Sampaolesi, Maurilio
   Smeets, Hubert
   Schoewel-Wolf, Verena
   Spuler, Simone
   Torrente, Yvan
   Van Tienen, Florence
TI Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle
SO FRONTIERS IN GENETICS
LA English
DT Review
DE cell transplantation; muscle stem cells; muscular dystrophies; mitochondrial myopathies; inflammatory myopathies; sphincter incontinence; volumetric muscle loss
ID duchenne muscular-dystrophy; mesenchymal stem-cells; autologous myoblast transplantation; mitochondrial-dna deletions; long-term persistence; satellite cells; urinary-incontinence; self-renewal; restore dystrophin; bladder exstrophy
AB This article will review myogenic cell transplantation for congenital and acquired diseases of skeletal muscle. There are already a number of excellent reviews on this topic, but they are mostly focused on a specific disease, muscular dystrophies and in particular Duchenne Muscular Dystrophy. There are also recent reviews on cell transplantation for inflammatory myopathies, volumetric muscle loss (VML) (this usually with biomaterials), sarcopenia and sphincter incontinence, mainly urinary but also fecal. We believe it would be useful at this stage, to compare the same strategy as adopted in all these different diseases, in order to outline similarities and differences in cell source, pre-clinical models, administration route, and outcome measures. This in turn may help to understand which common or disease-specific problems have so far limited clinical success of cell transplantation in this area, especially when compared to other fields, such as epithelial cell transplantation. We also hope that this may be useful to people outside the field to get a comprehensive view in a single review. As for any cell transplantation procedure, the choice between autologous and heterologous cells is dictated by a number of criteria, such as cell availability, possibility of in vitro expansion to reach the number required, need for genetic correction for many but not necessarily all muscular dystrophies, and immune reaction, mainly to a heterologous, even if HLA-matched cells and, to a minor extent, to the therapeutic gene product, a possible antigen for the patient. Finally, induced pluripotent stem cell derivatives, that have entered clinical experimentation for other diseases, may in the future offer a bank of immune-privileged cells, available for all patients and after a genetic correction for muscular dystrophies and other myopathies.
C1 [Boyer, Olivier] Normandy Univ, Rouen Univ Hosp, Inserm U1234, Dept Immunol & Biotherapy, Rouen, France.
   [Butler-Browne, Gillian; Mouly, Vincent] Sorbonne Univ, INSERM, Inst Myol, Ctr Rech Myol, Paris, France.
   [Chinoy, Hector; Lilleker, James B.] Salford Royal NHS Fdn, Manchester Acad Hlth Sci Ctr, Manchester Ctr Clin Neurosci, Salford, Lancs, England.
   [Chinoy, Hector; Galli, Francesco; Lilleker, James B.] Univ Manchester, Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.
   [Cossu, Giulio] Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.
   [Cossu, Giulio; Schoewel-Wolf, Verena; Spuler, Simone] Univ Med Berlin, Expeninental & Clin Res Ctr, Muscle Res Unit, Berlin, Germany.
   [Cossu, Giulio; Previtali, Stefano C.] Ist Ric & Cure Carattere Sci IRCCS Osped San Raff, InSpe, Milan, Italy.
   [Cossu, Giulio; Previtali, Stefano C.] Ist Ric & Cura Carattere Sci IRCCS Osped San Raff, Div Neurosci, Milan, Italy.
   [Magli, Alessandro; Perlingeiro, Rita C. R.] Univ Minnesota, Stem Cell Inst, Lillehei Heart Inst, Dept Med, Minneapolis, MN USA.
   [Sampaolesi, Maurilio] Katholieke Univ Leuven, Dept Dev & Regenerat, Translat Cardiomyol Lab, Leuven, Belgium.
   [Sampaolesi, Maurilio] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Human Anat Unit, Pavia, Italy.
   [Smeets, Hubert; Van Tienen, Florence] Maastricht Univ, Med Ctr, Dept Toxicogen, Maastricht, Netherlands.
   [Smeets, Hubert] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.
   [Smeets, Hubert] Maastricht Univ, Sch Dev Biol & Oncol GROW, Maastricht, Netherlands.
   [Torrente, Yvan] Univ Milan, Fdn Ist Ric & Cura Carattere Sci IRCCS Ca Granda, Ctr Dino Ferrari,Unit Neurol, Dept Pathophysiol & Transplantat,Stem Cell Lab, Milan, Italy.
C3 Universite de Rouen Normandie; CHU de Rouen; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Minnesota System; University of Minnesota Twin Cities; KU Leuven; University of Pavia; Maastricht University; Maastricht University; Maastricht University; University of Milan
RP Cossu, G (corresponding author), Univ Manchester, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.; Cossu, G (corresponding author), Univ Med Berlin, Expeninental & Clin Res Ctr, Muscle Res Unit, Berlin, Germany.
EM giulio.cossu@manchester.ac.uk
FU PHRC National Research Program [P020908/AOM02100]; Association Francaise contre les Myopathies; Fondation de l'Avenir; NIHR Manchester Biomedical Research Centre Funding Scheme; ERC [AIG 844952]; EC [H2020-MSCA-ITN-2019 860034, 20150256]; MRC [MR/S015116]; Duchenne Parent Project (Italy) [GOSH V4618]; NIHR Clinical Lecturship [MWN/006/025/A, R01AR071439]; Department of Defense [MD160035]; Duchenne UK; Fondazione Regionale per la Ricerca Biomedica FRRB [EJPRD19-118]; Telethon [GGP17009, RF-201602361246, 2020-EMR116]; FWO [G0D4517N, G066821N]; Deutsche Forschungsgemeinschaft (DFG) [KFO192]; DFG [IGK1631]; Foundations Gisela Krebs; French Telethon AFM [21104, 2014055]; Prinses Beatrix Spierfonds [PBS W.0R15-09]; British Academy [MD160035] Funding Source: British Academy
CR Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Albini S, 2013, CELL REP, V3, P661, DOI 10.1016/j.celrep.2013.02.012
   Alexander MS, 2016, CELL STEM CELL, V19, P800, DOI 10.1016/j.stem.2016.08.006
   Allen DG, 2016, PHYSIOL REV, V96, P253, DOI 10.1152/physrev.00007.2015
   Alonso-Martin S, 2016, FRONT CELL DEV BIOL, V4, P0, DOI 10.3389/fcell.2016.00058
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andrews PW, 2017, STEM CELL REP, V9, P1, DOI 10.1016/j.stemcr.2017.05.029
   Azzag K, 2020, SKELET MUSCLE, V10, P0, DOI 10.1186/s13395-020-00228-3
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bae Y, 2017, MITOCHONDRION, V37, P27, DOI 10.1016/j.mito.2017.06.005
   Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294
   Bar-Nur O, 2018, STEM CELL REP, V10, P1505, DOI 10.1016/j.stemcr.2018.04.009
   Benchaouir R, 2008, M S-MED SCI, V24, P99, DOI 10.1051/medsci/200824199
   Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016
   Berardi E, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00119
   Betteridge Z, 2019, J AUTOIMMUN, V101, P48, DOI 10.1016/j.jaut.2019.04.001
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   Biressi S, 2020, J CLIN INVEST, V130, P5652, DOI 10.1172/JCI142031
   Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237
   BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Bougl A, 2019, MUSCLE NERVE, V60, P328, DOI 10.1002/mus.26614
   Boyer O, 2018, ANN SURG, V267, P443, DOI 10.1097/SLA.0000000000002268
   Brzeszczynska J, 2016, AGING-US, V8, P1690, DOI 10.18632/aging.101006
   Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Canon S, 2008, J UROLOGY, V180, P2636, DOI 10.1016/j.juro.2008.08.048
   CARPENTER S, 1979, BRAIN, V102, P147, DOI 10.1093/brain/102.1.147
   Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y
   Centre for Canadian Language Benchmarks, 2019, CLB, V0, P0
   Chal J, 2015, NAT BIOTECHNOL, V33, P962, DOI 10.1038/nbt.3297
   Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547
   Chan DY, 2001, UROLOGY, V57, P774, DOI 10.1016/S0090-4295(00)01102-X
   Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694
   Chan SSK, 2018, CELL STEM CELL, V23, P74, DOI 10.1016/j.stem.2018.06.010
   Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004
   Chermansky CJ, 2004, UROLOGY, V63, P780, DOI 10.1016/j.urology.2003.10.035
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Choi A, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176269
   Choi IY, 2016, CELL REP, V15, P2301, DOI 10.1016/j.celrep.2016.05.016
   Chow SC, 2020, J BIOPHARM STAT, V30, P537, DOI 10.1080/10543406.2020.1726371
   Cordova G, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00114
   Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001
   Cossu G, 2018, LANCET, V391, P883, DOI 10.1016/S0140-6736(17)31366-1
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Costamagna D, 2020, J CACHEXIA SARCOPENI, V11, P783, DOI 10.1002/jcsm.12539
   Costamagna D, 2016, J MOL CELL BIOL, V8, P73, DOI 10.1093/jmcb/mjv059
   Dai A, 2018, DEGENER NEUROL NEURO, V8, P63, DOI 10.2147/DNND.S170087
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463
   DellAgnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247
   Dellavalle A, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1508
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   DENIS P, 1992, GASTROEN CLIN BIOL, V16, P344
   Díaz-Manera J, 2010, CELL DEATH DIS, V1, P0, DOI 10.1038/cddis.2010.35
   Domi T, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0055-5
   Ebert AK, 2020, FRONT PEDIATR, V8, P0, DOI 10.3389/fped.2020.00174
   Ebert AK, 2009, ORPHANET J RARE DIS, V4, P0, DOI 10.1186/1750-1172-4-23
   Elmi A, 2011, J UROLOGY, V186, P2021, DOI 10.1016/j.juro.2011.07.029
   Elsallab M, 2020, MOL THER-METH CLIN D, V18, P269, DOI 10.1016/j.omtm.2020.05.035
   English K, 2013, STEM CELLS DEV, V22, P512, DOI 10.1089/scd.2012.0386
   Escobar H, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.145994
   Fabry V, 2017, NEUROMUSCULAR DISORD, V27, PS155, DOI 10.1016/j.nmd.2017.06.225
   Feige P, 2018, CELL STEM CELL, V23, P653, DOI 10.1016/j.stem.2018.10.006
   Feng SW, 2008, CYTOTHERAPY, V10, P254, DOI 10.1080/14653240802020381
   Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631
   Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528
   Ferrua F, 2017, HUM GENE THER, V28, P972, DOI 10.1089/hum.2017.175
   Filareto A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2550
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Forcina L, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051297
   Frattini P, 2017, HUM MOL GENET, V26, P3682, DOI 10.1093/hmg/ddx252
   Frudinger A, 2010, GUT, V59, P55, DOI 10.1136/gut.2009.181347
   Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Furrer R, 2019, ANNU REV PHARMACOL, V59, P315, DOI 10.1146/annurev-pharmtox-010818-021041
   Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085
   Gang EJ, 2009, EXP CELL RES, V315, P2624, DOI 10.1016/j.yexcr.2009.05.009
   Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gomes JP, 2018, DNA CELL BIOL, V37, P798, DOI 10.1089/dna.2018.4158
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Greenberg SA, 2016, BRAIN, V139, P1348, DOI 10.1093/brain/aww024
   Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098
   Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970
   Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395
   He RJ, 2020, BIOL RES, V53, P0, DOI 10.1186/s40659-020-00288-1
   He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523
   Hicks MR, 2018, NAT CELL BIOL, V20, P46, DOI 10.1038/s41556-017-0010-2
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504
   Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006
   Incitti T, 2019, P NATL ACAD SCI USA, V116, P4346, DOI 10.1073/pnas.1808303116
   Ito N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-08232-2
   Jankowski RJ, 2018, INT UROL NEPHROL, V50, P2153, DOI 10.1007/s11255-018-2005-8
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015
   Kajbafzadeh AM, 2008, J UROLOGY, V180, P1098, DOI 10.1016/j.juro.2008.05.057
   Kang PB, 2010, MUSCLE NERVE, V41, P746, DOI 10.1002/mus.21702
   KARPATI G, 1993, ANN NEUROL, V34, P8, DOI 10.1002/ana.410340105
   Keefe AC, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8087
   Kerkis I, 2008, J TRANSL MED, V6, P0, DOI 10.1186/1479-5876-6-35
   Klimczak A, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051119
   Kuehn BM, 2006, JAMA-J AM MED ASSOC, V295, P1362, DOI 10.1001/jama.295.12.1362
   LaCross A, 2015, J MIDWIFERY WOM HEAL, V60, P37, DOI 10.1111/jmwh.12283
   Lam, 1999, COLORECTAL DIS, V1, P197, DOI 10.1046/j.1463-1318.1999.00044.x
   Lanza R, 2019, NAT REV IMMUNOL, V19, P723, DOI 10.1038/s41577-019-0200-1
   Leriche-Guérin K, 2002, NEUROMUSCULAR DISORD, V12, P167, DOI 10.1016/S0960-8966(01)00254-1
   Li P, 2015, INT J MOL MED, V35, P1051, DOI 10.3892/ijmm.2015.2084
   Liang Q, 2018, NATURE, V563, P701, DOI 10.1038/s41586-018-0733-7
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477
   Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665
   Liu YN, 2007, STEM CELLS DEV, V16, P695, DOI 10.1089/scd.2006.0118
   Loboda A, 2020, PHARMACOL REP, V72, P1227, DOI 10.1007/s43440-020-00134-x
   Lu AP, 2014, HUM MOL GENET, V23, P4786, DOI 10.1093/hmg/ddu194
   Maesner CC, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0106-6
   Maffioletti SM, 2015, NAT PROTOC, V10, P941, DOI 10.1038/nprot.2015.057
   Magli A, 2017, SEMIN CELL DEV BIOL, V72, P87, DOI 10.1016/j.semcdb.2017.10.031
   Magli A, 2017, CELL REP, V19, P2867, DOI 10.1016/j.celrep.2017.06.005
   Marg A, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13650-z
   Marg A, 2014, J CLIN INVEST, V124, P4257, DOI 10.1172/JCI63992
   Aragón IM, 2018, INT J MED SCI, V15, P195, DOI 10.7150/ijms.22130
   Mariampillai K, 2018, JAMA NEUROL, V75, P1528, DOI 10.1001/jamaneurol.2018.2598
   Martin I, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aat2189
   Maruf M, 2020, J UROLOGY, V203, P200, DOI 10.1097/JU.0000000000000505
   Matthias N, 2018, STEM CELL RES, V27, P65, DOI 10.1016/j.scr.2018.01.008
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303
   Meng JH, 2018, STEM CELL RES, V30, P43, DOI 10.1016/j.scr.2018.05.004
   Meregalli M, 2013, FEBS J, V280, P6045, DOI 10.1111/febs.12523
   Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289
   Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1
   Minasi MG, 2002, DEVELOPMENT, V129, P2773
   Minetto MA, 2021, CURR OPIN PHARMACOL, V57, P148, DOI 10.1016/j.coph.2021.02.002
   Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025
   Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174
   Mollard P, 2001, ATLAS UROLOGIC CLIN, V9, P9, DOI 10.1016/s1063-5777(05)70073-6
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M
   Morgan J, 2010, MUSCLE NERVE, V42, P584, DOI 10.1002/mus.21737
   Mouriquand PDE, 2003, BJU INT, V92, P997, DOI 10.1111/j.1464-410X.2003.04518.x
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005
   Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155
   Negroni E, 2016, HUM GENE THER, V27, P117, DOI 10.1089/hum.2015.139
   Negroni E, 2009, MOL THER, V17, P1771, DOI 10.1038/mt.2009.167
   Neumeyer AM, 1998, NEUROLOGY, V51, P589, DOI 10.1212/WNL.51.2.589
   Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7
   Oldroyd A, 2017, CLIN MED, V17, P322, DOI 10.7861/clinmedicine.17-4-322
   Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95
   Ortiz-Vitali JL, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010020
   Pandya JM, 2016, ARTHRITIS RES THER, V18, P0, DOI 10.1186/s13075-016-0974-5
   Parés D, 2015, DIS COLON RECTUM, V58, P1098, DOI 10.1097/DCR.0000000000000471
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Pelatti MV, 2016, STEM CELL REV REP, V12, P448, DOI 10.1007/s12015-016-9659-3
   Périé S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022
   Périé S, 2014, MOL THER, V22, P219, DOI 10.1038/mt.2013.155
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Petrany MJ, 2019, TRENDS CELL BIOL, V29, P964, DOI 10.1016/j.tcb.2019.09.002
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Porrett PM, 2014, CLIN LIVER DIS, V18, P687, DOI 10.1016/j.cld.2014.05.012
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224
   Rose MR, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001555.pub5
   Rotini A, 2018, PHARMACOL RES, V127, P58, DOI 10.1016/j.phrs.2017.05.029
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Sato T, 2019, STEM CELL REP, V13, P352, DOI 10.1016/j.stemcr.2019.06.006
   Scharner J, 2011, SKELET MUSCLE, V1, P0, DOI 10.1186/2044-5040-1-28
   Schrey A, 2017, J NEUROL SCI, V380, P142, DOI 10.1016/j.jns.2017.07.031
   Scimeca M, 2017, J TRANSL MED, V15, P0, DOI 10.1186/s12967-017-1143-6
   Seale Patrick, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0
   Shabbir A, 2009, TRANSPLANTATION, V87, P1275, DOI 10.1097/TP.0b013e3181a1719b
   Sharma G, 2021, MOL THER, V29, P571, DOI 10.1016/j.ymthe.2020.09.028
   Shieh PB, 2013, NEUROL CLIN, V31, P1009, DOI 10.1016/j.ncl.2013.04.004
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Shoukry AI, 2009, J PEDIATR UROL, V5, P496, DOI 10.1016/j.jpurol.2009.03.015
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   Sitzia C, 2016, MOL THER, V24, P1949, DOI 10.1038/mt.2016.163
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Skuk D, 2020, J NEUROPATH EXP NEUR, V79, P1265, DOI 10.1093/jnen/nlaa110
   Skuk D, 2017, TRANSPLANT DIRECT, V3, P0, DOI 10.1097/TXD.0000000000000740
   Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81
   Skuk D, 2014, CELL TRANSPLANT, V23, PS141, DOI 10.3727/096368914X685032
   Skuk D, 2014, MOL THER, V22, P897, DOI 10.1038/mt.2014.57
   Skuk D, 2014, CELL TRANSPLANT, V23, P13, DOI 10.3727/096368912X661337
   Skuk D, 2012, NEUROMUSCULAR DISORD, V22, P997, DOI 10.1016/j.nmd.2012.05.005
   Skuk D, 2011, J NEUROPATH EXP NEUR, V70, P770, DOI 10.1097/NEN.0b013e31822a6baa
   Snijders T, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00283
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Staal FJT, 2019, FRONT PEDIATR, V7, P0, DOI 10.3389/fped.2019.00443
   Sun CS, 2020, EXP NEUROL, V323, P0, DOI 10.1016/j.expneurol.2019.113086
   Surer I, 2003, J UROLOGY, V169, P1102, DOI 10.1097/01.ju.0000044921.19074.d0
   Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Tedesco FS, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003541
   Tedesco FS, 2011, SCI TRANSL MED, V3, P0, DOI 10.1126/scitranslmed.3002342
   Thin NN, 2013, BRIT J SURG, V100, P1430, DOI 10.1002/bjs.9226
   Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064
   Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325
   TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203
   Uezumi A, 2016, STEM CELL REP, V7, P263, DOI 10.1016/j.stemcr.2016.07.004
   Valero MC, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0029760
   van Tienen F, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1510-8
   Vieira NM, 2012, CELL TRANSPLANT, V21, P1407, DOI 10.3727/096368911X
   Vieira NM, 2010, STEM CELL REV REP, V6, P560, DOI 10.1007/s12015-010-9187-5
   Vilquin JT, 1999, GENE THER, V6, P792, DOI 10.1038/sj.gt.3300889
   Wilson JM, 2020, HUM GENE THER, V31, P695, DOI 10.1089/hum.2020.182
   Wu JB, 2021, MOL THER, V29, P121, DOI 10.1016/j.ymthe.2020.09.012
   Wu JB, 2018, CELL REP, V25, P1966, DOI 10.1016/j.celrep.2018.10.067
   Xi HB, 2017, CELL REP, V18, P1573, DOI 10.1016/j.celrep.2017.01.040
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021
   Zhao MM, 2020, STEM CELL REP, V15, P80, DOI 10.1016/j.stemcr.2020.06.004
   Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x
NR 230
TC 18
Z9 18
U1 3
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD AUG 2
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fgene.2021.702547
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA UJ5FO
UT WOS:000691311000001
PM 34408774
DA 2024-11-01
ER

PT J
AU Olimpio, C
   Tiet, MY
   Horvath, R
AF Olimpio, Catarina
   Tiet, May Yung
   Horvath, Rita
TI Primary mitochondrial myopathies in childhood
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE Mitochondria; Mitochondrial myopathy; Treatment; Next-generation sequencing; Muscle; Differential diagnosis
ID complex i deficiency; exercise intolerance; lactic-acidosis; mutation; gene; diseases; encephalomyopathy; manifestation; phenotype; children
AB Primary mitochondrial myopathies are genetic metabolic disorders of mitochondrial dysfunction affecting mainly, but not exclusively, skeletal muscle. Although individually rare, they are the most common inherited metabolic disorders in childhood. They can be similar to other childhood muscle diseases such as congenital myopathies, dystrophies, myasthenic syndromes or metabolic myopathies and a muscle biopsy and genetic testing are important in the differential diagnosis. Mitochondrial myopathies can present at any age but typically childhood onset myopathies have more significant muscle involvement and are caused by genes encoded in the nuclear DNA. Mitochondrial myopathy in infants presents with hypotonia, muscle weakness and difficulty feeding. In toddlers and older children delayed motor development, exercise intolerance and premature fatigue are common. A number of nuclear DNA and mitochondrial DNA encoded genes are known to cause isolated myopathy in childhood and they are important in a range of mitochondrial functions such as oxidative phosphorylation, mitochondrial transcription/translation and mitochondrial fusion/fission. A rare cause of isolated myopathy in children, reversible infantile respiratory chain deficiency myopathy, is non-progressive and typically associated with spontaneous full recovery. Promising targeted treatments have been reported for a number or mitochondrial myopathies including riboflavin in ACAD9 and ETFDH-myopathies and deoxynucleoside for TK2- related disease. (c) 2021 Published by Elsevier B.V.
C1 [Olimpio, Catarina] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England.
   [Tiet, May Yung; Horvath, Rita] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
C3 University of Cambridge; University of Cambridge
RP Horvath, R (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
EM rh732@medschl.cam.ac.uk
FU Wellcome Trust [109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1, MR/V009346/1]; European Research Council [309548]; Newton Fund (UK/Turkey) [MR/N027302/1]; Addenbrookes Charitable Trust [G100142]; Evelyn Trust; Stoneygate Trust; Lily Foundation; MRC [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; MRC [MR/N025431/2, MR/N025431/1, MR/V009346/1, MR/N010035/1, MR/S005021/1] Funding Source: UKRI; Newton Fund [MR/N027302/2, MR/N027302/1] Funding Source: UKRI
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Carlile TM, 2019, NAT CHEM BIOL, V15, P966, DOI 10.1038/s41589-019-0353-z
   Chen W, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1562-5
   Darin N, 2017, EUR J NEUROL, V24, P587, DOI 10.1111/ene.13249
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   Debray FG, 2014, MITOCHONDRION, V17, P101, DOI 10.1016/j.mito.2014.06.003
   Diebold I, 2019, MOL CELL PROBE, V44, P14, DOI 10.1016/j.mcp.2019.01.003
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Goldstein A, 2021, GENEREVIEWS, V0, P0
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Horváth R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Jou C, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8010068
   Keshavan N, 2020, GENET MED, V22, P199, DOI 10.1038/s41436-019-0613-z
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Leslie N, 2021, GENEREVIEWS, V0, P0
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Lim AZ, 2021, GENEREVIEWS, V0, P0
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mayr JA, 2006, NEUROMUSCULAR DISORD, V16, P874, DOI 10.1016/j.nmd.2006.08.010
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Merritt JL, 2020, REV ENDOCR METAB DIS, V21, P479, DOI 10.1007/s11154-020-09568-3
   MITOMAP, 2021, HUM MIT GEN DAT, V0, P0
   Mori M, 2015, MOLEC GENET METAB RE, V4, P39, DOI 10.1016/j.ymgmr.2015.06.001
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00024
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Oncul U, 2021, J PEDIAT HEMATOL ONC, V43, PE592, DOI 10.1097/MPH.0000000000001806
   Parikh S, 2019, DIAGNOSIS MANAGEMENT, V0, PP183, DOI 10. 1007/978- 3-030-05517-2_12
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Pyle A, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000006
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richter U, 2021, FEBS LETT, V595, P1003, DOI 10.1002/1873-3468.14049
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Schaefer A, 2019, DIAGNOSIS MANAGEMENT, V0, PP63, DOI 10.1007/978-3-030-05517-2_4
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schrank B, 2017, NEUROMUSCULAR DISORD, V27, P473, DOI 10.1016/j.nmd.2017.02.005
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Suzuki T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18068-6
   Thompson R, 2020, LANCET NEUROL, V19, P522, DOI 10.1016/S1474-4422(20)30028-4
   Trifunov S, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30143-z
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanders Ronald J A, 2020, J LIPID ATHEROSCLER, V9, P313, DOI 10.12997/jla.2020.9.3.313
   Wang J, 2021, GENEREVIEWS, V0, P0
   Webb Bryn D, 2020, J TRANSL GENET GENOM, V4, P71, DOI 10.20517/jtgg.2020.11
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zanolini A, 2017, MOL GENET METAB REP, V10, P24, DOI 10.1016/j.ymgmr.2016.11.009
NR 73
TC 4
Z9 4
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT 15
PY 2021
VL 31
IS 10
BP 978
EP 987
DI 10.1016/j.nmd.2021.08.005
EA NOV 2021
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA WU1UF
UT WOS:000716336700008
PM 34736635
DA 2024-11-01
ER

PT J
AU Saravanabavan, S
   Rangan, GK
AF Saravanabavan, Sayanthooran
   Rangan, Gopala K.
TI Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease
SO NEPHROLOGY
LA English
DT Review
DE autosomal dominant polycystic kidney disease; metabolic reprogramming; mitochondrial genome
ID stage renal-disease; transcription factor; skeletal-muscle; cyst formation; dna deletions; copy number; nuclear-dna; mutation; haplogroups; variability
AB Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic renal disease in adults and is due to heterozygous germ line variants in either PKD1, PKD2 or rarely other genes. It is characterized by marked intra-familial disease variability suggesting that other genetic and/or environmental factors are involved in determining the lifetime course ADPKD. Recently, research indicates that polycystin-mediated mitochondrial dysfunction and metabolic re-programming contributes to the progression of ADPKD. Although biochemical abnormalities have gained the most interest, variants in the mitochondrial genome could be one of the mechanisms underlying the phenotypic variability in ADPKD. This narrative review aims to evaluate the role of the mitochondrial genome in the pathogenesis of APDKD.
C1 [Saravanabavan, Sayanthooran; Rangan, Gopala K.] Univ Sydney, Westmead Inst Med Res, Michael Stern Lab Polycyst Kidney Dis, Westmead, NSW, Australia.
   [Saravanabavan, Sayanthooran; Rangan, Gopala K.] Westmead Hosp, Dept Renal Med, Westmead, NSW, Australia.
C3 University of Sydney; Westmead Institute for Medical Research; NSW Health; Westmead Hospital; University of Sydney
RP Saravanabavan, S (corresponding author), Westmead Inst Med Res, Ctr Transplant & Renal Res, 176 Hawkesbury Rd POB 412, Westmead, NSW 2145, Australia.
EM sayan.saravanabavan@sydney.edu.au
FU National Health and Medical Research Council [1164128]; PKD Australia [2019]; National Health and Medical Research Council of Australia [1164128] Funding Source: NHMRC
CR Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012
   Alexeyev M, 2020, MITOCHONDRIAL DNA A, V31, P45, DOI 10.1080/24701394.2020.1734586
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   [Anonymous], 2017, CURRENT PROTOCOLS HU, V0, P0
   Beadnell TC, 2018, CANCER METAST REV, V37, P615, DOI 10.1007/s10555-018-9772-7
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Carney EF, 2017, NAT REV NEPHROL, V13, P260, DOI 10.1038/nrneph.2017.33
   Cassina L, 2020, FASEB J, V34, P6493, DOI 10.1096/fj.201901739RR
   Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037
   Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231
   Chinnery PF, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00682
   CHOMYN A, 1994, AM J HUM GENET, V54, P966
   Cohen T, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1006407
   Connor TM, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006620
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   de Laat P, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.523
   Del Bo R, 2002, J NEUROL SCI, V202, P85, DOI 10.1016/S0022-510X(02)00247-2
   Diaz-Morales N, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7080220
   Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Eirin A, 2017, HANDB EXP PHARMACOL, V240, P229, DOI 10.1007/164_2016_6
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Emperador S, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1128-z
   Estopinal CB, 2014, INVEST OPHTH VIS SCI, V55, P5589, DOI 10.1167/iovs.14-15149
   Fain PR, 2005, KIDNEY INT, V67, P1256, DOI 10.1111/j.1523-1755.2005.00203.x
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Fazzini F, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33684-5
   Feeley KP, 2015, CANCER RES, V75, P4429, DOI 10.1158/0008-5472.CAN-15-0074
   Fervenza FC, 2019, AM J KIDNEY DIS, V73, P273, DOI 10.1053/j.ajkd.2018.06.032
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Freedman BI, 2000, AM J KIDNEY DIS, V35, P35, DOI 10.1016/S0272-6386(00)70298-8
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Gabow PA, 1990, INHERITANCE KIDNEY U, V0, P247
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Granata C, 2018, SPORTS MED, V48, P1541, DOI 10.1007/s40279-018-0894-4
   GRETZ N, 1995, KIDNEY INT, V48, P496, DOI 10.1038/ki.1995.319
   Grober OMV, 2011, BMC GENOMICS, V12, P0, DOI 10.1186/1471-2164-12-36
   Groennebaek T, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00713
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Gurgey A, 1996, PEDIATR NEPHROL, V10, P637
   Hajarnis S, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14395
   Hall AM, 2008, QJM-INT J MED, V101, P755, DOI 10.1093/qjmed/hcn060
   Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759
   Halvorson CR, 2010, INT J NEPHROL RENOV, V3, P69
   Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034
   Hasan-Olive MM, 2019, NEUROCHEM RES, V44, P22, DOI 10.1007/s11064-018-2588-6
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Heyer CM, 2016, J AM SOC NEPHROL, V27, P2872, DOI 10.1681/ASN.2015050583
   Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009
   Hopp K, 2020, KIDNEY INT, V97, P370, DOI 10.1016/j.kint.2019.08.038
   IAKOUBOVA OA, 1995, GENOMICS, V26, P107, DOI 10.1016/0888-7543(95)80088-4
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishii K, 2021, KIDNEY INT, V99, P657, DOI 10.1016/j.kint.2020.10.013
   Ishikawa I, 2000, AM J KIDNEY DIS, V35, P1072, DOI 10.1016/S0272-6386(00)70042-4
   Ishimoto Y, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00337-17
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Rangan GK, 2020, EXPERT OPIN ORPHAN D, V8, P285, DOI 10.1080/21678707.2020.1804859
   Kanagasundaram NS, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-37944-2
   Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021
   Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016
   Kesterson Robert A, 2016, BIO PROTOC, V6, P0
   Lanktree MB, 2019, KIDNEY INT REP, V4, P995, DOI 10.1016/j.ekir.2019.04.018
   Lanktree MB, 2018, J AM SOC NEPHROL, V29, P2593, DOI 10.1681/ASN.2018050493
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee JE, 2009, EXP MOL MED, V41, P253, DOI 10.3858/emm.2009.41.4.028
   Lee W, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.34
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lim PS, 2000, FREE RADICAL BIO MED, V29, P454, DOI 10.1016/S0891-5849(00)00334-8
   Lin CC, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20856-6
   Liu CS, 2001, NEPHROL DIAL TRANSPL, V16, P561, DOI 10.1093/ndt/16.3.561
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Lu Y, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aba3613
   Luciano RL, 2014, NEPHROL DIAL TRANSPL, V29, P247, DOI 10.1093/ndt/gft437
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McMartin KE, 2018, MITOCHONDRIAL BIOL E, V0, P193
   Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027
   Menezes LF, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003053
   Menezes LF, 2019, NAT REV NEPHROL, V15, P736, DOI 10.1038/s41581-019-0183-y
   Murphy EL, 2019, BMC NEPHROL, V20, P0, DOI 10.1186/s12882-019-1241-1
   NAKAO E, 1993, INTERNAL MED, V32, P742, DOI 10.2169/internalmedicine.32.742
   Naviaux RK, 2000, EUR J PEDIATR, V159, PS219, DOI 10.1007/PL00014407
   Nowak KL, 2020, CLIN J AM SOC NEPHRO, V15, P577, DOI 10.2215/CJN.13291019
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Padovano V, 2018, NAT REV NEPHROL, V14, P678, DOI 10.1038/s41581-018-0051-1
   Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597
   Pandey P, 2011, BMC SYST BIOL, V5, P0, DOI 10.1186/1752-0509-5-56
   Parr RL, 2012, HUM GENOMICS, V6, P0, DOI 10.1186/1479-7364-6-3
   Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539
   Podrini C, 2020, CELL SIGNAL, V68, P0, DOI 10.1016/j.cellsig.2019.109495
   Podrini C, 2018, COMMUN BIOL, V1, P0, DOI 10.1038/s42003-018-0200-x
   Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6
   Qian F, 1999, MOL GENET METAB, V68, P237, DOI 10.1006/mgme.1999.2896
   Rangan GK, 2016, NEPHROLOGY, V21, P705, DOI 10.1111/nep.12658
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Riley V, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9080395
   Rossato LB, 2008, RENAL FAILURE, V30, P9, DOI 10.1080/08860220701741650
   Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686
   Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165
   SOONG NW, 1992, NAT GENET, V2, P318
   Srivastava SP, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.543973
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tan J, 2020, EBIOMEDICINE, V54, P0, DOI 10.1016/j.ebiom.2020.102730
   Torres JA, 2019, CELL METAB, V30, P1007, DOI 10.1016/j.cmet.2019.09.012
   TSUZUKI T, 1983, GENE, V25, P223, DOI 10.1016/0378-1119(83)90226-3
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vivian CJ, 2017, CANCER RES, V77, P6202, DOI 10.1158/0008-5472.CAN-17-1473
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132
   Yamakawa T, 2001, AM J KIDNEY DIS, V37, P0, DOI 10.1053/ajkd.2001.21358
   Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101
   YIUM J, 1994, J AM SOC NEPHROL, V4, P1670
   Zascavage Roxanne R, 2019, CURR PROTOC HUM GENET, V104, Pe94, DOI 10.1002/cphg.94
   Zhang YH, 2017, MITOCHONDRIAL DNA A, V28, P725, DOI 10.1080/24701394.2016.1177038
   Zhou HB, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1062314
NR 128
TC 1
Z9 1
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-5358
EI 1440-1797
J9 NEPHROLOGY
JI Nephrology
PD NOV 15
PY 2021
VL 26
IS 11
BP 920
EP 930
DI 10.1111/nep.13957
EA AUG 2021
PG 11
WC Urology & Nephrology
SC Urology & Nephrology
GA WL1VX
UT WOS:000682896900001
PM 34331378
DA 2024-11-01
ER

PT J
AU Wang, S
   Miao, J
   Feng, JC
AF Wang, Shuang
   Miao, Jing
   Feng, Jiachun
TI Case Report: Mitochondrial Encephalomyopathy Presents as Epilepsy, Ataxia, and Dystonia With a Rare Mutation in <i>MT-TW</i>
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE mitochondrial encephalomyopathy; MT-TW; epilepsy; ataxia; dystonia
ID mtdna mutation; trna(trp)
AB Mitochondrial diseases are a group of common inherited disorders caused by mutations in nuclear DNA or mitochondrial DNA (mtDNA); the clinical phenotype of diseases caused by mutant mtDNA is challenging owing to heteroplasmy of mtDNA and may delay diagnosis and treatment. Herein, we report the case of an adult male who slowly developed epilepsy, ataxia, dystonia, impaired cognition, and hearing impairment over 14 years in the absence of clinical myopathy. His lactate level was normal. Brain computed tomography showed calcifications of the bilateral basal ganglia, thalamus, and cerebellar dentate nuclei. Magnetic resonance imaging revealed multiple lesions in the bilateral internal capsule and periventricular areas, which were hypointense on T1-weighted images and hyperintense on T2-weighted images. The first blood genetic test result was negative. Two years later, a muscle biopsy was performed. Succinate dehydrogenase (SDH) staining showed several ragged blue fibers and atypical strongly SDH-reactive vessels. Cytochrome C oxidase (COX) staining revealed abundant COX-deficient fibers. mtDNA testing of blood and muscle revealed a rare m.5549G>A mutation in the MT-TW gene. It was heteroplasmic, with 5.4% mutant mtDNA in the blood and 61.5% in the muscle. The patient was diagnosed with mitochondrial encephalomyopathy and treated with levetiracetam instead of valproate to reduce possible mitochondrial toxicity. After receiving anti-epileptic drugs and mitochondrial supplements, the patient remained clinically stable. For mitochondrial disease, when mutant mtDNA is not detected in blood, muscle biopsy should be performed in routine analysis, and it should be genetically tested, even if there are no manifestations of myopathy.
C1 [Wang, Shuang; Miao, Jing; Feng, Jiachun] First Hosp Jilin Univ, Dept Neurol, Changchun, Peoples R China.
C3 Jilin University
RP Miao, J; Feng, JC (corresponding author), First Hosp Jilin Univ, Dept Neurol, Changchun, Peoples R China.
EM jdyymiaojing@jlu.edu.cn; fengjc@jlu.edu.cn
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Cardaioli E, 2018, BIOCHEM BIOPH RES CO, V500, P158, DOI 10.1016/j.bbrc.2018.04.009
   Duff RM, 2015, MITOCHONDRION, V25, P113, DOI 10.1016/j.mito.2015.10.008
   Finsterer J, 2019, J NEUROL SCI, V404, P29, DOI 10.1016/j.jns.2019.07.013
   Finsterer J, 2017, SEIZURE-EUR J EPILEP, V50, P166, DOI 10.1016/j.seizure.2017.06.010
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Liu KM, 2021, CNS NEUROSCI THER, V27, P733, DOI 10.1111/cns.13618
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Mascalchi M, 2018, ESSAYS BIOCHEM, V62, P409, DOI 10.1042/EBC20170109
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Weissig V, 2020, TRENDS MOL MED, V26, P40, DOI 10.1016/j.molmed.2019.09.002
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
NR 17
TC 1
Z9 1
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD JUL 1
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fneur.2021.679302
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA TJ6RV
UT WOS:000673607200001
PM 34276539
DA 2024-11-01
ER

PT J
AU Dawod, PGA
   Jancic, J
   Marjanovic, A
   Brankovic, M
   Jankovic, M
   Samardzic, J
   Dawod, AGA
   Novakovic, I
   Motaleb, FAI
   Radlovic, V
   Kostic, VS
   Nikolic, D
AF Dawod, Phepy G. A.
   Jancic, Jasna
   Marjanovic, Ana
   Brankovic, Marija
   Jankovic, Milena
   Samardzic, Janko
   Dawod, Ayman Gamil Anwar
   Novakovic, Ivana
   Abdel Motaleb, Fayda I.
   Radlovic, Vladimir
   Kostic, Vladimir S.
   Nikolic, Dejan
TI Mutational Analysis and mtDNA Haplogroup Characterization in Three Serbian Cases of Mitochondrial Encephalomyopathies and Literature Review
SO DIAGNOSTICS
LA English
DT Review
DE MELAS; leigh syndrome; mtDNA; sanger sequencing; mutations; haplogroups
ID leigh-syndrome; dna mutations; transfer-rna; natural-history; lactic-acidosis; episodes melas; nt 8993; gene; disease; tool
AB Mitochondrial encephalomyopathies (MEMP) are heterogeneous multisystem disorders frequently associated with mitochondrial DNA (mtDNA) mutations. Clinical presentation varies considerably in age of onset, course, and severity up to death in early childhood. In this study, we performed molecular genetic analysis for mtDNA pathogenic mutation detection in Serbian children, preliminary diagnosed clinically, biochemically and by brain imaging for mitochondrial encephalomyopathies disorders. Sanger sequencing analysis in three Serbian probands revealed two known pathogenic mutations. Two probands had a heteroplasmic point mutation m.3243A > G in the MT-TL1 gene, which confirmed mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome (MELAS), while a single case clinically manifested for Leigh syndrome had an almost homoplasmic (close to 100%) m.8993T > G mutation in the MT-ATP6 gene. After full mtDNA MITOMASTER analysis and PhyloTree build 17, we report MELAS' association with haplogroups U and H (U2e and H15 subclades); likewise, the mtDNA-associated Leigh syndrome proband shows a preference for haplogroup H (H34 subclade). Based on clinical-genetic correlation, we suggest that haplogroup H may contribute to the mitochondrial encephalomyopathies' phenotypic variability of the patients in our study. We conclude that genetic studies for the distinctive mitochondrial encephalomyopathies should be well-considered for realizing clinical severity and possible outcomes.
C1 [Dawod, Phepy G. A.; Jancic, Jasna; Marjanovic, Ana; Brankovic, Marija; Novakovic, Ivana; Radlovic, Vladimir; Kostic, Vladimir S.; Nikolic, Dejan] Univ Belgrade, Fac Med, Belgrade 11000, Serbia.
   [Dawod, Phepy G. A.; Abdel Motaleb, Fayda I.] Ain Shams Univ, Dept Med Biochem & Mol Biol, Fac Med, Cairo 11591, Egypt.
   [Jancic, Jasna] Clin Neurol & Psychiat Children & Youth, Belgrade 11000, Serbia.
   [Jankovic, Milena; Kostic, Vladimir S.] Clin Ctr Serbia, Neurol Clin, Belgrade 11000, Serbia.
   [Samardzic, Janko; Radlovic, Vladimir] Univ Belgrade, Inst Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade 11000, Serbia.
   [Dawod, Ayman Gamil Anwar; Nikolic, Dejan] Ain Shams Univ, Hepatogastroenterol & Endoscopy Dept, Internal Med, Fac Med, Cairo 11591, Egypt.
   Univ Childrens Hosp, Dept Pediat Surg, Belgrade 11000, Serbia.
   Univ Childrens Hosp, Phys Med & Rehabil Dept, Tirsova 10, Belgrade 11000, Serbia.
C3 University of Belgrade; Egyptian Knowledge Bank (EKB); Ain Shams University; Clinical Centre of Serbia; University of Belgrade; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Belgrade; University of Belgrade
RP Nikolic, D (corresponding author), Ain Shams Univ, Hepatogastroenterol & Endoscopy Dept, Internal Med, Fac Med, Cairo 11591, Egypt.
EM fibygamilanwer@med.asu.edu.eg; jasna.jancic.npk@gmail.com; ana.marjanovic@yahoo.com; mara.brankovic@gmail.com; milena.jankovic.82@gmail.com; jankomedico@yahoo.es; ayman.gamil@med.asu.edu.eg; ivana.novakovic@med.bg.ac.rs; dr.fayda@hotmail.com; vladimir.radlovic@gmail.com; vladimir.s.kostic@gmail.com; denikol27@gmail.com
FU Serbian Ministry of Education, Science and Technological Development [ON175090, ON175091, 200110]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Al Yazidi G, 2022, NEUROHOSPITALIST, V12, P67, DOI 10.1177/19418744211000512
   Alwehaidah MS, 2021, MED PRIN PRACT, V30, P62, DOI 10.1159/000509937
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Angural A, 2019, MITOCHONDRION, V46, P209, DOI 10.1016/j.mito.2018.06.005
   Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2
   Balasubramaniam S, 2017, JIMD REP, V33, P99, DOI 10.1007/8904_2016_559
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Benson DA, 2017, NUCLEIC ACIDS RES, V45, PD37, DOI 10.1093/nar/gkp1024
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Bugiardini E, 2019, HUM MOL GENET, V28, P2711, DOI 10.1093/hmg/ddz093
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Chaig MR, 2008, BIOCHEM BIOPH RES CO, V368, P631, DOI 10.1016/j.bbrc.2008.01.143
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen ZT, 2015, MOL MED REP, V11, P1956, DOI 10.3892/mmr.2014.2911
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Colina-Tenorio L, 2020, J INTERN MED, V287, P645, DOI 10.1111/joim.13031
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dawod PGA, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11091037
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   Delgado-Sánchez R, 2007, REV NEUROLOGIA, V44, P18, DOI 10.33588/rn.4401.2006032
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Distelmaier F, 2014, JIMD REP, V13, P53, DOI 10.1007/8904_2013_271
   Dowlati MA, 2013, MOL BIOL REP, V40, P2689, DOI 10.1007/s11033-012-2355-8
   Fassone Elisa, 2013, BMJ CASE REP, V2013, P200838, DOI 10.1136/bcr-2013-200838
   Finsterer J, 2021, AM J CASE REP, V22, P0, DOI 10.12659/AJCR.930175
   Finsterer J, 2020, YONSEI MED J, V61, P904, DOI 10.3349/ymj.2020.61.10.904
   Fiuza-Luces C, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00790
   Fujii T, 1998, PEDIATR NEUROL, V18, P275, DOI 10.1016/S0887-8994(97)00187-2
   Georgiou A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0183444
   Ghabaee M, 2009, CELL MOL NEUROBIOL, V29, P341, DOI 10.1007/s10571-008-9325-7
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Fajardo RG, 2021, J RHEUMATOL, V48, P1603, DOI 10.3899/jrheum.201316
   Habbane M, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11091007
   Häkli S, 2015, BMC MED GENET, V16, P0, DOI 10.1186/s12881-015-0145-6
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hao XD, 2013, GENE, V512, P460, DOI 10.1016/j.gene.2012.10.054
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hong CM, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00267
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Inak G, 2019, BIORXIV, V0, P0, DOI DOI 10.1101/551390
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kimura S, 2021, BRAIN DEV-JPN, V43, P157, DOI 10.1016/j.braindev.2020.07.008
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Leung GPH, 2012, ADV EXP MED BIOL, V942, P347, DOI 10.1007/978-94-007-2869-1_16
   Levy RJ, 2014, J CHILD NEUROL, V29, PNP105, DOI 10.1177/0883073813506783
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Licchetta L, 2021, ANN CLIN TRANSL NEUR, V8, P704, DOI 10.1002/acn3.51259
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Mancuso M, 2004, NEUROSCI LETT, V371, P158, DOI 10.1016/j.neulet.2004.08.060
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, PD183, DOI 10.1093/nar/gkw1138
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   Ng YS, 2019, DIAGNOSIS MANAGEMENT, V0, P1
   Nyhan WL, 2019, ATLAS INHERITED META, V4th ed., P0
   Pacheu-Grau D, 2012, EUR ARCH OTO-RHINO-L, V269, P2003, DOI 10.1007/s00405-012-2066-8
   Parsons T, 2010, ARCH NEUROL-CHICAGO, V67, P976, DOI 10.1001/archneurol.2010.174
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pierron D, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-41
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   Prasad HVR, 2006, INTERNET J PEDIAT NE, V7, P1
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Queen RA, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0187862
   Rahman S, 2017, INHERITED METABOLIC, V0, P521
   Ridge PG, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045134
   Roberta C, 2018, TRENDS BIOMED RES, V1, P1, DOI 10.15761/JTBR.1000101
   Robinson R, 2007, NEUROL TODAY, V7, P26, DOI 10.1097/01.NT.0000300461.67787.bb
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Saneto RP, 2021, MITOCHONDRION, V59, P58, DOI 10.1016/j.mito.2021.04.010
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Seitun S, 2016, CASE REP CARDIOL, V2016, P0, DOI 10.1155/2016/1490181
   Serrano-Teruel Maria E, 2019, ASIAN CARDIOVASC THORAC ANN, V27, P5, DOI 10.1177/0218492318813220
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Sinnecker T, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1306-6
   Sofou K, 2021, EUR J PAEDIATR NEURO, V31, P31, DOI 10.1016/j.ejpn.2021.01.012
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Soto-Hermida A, 2015, RHEUMATOL INT, V35, P337, DOI 10.1007/s00296-014-3104-1
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Strachan J, 2001, J INHERIT METAB DIS, V24, P409, DOI 10.1023/A:1010573122748
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Tapias V, 2020, MITOCHONDRIAL DYSFUN, V0, P0
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Thorburn D, 2015, GENEREVIEWS, V0, P0
   Thorburn DR, 1993, GENEREVIEWS R, V0, P0
   Torraco A, 2021, HUM MUTAT, V42, P699, DOI 10.1002/humu.24195
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uziel G, 2011, SEMIN FETAL NEONAT M, V16, P205, DOI 10.1016/j.siny.2011.04.003
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   van Oven M, 2015, FORENS SCI INT-GEN S, V5, PE392, DOI 10.1016/j.fsigss.2015.09.155
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wang CY, 2008, CHINESE SCI BULL, V53, P2733, DOI 10.1007/s11434-008-0380-8
   Wang YW, 2016, FRONT AGING NEUROSCI, V8, P0, DOI 10.3389/fnagi.2016.00232
   Weerasinghe CAL, 2018, MOL MED REP, V17, P6919, DOI 10.3892/mmr.2018.8670
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yis U, 2009, EUR J PAEDIATR NEURO, V13, P550, DOI 10.1016/j.ejpn.2008.10.009
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
NR 120
TC 2
Z9 2
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD NOV 15
PY 2021
VL 11
IS 11
BP 
EP 
DI 10.3390/diagnostics11111969
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA XN1WY
UT WOS:000729304200001
PM 34829316
DA 2024-11-01
ER

PT J
AU Kim, JY
   Yang, HK
   Kim, N
   Kim, MJ
   Cho, SI
   Seong, MW
   Park, SS
   Hwang, JM
AF Kim, Ji Yeon
   Yang, Hee Kyung
   Kim, Namju
   Kim, Man Jin
   Cho, Sung Im
   Seong, Moon-Woo
   Park, Sung Sup
   Hwang, Jeong-Min
TI Strabismus in chronic progressive external ophthalmoplegia
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE chronic progressive external ophthalmoplegia; ophthalmoplegia; strabismus
ID mitochondrial-dna; deletions; management; repeat; ptosis
AB Purpose To elucidate the patterns of strabismus and ophthalmoplegia associated with chronic progressive external ophthalmoplegia (CPEO) confirmed by mitochondrial DNA (mtDNA) deletions in Asians. Methods A total of 10 patients confirmed to have mtDNA deletion associated with CPEO were included. Long-range PCR encompassing the entire mtDNA was carried out. In the cases with mtDNA deletion, the exact deletion ranges of mtDNA were identified by sequencing. A full ophthalmologic examination including prism and alternate cover test in the primary position, evaluation of ductions and versions, and binocularity was performed in 10 patients with confirmed mtDNA deletions associated with CPEO. Results All of the patients showed ophthalmoplegia as well as ptosis, even after eyelid surgeries. Ophthalmoplegia was symmetric between both eyes in nine patients (90%) while one patient (10%) showed asymmetric ophthalmoplegia with esotropia and left hypotropia. Among the nine patients with symmetric involvement, four patients (44%) showed exotropia, three (33%) had exotropia with vertical deviation, and the remaining two patients (22%) showed orthotropia. Five out of 10 patients (50%) complained of diplopia associated with strabismus, four of whom (80%) had vertical deviation. Three out of five patients (60%) without diplopia showed exotropia of 20 prism diopters (PD) to 50 PD. Conclusions Exotropia with/without vertical deviation is the most common form of strabismus in Asian patients with CPEO and only one of them showed a small angle of esotropia. Ophthalmoplegia could be asymmetric in 10% of CPEO patients.
C1 [Kim, Ji Yeon; Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.
   [Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, 82 Gumi Ro,173 Beon Gil, Seongnam, Gyeonggi Do, South Korea.
   [Kim, Man Jin; Cho, Sung Im; Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, 101 Daehak Ro, Seoul 03080, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital
RP Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, 82 Gumi Ro,173 Beon Gil, Seongnam, Gyeonggi Do, South Korea.; Park, SS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Lab Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM sparkle@snu.ac.kr; hjm@snu.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0014167]
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Ahn J, 2018, J CLIN NEUROL, V14, P333, DOI 10.3988/jcn.2018.14.3.333
   BRUST JCM, 1974, NEUROLOGY, V24, P755, DOI 10.1212/WNL.24.8.755
   Chatzistefanou KI, 2019, INT OPHTHALMOL, V39, P213, DOI 10.1007/s10792-017-0781-2
   Chia A, 2007, BRIT J OPHTHALMOL, V91, P0, DOI 10.1136/bjo.2007.116905
   Coulter-Mackie MB, 1998, CLIN BIOCHEM, V31, P627, DOI 10.1016/S0009-9120(98)00074-5
   Das JC, 2002, J PEDIAT OPHTH STRAB, V39, P52, DOI 10.3928/0191-3913-20020101-13
   Gonzalez-Moron D, 2013, BMJ CASE REP, V2013, P0
   Hansen A C, 1966, J NATL MED ASSOC, V58, P436
   Hwang JM, 2009, OPHTHALMOLOGY, V116, P813, DOI 10.1016/j.ophtha.2008.12.006
   JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kee C, 2013, J CHILD NEUROL, V28, P108, DOI 10.1177/0883073812438101
   Kersten RC, 2005, OPHTHAL PLAST RECONS, V21, P412, DOI 10.1097/01.iop.0000180068.17344.80
   Kim JH, 2003, OPHTHALMOLOGY, V110, P1458, DOI 10.1016/S0161-6420(03)00460-3
   Kim U, 2009, EYE, V23, P1560, DOI 10.1038/eye.2008.309
   LEFORESTIER N, 1995, MUSCLE NERVE, V18, P1338, DOI 10.1002/mus.880181120
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Moon-Woo S, 2005, J KOREAN OPHTHALMOL, V46, P323
   Murdock J, 2016, NEURO-OPHTHALMOLOGY, V40, P44, DOI 10.3109/01658107.2015.1122815
   Rajput Rehan, 2018, ORBIT, V37, P385, DOI 10.1080/01676830.2017.1423350
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Simon DK, 1999, ANNU REV MED, V50, P111
   Solano A, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e86
   Sorkin JA, 1997, AM J OPHTHALMOL, V123, P235, DOI 10.1016/S0002-9394(14)71041-4
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   Wabbels B, 2008, OPHTHALMOLOGE, V105, P550, DOI 10.1007/s00347-007-1643-5
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
NR 30
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD MAR 15
PY 2021
VL 99
IS 2
BP E274
EP E280
DI 10.1111/aos.14558
EA NOV 2020
PG 7
WC Ophthalmology
SC Ophthalmology
GA QT2FQ
UT WOS:000589552900001
PM 33191655
DA 2024-11-01
ER

PT J
AU Alonso, M
   Zabala, C
   Mansilla, S
   De Brun, L
   Martínez, J
   Garau, M
   Rivas, G
   Acosta, C
   Lens, D
   Cerisola, A
   Graña, M
   Naya, H
   Puentes, R
   Spangenberg, L
   Raggio, V
   Lemes, A
   Castro, L
   Quijano, C
AF Alonso, Martina
   Zabala, Cristina
   Mansilla, Santiago
   De Brun, Laureana
   Martinez, Jennyfer
   Garau, Mariela
   Rivas, Gabriela
   Acosta, Cecilia
   Lens, Daniela
   Cerisola, Alfredo
   Grana, Martin
   Naya, Hugo
   Puentes, Rodrigo
   Spangenberg, Lucia
   Raggio, Victor
   Lemes, Aida
   Castro, Laura
   Quijano, Celia
TI Blood cell respiration rates and mtDNA copy number: A promising tool for the diagnosis of mitochondrial disease
SO MITOCHONDRION
LA English
DT Article
DE Bioenergetics; Mitochondrial disease; Aging; PBMC; Platelets; mtDNA
ID skeletal-muscle; oxidative-phosphorylation; dna content; mutation; age; platelets; dysfunction; capacity; decline; quantification
AB Human mitochondrial diseases are a group of heterogeneous diseases caused by defects in oxidative phosphorylation, due to mutations in mitochondrial (mtDNA) or nuclear DNA. The diagnosis of mitochondrial disease is challenging since mutations in multiple genes can affect mitochondrial function, there is considerable clinical variability and a poor correlation between genotype and phenotype. Herein we assessed mitochondrial function in peripheral blood mononuclear cells (PBMCs) and platelets from volunteers without known metabolic pathology and patients with mitochondrial disease. Oxygen consumption rates were evaluated and respiratory parameters indicative of mitochondrial function were obtained. A negative correlation between age and respiratory parameters of PBMCs from control individuals was observed. Surprisingly, respiratory parameters of PBMCs normalized by cell number were similar in patients and young controls. Considering possible compensatory mechanisms, mtDNA copy number in PBMCs was quantified and an increase was found in patients with respect to controls. Hence, respiratory parameters normalized by mtDNA copy number were determined, and in these conditions a decrease in maximum respiration rate and spare respiratory capacity was observed in patients relative to control individuals. In platelets no decay was seen in mitochondrial function with age, while a reduction in basal, ATP independent and ATP-dependent respiration normalized by cell number was detected in patients compared to control subjects.
C1 [Alonso, Martina; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] Univ Republica, Dept Bioquim, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.
   [Alonso, Martina; Mansilla, Santiago; Martinez, Jennyfer; Castro, Laura; Quijano, Celia] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay.
   [Zabala, Cristina] Univ Republica, Clin Pediat A, Ctr Hosp Pereira Rossell, Fac Med, Montevideo, Uruguay.
   [Zabala, Cristina; Cerisola, Alfredo; Lemes, Aida] Banco Previs Social BPS, Ctr Referencia Nacl Defectos Congenitos & Enferme, Montevideo, Uruguay.
   [Mansilla, Santiago; Garau, Mariela] Univ Republica, Dept Metodos Cuantitat, Fac Med, Montevideo, Uruguay.
   [De Brun, Laureana; Puentes, Rodrigo] Univ Republica, Dept Patobiol, Unidad Microbiol, Fac Vet, Montevideo, Uruguay.
   [Rivas, Gabriela; Acosta, Cecilia] Univ Republica, Catedra & Dept Hemoterapia & Med Transfus, Hosp Clin, Fac Med, Montevideo, Uruguay.
   [Lens, Daniela] Univ Republica, Dept B asico Med, Hosp Clin, Fac Med, Montevideo, Uruguay.
   [Cerisola, Alfredo] Univ Republica, Catedra Neuropediat, Fac Med, Montevideo, Uruguay.
   [Grana, Martin; Naya, Hugo; Spangenberg, Lucia] Inst Pasteur Montevideo, Unidad Bioinformat, Montevideo, Uruguay.
   [Naya, Hugo] Univ Republica, Dept Prod Anim & Pasturas, Fac Agron, Montevideo, Uruguay.
   [Raggio, Victor] Univ Republica, Dept Genet, Fac Med, Montevideo, Uruguay.
C3 Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Pasteur Network; Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay
RP Castro, L; Quijano, C (corresponding author), Univ Republica, Dept Bioquim, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.; Castro, L; Quijano, C (corresponding author), Univ Republica, Ctr Invest Biomed CEINBIO, Fac Med, Ave Gen Flores 2125, Montevideo 11800, Uruguay.
EM lcastro@fmed.edu.uy; celiq@fmed.edu.uy
CR Ajaz S, 2021, AM J PHYSIOL-CELL PH, V320, PC57, DOI 10.1152/ajpcell.00426.2020
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Banas B, 2004, EUR J MED RES, V9, P371
   Bateman A, 2019, NUCLEIC ACIDS RES, V47, PD506, DOI 10.1093/nar/gky1049
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Braganza A, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.100835
   Braganza A, 2019, JCI INSIGHT, V4, P0, DOI 10.1172/jci.insight.128248
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Chacko BK, 2019, REDOX BIOL, V22, P0, DOI 10.1016/j.redox.2019.101165
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Czajka A, 2015, EBIOMEDICINE, V2, P499, DOI 10.1016/j.ebiom.2015.04.002
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Davizon-Castillo P, 2019, BLOOD, V134, P727, DOI 10.1182/blood.2019000200
   Breda CND, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101255
   Dogan SA, 2018, CELL METAB, V28, P764, DOI 10.1016/j.cmet.2018.07.012
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, PS4, DOI 10.1093/gerona/glu057
   Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gómez LA, 2012, SEMIN CELL DEV BIOL, V23, P758, DOI 10.1016/j.semcdb.2012.04.002
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gutmann C, 2020, ATHEROSCLEROSIS, V307, P87, DOI 10.1016/j.atherosclerosis.2020.05.022
   Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x
   Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Japiassú AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Kapniciz SM, 2018, METABOLISM, V81, P97, DOI 10.1016/j.metabol.2017.11.010
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kleiveland CR, 2015, IMPACT FOOD BIOACTIV, V0, P161
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee SH, 2016, EMBO MOL MED, V8, P779, DOI 10.15252/emmm.201506046
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lluberas N, 2015, SPRINGERPLUS, V4, P0, DOI 10.1186/s40064-015-1532-3
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Melchinger H, 2019, FRONT CARDIOVASC MED, V6, P0, DOI 10.3389/fcvm.2019.00153
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Napoli E, 2014, PEDIATRICS, V133, PE1405, DOI 10.1542/peds.2013-1545
   Naresh NU, 2019, CSH PERSPECT BIOL, V11, P0, DOI 10.1101/cshperspect.a033944
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   ONeill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005
   Pence BD, 2018, EXP GERONTOL, V108, P112, DOI 10.1016/j.exger.2018.04.008
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Rausser S, 2020, BIORXIV2020101634292, V2020, P0
   Reynolds LM, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1522-4
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sack MN, 2018, J CLIN INVEST, V128, P3651, DOI 10.1172/JCI120845
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   SHUSTER RC, 1988, BIOCHEM BIOPH RES CO, V155, P1360, DOI 10.1016/S0006-291X(88)81291-9
   Sjövall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001
   Sjövall F, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc9337
   Spangenberg L, 2019, MITOCHONDRION, V46, P337, DOI 10.1016/j.mito.2018.09.004
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Thavorntanaburt S, 2018, J PEDIATR SURG, V53, P489, DOI 10.1016/j.jpedsurg.2017.06.006
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zheng YF, 2020, PROTEIN CELL, V11, P740, DOI 10.1007/s13238-020-00762-2
NR 95
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2021
VL 61
IS 
BP 31
EP 43
DI 10.1016/j.mito.2021.09.004
EA SEP 2021
PG 13
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA WC9QP
UT WOS:000704585100004
PM 34536563
DA 2024-11-01
ER

PT J
AU Cheema, NJ
   Cameron, JM
   Hood, DA
AF Cheema, Nashwa J.
   Cameron, Jessie M.
   Hood, David A.
TI Effect of rapamycin on mitochondria and lysosomes in fibroblasts from patients with mtDNA mutations
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE human fibroblasts; lysosomes; mitochondrial health; mitochondrial myopathies; therapeutic agent
ID stroke-like episodes; lactic-acidosis; oxidative stress; melas syndrome; encephalopathy; metabolism; mitophagy; cells
AB Maintaining mitochondrial function and dynamics is crucial for cellular health. In muscle, defects in mitochondria result in severe myopathies where accumulation of damaged mitochondria causes deterioration and dysfunction. Importantly, understanding the role of mitochondria in disease is a necessity to determine future therapeutics. One of the most common myopathies is mitochondrial encephalopathy lactic acidosis stroke-like episodes (MELAS), which has no current treatment. Recently, patients with MELAS treated with rapamycin exhibited improved clinical outcomes. However, the cellular mechanisms of rapamycin effects in patients with MELAS are currently unknown. In this study, we used cultured skin fibroblasts as a window into the mitochondrial dysfunction evident in MELAS cells, as well as to study the mechanisms of rapamycin action, compared with control, healthy individuals. We observed that mitochondria from patients were fragmented, had a threefold decline in the average speed of motility, a twofold reduced mitochondrial membrane potential, and a 1.5- to 2-fold decline in basal respiration. Despite the reduction in mitochondrial function, mitochondrial import protein Tim23 was elevated in patient cell lines. MELAS fibroblasts exhibited increased MnSOD levels and lysosomal function when compared with healthy controls. Treatment of MELAS fibroblasts with rapamycin for 24 h resulted in increased mitochondrial respiration compared with control cells, a higher lysosome content, and a greater localization of mitochondria to lysosomes. Our studies suggest that rapamycin has the potential to improve cellular health even in the presence of mtDNA defects, primarily via an increase in lysosomal content.
C1 [Cheema, Nashwa J.; Hood, David A.] York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
   [Cameron, Jessie M.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada.
   [Cameron, Jessie M.] Univ Toronto, Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON, Canada.
C3 York University - Canada; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids)
RP Hood, DA (corresponding author), York Univ, Muscle Hlth Res Ctr, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.
EM dhood@yorku.ca
FU Natural Sciences and Engineering Research Council of Canada
CR Barca E, 2018, NEUROLOGY, V90, P0
   Bartolomé A, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00441-17
   Berbel-Garcia A, 2004, CLIN NEUROPHARMACOL, V27, P187, DOI 10.1097/01.wnf.0000137862.67131.bf
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, PC1176, DOI 10.1152/ajpcell.00017.2014
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Johnson SC, 2019, KIDNEY INT, V95, P455, DOI 10.1016/j.kint.2018.08.038
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, PC867, DOI 10.1152/ajpcell.00191.2003
   Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208
   Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009
   McAlary L, 2019, CNS DRUGS, V33, P883, DOI 10.1007/s40263-019-00657-9
   Menzies KJ, 2009, AM J PHYSIOL-CELL PH, V296, PC355, DOI 10.1152/ajpcell.00415.2007
   Moran M, 1842, BIOCH BIOPHYS ACTA, V0, P1059
   Paik K, 2019, CAN J NEUROL SCI, V46, P717, DOI 10.1017/cjn.2019.240
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Sato M, 2019, J PHARMACOL SCI, V140, P201, DOI 10.1016/j.jphs.2019.05.007
   Shin YJ, 2011, CURR EYE RES, V36, P1116, DOI 10.3109/02713683.2011.614372
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Suarez-Rivero Juan M, 2016, DISEASES, V5, P0, DOI 10.3390/diseases5010001
   Tokuyama T, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10030450
   Villa-Cuesta E, 2014, J CELL SCI, V127, P2282, DOI 10.1242/jcs.142026
   Zhang XL, 2019, PLOS BIOL, V17, P0, DOI 10.1371/journal.pbio.3000252
NR 31
TC 12
Z9 12
U1 1
U2 5
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6143
EI 1522-1563
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD JUL 15
PY 2021
VL 321
IS 1
BP C176
EP C186
DI 10.1152/ajpcell.00471.2020
PG 11
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA WC6WT
UT WOS:000704397000016
PM 34106788
DA 2024-11-01
ER

PT J
AU Kierdaszuk, B
   Kaliszewska, M
   Rusecka, J
   Kosinska, J
   Bartnik, E
   Tonska, K
   Kaminska, AM
   Kostera-Pruszczyk, A
AF Kierdaszuk, Biruta
   Kaliszewska, Magdalena
   Rusecka, Joanna
   Kosinska, Joanna
   Bartnik, Ewa
   Tonska, Katarzyna
   Kaminska, Anna M.
   Kostera-Pruszczyk, Anna
TI Progressive External Ophthalmoplegia in Polish Patients-From Clinical Evaluation to Genetic Confirmation
SO GENES
LA English
DT Article
DE mitochondrial disorders; progressive external ophthalmoplegia; POLG gene; TWNK gene; RNASEH1 gene; mitochondrial DNA deletions; multiple mitochondrial DNA deletions; muscle biopsy
AB Mitochondrial encephalomyopathies comprise a group of heterogeneous disorders resulting from impaired oxidative phosphorylation (OxPhos). Among a variety of symptoms progressive external ophthalmoplegia (PEO) seems to be the most common. The aim of this study is to present clinical and genetic characteristics of Polish patients with PEO. Clinical, electrophysiological, neuroradiological, and morphological data of 84 patients were analyzed. Genetic studies of mitochondrial DNA (mtDNA) were performed in all patients. Among nuclear DNA (nDNA) genes POLG was sequenced in 41 patients, TWNK (C10orf2) in 13 patients, and RNASEH1 in 2 patients. Total of 27 patients were included in the chronic progressive external ophthalmoplegia (CPEO) group, 24 in the CPEO+ group. Twenty-six patients had mitochondrial encephalomyopathy (ME), six patients Kearns-Sayre syndrome (KSS), and one patient sensory ataxic neuropathy, dysarthria, ophthalmoparesis (SANDO) syndrome. Genetic analysis of nDNA genes revealed the presence of pathogenic or possibly pathogenic variants in the POLG gene in nine patients, the TWNK gene in five patients and the RNASEH1 gene in two patients. Detailed patients' history and careful assessment of family history are essential in the diagnostic work-up. Genetic studies of both mtDNA and nDNA are necessary for the final diagnosis of progressive external ophthalmoplegia and for genetic counseling.
C1 [Kierdaszuk, Biruta; Kaminska, Anna M.; Kostera-Pruszczyk, Anna] Med Univ Warsaw, Dept Neurol, Banacha 1a, PL-02097 Warsaw, Poland.
   [Kaliszewska, Magdalena; Rusecka, Joanna; Bartnik, Ewa; Tonska, Katarzyna] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Pawinskiego 5a, PL-02106 Warsaw, Poland.
   [Kosinska, Joanna] Med Univ Warsaw, Dept Med Genet, Pawinskiego 3c, PL-02106 Warsaw, Poland.
C3 Medical University of Warsaw; University of Warsaw; Medical University of Warsaw
RP Kierdaszuk, B (corresponding author), Med Univ Warsaw, Dept Neurol, Banacha 1a, PL-02097 Warsaw, Poland.
EM bkierdaszuk@wum.edu.pl; mkaliszewska@gmail.com; ruseckaj@gmail.com; joanna.kosinska@wum.edu.pl; ebartnik@igib.uw.edu.pl; kaska@igib.uw.edu.pl; amkaminska@wum.edu.pl; anna.kostera-pruszczyk@wum.edu.pl
FU Ministry of Science and Higher Education [N N401 049238]; Polish National Science Center [2014/15/B/NZ5/00434]; EU Operational Programme Innovative Economy via the Foundation for Polish Science [VENTURES/2011-8/3]
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Auré K, 2007, BRAIN, V130, P1516, DOI 10.1093/brain/awm067
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Fekete B, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0934-4
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Galetta F, 2014, J NEUROL SCI, V345, P189, DOI 10.1016/j.jns.2014.07.044
   Gawel M, 2014, NEUROL NEUROCHIR POL, V48, P76, DOI 10.1016/j.pjnns.2013.09.003
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Jamali F, 2019, ARCH IRAN MED, V22, P728
   Kaliszewska M, 2015, HUM GENET, V134, P951, DOI 10.1007/s00439-015-1578-x
   Kierdaszuk B, 2009, NEUROL NEUROCHIR POL, V43, P216
   Komulainen T, 2015, JIMD REP, V23, P91, DOI 10.1007/8904_2015_438
   Kume K, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-01002-4
   Lee SJ, 2018, YONSEI MED J, V59, P1190
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Peter B, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11040408
   Ploski R, 2014, CIRC RES, V114, PE2, DOI 10.1161/CIRCRESAHA.114.302662
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Ronchi D, 2011, J NEUROL SCI, V308, P173, DOI 10.1016/j.jns.2011.05.042
   SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9
   Sciacco M, 2001, J NEUROL, V248, P778, DOI 10.1007/s004150170094
   Seo GH, 2019, J HUM GENET, V64, P1117, DOI 10.1038/s10038-019-0660-y
   Soong N W, 1996, METHODS ENZYMOL, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
   Zhang LS, 2011, ARCH PATHOL LAB MED, V135, P925, DOI 10.1043/2010-0356-RAR.1
NR 40
TC 1
Z9 1
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JAN 15
PY 2021
VL 12
IS 1
BP 
EP 
DI 10.3390/genes12010054
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA PV9EY
UT WOS:000610283600001
PM 33396418
DA 2024-11-01
ER

PT J
AU Tomita, K
   Kuwahara, Y
   Igarashi, K
   Roudkenar, MH
   Roushandeh, AM
   Kurimasa, A
   Sato, T
AF Tomita, Kazuo
   Kuwahara, Yoshikazu
   Igarashi, Kento
   Roudkenar, Mehryar Habibi
   Roushandeh, Amaneh Mohammadi
   Kurimasa, Akihiro
   Sato, Tomoaki
TI Mitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy
SO GENES
LA English
DT Review
DE mitochondria; mitochondrial DNA; clinically relevant radioresistant (CRR) cells; cancer radioresistance
ID clinically relevant radioresistant; dna copy number; progressive external ophthalmoplegia; peripheral-blood cells; stroke-like-episodes; hydrogen-peroxide; oxidative stress; cancer risk; pronuclear transfer; respiratory-chain
AB Mitochondria are very important intracellular organelles because they have various functions. They produce ATP, are involved in cell signaling and cell death, and are a major source of reactive oxygen species (ROS). Mitochondria have their own DNA (mtDNA) and mutation of mtDNA or change the mtDNA copy numbers leads to disease, cancer chemo/radioresistance and aging including longevity. In this review, we discuss the mtDNA mutation, mitochondrial disease, longevity, and importance of mitochondrial dysfunction in cancer first. In the later part, we particularly focus on the role in cancer resistance and the mitochondrial condition such as mtDNA copy number, mitochondrial membrane potential, ROS levels, and ATP production. We suggest a therapeutic strategy employing mitochondrial transplantation (mtTP) for treatment-resistant cancer.
C1 [Tomita, Kazuo; Kuwahara, Yoshikazu; Igarashi, Kento; Roudkenar, Mehryar Habibi; Roushandeh, Amaneh Mohammadi; Sato, Tomoaki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.
   [Kuwahara, Yoshikazu; Kurimasa, Akihiro] Tohoku Med & Pharmaceut Univ, Fac Med, Div Radiat Biol & Med, 1-15-1 Fukumuro, Sendai, Miyagi 9838536, Japan.
   [Roudkenar, Mehryar Habibi; Roushandeh, Amaneh Mohammadi] Guilan Univ Med Sci, Sch Med, Velayat Hosp, Burn & Regenerat Med Res Ctr, Parastar St, Rasht 4188794755, Iran.
C3 Kagoshima University; Tohoku Medical & Pharmaceutical University; Guilan University of Medical Sciences
RP Tomita, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.
EM ktomita@dent.kagoshima-u.ac.jp; y-kuwahara@tohoku-mpu.ac.jp; knt-igrs@dent.kagoshima-u.ac.jp; roudkenar@gums.ac.ir; mohammadi_roushandeh@gums.ac.ir; kurimasa@tohoku-mpu.ac.jp; tomsato@dent.kagoshima-u.ac.jp
FU JSPS KAKENHI [19K10138]; Grants-in-Aid for Scientific Research [19K10138] Funding Source: KAKEN
CR Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Callaway E, 2012, NATURE, V481, P419, DOI 10.1038/481419a
   Cardoso SA, 2004, NEUROCHEM INT, V45, P693, DOI 10.1016/j.neuint.2004.03.003
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Chang JC, 2019, J EXP CLIN CANC RES, V38, P0, DOI 10.1186/s13046-019-1028-z
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Clayton D A, 2000, HUM REPROD, V15 Suppl 2, P11
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Forkink M, 2010, BBA-BIOENERGETICS, V1797, P1034, DOI 10.1016/j.bbabio.2010.01.022
   Fukumoto M, 2014, CANCER SCI, V105, P1351, DOI 10.1111/cas.12489
   Gao JJ, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aaw7215
   Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gong JS, 1998, J CLIN BIOCHEM NUTR, V24, P105
   Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Guariento A, 2020, J HEART LUNG TRANSPL, V39, P1279, DOI 10.1016/j.healun.2020.06.023
   Gupta S, 2003, INT J ONCOL, V22, P15
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005
   Indo HP, 2018, FREE RADICAL BIO MED, V120, PS134, DOI 10.1016/j.freeradbiomed.2018.04.440
   Ishihara Y, 2016, J CLIN BIOCHEM NUTR, V59, P182, DOI 10.3164/jcbn.16-19
   Jabbari H, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165809
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kang D, 1998, MITOCHONDRIAL DNA MU, V0, P1
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kheirandish-Rostami M, 2020, LIFE SCI, V244, P0, DOI 10.1016/j.lfs.2020.117339
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590
   Kong Ling-hong, 2003, DI YI JUN YI DA XUE XUE BAO, V23, P990
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kulkarni R, 2009, MUTAT RES-FUND MOL M, V663, P46, DOI 10.1016/j.mrfmmm.2009.01.004
   Kuo CC, 2017, NEUROSURGERY, V80, P475, DOI 10.1093/neuros/nyw090
   Kuwahara Y, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.56
   Kuwahara Y, 2020, TECHNOL CANCER RES T, V19, P0, DOI 10.1177/1533033820980077
   Kuwahara Y, 2017, MED MOL MORPHOL, V50, P195, DOI 10.1007/s00795-017-0171-x
   Kuwahara Y, 2016, INT J RADIAT ONCOL, V96, P556, DOI 10.1016/j.ijrobp.2016.07.002
   Kuwahara Y, 2014, CANCER MED-US, V3, P310, DOI 10.1002/cam4.185
   Kuwahara Y, 2010, J RADIAT RES, V51, P297, DOI 10.1269/jrr.09094
   Kuwahara Y, 2009, CANCER SCI, V100, P747, DOI 10.1111/j.1349-7006.2009.01082.x
   LARSSON NG, 1995, MUSCLE NERVE, V0, PS102
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   McCully JD, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0095-4
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10039
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013
   Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107
   Nitzan K, 2019, J ALZHEIMERS DIS, V72, P587, DOI 10.3233/JAD-190853
   Ogura A, 2009, CANCER LETT, V277, P64, DOI 10.1016/j.canlet.2008.11.021
   Otaegui D, 2004, NEUROSCI LETT, V370, P171, DOI 10.1016/j.neulet.2004.08.012
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Pallast S, 2009, J NEUROCHEM, V111, P882, DOI 10.1111/j.1471-4159.2009.06379.x
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Petragnano F, 2020, J BIOMED SCI, V27, P0, DOI 10.1186/s12929-020-00683-6
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pourmohammadi-Bejarpasi Z, 2020, BRAIN RES BULL, V165, P70, DOI 10.1016/j.brainresbull.2020.09.018
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Qiu XX, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-19828-7
   REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   Roushandeh AM, 2020, MOL BIOL REP, V47, P4401, DOI 10.1007/s11033-020-05493-5
   Roushandeh AM, 2019, CYTOTECHNOLOGY, V71, P647, DOI 10.1007/s10616-019-00302-9
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shen J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131649
   Shin B, 2017, ADV EXP MED BIOL, V982, P595, DOI 10.1007/978-3-319-55330-6_31
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043
   Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Sun XC, 2018, SIGNAL TRANSDUCT TAR, V3, P0, DOI 10.1038/s41392-018-0011-z
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008
   Takashi Y, 2020, FREE RADICAL BIO MED, V161, P60, DOI 10.1016/j.freeradbiomed.2020.09.027
   Takashi Y, 2018, DATA BRIEF, V20, P402, DOI 10.1016/j.dib.2018.08.025
   TAKAYANAGI R, 1980, BIOCHEM J, V192, P853, DOI 10.1042/bj1920853
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8
   Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.0.CO;2-I
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tomita K, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158300
   Tomita K, 2019, BIOCHEM BIOPH RES CO, V518, P712, DOI 10.1016/j.bbrc.2019.08.117
   Tomita Kazuo, 2018, TUMOUR BIOL, V40, P1010428318799250, DOI 10.1177/1010428318799250
   Tomita K, 2017, BIOCHEM BIOPH RES CO, V490, P330, DOI 10.1016/j.bbrc.2017.06.044
   Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Woods DC, 2015, SEMIN REPROD MED, V33, P410, DOI 10.1055/s-0035-1567826
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yahata N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15871-y
   ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661
NR 125
TC 11
Z9 12
U1 2
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD SEP 15
PY 2021
VL 12
IS 9
BP 
EP 
DI 10.3390/genes12091348
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA UV9KD
UT WOS:000699787400001
PM 34573330
DA 2024-11-01
ER

PT J
AU Picard, M
AF Picard, Martin
TI Blood mitochondrial DNA copy number: What are we counting?
SO MITOCHONDRION
LA English
DT Review
DE White blood cells; Mitochondrial function; Mitochondrion; Biomarker; Count; Mitochondrial genome; Leukocytes
ID skeletal-muscle; mtdna depletion; immune cells; quantification; association; expression; stress; heteroplasmy; variability; biogenesis
AB There is growing scientific interest to develop scalable biological measures that capture mitochondrial (dys) function. Mitochondria have their own genome, the mitochondrial DNA (mtDNA). It has been proposed that the number of mtDNA copies per cell (mtDNA copy number; mtDNAcn) reflects mitochondrial health. The common availability of stored DNA material or existing DNA sequencing data, especially from blood and other easy-tocollect samples, has made its quantification a popular approach in clinical and epidemiological studies. However, the interpretation of mtDNAcn is not univocal, and either a reduction or elevation in mtDNAcn can indicate dysfunction. The major determinants of blood-derived mtDNAcn are the heterogeneous cell type composition of leukocytes and platelet abundance, which can change with time of day, aging, and with disease. Hematopoiesis is a likely driver of blood mtDNAcn. Here we discuss the rationale and available methods to quantify mtDNAcn, the influence of blood cell type variations, and consider important gaps in knowledge that need to be resolved to maximize the scientific value around the investigation of blood mtDNAcn.
C1 [Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Irving Med Ctr, Columbia Translat Neurosci Initiat, Merritt Ctr,Dept Neurol, New York, NY 10027 USA.
   [Picard, Martin] New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
C3 Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Columbia University; New York State Psychiatry Institute
RP Picard, M (corresponding author), Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Irving Med Ctr, Columbia Translat Neurosci Initiat, Merritt Ctr,Dept Neurol, New York, NY 10027 USA.; Picard, M (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
EM martin.picard@columbia.edu
FU National Institutes of Health [GM119793, MH119336, MH122706, AG066828]
CR Ajaz Saima, 2015, METHODS MOL BIOL, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12
   [Anonymous], 2013, BIOENERGETICS 4, V0, P0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Banas B, 2004, EUR J MED RES, V9, P371
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Berry BJ, 2021, GEROSCIENCE, V43, P1591, DOI 10.1007/s11357-021-00365-7
   Biino G, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054289
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brinckmann A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013513
   Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008
   Chernecky CC, 2013, LAB TESTS DIAGNOSTIC, V6th, P0
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR
   Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008
   DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Egan B, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074098
   Fazzini F, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-33684-5
   Ferrucci L, 2020, NAT REV ENDOCRINOL, V16, P133, DOI 10.1038/s41574-020-0319-y
   Feusier J, 2017, MOBILE DNA-UK, V8, P0, DOI 10.1186/s13100-017-0093-0
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fuke S, 2011, BBA-BIOENERGETICS, V1807, P270, DOI 10.1016/j.bbabio.2010.11.016
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano L, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2015.364
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gumpp AM, 2020, P NATL ACAD SCI USA, V117, P24778, DOI 10.1073/pnas.2005885117
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hägg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w
   Hummel EM, 2018, TRANSL PSYCHIAT, V8, P0, DOI 10.1038/s41398-018-0264-x
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Ikeda M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0119687
   Ince LM, 2019, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.03143
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kim C, 2015, CANCER EPIDEM BIOMAR, V24, P148, DOI 10.1158/1055-9965.EPI-14-0753
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Konkel MK, 2015, GENOME BIOL EVOL, V7, P2608, DOI 10.1093/gbe/evv167
   Kramer PA, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51301
   Kumar P, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-31122-0
   Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   McLaughlin KL, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-74718-1
   Melchinger H, 2019, FRONT CARDIOVASC MED, V6, P0, DOI 10.3389/fcvm.2019.00153
   Meng SS, 2016, ONCOTARGET, V7, P60676, DOI 10.18632/oncotarget.10325
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Meyer JN, 2018, TOXICOL SCI, V162, P15, DOI 10.1093/toxsci/kfy008
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Moore AZ, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12683
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Nakahira K, 2013, PLOS MED, V10, P0, DOI 10.1371/journal.pmed.1001577
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Osto Corey, 2020, CURR PROTOC CELL BIOL, V89, Pe116, DOI 10.1002/cpcb.116
   Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7
   Picard M, 2019, CURR OPIN BEHAV SCI, V28, P142, DOI 10.1016/j.cobeha.2019.04.015
   Picard M, 2018, BIOL PSYCHIAT, V84, P9, DOI 10.1016/j.biopsych.2018.01.012
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Rausser S, 2021, MITOCHONDRIAL PHENOT, V0, P0, DOI DOI 10.1101/2020.10.16.342923
   Riley JS, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949799
   Rosa HS, 2020, FASEB J, V34, P12278, DOI 10.1096/fj.202000959RR
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Saenen ND, 2019, ENVIRON INT, V123, P39, DOI 10.1016/j.envint.2018.11.028
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Schubert S, 2015, INT J MOL SCI, V16, P9850, DOI 10.3390/ijms16059850
   Scozzi D, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.143299
   Segerstrom SC, 2017, PSYCHONEUROENDOCRINO, V78, P114, DOI 10.1016/j.psyneuen.2017.01.026
   Selvaraj V, 2018, BIOL REPROD, V99, P13, DOI 10.1093/biolre/ioy102
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Stephens OR, 2020, MITOCHONDRION, V54, P102, DOI 10.1016/j.mito.2020.08.002
   Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007
   Theda C, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-25311-0
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026
   Tyrka AR, 2016, BIOL PSYCHIAT, V79, P78, DOI 10.1016/j.biopsych.2014.12.025
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Verhoeven JE, 2018, MOL PSYCHIATR, V23, P850, DOI 10.1038/mp.2017.48
   Vettor R, 2014, AM J PHYSIOL-ENDOC M, V306, PE519, DOI 10.1152/ajpendo.00617.2013
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Ware SA, 2020, J BIOL CHEM, V295, P15677, DOI 10.1074/jbc.RA120.015237
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   Yonova-Doing E, 1900, P2021, V0, P0
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Zhang J, 2015, HEMATOL TRANSFUS INT J, V1, P108
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
NR 109
TC 85
Z9 92
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2021
VL 60
IS 
BP 1
EP 11
DI 10.1016/j.mito.2021.06.010
EA JUL 2021
PG 11
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA WD0EX
UT WOS:000704622300001
PM 34157430
DA 2024-11-01
ER

PT J
AU Nicoletti, V
   Palermo, G
   Del Prete, E
   Mancuso, M
   Ceravolo, R
AF Nicoletti, Valentina
   Palermo, Giovanni
   Del Prete, Eleonora
   Mancuso, Michelangelo
   Ceravolo, Roberto
TI Understanding the Multiple Role of Mitochondria in Parkinson's Disease and Related Disorders: Lesson From Genetics and Protein-Interaction Network
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Parkinson&#8217; s disease; atypical parkinsonism; Huntington disease; mitochondrial dysfunction; neurodegenerative diseases; Pink1; parkin pathway; alpha-synuclein
ID progressive supranuclear palsy; huntingtons-disease; respiratory-chain; alpha-synuclein; mutant huntingtin; skeletal-muscle; axonal-transport; oxidative stress; dna deletions; complex-i
AB As neurons are highly energy-demanding cell, increasing evidence suggests that mitochondria play a large role in several age-related neurodegenerative diseases. Synaptic damage and mitochondrial dysfunction have been associated with early events in the pathogenesis of major neurodegenerative diseases, including Parkinson's disease, atypical parkinsonisms, and Huntington disease. Disruption of mitochondrial structure and dynamic is linked to increased levels of reactive oxygen species production, abnormal intracellular calcium levels, and reduced mitochondrial ATP production. However, recent research has uncovered a much more complex involvement of mitochondria in such disorders than has previously been appreciated, and a remarkable number of genes and proteins that contribute to the neurodegeneration cascade interact with mitochondria or affect mitochondrial function. In this review, we aim to summarize and discuss the deep interconnections between mitochondrial dysfunction and basal ganglia disorders, with an emphasis into the molecular triggers to the disease process. Understanding the regulation of mitochondrial pathways may be beneficial in finding pharmacological or non-pharmacological interventions to delay the onset of neurodegenerative diseases.
C1 [Nicoletti, Valentina; Palermo, Giovanni; Del Prete, Eleonora; Mancuso, Michelangelo; Ceravolo, Roberto] Univ Pisa, Dept Clin & Expt Med, Neurol Unit, Pisa, Italy.
C3 University of Pisa
RP Ceravolo, R (corresponding author), Univ Pisa, Dept Clin & Expt Med, Neurol Unit, Pisa, Italy.
EM roberto.ceravolo@unipi.it
FU Telethon Grant [GUP09004]; Telethon-MITOCON Grant [GSP16001];  [RF-2016-02361495];  [EJPRD2019-145 GENOMIT]
CR Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015
   Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277
   Albers DS, 2001, EXP NEUROL, V168, P196, DOI 10.1006/exnr.2000.7607
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   Anvret Anna, 2012, OPEN NEUROL J, V6, P1, DOI 10.2174/1874205X01206010001
   Apetauerova D, 2016, NEUROL-NEUROIMMUNOL, V3, P0, DOI 10.1212/NXI.0000000000000266
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Barca E, 2016, J NEUROPATH EXP NEUR, V75, P663, DOI 10.1093/jnen/nlw037
   BEAL MF, 1993, J NEUROSCI, V13, P4181
   Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Björkblom B, 2013, J BIOL CHEM, V288, P22809, DOI 10.1074/jbc.M113.482091
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bonifati V, 2007, PARKINSONISM RELAT D, V13, PS233, DOI 10.1016/S1353-8020(08)70008-7
   Borsche M, 2021, J PARKINSON DIS, V11, P45, DOI 10.3233/JPD-201981
   Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004
   Bové J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86
   Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514
   Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018
   Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489
   Calì T, 2012, CELL CALCIUM, V52, P73, DOI 10.1016/j.ceca.2012.04.015
   Calì T, 2012, J BIOL CHEM, V287, P17914, DOI 10.1074/jbc.M111.302794
   Cantuti-Castelvetri I, 2002, BRAIN RES, V930, P170, DOI 10.1016/S0006-8993(02)02244-8
   Celardo I, 2014, BRIT J PHARMACOL, V171, P1943, DOI 10.1111/bph.12433
   Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007
   Chao YX, 2015, NEUROGENETICS, V16, P241, DOI 10.1007/s10048-015-0443-3
   Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chirichigno JW, 2002, BRAIN RES, V951, P31, DOI 10.1016/S0006-8993(02)03101-3
   Cisbani G, 2012, CELL DEATH DIS, V3, P0, DOI 10.1038/cddis.2012.121
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Clarke Donald D, 1999, P637, V0, P0
   Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Compagnoni GM, 2018, STEM CELL REP, V11, P1185, DOI 10.1016/j.stemcr.2018.09.007
   Compagnoni GM, 2018, BBA-MOL BASIS DIS, V1864, P3588, DOI 10.1016/j.bbadis.2018.09.018
   Compta Y, 2018, PARKINSONISM RELAT D, V46, P16, DOI 10.1016/j.parkreldis.2017.10.010
   Cornejo-Olivas MR, 2015, PARKINSONISM RELAT D, V21, P444, DOI 10.1016/j.parkreldis.2015.01.005
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Costa AC, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2012.205
   Dalfó E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a
   Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012
   Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599
   Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526
   DEXTER DT, 1992, ANN NEUROL, V32, PS94, DOI 10.1002/ana.410320716
   Di Maio R, 2018, SCI TRANSL MED, V10, P0, DOI 10.1126/scitranslmed.aar5429
   Di Maio R, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf3634
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Doherty KM, 2013, MOVEMENT DISORD, V28, P702, DOI 10.1002/mds.25486
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   Eguchi T, 2018, P NATL ACAD SCI USA, V115, PE9115, DOI 10.1073/pnas.1812196115
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007
   Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488
   Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132
   Fiesel FC, 2015, EMBO REP, V16, P1114, DOI 10.15252/embr.201540514
   Fitzgerald JC, 2017, BRAIN, V140, P2444, DOI 10.1093/brain/awx202
   Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102
   Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163
   Fransson Å, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514
   Gasser T, 2009, EXPERT REV MOL MED, V11, P0, DOI 10.1017/S1462399409001148
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067
   Gomez-Pastor R, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14405
   Grassi D, 2018, P NATL ACAD SCI USA, V115, PE2634, DOI 10.1073/pnas.1713849115
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   Gu M, 1997, MOVEMENT DISORD, V12, P418, DOI 10.1002/mds.870120323
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   Guo X, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12646
   Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438
   HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409
   Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0
   Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593
   Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039
   Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6
   Höllerhage M, 2009, EXP NEUROL, V220, P133, DOI 10.1016/j.expneurol.2009.08.004
   Höglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   Huttenlocher J, 2015, J MED GENET, V52, P37, DOI 10.1136/jmedgenet-2014-102570
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92
   Intihar TA, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00103
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Jellinger KA, 2018, J ALZHEIMERS DIS, V62, P1141, DOI 10.3233/JAD-170397
   Jenner P, 1996, NEUROLOGY, V47, PS161, DOI 10.1212/WNL.47.6_Suppl_3.161S
   Jeon BS, 2014, NEW ENGL J MED, V371, P80, DOI 10.1056/NEJMc1311763
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Kang SS, 2018, EMBO J, V37, P0, DOI 10.15252/embj.201798878
   Kasai T, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0147574
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khalil B, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2014.581
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   Krismer F, 2017, NAT REV NEUROL, V13, P232, DOI 10.1038/nrneurol.2017.26
   Lannuzel A, 2003, NEUROSCIENCE, V121, P287, DOI 10.1016/S0306-4522(03)00441-X
   Lannuzel A, 2007, BRAIN, V130, P816, DOI 10.1093/brain/awl347
   Lautenschäger J, 2019, PROG NEUROBIOL, V181, P0, DOI 10.1016/j.pneurobio.2019.101660
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Lee JH, 2015, NEURON, V85, P303, DOI 10.1016/j.neuron.2014.12.019
   Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014
   Limanaqi F, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20133274
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin KJ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20215312
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056
   Liu ML, 2009, J CELL SCI, V122, P1917, DOI 10.1242/jcs.042226
   Liu S, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002537
   Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Mahy N, 2000, NEUROBIOLOGY (BUDAPEST), V8, P47
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martínez JH, 2018, ARCH BIOCHEM BIOPHYS, V651, P1, DOI 10.1016/j.abb.2018.04.018
   Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033
   Melo TQ, 2018, NEUROCHEM RES, V43, P2212, DOI 10.1007/s11064-018-2673-x
   Menke T, 2003, BIOFACTORS, V18, P65, DOI 10.1002/biof.5520180208
   Miraglia F, 2018, NEURAL REGEN RES, V13, P1136, DOI 10.4103/1673-5374.235013
   Mitsui J, 2016, JAMA NEUROL, V73, P1499, DOI 10.1001/jamaneurol.2016.4133
   Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115
   Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052
   Miyakawa S, 2013, MOVEMENT DISORD, V28, P388, DOI 10.1002/mds.25346
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166
   Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x
   Mor DE, 2017, NAT NEUROSCI, V20, P1560, DOI 10.1038/nn.4641
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Morán M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038
   Nixon RA, 2020, BBA-PROTEINS PROTEOM, V1868, P0, DOI 10.1016/j.bbapap.2020.140443
   Odetti P, 2000, J NEUROPATH EXP NEUR, V59, P393, DOI 10.1093/jnen/59.5.393
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Pandey M, 2008, J NEUROCHEM, V104, P420, DOI 10.1111/j.1471-4159.2007.04996.x
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Parnetti L, 2014, MOVEMENT DISORD, V29, P1019, DOI 10.1002/mds.25772
   Perfeito R, 2014, MOL CELL NEUROSCI, V62, P51, DOI 10.1016/j.mcn.2014.08.002
   Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011
   Pieri L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24526
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Devoto VMP, 2017, DIS MODEL MECH, V10, P1075, DOI 10.1242/dmm.026294
   Devoto VMP, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05334-9
   Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215
   Rango M, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9050250
   Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016
   Ries V, 2011, J MOL NEUROSCI, V45, P684, DOI 10.1007/s12031-011-9606-3
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Roe AJ, 2018, BIOCHEM BIOPH RES CO, V496, P706, DOI 10.1016/j.bbrc.2018.01.114
   Ronchi D, 2016, NEUROBIOL AGING, V45, P0, DOI 10.1016/j.neurobiolaging.2016.05.022
   Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3
   Rott R, 2017, P NATL ACAD SCI USA, V114, P13176, DOI 10.1073/pnas.1704351114
   Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695
   Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003
   Ryan T, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03241-9
   Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373
   Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   Schottlaender LV, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0149557
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Soubannier V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052830
   Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008
   Stamelou M, 2008, MOVEMENT DISORD, V23, P942, DOI 10.1002/mds.22023
   Stamelou M, 2013, MOVEMENT DISORD, V28, P1184, DOI 10.1002/mds.25509
   Stamelou M, 2009, J CEREBR BLOOD F MET, V29, P861, DOI 10.1038/jcbfm.2009.2
   Steele JC, 2015, ANN NEUROL, V77, P458, DOI 10.1002/ana.24346
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521
   Swerdlow RH, 2000, J NEUROCHEM, V75, P1681, DOI 10.1046/j.1471-4159.2000.0751681.x
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7
   Takanashi M, 2016, NEUROLOGY, V86, P2212, DOI 10.1212/WNL.0000000000002744
   Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001
   Theurey P, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9010022
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105
   Vicario M, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00388
   Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369
   Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1
   Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983
   Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018
   Wanker EE, 2019, J NEUROCHEM, V151, P507, DOI 10.1111/jnc.14853
   Weber CA, 2006, ANN PHARMACOTHER, V40, P935, DOI 10.1345/aph.1G551
   Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178
   Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102
   Winkler-Stuck K, 2005, J NEURAL TRANSM, V112, P499, DOI 10.1007/s00702-004-0195-y
   Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Yan X, 2020, FRONT CELL NEUROSCI, V14, P0, DOI 10.3389/fncel.2020.00138
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Ysselstein D, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13413-w
   Zhang L, 2013, HUM MOL GENET, V22, P2829, DOI 10.1093/hmg/ddt132
   Zhao YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09291-x
   Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008
NR 237
TC 43
Z9 43
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD APR 1
PY 2021
VL 9
IS 
BP 
EP 
DI 10.3389/fcell.2021.636506
PG 20
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA RN4MX
UT WOS:000640328000001
PM 33869180
DA 2024-11-01
ER

PT J
AU Oller, J
   Gabandé-Rodríguez, E
   Ruiz-Rodríguez, MJ
   Desdín-Micó, G
   Aranda, JF
   Rodrigues-Diez, R
   Ballesteros-Martínez, C
   Blanco, EM
   Roldan-Montero, R
   Acuña, P
   Gil, AF
   Martín-López, CE
   Nistal, JF
   Cardenas, CLL
   Lindsay, ME
   Martín-Ventura, JL
   Briones, AM
   Redondo, JM
   Mittelbrunn, M
AF Oller, Jorge
   Gabande-Rodriguez, Enrique
   Ruiz-Rodriguez, Maria Jesus
   Desdin-Mico, Gabriela
   Aranda, Juan Francisco
   Rodrigues-Diez, Raquel
   Ballesteros-Martinez, Constanza
   Blanco, Eva Maria
   Roldan-Montero, Raquel
   Acuna, Pedro
   Forteza Gil, Alberto
   Martin-Lopez, Carlos E.
   Nistal, J. Francisco
   Lino Cardenas, Christian L.
   Lindsay, Mark Evan
   Martin-Ventura, Jose Luis
   Briones, Ana M.
   Miguel Redondo, Juan
   Mittelbrunn, Maria
TI Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm
SO CIRCULATION
LA English
DT Article
DE aortic aneurysm; DNA; mitochondrial; extracellular matrix; genetic diseases; inborn; glycolysis; Marfan syndrome; muscle; smooth; vascular
ID vascular smooth-muscle; marfan-syndrome; mouse model; nad(+) deficiency; metabolism; cells; losartan; genetics; mechanotransduction; degeneration
AB Background: Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thoracic aortic aneurysm. To date, no effective pharmacologic therapies have been identified for the management of thoracic aortic disease and the only options capable of preventing aneurysm rupture are endovascular repair or open surgery. Here, we have studied the role of mitochondrial dysfunction in the progression of thoracic aortic aneurysm and mitochondrial boosting strategies as a potential treatment to managing aortic aneurysms. Methods: Combining transcriptomics and metabolic analysis of aortas from an MFS mouse model (Fbn1(c1039g/+)) and MFS patients, we have identified mitochondrial dysfunction alongside with mtDNA depletion as a new hallmark of aortic aneurysm disease in MFS. To demonstrate the importance of mitochondrial decline in the development of aneurysms, we generated a conditional mouse model with mitochondrial dysfunction specifically in vascular smooth muscle cells (VSMC) by conditional depleting Tfam (mitochondrial transcription factor A; Myh11-Cre(ERT2)Tfam(flox/flox) mice). We used a mouse model of MFS to test for drugs that can revert aortic disease by enhancing Tfam levels and mitochondrial respiration. Results: The main canonical pathways highlighted in the transcriptomic analysis in aortas from Fbn1(c1039g/+) mice were those related to metabolic function, such as mitochondrial dysfunction. Mitochondrial complexes, whose transcription depends on Tfam and mitochondrial DNA content, were reduced in aortas from young Fbn1(c1039g/+) mice. In vitro experiments in Fbn1-silenced VSMCs presented increased lactate production and decreased oxygen consumption. Similar results were found in MFS patients. VSMCs seeded in matrices produced by Fbn1-deficient VSMCs undergo mitochondrial dysfunction. Conditional Tfam-deficient VSMC mice lose their contractile capacity, showed aortic aneurysms, and died prematurely. Restoring mitochondrial metabolism with the NAD precursor nicotinamide riboside rapidly reverses aortic aneurysm in Fbn1(c1039g/+) mice. Conclusions: Mitochondrial function of VSMCs is controlled by the extracellular matrix and drives the development of aortic aneurysm in Marfan syndrome. Targeting vascular metabolism is a new available therapeutic strategy for managing aortic aneurysms associated with genetic disorders.
C1 [Oller, Jorge; Gabande-Rodriguez, Enrique; Desdin-Mico, Gabriela; Aranda, Juan Francisco; Blanco, Eva Maria; Acuna, Pedro; Mittelbrunn, Maria] Consejo Super Invest Cient Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Spain.
   [Oller, Jorge; Gabande-Rodriguez, Enrique; Desdin-Mico, Gabriela; Aranda, Juan Francisco; Blanco, Eva Maria; Mittelbrunn, Maria] Inst Invest Sanitaria Hosp 12 Octubre i 12, Madrid, Spain.
   [Oller, Jorge; Rodrigues-Diez, Raquel; Roldan-Montero, Raquel; Briones, Ana M.; Miguel Redondo, Juan] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain.
   [Ruiz-Rodriguez, Maria Jesus; Miguel Redondo, Juan] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.
   [Rodrigues-Diez, Raquel; Ballesteros-Martinez, Constanza; Briones, Ana M.] Univ Autonoma Madrid, Inst Invest Hosp La Paz, Dept Farmacol, Madrid, Spain.
   [Roldan-Montero, Raquel; Martin-Ventura, Jose Luis] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain.
   [Roldan-Montero, Raquel; Martin-Ventura, Jose Luis] Hosp Univ Puerta Hierro, Madrid, Spain.
   [Nistal, J. Francisco] Univ Cantabria, Hosp Univ Marques Valdecilla, Cardiovasc Surg, IDIVAL, Santander, Spain.
   [Lino Cardenas, Christian L.; Lindsay, Mark Evan] Massachusetts Gen Hosp, Thorac Aort Ctr, Boston, MA 02114 USA.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Harvard University; Massachusetts General Hospital
RP Mittelbrunn, M (corresponding author), Ctr Biol Mol Severo Ochoa, Immunometab & Inflammat Lab, C Nicolas Cabrera 1, Madrid 28049, Spain.
EM jorge.oller@cbm.csic.es; egabande@cbm.csic.es; gdesdin@cbm.csic.es; jmredondo@cnic.es; Raquel.roldanm@quironsalud.es; constanza.ballesteros.martinez@gmail.com; eblanco@cbm.csic.es; Raquel.roldanm@quironsalud.es; pedro.acunna@estudiante.uam.es; apforteza@yahoo.es; carlosestebanmartin@hotmail.com; jfnistal@gmail.com; CLINOCARDENAS@mgh.harvard.edu; Lindsay.Mark@mgh.harvard.edu; jmredondo@cnic.es; mmittelbrunn@cbm.csic.es
FU Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI16/188, PI19/855]; European Regional Development Fund; European Commission through H2020-EU.1.1; European Research Council grant ERC-2016-StG [715322]; Gobierno de Espana [SAF2016-80305P]; Comunidad de Madrid [S2017/BMD 3867 RENIM-CM]; European Structural and Investment Fund; Miguel Servet Program (Fundacion de Investigacion del Hospital 12 de Octubre) [CP 19/014]; Juan de la Cierva [FJCI2017-33855, IJC2018-036850-I, IJCI-2017-31399]; Ministerio de Ciencia e Innovacion [RTI2018-099246-B-I00, PI18/00543]; Comunidad de Madrid; Fondo Social Europeo funds (AORTASANA-CM) [B2017/BMD-3676]; Fundacion La Caixa [HR18-00068]; Marfan Foundation (USA); Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares of Ministerio de Ciencia e Innovacion [CB16/11/00264]; Ministerio de Economia y Competitividad [PI18/00543]; Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares [CB16/11/00264]; Fondo Europeo de Desarrollo Regional; European Research Council (ERC) [715322] Funding Source: European Research Council (ERC)
CR Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075
   Bartolák-Suki E, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18081812
   Bays JL, 2017, NAT CELL BIOL, V19, P724, DOI 10.1038/ncb3537
   Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Castello-Cros Remedios, 2009, V522, V0, PP275, DOI 10.1007/978-1-59745-413-1_19
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chou EL, 2020, AM J MED GENET C, V184, P136, DOI 10.1002/ajmg.c.31771
   Chung KW, 2019, CELL METAB, V30, P784, DOI 10.1016/j.cmet.2019.08.003
   Crosas-Molist E, 2015, ARTERIOSCL THROM VAS, V35, P960, DOI 10.1161/ATVBAHA.114.304412
   Dai JB, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06376-x
   De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037
   DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R
   Desdín-Micó G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860
   DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0
   Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503
   Forteza A, 2016, EUR HEART J, V37, P978, DOI 10.1093/eurheartj/ehv575
   Gillis E, 2013, CIRC RES, V113, P327, DOI 10.1161/CIRCRESAHA.113.300675
   Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042
   Humphrey JD, 2015, CIRC RES, V116, P1448, DOI 10.1161/CIRCRESAHA.114.304936
   Jana S, 2019, EXP MOL MED, V51, P0, DOI 10.1038/s12276-019-0286-3
   Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523
   Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P29, DOI 10.1111/j.1540-8175.2010.01241.x
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695
   Luo W, 2020, CIRCULATION, V141, P42, DOI 10.1161/CIRCULATIONAHA.119.041460
   Michel JB, 2018, CARDIOVASC RES, V114, P578, DOI 10.1093/cvr/cvy006
   Nolasco P, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2019.165587
   Okamura H, 2017, PHYSIOL REP, V5, P0, DOI 10.14814/phy2.13257
   Oller J, 2017, NAT MED, V23, P200, DOI 10.1038/nm.4266
   Oller J, 2015, MOL CELL BIOL, V35, P3409, DOI 10.1128/MCB.00494-15
   Park JS, 2020, NATURE, V578, P621, DOI 10.1038/s41586-020-1998-1
   Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001
   Petsophonsakul P, 2019, ARTERIOSCL THROM VAS, V39, P1351, DOI 10.1161/ATVBAHA.119.312787
   Pinard A, 2019, CIRC RES, V124, P588, DOI 10.1161/CIRCRESAHA.118.312436
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Prolla TA, 2014, CELL METAB, V19, P178, DOI 10.1016/j.cmet.2014.01.005
   Quintana RA, 2019, CIRC RES, V124, P607, DOI 10.1161/CIRCRESAHA.118.313187
   Rocha RV, 2020, J VASC SURG, V71, P1396, DOI 10.1016/j.jvs.2019.06.216
   Roussin I, 2011, CIRCULATION, V124, P100, DOI 10.1161/CIRCULATIONAHA.111.025056
   SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P21, DOI 10.1016/S0002-9149(77)80005-2
   Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327
   Sullivan WJ, 2018, CELL, V175, P117, DOI 10.1016/j.cell.2018.08.017
   Teixido-Tura G, 2018, J AM COLL CARDIOL, V72, P1613, DOI 10.1016/j.jacc.2018.07.052
   Uriarte JJ, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0152124
   van der Pluijm I, 2018, CARDIOVASC RES, V114, P1776, DOI 10.1093/cvr/cvy150
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Watson A, 2017, CIRC RES, V120, P1889, DOI 10.1161/CIRCRESAHA.116.310022
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhao X, 2019, NAT METAB, V1, P147, DOI 10.1038/s42255-018-0008-5
NR 57
TC 60
Z9 63
U1 2
U2 27
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD MAY 25
PY 2021
VL 143
IS 21
BP 2091
EP 2109
DI 10.1161/CIRCULATIONAHA.120.051171
PG 19
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA SH2JJ
UT WOS:000653959500010
PM 33709773
DA 2024-11-01
ER

PT J
AU Shen, XY
   Du, AL
AF Shen, Xiya
   Du, Ailian
TI The non-syndromic clinical spectrums of mtDNA 3243A&gt;G mutation
SO NEUROSCIENCES
LA English
DT Review
ID chronic intestinal pseudoobstruction; mitochondrial-dna mutations; deafness midd; m.3243a-greater-than-g mutation; phenotypic spectrum; natural-history; melas; prevalence; carriers; disease
AB The m.3243A >G mutation in the tRNA Leu (UUR) gene (MT-TL1) of the mitochondrial DNA is the most widely seen pathogenic mtDNA mutation which has major phenotypic variations. The clinical phenotype involves various organs such as the brain and nerves, skeletal muscles, heart, endocrine system, gastrointestinal tract, and skin. Some phenotypes conform to well established syndromes, while most of the symptoms appear individually or concomitant to other syndromes, making identification difficult. Furthermore, some progress has been made on cardiac manifestations as well as complications during pregnancy and perinatal period. This article provides a systematic review of the non-syndromic phenotypes and latest developments in m.3243A>G mutation.
C1 [Shen, Xiya; Du, Ailian] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University
RP Du, AL (corresponding author), Shanghai Jiao Tong Univ, Tongren Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China.
EM lotusdu@126.com
CR Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   Cardenas-Robledo S, 2016, J NEURO-OPHTHALMOL, V36, P134, DOI 10.1097/WNO.0000000000000340
   Chae HW, 2020, EUR J ENDOCRINOL, V183, P505, DOI 10.1530/EJE-20-0189
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   de Laat P, 2020, J MED GENET, V0, P0
   de Laat P, 2015, MITOCHONDRION, V25, P98, DOI 10.1016/j.mito.2015.10.005
   Dodick DW, 2018, LANCET, V391, P1315, DOI 10.1016/S0140-6736(18)30478-1
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Finsterer J, 2016, MOL GENET METAB REP, V8, P33, DOI 10.1016/j.ymgmr.2016.07.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Imai-Okazaki A, 2019, INT J CARDIOL, V279, P115, DOI 10.1016/j.ijcard.2019.01.017
   Inoue A, 2019, OTOL NEUROTOL, V40, P359, DOI 10.1097/MAO.0000000000002091
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Kraya T, 2018, HEADACHE, V58, P45, DOI 10.1111/head.13219
   Kuleva M, 2019, BJOG-INT J OBSTET GY, V126, P1372, DOI 10.1111/1471-0528.15515
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Miyaoka H, 1997, BIOL PSYCHIAT, V42, P524, DOI 10.1016/S0006-3223(97)00280-1
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naing A, 2014, J DIABETES COMPLICAT, V28, P542, DOI 10.1016/j.jdiacomp.2014.03.006
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634
   Pan XL, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00780
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Say RE, 2011, OBSTET MED, V4, P90, DOI 10.1258/om.2011.110008
   Smeitink Jan, 2019, JIMD REP, V46, P52, DOI 10.1002/jmd2.12017
   Stanghellini V, 2007, NEUROGASTROENT MOTIL, V19, P440, DOI 10.1111/j.1365-2982.2007.00902.x
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   [孙翀 Sun Chong], 2018, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V51, P118
   Tiehuis LH, 2020, MITOCHONDRION, V53, P128, DOI 10.1016/j.mito.2020.05.004
   Tsujikawa K, 2016, MITOCHONDRION, V30, P229, DOI 10.1016/j.mito.2016.08.011
   van den Ameele J, 2020, NEUROMUSCULAR DISORD, V30, P413, DOI 10.1016/j.nmd.2020.02.017
   Verhaak C, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0403-5
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
   Yu-Wai-Man P, 2017, HUM MOL GENET, V26, PR12, DOI 10.1093/hmg/ddx182
   [张哲 Zhang Zhe], 2016, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V49, P237
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 50
TC 8
Z9 8
U1 0
U2 9
PU RIYADH ARMED FORCES HOSPITAL
PI RIYADH
PA PO BOX 7897, RIYADH, KSA 11159, SAUDI ARABIA
SN 1319-6138
EI 
J9 NEUROSCIENCES
JI Neurosciences
PD APR 15
PY 2021
VL 26
IS 2
BP 128
EP 133
DI 10.17712/nsj.2021.2.20200145
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA TS5HW
UT WOS:000679680900002
PM 33814365
DA 2024-11-01
ER

PT J
AU Zekonyte, U
   Bacman, SR
   Smith, J
   Shoop, W
   Pereira, CV
   Tomberlin, G
   Stewart, J
   Jantz, D
   Moraes, CT
AF Zekonyte, Ugne
   Bacman, Sandra R.
   Smith, Jeff
   Shoop, Wendy
   Pereira, Claudia, V
   Tomberlin, Ginger
   Stewart, James
   Jantz, Derek
   Moraes, Carlos T.
TI Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo
SO NATURE COMMUNICATIONS
LA English
DT Article
ID selective degradation; dna heteroplasmy; aav serotypes; gene-transfer; endonucleases; mutations; genm; mouse; cleavage; delivery
AB Diseases caused by heteroplasmic mitochondrial DNA mutations have no effective treatment or cure. In recent years, DNA editing enzymes were tested as tools to eliminate mutant mtDNA in heteroplasmic cells and tissues. Mitochondrial-targeted restriction endonucleases, ZFNs, and TALENs have been successful in shifting mtDNA heteroplasmy, but they all have drawbacks as gene therapy reagents, including: large size, heterodimeric nature, inability to distinguish single base changes, or low flexibility and effectiveness. Here we report the adaptation of a gene editing platform based on the I-CreI meganuclease known as ARCUS((R)). These mitochondrial-targeted meganucleases (mitoARCUS) have a relatively small size, are monomeric, and can recognize sequences differing by as little as one base pair. We show the development of a mitoARCUS specific for the mouse m.5024C>T mutation in the mt-tRNA(Ala) gene and its delivery to mice intravenously using AAV9 as a vector. Liver and skeletal muscle show robust elimination of mutant mtDNA with concomitant restoration of mt-tRNA(Ala) levels. We conclude that mitoARCUS is a potential powerful tool for the elimination of mutant mtDNA. Heteroplasmic mitochondrial DNA mutations lack effective treatments. Here the authors adapt I-CreI meganuclease to target the mitochondria and specifically-eliminate mtDNA with a m.5024C>T mutation in the mttRNA Ala gene.
C1 [Zekonyte, Ugne] Univ Miami, Miller Sch Med, Grad Program Human Genet & Genom, Miami, FL 33136 USA.
   [Bacman, Sandra R.; Pereira, Claudia, V; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
   [Smith, Jeff; Shoop, Wendy; Tomberlin, Ginger; Jantz, Derek] Precis BioSci, Durham, NC USA.
   [Stewart, James] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Stewart, James] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
C3 University of Miami; University of Miami; Newcastle University - UK; Newcastle University - UK
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.
EM Cmoraes@med.miami.edu
FU Muscular Dystrophy Association; National Institute of Health [5R01EY010804]; NIH [1R01NS079965, 1R01AG036871]; CHAMP Foundation
CR Antunes MS, 2012, BMC BIOTECHNOL, V12, P0, DOI 10.1186/1472-6750-12-86
   Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065
   Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2020, MOL CELL, V79, P708, DOI 10.1016/j.molcel.2020.08.009
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123
   Candas D, 2016, J VIS EXP, V53417, P0
   Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gray SJ, 2016, MOL THER, V24, P1017, DOI 10.1038/mt.2016.20
   Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   He T, 2019, HUM GENE THER CL DEV, V30, P169, DOI 10.1089/humc.2019.030
   Hickey DG, 2017, GENE THER, V24, P787, DOI 10.1038/gt.2017.85
   Jantz D, 2013, US PATENT, V0, Patent No. [US8021867B2, 8021867]
   Kanaan NM, 2017, MOL THER-NUCL ACIDS, V8, P184, DOI 10.1016/j.omtn.2017.06.011
   Katwal AB, 2013, GENE THER, V20, P930, DOI 10.1038/gt.2013.16
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Lee H, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21464-1
   Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4
   Martino AT, 2013, BLOOD, V121, P2224, DOI 10.1182/blood-2012-10-460733
   Matsuzaki Y, 2019, MOL THER, V27, P700, DOI 10.1016/j.ymthe.2019.02.016
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Pacak Christina A, 2008, GENET VACCINES THER, V6, P13, DOI 10.1186/1479-0556-6-13
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Pereira CV, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708084
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Smith JJ, 2017, US PATENT, V0, Patent No. [US9683257B2, 9683257]
   Smith JJ, 2012, USPATENT, V0, Patent No. [201113245596 A, 201113245596]
   Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Wang LL, 2018, NAT BIOTECHNOL, V36, P717, DOI 10.1038/nbt.4182
   Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76
NR 53
TC 47
Z9 55
U1 6
U2 23
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2041-1723
EI 
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 28
PY 2021
VL 12
IS 1
BP 
EP 
DI 10.1038/s41467-021-23561-7
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA SO7GY
UT WOS:000659144000007
PM 34050192
DA 2024-11-01
ER

PT J
AU Yap, ZY
   Park, YH
   Wortmann, SB
   Gunning, AC
   Ezer, S
   Lee, S
   Duraine, L
   Wilichowski, E
   Wilson, K
   Mayr, JA
   Wagner, M
   Li, H
   Kini, U
   Black, ED
   Monaghan, KG
   Lupski, JR
   Ellard, S
   Westphal, DS
   Harel, T
   Yoon, WH
AF Yap, Zheng Yie
   Park, Yo Han
   Wortmann, Saskia B.
   Gunning, Adam C.
   Ezer, Shlomit
   Lee, Sukyeong
   Duraine, Lita
   Wilichowski, Ekkehard
   Wilson, Kate
   Mayr, Johannes A.
   Wagner, Matias
   Li, Hong
   Kini, Usha
   Black, Emily Davis
   Monaghan, Kristin G.
   Lupski, James R.
   Ellard, Sian
   Westphal, Dominik S.
   Harel, Tamar
   Yoon, Wan Hee
TI Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes
SO GENOME MEDICINE
LA English
DT Article
DE ATAD3A; Mitochondria; Disease; Autosomal recessive; Autophagy; Neurogenesis; Drosophila; AAA plus protein
AB BackgroundATPase family AAA-domain containing protein 3A (ATAD3A) is a nuclear-encoded mitochondrial membrane-anchored protein involved in diverse processes including mitochondrial dynamics, mitochondrial DNA organization, and cholesterol metabolism. Biallelic deletions (null), recessive missense variants (hypomorph), and heterozygous missense variants or duplications (antimorph) in ATAD3A lead to neurological syndromes in humans.MethodsTo expand the mutational spectrum of ATAD3A variants and to provide functional interpretation of missense alleles in trans to deletion alleles, we performed exome sequencing for identification of single nucleotide variants (SNVs) and copy number variants (CNVs) in ATAD3A in individuals with neurological and mitochondrial phenotypes. A Drosophila Atad3a Gal4 knockin-null allele was generated using CRISPR-Cas9 genome editing technology to aid the interpretation of variants.ResultsWe report 13 individuals from 8 unrelated families with biallelic ATAD3A variants. The variants included four missense variants inherited in trans to loss-of-function alleles (p.(Leu77Val), p.(Phe50Leu), p.(Arg170Trp), p.(Gly236Val)), a homozygous missense variant p.(Arg327Pro), and a heterozygous non-frameshift indel p.(Lys568del). Affected individuals exhibited findings previously associated with ATAD3A pathogenic variation, including developmental delay, hypotonia, congenital cataracts, hypertrophic cardiomyopathy, and cerebellar atrophy. Drosophila studies indicated that Phe50Leu, Gly236Val, Arg327Pro, and Lys568del are severe loss-of-function alleles leading to early developmental lethality. Further, we showed that Phe50Leu, Gly236Val, and Arg327Pro cause neurogenesis defects. On the contrary, Leu77Val and Arg170Trp are partial loss-of-function alleles that cause progressive locomotion defects and whose expression leads to an increase in autophagy and mitophagy in adult muscles.ConclusionOur findings expand the allelic spectrum of ATAD3A variants and exemplify the use of a functional assay in Drosophila to aid variant interpretation.
C1 [Yap, Zheng Yie; Park, Yo Han; Yoon, Wan Hee] Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA.
   [Wortmann, Saskia B.; Wagner, Matias; Westphal, Dominik S.] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ PMU, Univ Childrens Hosp, Salzburg, Austria.
   [Wortmann, Saskia B.] Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
   [Gunning, Adam C.; Ellard, Sian] Royal Devon & Exeter NHS Fdn Trust, Exeter Genom Lab, Exeter EX2 5DW, Devon, England.
   [Gunning, Adam C.; Ellard, Sian] Univ Exeter, Coll Med & Hlth, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.
   [Ezer, Shlomit; Harel, Tamar] Hadassah Med Ctr, Dept Genet, POB 12000, IL-9112001 Jerusalem, Israel.
   [Ezer, Shlomit; Harel, Tamar] Hebrew Univ Jerusalem, Fac Med, POB 12000, IL-9112001 Jerusalem, Israel.
   [Lee, Sukyeong] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Duraine, Lita] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
   [Wilichowski, Ekkehard] Georg August Univ Gottingen, Univ Med Ctr Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany.
   [Wilson, Kate; Kini, Usha] Oxford Univ Hosp NHS Fdn Trust, Oxford Ctr Genom Med, Oxford, England.
   [Wagner, Matias] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Li, Hong; Black, Emily Davis] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA.
   [Li, Hong] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta, Atlanta, GA USA.
   [Monaghan, Kristin G.] GeneDx Inc, Gaithersburg, MD USA.
   [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA.
C3 Oklahoma Medical Research Foundation; Technical University of Munich; Paracelsus Private Medical University; University of Exeter; University of Exeter; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Baylor College of Medicine; Baylor College of Medicine; University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL; Oxford University Hospitals NHS Foundation Trust; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Yoon, WH (corresponding author), Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA.; Harel, T (corresponding author), Hadassah Med Ctr, Dept Genet, POB 12000, IL-9112001 Jerusalem, Israel.; Harel, T (corresponding author), Hebrew Univ Jerusalem, Fac Med, POB 12000, IL-9112001 Jerusalem, Israel.
EM tamarhe@hadassah.org.il; wanhee-yoon@omrf.org
FU NIH/COBRE [GM103636]
CR Al Madhoun A, 2019, APPL CLIN GENET, V12, P79, DOI 10.2147/TACG.S194204
   Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373
   Bellen HJ, 2019, HUM MOL GENET, V28, PR207, DOI 10.1093/hmg/ddz135
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059
   Dorison N, 2020, MOL GENET METAB, V131, P107, DOI 10.1016/j.ymgme.2020.09.002
   Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034
   Frazier AE, 2021, MED-CAMBRIDGE, V2, P49, DOI 10.1016/j.medj.2020.06.004
   Frazier AE, 2017, BRAIN, V140, P0, DOI 10.1093/brain/awx240
   Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10
   Goller T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054799
   Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084
   Gunning AC, 2020, AM J HUM GENET, V106, P272, DOI 10.1016/j.ajhg.2020.01.007
   Hanes I, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000452
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266
   Hoffmann M, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0007644
   Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503
   Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737
   Lang LW, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21217917
   Lee PT, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.35574
   Li H, 1900, DOI 10.1186/S13073-021-00873-3, V0, P0
   Li SJ, 2014, GENE, V535, P60, DOI 10.1016/j.gene.2013.10.062
   Madabattula ST, 2015, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/52741
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Peeters-Scholte CMPCD, 2017, BRAIN, V140, P0, DOI 10.1093/brain/awx239
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6
   Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sacoto MJG, 2020, AM J HUM GENET, V107, P352, DOI 10.1016/j.ajhg.2020.06.013
   Stals KL, 2018, PRENATAL DIAG, V38, P33, DOI 10.1002/pd.5175
   Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1
   Teng Y, 2016, ONCOGENE, V35, P333, DOI 10.1038/onc.2015.86
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yachdav G, 2014, NUCLEIC ACIDS RES, V42, PW337, DOI 10.1093/nar/gku366
   You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077
   Zhao YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09291-x
NR 43
TC 16
Z9 17
U1 2
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
EI 
J9 GENOME MED
JI Genome Med.
PD APR 12
PY 2021
VL 13
IS 1
BP 
EP 
DI 10.1186/s13073-021-00873-3
PG 21
WC Genetics & Heredity
SC Genetics & Heredity
GA RM8EB
UT WOS:000639889100001
PM 33845882
DA 2024-11-01
ER

PT J
AU Bychkov, IO
   Itkis, YS
   Tsygankova, PG
   Krylova, TD
   Mikhaylova, SV
   Klyushnikov, SA
   Pechatnikova, NL
   Degtyareva, AV
   Nikolaeva, EA
   Seliverstov, YA
   Kurbatov, SA
   Dadali, EL
   Rudenskaya, GE
   Illarioshkin, SN
   Zakharova, EY
AF Bychkov, I. O.
   Itkis, Y. S.
   Tsygankova, P. G.
   Krylova, T. D.
   Mikhaylova, S., V
   Klyushnikov, S. A.
   Pechatnikova, N. L.
   Degtyareva, A., V
   Nikolaeva, E. A.
   Seliverstov, Y. A.
   Kurbatov, S. A.
   Dadali, E. L.
   Rudenskaya, G. E.
   Illarioshkin, S. N.
   Zakharova, E. Y.
TI Mitochondrial DNA maintenance disorders in 102 patients from different parts of Russia: Mutational spectrum and phenotypes
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial replication; Mutations; Nuclear genes; Mitochondrial DNA copy number; Mitochondrial depletion syndrome; qPCR
ID time quantitative pcr; depletion; variants; disease; proteins; genetics; features; defects; ataxia; onset
AB Currently, pathogenic variants in more than 25 nuclear genes, involved in mtDNA maintenance, are associated with human disorders. mtDNA maintenance disorders manifest with a wide range of phenotypes, from severe infantile-onset forms of myocerebrohepatopathy to late-onset forms of myopathies, chronic progressive external ophthalmoplegia, and parkinsonism. This study represents the results of molecular genetic analysis and phenotypes of 102 probands with mtDNA maintenance disorders. So far, this is the largest Russian cohort for this group of diseases. Mutations were identified in 10 mtDNA maintenance genes: POLG (n = 59), DGUOK (n = 14), TWNK (n = 14), TK2 (n = 8), MPV17 (n = 2), OPA3 (n = 1), FBXL4 (n = 1), RRM2B (n = 1), SUCLG1 (n = 1) and TYMP (n = 1). We review a mutation spectrum for the DGUOK and TWNK genes, that can be specific for the Russian population. In 34 patients we measured the blood mtDNA copy number and showed its significant reduction. Novel variants were found in 41 cases, which significantly expands the mutational landscape of mtDNA maintenance disorders.
C1 [Bychkov, I. O.; Itkis, Y. S.; Tsygankova, P. G.; Krylova, T. D.; Dadali, E. L.; Rudenskaya, G. E.; Zakharova, E. Y.] Res Ctr Med Genet, Moscow, Russia.
   [Mikhaylova, S., V] Russian Childrens Hosp, Med Genet Dept, Moscow, Russia.
   [Nikolaeva, E. A.] Pirogov Russian Natl Res Med Univ, Veltishchev Res Clin Inst Pediat, Moscow, Russia.
   [Pechatnikova, N. L.] Morozov Childrens City Clin Hosp, Moscow, Russia.
   [Degtyareva, A., V] Kulakov Natl Med Res Ctr Obstet Gynecol & Perinat, Moscow, Russia.
   [Klyushnikov, S. A.; Seliverstov, Y. A.; Illarioshkin, S. N.] Res Ctr Neurol, Moscow, Russia.
   [Degtyareva, A., V] Sechenov First Moscow State Med Univ, Sechenovskiy Univ, Moscow, Russia.
   [Kurbatov, S. A.] Semant Hub, Moscow, Russia.
   [Kurbatov, S. A.] Zdorovii Rebenok Ltd, Med Ctr, Moscow, Russia.
C3 Research Centre for Medical Genetics; Pirogov Russian National Research Medical University; Research Center of Neurology; Sechenov First Moscow State Medical University
RP Bychkov, IO (corresponding author), Res Ctr Med Genet, Moscow, Russia.
EM bychkov@med-gen.ru
CR Bendl J, 2014, PLOS COMPUT BIOL, V10, P0, DOI 10.1371/journal.pcbi.1003440
   Biino G, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054289
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Degtyareva AV, 2017, ROSSIYSKIY VESTNIK P, V62, P55, DOI 10.21508/1027-4065-2017-62-5-55-62
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filatova AY, 2019, EUR J HUM GENET, V27, P488, DOI 10.1038/s41431-018-0288-y
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hikmat O, 2020, J INHERIT METAB DIS, V0, P0
   Iodice A, 2016, J PEDIATR NEUROL, V14, P112, DOI 10.1055/s-0036-1586726
   Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kumar P, 2019, COLD SPRING HARB PRO, V2019, P0
   [Курбатов САKurbatov SA], 2019, НЕРВНО-МЫШЕЧНЫЕ БОЛЕЗНИ NEUROMUSCULAR DISEASES NERVNO-MYSHECHNYE BOLEZNI, V9, P67
   Kurbatov SA, 2015, NEUROMUSC DIS, V2015, P2
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Ferrando V, 2017, NUCLEIC ACIDS RES, V45, PW222, DOI 10.1093/nar/gkx313
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   NOVAK RW, 1987, LAB MED, V18, P613, DOI 10.1093/labmed/18.9.613
   Pejaver V, 2017, 134981 BIORXIV, V0, P0
   Peter B, 2019, HUM MOL GENET, V28, P1090, DOI 10.1093/hmg/ddy415
   Piekutowska-Abramczuk D, 2019, MITOCHONDRION, V47, P179, DOI 10.1016/j.mito.2018.11.004
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scaglia F, 2018, PEDIATR CLIN N AM, V0, P0
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, PW296, DOI 10.1093/nar/gky427
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 40
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2021
VL 57
IS 
BP 205
EP 212
DI 10.1016/j.mito.2021.01.004
EA JAN 2021
PG 8
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA RY1HX
UT WOS:000647668600010
PM 33486010
DA 2024-11-01
ER

PT J
AU Gupta, R
   Karczewski, KJ
   Howrigan, D
   Neale, BM
   Mootha, VK
AF Gupta, Rahul
   Karczewski, Konrad J.
   Howrigan, Daniel
   Neale, Benjamin M.
   Mootha, Vamsi K.
TI Human genetic analyses of organelles highlight the nucleus in age-related trait heritability
SO ELIFE
LA English
DT Article
DE aging; mitochondria; transcription factors; haplosufficiency; enrichment; constraint; Human
ID mitochondrial-dna variants; genome-wide association; human skeletal-muscle; human-diseases; oxidative-phosphorylation; missing heritability; susceptibility loci; transcription; dysfunction; common
AB eLife digest Getting older increases our risk of experiencing a wide range of diseases, such as diabetes, heart disease and neurodegenerative disease. The genetic variations that we inherit from our parents play a major role in predicting this risk. However, the biological networks involved in this process are extremely complex and remain challenging to decipher. Prior studies have suggested that specialised structures inside our body's cells, called organelles, may have an important role to play in aging. Organelles represent self-contained biological factories inside each cell, designed to perform specific tasks. Examples include the nucleus, which harbours most of the cell's genetic material, and mitochondria, which help provide cells with energy. Organelles tend to deteriorate and become dysfunctional with age, and mitochondria in particular are badly affected by the ageing process. A decline in organelle activity has been thought to explain ageing and the development of age-related diseases. However, this has never been systematically tested on a large scale at the inherited genetic level. Gupta et al. assessed whether common inherited genetic variation in genes associated with ten different organelles could affect the risk of age-related disease, using a database of DNA samples from more than 300,000 individuals. They considered 24 diseases and traits that become more common with advanced age. Gupta et al. discovered that inherited variants in or near genes associated with the nucleus were consistently linked to age-related disease risks. Most of this signal arose from genes encoding the nuclear transcription factors, proteins that help to control the rate at which genes are expressed. However, variants in genes associated with other organelles, including mitochondria, did not appear to be linked to age-related diseases. This research suggests that inherited variation in transcription factors in the nucleus could act as genetic levers that increase the risk of common, age-related diseases. It also suggests that common genetic variation in other cellular organelles may not be as heavily involved in the development of such diseases. Such insights into the cellular structures and biological pathways involved in ageing and age-related disease also establish new targets for drugs to prevent or treat disease. Most age-related human diseases are accompanied by a decline in cellular organelle integrity, including impaired lysosomal proteostasis and defective mitochondrial oxidative phosphorylation. An open question, however, is the degree to which inherited variation in or near genes encoding each organelle contributes to age-related disease pathogenesis. Here, we evaluate if genetic loci encoding organelle proteomes confer greater-than-expected age-related disease risk. As mitochondrial dysfunction is a 'hallmark' of aging, we begin by assessing nuclear and mitochondrial DNA loci near genes encoding the mitochondrial proteome and surprisingly observe a lack of enrichment across 24 age-related traits. Within nine other organelles, we find no enrichment with one exception: the nucleus, where enrichment emanates from nuclear transcription factors. In agreement, we find that genes encoding several organelles tend to be 'haplosufficient,' while we observe strong purifying selection against heterozygous protein-truncating variants impacting the nucleus. Our work identifies common variation near transcription factors as having outsize influence on age-related trait risk, motivating future efforts to determine if and how this inherited variation then contributes to observed age-related organelle deterioration.
C1 [Gupta, Rahul; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.
   [Gupta, Rahul; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Gupta, Rahul; Karczewski, Konrad J.; Howrigan, Daniel; Neale, Benjamin M.; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Gupta, Rahul; Karczewski, Konrad J.; Howrigan, Daniel; Neale, Benjamin M.] Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital
RP Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Gupta, R; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Gupta, R; Neale, BM; Mootha, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Gupta, R; Neale, BM (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
EM rahul_gupta@hms.harvard.edu; bneale@broadinstitute.org; vamsi_mootha@hms.harvard.edu
FU National Institutes of Health [T32AG000222, R35GM122455, R01MH101244]; National Institute of General Medical Sciences [R35GM122455] Funding Source: NIH RePORTER
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   [Anonymous], 2017, DETAILS AND CONSIDERATIONS OF THE UK BIOBANK GWAS, V0, P0
   [Anonymous], 2021, HERITAGE, V0, P0
   [Anonymous], 2021, HERITAGE, V0, P0
   Ashar FN, 2017, JAMA CARDIOL, V2, P1247, DOI 10.1001/jamacardio.2017.3683
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhattarai KR, 2020, TRENDS CELL BIOL, V30, P672, DOI 10.1016/j.tcb.2020.05.004
   Biffi A, 2010, AM J HUM GENET, V86, P904, DOI 10.1016/j.ajhg.2010.05.005
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, P0, DOI 10.1038/s41531-019-0080-x
   Binder JX, 2014, DATABASE-OXFORD, V0, P0, DOI DOI 10.1093/database/bau012
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, PD330, DOI 10.1093/nar/gky1055
   CHANCE B, 1955, J BIOL CHEM, V217, P409
   Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843
   Claussnitzer M, 2020, NATURE, V577, P179, DOI 10.1038/s41586-019-1879-7
   CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1
   Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   DAngelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037
   de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29
   de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004219
   Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405
   Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4
   Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404
   FLAMENG W, 1991, J MOL CELL CARDIOL, V23, P1, DOI 10.1016/0022-2828(91)90034-J
   Fleischman A, 2010, J CLIN ENDOCR METAB, V95, PE69, DOI 10.1210/jc.2010-0527
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642
   Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644
   Ge P, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00367-7
   Golan D, 2014, P NATL ACAD SCI USA, V111, PE5272, DOI 10.1073/pnas.1419064111
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005
   Hill WG, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000008
   Howrigan DP, 2021, HERITAGE, V0, P0
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hudson G, 2013, ANN RHEUM DIS, V72, P136, DOI 10.1136/annrheumdis-2012-201932
   Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9
   Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050
   KACSER H, 1981, GENETICS, V97, P639
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x
   Kapopoulou A, 2016, EVOLUTION, V70, P167, DOI 10.1111/evo.12819
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Kuan V, 2019, LANCET DIGIT HEALTH, V1, PE63, DOI 10.1016/S2589-7500(19)30012-3
   Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Litman T, 2019, SEMIN ONCOL, V46, P3, DOI 10.1053/j.seminoncol.2018.11.002
   Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, PD896, DOI 10.1093/nar/gkw1133
   Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Melé M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383
   Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5
   Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pardiñas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2
   Pattaro C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms10023
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMOA031314
   Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285
   Rand DM, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0188
   Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013
   Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784
   Segrè AV, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001058
   Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043
   Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Sudlow C, 2015, PLOS MED, V12, P0, DOI 10.1371/journal.pmed.1001779
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Timmers PRHJ, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.39856
   To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van Der Lee R, 2020, TRENDS GENET, V36, P523, DOI 10.1016/j.tig.2020.04.006
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang K, 2017, NAT GENET, V49, P1319, DOI 10.1038/ng.3931
   Wasmer K, 2017, J GERIATR CARDIOL, V14, P179, DOI 10.11909/j.issn.1671-5411.2017.03.010
   Weinbrenner C, 1998, CARDIOVASC RES, V38, P676, DOI 10.1016/S0008-6363(98)00064-9
   Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7
   Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xue A, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04951-w
   Yamamoto K, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-0812-9
   Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042
   Yates AD, 2020, NUCLEIC ACIDS RES, V48, PD682, DOI 10.1093/nar/gkz966
   Yu XH, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0001530
   Zenin A, 2019, COMMUN BIOL, V2, P0, DOI 10.1038/s42003-019-0290-0
   Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001
NR 118
TC 5
Z9 6
U1 0
U2 3
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
EI 
J9 ELIFE
JI eLife
PD SEP 1
PY 2021
VL 10
IS 
BP 
EP 
DI 10.7554/eLife.68610; 10.7554/eLife.68610.sa1; 10.7554/eLife.68610.sa2
PG 33
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA WA8AC
UT WOS:000703105100001
PM 34467851
DA 2024-11-01
ER

PT J
AU Ozes, B
   Moss, K
   Myers, M
   Ridgley, A
   Chen, L
   Murrey, D
   Sahenk, Z
AF Ozes, Burcak
   Moss, Kyle
   Myers, Morgan
   Ridgley, Alicia
   Chen, Lei
   Murrey, Darren
   Sahenk, Zarife
TI AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>Gars<SUP>P278KY/+</SUP></i> mice
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE NT-3; CMT2D; gars; AAV
ID disease type 2d; mitochondrial-dna; mammalian target; skeletal-muscle; growth-factor; mouse models; neuropathy; mutations; nerve; neurotrophin-3
AB Glycyl-tRNA synthetase mutations are associated to the Charcot-Marie-Tooth disease type-2D. The Gars(P278KY/+) model for Charcot-Marie-Tooth disease type-2D is known best for its early onset severe neuropathic phenotype with findings including reduced axon size, slow conduction velocities and abnormal neuromuscular junction. Muscle involvement remains largely unexamined. We tested the efficacy of neurotrophin 3 gene transfer therapy in two Gars mutants with severe (Gars(P278KY/+)) and milder (Gars(Delta ETAQ/+)) phenotypes via intramuscular injection of adeno-associated virus setoype-1, triple tandem muscle creatine kinase promoter, neurotrophin 3 (AAV1.tMCK.NT-3) at 1 x 10(11) vg dose. In the Gars(P278KY/+) mice, the treatment efficacy was assessed at 12 weeks post-injection using rotarod test, electrophysiology and detailed quantitative histopathological studies of the peripheral nervous system including neuromuscular junction and muscle. Neurotrophin 3 gene transfer therapy in Gars(P278KY/+) mice resulted in significant functional and electrophysiological improvements, supported with increases in myelin thickness and improvements in the denervated status of neuromuscular junctions as well as increases in muscle fibre size along with attenuation of myopathic changes. Improvements in the milder phenotype Gars(Delta ETAQ/+) was less pronounced. Furthermore, oxidative enzyme histochemistry in muscles from Gars mutants revealed alterations in the content and distribution of oxidative enzymes with increased expression levels of Pgc1a. Cox1, Cox3 and Atp5d transcripts were significantly decreased suggesting that the muscle phenotype might be related to mitochondrial dysfunction. Neurotrophin 3 gene therapy attenuated these abnormalities in the muscle. This study shows that neurotrophin 3 gene transfer therapy has disease modifying effect in a mouse model for Charcot-Marie-Tooth disease type-2D, leading to meaningful improvements in peripheral nerve myelination and neuromuscular junction integrity as well as in a unique myopathic process, associated with mitochondria dysfunction, all in combination contributing to functional outcome. Based on the multiple biological effects of this versatile molecule, we predict neurotrophin 3 has the potential to be beneficial in other aminoacyl-tRNA synthetase-linked Charcot-Marie-Tooth disease subtypes. Ozes et al. report that Adeno-associated virus serotype 1-neurotrophin 3 gene therapy has disease modifying effect in a Gars mouse model of Charcot-Marie-Tooth disease type 2D leading to functional and, electrophysiological improvements correlating with increased myelin thickness, neuromuscular junction integrity attenuation of a myopathic process associated with mitochondrial dysfunction.
C1 [Ozes, Burcak; Moss, Kyle; Myers, Morgan; Ridgley, Alicia; Chen, Lei; Murrey, Darren; Sahenk, Zarife] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Gene Therapy, Dept Pediat, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Nationwide Childrens Hosp, Dept Pediat & Neurol, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Ohio State Univ, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital
RP Sahenk, Z (corresponding author), Neuromuscular Pathol, 700 Childrens Dr,Rm WA 3024, Columbus, OH 43205 USA.
EM zarife.sahenk@nationwidechildrens.org
FU Sarepta Therapeutics, Inc. [820344-0322-00]
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Benoy V, 2018, BRAIN, V141, P673, DOI 10.1093/brain/awx375
   Boczonadi V, 2018, HUM MOL GENET, V27, P2187, DOI 10.1093/hmg/ddy127
   Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110
   Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121
   Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107
   Coelho RP, 2009, GLIA, V57, P1754, DOI 10.1002/glia.20888
   Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b
   Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac
   Dubourg O, 2006, NEUROMOL MED, V8, P75, DOI 10.1385/NMM:8:1:75
   Forrester N, 2020, J NEUROMUSCULAR DIS, V7, P137, DOI 10.3233/JND-200472
   Grice SJ, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00055
   Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176
   GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104
   Griffin DA, 2016, HUM MOL GENET, V25, P1900, DOI 10.1093/hmg/ddw063
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510
   He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108
   Hindi L, 2017, BIO-PROTOCOL, V7, P0, DOI 10.21769/BioProtoc.2248
   James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc
   Jousse C, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0104896
   Karpati George, 2008, V3, V0, P199
   Kim JK, 2020, J CLIN INVEST, V130, P1271, DOI 10.1172/JCI131989
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   McMillan HJ, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-36
   MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716
   Meier C, 1999, J NEUROSCI, V19, P3847
   Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251
   Mo ZY, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03461-z
   Morelli KH, 2019, J CLIN INVEST, V129, P5568, DOI 10.1172/JCI130600
   Motley WW, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002399
   Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001
   Nafisinia M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178125
   Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009
   Niehues S, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8520
   Oprescu SN, 2017, HUM MUTAT, V38, P1412, DOI 10.1002/humu.23287
   Ozes B, 2022, GENE THER, V29, P127, DOI 10.1038/s41434-021-00231-3
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   SAHENK Z, 1980, BRAIN RES, V186, P343, DOI 10.1016/0006-8993(80)90980-4
   SAHENK Z, 1991, J NEUROCYTOL, V20, P365, DOI 10.1007/BF01355533
   SAHENK Z, 1979, J NEUROPATH EXP NEUR, V38, P532, DOI 10.1097/00005072-197909000-00007
   Sahenk Z, 2005, NEUROLOGY, V65, P681, DOI 10.1212/01.WNL.0000171978.70849.c5
   SAHENK Z, 1990, ACTA NEUROPATHOL, V81, P141, DOI 10.1007/BF00334502
   Sahenk Z, 2020, BRAIN RES, V1727, P0, DOI 10.1016/j.brainres.2019.146533
   Sahenk Z, 2018, BRAIN BEHAV, V8, P0, DOI 10.1002/brb3.1118
   Sahenk Z, 2014, MOL THER, V22, P511, DOI 10.1038/mt.2013.250
   Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0
   Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027
   Sheard PW, 2010, EUR J NEUROSCI, V31, P29, DOI 10.1111/j.1460-9568.2009.07032.x
   Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Sleigh JN, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-02798-y
   Sleigh JN, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-10005-w
   Sleigh JN, 2017, P NATL ACAD SCI USA, V114, PE3324, DOI 10.1073/pnas.1614557114
   Sleigh JN, 2014, HUM MOL GENET, V23, P2639, DOI 10.1093/hmg/ddt659
   Spaulding EL, 2016, J NEUROSCI, V36, P3254, DOI 10.1523/JNEUROSCI.1762-15.2016
   SPENCER PS, 1977, J NEUROPATH EXP NEUR, V36, P300, DOI 10.1097/00005072-197703000-00006
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009
   Valdez G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093140
   Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104
   Wang LL, 2020, FEBS J, V287, P108, DOI 10.1111/febs.15024
   WANG T, 1995, J NEUROSCI, V15, P4796
   Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955
   Yalvac ME, 2018, GENE THER, V25, P129, DOI 10.1038/s41434-018-0009-8
   Yalvac ME, 2017, SKELET MUSCLE, V7, P0, DOI 10.1186/s13395-017-0146-6
   Yalvac ME, 2014, MOL THER, V22, P1353, DOI 10.1038/mt.2014.77
   Young C, 2001, RESTOR NEUROL NEUROS, V18, P167
NR 70
TC 16
Z9 16
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD OCT 1
PY 2021
VL 3
IS 4
BP 
EP 
DI 10.1093/braincomms/fcab252
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 1T5TZ
UT WOS:000804791900034
PM 34755111
DA 2024-11-01
ER

PT J
AU Shemiakova, T
   Ivanova, E
   Wu, WK
   Kirichenko, TV
   Starodubova, AV
   Orekhov, AN
AF Shemiakova, Taisiia
   Ivanova, Ekaterina
   Wu, Wei-Kai
   Kirichenko, Tatiana V.
   Starodubova, Antonina V.
   Orekhov, Alexander N.
TI Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies
SO FRONTIERS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
DE atherosclerosis; mitochondriopathy; mitochondrial disease; chronic inflammation; mitochondrial therapies
ID oxidative stress; dna-damage; targeting antioxidants; cholesterol efflux; dysfunction; inflammation; nanoparticles; mechanisms; metformin; apoptosis
AB Atherosclerosis is a complex pathology that involves both metabolic dysfunction and chronic inflammatory process. During the last decade, a considerable progress was achieved in describing the pathophysiological features of atherosclerosis and developing approaches that target the abnormal lipid metabolism and chronic inflammation. However, early events in the arterial wall that initiate the disease development still remain obscure. Finding effective therapeutic targets in these early processes would allow developing methods for disease prevention and, possibly, atherosclerotic plaque regression. Currently, these early events are being actively studied by several research groups. One of the processes that are being investigated is the development of mitochondrial dysfunction, which was demonstrated to be present in the affected areas of the arterial wall. Detection and characterization of mitochondrial dysfunction associated with several chronic human disorders was made possible by the improved methods of studying mitochondrial biology and detecting mitochondrial DNA (mtDNA) mutations. It was found to be involved in several key atherogenic processes, such as oxidative stress, chronic inflammation, and intracellular lipid accumulation. Mitochondrial dysfunction can occur in all types of cells involved in the pathogenesis of atherosclerosis: monocytes and macrophages, smooth muscle cells, lymphocytes, and the endothelial cells. However, therapies that would specifically target the mitochondria to correct mitochondrial dysfunction and neutralize the defective organelles are still remain to be developed and characterized. The aim of this review is to outline the prospects for mitochondrial therapy for atherosclerosis. We discuss mechanisms of mitochondria-mediated atherogenic processes, known mitochondria-targeting therapy strategies, and novel mitochondria-targeting drugs in the context of atherosclerosis.
C1 [Shemiakova, Taisiia] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia.
   [Ivanova, Ekaterina] Inst Atherosclerosis Res, Moscow, Russia.
   [Wu, Wei-Kai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.
   [Kirichenko, Tatiana V.] Natl Med Res Ctr Cardiol, Inst Expt Cardiol, Moscow, Russia.
   [Kirichenko, Tatiana V.; Orekhov, Alexander N.] Inst Human Morphol, Lab Cellular & Mol Pathol Cardiovasc Syst, Moscow, Russia.
   [Starodubova, Antonina V.] Fed Res Ctr Nutr Biotechnol & Food Safety, Moscow, Russia.
   [Starodubova, Antonina V.] Pirogov Russian Natl Res Med Univ, Fac Therapy, Moscow, Russia.
   [Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
C3 Saint Petersburg State University; National Taiwan University; National Taiwan University Hospital; National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Federal Research Center of Nutrition, Biotechnology & Food Safety; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS
RP Ivanova, E (corresponding author), Inst Atherosclerosis Res, Moscow, Russia.
EM kate.ivanov@gmail.com
FU Russian Science Foundation [19-15-00010]; Russian Science Foundation [19-15-00010] Funding Source: Russian Science Foundation
CR Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Bendall JK, 2014, ANTIOXID REDOX SIGN, V20, P3040, DOI 10.1089/ars.2013.5566
   Bobryshev YV, 2016, BIOMED RES INT, V2016, P0, DOI 10.1155/2016/9582430
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Checa J, 2020, J INFLAMM RES, V13, P1057, DOI 10.2147/JIR.S275595
   Chen HC, 2005, HUM MOL GENET, V14, PR283, DOI 10.1093/hmg/ddi270
   Chen HI, 2020, NUTR METAB CARDIOVAS, V30, P1032, DOI 10.1016/j.numecd.2020.02.014
   Chen Q, 2017, TRANSL RES, V190, P40, DOI 10.1016/j.trsl.2017.09.003
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   Creager MA, 2013, METFORMIN MUSCLE ENE, V0, P0
   Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, PH13, DOI 10.1152/ajpheart.00368.2009
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300
   Ghosh P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093363
   Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0
   Grootaert MOJ, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/7687083
   Guo CX, 2018, CHEMOSPHERE, V210, P183, DOI 10.1016/j.chemosphere.2018.06.170
   Heller A, 2012, EUR J PHARM BIOPHARM, V82, P1, DOI 10.1016/j.ejpb.2012.05.014
   Hernandez-Mijares A, 2016, ATHEROSCLEROSIS, V247, P40, DOI 10.1016/j.atherosclerosis.2016.01.044
   Hosen MR, 2020, ANTIOXID REDOX SIGN, V33, P621, DOI 10.1089/ars.2020.8107
   Hu HC, 2020, EXP MOL PATHOL, V114, P0, DOI 10.1016/j.yexmp.2020.104412
   Iwai K, 2003, EUR J APPL PHYSIOL, V88, P515, DOI 10.1007/s00421-002-0745-7
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624
   Kim HK, 2017, ADV EXP MED BIOL, V982, P621, DOI 10.1007/978-3-319-55330-6_32
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Li AY, 2016, MOL CELL ENDOCRINOL, V434, P36, DOI 10.1016/j.mce.2016.06.008
   Li XY, 2020, REDOX BIOL, V28, P0, DOI 10.1016/j.redox.2019.101373
   Lin FM, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23113016
   Liu Y, 2020, EVID-BASED COMPL ALT, V2020, P0, DOI 10.1155/2020/1561342
   Lu P, 2016, J CONTROL RELEASE, V240, P38, DOI 10.1016/j.jconrel.2015.10.023
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Maranhao RC, 2015, CURR PHARM DESIGN, V21, P1196, DOI 10.2174/1381612820666141013150714
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Maseri A, 2002, EUR HEART J SUPPL, V4, PB8, DOI 10.1016/S1520-765X(02)90009-X
   Meng Kai, 2015, MOLECULAR MEDICINE (BALTIMORE), V21, P0, DOI 10.2119/molmed.2014.00195
   Mercer JR, 2014, PHARMACOL THERAPEUT, V141, P13, DOI 10.1016/j.pharmthera.2013.07.011
   Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5
   Morató L, 2020, STRESS RESILIENCE: MOLECULAR AND BEHAVIORAL ASPECTS, V0, PP119, DOI 10.1016/B978-0-12-813983-7.00009-4
   Moriya J, 2019, J CARDIOL, V73, P22, DOI 10.1016/j.jjcc.2018.05.010
   Moulis M, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8060638
   Nam TG, 2011, TOX RESEARCH, V27, P1, DOI 10.5487/TR.2011.27.1.001
   National Heart Centre, 2019, TARGETING MITOCHONDR, V0, P0
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Oliveira HCF, 2004, FASEB J, V18, P278, DOI 10.1096/fj.04-2095fje
   Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218
   Paramasivam A, 2020, HYPERTENS RES, V43, P851, DOI 10.1038/s41440-020-0423-3
   Park S-Y, 2018, EFFECTS TETRAHYDROBI, V0, P0
   Park S-Y, 2018, IMPACTS MITOCHONDRIA, V0, P0
   Park YM, 2014, EXP MOL MED, V46, P0, DOI 10.1038/emm.2014.38
   Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552
   Peterlin A, 2019, CURR VASC PHARMACOL, V17, P25, DOI 10.2174/1570161116666180206111725
   Poznyak AV, 2020, BIOLOGY-BASEL, V9, P0, DOI 10.3390/biology9030060
   Prakash R, 2021, PROG MOL BIOL TRANSL, V178, P193, DOI 10.1016/bs.pmbts.2020.12.009
   Rimessi A, 2016, INT J BIOCHEM CELL B, V81, P281, DOI 10.1016/j.biocel.2016.06.015
   Rocha M, 2007, MED SCI MONITOR, V13, P0
   Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519
   Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589
   Saad A, 2017, CIRC-CARDIOVASC INTE, V10, P0, DOI 10.1161/CIRCINTERVENTIONS.117.005487
   Safdar A, 2016, SKELET MUSCLE, V6, P0, DOI 10.1186/s13395-016-0075-9
   Sarzi E, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20838-8
   Sazonova MA, 2017, VESSEL PLUS, V1, P182, DOI 10.20517/2574-1209.2017.16
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shemiakova T, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8060166
   Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355
   Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5
   Smith PM, 2011, J INHERIT METAB DIS, V34, P309, DOI 10.1007/s10545-010-9122-6
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Smith RAJ, 2011, ANTIOXID REDOX SIGN, V15, P3021, DOI 10.1089/ars.2011.3969
   Sobenin IA, 2020, CURR PHARM DESIGN, V26, P6, DOI 10.2174/138161282601200225102449
   Song N, 2020, BIOMED RES INT, V2020, P0, DOI 10.1155/2020/2819658
   Stanzl EG, 2013, ACCOUNTS CHEM RES, V46, P2944, DOI 10.1021/ar4000554
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Swiader A, 2016, ONCOTARGET, V7, P28821, DOI 10.18632/oncotarget.8936
   Taleb S, 2016, ARCH CARDIOVASC DIS, V109, P708, DOI 10.1016/j.acvd.2016.04.002
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   Tomkin GeealdH, 2012, OPEN ATHEROSCLEROSIS AND THROMBOSIS JOURNAL, V5, P13, DOI 10.2174/1876506801205010013
   Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968
   University of Minnesota, 2019, USE ENTRESTO SACUBIT, V0, P0
   Victor VM, 2007, CURR PHARM DESIGN, V13, P845, DOI 10.2174/138161207780363077
   Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265
   Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33
   Wang Y, 2014, J ATHEROSCLER THROMB, V21, P381, DOI 10.5551/jat.23929
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024
   Witte I, 2012, J LIPIDS, V2012, P0, DOI 10.1155/2012/342806
   Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zakirov FH, 2020, PHARMACOL RES PERSPE, V8, P0, DOI 10.1002/prp2.584
NR 90
TC 14
Z9 14
U1 2
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2297-055X
EI 
J9 FRONT CARDIOVASC MED
JI Front. Cardiovasc. Med.
PD MAY 4
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fcvm.2021.660473
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA SD5DS
UT WOS:000651393600001
PM 34017868
DA 2024-11-01
ER

PT J
AU Marek-Iannucci, S
   Ozdemir, AB
   Moreira, D
   Gomez, AC
   Lane, M
   Porritt, RA
   Lee, Y
   Shimada, K
   Abe, M
   Stotland, A
   Zemmour, D
   Parker, S
   Sanchez-Lopez, E
   Van Eyk, J
   Gottlieb, RA
   Fishbein, MC
   Karin, M
   Crother, TR
   Noval Rivas, M
   Arditi, M
AF Marek-Iannucci, Stefanie
   Ozdemir, Asli B.
   Moreira, Debbie
   Gomez, Angela C.
   Lane, Malcolm
   Porritt, Rebecca A.
   Lee, Youngho
   Shimada, Kenichi
   Abe, Masanori
   Stotland, Aleksandr
   Zemmour, David
   Parker, Sarah
   Sanchez-Lopez, Elsa
   Van Eyk, Jennifer
   Gottlieb, Roberta A.
   Fishbein, Michael C.
   Karin, Michael
   Crother, Timothy R.
   Noval Rivas, Magali
   Arditi, Moshe
TI Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis
SO JCI INSIGHT
LA English
DT Article
ID nlrp3 inflammasome; mouse model; mitochondrial-dna; metformin; children; interleukin-1-beta; dysfunction; activation; management; aneurysms
AB Kawasaki disease (KD) is the leading cause of acquired heart disease among children. Murine and human data suggest that the NLRP3-IL-1 beta pathway is the main driver of KD pathophysiology. NLRP3 can be activated during defective autophagy/mitophagy. We used the Lactobacillus casei cell wall extract (LCWE) murine model of KD vasculitis to examine the role of autophagy/mitophagy on cardiovascular lesion development. LCWE-injected mice had impaired autophagy/mitophagy and increased levels of ROS in cardiovascular lesions, together with increased systemic 8-OHdG release. Enhanced autophagic flux significantly reduced cardiovascular lesions in LCWE-injected mice, whereas autophagy blockade increased inflammation. Vascular smooth muscle cell-specific deletion of Atg16l1 and global Parkin(-/-) significantly increased disease formation, supporting the importance of autophagy/mitophagy in this model. Ogg1(-/-) mice had significantly increased lesions with increased NLRP3 activity, whereas treatment with MitoQ reduced vascular tissue inflammation, ROS production, and systemic 8-OHdG release. Treatment with MN58b or Metformin (increasing AMPK and reducing ROS) resulted in decreased cardiovascular lesions. Our results demonstrate that impaired autophagy/mitophagy and ROS-dependent damage exacerbate the development of murine KD vasculitis. This pathway can be efficiently targeted to reduce disease severity. These findings enhance our understanding of KD pathogenesis and identify potentially novel therapeutic avenues for KD treatment.
C1 [Marek-Iannucci, Stefanie] Cedars Sinai Med Ctr, Grad Sch Biomed Sci, Los Angeles, CA 90048 USA.
   [Marek-Iannucci, Stefanie; Ozdemir, Asli B.; Moreira, Debbie; Gomez, Angela C.; Lane, Malcolm; Porritt, Rebecca A.; Lee, Youngho; Shimada, Kenichi; Abe, Masanori; Crother, Timothy R.; Noval Rivas, Magali; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis & Immunol, Los Angeles, CA 90048 USA.
   [Marek-Iannucci, Stefanie; Ozdemir, Asli B.; Moreira, Debbie; Gomez, Angela C.; Lane, Malcolm; Porritt, Rebecca A.; Lee, Youngho; Shimada, Kenichi; Abe, Masanori; Crother, Timothy R.; Noval Rivas, Magali; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Biomed Sci, Infect & Immunol Dis Res Ctr IIDRC, Los Angeles, CA 90048 USA.
   [Stotland, Aleksandr; Parker, Sarah; Van Eyk, Jennifer] Cedars Sinai Med Ctr, Adv Clin Biosyst Res Inst, Los Angeles, CA 90048 USA.
   [Zemmour, David] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.
   [Zemmour, David] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Sanchez-Lopez, Elsa; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA USA.
   [Gottlieb, Roberta A.; Arditi, Moshe] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.
   [Fishbein, Michael C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Arditi, M (corresponding author), 8700 Beverly Blvd, Los Angeles, CA 90048 USA.
EM moshe.arditi@cshs.org
FU NIH [R01 HL139766, R01 AI072726]
CR Alphonse MP, 2016, J IMMUNOL, V197, P3481, DOI 10.4049/jimmunol.1600388
   Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416
   Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004
   Barazzuol L, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21051772
   Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314
   Biasizzo M, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.591803
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Brogan P, 2020, HEART, V106, P411, DOI 10.1136/heartjnl-2019-315925
   Burns JC, 2009, INDIAN J PEDIATR, V76, P71, DOI 10.1007/s12098-009-0031-3
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Clément M, 2019, ARTERIOSCL THROM VAS, V39, P1149, DOI 10.1161/ATVBAHA.118.311727
   Crother TR, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.00754
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768
   Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102
   Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787
   Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757
   Huang FC, 2020, CHILDREN-BASEL, V7, P0, DOI 10.3390/children7100166
   Huang SM, 2008, CIRC J, V72, P1583, DOI 10.1253/circj.CJ-08-0121
   KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Lee Y, 2015, ARTERIOSCL THROM VAS, V35, P2605, DOI 10.1161/ATVBAHA.115.306475
   Lee Y, 2012, CIRCULATION, V125, P1542, DOI 10.1161/CIRCULATIONAHA.111.072769
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li YB, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0790-6
   Lu M, 2016, INT J NEUROPSYCHOPH, V19, P0, DOI 10.1093/ijnp/pyw047
   Marek-Iannucci S, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-46452-w
   MAURY CPJ, 1988, NEW ENGL J MED, V319, P1670
   McCrindle BW, 2017, CIRCULATION, V135, PE927, DOI 10.1161/CIR.0000000000000484
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Mohsin AA, 2019, J PHARMACOL EXP THER, V369, P282, DOI 10.1124/jpet.118.254300
   Morciano G, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9030892
   Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073
   Niedra E, 2014, PEDIATR CARDIOL, V35, P89, DOI 10.1007/s00246-013-0746-9
   Noval Rivas M, 2020, NAT REV RHEUMATOL, V16, P391, DOI 10.1038/s41584-020-0426-0
   Noval Rivas M, 2017, ARTHRITIS RHEUMATOL, V69, P410, DOI 10.1002/art.39939
   Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040
   Peng S, 2018, FRONT PHARMACOL, V9, P0, DOI 10.3389/fphar.2018.00438
   Porritt RA, 1900, V2021, V0, P0
   Porritt RA, 2020, ARTERIOSCL THROM VAS, V40, P802, DOI 10.1161/ATVBAHA.119.313863
   Ramadan A, 2017, ATHEROSCLEROSIS, V257, P288, DOI 10.1016/j.atherosclerosis.2017.01.017
   Rogers GW, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021746
   Salmon M, 2019, PHYSIOL REP, V7, P0, DOI 10.14814/phy2.14058
   Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011
   Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015
   Sasaki Y, 2017, INT HEART J, V58, P666, DOI 10.1536/ihj.17-246
   Sciarretta S, 2018, ANNU REV PHYSIOL, V80, P1, DOI 10.1146/annurev-physiol-021317-121427
   Senzaki H, 2006, ARCH DIS CHILD, V91, P847, DOI 10.1136/adc.2005.087437
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shires SE, 2015, J MOL MED, V93, P253, DOI 10.1007/s00109-015-1254-6
   Soni PR, 2020, CURR RHEUMATOL REP, V22, P0, DOI 10.1007/s11926-020-0882-1
   Stotland AB, 2020, J MOL CELL CARDIOL, V142, P1, DOI 10.1016/j.yjmcc.2020.03.011
   Sun Q, 2017, MOL MED, V23, P188, DOI 10.2119/molmed.2017.00077
   Tremoulet AH, 2019, J PEDIATR-US, V215, P107, DOI 10.1016/j.jpeds.2019.07.064
   Tsuji G, 2020, CELL DEATH DISCOV, V6, P0, DOI 10.1038/s41420-020-0245-8
   Tumurkhuu G, 2016, CIRC RES, V119, PE76, DOI 10.1161/CIRCRESAHA.116.308362
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Wakita D, 2016, ARTERIOSCL THROM VAS, V36, P886, DOI 10.1161/ATVBAHA.115.307072
   Wang QL, 2018, METHODS MOL BIOL, V1732, P507, DOI 10.1007/978-1-4939-7598-3_32
   Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841
   Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070
   Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111
   Weng KP, 2010, CIRC J, V74, P544, DOI 10.1253/circj.CJ-09-0664
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022
   Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014
   Zhang H, 2017, J IMMUNOL, V198, P2133, DOI 10.4049/jimmunol.1601293
   Zhang Y, 2020, CIRC RES, V127, P855, DOI 10.1161/CIRCRESAHA.120.316951
   Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709
NR 78
TC 32
Z9 35
U1 0
U2 25
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD SEP 22
PY 2021
VL 6
IS 18
BP 
EP 
DI 10.1172/jci.insight.151981
PG 20
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA UY7RX
UT WOS:000701717500002
PM 34403365
DA 2024-11-01
ER

PT J
AU Loos, MA
   Gomez, G
   Mayorga, L
   Caraballo, RH
   Eiroa, HD
   Obregon, MG
   Rugilo, C
   Lubieniecki, F
   Taratuto, AL
   Saccoliti, M
   Alonso, CN
   Araoz, HV
AF Loos, Mariana Amina
   Gomez, Gimena
   Mayorga, Lia
   Caraballo, Roberto Horacio
   Eiroa, Hernan Diego
   Obregon, Maria Gabriela
   Rugilo, Carlos
   Lubieniecki, Fabiana
   Taratuto, Ana Lia
   Saccoliti, Maria
   Alonso, Cristina Noemi
   Araoz, Hilda Veronica
TI Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Mitochondrial diseases; MELAS; Leigh syndrome; Molecular diagnosis; Pediatrics; Mitochondrial DNA
ID hereditary optic neuropathy; leigh-syndrome; transfer-rna; disease phenotypes; mutation; deletions; ataxia; deficiency; management; diagnosis
AB Objective: To describe the clinical and molecular features of a group of Argentinian pediatric patients with mitochondrial DNA (mtDNA) disorders, and to evaluate the results of the implementation of a classical approach for the molecular diagnosis of mitochondrial diseases. Methods: Clinical data from 27 patients with confirmed mtDNA pathogenic variants were obtained from a database of 89 patients with suspected mitochondrial disease, registered from 2014 to 2020. Clinical data, biochemical analysis, neuroimaging findings, muscle biopsy and molecular studies were analyzed. Results: Patients were 18 females and 9 males, with ages at onset ranging from 1 week to 14 years (median = 4 years). The clinical phenotypes were: mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome (n = 11), Leigh syndrome (n = 5), Kearns-Sayre syndrome (n = 3), Chronic Progressive External Ophthalmoplegia (n = 2), Leber hereditary optic neuropathy (n = 2), myoclonic epilepsy associated with ragged-red fibers (n = 1) and reversible infantile myopathy with cytochrome-C oxidase deficiency (n = 3). Most of the patients harbored pathogenic single nucleotide variants, mainly involving mt-tRNA genes, such as MT-TL1, MT-TE and MT-TK. Other point variants were found in complex I subunits, like MT-ND6, MT-ND4, MT-ND5; or in MT-ATP6. The m.13513G > A variant in MT-ND5 and the m.9185 T > C variant in MTATP6 were apparently de novo. The rest of the patients presented large scale-rearrangements, either the "common" deletion or a larger deletion. Conclusions: This study highlights the clinical and genetic heterogeneity of pediatric mtDNA disorders. All the cases presented with classical phenotypes, being MELAS the most frequent. Applying classical molecular methods, it was possible to achieve a genetic diagnosis in 30% of the cases, suggesting that this is an effective first approach, especially for those centers from low-middle income countries, leaving NGS studies for those patients with inconclusive results.
C1 [Loos, Mariana Amina; Caraballo, Roberto Horacio] Hosp Pediatr Juan P Garrahan, Dept Neurol, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Gomez, Gimena; Alonso, Cristina Noemi] Hosp Pediatr Juan P Garrahan, Genom Lab, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Mayorga, Lia] Univ Nacl Cuyo, Ctr Univ UNCuyo, CONICET,IHEM, Inst Histol & Embriol Mendoza, RA-5500 Mendoza, Argentina.
   [Eiroa, Hernan Diego] Hosp Pediat Juan P Garrahan, Dept Inborn Errors Metab, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Obregon, Maria Gabriela; Araoz, Hilda Veronica] Hosp Pediatria Juan P Garrahan, Dept Med Genet, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Rugilo, Carlos] Hosp Pediatr Juan P Garrahan, Dept Diagnost Imaging, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Lubieniecki, Fabiana] Hosp Pediat Juan P Garrahan, Dept Pathol, Combate Los Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
   [Taratuto, Ana Lia; Saccoliti, Maria] Neuropathol & Neuromusc Dis Lab, Buenos Aires, DF, Argentina.
C3 Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan; Hospital de Pediatria Doctor Juan Garrahan
RP Loos, MA (corresponding author), Hosp Pediatr Juan P Garrahan, Dept Neurol, Combate Pozos 1881, RA-1245 Buenos Aires, DF, Argentina.
EM mloos@garrahan.gov.ar
FU Hospital de Pediatria "J. P. Garrahan"
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Brautbar A, 2008, MOL GENET METAB, V94, P485, DOI 10.1016/j.ymgme.2008.04.004
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Couser N, 2017, CLIN ASPECTS LAB DET, V2, P167, DOI 10.1016/B978-0-12-802896-4.00008-0
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   Davison JE, 2017, ARCH DIS CHILD, V102, P1082, DOI 10.1136/archdischild-2016-311370
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Diogo L, 2009, PEDIATR NEUROL, V40, P351, DOI 10.1016/j.pediatrneurol.2008.11.012
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Jou C, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8010068
   JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Lamont PJ, 1998, ARCH DIS CHILD, V79, P22, DOI 10.1136/adc.79.1.22
   Mayorga L, 2019, CELL MOL LIFE SCI, V76, P1397, DOI 10.1007/s00018-019-03008-5
   Mayorga L, 2019, MITOCHONDRIAL DNA B, V4, P530, DOI 10.1080/23802359.2018.1553510
   Mayorga L, 2016, MITOCHONDRIAL DNA A, V27, P2864, DOI 10.3109/19401736.2015.1053132
   Morava E, 2015, J INHERIT METAB DIS, V38, P387, DOI 10.1007/s10545-015-9852-6
   Muramatsu D, 2019, INTERNAL MED, V58, P1797, DOI 10.2169/internalmedicine.2190-18
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Nissenkorn A, 2000, J CHILD NEUROL, V15, P44, DOI 10.1177/088307380001500110
   Orsucci D, 2018, EBIOMEDICINE, V30, P3, DOI 10.1016/j.ebiom.2018.03.007
   Oyama M, 2020, BMC NEUROL, V20, P0, DOI 10.1186/s12883-020-01748-7
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2014, GENEREVIEWS, V0, P1
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Ronchi D, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-85
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHOFFNER JM, 1995, ANN NEUROL, V38, P163, DOI 10.1002/ana.410380207
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Sue CM, 1999, J PEDIATR-US, V134, P696, DOI 10.1016/S0022-3476(99)70283-0
   Takada R, 2020, BRAIN DEV-JPN, V42, P69, DOI 10.1016/j.braindev.2019.08.006
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Xing GQ, 2007, CELL RES, V17, P227, DOI 10.1038/sj.cr.7310124
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
NR 54
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD JUN 15
PY 2021
VL 27
IS 
BP 
EP 
DI 10.1016/j.ymgmr.2021.100733
EA FEB 2021
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA SV0DH
UT WOS:000663497800033
PM 33717984
DA 2024-11-01
ER

PT J
AU Li, D
   Yang, SJ
   Xing, YW
   Pan, LM
   Zhao, R
   Zhao, YX
   Liu, LT
   Wu, M
AF Li, Dan
   Yang, Shengjie
   Xing, Yanwei
   Pan, Limin
   Zhao, Ran
   Zhao, Yixi
   Liu, Longtao
   Wu, Min
TI Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondria; morphology; fission; fusion; cytoskeleton; transport
ID smooth-muscle-cells; nlrp3 inflammasome activation; low-density-lipoprotein; higher-risk plaques; nf-kappa-b; oxidative stress; cardiovascular-disease; alleviates atherosclerosis; endothelial dysfunction; pulmonary-hypertension
AB Cardiovascular disease (CVD) is the main cause of death worldwide. Atherosclerosis is the underlying pathological basis of CVD. Mitochondrial homeostasis is maintained through the dynamic processes of fusion and fission. Mitochondria are involved in many cellular processes, such as steroid biosynthesis, calcium homeostasis, immune cell activation, redox signaling, apoptosis, and inflammation, among others. Under stress conditions, mitochondrial dynamics, mitochondrial cristae remodeling, and mitochondrial ROS (mitoROS) production increase, mitochondrial membrane potential (MMP) decreases, calcium homeostasis is imbalanced, and mitochondrial permeability transition pore open (mPTP) and release of mitochondrial DNA (mtDNA) are activated. mtDNA recognized by TLR9 can lead to NF-kappa B pathway activation and pro-inflammatory factor expression. At the same time, TLR9 can also activate NLRP3 inflammasomes and release interleukin, an event that eventually leads to tissue damage and inflammatory responses. In addition, mitochondrial dysfunction may amplify the activation of NLRP3 through the production of mitochondrial ROS, which together aggravate accumulating mitochondrial damage. In addition, mtDNA defects or gene mutation can lead to mitochondrial oxidative stress. Finally, obesity, diabetes, hypertension and aging are risk factors for the progression of CVD, which are closely related to mitochondrial dynamics. Mitochondrial dynamics may represent a new target in the treatment of atherosclerosis. Antioxidants, mitochondrial inhibitors, and various new therapies to correct mitochondrial dysfunction represent a few directions for future research on therapeutic intervention and amelioration of atherosclerosis.
C1 [Li, Dan; Yang, Shengjie; Xing, Yanwei; Pan, Limin; Zhao, Ran; Zhao, Yixi; Wu, Min] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.
   [Liu, Longtao] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China.
C3 China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS
RP Wu, M (corresponding author), China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China.; Liu, LT (corresponding author), China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China.
EM liulongtao1976@126.com; wumin19762000@126.com
FU National Natural Science Foundation of China [81202805, 81973689, 81573821, 82074254]; Beijing Natural Science Foundation [7172185, 7202176]
CR Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073
   Apostolova N, 2020, REDOX BIOL, V34, P0, DOI 10.1016/j.redox.2020.101517
   Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101
   Breitzig MT, 2018, AM J PHYSIOL-CELL PH, V315, PC80, DOI 10.1152/ajpcell.00042.2018
   Bugger H, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165768
   Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532
   Cai Y, 2018, J CARDIOVASC TRANSL, V11, P450, DOI 10.1007/s12265-018-9828-7
   Corona JC, 2014, EXP NEUROL, V253, P16, DOI 10.1016/j.expneurol.2013.12.012
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen AO, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-021-03389-1
   Chen CC, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9040275
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/6699516
   Chen YB, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065455
   Cheng GJ, 2015, BIOCHEM BIOPH RES CO, V465, P41, DOI 10.1016/j.bbrc.2015.07.118
   Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116
   Chiong M, 2014, FRONT CELL DEV BIOL, V2, P0, DOI 10.3389/fcell.2014.00072
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Cid-Castro C, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/8832863
   Commodore-Mensah Y, 2021, DIABETES CARE, V44, P1657, DOI 10.2337/dc20-2227
   Cui L, 2017, VASC PHARMACOL, V88, P21, DOI 10.1016/j.vph.2016.11.006
   DAmico D, 2019, MOL CELL, V73, P775, DOI 10.1016/j.molcel.2018.11.034
   Dehnavi S, 2021, DRUGS, V81, P923, DOI 10.1007/s40265-021-01510-4
   Dikalova AE, 2020, CIRC RES, V126, P439, DOI 10.1161/CIRCRESAHA.119.315767
   Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114
   Du JK, 2022, PSYCHOPHARMACOLOGY, V239, P2083, DOI 10.1007/s00213-021-05811-0
   Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Elorza AA, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.625020
   Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833
   Faelber K, 2019, NATURE, V571, P429, DOI 10.1038/s41586-019-1372-3
   Fang X, 2016, J CARDIOVASC PHARM, V67, P164, DOI 10.1097/FJC.0000000000000333
   Farré AL, 2001, HYPERTENSION, V38, P1400, DOI 10.1161/hy1201.099612
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0372-y
   Fletcher EA, 2018, PUBLIC HEALTH NUTR, V21, P1115, DOI 10.1017/s136898001700372x
   Förstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326
   Foote K, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12773
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Forte M, 2019, J MOL MED, V97, P579, DOI 10.1007/s00109-019-01771-3
   Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704
   Fukai T, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9081849
   Gao P, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.604240
   Gent S, 2017, AM J PHYSIOL-HEART C, V312, PH478, DOI 10.1152/ajpheart.00749.2016
   Gherardi G, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.554904
   Gisterå A, 2018, CURR OPIN LIPIDOL, V29, P375, DOI 10.1097/MOL.0000000000000540
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010
   Gu Q, 2014, EXP GERONTOL, V56, P37, DOI 10.1016/j.exger.2014.02.014
   Guo DQ, 2017, ONCOTARGET, V8, P77020, DOI 10.18632/oncotarget.20331
   Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644
   Guo YH, 2007, BIOCHEM BIOPH RES CO, V363, P411, DOI 10.1016/j.bbrc.2007.08.191
   Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034
   Hasan P, 2018, J MOL CELL CARDIOL, V121, P103, DOI 10.1016/j.yjmcc.2018.07.004
   Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604
   Hong ST, 2017, BIOCHEM BIOPH RES CO, V487, P728, DOI 10.1016/j.bbrc.2017.04.126
   Hu C, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-03152-y
   Hu L, 2019, THERANOSTICS, V9, P3687, DOI 10.7150/thno.33684
   Huang D, 2020, AGING-US, V12, P18181, DOI 10.18632/aging.103666
   Hughes WE, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0802-6
   Humeres C, 2019, JACC-BASIC TRANSL SC, V4, P449, DOI 10.1016/j.jacbts.2019.02.006
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Jong CJ, 2019, MOL CELL BIOCHEM, V454, P33, DOI 10.1007/s11010-018-3450-5
   Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183
   Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.00012
   Karnewar S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24108
   Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199
   Kim J, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25437
   Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054
   Kiyuna LA, 2018, FREE RADICAL BIO MED, V129, P155, DOI 10.1016/j.freeradbiomed.2018.09.019
   Kleinbongard P, 2018, BASIC RES CARDIOL, V113, P1, DOI 10.1007/s00395-017-0660-z
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   Koltover Vitaly K, 2017, CURR AGING SCI, V10, P12
   Kuznetsova DA, 2019, J MATER CHEM B, V7, P7351, DOI 10.1039/c9tb01853k
   Kyriakoudi S, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22094617
   Lackner LL, 2019, TRENDS CELL BIOL, V29, P580, DOI 10.1016/j.tcb.2019.02.009
   Laslett LJ, 2012, J AM COLL CARDIOL, V60, PS1, DOI 10.1016/j.jacc.2012.11.002
   Li AX, 2022, HEART FAIL REV, V27, P1387, DOI 10.1007/s10741-021-10109-6
   Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010
   Li J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep12724
   Li SS, 2017, EUR J PHARMACOL, V815, P118, DOI 10.1016/j.ejphar.2017.07.041
   Li Y, 2016, ANTIOXID REDOX SIGN, V24, P893, DOI 10.1089/ars.2015.6479
   Linton MF, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112703
   Liu M, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.598078
   Liu MY, 2016, HYPERTENSION, V68, P1245, DOI 10.1161/HYPERTENSIONAHA.116.07974
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Luptak I, 2019, ANTIOXID REDOX SIGN, V31, P539, DOI 10.1089/ars.2018.7707
   Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4
   Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI 10.1161/ATVBAHA.117.309017
   Markin AM, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11020165
   Marshall JD, 2018, AM J PHYSIOL-LUNG C, V314, PL782, DOI 10.1152/ajplung.00331.2017
   Mathew A, 2012, J ALZHEIMERS DIS, V30, P617, DOI 10.3233/JAD-2012-120145
   Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500
   Micha R, 2009, NAT REV ENDOCRINOL, V5, P335, DOI 10.1038/nrendo.2009.79
   Mohanty A, 2019, J CELL COMMUN SIGNAL, V13, P303, DOI 10.1007/s12079-019-00507-9
   Morales PE, 2020, MOL ASPECTS MED, V71, P0, DOI 10.1016/j.mam.2019.09.006
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Müller J, 2014, BASIC RES CARDIOL, V109, P0, DOI 10.1007/s00395-014-0440-y
   Muñoz-Carvajal F, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.581849
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Navaratnarajah T, 2021, INT J BIOCHEM CELL B, V134, P0, DOI 10.1016/j.biocel.2021.105951
   Nazzal D, 2006, J INFECT DIS, V193, P136, DOI 10.1086/498617
   Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013
   Nielsen SH, 2019, MATRIX BIOL, V75-76, P43, DOI 10.1016/j.matbio.2017.12.001
   Norton M, 2014, SCI SIGNAL, V7, P0, DOI 10.1126/scisignal.2004374
   Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537
   Ordog K, 2021, LIFE SCI, V268, P0, DOI 10.1016/j.lfs.2020.118936
   Ostojic SM, 2016, CLIN SCI, V130, P1407, DOI 10.1042/CS20160200
   Ota A, 2020, J BIOCHEM, V167, P287, DOI 10.1093/jb/mvz112
   Paltauf-Doburzynska J, 2004, J CARDIOVASC PHARM, V44, P423, DOI 10.1097/01.fjc.0000139449.64337.1b
   Pataky MW, 2021, CELL METAB, V33, P847, DOI 10.1016/j.cmet.2021.04.008
   Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394
   Peyravi A, 2020, J FOOD BIOCHEM, V44, P0, DOI 10.1111/jfbc.13125
   Pham L, 2021, BIOMATERIALS, V269, P0, DOI 10.1016/j.biomaterials.2021.120677
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Picca A, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18050933
   Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439
   Qin X, 2019, THERANOSTICS, V9, P1698, DOI 10.7150/thno.30640
   Qiu Y, 2020, MOL THER-NUCL ACIDS, V19, P1343, DOI 10.1016/j.omtn.2020.01.017
   Rababah AM, 2018, CURR CARDIOL REV, V14, P53, DOI 10.2174/1573403X14666180111145207
   Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006
   Saigusa R, 2020, NAT REV CARDIOL, V17, P387, DOI 10.1038/s41569-020-0352-5
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Schiano C, 2015, TRENDS PHARMACOL SCI, V36, P226, DOI 10.1016/j.tips.2015.02.005
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Shao ZQ, 2021, NEURAL REGEN RES, V16, P1044, DOI 10.4103/1673-5374.300725
   Sharp WW, 2015, J MOL MED, V93, P225, DOI 10.1007/s00109-015-1258-2
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87
   Sobenin IA, 2013, CURR PHARM DESIGN, V19, P5942
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Song R, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8121475
   Stanzione R, 2022, CURR NEUROPHARMACOL, V20, P662, DOI 10.2174/1570159X19666210421094204
   Strutynska N A, 2016, FIZIOL ZH, V62, P3
   Suárez-Rivero JM, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9030258
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tang JX, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113820
   Teixeira LD, 2021, FOOD FUNCT, V12, P3680, DOI 10.1039/d0fo03245j
   Thijssen DHJ, 2010, EUR J APPL PHYSIOL, V108, P845, DOI 10.1007/s00421-009-1260-x
   Tibaut M, 2019, HEART LUNG CIRC, V28, P667, DOI 10.1016/j.hlc.2018.06.1057
   Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388
   Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP
   Tumurkhuu G, 2016, CIRC RES, V119, PE76, DOI 10.1161/CIRCRESAHA.116.308362
   Ueda S, 2015, FREE RADICAL BIO MED, V87, P181, DOI 10.1016/j.freeradbiomed.2015.06.028
   Vaka VR, 2018, HYPERTENSION, V72, P703, DOI 10.1161/HYPERTENSIONAHA.118.11290
   Valenzuela CA, 2019, PROG LIPID RES, V76, P0, DOI 10.1016/j.plipres.2019.101009
   van Empel VPM, 2004, CARDIOVASC RES, V63, P487, DOI 10.1016/j.cardiores.2004.02.013
   Vendrov AE, 2015, ANTIOXID REDOX SIGN, V23, P1389, DOI 10.1089/ars.2014.6221
   Victor VM, 2015, ATHEROSCLEROSIS, V242, P167, DOI 10.1016/j.atherosclerosis.2015.07.017
   Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33
   Volobueva A, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9080377
   Wang L, 2015, CARDIOVASC RES, V106, P272, DOI 10.1093/cvr/cvv005
   Wang QL, 2017, AUTOPHAGY, V13, P404, DOI 10.1080/15548627.2016.1263776
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang RH, 2021, MOL BIOL CELL, V32, P157, DOI 10.1091/mbc.E20-09-0605
   Wang SS, 2021, EXP GERONTOL, V143, P0, DOI 10.1016/j.exger.2020.111152
   Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, PC695, DOI 10.1152/ajpcell.00322.2010
   Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027
   Weaver D, 2014, MOL CELL, V54, P870, DOI 10.1016/j.molcel.2014.03.048
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Wolf C, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9040815
   Wu YL, 2018, BIOMED PHARMACOTHER, V97, P1673, DOI 10.1016/j.biopha.2017.12.024
   Xie TQ, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.01034
   Xin YG, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.647631
   Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004
   Xue W, 2020, BIOMED PHARMACOTHER, V124, P0, DOI 10.1016/j.biopha.2020.109849
   Yan Y, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19113534
   Yang JN, 2019, NUTR METAB, V16, P0, DOI 10.1186/s12986-019-0338-7
   Yapa NMB, 2021, FEBS LETT, V595, P1184, DOI 10.1002/1873-3468.14077
   Yeh HL, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/5086869
   Yu E, 2014, CIRCULATION, V129, PE408, DOI 10.1161/CIRCULATIONAHA.113.008032
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu SJ, 2019, EXP CELL RES, V379, P191, DOI 10.1016/j.yexcr.2019.04.002
   Zhang BB, 2017, MOL NUTR FOOD RES, V61, P0, DOI 10.1002/mnfr.201600710
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao J, 2019, BASIC RES CARDIOL, V114, P0, DOI 10.1007/s00395-019-0721-6
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
   Zhou J, 2016, ONCOTARGET, V7, P31284, DOI 10.18632/oncotarget.8893
   Zhou Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0154720
   Zhu YC, 2019, DRUG DEVELOP RES, V80, P481, DOI 10.1002/ddr.21521
   Zhuan B, 2020, AGING-US, V12, P23684, DOI 10.18632/aging.103892
   Zhuang XY, 2017, EXP THER MED, V14, P515, DOI 10.3892/etm.2017.4541
   Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042
NR 197
TC 33
Z9 33
U1 1
U2 29
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD JUL 7
PY 2021
VL 9
IS 
BP 
EP 
DI 10.3389/fcell.2021.673839
PG 16
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA TL6EO
UT WOS:000674952500001
PM 34307357
DA 2024-11-01
ER

PT J
AU Borsche, M
   Pereira, SL
   Klein, C
   Grünewald, A
AF Borsche, Max
   Pereira, Sandro L.
   Klein, Christine
   Gruenewald, Anne
TI Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects
SO JOURNAL OF PARKINSONS DISEASE
LA English
DT Review
DE Parkinson's disease; mitochondria; mitochondrial dysfunction; Parkin; PINK1; DJ-1; POLG; gene-specific therapy; clinical trial
ID dna-polymerase-gamma; progressive external ophthalmoplegia; alpha-synuclein; complex-i; dopaminergic neurotoxicity; juvenile parkinsonism; movement-disorders; catalytic-activity; substantia-nigra; quality-control
AB Mitochondrial dysfunction represents a well-established player in the pathogenesis of both monogenic and idiopathic Parkinson's disease (PD). Initially originating from the observation that mitochondrial toxins cause PD, findings from genetic PD supported a contribution of mitochondrial dysfunction to the disease. Here, proteins encoded by the autosomal recessively inherited PD genes Parkin, PTEN-induced kinase 1 (PINK1), and DJ-1 are involved in mitochondrial pathways. Additional evidence for mitochondrial dysfunction stems from models of autosomal-dominant PD due to mutations in alpha-synuclein (SNCA) and leucine-rich repeat kinase 2 (LRRK2). Moreover, patients harboring alterations in mitochondrial polymerase gamma (POLG) often exhibit signs of parkinsonism. While some molecular studies suggest that mitochondrial dysfunction is a primary event in PD, others speculate that it is the result of impaired mitochondrial clearance. Most recent research even implicated damage-associated molecular patterns released from non-degraded mitochondria in neuroinflammatory processes in PD. Here, we summarize the manifold literature dealing with mitochondria in the context of PD. Moreover, in light of recent advances in the field of personalized medicine, patient stratification according to the degree of mitochondrial impairment followed by mitochondrial enhancement therapy may hold potential for at least a subset of genetic and idiopathic PD cases. Thus, in the second part of this review, we discuss therapeutic approaches targeting mitochondrial dysfunction with the aim to prevent or delay neurodegeneration in PD.
C1 [Borsche, Max; Klein, Christine; Gruenewald, Anne] Univ Lubeck, Inst Neurogenet, Ratzeburger Allee 160,BMF Bldg 67, D-23538 Lubeck, Germany.
   [Borsche, Max] Univ Lubeck, Dept Neurol, Lubeck, Germany.
   [Pereira, Sandro L.; Gruenewald, Anne] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.
C3 University of Lubeck; University of Lubeck; University of Luxembourg
RP Klein, C (corresponding author), Univ Lubeck, Inst Neurogenet, Ratzeburger Allee 160,BMF Bldg 67, D-23538 Lubeck, Germany.
EM christine.klein@neuro.uni-luebeck.de
FU SysMedPD (European Union's Horizon 2020 research and innovation program [668738]; German Research Foundation [FOR2488, GR 3731/5-1]; Luxembourg National Research Fund (ATTRACT career development grant) [FNR9631103, FNR11250962]; H2020 Societal Challenges Programme [668738] Funding Source: H2020 Societal Challenges Programme
CR Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   Arias-Fuenzalida J, 2017, STEM CELL REP, V9, P1423, DOI 10.1016/j.stemcr.2017.08.026
   Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7
   Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384
   Bernardini JP, 2019, EMBO J, V38, P0, DOI 10.15252/embj.201899916
   Blesa J, 2015, FRONT NEUROANAT, V9, P0, DOI 10.3389/fnana.2015.00091
   Bonello F, 2019, HUM MOL GENET, V28, P1645, DOI 10.1093/hmg/ddz004
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Brüggemann N, 2019, MOVEMENT DISORD, V34, P1294, DOI 10.1002/mds.27699
   Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080
   Cerqua C, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-43014-y
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Copeland William C, 2003, SCIENTIFICWORLDJOURNAL, V3, P34
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64
   Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039
   Giannoccaro MP, 2017, MOVEMENT DISORD, V32, P346, DOI 10.1002/mds.26966
   Gómez-Suaga P, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0079-3
   Grassi D, 2018, P NATL ACAD SCI USA, V115, PE2634, DOI 10.1073/pnas.1713849115
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grünewald A, 2019, PROG NEUROBIOL, V177, P73, DOI 10.1016/j.pneurobio.2018.09.003
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Grünewald A, 2013, JAMA NEUROL, V70, P1186, DOI 10.1001/jamaneurol.2013.488
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898
   Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167
   Haque ME, 2020, MOVEMENT DISORD, V35, P20, DOI 10.1002/mds.27874
   HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0
   Heo JY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032629
   Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030
   Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Hudson G, 2006, HUM MOL GENET MATHEO, V0, P0
   Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007
   Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Langston JW, 2017, J PARKINSON DIS, V7, PS11, DOI 10.3233/JPD-179006
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   LANGSTON JW, 1984, NEUROSCI LETT, V48, P87, DOI 10.1016/0304-3940(84)90293-3
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999
   Lee KS, 2018, P NATL ACAD SCI USA, V115, PE8844, DOI 10.1073/pnas.1721136115
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749
   Mao CY, 2019, NEUROBIOL AGING, V75, P38, DOI 10.1016/j.neurobiolaging.2018.10.020
   Marras C, 2016, MOVEMENT DISORD, V31, P436, DOI 10.1002/mds.26527
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y
   Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mouton-Ligeri F, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00120
   Narendra D, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011338
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1264, DOI 10.1002/mds.27115
   Okatsu K, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms2016
   Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335
   Ottolini D, 2013, HUM MOL GENET, V22, P2152, DOI 10.1093/hmg/ddt068
   Ouzren N, 2019, ANN NEUROL, V86, P324, DOI 10.1002/ana.25510
   Paillusson S, 2017, ACTA NEUROPATHOL, V134, P129, DOI 10.1007/s00401-017-1704-z
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parkinson Study Group STEADY-PD III Investigators, 2020, ANN INTERN MED, V172, P591, DOI 10.7326/M19-2534
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pirooznia SK, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00363-x
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Prasuhn J, 2019, NEUROL RES PRACT, V1, P0, DOI 10.1186/s42466-019-0033-1
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680
   Reed X, 2019, NEUROBIOL DIS, V124, P230, DOI 10.1016/j.nbd.2018.11.012
   Roosen DA, 2016, MOL NEURODEGENER, V11, P0, DOI 10.1186/s13024-016-0140-1
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Sarkar S, 2017, NPJ PARKINSON DIS, V3, P0, DOI 10.1038/s41531-017-0032-2
   Sarraf SA, 2019, CELL REP, V29, P225, DOI 10.1016/j.celrep.2019.08.085
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schapira AHV, 2011, CNS DRUGS, V25, P1061, DOI 10.2165/11596310-000000000-00000
   Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2
   Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOULSON I, 1989, NEW ENGL J MED, V321, P1364
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148
   Soubannier V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052830
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Storch A, 2004, J NEURAL TRANSM, V111, P1267, DOI 10.1007/s00702-004-0203-2
   Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39
   Tabata Y, 2018, STEM CELL REP, V11, P1171, DOI 10.1016/j.stemcr.2018.09.006
   Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001
   TATTON WG, 1991, J NEUROSCI RES, V30, P666, DOI 10.1002/jnr.490300410
   Trinh J, 2018, MOVEMENT DISORD, V33, P1857, DOI 10.1002/mds.27527
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Vingill S, 2018, BEHAV BRAIN RES, V352, P133, DOI 10.1016/j.bbr.2017.10.021
   Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632
   Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983
   Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018
   Wang Y, 2013, HUM MOL GENET, V22, P4768, DOI 10.1093/hmg/ddt330
   Wauters F, 2020, AUTOPHAGY, V16, P203, DOI 10.1080/15548627.2019.1603548
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Xi Y, 2018, BBA-MOL BASIS DIS, V1864, P2859, DOI 10.1016/j.bbadis.2018.05.018
   Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Zeuner KL, 2019, CLIN PHARMACOL THER, V105, P1106, DOI 10.1002/cpt.1374
   Zhou LP, 2017, BBA-MOL BASIS DIS, V1863, P2791, DOI 10.1016/j.bbadis.2017.07.032
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
   Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008
   Zsurka G, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9040175
NR 144
TC 125
Z9 139
U1 15
U2 105
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1877-7171
EI 1877-718X
J9 J PARKINSON DIS
JI J. Parkinsons Dis.
PD JUN 15
PY 2021
VL 11
IS 1
BP 45
EP 60
DI 10.3233/JPD-201981
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA QH1US
UT WOS:000618063800005
PM 33074190
DA 2024-11-01
ER

PT J
AU Primiano, G
   Brunetti, V
   Vollono, C
   Losurdo, A
   Moroni, R
   Della Marca, G
   Servidei, S
AF Primiano, Guido
   Brunetti, Valerio
   Vollono, Catello
   Losurdo, Anna
   Moroni, Rossana
   Della Marca, Giacomo
   Servidei, Serenella
TI Sleep-Disordered Breathing in Adult Patients With Mitochondrial Diseases A Cohort Study
SO NEUROLOGY
LA English
DT Article
ID mutation
AB Objective To describe the prevalence and characteristics of sleep-disordered breathing (SDB) in a large cohort of patients with genetically confirmed mitochondrial diseases. Methods This is a prospective observational study performed at the Neurophysiopatology Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS. All participants had a defined mitochondrial disease and were investigated by full-night polysomnography. Results One hundred three consecutive patients were enrolled. SDB was demonstrated in 49 patients (47.6%). Regarding phenotypes, we found differences in distribution between the groups: patients affected by progressive external ophthalmoplegia with single or multiple mtDNA deletions frequently had obstructive apneas (50% and 43.8%) or REM-related hypoventilation when associated with m.3243A>G mutations (75%). Furthermore, a high percentage of participants with maternally inherited diabetes and deafness and myoclonic epilepsy with ragged-red fibers syndromes were characterized by obstructive sleep apnea and REM-related hypoventilation, respectively. In contrast to what has been described in previous studies, central sleep apnea was rarely reported in our cohort. Conclusions SDB has a higher prevalence in mitochondrial diseases compared to general population-based data. Overall, these results suggest that patients characterized by a specific phenotype-genotype combination are most at risk of developing a specific subgroup of SDB. The early identification of this disorder is crucial in the management of these fragile patients.
C1 [Primiano, Guido; Vollono, Catello; Losurdo, Anna; Servidei, Serenella] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.
   [Brunetti, Valerio; Della Marca, Giacomo] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurol, Rome, Italy.
   [Moroni, Rossana] Fdn Policlin Univ A Gemelli IRCCS, Direz Sci, Rome, Italy.
   [Primiano, Guido; Della Marca, Giacomo; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Primiano, G (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.; Primiano, G (corresponding author), Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
EM guido.primiano@gmail.com
CR Albdewi MA, 2018, SLEEP BREATH, V22, P277, DOI 10.1007/s11325-017-1538-x
   [Anonymous], 2014, INT CLASSIFICATION S, V0, P0
   Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Della Marca G, 2009, J NEUROL SCI, V285, P54, DOI 10.1016/j.jns.2009.05.014
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Guilleminault C, 2001, EUR RESPIR J, V17, P838, DOI 10.1183/09031936.01.17508380
   Iber C, 2007, AASM MANUAL SCORING, V1st, P0
   Javaheri Shahrokh, 2011, HANDB CLIN NEUROL, V98, P327, DOI 10.1016/B978-0-444-52006-7.00020-4
   Mosquera RA, 2014, PULM MED, V2014, P0, DOI 10.1155/2014/467576
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Perrin C, 2004, MUSCLE NERVE, V29, P5, DOI 10.1002/mus.10487
   Ramezani RJ, 2014, J CLIN SLEEP MED, V10, P1233, DOI 10.5664/jcsm.4212
   Smits BW, 2012, EUR J NEUROL, V19, P176, DOI 10.1111/j.1468-1331.2011.03496.x
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
NR 23
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN 12
PY 2021
VL 96
IS 2
BP E241
EP E249
DI 10.1212/WNL.0000000000011005
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA SL0VN
UT WOS:000656634500014
PM 33024021
DA 2024-11-01
ER

PT J
AU Darin, N
   Siibak, T
   Peter, B
   Hedberg-Oldfors, C
   Kollberg, G
   Kalbin, V
   Moslemi, AR
   Macao, B
   Oldfors, A
   Falkenberg, M
AF Darin, Niklas
   Siibak, Triinu
   Peter, Bradley
   Hedberg-Oldfors, Carola
   Kollberg, Gittan
   Kalbin, Vassili
   Moslemi, Ali-Reza
   Macao, Bertil
   Oldfors, Anders
   Falkenberg, Maria
TI Functional analysis of a novel POLγ A mutation associated with a severe perinatal mitochondrial encephalomyopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE DNA polymerase gamma; Mutation; Mitochondrial replication; Disease; Perinatal phenotype
ID dna-polymerase-gamma; cis t251i; spectrum; replication; stability; diseases; mutants
AB Mutations in the mitochondrial DNA polymerase gamma catalytic subunit (POL. A) compromise the stability of mitochondrial DNA (mtDNA) by leading to mutations, deletions and depletions in mtDNA. Patients with mutations in POL gamma A often differ remarkably in disease severity and age of onset. In this work we have studied the functional consequence of POL gamma A mutations in a patient with an uncommon and a very severe disease phenotype characterized by prenatal onset with intrauterine growth restriction, lactic acidosis from birth, encephalopathy, hepatopathy, myopathy, and early death. Muscle biopsy identified scattered COX-deficient muscle fibers, respiratory chain dysfunction and mtDNA depletion. We identified a novel POL.A mutation (p.His1134Tyr) in trans with the previously identified p.Thr251Ile/Pro587Leu double mutant. Biochemical characterization of the purified recombinant POL gamma A variants showed that the p.His1134Tyr mutation caused severe polymerase dysfunction. The p.Thr251Ile/Pro587Leu mutation caused reduced polymerase function in conditions of low dNTP concentration that mimic postmitotic tissues. Critically, when p.His1134Tyr and p.Thr251Ile/Pro587Leu were combined under these conditions, mtDNA replication was severely diminished and featured prominent stalling. Our data provide a molecular explanation for the patients mtDNA depletion and clinical features, particularly in tissues such as brain and muscle that have low dNTP concentration. (c) 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
C1 [Darin, Niklas] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden.
   [Siibak, Triinu; Peter, Bradley; Kalbin, Vassili; Macao, Bertil; Falkenberg, Maria] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Box 440, S-40530 Gothenburg, Sweden.
   [Hedberg-Oldfors, Carola; Kollberg, Gittan; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of Gothenburg
RP Darin, N (corresponding author), Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden.; Falkenberg, M (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Box 440, S-40530 Gothenburg, Sweden.
EM niklas.darin@vgregion.se; maria.falkenberg@medkem.gu.se
FU Swedish Research Council; Swedish Cancer Foundation; European Research Council; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation; AnnMari and Per Ahlqvist Foundation; Vastra Gotalands Regionen [ALFGBG-727491, ALFGBG-718681, ALFGBG-716821]
CR Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Chinnery Patrick F, 2008, NEUROMUSCUL DISORD, V18, P259, DOI 10.1016/j.nmd.2007.11.005
   CLAYTON DA, 1992, J INHERIT METAB DIS, V15, P439, DOI 10.1007/BF01799602
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000391
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kong ZQ, 2018, NUCLEIC ACIDS RES, V46, P0, DOI 10.1093/nar/gky203
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Lovan Alyson, 2013, BMJ CASE REP, V2013, P0, DOI 10.1136/bcr-2013-010343
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 37
TC 2
Z9 2
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR 15
PY 2021
VL 31
IS 4
BP 348
EP 358
DI 10.1016/j.nmd.2021.01.004
EA APR 2021
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA RO6EP
UT WOS:000641136000009
PM 33579567
DA 2024-11-01
ER

PT J
AU Sparber, P
   Krylova, T
   Repina, S
   Demina, N
   Rudenskaya, G
   Sharkova, I
   Sharkov, A
   Kadyshev, V
   Kanivets, I
   Korostelev, S
   Pomerantseva, E
   Kaimonov, V
   Mikhailova, S
   Zakharova, E
   Skoblov, M
AF Sparber, Peter
   Krylova, Tatiana
   Repina, Svetlana
   Demina, Nina
   Rudenskaya, Galina
   Sharkova, Inna
   Sharkov, Artem
   Kadyshev, Vitaly
   Kanivets, Ilya
   Korostelev, Sergey
   Pomerantseva, Ekaterina
   Kaimonov, Vladimir
   Mikhailova, Svetlana
   Zakharova, Ekaterina
   Skoblov, Mikhail
TI Retrospective analysis of 17 patients with mitochondrial membrane protein-associated neurodegeneration diagnosed in Russia
SO PARKINSONISM & RELATED DISORDERS
LA English
DT Article
DE MPAN; NBIA; MRI; Pathogenic variants; Russian cohort
ID brain iron accumulation; variants; c19orf12; mutations; subtype
AB Introduction: Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurological syndrome caused by pathogenic variants in the C19orf12 and is characterized by iron deposition in the basal ganglia and substantia nigra. Only a limited number of cohort studies were published to date and the prevalence of MPAN remains uncertain. Methods: Recruited subjects with MPAN in Russia were diagnosed by whole-exome sequencing or Sanger sequencing of the C19orf12 gene. Data of over 14000 whole exome sequencing analyses was used to calculate the estimated disease frequency. RNA analysis was performed by RT-PCR. QSVanalyzer software was used to quantify the allelic disbalance. Results: We describe the clinical and molecular characterizations of 17 patients with MPAN. DNA analysis detected three previously undescribed pathogenic/likely pathogenic variants in the C19orf12 gene. The esti-mated disease frequency was calculated to be 1:619150. We describe unusual clinical observations in several cases. One patient showed severe neurogenic muscle weakness along with a lack of marked spasticity or optic nerve atrophy. In another mild clinical case with the NM_001031726.3:c.204_214del (p.(Gly69Argfs*10)) variant in a heterozygous state, a marked allelic disbalance was observed on the RNA level with reduced expression level of the wild-type allele. Thus, this case became the first one of a possible regulatory variant causing MPAN. Conclusion: We reported a detailed clinical and molecular characterization of the third-largest MPAN cohort. We expanded the mutational and clinical spectrum of MPAN. Moreover, we calculated the estimated MPAN fre-quency in the Russian population for the first time.
C1 [Sparber, Peter; Krylova, Tatiana; Repina, Svetlana; Demina, Nina; Rudenskaya, Galina; Sharkova, Inna; Kadyshev, Vitaly; Zakharova, Ekaterina; Skoblov, Mikhail] Res Ctr Med Genet, Moscow, Russia.
   [Sharkov, Artem; Kanivets, Ilya; Korostelev, Sergey] Genomed Ltd, Moscow, Russia.
   [Sharkov, Artem] Res & Clin Inst Pediat Pirogov RNRMU, Moscow, Russia.
   [Sharkov, Artem] RAS, Inst Gene Biol, Moscow, Russia.
   [Pomerantseva, Ekaterina; Kaimonov, Vladimir] Ctr Genet & Reprod Med Genet, Moscow, Russia.
   [Mikhailova, Svetlana] Russian Childrens Clin Hosp, Moscow, Russia.
C3 Research Centre for Medical Genetics; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences
RP Sparber, P (corresponding author), Moscow Ctr Med Genet, Moskvorechie 1, Moscow 115522, Russia.
EM psparber93@gmail.com
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Akçakaya NH, 2019, NEUROL NEUROCHIR POL, V53, P476, DOI 10.5603/PJNNS.a2019.0062
   Altuame FD, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01355-2
   Brezavar D, 2019, MOL GENET METAB, V128, P463, DOI 10.1016/j.ymgme.2019.09.002
   Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583
   Dastsooz H, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0439-y
   Deschauer M, 2012, J NEUROL, V259, P2434, DOI 10.1007/s00415-012-6521-7
   Di Meo I, 2018, EUR J PAEDIATR NEURO, V22, P272, DOI 10.1016/j.ejpn.2018.01.008
   Dogu O, 2013, CLIN GENET, V84, P350, DOI 10.1111/cge.12079
   Gowda VK, 2019, INDIAN J PEDIATR, V86, P746, DOI 10.1007/s12098-019-02903-w
   Gregory A, 2013, NEURODEGENERATION BR, V0, P0
   Gregory A, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.736
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034
   Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be
   Horvath R, 2012, MOVEMENT DISORD, V27, P789, DOI 10.1002/mds.24980
   Jin YH, 2020, MILITARY MED RES, V7, P0, DOI 10.1186/s40779-020-0233-6
   Korvigo I, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0192829
   Monfrini E, 2018, PARKINSONISM RELAT D, V48, P109, DOI 10.1016/j.parkreldis.2017.12.025
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Olgiati S, 2017, PARKINSONISM RELAT D, V39, P64, DOI 10.1016/j.parkreldis.2017.03.012
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Skowronska M, 2017, PARKINSONISM RELAT D, V39, P71, DOI 10.1016/j.parkreldis.2017.03.013
   Sparber P, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-01128-5
   Sparber P, 2018, NEUROGENETICS, V19, P257, DOI 10.1007/s10048-018-0558-4
   Tariq H, 2019, PARKINSONISM RELAT D, V65, P267, DOI 10.1016/j.parkreldis.2019.05.020
   Zakharova E Yu, 2014, ZH NEVROL PSIKHIATR IM S S KORSAKOVA, V114, P4
NR 27
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8020
EI 1873-5126
J9 PARKINSONISM RELAT D
JI Parkinsonism Relat. Disord.
PD MAR 15
PY 2021
VL 84
IS 
BP 98
EP 104
DI 10.1016/j.parkreldis.2021.02.002
EA FEB 2021
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA RB3PM
UT WOS:000632026700017
PM 33607528
DA 2024-11-01
ER

PT J
AU Bai, RK
   Cui, H
   Devaney, JM
   Allis, KM
   Balog, AM
   Liu, XY
   Schnur, RE
   Shapiro, FL
   Brautbar, A
   Estrada-Veras, J
   Hochstetler, L
   McConkie-Rosell, A
   McDonald, MT
   Solomon, BD
   Hofherr, S
   Richard, G
   Suchy, SF
AF Bai, Renkui
   Cui, Hong
   Devaney, Joseph M.
   Allis, Katrina M.
   Balog, Amanda M.
   Liu, Xinyue
   Schnur, Rhonda E.
   Shapiro, Faye L.
   Brautbar, Ariel
   Estrada-Veras, Juvianee, I
   Hochstetler, Laurel
   McConkie-Rosell, Allyn
   McDonald, Marie T.
   Solomon, Benjamin D.
   Hofherr, Sean
   Richard, Gabriele
   Suchy, Sharon F.
TI Interference of nuclear mitochondrial DNA segments in mitochondrial DNA testing resembles biparental transmission of mitochondrial DNA in humans
SO GENETICS IN MEDICINE
LA English
DT Article
AB Purpose Reports have questioned the dogma of exclusive maternal transmission of human mitochondrial DNA (mtDNA), including the recent report of an admixture of two mtDNA haplogroups in individuals from three multigeneration families. This was interpreted as being consistent with biparental transmission of mtDNA in an autosomal dominant-like mode. The authenticity and frequency of these findings are debated. Methods We retrospectively analyzed individuals with two mtDNA haplogroups from 2017 to 2019 and selected four families for further study. Results We identified this phenomenon in 104/27,388 (approximately 1/263) unrelated individuals. Further study revealed (1) a male with two mitochondrial haplogroups transmits only one haplogroup to some of his offspring, consistent with nuclear transmission; (2) the heteroplasmy level of paternally transmitted variants is highest in blood, lower in buccal, and absent in muscle or urine of the same individual, indicating it is inversely correlated with mtDNA content; and (3) paternally transmitted apparent large-scale mtDNA deletions/duplications are not associated with a disease phenotype. Conclusion These findings strongly suggest that the observed mitochondrial haplogroup of paternal origin resulted from coamplification of rare, concatenated nuclear mtDNA segments with genuine mtDNA during testing. Evaluation of additional specimen types can help clarify the clinical significance of the observed results.
C1 [Bai, Renkui; Cui, Hong; Devaney, Joseph M.; Allis, Katrina M.; Balog, Amanda M.; Liu, Xinyue; Schnur, Rhonda E.; Solomon, Benjamin D.; Hofherr, Sean; Richard, Gabriele; Suchy, Sharon F.] GeneDx Inc, Gaithersburg, MD 20877 USA.
   [Schnur, Rhonda E.; Shapiro, Faye L.] Rowan Univ, Cooper Univ Hlth Care, Cooper Med Sch, Camden, NJ USA.
   [Brautbar, Ariel] Cook Childrens Hlth Care Syst, Dept Genet, Ft Worth, TX USA.
   [Estrada-Veras, Juvianee, I; Hochstetler, Laurel] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA.
   [Estrada-Veras, Juvianee, I] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Estrada-Veras, Juvianee, I; Hochstetler, Laurel] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [McConkie-Rosell, Allyn; McDonald, Marie T.] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA.
   [Hochstetler, Laurel] UCSF, ZSFG Canc Genet & Prevent Program, San Francisco, CA USA.
   [Hochstetler, Laurel] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA.
   [Solomon, Benjamin D.] NHGRI, NIH, Bethesda, MD 20892 USA.
C3 Rowan University; Cooper Medical School of Rowan University; Cook Children's Medical Center; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)
RP Bai, RK (corresponding author), GeneDx Inc, Gaithersburg, MD 20877 USA.
EM rbai@genedx.com
FU GeneDx Inc.
CR Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Balciuniene J, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00518
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S4-S15
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Djordjevic D, 2016, MITOCHONDRION, V31, P40, DOI 10.1016/j.mito.2016.09.002
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Goldstein A, 1993, GENEREVIEWS((R)), V0, P0
   Gustafson AW, 2002, NEW ENGL J MED, V347, P2081
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   HUTCHISOCA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0
   Johns DR, 2003, ANN NEUROL, V54, P422, DOI 10.1002/ana.10771
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Lutz-Bonengel S, 2019, P NATL ACAD SCI USA, V116, P1821, DOI 10.1073/pnas.1820533116
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046
   McWilliams TG, 2019, NATURE, V565, P296, DOI 10.1038/d41586-019-00093-1
   Mishmar D, 2004, HUM MUTAT, V23, P125, DOI 10.1002/humu.10304
   Pyle A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005040
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, P0, DOI 10.1016/j.fsigen.2020.102274
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Simone D, 2011, BMC GENOMICS, V12, P0, DOI 10.1186/1471-2164-12-517
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673
   Vissing J, 2019, P NATL ACAD SCI USA, V116, P1475, DOI 10.1073/pnas.1821192116
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   2018, 1900, V10, V0, PPE8262, DOI 10.15252/emmm.201708262
NR 30
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD AUG 15
PY 2021
VL 23
IS 8
BP 1514
EP 1521
DI 10.1038/s41436-021-01166-1
EA APR 2021
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA TY4MA
UT WOS:000639628000001
PM 33846581
DA 2024-11-01
ER

PT J
AU Herbst, A
   Lee, CC
   Vandiver, AR
   Aiken, JM
   McKenzie, D
   Hoang, A
   Allison, D
   Liu, NJ
   Wanagat, J
AF Herbst, Allen
   Lee, Cathy C.
   Vandiver, Amy R.
   Aiken, Judd M.
   McKenzie, Debbie
   Hoang, Austin
   Allison, David
   Liu, Nianjun
   Wanagat, Jonathan
TI Mitochondrial DNA deletion mutations increase exponentially with age in human skeletal muscle
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE MtDNA; Mitochondria; Mutation; Deletion; Sarcopenia; Biomarker
ID different fiber types; vastus lateralis; abnormality; accumulation; atrophy; mice
AB Background Mitochondrial DNA (mtDNA) deletion mutations lead to electron transport chain-deficient cells and age-induced cell loss in multiple tissues and mammalian species. Accurate quantitation of somatic mtDNA deletion mutations could serve as an index of age-induced cell loss. Quantitation of mtDNA deletion molecules is confounded by their low abundance in tissue homogenates, the diversity of deletion breakpoints, stochastic accumulation in single cells, and mosaic distribution between cells. Aims Translate a pre-clinical assay to quantitate mtDNA deletions for use in human DNA samples, with technical and biological validation, and test this assay on human subjects of different ages. Methods We developed and validated a high-throughput droplet digital PCR assay that quantitates human mtDNA deletion frequency. Results Analysis of human quadriceps muscle samples from 14 male subjects demonstrated that mtDNA deletion frequency increases exponentially with age-on average, a 98-fold increase from age 20-80. Sequence analysis of amplification products confirmed the specificity of the assay for human mtDNA deletion breakpoints. Titration of synthetic mutation mixtures found a lower limit of detection of at least 0.6 parts per million. Using muscle DNA from 6-month-old mtDNA mutator mice, we measured a 6.4-fold increase in mtDNA deletion frequency (i.e., compared to wild-type mice), biologically validating the approach. Discussion/conclusions The exponential increase in mtDNA deletion frequency is concomitant with the known muscle fiber loss and accelerating mortality that occurs with age. The improved assay permits the accurate and sensitive quantification of deletion mutations from DNA samples and is sufficient to measure changes in mtDNA deletion mutation frequency in healthy individuals across the lifespan and, therefore, patients with suspected mitochondrial diseases.
C1 [Herbst, Allen; Aiken, Judd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Lee, Cathy C.; Wanagat, Jonathan] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   [Lee, Cathy C.; Hoang, Austin; Wanagat, Jonathan] Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
   [Vandiver, Amy R.] Univ Calif Los Angeles, Dept Med, Div Dermatol, 10945 Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.
   [McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.
   [Allison, David; Liu, Nianjun] Indiana Univ Bloomington, Dept Epidemiol & Biostat, Bloomington, IN USA.
C3 University of Alberta; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Alberta; Indiana University System; Indiana University Bloomington
RP Wanagat, J (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.; Wanagat, J (corresponding author), Univ Calif Los Angeles, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
EM jwanagat@mednet.ucla.edu
FU National Institute on Aging at the National Institutes of Health [R56AG060880, R01AG055518, K02AG059847, R21AR072950]
CR Administration SS, 2015, ACT LIF TABL, V0, P0
   Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   [Anonymous], 2018, BIOANALYTICAL METHOD VALIDATION GUIDANCE FOR INDUSTRY, V0, P0
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Belsky DW, 2018, AM J EPIDEMIOL, V187, P1220, DOI 10.1093/aje/kwx346
   Bielas J, 2018, EXP GERONTOL, V106, P125, DOI 10.1016/j.exger.2018.02.021
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Cheema N, 2015, AGING CELL, V14, P1085, DOI 10.1111/acel.12399
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Ferrucci L, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13080
   Finch CE, 2016, P NATL ACAD SCI USA, V113, P1121, DOI 10.1073/pnas.1524017113
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gompertz B, 1825, PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON, V115, P513, DOI 10.1098/RSTL.1825.0026
   Goudenège D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00211
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herbst A, 2019, MECH AGEING DEV, V182, P0, DOI 10.1016/j.mad.2019.111126
   Herbst A, 2017, J GERONTOL A-BIOL, V72, P1327, DOI 10.1093/gerona/glx058
   Kaeberlein Matt, 2013, F1000PRIME REP, V5, P5, DOI 10.12703/P5-5
   Lee CC, 2020, J CYTOL HISTOL, V0, P0, DOI DOI 10.3742/jch.2020.11.553
   LEE CM, 1993, J GERONTOL, V48, PB201, DOI 10.1093/geronj/48.6.B201
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LEXELL J, 1986, J NEUROL SCI, V72, P211, DOI 10.1016/0022-510X(86)90009-2
   McKiernan SH, 2007, AM J PHYSIOL-RENAL, V292, PF1751, DOI 10.1152/ajprenal.00307.2006
   Miller RA, 2001, BIOMARKERS AGING, V0, P0
   OHara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119
   Oliveira MT, 2020, GENET MOL BIOL, V43, P0, DOI 10.1590/1678-4685-GMB-2019-0069
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SLICHTER SJ, 1976, TRANSFUSION, V16, P8
   Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014
   Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Warner HR, 1997, J AM GERIATR SOC, V45, P1140, DOI 10.1111/j.1532-5415.1997.tb05981.x
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
NR 47
TC 28
Z9 29
U1 4
U2 18
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD JUL 15
PY 2021
VL 33
IS 7
BP 1811
EP 1820
DI 10.1007/s40520-020-01698-7
EA SEP 2020
PG 10
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA TC8NN
UT WOS:000572315500001
PM 32965609
DA 2024-11-01
ER

PT J
AU Koklesova, L
   Samec, M
   Liskova, A
   Zhai, KV
   Büsselberg, D
   Giordano, FA
   Kubatka, P
   Golunitschaja, O
AF Koklesova, Lenka
   Samec, Marek
   Liskova, Alena
   Zhai, Kevin
   Busselberg, Dietrich
   Giordano, Frank A.
   Kubatka, Peter
   Golunitschaja, Olga
TI Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
SO EPMA JOURNAL
LA English
DT Review
DE Mitochondrial impairment; Injury; ROS; Energy imbalance; Vicious circle; Oxidative stress; Aetiopathology multi-organ dysfunction; Suboptimal health; Reversible damage; Vasospasm; Mitigating measures; Repair; Mechanisms; Multifactorial disease; Ageing; Neurodegeneration; Glaucoma; Alzheimer; Cancer; Cardiovascular disease; Predictive preventive personalised medicine (PPPM; 3PM); Multi-modal diagnostics; Liquid biopsy; Molecular patterns; Biomarker panel; Patient stratification; Individualised patient profiling; Origin; Outcomes; Complementary medicine; Health policy; Cost efficacy; COVID-19
ID tumor-suppressor gene; chronic heart-failure; parkinsons-disease; alzheimers-disease; skeletal-muscle; dysfunction; mutations; biomarkers; exercise; risks
AB Mitochondrial injury plays a key role in the aetiopathology of multifactorial diseases exhibiting a "vicious circle" characteristic for pathomechanisms of the mitochondrial and multi-organ damage frequently developed in a reciprocal manner. Although the origin of the damage is common (uncontrolled ROS release, diminished energy production and extensive oxidative stress to life-important biomolecules such as mtDNA and chrDNA), individual outcomes differ significantly representing a spectrum of associated pathologies including but not restricted to neurodegeneration, cardiovascular diseases and cancers. Contextually, the role of predictive, preventive and personalised (PPPM/3P) medicine is to introduce predictive analytical approaches which allow for distinguishing between individual outcomes under circumstance of mitochondrial impairments followed by cost-effective targeted prevention and personalisation of medical services. Current article considers innovative concepts and analytical instruments to advance management of mitochondriopathies and associated pathologies.
C1 [Koklesova, Lenka; Samec, Marek; Liskova, Alena] Comenius Univ, Jessenius Fac Med, Dept Obstet & Gynaecol, Martin 03601, Slovakia.
   [Zhai, Kevin; Busselberg, Dietrich] Qatar Fdn, Weill Cornell Med Qatar, Dept Physiol & Biophys, Doha 24144, Qatar.
   [Giordano, Frank A.] Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, D-53127 Bonn, Germany.
   [Kubatka, Peter] Comenius Univ, Jessenius Fac Med, Dept Med Biol, Martin 03601, Slovakia.
   [Golunitschaja, Olga] Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, Predict Prevent Personalised 3P Med, D-53127 Bonn, Germany.
C3 Comenius University Bratislava; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Bonn; Comenius University Bratislava; University of Bonn
RP Golunitschaja, O (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, Predict Prevent Personalised 3P Med, D-53127 Bonn, Germany.
EM olga.golubnitschaja@ukbonn.de
FU Projekt DEAL; Scientific Grant Agency, VEGA [1/0136/19]; National Priorities Research Programme grant from the Qatar National Research Fund (QNRF, a member of Qatar Foundation) [NPRP 11S-1214-170101]
CR Alena, 2021, MEDICINE, V0, P0
   ALLARD MF, 1994, AM J PHYSIOL, V267, PH742, DOI 10.1152/ajpheart.1994.267.2.H742
   Annesley SJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8070680
   Antosova M, 2015, EUR RESPIR J, V46, P0
   Ashrafizadeh Milad, 2020, J BASIC CLIN PHYSIOL PHARMACOL, V31, P0, DOI 10.1515/jbcpp-2019-0191
   Ashrafizadeh M, 2020, PHYTOTHER RES, V34, P1745, DOI 10.1002/ptr.6642
   Ashrafizadeh M, 2020, J CELL PHYSIOL, V235, P4135, DOI 10.1002/jcp.29327
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Balakumar P, 2016, PHARMACOL RES, V113, P600, DOI 10.1016/j.phrs.2016.09.040
   Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003
   Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353
   BELARDINELLI R, 1995, J AM COLL CARDIOL, V26, P975, DOI 10.1016/0735-1097(95)00267-1
   Boakye D, 2020, INT J CANCER, V147, P2373, DOI 10.1002/ijc.33018
   BORSCHE M, 2020, J PARKINSONS DIS, V0, P0
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Buja LM, 2013, TEX HEART I J, V40, P221
   Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083
   Carew Jennifer S, 2002, MOL CANCER, V1, P9, DOI 10.1186/1476-4598-1-9
   Catalá-López F, 2014, PSYCHOTHER PSYCHOSOM, V83, P89, DOI 10.1159/000356498
   Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100
   Chaari L, 2020, EPMA J, V11, P133, DOI 10.1007/s13167-020-00207-0
   Chen AX, 2021, EYE, V35, P74, DOI 10.1038/s41433-020-1110-y
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, PC137, DOI 10.1152/ajpcell.00270.2006
   Chen SW, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9070355
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chou CH, 2019, INT J CARDIOL, V274, P214, DOI 10.1016/j.ijcard.2018.07.104
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Corsetti V, 2015, HUM MOL GENET, V24, P3058, DOI 10.1093/hmg/ddv059
   Crigna AT, 2020, EPMA J, V11, P603, DOI 10.1007/s13167-020-00226-x
   DAmelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x
   Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166
   Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575
   DE M, 2010, ENVIRON MOL MUTAGEN, V0, P0
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038
   Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115
   El-Soud MRA, 2019, MED RES J, V4, P1, DOI 10.5603/MRJ.A2018.0039
   Elbaz A, 2002, EPIDEMIOLOGY, V13, P157, DOI 10.1097/00001648-200203000-00010
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165845
   Faustini G, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8120377
   Feldman AM, 2013, CIRC-HEART FAIL, V6, P461, DOI 10.1161/CIRCHEARTFAILURE.112.000185
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Folsom AR, 2016, STROKE, V47, P18, DOI 10.1161/STROKEAHA.115.011035
   Francula-Zaninovic S, 2018, CURR CARDIOL REV, V14, P153, DOI 10.2174/1573403X14666180222102312
   Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199
   Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042
   Garcia-Heredia JM, 2015, ONCOTARGET, V6, P41582, DOI 10.18632/oncotarget.6057
   García-Moreno JM, 2013, ANTIOXID REDOX SIGN, V18, P1296, DOI 10.1089/ars.2012.5026
   Gaziano JM, 2005, BRAUNWALDS HEART DIS, V0, P0
   Gerner C, 2020, MASS SPECTROM REV, V39, P442, DOI 10.1002/mas.21612
   Goldenthal MJ, 2016, HEART FAIL REV, V21, P137, DOI 10.1007/s10741-016-9531-1
   Goldstein E, 2020, EPMA J, V11, P505, DOI 10.1007/s13167-020-00221-2
   Golubnitschaja O, 2019, ADVANCES IN PREDICTIVE, V0, Preventive and Personalised Medicine
   Golubnitschaja O, 2007, SURV OPHTHALMOL, V52, PS155, DOI 10.1016/j.survophthal.2007.08.011
   Golubnitschaja O, 2018, KLIN MONATSBL AUGENH, V235, P146, DOI 10.1055/s-0044-101164
   Golubnitschaja O, 2016, TUMOR BIOL, V37, P12941, DOI 10.1007/s13277-016-5168-x
   Golubnitschaja O, 2016, EPMA J, V7, P0, DOI 10.1186/s13167-016-0072-4
   Gómez-Benito M, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00356
   Goncharenko V, 2019, EPMA J, V10, P0, DOI 10.1007/s13167-019-00164-3
   Guerra F, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00295
   Hadrava Vanova K, 2020, REDOX REP, V25, P26, DOI 10.1080/13510002.2020.1752002
   Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6
   HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00211
   Herbert MK, 2014, PARKINSONISM RELAT D, V20, P112, DOI 10.1016/j.parkreldis.2013.09.003
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787
   Hu QS, 2016, TRANSL NEURODEGENER, V5, P0, DOI 10.1186/s40035-016-0060-6
   Israeli E, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0019622
   Jain A, 2018, PEDIATR BLOOD CANCER, V65, P0, DOI 10.1002/pbc.26874
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jia JY, 2019, J NEUROL NEUROSUR PS, V90, P1347, DOI 10.1136/jnnp-2018-320199
   Jusic A, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-020-0783-5
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kaski JC, 2018, CIRCULATION, V138, P1463, DOI 10.1161/CIRCULATIONAHA.118.031373
   Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   KOKLESOVA L, 2020, CANCERS, V12, P0
   Koklesova L, 2020, BIOMOLECULES, V10, P0, DOI 10.3390/biom10121653
   Koklesova L, 2020, EPMA J, V11, P261, DOI 10.1007/s13167-020-00210-5
   Kosenko EA, 2016, CNS NEUROL DISORD-DR, V15, P113, DOI 10.2174/1871527314666150821103444
   Kozlov S, 2017, REV NEUROSCIENCE, V28, P825, DOI 10.1515/revneuro-2017-0006
   Kralj V, 2013, CARDIOL CROAT, V8, P373, DOI 10.15836/CCAR.2013.373
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kubatka P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22010183
   Kubatka P, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25061399
   Kubatka P, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20071749
   Kucera R, 2020, EPMA J, V11, P399, DOI 10.1007/s13167-020-00214-1
   Kumetsov AV, 2004, FEBS LETT, V577, P1, DOI 10.1016/j.febslet.2004.10.021
   Kunin A, 2020, EPMA J, V11, P517, DOI 10.1007/s13167-020-00229-8
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Larsen SB, 2018, CELL TISSUE RES, V373, P21, DOI 10.1007/s00441-017-2768-8
   Liskova A, 2020, CLIN EXP MED, V20, P173, DOI 10.1007/s10238-020-00611-w
   Llano DA, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0182098
   Luan H, 2015, PARKINSONISM RELAT D, V21, P1371, DOI 10.1016/j.parkreldis.2015.09.009
   Ma LL, 2014, J ALZHEIMERS DIS, V42, P565, DOI 10.3233/JAD-140168
   Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Meijers WC, 2019, CARDIOVASC RES, V115, P844, DOI 10.1093/cvr/cvz035
   Munzar Michael, 2002, NEUROL CLIN NEUROPHYSIOL, V2002, P2, DOI 10.1162/15268740252769709
   Naoi M, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102451
   Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oboudiyat C, 2013, SEMIN NEUROL, V33, P313, DOI 10.1055/s-0033-1359319
   Ording AG, 2019, J ALZHEIMERS DIS, V72, P1269, DOI 10.3233/JAD-190867
   Papageorgakopoulos Tilemachos Nektarios, 2017, HELL J NUCL MED, V20 Suppl, P45
   Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230
   Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824
   Pellecchia MT, 2016, J NEURAL TRANSM, V123, P1399, DOI 10.1007/s00702-016-1622-6
   Peña-Bautista C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20246136
   Pérez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00441
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   PLUNFAVREAU H, 2010, BBA-BIOENERGETICS, V6, P0
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, P0, DOI 10.1038/nrdp.2017.13
   Polivka J, 2019, EPMA J, V10, P0, DOI 10.1007/s13167-019-00162-5
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Qian SH, 2019, EPMA J, V10, P365, DOI 10.1007/s13167-019-00194-x
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1016/j.atherosclerosis.2011.06.012
   Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Saeed Anum, 2017, METHODIST DEBAKEY CARDIOVASC J, V13, P185, DOI 10.14797/mdcj-13-4-185
   Safarzadeh E, 2014, ADV PHARM BULL, V4, P421, DOI 10.5681/apb.2014.062
   Samec M, 2020, EPMA J, V11, P377, DOI 10.1007/s13167-020-00217-y
   Sarasija S, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7090111
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Schmidt LS, 2014, INT J NEPHROL RENOV, V7, P253, DOI 10.2147/IJNRD.S42097
   Scozz, 2020, CIRCULATING MITOCHON, V0, P0, DOI DOI 10.1101/2020.07.30.227553
   Sekino Y, 2020, UROL ONCOL-SEMIN ORI, V38, P0, DOI 10.1016/j.urolonc.2020.04.032
   Shi HB, 2015, J CANCER RES CLIN, V141, P485, DOI 10.1007/s00432-014-1773-5
   Shukla S, 2020, DIAGNOSTICS, V10, P0, DOI 10.3390/diagnostics10030126
   Skoumalová A, 2011, EXP GERONTOL, V46, P38, DOI 10.1016/j.exger.2010.09.015
   Smith AM, 2018, MOVEMENT DISORD, V33, P1580, DOI 10.1002/mds.104
   Spencer NY, 2019, SEMIN NEPHROL, V39, P380, DOI 10.1016/j.semnephrol.2019.04.007
   Stockburger C, 2018, J ALZHEIMERS DIS, V64, PS455, DOI 10.3233/JAD-179915
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Taghizadeh G, 2016, FREE RADICAL BIO MED, V99, P11, DOI 10.1016/j.freeradbiomed.2016.07.018
   Takahashi-Niki K, 2012, YAKUGAKU ZASSHI, V132, P1105, DOI 10.1248/yakushi.12-00220-3
   Toraih EA, 2019, CLIN BIOCHEM, V63, P10, DOI 10.1016/j.clinbiochem.2018.12.001
   van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016
   Vassar R, 2013, NEURON, V80, P250, DOI 10.1016/j.neuron.2013.09.031
   Vida C, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20030771
   Vilades D, 2020, FASEB J, V34, P4403, DOI 10.1096/fj.201902507R
   Wang LY, 2019, ATHEROSCLEROSIS, V286, P88, DOI 10.1016/j.atherosclerosis.2019.05.006
   Wang YT, 2019, CLIN CARDIOL, V42, P56, DOI 10.1002/clc.23104
   Webster KA, 2009, AM SCI, V97, P384, DOI 10.1511/2009.80.384
   Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/9825061
   Yeghiazaryan K, 2010, EPMA J, V1, P263, DOI 10.1007/s13167-010-0032-3
   Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377
   Zaorsky NG, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-13120-6
   Zhang PC, 2019, ACS CHEM NEUROSCI, V10, P4430, DOI 10.1021/acschemneuro.9b00498
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zhu JB, 2017, J ALZHEIMERS DIS, V58, P631, DOI 10.3233/JAD-170062
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 159
TC 36
Z9 36
U1 2
U2 8
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1878-5077
EI 1878-5085
J9 EPMA J
JI EPMA J.
PD MAR 15
PY 2021
VL 12
IS 1
BP 27
EP 40
DI 10.1007/s13167-021-00237-2
EA MAR 2021
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA QV8OR
UT WOS:000625768400002
PM 33686350
DA 2024-11-01
ER

PT J
AU Filograna, R
   Mennuni, M
   Alsina, D
   Larsson, NG
AF Filograna, Roberta
   Mennuni, Mara
   Alsina, David
   Larsson, Nils-Goran
TI Mitochondrial DNA copy number in human disease: the more the better?
SO FEBS LETTERS
LA English
DT Review
DE ageing; Alzheimer&#8217; s disease; cancer; mitochondria; mitochondrial diseases; mtDNA; mtDNA copy number; neurodegenerative disorders; Parkinson&#8217; s disease; TFAM
ID transcription factor-a; peripheral-blood cells; in-situ hybridization; skeletal-muscle; colorectal-cancer; mtdna heteroplasmy; polymerase-gamma; point mutations; mouse model; genomic landscape
AB Most of the genetic information has been lost or transferred to the nucleus during the evolution of mitochondria. Nevertheless, mitochondria have retained their own genome that is essential for oxidative phosphorylation (OXPHOS). In mammals, a gene-dense circular mitochondrial DNA (mtDNA) of about 16.5 kb encodes 13 proteins, which constitute only 1% of the mitochondrial proteome. Mammalian mtDNA is present in thousands of copies per cell and mutations often affect only a fraction of them. Most pathogenic human mtDNA mutations are recessive and only cause OXPHOS defects if present above a certain critical threshold. However, emerging evidence strongly suggests that the proportion of mutated mtDNA copies is not the only determinant of disease but that also the absolute copy number matters. In this review, we critically discuss current knowledge of the role of mtDNA copy number regulation in various types of human diseases, including mitochondrial disorders, neurodegenerative disorders and cancer, and during ageing. We also provide an overview of new exciting therapeutic strategies to directly manipulate mtDNA to restore OXPHOS in mitochondrial diseases.
C1 [Filograna, Roberta; Mennuni, Mara; Alsina, David; Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Metab, S-17176 Stockholm, Sweden.
   [Filograna, Roberta; Mennuni, Mara; Alsina, David; Larsson, Nils-Goran] Karolinska Inst, Karolinska Inst Lab, Max Planck Inst Biol Ageing, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet
RP Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Metab, S-17176 Stockholm, Sweden.
EM nils-goran.larsson@ki.se
FU Swedish Research Council [2015.00418]; Knut and Alice Wallenberg Foundation [KAW 2016.0050]; European Research Council [2016-741366]; Swedish Cancer Society [2018.602]; Novo Nordisk Foundation; Swedish government [SLL2018.0471]; Swedish county councils, the ALF agreement [SLL2018.0471]
CR Alán L, 2010, ACTA BIOCHIM POL, V57, P403
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Alsina D, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911659
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196
   Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Barriocanal-Casado E, 2019, EBIOMEDICINE, V42, P511, DOI 10.1016/j.ebiom.2019.03.025
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bensard CL, 2020, CELL METAB, V31, P284, DOI 10.1016/j.cmet.2019.11.002
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   Bianco A, 2017, INVEST OPHTH VIS SCI, V58, P2193, DOI 10.1167/iovs.16-20389
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bonekamp NA, 2018, CELL, V172, P388, DOI 10.1016/j.cell.2017.12.039
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11
   Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chu HT, 2012, BMC GENOMICS, V13, P0, DOI 10.1186/1471-2164-13-S7-S5
   Ciron C, 2012, HUM MOL GENET, V21, P1861, DOI 10.1093/hmg/ddr618
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Cui HH, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-110
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889
   Dasgupta S, 2012, J CELL PHYSIOL, V227, P2451, DOI 10.1002/jcp.22980
   Datta S, 2015, TUMOR BIOL, V36, P3025, DOI 10.1007/s13277-014-2937-2
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   EVANS MJ, 1989, J BIOL CHEM, V264, P14361
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   Falkenberg M, 2018, ESSAYS BIOCHEM, V62, P287, DOI 10.1042/EBC20170100
   Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Fink W J, 1977, ANN N Y ACAD SCI, V301, P323
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fukuoh A, 2014, MOL SYST BIOL, V10, P0, DOI 10.15252/msb.20145117
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gopal RK, 2018, P NATL ACAD SCI USA, V115, PE6283, DOI 10.1073/pnas.1711888115
   Gorelick AN, 2020, RESP COMPLEX TISSUE, V0, P0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grandhi S, 2017, HUM MOL GENET, V26, P2912, DOI 10.1093/hmg/ddx172
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Griffiths LM, 2009, METHODS MOL BIOL, V554, P267, DOI 10.1007/978-1-59745-521-3_17
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Guo Y, 2013, BIOINFORMATICS, V29, P1210, DOI 10.1093/bioinformatics/btt118
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008
   He YH, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.01.015
   Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045
   Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297
   Hurtado-Roca Y, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0163770
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Joshi S, 2015, CELL REP, V13, P1895, DOI 10.1016/j.celrep.2015.10.059
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   KASAMATSH, 1973, NATURE-NEW BIOL, V241, P103, DOI 10.1038/newbio241103a0
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kühl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Kürschner G, 2017, ONCOTARGET, V8, P105882, DOI 10.18632/oncotarget.22413
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Lemnrau A, 2015, CANCER RES, V75, P2844, DOI 10.1158/0008-5472.CAN-14-1692
   Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, P0, DOI 10.1186/2050-6511-14-9
   Lin Chen-Sung, 2008, INTERACT CARDIOVASC THORAC SURG, V7, P954, DOI 10.1510/icvts.2008.177006
   Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4
   Lindholm D, 2012, CELL MOL LIFE SCI, V69, P2465, DOI 10.1007/s00018-012-1043-0
   Lindsay AK, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004567
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029
   Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Matsushima Y, 2003, J BIOL CHEM, V278, P31149, DOI 10.1074/jbc.M303842200
   McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012
   Memon Ashfaque A, 2017, BIOMOL DETECT QUANTIF, V13, P32, DOI 10.1016/j.bdq.2017.08.001
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Mi J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10039
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Momcilovic M, 2019, NATURE, V575, P380, DOI 10.1038/s41586-019-1715-0
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Ngo Huu B, 2014, NAT COMMUN, V5, P3077, DOI 10.1038/ncomms4077
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nishiyama S, 2010, BIOCHEM BIOPH RES CO, V401, P26, DOI 10.1016/j.bbrc.2010.08.143
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Oka S, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37889
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515
   Qian Y, 2017, BIOINFORMATICS, V33, P1399, DOI 10.1093/bioinformatics/btw835
   Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027
   Rackham O, 2016, CELL REP, V16, P1874, DOI 10.1016/j.celrep.2016.07.031
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Reznik E, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10769
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160
   Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schöpf B, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15237-5
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shen J, 2016, MOL CARCINOGEN, V55, P2089, DOI 10.1002/mc.22453
   Shen J, 2015, CARCINOGENESIS, V36, P1307, DOI 10.1093/carcin/bgv130
   Shen J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0131649
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smith ALM, 2020, NAT CANCER, V1, P976, DOI 10.1038/s43018-020-00112-5
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008
   Valente WJ, 2016, NUCLEIC ACIDS RES, V44, P8513, DOI 10.1093/nar/gkw716
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Viscomi C, 2016, BIOCHEM SOC T, V44, P1483, DOI 10.1042/BST20160085
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Wang Y, 2016, INT J BIOL MARKER, V31, PE382, DOI 10.5301/jbm.5000211
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Weerts MJA, 2016, ONCOTARGET, V7, P29166, DOI 10.18632/oncotarget.8688
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Yadav N, 2013, BBA-REV CANCER, V1836, P336, DOI 10.1016/j.bbcan.2013.10.002
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   YONEDA M, 1995, MUSCLE NERVE, V0, PS95
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zdralevic M, 2018, J BIOL CHEM, V293, P15947, DOI 10.1074/jbc.RA118.004180
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zhang H, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0105242
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zhang YF, 2015, AM J CANCER RES, V5, P1207
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 253
TC 240
Z9 257
U1 8
U2 68
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD APR 15
PY 2021
VL 595
IS 8
BP 976
EP 1002
DI 10.1002/1873-3468.14021
EA DEC 2020
PG 27
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RU2RV
UT WOS:000601879900001
PM 33314045
DA 2024-11-01
ER

PT J
AU Wiedmer, P
   Jung, T
   Castro, JP
   Pomatto, LCD
   Sun, PY
   Davies, KJA
   Grune, T
AF Wiedmer, Petra
   Jung, Tobias
   Castro, Jose Pedro
   Pomatto, Laura C. D.
   Sun, Patrick Y.
   Davies, Kelvin J. A.
   Grune, Tilman
TI Sarcopenia - Molecular mechanisms and open questions
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Molecular pathways; Proteostasis; Proteasome; Autophagy; Mitochondria, Muscle fibre composition
ID human skeletal-muscle; dna deletion mutations; human bj fibroblasts; mitochondrial-function; potential contribution; cellular senescence; insulin-resistance; protein oxidation; national-health; cancer-patients
AB Sarcopenia represents a muscle-wasting syndrome characterized by progressive and generalized degenerative loss of skeletal muscle mass, quality, and strength occurring during normal aging. Sarcopenia patients are mainly suffering from the loss in muscle strength and are faced with mobility disorders reducing their quality of life and are, therefore, at higher risk for morbidity (falls, bone fracture, metabolic diseases) and mortality. Several molecular mechanisms have been described as causes for sarcopenia that refer to very different levels of muscle physiology. These mechanisms cover e. g. function of hormones (e. g. IGF-1 and Insulin), muscle fiber composition and neuromuscular drive, myo-satellite cell potential to differentiate and proliferate, inflammatory pathways as well as intracellular mechanisms in the processes of proteostasis and mitochondrial function. In this review, we describe sarcopenia as a muscle-wasting syndrome distinct from other atrophic diseases and summarize the current view on molecular causes of sarcopenia development as well as open questions provoking further research efforts for establishing efficient lifestyle and therapeutic interventions.
C1 [Wiedmer, Petra; Jung, Tobias; Castro, Jose Pedro; Grune, Tilman] German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany.
   [Pomatto, Laura C. D.; Sun, Patrick Y.; Davies, Kelvin J. A.] Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
   [Davies, Kelvin J. A.] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.
   [Davies, Kelvin J. A.] Univ Southern Calif, Keck Sch Med USC, Dept Biochem & Mol Med, Los Angeles, CA 90089 USA.
   [Grune, Tilman] German Ctr Diabet Res DZD, D-85764 Munich, Germany.
   [Grune, Tilman] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, D-13347 Berlin, Germany.
   [Grune, Tilman] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany.
   [Grune, Tilman] NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany.
   [Castro, Jose Pedro] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.
   [Pomatto, Laura C. D.] Natl Inst Gen Med Sci, 45 Ctr Dr MSC 6200, Bethesda, MD 20892 USA.
C3 Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Southern California; University of Southern California; University of Southern California; German Centre for Cardiovascular Research; University of Potsdam; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)
RP Grune, T (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany.; Grune, T (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.; Grune, T (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Berlin, D-13347 Berlin, Germany.; Grune, T (corresponding author), Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany.; Grune, T (corresponding author), NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany.
EM tilman.grune@dife.de
FU National Institute of Environmental Health Sciences of the US National Institutes of Health [ES003598]; National Institute on Aging of the US National Institutes of Health [AG052374]; Deutsche Forschungsgemeinschaft (DFG) [GR1240/20-1, GR 1240/22-1]
CR Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031
   Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718
   Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959
   Anandavadivelan P, 2016, CLIN NUTR, V35, P724, DOI 10.1016/j.clnu.2015.05.011
   Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x
   Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N
   Argilés JM, 2017, CLIN NUTR, V36, P798, DOI 10.1016/j.clnu.2016.05.010
   Argilés JM, 2015, CURR OPIN PHARMACOL, V22, P100, DOI 10.1016/j.coph.2015.04.003
   Aunan JR, 2016, BRIT J SURG, V103, PE29, DOI 10.1002/bjs.10053
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/360438
   Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879
   Baehr LM, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00069
   Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845
   Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, PE203, DOI 10.1152/ajpendo.2001.280.2.E203
   Barberi L, 2013, BIOGERONTOLOGY, V14, P273, DOI 10.1007/s10522-013-9429-4
   Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117
   Batsis JA, 2016, CLIN NUTR, V35, P1472, DOI 10.1016/j.clnu.2016.03.028
   Bauer J, 2019, J CACHEXIA SARCOPENI, V10, P956, DOI 10.1002/jcsm.12483
   Bechet D, 2005, INT J BIOCHEM CELL B, V37, P2098, DOI 10.1016/j.biocel.2005.02.029
   Bédard N, 2015, FASEB J, V29, P3889, DOI 10.1096/fj.15-270579
   Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X
   Bian AL, 2020, BMC MUSCULOSKEL DIS, V21, P0, DOI 10.1186/s12891-020-03236-y
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, PE469, DOI 10.1152/ajpendo.00204.2014
   Bollinger LM, 2014, AM J PHYSIOL-CELL PH, V307, PC278, DOI 10.1152/ajpcell.00391.2013
   Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043
   Braun TP, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00012
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Brown DM, 2015, AGEING RES REV, V24, P263, DOI 10.1016/j.arr.2015.08.007
   Busquets S, 2005, INT J MOL MED, V16, P471
   Cade WT, 2006, PRINCIPLES OF MOLECULAR MEDICINE, V0, PP529, DOI 10.1007/978-1-59259-963-950
   Carneiro IP, 2016, CURR ONCOL REP, V18, P0, DOI 10.1007/s11912-016-0546-5
   Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061
   Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Cho SH, 2016, ENDOCRINOL METAB, V31, P31, DOI 10.3803/EnM.2016.31.1.31
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552
   Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829
   Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002
   Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052
   Conte M, 2015, BIOGERONTOLOGY, V16, P329, DOI 10.1007/s10522-014-9549-5
   Conte M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0073709
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dalle S, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.01045
   Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559
   Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9
   Dodds RM, 2015, J CLIN DENSITOM, V18, P461, DOI 10.1016/j.jocd.2015.04.012
   Domingues-Faria C, 2016, AGEING RES REV, V26, P22, DOI 10.1016/j.arr.2015.12.004
   dos Santos SL, 2015, REDOX BIOL, V5, P267, DOI 10.1016/j.redox.2015.05.006
   Drescher C, 2016, INT J CARDIOL, V202, P766, DOI 10.1016/j.ijcard.2015.10.033
   Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Fernando R, 2019, EXP GERONTOL, V117, P45, DOI 10.1016/j.exger.2018.10.018
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   Figueras M, 2004, FEBS LETT, V569, P201, DOI 10.1016/j.febslet.2004.05.066
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, P0, DOI 10.3389/fmed.2018.00061
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, PS4, DOI 10.1093/gerona/glu057
   Fulop T, 2018, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.01960
   Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733
   Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, PE366, DOI 10.1152/ajpendo.2000.279.2.E366
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gensous N, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00996
   Goljanek-Whysall K, 2016, MAMM GENOME, V27, P341, DOI 10.1007/s00335-016-9643-x
   Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   He LX, 2019, J CACHEXIA SARCOPENI, V10, P1295, DOI 10.1002/jcsm.12478
   Heilbronn L, 2004, INT J OBESITY, V28, PS12, DOI 10.1038/sj.ijo.0802853
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6
   Hirner S, 2008, J MOL BIOL, V379, P666, DOI 10.1016/j.jmb.2008.03.049
   Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Hoppeler H, 2016, J EXP BIOL, V219, P205, DOI 10.1242/jeb.128207
   Jackson MP, 2016, ESSAYS BIOCHEM, V60, P173, DOI 10.1042/EBC20160005
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   Jiao JQ, 2017, CURR OPIN PHARMACOL, V34, P1, DOI 10.1016/j.coph.2017.03.009
   Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001
   Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008
   KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P861, DOI 10.1097/00005072-197709000-00010
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kido A, 2004, CAN J PHYSIOL PHARM, V82, P238, DOI 10.1139/Y04-017
   Kim H, 2016, GERIATR GERONTOL INT, V16, P110, DOI 10.1111/ggi.12723
   Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130
   Kirk-Ballard H, 2014, NUTRITION, V30, PS21, DOI 10.1016/j.nut.2014.02.027
   Kon M, 2010, FEBS LETT, V584, P1399, DOI 10.1016/j.febslet.2009.12.025
   Lee CM, 1997, FREE RADICAL BIO MED, V22, P1259, DOI 10.1016/S0891-5849(96)00546-1
   Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588
   Lokireddy S, 2012, AM J PHYSIOL-CELL PH, V303, PC512, DOI 10.1152/ajpcell.00402.2011
   Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lorenzi M, 2018, BIOGERONTOLOGY, V19, P209, DOI 10.1007/s10522-018-9749-5
   Lu-Nguyen N, 2017, MOL THER-NUCL ACIDS, V6, P15, DOI 10.1016/j.omtn.2016.11.009
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Diz JBM, 2017, GERIATR GERONTOL INT, V17, P5, DOI 10.1111/ggi.12720
   Mayans O, 2012, ADV EXP MED BIOL, V770, P119
   McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Mitchell WK, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00260
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Moore-Carrasco R, 2007, INT J ONCOL, V30, P1239
   Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P83, DOI 10.1007/s13539-014-0149-7
   Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978
   Müller MJ, 2014, EUR J CLIN NUTR, V68, P1220, DOI 10.1038/ejcn.2014.169
   Murton AJ, 2015, P NUTR SOC, V74, P387, DOI 10.1017/S0029665115000130
   Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200
   Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6
   Narici M, 2016, J EXP BIOL, V219, P276, DOI 10.1242/jeb.128017
   Neeland IJ, 2015, J AM COLL CARDIOL, V65, P2150, DOI 10.1016/j.jacc.2015.01.061
   Nicolini A, 2013, BIOMED PHARMACOTHER, V67, P807, DOI 10.1016/j.biopha.2013.08.005
   Pacifici F, 2020, ANTIOXIDANTS-BASEL, V9, P0, DOI 10.3390/antiox9040329
   Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b
   Park SY, 2010, CELL MOL BIOL LETT, V15, P1, DOI 10.2478/s11658-009-0030-4
   Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005
   Peterson SJ, 2016, NUTR CLIN PRACT, V31, P40, DOI 10.1177/0884533615622537
   Philippou A, 2007, JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, V7, P208
   Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pomatto LCD, 2017, J PHYSIOL-LONDON, V595, P7275, DOI 10.1113/JP275072
   Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0
   Qureshi AA, 2011, LIPIDS HEALTH DIS, V10, P0, DOI 10.1186/1476-511X-10-177
   Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001
   Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x
   Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x
   Rom O, 2016, FREE RADICAL BIO MED, V98, P218, DOI 10.1016/j.freeradbiomed.2015.12.031
   Romanello V, 2016, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00422
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Sakuma K, 2015, PFLUG ARCH EUR J PHY, V467, P213, DOI 10.1007/s00424-014-1527-x
   Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056
   Schaap LA, 2006, AM J MED, V119, P0, DOI 10.1016/j.amjmed.2005.10.049
   Schütz T, 2012, NUTRITION, V28, P378, DOI 10.1016/j.nut.2011.07.019
   Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x
   Shenkman BS, 2015, ARCH BIOCHEM BIOPHYS, V584, P36, DOI 10.1016/j.abb.2015.07.011
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9
   Spira D, 2016, Z GERONTOL GERIATR, V49, P94, DOI 10.1007/s00391-015-0886-z
   Srikanthan P, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010805
   Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x
   Staunton Lisa, 2011, J AGING RES, V2011, P908035, DOI 10.4061/2011/908035
   Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026
   Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009
   Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263
   Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005
   Tichy ED, 2017, STEM CELL REP, V9, P1328, DOI 10.1016/j.stemcr.2017.08.003
   Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095
   Umegaki H, 2015, J DIABETES INVEST, V6, P623, DOI 10.1111/jdi.12365
   van Nieuwpoort IC, 2018, EUR J ENDOCRINOL, V179, P73, DOI 10.1530/EJE-18-0076
   Vary TC, 2008, AM J PHYSIOL-REG I, V294, PR1777, DOI 10.1152/ajpregu.00056.2008
   Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2
   Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x
   Vitale JA, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20174318
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8
   Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Woo J, 2014, AGE, V36, P0, DOI 10.1007/s11357-014-9711-7
   Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135
   Yip C, 2015, INSIGHTS IMAGING, V6, P489, DOI 10.1007/s13244-015-0414-0
   Zhang GH, 2012, SKELET MUSCLE, V2, P0, DOI 10.1186/2044-5040-2-20
   Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102
   Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398
NR 173
TC 198
Z9 217
U1 28
U2 152
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD JAN 15
PY 2021
VL 65
IS 
BP 
EP 
DI 10.1016/j.arr.2020.101200
PG 17
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA PO5BO
UT WOS:000605184600007
PM 33130247
DA 2024-11-01
ER

PT J
AU Varhaug, KN
   Hikmat, O
   Nakkestad, HL
   Vedeler, CA
   Bindoff, LA
AF Varhaug, Kristin N.
   Hikmat, Omar
   Nakkestad, Hanne Linda
   Vedeler, Christian A.
   Bindoff, Laurence A.
TI Serum biomarkers in primary mitochondrial disorders
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE mitochondrial disease; neurofilaments; FGF-21; GDF-15
AB The aim of this study was to explore the utility of the serum biomarkers neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 in diagnosing primary mitochondrial disorders. We measured serum neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 in 26 patients with a genetically proven mitochondrial disease. Fibroblast growth factor 21 and growth and differentiation factor 15 were measured by enzyme-linked immunosorbent assay and neurofilament light chain with the Simoa assay. Neurofilament light chain was highest in patients with multi-systemic involvement that included the central nervous system such as those with the m.3242A>G mutation. Mean neurofilament light chain was also highest in patients with epilepsy versus those without [49.74 pg/ml versus 19.7 pg/ml (P = 0.015)], whereas fibroblast growth factor 21 and growth and differentiation factor 15 levels were highest in patients with prominent myopathy, such as those with single-mitochondrial DNA deletion. Our results suggest that the combination of neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 is useful in the diagnostic evaluation of mitochondrial disease. Growth and differentiation factor 15 and fibroblast growth factor 21 identify those with muscle involvement, whereas neurofilament light chain is a clear marker for central nervous system involvement independent of underlying mitochondrial pathology. Levels of neurofilament light chain appear to correlate with the degree of ongoing damage suggesting, therefore, that monitoring neurofilament light chain levels may provide prognostic information and a way of monitoring disease activity.
C1 [Varhaug, Kristin N.; Nakkestad, Hanne Linda; Vedeler, Christian A.; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Varhaug, Kristin N.; Hikmat, Omar; Vedeler, Christian A.; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Hikmat, Omar] Haukeland Hosp, Dept Paediat & Adolescents, Bergen, Norway.
   [Nakkestad, Hanne Linda; Vedeler, Christian A.; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, NeurosysMed, Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital
RP Varhaug, KN (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM Kristin.nielsen.varhaug@helse-bergen.no
FU Torbjorg Hauge's legacy; Helse Bergen, Stimuleringsmidler [370204]; Research Council of Norway [288164]
CR Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Sofou K, 2019, MITOCHONDRION, V46, P228, DOI 10.1016/j.mito.2018.07.002
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Turnbull D, 2011, LANCET NEUROL, V10, P777, DOI 10.1016/S1474-4422(11)70172-7
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Varhaug KN, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00338
   Varhaug KN, 2018, NEUROL-NEUROIMMUNOL, V5, P0, DOI 10.1212/NXI.0000000000000422
   Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
NR 18
TC 13
Z9 13
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD JUN 15
PY 2021
VL 3
IS 1
BP 
EP 
DI 10.1093/braincomms/fcaa222
EA JAN 2021
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA RV0UT
UT WOS:000645553500015
PM 33501425
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Mechanisms of the effect of oxidative phosphorylation deficiencies on the skeletal muscle bioenergetic system in patients with mitochondrial myopathies
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE mitochondrial myopathies; moderate exercise; OXPHOS deficiencies; very heavy exercise; (V)over dotO(2) on-kinetics
ID magnetic-resonance spectroscopy; power-duration relationship; each-step activation; o-2 uptake kinetics; dna mutations; exercise intolerance; metabolic myopathy; intensity exercise; humans; diagnosis
AB Simulations carried out using a previously developed model of the skeletal muscle bioenergetic system, involving the "inorganic phosphate (P-i) double-threshold" mechanism of muscle fatigue, lead to the conclusion that a decrease in the oxidative phosphorylation (OXPHOS) activity, caused by mutations in mitochondrial or nuclear DNA, is the main mechanism underlying the changes in the kinetic properties of the system in mitochondrial myopathies (MM). These changes generally involve the very-heavy-exercise-like behavior and exercise termination because of fatigue at low work intensities. In particular, a sufficiently large (at a given work intensity) decrease in . OXPHOS activity leads to slowing of the primary phase II of the oxygen uptake ((V)over dotO(2)) on-kinetics, decrease in maximal (V)over dotO(2) ((V)over dotO(2max)), appearance of the slow component of the (V)over dotO(2) on-kinetics, exercise intolerance, and lactic acidosis at relatively low power outputs encountered in experimental studies in patients with MM. Thus, the "P-i double-threshold" mechanism of muscle fatigue is able to account, at least semiquantitatively, for various kinetic effects of inborn OXPHOS deficiencies of the skeletal muscle bioenergetic system. Exercise can be potentially lengthened and (V)over dotO(2ma)(x) elevated in patients with MM through an increase in peak P-i (Pi(peak)), at which exercise is terminated because of fatigue. Generally, a mechanism underlying the kinetic effects of OXPHOS deficiencies on the skeletal muscle bioenergetic system in MM is proposed that was absent in the literature. NEW & NOTEWORTHY A mechanism of the OXPHOS deficiencies-induced changes of the skeletal muscle bioenergetic system in patients with mitochondria! myopathies (MM), namely, appearance of the slow component of the (V)over dotO(2) on-kinetics at relatively low work intensities, slowed primary phase II of the (V)over dotO(2)on-kinetics, lowered (V)over dotO(2max) and lactic acidosis is proposed. It involves a decrease in OXPHOS activity acting through the "P-i double-threshold" mechanism of muscle fatigue comprising initiation of the additional ATP usage and termination of exercise.
C1 [Korzeniewski, Bernard] BioSimulat Ctr, Krakow, Poland.
RP Korzeniewski, B (corresponding author), BioSimulat Ctr, Krakow, Poland.
EM bernard.korzeniewski@gmail.com
CR Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   Burnley M, 2010, EXP PHYSIOL, V95, P798, DOI 10.1113/expphysiol.2010.052688
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chen JT, 2001, MAGNET RESON MED, V46, P870, DOI 10.1002/mrm.1271
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Grassi B, 1996, J APPL PHYSIOL, V80, P988, DOI 10.1152/jappl.1996.80.3.988
   Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Haller RG, 2000, EXERCISE CIRCULATION, V0, P271
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307
   KEMP GJ, 1993, NMR BIOMED, V6, P302, DOI 10.1002/nbm.1940060504
   Korzeniewski B, 2004, BIOCHEM J, V379, P703, DOI 10.1042/BJ20031740
   Korzeniewski B, 2003, JPN J PHYSIOL, V53, P271, DOI 10.2170/jjphysiol.53.271
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011
   Korzeniewski B, 2021, J APPL PHYSIOL, V130, P498, DOI 10.1152/japplphysiol.00745.2020
   Korzeniewski B, 2020, EUR J APPL PHYSIOL, V120, P1609, DOI 10.1007/s00421-020-04388-4
   Korzeniewski B, 2019, EUR J APPL PHYSIOL, V119, P2201, DOI 10.1007/s00421-019-04204-8
   Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001
   Korzeniewski B, 2016, J APPL PHYSIOL, V121, P424, DOI 10.1152/japplphysiol.00358.2016
   Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Krustrup P, 2009, J PHYSIOL-LONDON, V587, P1843, DOI 10.1113/jphysiol.2008.166397
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lilleker James B, 2018, PRACT NEUROL, V18, P14, DOI 10.1136/practneurol-2017-001708
   MATTHEWS PM, 1991, ANN NEUROL, V29, P435, DOI 10.1002/ana.410290416
   Murgatroyd SR, 2011, J PHYSIOL-LONDON, V589, P2443, DOI 10.1113/jphysiol.2011.209346
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Porcelli S, 2019, CURR OPIN PHYSIOL, V10, P202, DOI 10.1016/j.cophys.2019.05.011
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333
NR 51
TC 6
Z9 6
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD AUG 15
PY 2021
VL 131
IS 2
BP 768
EP 777
DI 10.1152/japplphysiol.00196.2021
PG 10
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA UM9SV
UT WOS:000693665100036
PM 34197225
DA 2024-11-01
ER

PT J
AU Figuccia, S
   Degiorgi, A
   Berti, CC
   Baruffini, E
   Dallabona, C
   Goffrini, P
AF Figuccia, Sonia
   Degiorgi, Andrea
   Ceccatelli Berti, Camilla
   Baruffini, Enrico
   Dallabona, Cristina
   Goffrini, Paola
TI Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast Contribution for Functional Analysis of Novel Variants
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial aminoacyl-tRNA synthetases; yeast model; novel variants; mitochondrial diseases
ID sensorineural hearing-loss; homozygous yars2 mutation; lactic-acidosis; saccharomyces-cerevisiae; compound heterozygosity; pathogenic variants; ovarian failure; causes myopathy; gene encodes; leukodystrophy
AB In most eukaryotes, mitochondrial protein synthesis is essential for oxidative phosphorylation (OXPHOS) as some subunits of the respiratory chain complexes are encoded by the mitochondrial DNA (mtDNA). Mutations affecting the mitochondrial translation apparatus have been identified as a major cause of mitochondrial diseases. These mutations include either heteroplasmic mtDNA mutations in genes encoding for the mitochondrial rRNA (mtrRNA) and tRNAs (mttRNAs) or mutations in nuclear genes encoding ribosomal proteins, initiation, elongation and termination factors, tRNA-modifying enzymes, and aminoacyl-tRNA synthetases (mtARSs). Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of specific amino acids to their cognate tRNAs. Differently from most mttRNAs, which are encoded by mitochondrial genome, mtARSs are encoded by nuclear genes and then imported into the mitochondria after translation in the cytosol. Due to the extensive use of next-generation sequencing (NGS), an increasing number of mtARSs variants associated with large clinical heterogeneity have been identified in recent years. Being most of these variants private or sporadic, it is crucial to assess their causative role in the disease by functional analysis in model systems. This review will focus on the contributions of the yeast Saccharomyces cerevisiae in the functional validation of mutations found in mtARSs genes associated with human disorders.
C1 [Figuccia, Sonia; Degiorgi, Andrea; Ceccatelli Berti, Camilla; Baruffini, Enrico; Dallabona, Cristina; Goffrini, Paola] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Dallabona, C; Goffrini, P (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM sonia.figuccia@unipr.it; andrea.degiorgi@unipr.it; camilla.ceccatelliberti@unipr.it; enrico.baruffini@unipr.it; cristina.dallabona@unipr.it; paola.goffrini@unipr.it
FU Italian Ministry of Health [RF-2016-02361241, GR-2016-02361449]; COMP-HUB Initiative - 'Departments of Excellence' program of the Italian Ministry for Education, University and Research (MIUR, 2018-2022)
CR Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006
   Ardissone A, 2015, NEUROLOGY, V84, P2193, DOI 10.1212/WNL.0000000000001613
   Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397
   Berti CC, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12020300
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   Cappuccio G, 2021, HUM MUTAT, V42, P745, DOI 10.1002/humu.24210
   Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Chen SJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033363
   Chien CI, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094659
   Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910
   Chin HL, 2019, J MOL MED, V97, P1557, DOI 10.1007/s00109-019-01834-5
   CHIU MI, 1992, GENETICS, V132, P987
   Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819
   Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O
   Demain LAM, 2020, J HUM GENET, V65, P305, DOI 10.1038/s10038-019-0706-1
   Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011
   Dias J, 2012, BIOCHEMISTRY-US, V51, P909, DOI 10.1021/bi201337b
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590
   Dong Q, 2018, J HUM GENET, V63, P841, DOI 10.1038/s10038-018-0446-7
   EDWARDS H, 1987, CELL, V51, P643, DOI 10.1016/0092-8674(87)90133-4
   Euro L, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00021
   Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200
   Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109
   Freel KC, 2015, FEMS YEAST RES, V15, P0, DOI 10.1093/femsyr/fov023
   Friederich MW, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06250-w
   GATTI DL, 1991, J MOL BIOL, V218, P557, DOI 10.1016/0022-2836(91)90701-7
   González-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681
   Hamatani M, 2016, J HUM GENET, V61, P899, DOI 10.1038/jhg.2016.64
   Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Kamps R, 2018, EUR J HUM GENET, V26, P537, DOI 10.1038/s41431-017-0058-2
   Karstensen HG, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.103733
   Kim EJ, 2018, NEUROBIOL AGING, V72, P0, DOI 10.1016/j.neurobiolaging.2018.06.031
   Kiraly-Borri C, 2019, CSH MOL CASE STUD, V5, P0, DOI 10.1101/mcs.a003699
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Kuo ME, 2020, CEREBELLUM, V19, P154, DOI 10.1007/s12311-019-01080-y
   LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986
   Lee DC, 2019, J PERIPHER NERV SYST, V0, P0, DOI DOI 10.1111/jns.12353
   Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109
   Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210
   Lynch DS, 2017, BRAIN, V140, P1204, DOI 10.1093/brain/awx045
   Lynch DS, 2016, JAMA NEUROL, V73, P1433, DOI 10.1001/jamaneurol.2016.2229
   Maffezzini C, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.654
   Markovitz R, 2020, AM J MED GENET A, V182, P1167, DOI 10.1002/ajmg.a.61544
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008
   Merz S, 2009, GENOME BIOL, V10, P0, DOI 10.1186/gb-2009-10-9-r95
   Morgenstern M, 2017, CELL REP, V19, P2836, DOI 10.1016/j.celrep.2017.06.014
   Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001
   Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277
   MULERO JJ, 1994, CURR GENET, V25, P299, DOI 10.1007/BF00351481
   Nafisinia M, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0178125
   Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156
   NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3
   Oprescu SN, 2017, HUM MUTAT, V38, P1412, DOI 10.1002/humu.23287
   Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013
   Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249
   Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886
   Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheffler IE, 2001, MITOCHONDRION, V1, P3, DOI 10.1016/S1567-7249(00)00002-7
   Scheidecker S, 2019, HUM MUTAT, V40, P1826, DOI 10.1002/humu.23799
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927
   Sepuri NBV, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035321
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Smith F, 2018, HAEMATOLOGICA, V103, PE564, DOI 10.3324/haematol.2018.194464
   Sommerville EW, 2019, HUM MOL GENET, V28, P258, DOI 10.1093/hmg/ddy294
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Srivastava S, 2019, AM J MED GENET A, V179, P1556, DOI 10.1002/ajmg.a.61188
   Stellingwerff MD, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000559
   Su D, 2011, NUCLEIC ACIDS RES, V39, P4866, DOI 10.1093/nar/gkr073
   Sun C, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000316
   Szpisjak L, 2017, J HUM GENET, V62, P329, DOI 10.1038/jhg.2016.126
   Taglia I, 2018, ACTA NEUROL SCAND, V138, P278, DOI 10.1111/ane.12954
   Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200
   Tang Y, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.582
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200
   Turner RJ, 2000, J BIOL CHEM, V275, P27681
   Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931
   Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c
   Wang DQ, 2018, J NEUROPATH EXP NEUR, V77, P997, DOI 10.1093/jnen/nly087
   Wang Y, 2020, SCI CHINA LIFE SCI, V63, P1227, DOI 10.1007/s11427-019-1619-x
   Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849
   WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x
   Yu J, 2020, HEREDITAS, V157, P0, DOI 10.1186/s41065-020-00157-7
NR 106
TC 14
Z9 15
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 15
PY 2021
VL 22
IS 9
BP 
EP 
DI 10.3390/ijms22094524
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA SC0GQ
UT WOS:000650361800001
PM 33926074
DA 2024-11-01
ER

PT J
AU Sanderson, KG
   Millar, E
   Tumber, A
   Klatt, R
   Sondheimer, N
   Vincent, A
AF Sanderson, Kit Green
   Millar, Eoghan
   Tumber, Anupreet
   Klatt, Regan
   Sondheimer, Neal
   Vincent, Ajoy
TI Rod bipolar cell dysfunction in <i>POLG</i> retinopathy
SO DOCUMENTA OPHTHALMOLOGICA
LA English
DT Article
DE POLG; POLG1; Polymerase gamma; Electroretinography; Light signal transduction; Retinal bipolar cells
ID progressive external ophthalmoplegia; mitochondrial-dna; neuronal degeneration; ataxic neuropathy; mutations; disease; electroretinography; childhood; spectrum; disorders
AB Objective To report the clinical and novel electrophysiological features in a child withPOLG-related sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO). Methods The proband, a male child of Indian descent, underwent serial systemic and ophthalmological evaluations from birth until 14 years of age. Eye examinations included visual acuity and extraocular movement assessments, fundus photography, spectral domain optical coherence tomography and full-field electroretinography (ERG). Detailed genetic testing was also performed. Results The child carried a homozygous mutation inPOLG(c.911T > G/p.Leu304Arg) and manifested systemic features such as seizures, headaches, areflexia, hypotonia, myopathy and vomiting. The child's distance visual acuity was 0.50 and 0.40 LogMAR in the right and left eyes, respectively. Bilateral ophthalmoplegia and ptosis were observed at 5 years of age. The dark-adapted (DA) ERG responses to 2.29 cd s m(-2)and 7.6 cd s m(-2)stimuli showed a markedly reducedb/aratio; an electronegative configuration was noted to a DA 7.6 ERG. Conclusion This is the first documented case of an electronegative ERG in aPOLG-related disorder consistent with generalized rod ON-bipolar dysfunction. The rest of the proband's systemic and ophthalmological features were consistent with SANDO but some features overlapped with otherPOLG-related disorders such as Alpers-Huttenlocher syndrome and autosomal dominant progressive external ophthalmoplegia demonstrating the wide phenotypic overlap expected due toPOLGmutations.
C1 [Sanderson, Kit Green; Sondheimer, Neal; Vincent, Ajoy] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada.
   [Millar, Eoghan; Tumber, Anupreet; Klatt, Regan; Vincent, Ajoy] Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
   [Sondheimer, Neal] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; Hospital for Sick Children (SickKids)
RP Vincent, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
EM ajoy.vincent@sickkids.ca
FU Foundation Fighting Blindness, USA [CD-CL-0617-0727-HSC]
CR Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010
   BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Cohen BH, 1993, GENEREVIEWS R, V0, P0
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45
   McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scuderi C, 2015, NEUROMUSCULAR DISORD, V25, P333, DOI 10.1016/j.nmd.2015.01.004
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 43
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0012-4486
EI 1573-2622
J9 DOC OPHTHALMOL
JI Doc. Ophthalmol.
PD FEB 15
PY 2021
VL 142
IS 1
BP 111
EP 118
DI 10.1007/s10633-020-09777-w
EA JUN 2020
PG 8
WC Ophthalmology
SC Ophthalmology
GA QM5WY
UT WOS:000541682800001
PM 32567010
DA 2024-11-01
ER

PT J
AU Kuthethur, R
   Prasad, K
   Chakrabarty, S
   Kabekkodu, SP
   Singh, KK
   Thangaraj, K
   Satyamoorthy, K
AF Kuthethur, Raviprasad
   Prasad, Keshava
   Chakrabarty, Sanjiban
   Kabekkodu, Shama Prasada
   Singh, Keshav K.
   Thangaraj, Kumarasamy
   Satyamoorthy, Kapaettu
TI Advances in mitochondrial medicine and translational research
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial disorders; Mitochondrial metabolism; Anterograde and retrograde signaling; Cancer and mitochondria; miRNAs and mitochondria; Therapeutics and mitochondria
ID myoclonic epilepsy; mutation; disease; dna; deficiency; myopathy; cells; therapy; pathology; patient
AB Current knowledge of mitochondrial biology and function has provided tools and technologies that helped a better understanding of the molecular etiology of complex mitochondrial disorders. Dual genetic control of this subcellular organelle function regulates various signaling mechanisms which are essential for metabolism, bioenergetics, fatty acid biosynthesis, and DNA replication & repair. Understanding nuclear mitochondrial crosstalk through advanced genomics as well as clinical perspectives is the overall basis of mitochondrial research and medicine, also the sole objective of Society for Mitochondrial Medicine and Research (SMRM) - India. The eighth virtual international conference on 'Advances in Mitochondrial Medicine and Translational Research' was organized at the Manipal School of Life Sciences, MAHE, Manipal, India, during 6 - 7 November 2020. The aim of the virtual conference was to highlight the recent advances and future perspectives that represent comprehensive clinical and fundamental research interests in the area of mitochondrial biology of human diseases. To systematically present the various findings in mitochondrial biology, the meeting was themed with specific aspects comprising (a) mitochondrial disorders: clinical & genomic perspectives, (b) mitochondria in cancer, (c) mitochondrial metabolism & disorders, and (d) mitochondrial diseases & therapy. This report provides an overview of the recent advancements in the area of mitochondrial biology and medicine that was discussed at the conference.
C1 [Kuthethur, Raviprasad; Prasad, Keshava; Chakrabarty, Sanjiban; Kabekkodu, Shama Prasada; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, India.
   [Singh, Keshav K.] Univ Alabama Birmingham, Sch Med, Dept Genet, Kaul Genet Bldg,Rm 620,720 20th St South, Birmingham, AL 35294 USA.
   [Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, India.
   [Thangaraj, Kumarasamy] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, India.
C3 Manipal Academy of Higher Education (MAHE); University of Alabama System; University of Alabama Birmingham; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)
RP Satyamoorthy, K (corresponding author), Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, India.
EM ksatyamoorthy@manipal.edu
CR Abad E, 2020, CANCER LETT, V474, P106, DOI 10.1016/j.canlet.2020.01.008
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Aranca TV, 2016, NEURODEGENER DIS MAN, V6, P49, DOI 10.2217/nmt.15.73
   Barcelos I, 2020, CURR OPIN PEDIATR, V32, P707, DOI 10.1097/MOP.0000000000000954
   Carden T, 2017, J BIOL CHEM, V292, P20694, DOI 10.1074/jbc.M117.797001
   Chou SJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23661
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fakouri NB, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-20586-9
   Falk MJ, 2021, J INHERIT METAB DIS, V44, P312, DOI 10.1002/jimd.12319
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Falk MJ, 2020, MITOCHONDRIAL DISEASE GENES COMPENDIUM: FROM GENES TO CLINICAL MANIFESTATIONS, V0, P0
   FANG W, 1994, MUSCLE NERVE, V17, P52, DOI 10.1002/mus.880170107
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Farhan SMK, 2014, MOL GENET GENOM MED, V2, P73, DOI 10.1002/mgg3.46
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Ghosh A, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aax9778
   Gurgel-Giannetti J, 2018, BRAIN, V141, P2289, DOI 10.1093/brain/awy172
   Holmes-Hampton GP, 2016, HUM MOL GENET, V25, P5178, DOI 10.1093/hmg/ddw338
   Jo Y, 2018, THERANOSTICS, V8, P5259, DOI 10.7150/thno.29098
   Kaufman DM, 2017, CELL DEATH DIFFER, V24, P1730, DOI 10.1038/cdd.2017.101
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Lim AZ, 2019, MITOCHONDRION, V47, P18, DOI 10.1016/j.mito.2019.04.007
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maniyadath B, 2019, CELL REP, V26, P2212, DOI 10.1016/j.celrep.2019.01.087
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Maynard S, 2015, AGING-US, V7, P793, DOI 10.18632/aging.100810
   McCormack S, 2015, MITOCHONDRION, V22, P45, DOI 10.1016/j.mito.2015.02.005
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Mishra A, 2018, MOL CELL BIOL, V38, P0, DOI 10.1128/MCB.00489-17
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Patel J, 2020, CARCINOGENESIS, V41, P1625, DOI 10.1093/carcin/bgaa114
   Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155
   Rawat S, 2020, J CELL SCI, V133, P0, DOI 10.1242/jcs.248492
   Rawat S, 2019, J MOL BIOL, V431, P996, DOI 10.1016/j.jmb.2019.01.022
   Shaw E, 2020, MOL CELL BIOL, V40, P0, DOI 10.1128/MCB.00212-19
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Vendramin R, 2017, EMBO J, V36, P1123, DOI 10.15252/embj.201695546
   Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014
   Wu YT, 2018, STEM CELL RES, V27, P10, DOI 10.1016/j.scr.2017.12.013
   Zhang Z, 2014, INT J BIOCHEM CELL B, V50, P106, DOI 10.1016/j.biocel.2014.02.012
   Zolkipli-Cunningham Z, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0197513
NR 53
TC 0
Z9 0
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2021
VL 61
IS 
BP 62
EP 68
DI 10.1016/j.mito.2021.09.008
EA OCT 2021
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA WC9QP
UT WOS:000704585100007
PM 34571249
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Atheromatosis of the Scalp: A Novel Feature of Chronic Progressive External Ophthalmoplegia Plus Due to a Single Mitochondrial DNA Deletion
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE phenotypic heterogeneity; phenotype; psoriasis; respiratory chain; atheroma; mitochondrial; multisystem; ophthalmoplegia; deletion; mtdna
ID retinal degeneration; mutation
AB Chronic progressive external ophthalmoplegia (CPEO) manifests phenotypically as ptosis with ophthalmoplegia or CPEO-plus, with the affection of muscles or organs other than the extra-ocular eye muscles. Herein, a case of CPEO-plus caused by a single mitochondrial DNA (mtDNA) deletion is represented, along with several previously unreported phenotypic features. The patient is a 76-year-old Caucasian female who had experienced slowly progressive bilateral ptosis since the age of 15, followed by gradual ophthalmoparesis without double vision. Since the age of 56, she had developed mild quadriparesis, depression, easy fatigability, hypersomnia, a facial tic, optic atrophy, cataract, glaucoma, hepatomegaly, hepatic steatosis, cholecystolithiasis, diverticulosis, hyperhidrosis, mild hyper-creatine-kinase-emia, hyperlipidemia, and hyperuricemia. Moreover, she had faced previously unreported manifestations of mitochondrial disorders, psoriasis, and multiple scalp atheromas. The phenotype and a single 5kb mtDNA deletion were employed to diagnose CPEO-plus. This case demonstrates that the phenotypic spectrum of CPEO-plus is broader than expected, that psoriasis and scalp atheromas are unique features of a mitochondrial disorder, and that CPEO progresses to CPEO-plus during the years.
C1 [Finsterer, Josef] Neurol Neurol & Neurophysiol Ctr, Vienna, Austria.
RP Finsterer, J (corresponding author), Neurol Neurol & Neurophysiol Ctr, Vienna, Austria.
EM fipaps@yahoo.de
CR BEC P, 1974, ARCH OPHTALMOL-PARIS, V34, P879
   Berardo A, 2010, NEUROMUSCULAR DISORD, V20, P204, DOI 10.1016/j.nmd.2010.01.006
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Filosto M, 2016, MOL GENET METAB REP, V6, P70, DOI 10.1016/j.ymgmr.2016.02.001
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Finsterer J, 2013, NEUROL INT, V5, P28, DOI 10.4081/ni.2013.e9
   Guo L, 2021, NEUROMUSCULAR DISORD, V31, P859, DOI 10.1016/j.nmd.2021.06.014
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Jiang PF, 2020, BIOSCIENCE REP, V40, P0, DOI 10.1042/BSR20201856
   Lv ZY, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000008869
   Ma L, 2020, INT J NEUROSCI, V130, P319, DOI 10.1080/00207454.2019.1681422
   Maghbooli M, 2020, NEUROL INDIA, V68, P760, DOI 10.4103/0028-3886.293454
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Orimo S, 1992, RINSHO SHINKEIGAKU, V32, P37
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Santoro L, 2006, J NEUROL, V253, P869, DOI 10.1007/s00415-006-0082-6
   Tafakhori A, 2016, ARCH IRAN MED, V19, P87, DOI 0161902/AIM.004
   TROBE JD, 1977, AM J OPHTHALMOL, V83, P372, DOI 10.1016/0002-9394(77)90736-X
   Wong LJC, 2003, J MED GENET, V40, P0
   Yasui M, 1993, NO TO SHINKEI, V45, P741
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD DEC 23
PY 2021
VL 13
IS 12
BP 
EP 
DI 10.7759/cureus.20641
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA XX2FX
UT WOS:000736119600005
PM 35103203
DA 2024-11-01
ER

PT J
AU Mietsch, M
   Hinkel, R
AF Mietsch, Matthias
   Hinkel, Rabea
TI "Empowering" Cardiac Cells via Stem Cell Derived Mitochondrial Transplantation- Does Age Matter?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE stem cell; aging; senescence; mitochondria; transplantation; cardiovascular; heart
ID skeletal-muscle; molecular-patterns; plasma nuclear; self-renewal; dna-damage; in-vivo; myocardial protection; autophagy maintains; functional decline; absolute numbers
AB With cardiovascular diseases affecting millions of patients, new treatment strategies are urgently needed. The use of stem cell based approaches has been investigated during the last decades and promising effects have been achieved. However, the beneficial effect of stem cells has been found to being partly due to paracrine functions by alterations of their microenvironment and so an interesting field of research, the "stem- less" approaches has emerged over the last years using or altering the microenvironment, for example, via deletion of senescent cells, application of micro RNAs or by modifying the cellular energy metabolism via targeting mitochondria. Using autologous muscle-derived mitochondria for transplantations into the affected tissues has resulted in promising reports of improvements of cardiac functions in vitro and in vivo. However, since the targeted treatment group represents mainly elderly or otherwise sick patients, it is unclear whether and to what extent autologous mitochondria would exert their beneficial effects in these cases. Stem cells might represent better sources for mitochondria and could enhance the effect of mitochondrial transplantations. Therefore in this review we aim to provide an overview on aging effects of stem cells and mitochondria which might be important for mitochondrial transplantation and to give an overview on the current state in this field together with considerations worthwhile for further investigations.
C1 [Mietsch, Matthias; Hinkel, Rabea] Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Lab Anim Sci Unit, Kellnerweg 4, D-37077 Gottingen, Germany.
   [Mietsch, Matthias; Hinkel, Rabea] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, D-37077 Gottingen, Germany.
C3 Deutsches Primatenzentrum (DPZ); German Centre for Cardiovascular Research
RP Hinkel, R (corresponding author), Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Lab Anim Sci Unit, Kellnerweg 4, D-37077 Gottingen, Germany.; Hinkel, R (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, D-37077 Gottingen, Germany.
EM mmietsch@dpz.eu; rhinkel@dpz.eu
CR Ahlqvist KJ, 2015, BBA-BIOENERGETICS, V1847, P1380, DOI 10.1016/j.bbabio.2015.05.014
   Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Ahmadi M, 2021, CELL BIOCHEM FUNCT, V39, P60, DOI 10.1002/cbf.3602
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amartuvshin O, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13191
   Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728
   Bakula D, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00239
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Baseler WA, 2011, AM J PHYSIOL-REG I, V300, PR186, DOI 10.1152/ajpregu.00423.2010
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Behfar A, 2015, J AM COLL CARDIOL, V65, P148, DOI 10.1016/j.jacc.2014.10.041
   Bellows CG, 2003, MECH AGEING DEV, V124, P747, DOI 10.1016/S0047-6374(03)00088-5
   Belosludtsev KN, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21186559
   Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543
   Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602
   Brazhnik K, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aax2659
   Broughton KM, 2016, CIRC RES, V118, P867, DOI 10.1161/CIRCRESAHA.115.305227
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Caicedo A, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/7610414
   Caicedo A, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09073
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   Castaldi A, 2017, J PHYSIOL-LONDON, V595, P6249, DOI 10.1113/JP274775
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chang CY, 2019, TRANSL NEURODEGENER, V8, P0, DOI 10.1186/s40035-019-0158-8
   Charles CJ, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.601990
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547
   Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cowan DB, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17813-0
   Cowan DB, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160889
   Croston TL, 2013, LIFE SCI, V93, P313, DOI 10.1016/j.lfs.2013.07.005
   Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, PH529, DOI 10.1152/ajpheart.00267.2010
   Dabkowski ER, 2009, AM J PHYSIOL-HEART C, V296, PH359, DOI 10.1152/ajpheart.00467.2008
   Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Doulamis IP, 2020, AM J PHYSIOL-RENAL, V319, PF403, DOI 10.1152/ajprenal.00255.2020
   Doulamis IP, 2020, EUR J CARDIO-THORAC, V57, P836, DOI 10.1093/ejcts/ezz326
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   García-Prat L, 2016, AUTOPHAGY, V12, P612, DOI 10.1080/15548627.2016.1143211
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gheorghiade M, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.115.002727
   Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x
   GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807
   Glauche I, 2011, AGING CELL, V10, P457, DOI 10.1111/j.1474-9726.2011.00692.x
   Guariento A, 2020, J HEART LUNG TRANSPL, V39, P1279, DOI 10.1016/j.healun.2020.06.023
   Guariento A, 2020, J THORAC CARDIOV SUR, V160, PE15, DOI 10.1016/j.jtcvs.2019.06.111
   Guo XX, 2020, NAR GENOM BIOINFORM, V2, P0, DOI 10.1093/nargab/lqaa065
   HAGINOYA K, 1990, ACTA NEUROPATHOL, V80, P642, DOI 10.1007/BF00307633
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Hashemi SM, 2008, EUR HEART J, V29, P251, DOI 10.1093/eurheartj/ehm559
   Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991
   Hazeldine J, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.00685
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Hollander JM, 2014, AM J PHYSIOL-HEART C, V307, PH1, DOI 10.1152/ajpheart.00747.2013
   Hong KU, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096725
   Hong KU, 2013, BASIC RES CARDIOL, V108, P0, DOI 10.1007/s00395-013-0346-0
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jurecic R, 2019, ADV EXP MED BIOL, V1169, P195, DOI 10.1007/978-3-030-24108-7_10
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Kesner EE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26057
   Kirschner K, 2017, CELL REP, V19, P1503, DOI 10.1016/j.celrep.2017.04.074
   Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316
   Kuribayashi W, 2021, J EXP MED, V218, P0, DOI 10.1084/jem.20192283
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Kuznetsov AV, 2003, ANAL BIOCHEM, V319, P296, DOI 10.1016/S0003-2697(03)00326-9
   Lauridsen FKB, 2018, CELL REP, V24, P766, DOI 10.1016/j.celrep.2018.06.057
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029
   Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC
   Lin LW, 2019, AM J TRANSPLANT, V19, P1917, DOI 10.1111/ajt.15309
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749
   Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201
   Maeda H, 2020, J CELL MOL MED, V24, P5007, DOI 10.1111/jcmm.15120
   Mahrouf-Yorgov M, 2017, CELL DEATH DIFFER, V24, P1224, DOI 10.1038/cdd.2017.51
   Mansell E, 2021, CELL STEM CELL, V28, P241, DOI 10.1016/j.stem.2020.09.018
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004
   McCully JD, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0095-4
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Minet AD, 2011, BIOCHEM BIOPH RES CO, V409, P591, DOI 10.1016/j.bbrc.2011.04.028
   Mohsin S, 2015, CIRC RES, V117, P1024, DOI 10.1161/CIRCRESAHA.115.307362
   Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, PL78, DOI 10.1152/ajplung.00221.2019
   Moskowitzova K, 2019, J HEART LUNG TRANSPL, V38, P92, DOI 10.1016/j.healun.2018.09.025
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nagendran J, 2008, J THORAC CARDIOV SUR, V136, P168, DOI 10.1016/j.jtcvs.2008.01.040
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Nicaise AM, 2020, FRONT AGING NEUROSCI, V12, P0, DOI 10.3389/fnagi.2020.00247
   Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7
   Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Paliwal S, 2018, STEM CELL RES THER, V9, P0, DOI 10.1186/s13287-018-1012-0
   Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Pham TD, 2016, SENSORS-BASEL, V16, P0, DOI 10.3390/s16071065
   Phinney DG, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9472
   Pollara J, 2018, JCI INSIGHT, V3, P0, DOI 10.1172/jci.insight.121622
   Preble JM, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51682
   Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016
   Ramirez-Barbieri G, 2019, MITOCHONDRION, V46, P103, DOI 10.1016/j.mito.2018.03.002
   Ren L, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.580070
   Romine J, 2015, NEUROBIOL AGING, V36, P1716, DOI 10.1016/j.neurobiolaging.2015.01.003
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, PH1967, DOI 10.1152/ajpheart.00338.2004
   Saha P, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aau1168
   Sansone P, 2017, P NATL ACAD SCI USA, V114, PE9066, DOI 10.1073/pnas.1704862114
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   Shefer G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013307
   Sheleg S, 2008, INT J CLIN EXP PATHO, V1, P440
   Shi Changyou, 2020, TRANSL MED AGING, V4, P121, DOI 10.1016/j.tma.2020.08.002
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shin B, 2019, JACC-BASIC TRANSL SC, V4, P871, DOI 10.1016/j.jacbts.2019.08.007
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simmons JD, 2017, J TRAUMA ACUTE CARE, V82, P1023, DOI 10.1097/TA.0000000000001421
   Simmons JD, 2015, CORONARY ARTERY DIS, V26, P286, DOI 10.1097/MCA.0000000000000244
   Sinha P, 2016, CURR OPIN GENET DEV, V38, P97, DOI 10.1016/j.gde.2016.05.002
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stumpf PS, 2020, PHYS BIOL, V17, P0, DOI 10.1088/1478-3975/abba85
   Sudakov NP, 2017, EUR J MED RES, V22, P0, DOI 10.1186/s40001-016-0241-x
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sun X, 2018, BIOCHEM BIOPH RES CO, V503, P2611, DOI 10.1016/j.bbrc.2018.08.012
   Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenti D, 2014, ANAL BIOCHEM, V444, P25, DOI 10.1016/j.ab.2013.08.030
   van der Bogt KEA, 2008, CIRCULATION, V118, PS121, DOI 10.1161/CIRCULATIONAHA.107.759480
   Vandergriff AC, 2015, STEM CELLS INT, V2015, P0, DOI 10.1155/2015/960926
   Virani SS, 2020, CIRCULATION, V141, PE139, DOI 10.1161/CIR.0000000000000757
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131
   Wang HC, 2014, J NEUROTRAUM, V31, P1039, DOI 10.1089/neu.2013.3070
   Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231
   Wang LF, 2020, BMC EMERG MED, V20, P0, DOI 10.1186/s12873-020-00320-3
   Wang MJ, 2019, AGING DIS, V10, P871, DOI 10.14336/AD.2018.1119
   Webb M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21207580
   Weixler V, 2021, J THORAC CARDIOV SUR, V162, PE111, DOI 10.1016/j.jtcvs.2020.08.011
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Xin Y, 2010, ARTIF ORGANS, V34, P215, DOI 10.1111/j.1525-1594.2009.00824.x
   Yamada Y, 2014, YAKUGAKU ZASSHI, V134, P1143, DOI 10.1248/yakushi.14-00191
   Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang YL, 2016, STEM CELL REP, V7, P749, DOI 10.1016/j.stemcr.2016.08.009
   Zhang ZH, 2020, J ALZHEIMERS DIS, V78, P1161, DOI 10.3233/JAD-200686
NR 174
TC 5
Z9 6
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 15
PY 2021
VL 22
IS 4
BP 
EP 
DI 10.3390/ijms22041824
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA QP3XN
UT WOS:000623770700001
PM 33673127
DA 2024-11-01
ER

PT J
AU Alfahad, AJ
   Alzaydi, MM
   Aldossary, AM
   Alshehri, AA
   Almughem, FA
   Zaidan, NM
   Tawfik, EA
AF Alfahad, Ahmed J.
   Alzaydi, Mai M.
   Aldossary, Ahmad M.
   Alshehri, Abdullah A.
   Almughem, Fahad A.
   Zaidan, Nada M.
   Tawfik, Essam A.
TI Current views in chronic obstructive pulmonary disease pathogenesis and management
SO SAUDI PHARMACEUTICAL JOURNAL
LA English
DT Review
DE Chronic obstructive pulmonary disease&nbsp; (COPD); Mitochondrial alterations; Epigenetic alterations; Mitochondrial epigenetics; Nanomedicine
ID long noncoding rnas; oxidative stress; cigarette-smoke; drug-delivery; dna methylation; mitochondrial dysfunction; epithelial-cells; skeletal-muscle; aav vector; cross-talk
AB Chronic obstructive pulmonary disease (COPD) is a progressive lung dysfunction caused mainly by inhaling toxic particles and cigarette smoking (CS). The continuous exposure to ruinous molecules can lead to abnormal inflammatory responses, permanent damages to the respiratory system, and irreversible pathological changes. Other factors, such as genetics and aging, influence the development of COPD. In the last decade, accumulating evidence suggested that mitochondrial alteration, including mitochondrial DNA damage, increased mitochondrial reactive oxygen species (ROS), abnormal autophagy, and apoptosis, have been implicated in the pathogenesis of COPD. The alteration can also extend to epigenetics, namely DNA methylation, histone modification, and non-coding RNA. This review will discuss the recent progressions in COPD pathology, pathophysiology, and molecular pathways. More focus will be shed on mitochondrial and epigenetic variations related to COPD development and the role of nanomedicine as a potential tool for the prevention and treatment of this disease. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Alfahad, Ahmed J.; Alzaydi, Mai M.; Aldossary, Ahmad M.; Alshehri, Abdullah A.; Almughem, Fahad A.; Tawfik, Essam A.] King Abdulaziz City Sci & Technol, Life Sci & Environm Res Inst, Natl Biotechnol Ctr, POB 6086, Riyadh 11442, Saudi Arabia.
   [Zaidan, Nada M.; Tawfik, Essam A.] King Abdulaziz City Sci & Technol, Ctr Excellence Biomed, Joint Ctr Excellence Program, POB 6086, Riyadh 11442, Saudi Arabia.
RP Tawfik, EA (corresponding author), King Abdulaziz City Sci & Technol, Life Sci & Environm Res Inst, Natl Biotechnol Ctr, POB 6086, Riyadh 11442, Saudi Arabia.
EM ajlfahad@kacst.edu.sa; malzaydi@kacst.edu.sa; aaldossary@kacst.edu.sa; abdualshehri@kacst.edu.sa; falmughem@kacst.edu.sa; nzaidan@kacst.edu.sa; etawfik@kacst.edu.sa
FU National Industrial Develop-ment and Logistics Program (NIDLP) through the Health Initiative and the Technology Leader Program Initiative [20-0103, 20-0051]
CR Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088
   Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402
   Al Faraj A, 2014, INT J NANOMED, V9, P1491, DOI 10.2147/IJN.S59394
   Almughem FA, 2021, ROLE EXOSOMES BIOLOG, V0, PP337, DOI 10.1007/978-981-15-6599-1_17
   Alvarado-Vazquez PA, 2017, IMMUNOBIOLOGY, V222, P900, DOI 10.1016/j.imbio.2017.05.011
   [Anonymous], 2019, WHO HIGHL HUG SCAL T, V0, P0
   Antó JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820
   Araya J, 2013, INTERNAL MED, V52, P2295, DOI 10.2169/internalmedicine.52.1118
   Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495
   Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, PL895, DOI 10.1152/ajplung.00180.2014
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487
   Barnes Peter J, 2009, PROC AM THORAC SOC, V6, P693, DOI 10.1513/pats.200907-071DP
   Barnes PJ, 2004, CELL MOL BIOL, V50, P627
   Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609
   Bi H, 2015, INFLAMM RES, V64, P119, DOI 10.1007/s00011-014-0790-9
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   Broekman W, 2018, THORAX, V73, P565, DOI 10.1136/thoraxjnl-2017-210672
   Brown TA, 2016, NANOTOXICOLOGY, V10, P453, DOI 10.3109/17435390.2015.1078852
   Burhan E, 2013, ANTIMICROB AGENTS CH, V57, P3614, DOI 10.1128/AAC.02468-12
   Busch R, 2016, RESP RES, V17, P0, DOI 10.1186/s12931-016-0459-8
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cantin AM, 2012, CURR MOL MED, V12, P836
   Carvalho TC, 2011, INT J PHARMACEUT, V406, P1, DOI 10.1016/j.ijpharm.2010.12.040
   Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505
   Chen Y, 2012, J INFLAMM-LOND, V9, P0, DOI 10.1186/1476-9255-9-10
   Chen YC, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-83185-1
   Chikuma K, 2020, FREE RADICAL RES, V54, P829, DOI 10.1080/10715762.2019.1696965
   Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104
   Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017
   Conickx G, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-13265-8
   Conickx G, 2017, AM J RESP CRIT CARE, V195, P43, DOI 10.1164/rccm.201506-1182OC
   Dagar V, 2018, CLIN EPIGENETICS, V10, P0, DOI 10.1186/s13148-018-0546-4
   Dasgupta A, 2020, COMPR PHYSIOL, V10, P713, DOI 10.1002/cphy.c190027
   De Smet EG, 2020, MUCOSAL IMMUNOL, V13, P423, DOI 10.1038/s41385-019-0241-6
   de Vries M, 2019, RESP RES, V20, P0, DOI 10.1186/s12931-019-1222-8
   de Vries M, 2018, BMJ OPEN RESPIR RES, V5, P0, DOI 10.1136/bmjresp-2018-000282
   Deeb RS, 2016, AM J RESP CELL MOL, V54, P231, DOI 10.1165/rcmb.2015-0055OC
   Dixit Deepali, 2016, P T, V41, P703
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   Du Y, 2017, RESP RES, V18, P0, DOI 10.1186/s12931-017-0639-1
   Duan RR, 2020, INT J CHRONIC OBSTR, V15, P1391, DOI 10.2147/COPD.S252896
   Forteza RM, 2012, J BIOL CHEM, V287, P42288, DOI 10.1074/jbc.M112.387795
   Gallou-Kabani C, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0014398
   Gao X, 2016, ONCOTARGET, V7, P59017, DOI 10.18632/oncotarget.10007
   Geiser M, 2013, PART FIBRE TOXICOL, V10, P0, DOI 10.1186/1743-8977-10-19
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Grimm D, 2017, HUM GENE THER, V28, P1075, DOI 10.1089/hum.2017.172
   Hara H, 2013, AM J PHYSIOL-LUNG C, V305, PL737, DOI 10.1152/ajplung.00146.2013
   Hassan F, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050837
   He X, 2017, INT J CHRONIC OBSTR, V12, P3245, DOI 10.2147/COPD.S144881
   Henrot P, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112785
   HEYDER J, 1986, J AEROSOL SCI, V17, P811, DOI 10.1016/0021-8502(86)90035-2
   Hikichi M, 2019, J THORAC DIS, V11, PS2129, DOI 10.21037/jtd.2019.10.43
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hoffmann RF, 2013, RESP RES, V14, P0, DOI 10.1186/1465-9921-14-97
   Holmström KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Hu G, 1998, FRONT IMMUNOL, V10, P0
   Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892
   Janib SM, 2010, ADV DRUG DELIVER REV, V62, P1052, DOI 10.1016/j.addr.2010.08.004
   Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4
   Jiang Y, 2017, INT J CHRONIC OBSTR, V12, P1153, DOI 10.2147/COPD.S130168
   Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC
   Kim V, 2015, BMC PULM MED, V15, P0, DOI 10.1186/s12890-015-0103-2
   Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733
   Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041
   Kukrety SP, 2018, LUNG INDIA, V35, P321, DOI 10.4103/lungindia.lungindia_266_17
   Kuwano K, 2016, RESPIR INVESTIG, V54, P397, DOI 10.1016/j.resinv.2016.03.010
   Kuzmov A, 2015, J CONTROL RELEASE, V219, P500, DOI 10.1016/j.jconrel.2015.07.024
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003
   Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006
   Li MZ, 2020, ENVIRON INT, V143, P0, DOI 10.1016/j.envint.2020.105976
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Lloreta J, 1996, ULTRASTRUCT PATHOL, V20, P67, DOI 10.3109/01913129609023240
   Luo J, 2020, AGEING RES REV, V57, P0, DOI 10.1016/j.arr.2019.100982
   Ma L, 2016, ACS NANO, V10, P6952, DOI 10.1021/acsnano.6b02878
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   MacNee William, 2005, PROC AM THORAC SOC, V2, P50, DOI 10.1513/pats.200411-056SF
   MacNee William, 2005, PROC AM THORAC SOC, V2, P258, DOI 10.1513/pats.200504-045SR
   Maguire CA, 2012, MOL THER, V20, P960, DOI 10.1038/mt.2011.303
   Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4
   Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC
   Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037
   McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35
   McCloskey SC, 2001, AM J RESP CRIT CARE, V164, P1419, DOI 10.1164/ajrccm.164.8.2105002
   Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200
   Mercer Becky A, 2006, INT J CHRON OBSTRUCT PULMON DIS, V1, P137, DOI 10.2147/copd.2006.1.2.137
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985
   Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708
   Nam HS, 2017, BIOMARK MED, V11, P475, DOI 10.2217/bmm-2016-0373
   Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010
   Nita M, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/3164734
   OFarrell HE, 2019, J THORAC DIS, V11, PS2141, DOI 10.21037/jtd.2019.10.16
   Osei Emmanuel T, 2017, EUR RESPIR J, V49, P0, DOI 10.1183/13993003.02538-2016
   Passi M, 2020, INT J NANOMED, V15, P3803, DOI 10.2147/IJN.S242516
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pinheiro M, 2011, NANOMEDICINE-UK, V6, P1413, DOI 10.2217/NNM.11.122
   Qi H, 2021, CIRCULATION, V0, P0
   Quinn M, 2020, THER CLIN RISK MANAG, V16, P1243, DOI 10.2147/TCRM.S234377
   Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306
   Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002
   Ragland MF, 2019, AM J RESP CRIT CARE, V200, P677, DOI 10.1164/rccm.201808-1455SO
   Ratemi E, 2016, CLIN EXP ALLERGY, V46, P1033, DOI 10.1111/cea.12771
   Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010
   Remels AH, 2008, EUR RESPIR J, V31, P502, DOI 10.1183/09031936.00068207
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013
   Ribera F, 2003, AM J RESP CRIT CARE, V167, P873, DOI 10.1164/rccm.200206-519OC
   Ringh MV, 2019, EBIOMEDICINE, V46, P290, DOI 10.1016/j.ebiom.2019.07.006
   Roulet A, 2012, BMC PULM MED, V12, P0, DOI 10.1186/1471-2466-12-38
   Roy I, 2010, NANOMED-NANOTECHNOL, V6, P237, DOI 10.1016/j.nano.2009.07.001
   Rytting E, 2008, EXPERT OPIN DRUG DEL, V5, P629, DOI 10.1517/17425247.5.6.629
   Sahib MN, 2011, INT J NANOMED, V6, P2351, DOI 10.2147/IJN.S25363
   Salimian J, 2018, J RES MED SCI, V23, P0, DOI 10.4103/jrms.JRMS_1054_17
   Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011
   Sauleda J, 1998, AM J RESP CRIT CARE, V157, P1413, DOI 10.1164/ajrccm.157.5.9710039
   Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87
   Schieber M, 2014, CURR BIOL, V24, PR453, DOI 10.1016/j.cub.2014.03.034
   Selman M, 2019, AM J RESP CRIT CARE, V199, P279, DOI 10.1164/rccm.201806-1166PP
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Silverman EK, 2020, ANNU REV PHYSIOL, V82, P413, DOI 10.1146/annurev-physiol-021317-121224
   Stolk J, 2016, QJM-INT J MED, V109, P331, DOI 10.1093/qjmed/hcw001
   Su S, 2020, NANOMATERIALS-BASEL, V10, P0, DOI 10.3390/nano10040656
   Suk JS, 2016, ADV DRUG DELIVER REV, V99, P28, DOI 10.1016/j.addr.2015.09.012
   Suk JS, 2011, MOL THER, V19, P1981, DOI 10.1038/mt.2011.160
   Sundar IK, 2016, AM J PHYSIOL-LUNG C, V311, PL1245, DOI 10.1152/ajplung.00253.2016
   Sung JC, 2007, TRENDS BIOTECHNOL, V25, P563, DOI 10.1016/j.tibtech.2007.09.005
   Taivassalo T, 2016, CHEST, V149, P1302, DOI 10.1016/j.chest.2015.11.021
   Thomas RJ, 2008, APPL ENVIRON MICROB, V74, P6437, DOI 10.1128/AEM.01194-08
   Trivedi A, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9010053
   Tsubouchi K, 2018, INFLAMM REGEN, V38, P0, DOI 10.1186/s41232-018-0077-6
   Tzortzaki EG, 2013, CURR DRUG TARGETS, V14, P141
   van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, PL1211, DOI 10.1152/ajplung.00291.2006
   Van Eeden SF, 2013, CAN RESPIR J, V20, P27, DOI 10.1155/2013/509130
   van Rijt SH, 2014, EUR RESPIR J, V44, P765, DOI 10.1183/09031936.00212813
   Velasco-Torres Y, 2019, BMC PULM MED, V19, P0, DOI 10.1186/s12890-019-0977-5
   Vij N, 2018, AM J PHYSIOL-CELL PH, V314, PC73, DOI 10.1152/ajpcell.00110.2016
   Vij N, 2011, EXPERT OPIN DRUG DEL, V8, P1105, DOI 10.1517/17425247.2011.597381
   Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Vucic EA, 2014, AM J RESP CELL MOL, V50, P912, DOI 10.1165/rcmb.2013-0304OC
   Wang H, 2017, ONCOTARGET, V8, P115647, DOI 10.18632/oncotarget.23362
   Wang MY, 2020, INT J NANOMED, V15, P2287, DOI 10.2147/IJN.S240301
   Wang YJ, 2018, INT J CHRONIC OBSTR, V13, P3341, DOI 10.2147/COPD.S176122
   Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094
   WHO,, 1900, P2021, V0, P0
   Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046
   Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, P0, DOI 10.3402/jev.v4.26316
   Willis L, 2012, LUNG, V190, P251, DOI 10.1007/s00408-011-9360-x
   Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640
   Xu H, 2018, THERANOSTICS, V8, P5419, DOI 10.7150/thno.27876
   Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006
   Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024
   Yoon YS, 2019, EXPERT REV RESP MED, V13, P369, DOI 10.1080/17476348.2019.1580576
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zhang HY, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-25702-3
   Zhang XP, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20225573
   Zhao MY, 2019, NEUROL RES, V41, P489, DOI 10.1080/01616412.2018.1548747
   Zong DD, 2015, EUR REV MED PHARMACO, V19, P844
   Zorzetto M, 2008, CLIN CHEM, V54, P1331, DOI 10.1373/clinchem.2007.102798
NR 168
TC 19
Z9 22
U1 5
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1319-0164
EI 2213-7475
J9 SAUDI PHARM J
JI Saudi Pharm. J.
PD DEC 15
PY 2021
VL 29
IS 12
BP 1361
EP 1373
DI 10.1016/j.jsps.2021.10.008
EA DEC 2021
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA XY7BF
UT WOS:000737122200002
PM 35002373
DA 2024-11-01
ER

PT J
AU Ramón, J
   Vila-Julia, F
   Molina-Granada, D
   Molina-Berenguer, M
   Melià, MJ
   Garcia-Arumí, E
   Torres-Torronteras, J
   Cámara, Y
   Martí, R
AF Ramon, Javier
   Vila-Julia, Ferran
   Molina-Granada, David
   Molina-Berenguer, Miguel
   Jesus Melia, Maria
   Garcia-Arumi, Elena
   Torres-Torronteras, Javier
   Camara, Yolanda
   Marti, Ramon
TI Therapy Prospects for Mitochondrial DNA Maintenance Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondria; mtDNA; replication; depletion; multiple deletions; therapy; nucleoside; gene therapy
ID progressive external ophthalmoplegia; stem-cell transplantation; pyrimidine nucleotide carrier; hematopoietic gene-therapy; enzyme-replacement therapy; impair mtdna replication; thymidine phosphorylase; neurogastrointestinal encephalomyopathy; murine model; mouse model
AB Mitochondrial DNA depletion and multiple deletions syndromes (MDDS) constitute a group of mitochondrial diseases defined by dysfunctional mitochondrial DNA (mtDNA) replication and maintenance. As is the case for many other mitochondrial diseases, the options for the treatment of these disorders are rather limited today. Some aggressive treatments such as liver transplantation or allogeneic stem cell transplantation are among the few available options for patients with some forms of MDDS. However, in recent years, significant advances in our knowledge of the biochemical pathomechanisms accounting for dysfunctional mtDNA replication have been achieved, which has opened new prospects for the treatment of these often fatal diseases. Current strategies under investigation to treat MDDS range from small molecule substrate enhancement approaches to more complex treatments, such as lentiviral or adenoassociated vector-mediated gene therapy. Some of these experimental therapies have already reached the clinical phase with very promising results, however, they are hampered by the fact that these are all rare disorders and so the patient recruitment potential for clinical trials is very limited.
C1 [Ramon, Javier; Vila-Julia, Ferran; Molina-Granada, David; Molina-Berenguer, Miguel; Jesus Melia, Maria; Garcia-Arumi, Elena; Torres-Torronteras, Javier; Camara, Yolanda; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona 08035, Spain.
   [Ramon, Javier; Vila-Julia, Ferran; Molina-Granada, David; Molina-Berenguer, Miguel; Jesus Melia, Maria; Garcia-Arumi, Elena; Torres-Torronteras, Javier; Camara, Yolanda; Marti, Ramon] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Martí, R (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Res Grp Neuromuscular & Mitochondrial Dis, Barcelona 08035, Spain.; Martí, R (corresponding author), Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid 28029, Spain.
EM javier.ramon@vhir.org; ferran.vila@vhir.org; david.molina@vhir.org; miguel.molina@vhir.org; maria.jesus.melia@vhir.org; elena.garcia@vhir.org; javier.torres@vhir.org; yolanda.camara@vhir.org; ramon.marti@vhir.org
FU Spanish Instituto de Salud Carlos III (E.R.D.F.) [PMP15/00025, PI18/01574]; Catalan Generalitat de Catalunya (PERIS program) [SLT002/16/00370]; Catalan Generalitat de Catalunya (FI-AGAUR program) [2018FI_B_01115]
CR Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Alsina D, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911659
   Baderna V, 2020, ACTA NEUROPATHOL COM, V8, P0, DOI 10.1186/s40478-020-00975-w
   Bax BE, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081096
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Boczonadi V, 2018, GENET MED, V20, P1224, DOI 10.1038/gim.2017.251
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Boschetti E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096692
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Cabrera-Pérez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217
   Cabrera-Pérez R, 2015, EXPERT OPIN ORPHAN D, V3, P1167, DOI 10.1517/21678707.2015.1090307
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Cass C E, 1999, PHARM BIOTECHNOL, V12, P313
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   DAngelo R, 2020, J NEUROL, V267, P3702, DOI 10.1007/s00415-020-10051-x
   DAngelo R, 2017, MITOCHONDRION, V34, P101, DOI 10.1016/j.mito.2017.02.006
   DAngelo R, 2016, NEUROL SCI, V37, P1149, DOI 10.1007/s10072-016-2552-7
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   Breda CND, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101255
   De Vocht C, 2010, J CONTROL RELEASE, V148, PE19, DOI 10.1016/j.jconrel.2010.07.011
   De Vocht C, 2009, J CONTROL RELEASE, V137, P246, DOI 10.1016/j.jconrel.2009.03.020
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   DESGRANGES C, 1981, BIOCHIM BIOPHYS ACTA, V654, P211, DOI 10.1016/0005-2787(81)90174-X
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2018, GENE REV, V0, P0
   El-Hattab AW, 2018, MOL GENET METAB, V125, P315, DOI 10.1016/j.ymgme.2018.10.003
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Epand RM, 2009, BIOCHEMISTRY-US, V48, P12358, DOI 10.1021/bi901769r
   Facchinello N, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-020-03359-z
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103
   Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9
   Flierl A, 2005, GENE THER, V12, P570, DOI 10.1038/sj.gt.3302443
   Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.E06-12-1109
   Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110
   Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Garcia-Diaz B, 2014, BRAIN, V137, P1337, DOI 10.1093/brain/awu068
   Garc┬u┬ia-Rodr┬u┬iguez LJ, 2007, ECHINODERMS B, V80, P809, DOI 10.1016/s0091-679x(06)80040-3
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Gray MW, 2017, MOL BIOL CELL, V28, P1285, DOI 10.1091/mbc.E16-07-0509
   György H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, P0, DOI 10.1136/bmjresp-2020-000774
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hoff KE, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0203198
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hussein E, 2013, TRANSFUS APHER SCI, V49, P208, DOI 10.1016/j.transci.2013.01.014
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Jurkute N, 2019, ANN NEUROL, V86, P368, DOI 10.1002/ana.25550
   Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kelly D A, 2000, PEDIATR TRANSPLANT, V4, P170, DOI 10.1034/j.1399-3046.2000.00125.x
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212
   Kishita Y, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1427
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022
   Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710
   Krähenbühl S, 2000, LIVER, V20, P346, DOI 10.1034/j.1600-0676.2000.020004346.x
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Kuszak AJ, 2018, ANNU REV PATHOL-MECH, V13, P163, DOI 10.1146/annurev-pathol-020117-043644
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   Levene M, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8040457
   Levene M, 2013, TOXICOL SCI, V131, P311, DOI 10.1093/toxsci/kfs278
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   Martin CA, 2018, AM J HUM GENET, V103, P221, DOI 10.1016/j.ajhg.2018.07.001
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Martinez-Arribas B, 2020, CELL MOL LIFE SCI, V77, P1645, DOI 10.1007/s00018-019-03250-x
   McBride HM, 2006, CURR BIOL, V16, PR551, DOI 10.1016/j.cub.2006.06.054
   Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Moran NF, 2008, NEUROLOGY, V71, P686, DOI 10.1212/01.wnl.0000324602.97205.ab
   Morgan NV, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000833
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Munro B, 2019, HUM MOL GENET, V28, P796, DOI 10.1093/hmg/ddy389
   Nambot S, 2017, CLIN GENET, V92, P188, DOI 10.1111/cge.12985
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Oliveira MT, 2020, GENET MOL BIOL, V43, P0, DOI 10.1590/1678-4685-GMB-2019-0069
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pastor-Anglada M, 2018, COMPR PHYSIOL, V8, P1003, DOI 10.1002/cphy.c170039
   Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, P0, DOI 10.3389/fphar.2015.00013
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Punzi G, 2018, HUM MOL GENET, V27, P499, DOI 10.1093/hmg/ddx419
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Rajendran J, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809456
   Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Requena CE, 2014, BIOCHEM J, V459, P171, DOI 10.1042/BJ20130894
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Röeben B, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0687-0
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUIZ MD, 2019, J TRANSL MED, V17, P290, DOI 10.1186/S12967-019-2041-X
   Russell BE, 2019, HEPATOLOGY, V70, P1066, DOI 10.1002/hep.30627
   Ruzzenente B, 2016, HUM MOL GENET, V25, PR115, DOI 10.1093/hmg/ddw176
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Sharma H, 2020, HELIYON, V6, P0, DOI 10.1016/j.heliyon.2020.e04643
   Shimura M, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01441-5
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Silva-Pinheiro P, 2021, NUCLEIC ACIDS RES, V49, P5230, DOI 10.1093/nar/gkab282
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Stussi G, 2010, BONE MARROW TRANSPL, V45, P103, DOI 10.1038/bmt.2009.123
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24
   Torres-Torronteras J, 2018, HUM GENE THER, V29, P708, DOI 10.1089/hum.2017.133
   Torres-Torronteras J, 2016, HUM GENE THER, V27, P656, DOI 10.1089/hum.2015.160
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, METHODS, V51, P405, DOI 10.1016/j.ymeth.2010.03.009
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012
   Vercauteren K, 2016, MOL THER, V24, P1042, DOI 10.1038/mt.2016.61
   Vila-Julià F, 2020, EBIOMEDICINE, V62, P0, DOI 10.1016/j.ebiom.2020.103133
   VIOQUE EG, 2011, PLOS GENET, V7, P0
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Wevers RA, 2019, J INHERIT METAB DIS, V42, P494, DOI 10.1002/jimd.12081
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yadak R, 2018, MOL THER-METH CLIN D, V8, P152, DOI 10.1016/j.omtm.2018.01.001
   Yapa NMB, 2021, FEBS LETT, V595, P1184, DOI 10.1002/1873-3468.14077
   Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
   Zhou XS, 2019, HUM MOL GENET, V28, P2874, DOI 10.1093/hmg/ddz103
NR 215
TC 12
Z9 12
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN 15
PY 2021
VL 22
IS 12
BP 
EP 
DI 10.3390/ijms22126447
PG 35
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA SY6UK
UT WOS:000666020300001
PM 34208592
DA 2024-11-01
ER

PT J
AU Elstner, M
   Olszewski, K
   Prokisch, H
   Klopstock, T
   Murgia, M
AF Elstner, Matthias
   Olszewski, Konrad
   Prokisch, Holger
   Klopstock, Thomas
   Murgia, Marta
TI Multi-Omics Approach to Mitochondrial DNA Damage in Human Muscle Fibers
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE skeletal muscle; mtDNA deletions; transcriptomics; proteomics; myopathy; disease models
ID deletion mutations; oxidative damage; proteomics; genetics
AB Mitochondrial DNA deletions affect energy metabolism at tissue-specific and cell-specific threshold levels, but the pathophysiological mechanisms determining cell fate remain poorly understood. Chronic progressive external ophthalmoplegia (CPEO) is caused by mtDNA deletions and characterized by a mosaic distribution of muscle fibers with defective cytochrome oxidase (COX) activity, interspersed among fibers with retained functional respiratory chain. We used diagnostic histochemistry to distinguish COX-negative from COX-positive fibers in nine muscle biopsies from CPEO patients and performed laser capture microdissection (LCM) coupled to genome-wide gene expression analysis. To gain molecular insight into the pathogenesis, we applied network and pathway analysis to highlight molecular differences of the COX-positive and COX-negative fiber transcriptome. We then integrated our results with proteomics data that we previously obtained comparing COX-positive and COX-negative fiber sections from three other patients. By virtue of the combination of LCM and a multi-omics approach, we here provide a comprehensive resource to tackle the pathogenic changes leading to progressive respiratory chain deficiency and disease in mitochondrial deletion syndromes. Our data show that COX-negative fibers upregulate transcripts involved in translational elongation and protein synthesis. Furthermore, based on functional annotation analysis, we find that mitochondrial transcripts are the most enriched among those with significantly different expression between COX-positive and COX-negative fibers, indicating that our unbiased large-scale approach resolves the core of the pathogenic changes. Further enrichments include transcripts encoding LIM domain proteins, ubiquitin ligases, proteins involved in RNA turnover, and, interestingly, cell cycle arrest and cell death. These pathways may thus have a functional association to the molecular pathogenesis of the disease. Overall, the transcriptome and proteome show a low degree of correlation in CPEO patients, suggesting a relevant contribution of post-transcriptional mechanisms in shaping this disease phenotype.
C1 [Elstner, Matthias] Tech Univ Munich, Dept Neurol, D-81675 Munich, Germany.
   [Olszewski, Konrad] Univ Zurich, Psychiat Hosp, Ctr Addict Disorders, Dept Psychiat Psychotherapy & Psychosomat, CH-8001 Zurich, Switzerland.
   [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Prokisch, Holger] Helmholtz Zentrum Munich, Inst Neurogen, D-85764 Neuherberg, Germany.
   [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany.
   [Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, D-81675 Munich, Germany.
   [Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-81675 Munich, Germany.
   [Murgia, Marta] Max Planck Inst Biochem, Dept Prote Signal Transduct, D-82352 Martinsried, Germany.
   [Murgia, Marta] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
C3 Technical University of Munich; University of Zurich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Max Planck Society; University of Padua
RP Murgia, M (corresponding author), Max Planck Inst Biochem, Dept Prote Signal Transduct, D-82352 Martinsried, Germany.; Murgia, M (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
EM m.elstner@tum.de; kolsz@gmx.net; prokisch@helmholtz-muenchen.de; Thomas.Klopstock@med.uni-muenchen.de; mmurgia@biochem.mpg.de
FU German Bundesministerium fur Bildung und Forschung (BMBF) [01GM1906A, 01GM1920A, 01GM1920B]; Italian Space Agency, grant MARS-PRE [DC-VUM-2017-006]
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S16-S12
   Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Elstner M, 2012, BRAIN RES BULL, V88, P285, DOI 10.1016/j.brainresbull.2011.07.018
   Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Guglielmi V, 2016, CLIN SCI, V130, P167, DOI 10.1042/CS20150394
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazachkova N, 2013, NEURODEGENER DIS, V11, P206, DOI 10.1159/000339207
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lu CY, 1999, MUTAT RES-FUND MOL M, V423, P11, DOI 10.1016/S0027-5107(98)00220-6
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Pereira CV, 2021, CRIT REV BIOCHEM MOL, V56, P510, DOI 10.1080/10409238.2021.1934812
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Santacatterina F, 2018, FREE RADICAL BIO MED, V126, P235, DOI 10.1016/j.freeradbiomed.2018.08.020
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, PD607, DOI 10.1093/nar/gky1131
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI 10.1038/nmeth.3901
   Viscomi C, 2016, BIOCHEM SOC T, V44, P1483, DOI 10.1042/BST20160085
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Wilson WC, 2014, HUM MOL GENET, V23, P6345, DOI 10.1093/hmg/ddu352
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
NR 44
TC 2
Z9 2
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT 15
PY 2021
VL 22
IS 20
BP 
EP 
DI 10.3390/ijms222011080
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA WU0TD
UT WOS:000716266100001
PM 34681740
DA 2024-11-01
ER

PT J
AU Ticci, C
   Orsucci, D
   Ardissone, A
   Bello, L
   Bertini, E
   Bonato, I
   Bruno, C
   Carelli, V
   Diodato, D
   Doccini, S
   Donati, MA
   Dosi, C
   Filosto, M
   Fiorillo, C
   La Morgia, C
   Lamperti, C
   Marchet, S
   Martinelli, D
   Minetti, C
   Maurizio,
   Enrica, T
   Montano, V
   Moroni, I
   Musumeci, O
   Pancheri, E
   Pegoraro, E
   Primiano, G
   Procopio, E
   Rubegni, A
   Scalise, R
   Sciacco, M
   Servidei, S
   Siciliano, G
   Simoncini, C
   Tolomeo, D
   Tonin, P
   Toscano, A
   Tubili, F
   Mancuso, M
   Battini, R
   Santorelli, FM
AF Ticci, Chiara
   Orsucci, Daniele
   Ardissone, Anna
   Bello, Luca
   Bertini, Enrico
   Bonato, Irene
   Bruno, Claudio
   Carelli, Valerio
   Diodato, Daria
   Doccini, Stefano
   Donati, Maria Alice
   Dosi, Claudia
   Filosto, Massimiliano
   Fiorillo, Chiara
   La Morgia, Chiara
   Lamperti, Costanza
   Marchet, Silvia
   Martinelli, Diego
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana Enrica
   Montano, Vincenzo
   Moroni, Isabella
   Musumeci, Olimpia
   Pancheri, Elia
   Pegoraro, Elena
   Primiano, Guido
   Procopio, Elena
   Rubegni, Anna
   Scalise, Roberta
   Sciacco, Monica
   Servidei, Serenella
   Siciliano, Gabriele
   Simoncini, Costanza
   Tolomeo, Deborah
   Tonin, Paola
   Toscano, Antonio
   Tubili, Flavia
   Mancuso, Michelangelo
   Battini, Roberta
   Santorelli, Filippo Maria
TI Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial disease; movement disorder; childhood onset; multicenter cross-sectional study
ID international parkinson; cerebellum; consensus; dystonia; mutation; classification; phenomenology; myopathy; features; ataxia
AB Movement disorders are increasingly being recognized as a manifestation of childhood-onset mitochondrial diseases (MDs). However, the spectrum and characteristics of these conditions have not been studied in detail in the context of a well-defined cohort of patients. We retrospectively explored a cohort of individuals with childhood-onset MDs querying the Nationwide Italian Collaborative Network of Mitochondrial Diseases database. Using a customized online questionnaire, we attempted to collect data from the subgroup of patients with movement disorders. Complete information was available for 102 patients. Movement disorder was the presenting feature of MD in 45 individuals, with a mean age at onset of 11 years. Ataxia was the most common movement disorder at onset, followed by dystonia, tremor, hypokinetic disorders, chorea, and myoclonus. During the disease course, most patients (67.7%) encountered a worsening of their movement disorder. Basal ganglia involvement, cerebral white matter changes, and cerebellar atrophy were the most commonly associated neuroradiological patterns. Forty-one patients harbored point mutations in the mitochondrial DNA, 10 carried mitochondrial DNA rearrangements, and 41 cases presented mutations in nuclear-DNA-encoded genes, the latter being associated with an earlier onset and a higher impairment in activities of daily living. Among our patients, 32 individuals received pharmacological treatment; clonazepam and oral baclofen were the most commonly used drugs, whereas levodopa and intrathecal baclofen administration were the most effective. A better delineation of the movement disorders phenotypes starting in childhood may improve our diagnostic workup in MDs, fine tuning management, and treatment of affected patients.
C1 [Ticci, Chiara; Doccini, Stefano; Dosi, Claudia; Rubegni, Anna; Scalise, Roberta; Tolomeo, Deborah; Battini, Roberta; Santorelli, Filippo Maria] IRCCS Fdn Stella Maris, I-56018 Pisa, Italy.
   [Orsucci, Daniele] San Luca Hosp, Neurol Unit, I-55100 Lucca, Italy.
   [Ardissone, Anna; Moroni, Isabella] Fdn IRCCS Ist Neurol Carlo, Child Neurol, I-20133 Milan, Italy.
   [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Neuromuscular Unit, I-35121 Padua, Italy.
   [Bertini, Enrico; Diodato, Daria; Martinelli, Diego] Bambino Gesu Childrens Hosp IRCCS, I-00165 Rome, Italy.
   [Bonato, Irene; Bruno, Claudio] IRCCS Ist Giannina Gaslini, Ctr Translat & Expt Myol, I-16147 Genoa, Italy.
   [Carelli, Valerio; La Morgia, Chiara] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, I-40139 Bologna, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, I-40126 Bologna, Italy.
   [Donati, Maria Alice; Procopio, Elena; Tubili, Flavia] A Meyer Children Hosp, I-50139 Florence, Italy.
   [Filosto, Massimiliano] Univ Brescia, NeMO Brescia Clin Ctr Neuromuscular Dis, Dept Clin & Expt Sci, I-25064 Brescia, Italy.
   [Fiorillo, Chiara; Minetti, Carlo] Univ Genoa, DINOGMI, IRCCS Ist Giannina Gaslini, Neuromuscular Disorders Unit, I-16147 Genoa, Italy.
   [La Morgia, Chiara] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, I-40139 Bologna, Italy.
   [Lamperti, Costanza; Marchet, Silvia] Fdn IRCCS Ist Neurol C Besta, Genet & Neuroget, I-20133 Milan, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Neuromuscular & Rare Dis Unit, Dino Ferrari Ctr, Fdn IRCCS Ca Granda Osped Maggiore Policlin, I-20122 Milan, Italy.
   [Mongini, Tiziana Enrica] Univ Torino, Dept Neurosci Rita Levi Montalcini, Neuromuscular Unit, I-10124 Turin, Italy.
   [Montano, Vincenzo; Siciliano, Gabriele; Simoncini, Costanza; Mancuso, Michelangelo; Battini, Roberta] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
   [Musumeci, Olimpia; Toscano, Antonio] Univ Messina, Unit Neurol & Neuromuscular Disorders, Dept Clin & Expt Med, I-98125 Messina, Italy.
   [Pancheri, Elia; Tonin, Paola] Univ Verona, Neurol Clin, I-37134 Verona, Italy.
   [Primiano, Guido; Servidei, Serenella] Fdn Policlin Univ A Gemelli IRCCS, I-00168 Rome, Italy.
   [Primiano, Guido; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, I-00168 Rome, Italy.
   [Scalise, Roberta] Univ Florence Pisa & Siena, Tuscan PhD Program Neurosci, I-50139 Florence, Italy.
C3 IRCCS Fondazione Stella Maris; University of Padua; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Brescia; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Turin; University of Pisa; University of Messina; University of Verona; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Battini, R (corresponding author), IRCCS Fdn Stella Maris, I-56018 Pisa, Italy.; Battini, R (corresponding author), Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
EM chiara.ticci@fsm.unipi.it; daniele.orsucci@uslnordovest.toscana.it; Anna.Ardissone@istituto-besta.it; luca.bello@unipd.it; ebertini@gmail.com; ire.bonato92@gmail.com; claudio2246@gmail.com; valerio.carelli@unibo.it; daria.diodato@opbg.net; stefano.doccini@fsm.unipi.it; maria.donati@meyer.it; dosiclaudia@gmail.com; massimiliano.filosto@unibs.it; chi.fiorillo@gmail.com; chiara.lamorgia@unibo.it; costanza.lamperti@istituto-besta.it; maerchet.s@istituto-besta.it; diego.martinelli@opbg.net; minettic@unige.it; mmmoggio@gmail.com; tmongini@cittadellasalute.to.it; v.montano89@gmail.com; isabella.moroni@istituto-besta.it; omusumeci@unime.it; eliapancheri88@gmail.com; elena.pegoraro@unipd.it; guido.primiano@gmail.com; elena.procopio@meyer.it; anna.rubegni@fsm.unipi.it; roberta.scalise@fsm.unipi.it; monica.sciacco@policlinico.mi.it; serenella.servidei@policlinicogemelli.it; gsicilia@neuro.med.unipi.it; costanza.simoncini85@gmail.com; deborah.tolomeo@fsm.unipi.it; paola.tonin@ospedaleuniverona.it; atoscano@unime.it; flavia.tubili@meyer.it; mancusomichelangelo@gmail.com; roberta.battini@fsm.unipi.it; filippo3364@gmail.com
FU Telethon Grant [GUP09004]; Telethon-MITOCON grant [GSP16001]; EJPRD2019 project GENOMIT;  [RF-2016-02361495]
CR Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Battini R, 2008, PEDIATR NEUROL, V39, P259, DOI 10.1016/j.pediatrneurol.2008.07.002
   Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121
   Caer M, 2005, MOVEMENT DISORD, V20, P490, DOI 10.1002/mds.20363
   Eggink H, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0177-6
   Filip P, 2013, CLIN NEUROPHYSIOL, V124, P1269, DOI 10.1016/j.clinph.2013.01.003
   Filosto M, 2019, J NEUROL, V266, P953, DOI 10.1007/s00415-019-09219-x
   Ganos C, 2014, MOVEMENT DISORD, V29, P437, DOI 10.1002/mds.25867
   Ghaoui R, 2018, J NEUROL, V265, P1230, DOI 10.1007/s00415-017-8722-6
   Ji KQ, 2020, J NEUROL, V267, P3319, DOI 10.1007/s00415-020-10017-z
   Koene S, 2018, J INHERIT METAB DIS, V41, P1267, DOI 10.1007/s10545-018-0229-5
   Koy A, 2016, LANCET NEUROL, V15, P719, DOI 10.1016/S1474-4422(16)00132-0
   Kurian Manju A, 2016, CONTINUUM (MINNEAP MINN), V22, P1159, DOI 10.1212/CON.0000000000000367
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marras C, 2017, MOVEMENT DISORD, V32, P724, DOI 10.1002/mds.27045
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Musumeci O, 2020, J TRANSL GENET GENOM, V4, P221, DOI 10.20517/JTGG.2020.22
   Musumeci O, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00160
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pavone P, 2017, ITAL J PEDIATR, V43, P0, DOI 10.1186/s13052-016-0325-9
   Pitceathly RDS, 2016, JAMA NEUROL, V73, P630, DOI 10.1001/jamaneurol.2016.0756
   Rees EM, 2014, MOVEMENT DISORD, V29, P1648, DOI 10.1002/mds.25984
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schmitz-Hübsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   Schreglmann SR, 2018, MOVEMENT DISORD, V33, P146, DOI 10.1002/mds.27174
   Shakkottai VG, 2017, CEREBELLUM, V16, P577, DOI 10.1007/s12311-016-0825-6
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Ticci C, 2020, NEUROGENETICS, V21, P87, DOI 10.1007/s10048-019-00601-5
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tolomeo D, 2019, J NEUROL SCI, V399, P69, DOI 10.1016/j.jns.2019.02.010
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Zutt R, 2015, NAT REV NEUROL, V11, P0, DOI 10.1038/nrneurol.2015.198
NR 40
TC 9
Z9 11
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAY 15
PY 2021
VL 10
IS 10
BP 
EP 
DI 10.3390/jcm10102063
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA SI5YZ
UT WOS:000654903800001
PM 34065803
DA 2024-11-01
ER

PT J
AU Li, T
   Lu, ZH
   Wang, JJ
   Chen, JY
   Fu, HD
   Mao, JH
AF Li, Ting
   Lu, Zhihong
   Wang, Jingjing
   Chen, Junyi
   Fu, Haidong
   Mao, Jianhua
TI Growth Retardation in the Course of Fanconi Syndrome Caused by the 4977-bp Mitochondrial DNA Deletion: A Case Report
SO CHILDREN-BASEL
LA English
DT Article
DE mitochondrial DNA; 4977-bp deletion; Fanconi syndrome; growth retardation; children
ID patient; duplication; myopathy
AB Fanconi syndrome is one of the primary renal manifestations of mitochondrial cytopathies caused by mitochondrial DNA (mtDNA) mutation. The common 4977-bp mtDNA deletion has been reported to be associated with aging and diseases involving multiple extrarenal organs. Cases of Fanconi syndrome caused by the 4977-bp deletion were rarely reported previously. Here, we report a 6-year-old girl with growth retardation in the course of Fanconi syndrome. She had mild ptosis and pigmented retinopathy. Abnormal biochemical findings included low-molecular-weight proteinuria, normoglycemic glycosuria, increased urine phosphorus excretion, metabolic acidosis, and hypophosphatemia. Growth records showed that her body weight and height were normal in the first year and failed to thrive after the age of three. Using a highly sensitive mtDNA analysis methodology, she was identified to possess the common 4977-bp mtDNA deletion. The mutation rate was 84.7% in the urine exfoliated cells, 78.67% in the oral mucosal cells, and 23.99% in the blood sample. After three months of oral coenzyme Q10 and levocarnitine treatment in combination with standard electrolyte supplement, her condition was improved. This is a report of growth retardation as the initial major clinical presentation of Fanconi syndrome caused by the deletion of the 4977-bp fragment. Renal tubular abnormality without any other extrarenal dysfunction may be an initial clinical sign of mitochondrial disorders. Moreover, considering the heterogeneity of the phenotypes associated with mtDNA mutations, the risk of developing Kearns-Sayre syndrome (KSS) with age in this patient should be noted because she had ptosis, retinal involvement, and changes in the brain and skeletal muscle.
C1 [Li, Ting; Lu, Zhihong; Wang, Jingjing; Chen, Junyi; Fu, Haidong; Mao, Jianhua] Zhejiang Univ, Childrens Hosp, Dept Nephrol, Sch Med,Natl Clin Res Ctr Child Hlth,Natl Childre, 3333 Binsheng Rd, Hangzhou 310052, Peoples R China.
C3 Zhejiang University
RP Mao, JH (corresponding author), Zhejiang Univ, Childrens Hosp, Dept Nephrol, Sch Med,Natl Clin Res Ctr Child Hlth,Natl Childre, 3333 Binsheng Rd, Hangzhou 310052, Peoples R China.
EM liting170209@126.com; lzhsjf@zju.edu.cn; 6506027@zju.edu.cn; chenjunyi0578@163.com; ch61312@163.com; maojh88@zju.edu.cn
FU National Natural Science Foundation of China [81770710]; Key Research and Development Plan of Zhejiang Province [2019C03028]; Zhejiang Province and National Health Commission [WKJ-ZJ-1908]; Natural Science Foundation of Zhejiang Province [LQ18H050001]
CR Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   CAMPOS Y, 1995, PEDIATR NEUROL, V13, P69, DOI 10.1016/0887-8994(95)00082-Q
   Diba LZ, 2016, MITOCHONDRIAL DNA A, V27, P3008, DOI 10.3109/19401736.2015.1063046
   Foreman JW, 2019, PEDIATR CLIN N AM, V66, P159, DOI 10.1016/j.pcl.2018.09.002
   Goldstein A, 1993, GENEREVIEWS((R)), V0, P0
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Han BA, 2019, MEDICINE, V98, P0, DOI 10.1097/MD.0000000000016302
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Liu HM, 2012, PEDIATR NEONATOL, V53, P264, DOI 10.1016/j.pedneo.2011.08.013
   LUDER A, 1994, J INHERIT METAB DIS, V17, P298, DOI 10.1007/BF00711812
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Mihai Cristina Maria, 2009, J MED CASE REP, V3, P101, DOI 10.1186/1752-1947-3-101
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   Pitchon EM, 2007, KLIN MONATSBL AUGENH, V224, P340, DOI 10.1055/s-2007-962854
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Solano A, 2004, PEDIATR NEPHROL, V19, P790, DOI 10.1007/s00467-004-1473-5
   SUPERTIFURGA A, 1993, EUR J PEDIATR, V152, P44, DOI 10.1007/BF02072515
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Tzoufi M, 2013, EUR J PEDIATR, V172, P557, DOI 10.1007/s00431-012-1798-1
NR 21
TC 0
Z9 0
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2227-9067
J9 CHILDREN-BASEL
JI Children-Basel
PD OCT 15
PY 2021
VL 8
IS 10
BP 
EP 
DI 10.3390/children8100887
PG 7
WC Pediatrics
SC Pediatrics
GA WO1RH
UT WOS:000712238200001
PM 34682152
DA 2024-11-01
ER

PT J
AU Guo, L
   Govindaraj, P
   Kievit, M
   de Coo, IFM
   Gerards, M
   Hellebrekers, DMEI
   Stassen, APM
   Gayathri, N
   Taly, AB
   Sankaran, BP
   Smeets, HJM
AF Guo, Le
   Govindaraj, Periyasamy
   Kievit, Marielle
   Coo, Irenaeus F. M. de
   Gerards, Mike
   Hellebrekers, Debby M. E. I.
   Stassen, Alphons P. M.
   Gayathri, Narayanappa
   Taly, Arun B.
   Sankaran, Bindu Parayil
   Smeets, Hubert J. M.
TI Whole exome sequencing reveals a homozygous<i> C1QBP</i> deletion as the cause of progressive external ophthalmoplegia and multiple mtDNA deletions
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Whole exome sequencing; C1QBP gene; Progressive external ophthalmoplegia; Multiple mtDNA deletions
ID cell-metabolism; mitochondrial; variants
AB Whole exome sequencing (WES), analyzed with GENESIS and WeGET, revealed a homozygous deletion in the C1QBP gene in a patient with progressive external ophthalmoplegia (PEO) and multiple mtDNA deletions. The gene encodes the mitochondria-located complementary 1 Q subcomponent-binding protein, involved in mitochondrial homeostasis. Biallelic mutations in C1QBP cause mitochondrial cardiomyopathy and/or PEO with variable age of onset. Our patient showed only late-onset PEO-plus syndrome without overt cardiac involvement. Available data suggest that early-onset cardiomyopathy variants localize in important structural domains and PEO-plus variants in the coiled-coil region. Our patient demonstrates that C1QBP mutations should be considered in individuals with PEO with or without cardiomyopathy. (c) 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
C1 [Guo, Le; Kievit, Marielle; Coo, Irenaeus F. M. de; Smeets, Hubert J. M.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.
   [Guo, Le; Coo, Irenaeus F. M. de; Smeets, Hubert J. M.] Maastricht Univ, Dept Toxicogenom, Clin Genom Unit, Maastricht, Netherlands.
   [Govindaraj, Periyasamy; Gayathri, Narayanappa] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy; Gayathri, Narayanappa; Taly, Arun B.] Natl Inst Mental Hlth & Neurosci NIMHANS, Neurobiol Res Ctr, Neuromuscular Lab, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy] Ctr DNA Fingerprinting & Diagnost CDFD, Hyderabad, India.
   [Gerards, Mike] Maastricht Univ, Maastricht Ctr Syst Biol MacsBio, Maastricht, Netherlands.
   [Hellebrekers, Debby M. E. I.; Stassen, Alphons P. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands.
   [Taly, Arun B.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
   [Sankaran, Bindu Parayil] Univ Sydney, Childrens Hosp, Westmead Clin Sch, Sydney Med Sch,Fac Med & Hlth, Sydney, NSW, Australia.
   [Smeets, Hubert J. M.] Maastricht Univ, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands.
C3 Maastricht University; Maastricht University; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Maastricht University; Maastricht University; National Institute of Mental Health & Neurosciences - India; NSW Health; The Children's Hospital at Westmead; University of Sydney; Maastricht University
RP Smeets, HJM (corresponding author), Maastricht Univ, Dept Toxicogenom, Clin Genom Unit, Maastricht, Netherlands.
EM smeets@maastrichtuniversity.nl
FU China Scholarship Council [201606310036]; National Post-Doctoral Fellowship (N-PDF) from the SERB, DST Government of India [PDF/2016/001625]; Dutch Province of Limburg; Mito-Foundation Australia; Stichting NeMO [N9_2020]
CR Amberger JS, 2019, NUCLEIC ACIDS RES, V47, PD1038, DOI 10.1093/nar/gky1151
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Carreño-Gago L, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00576
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836
   Gotoh K, 2018, CELL REP, V25, P1800, DOI 10.1016/j.celrep.2018.10.057
   Hu MJ, 2013, BIOCHEM J, V453, P381, DOI 10.1042/BJ20121829
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Nguyen M, 2016, EUR J HUM GENET, V24, P619, DOI 10.1038/ejhg.2015.158
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sachdev A, 2018, CAN J OPHTHALMOL, V53, PE203, DOI 10.1016/j.jcjo.2018.01.005
   Saha SK, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8040513
   Saito T, 2017, CARDIOVASC RES, V113, P1173, DOI 10.1093/cvr/cvx095
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Szklarczyk R, 2016, NUCLEIC ACIDS RES, V44, PD567, DOI 10.1093/nar/gkv1228
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang J, 2020, FRONT PEDIATR, V8, P0, DOI 10.3389/fped.2020.583047
   Wu HJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0071006
   Yagi M, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15414-5
NR 23
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP 15
PY 2021
VL 31
IS 9
BP 859
EP 864
DI 10.1016/j.nmd.2021.06.014
EA OCT 2021
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA WG0IR
UT WOS:000706683000009
PM 34419324
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A&gt;G Carrier
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article
DE MELAS Syndrome; Mitochondria; Mitochondrial Proton-Translocating ATPases
ID mitochondrial disease; melas
AB Objective: Challenging differential diagnosis Background: The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. Case Report: A 57-year-old woman was diagnosed with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) due to the m.3243A>G variant, with low heteroplasmy rates (31%), at age 50. The initial manifestations were short stature, migraine, and diabetes. With progression of the disease, multisystem involvement developed, affecting the brain (stroke-like episode, mild cognitive impairment), eyes (pigmentary retinopathy), ears and the vestibular system (impaired hearing, tinnitus, imbalance, drop attacks, vertigo), intestines (constipation, distended abdomen, gastro-esophageal reflux, gastroparesis), and the muscles (muscle weakness). The gastrointestinal involvement was most prominent and most significantly lowered the patient's quality of life. The diabetes was well controlled with an insulin pump. Recurrent, acute deteriorations responded favorably to L-arginine. Owing to lifestyle and diet changes 2 years after diagnosis (start of art classes, increase in spin biking to 22.5 km 3 times per week, travel to Hawaii, adherence to low-carbohydrate high-protein diet), the patient managed to lower elevated serum lactate levels to largely normal values. Conclusions: Gastrointestinal compromise may be the prominent manifestation of the m.3243A>G variant, lifestyle and diet changes may lower serum lactate in m.3243A>G carriers, and low heteroplasmy rates of the m.3243A>G variant in scarcely affected tissues do not exclude pathogenicity.
C1 [Finsterer, Josef] Messerli Inst, Landstrasse Clin, Dept Neurol, Vienna, Austria.
RP Finsterer, J (corresponding author), Messerli Inst, Landstrasse Clin, Dept Neurol, Vienna, Austria.
EM fifigs1@yahoo.de
CR de Laat P, 2015, NETH J MED, V73, P30
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   Finsterer J, 2020, HERZ, V45, P356, DOI 10.1007/s00059-018-4739-6
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2018, INTERNAL MED, V57, P769, DOI 10.2169/internalmedicine.9439-17
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yee ML, 2018, ENDOCRINOL DIABETES METAB CASE REP, V2018, P18
NR 10
TC 2
Z9 2
U1 1
U2 1
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 
EI 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD APR 19
PY 2021
VL 22
IS 
BP 
EP 
DI 10.12659/AJCR.930175
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA RQ5PG
UT WOS:000642470200002
PM 33867519
DA 2024-11-01
ER

PT J
AU Dudakova, L
   Skalicka, P
   Davidson, AE
   Sadan, AN
   Chylova, M
   Jahnova, H
   Anteneova, N
   Tesarova, M
   Honzik, T
   Liskova, P
AF Dudakova, Lubica
   Skalicka, Pavlina
   Davidson, Alice E.
   Sadan, Amanda N.
   Chylova, Monika
   Jahnova, Helena
   Anteneova, Nicole
   Tesarova, Marketa
   Honzik, Tomas
   Liskova, Petra
TI Should Patients with Kearns-Sayre Syndrome and Corneal Endothelial Failure Be Genotyped for a <i>TCF4</i> Trinucleotide Repeat, Commonly Associated with Fuchs Endothelial Corneal Dystrophy?
SO GENES
LA English
DT Article
DE Kearns-Sayre syndrome; corneal endothelium; CTG18; 1; TCF4; corneal dystrophy; endothelial failure; exome sequencing
ID noncoding mutations; phenotypes
AB The aim of this study was to describe the ocular phenotype in a case with Kearns-Sayre syndrome (KSS) spectrum and to determine if corneal endothelial cell dysfunction could be attributed to other known distinct genetic causes. Herein, genomic DNA was extracted from blood and exome sequencing was performed. Non-coding gene regions implicated in corneal endothelial dystrophies were screened by Sanger sequencing. In addition, a repeat expansion situated within an intron of TCF4 (termed CTG18.1) was genotyped using the short tandem repeat assay. The diagnosis of KSS spectrum was based on the presence of ptosis, chronic progressive external ophthalmoplegia, pigmentary retinopathy, hearing loss, and muscle weakness, which were further supported by the detection of ~6.5 kb mtDNA deletion. At the age of 33 years, the proband's best corrected visual acuity was reduced to 0.04 in the right eye and 0.2 in the left eye. Rare ocular findings included marked corneal oedema with central corneal thickness of 824 and 844 mu m in the right and left eye, respectively. No pathogenic variants in the genes, which are associated with corneal endothelial dystrophies, were identified. Furthermore, the CTG18.1 genotype was 12/33, which exceeds a previously determined critical threshold for toxic RNA foci appearance in corneal endothelial cells.
C1 [Dudakova, Lubica; Skalicka, Pavlina; Chylova, Monika; Jahnova, Helena; Anteneova, Nicole; Tesarova, Marketa; Honzik, Tomas; Liskova, Petra] Charles Univ Prague, Dept Paediat & Inherited Metab Disorders, Fac Med 1, Prague 12808, Czech Republic.
   [Dudakova, Lubica; Skalicka, Pavlina; Chylova, Monika; Jahnova, Helena; Anteneova, Nicole; Tesarova, Marketa; Honzik, Tomas; Liskova, Petra] Gen Univ Hosp Prague, Prague 12808, Czech Republic.
   [Skalicka, Pavlina; Liskova, Petra] Charles Univ Prague, Dept Ophthalmol, Fac Med 1, Prague 12808, Czech Republic.
   [Davidson, Alice E.; Sadan, Amanda N.; Liskova, Petra] UCL Inst Ophthalmol, London EC1V 9EL, England.
   [Davidson, Alice E.] Moorfields Eye Hosp, London EC1V 2PD, England.
C3 Charles University Prague; General University Hospital Prague; General University Hospital Prague; Charles University Prague; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust
RP Liskova, P (corresponding author), Charles Univ Prague, Dept Paediat & Inherited Metab Disorders, Fac Med 1, Prague 12808, Czech Republic.; Liskova, P (corresponding author), Gen Univ Hosp Prague, Prague 12808, Czech Republic.; Liskova, P (corresponding author), Charles Univ Prague, Dept Ophthalmol, Fac Med 1, Prague 12808, Czech Republic.; Liskova, P (corresponding author), UCL Inst Ophthalmol, London EC1V 9EL, England.
EM lubica.dudakova@lf1.cuni.cz; pavlina.skalicka@vfn.cz; alice.davidson@ucl.ac.uk; amanda.sadan.18@ucl.ac.uk; monika.chylova@lf1.cuni.cz; helena.jahnova@vfn.cz; nicole.anteneova@vfn.cz; marketa.tesarova@lf1.cuni.cz; tomas.honzik@vfn.cz; petra.liskova@lf1.cuni.cz
FU FLF [MR/S031820/1] Funding Source: UKRI
CR Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559
   CHANG TS, 1994, CORNEA, V13, P269, DOI 10.1097/00003226-199405000-00014
   Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018
   Dudakova L, 2019, EXP EYE RES, V182, P160, DOI 10.1016/j.exer.2019.03.002
   Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090
   Fautsch MP, 2021, PROG RETIN EYE RES, V81, P0, DOI 10.1016/j.preteyeres.2020.100883
   Finsterer J, 2016, CORNEA, V35, PE39, DOI 10.1097/ICO.0000000000001043
   Gilani F, 2013, J CATARACT REFR SURG, V39, P1707, DOI 10.1016/j.jcrs.2013.05.042
   Gonnermann J, 2014, CORNEA, V33, P1232, DOI 10.1097/ICO.0000000000000252
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kim J, 2016, CORNEA, V35, P1250, DOI 10.1097/ICO.0000000000000927
   Liskova P, 2018, AM J HUM GENET, V102, P447, DOI 10.1016/j.ajhg.2018.02.002
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Martin AR, 2019, NAT GENET, V51, P1560, DOI 10.1038/s41588-019-0528-2
   Ortiz Alvaro, 2017, INT J RETINA VITREOUS, V3, P24, DOI 10.1186/s40942-017-0077-8
   ROWLAND LP, 1983, NEUROLOGY, V33, P1179, DOI 10.1212/WNL.33.9.1179
   Wieben ED, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049083
   Zarouchlioti C, 2018, AM J HUM GENET, V102, P528, DOI 10.1016/j.ajhg.2018.02.010
NR 20
TC 0
Z9 0
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD DEC 15
PY 2021
VL 12
IS 12
BP 
EP 
DI 10.3390/genes12121918
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA YJ6VA
UT WOS:000744668600001
PM 34946867
DA 2024-11-01
ER

PT J
AU Deepha, S
   Govindaraj, P
   Sankaran, BP
   Chiplunkar, S
   Kashinkunti, C
   Nunia, V
   Nagappa, M
   Sinha, S
   Khanna, T
   Thangaraj, K
   Taly, AB
   Gayathri, N
AF Deepha, Sekar
   Govindaraj, Periyasamy
   Sankaran, Bindu Parayil
   Chiplunkar, Shwetha
   Kashinkunti, Chetan
   Nunia, Vandana
   Nagappa, Madhu
   Sinha, Sanjib
   Khanna, Tripti
   Thangaraj, Kumarasamy
   Taly, Arun B.
   Gayathri, Narayanappa
TI Clinico-pathological and Molecular Spectrum of Mitochondrial Polymerase γ Mutations in a Cohort from India
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article
DE POLG; Mitochondrial disease; CPEO; Mutations; mtDNA deletions
ID w748s mutation; dna; polg; disorders; pcr
AB Polymerase gamma catalytic subunit (POLG), a nuclear gene, encodes the enzyme responsible for mitochondrial DNA (mtDNA) replication. POLG mutations are a major cause of inherited mitochondrial diseases. They present with varied phenotypes, age of onset, and severity. Reports on POLG mutations from India are limited. Hence, this study aimed to describe the clinico-pathological and molecular observations of POLG mutations. A total of 446 patients with clinical diagnosis of mitochondrial disorders were sequenced for all exons and intron-exon boundaries of POLG. Of these, 19 (4.26%) patients (M:F: 10:9) had POLG mutations. The age of onset ranged from 5 to 55 years with an overlapping phenotypic spectrum. Ptosis, peripheral neuropathy, seizures, and ataxia were the common neurological features observed. The most common clinical phenotype was chronic progressive external ophthalmoplegia (CPEO) and CPEO plus (n = 14). Muscle biopsy showed characteristic features of mitochondrial myopathy in fourteen patients (14/19) and respiratory chain enzyme deficiency in eleven patients (11/19). Multiple mtDNA deletions were seen in 47.36% (9/19) patients. Eight pathogenic POLG variations including two novel variations (p.G132R and p.V1106A) were identified. The common pathogenic mutation identified was p.L304R, being present in eight patients (42.1%) predominantly in the younger age group followed by p.W748S in four patients (21%). To the best of our knowledge, this is the first extensive study from India, highlights the clinico-pathological and molecular spectrum of POLG mutations.
C1 [Deepha, Sekar; Govindaraj, Periyasamy; Gayathri, Narayanappa] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.
   [Deepha, Sekar; Govindaraj, Periyasamy; Sankaran, Bindu Parayil; Chiplunkar, Shwetha; Nagappa, Madhu; Taly, Arun B.; Gayathri, Narayanappa] Natl Inst Mental Hlth & Neurosci NIMHANS, Neurobiol Res Ctr NRC, Neuromuscular Lab, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy] Inst Bioinformat, Int Tech Pk, Bangalore, Karnataka, India.
   [Govindaraj, Periyasamy] Manipal Acad Higher Educ, Manipal, Karnataka, India.
   [Sankaran, Bindu Parayil; Kashinkunti, Chetan; Nagappa, Madhu; Sinha, Sanjib; Taly, Arun B.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
   [Sankaran, Bindu Parayil] Childrens Hosp Westmead, Genet Metab Disorders Serv, Sydney, NSW, Australia.
   [Chiplunkar, Shwetha] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Neurosci, Bangalore, Karnataka, India.
   [Nunia, Vandana; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, India.
   [Nunia, Vandana] Univ Rajasthan, Dept Zool, Radiat & Canc Biol Lab, Jaipur, Rajasthan, India.
   [Khanna, Tripti] Indian Council Med Res ICMR, New Delhi, India.
   [Thangaraj, Kumarasamy] Ctr DNA Fingerprinting & Diagnost, Hyderabad, India.
C3 National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Manipal Academy of Higher Education (MAHE); National Institute of Mental Health & Neurosciences - India; NSW Health; The Children's Hospital at Westmead; University of Sydney; National Institute of Mental Health & Neurosciences - India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Rajasthan; Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)
RP Gayathri, N (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.; Gayathri, N (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Neurobiol Res Ctr NRC, Neuromuscular Lab, Bangalore, Karnataka, India.
EM gayathri.narayanappa@gmail.com
FU Department of Biotechnology, Government of India [BT/PR7470/MED/14/1011/2006]; Indian Council of Medical Research [5/4-5/145/Neuro/2014-NCD-I]
CR Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   Blázquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Govindaraj P, 2011, MITOCHONDRION, V11, P504, DOI 10.1016/j.mito.2011.01.009
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358
   Kaliszewska M, 2015, HUM GENET, V134, P951, DOI 10.1007/s00439-015-1578-x
   Nagappa Madhu, 2015, MOV DISORD CLIN PRACT, V2, P318, DOI 10.1002/mdc3.12195
   Nurminen A, 2017, BBA CLIN, V7, P147, DOI 10.1016/j.bbacli.2017.04.001
   Paramasiyam A, 2019, MITOCHONDRION, V48, P78, DOI 10.1016/j.mito.2019.08.003
   Piekutowska-Abramczuk D, 2019, MITOCHONDRION, V47, P179, DOI 10.1016/j.mito.2018.11.004
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Thangaraj K, 2002, J ANDROL, V23, P815
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 28
TC 8
Z9 8
U1 0
U2 4
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD NOV 15
PY 2021
VL 71
IS 11
BP 2219
EP 2228
DI 10.1007/s12031-020-01765-8
EA JAN 2021
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA WV9NA
UT WOS:000608943400001
PM 33469851
DA 2024-11-01
ER

PT J
AU Yang, MG
   Xu, LS
   Xu, CM
   Cui, YY
   Jiang, S
   Dong, JJ
   Liao, L
AF Yang, Mengge
   Xu, Lusi
   Xu, Chunmei
   Cui, Yuying
   Jiang, Shan
   Dong, Jianjun
   Liao, Lin
TI The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE treatment; diagnosis; mitochondrial gene mutations; heteroplasmy; maternally inherited diabetes and deafness
ID transfer rna(leu(uur)) gene; mitochondrial-dna mutation; a3243g mutation; insulin-resistance; mellitus; midd; melas; heteroplasmy; polymorphism; dysfunction
AB Aims: To investigate the clinical features and mitochondrial mutations for maternally inherited diabetes and deafness. Methods: PubMed, Embase, Medline, Web of Science, the China National Knowledge Infrastructure, and Wanfang were searched with the following search terms: "Maternally inherited diabetes and deafness" OR "MIDD" OR "Mitochondrial diabetes". The mutations and clinical features were analyzed. Correlation between the heteroplasmy levels of the m.3243A>G mutation in the peripheral blood and age at the onset of diabetes was conducted by Spearman test. The significance level was set as p < 0.05. Statistical analysis was performed using the Statistical Package for the Social Sciences version 26 for Windows. Results: Totally 161 patients with 21 different mitochondrial mutations were enrolled. The most common mutation was the m.3243A>G mutation in 136 cases. Of 142 patients, 120 (84.51%) had family histories of diabetes or hearing loss. Hearing loss presented in 85.71% of the patients with mitochondrial mutations. Central nervous system diseases were found in 29.19%, myopathy in 22.98%, oculopathy in 23.60%, cardiac disease in 23.60%, and nephropathy in 13.66% of the patients. Forty-two of 101 (41.58%) patients were underweight. A significant negative correlation was found between the heteroplasmy levels of the m.3243A>G mutation in the peripheral blood and age at the onset of diabetes. Conclusions: The young onset of diabetes with low or normal BMI, maternal inheritance, and presence of impairments of multiple systems should prompt a genetic testing in order to differentiate MIDD from other types of diabetes earlier.
C1 [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong Univ, Dept Endocrinol & Metabol, Cheeloo Coll Med, Shandong Prov Qianfoshan Hosp,Shandong Key Lab Rh, Jinan, Peoples R China.
   [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong First Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metabol, Jinan, Peoples R China.
   [Yang, Mengge; Xu, Lusi; Xu, Chunmei; Liao, Lin] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China.
   [Cui, Yuying] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan, Peoples R China.
   [Jiang, Shan; Dong, Jianjun] Shandong Univ, Qilu Hosp, Dept Internal Med, Div Endocrinol, Jinan, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University of Traditional Chinese Medicine; Shandong University
RP Liao, L (corresponding author), Shandong Univ, Dept Endocrinol & Metabol, Cheeloo Coll Med, Shandong Prov Qianfoshan Hosp,Shandong Key Lab Rh, Jinan, Peoples R China.; Liao, L (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metabol, Jinan, Peoples R China.; Liao, L (corresponding author), Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China.; Dong, JJ (corresponding author), Shandong Univ, Qilu Hosp, Dept Internal Med, Div Endocrinol, Jinan, Peoples R China.
EM dongjianjun@sdu.edu.cn; liaolin@sdu.edu.cn
FU National Natural Science Foundation of China [81770822]
CR Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970
   Cao XY, 2013, INDIAN J PATHOL MICR, V56, P272, DOI 10.4103/0377-4929.120392
   Chatzispyrou IA, 2015, CANCER RES, V75, P4446, DOI 10.1158/0008-5472.CAN-15-1626
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   DIMARIO U, 1990, ACTA ENDOCRINOL-COP, V122, P303, DOI 10.1530/acta.0.1220303
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Finsterer Josef, 2018, OMAN MED J, V33, P437, DOI 10.5001/omj.2018.80
   Fragaki K, 2016, BIOL RES, V49, P0, DOI 10.1186/s40659-015-0065-0
   Fukao T, 2009, MOL MED REP, V2, P69, DOI 10.3892/mmr_00000063
   Gebhart SSP, 1996, METABOLISM, V45, P526, DOI 10.1016/S0026-0495(96)90231-0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Greenfield A, 2018, NAT BIOTECHNOL, V36, P196, DOI 10.1038/nbt0218-196b
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Henzen C, 2012, SWISS MED WKLY, V142, P0, DOI 10.4414/smw.2012.13690
   Hoptasz M, 2014, NEUROL NEUROCHIR POL, V48, P150, DOI 10.1016/j.pjnns.2013.12.007
   Hu L, 2006, J MODERN LAB MED, V02, P15, DOI 10.3969/j.issn.1671-7414.2006.02.005
   Kim NH, 2021, ANN INTERN MED, V174, P124, DOI 10.7326/L20-0292
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Leiter LM, 1999, J CELL PHYSIOL, V180, P334, DOI 10.1002/(SICI)1097-4652(199909)180:3<334::AID-JCP4>3.0.CO;2-Q
   Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   Liou CW, 2001, DIABETES RES CLIN PR, V54, PS39, DOI 10.1016/S0168-8227(01)00334-5
   Maassen JA, 2002, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913
   Moyle Graeme, 2004, J HIV THER, V9, P45
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Oexle K, 1996, EXP CLIN ENDOCR DIAB, V104, P212, DOI 10.1055/s-0029-1211445
   Okuyama H, 2015, EXPERT REV CLIN PHAR, V8, P189, DOI 10.1586/17512433.2015.1011125
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rong Y, 2011, THESIS HEBEI MED U, V0, P0
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Schleiffer T, 2000, EXP CLIN ENDOCR DIAB, V108, P81, DOI 10.1055/s-2000-5800
   Shin CS, 1998, ENDOCR J, V45, P105, DOI 10.1507/endocrj.45.105
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tanaka K, 2000, INTERNAL MED, V39, P249, DOI 10.2169/internalmedicine.39.249
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   van Essen EHR, 2000, DIABETIC MED, V17, P841, DOI 10.1046/j.1464-5491.2000.00379.x
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Xiu L, 1997, NATL MED J CHINA, V06, P111, DOI 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2002.0036
   Yu P, 2003, CHINESE J MED GENET, V03, P63
   Yu Z, 2020, INT J ENDOCRINOL MET, V40, P279
NR 52
TC 23
Z9 26
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
EI 
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD NOV 25
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fendo.2021.728043
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 6A3ZU
UT WOS:000880597300001
PM 34899594
DA 2024-11-01
ER

PT J
AU Gramegna, LL
   Evangelisti, S
   Di Vito, L
   La Morgia, C
   Maresca, A
   Caporali, L
   Amore, G
   Talozzi, L
   Bianchini, C
   Testa, C
   Manners, DN
   Cortesi, I
   Valentino, ML
   Liguori, R
   Carelli, V
   Tonon, C
   Lodi, R
AF Gramegna, Laura L.
   Evangelisti, Stefania
   Di Vito, Lidia
   La Morgia, Chiara
   Maresca, Alessandra
   Caporali, Leonardo
   Amore, Giulia
   Talozzi, Lia
   Bianchini, Claudio
   Testa, Claudia
   Manners, David N.
   Cortesi, Irene
   Valentino, Maria L.
   Liguori, Rocco
   Carelli, Valerio
   Tonon, Caterina
   Lodi, Raffaele
TI Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID stroke-like episodes; lactic-acidosis; m.3243a-greater-than-g mutation; matter; disease; encephalomyopathy; spectroscopy; encephalopathy; pathogenesis; diagnosis
AB Objective: The purpose of this study was to investigate correlations between brain proton magnetic resonance spectroscopy (H-1-MRS) findings with serum biomarkers and heteroplasmy of mitochondrial DNA (mtDNA) mutations. This study enrolled patients carrying mtDNA mutations associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS), and MELAS-Spectrum Syndrome (MSS). Methods: Consecutive patients carrying mtDNA mutations associated with MELAS and MSS were recruited and their serum concentrations of lactate, alanine, and heteroplasmic mtDNA mutant load were evaluated. The brain protocol included single-voxel H-1-MRS (1.5T) in the medial parieto-occipital cortex (MPOC), left cerebellar hemisphere, parieto-occipital white matter (POWM), and lateral ventricles. Relative metabolite concentrations of N-acetyl-aspartate (NAA), choline (Cho), and myo-inositol (mI) were estimated relative to creatine (Cr), using LCModel 6.3. Results: Six patients with MELAS (age 28 +/- 13 years, 3 [50%] female) and 17 with MSS (age 45 +/- 11 years, 7 [41%] female) and 39 sex- and age-matched healthy controls (HC) were enrolled. These patients demonstrated a lower NAA/Cr ratio in MPOC compared to HC (p = 0.006), which inversely correlated with serum lactate (p = 0.021, rho = -0.68) and muscle mtDNA heteroplasmy (p < 0.001, rho = -0.80). Similarly, in the cerebellum patients had lower NAA/Cr (p < 0.001), Cho/Cr (p = 0.002), and NAA/mI (p = 0.001) ratios, which negatively correlated with mtDNA blood heteroplasmy (p = 0.001, rho = -0.81) and with alanine (p = 0.050, rho = -0.67). Ventricular lactate was present in 78.3% (18/23) of patients, correlating with serum lactate (p = 0.024, rho = 0.58). Conclusion: Correlations were found between the peripheral and biochemical markers of mitochondrial dysfunction and brain in vivo markers of neurodegeneration, supporting the use of both biomarkers as signatures of MELAS and MSS disease, to evaluate the efficacy of potential treatments.
C1 [Gramegna, Laura L.; Tonon, Caterina; Lodi, Raffaele] IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
   [Gramegna, Laura L.; Evangelisti, Stefania; Amore, Giulia; Talozzi, Lia; Bianchini, Claudio; Manners, David N.; Cortesi, Irene; Valentino, Maria L.; Liguori, Rocco; Carelli, Valerio; Tonon, Caterina; Lodi, Raffaele] Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy.
   [Di Vito, Lidia; La Morgia, Chiara; Maresca, Alessandra; Caporali, Leonardo; Valentino, Maria L.; Liguori, Rocco; Carelli, Valerio] IRCCS Ist Sci Neurol Bologna, UOC Clin Neurol, Bologna, Italy.
   [Testa, Claudia] Univ Bologna, Dept Phys & Astron, Bologna, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna
RP Tonon, C (corresponding author), IRCCS Ist Sci Neurol Bologna, Funct & Mol Neuroimaging Unit, Via Altura 3, I-40139 Bologna, Italy.
EM caterina.tonon@unibo.it
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gramegna LL, 2018, AM J NEURORADIOL, V39, P427, DOI 10.3174/ajnr.A5507
   Gramegna LL, 2018, NEUROMUSCULAR DISORD, V28, P144, DOI 10.1016/j.nmd.2017.10.007
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Harper L, 2015, J NEUROL NEUROSUR PS, V86, P1225, DOI 10.1136/jnnp-2014-310090
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hovsepian DA, 2019, ACTA NEUROL SCAND, V139, P82, DOI 10.1111/ane.13027
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505
   Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554
   Li XD, 2018, J CLIN NEUROSCI, V55, P65, DOI 10.1016/j.jocn.2018.06.015
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Modrego PJ, 2006, CNS DRUGS, V20, P867, DOI 10.2165/00023210-200620100-00006
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Öz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531
   Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604
   Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244
   Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318
   Whitehead MT, 2017, PEDIATR NEUROL, V75, P61, DOI 10.1016/j.pediatrneurol.2017.06.017
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
NR 46
TC 9
Z9 9
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN 15
PY 2021
VL 8
IS 6
BP 1200
EP 1211
DI 10.1002/acn3.51329
EA MAY 2021
PG 12
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA SK1MK
UT WOS:000647180900001
PM 33951347
DA 2024-11-01
ER

PT J
AU Jeppesen, TD
   Madsen, KL
   Poulsen, NS
   Lokken, N
   Vissing, J
AF Jeppesen, Tina D.
   Madsen, Karen L.
   Poulsen, Nanna S.
   Lokken, Nicoline
   Vissing, John
TI Exercise Testing, Physical Training and Fatigue in Patients with Mitochondrial Myopathy Related to mtDNA Mutations
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE mitochondrial myopathy; mtDNA mutation; exercise testing; fatigue
AB Mutations in mitochondrial DNA (mtDNA) cause disruption of the oxidative phosphorylation chain and impair energy production in cells throughout the human body. Primary mitochondrial disorders due to mtDNA mutations can present with symptoms from adult-onset mono-organ affection to death in infancy due to multi-organ involvement. The heterogeneous phenotypes that patients with a mutation of mtDNA can present with are thought, at least to some extent, to be a result of differences in mtDNA mutation load among patients and even among tissues in the individual. The most common symptom in patients with mitochondrial myopathy (MM) is exercise intolerance. Since mitochondrial function can be assessed directly in skeletal muscle, exercise studies can be used to elucidate the physiological consequences of defective mitochondria due to mtDNA mutations. Moreover, exercise tests have been developed for diagnostic purposes for mitochondrial myopathy. In this review, we present the rationale for exercise testing of patients with MM due to mutations in mtDNA, evaluate the diagnostic yield of exercise tests for MM and touch upon how exercise tests can be used as tools for follow-up to assess disease course or effects of treatment interventions.
C1 [Jeppesen, Tina D.; Madsen, Karen L.; Poulsen, Nanna S.; Lokken, Nicoline; Vissing, John] Univ Hosp Copenhagen, Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, DK-2100 Copenhagen, Denmark.
C3 Rigshospitalet; University of Copenhagen
RP Jeppesen, TD (corresponding author), Univ Hosp Copenhagen, Rigshosp, Dept Neurol, Copenhagen Neuromuscular Ctr, DK-2100 Copenhagen, Denmark.
EM tina.dysgaard.jeppesen.03@regionh.dk; karen.lindhardt.madsen@regionh.dk; nanna.scharff.nielsen.01@regionh.dk; nicoline.loekken@regionh.dk; john.vissing@regionh.dk
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794
   [Anonymous], 2010, TRANSLATIONAL PAIN R, V0, P0
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   ASTRAND PO, 1976, PROG CARDIOVASC DIS, V19, P51, DOI 10.1016/0033-0620(76)90008-6
   Axelson HW, 2002, MUSCLE NERVE, V26, P520, DOI 10.1002/mus.10249
   Bank William, 1998, BIOFACTORS, V7, P243
   Barcia G, 2020, NEUROMUSCULAR DISORD, V30, P593, DOI 10.1016/j.nmd.2020.06.002
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012
   BERGLUND B, 1991, J INTERN MED, V229, P125, DOI 10.1111/j.1365-2796.1991.tb00319.x
   BOGAARD JM, 1985, ADV EXP MED BIOL, V191, P409
   Boone J, 2014, RESP PHYSIOL NEUROBI, V190, P70, DOI 10.1016/j.resp.2013.09.007
   Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006
   Bravo DM, 2012, EUR J APPL PHYSIOL, V112, P1763, DOI 10.1007/s00421-011-2136-4
   BROOKE MH, 1979, NEUROLOGY, V29, P636, DOI 10.1212/WNL.29.5.636
   Bruce RM, 2019, EXP PHYSIOL, V104, P1605, DOI 10.1113/EP087649
   Burnstock G, 1999, J ANAT, V194, P335, DOI 10.1046/j.1469-7580.1999.19430335.x
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Celie BM, 2015, APPL SPECTROSC, V69, P342, DOI 10.1366/14-07604
   Chan A, 1998, J NEUROL, V245, P681, DOI 10.1007/s004150050267
   Charlton Gerald A, 1997, CARDIOLOGY CLINICS, V15, P345, DOI 10.1016/S0733-8651(05)70344-1
   Chelimsky TC, 1997, ADV EXP MED BIOL, V411, P445
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   CONSOLI A, 1990, AM J PHYSIOL, V259, PE677, DOI 10.1152/ajpendo.1990.259.5.E677
   DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182
   DAVIS HA, 1983, EUR J APPL PHYSIOL, V50, P383, DOI 10.1007/BF00423244
   DAVIS JA, 1982, MED SCI SPORT EXER, V14, P339
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Delaney NF, 2017, P NATL ACAD SCI USA, V114, P8402, DOI 10.1073/pnas.1703338114
   DEMPSEY JA, 1985, FED PROC, V44, P2260
   Dengler R, 1996, MUSCLE NERVE, V19, P456, DOI 10.1002/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B
   di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   ELLIOT DL, 1989, MEDICINE, V68, P163, DOI 10.1097/00005792-198905000-00004
   Ellsworth ML, 2000, ACTA PHYSIOL SCAND, V168, P551, DOI 10.1046/j.1365-201x.2000.00708.x
   Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001
   Finsterer J, 2004, EUR J NEUROL, V11, P811, DOI 10.1111/j.1468-1331.2004.00859.x
   Finsterer J, 1998, J NEUROL SCI, V159, P176, DOI 10.1016/S0022-510X(98)00170-1
   Finsterer J, 2003, METAB BRAIN DIS, V18, P155, DOI 10.1023/A:1023867104002
   Finsterer J, 2001, J NEUROSCI METH, V108, P65, DOI 10.1016/S0165-0270(01)00371-5
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   Forster H V, 1988, ADV EXP MED BIOL, V227, P257
   FORSTER HV, 1994, MED SCI SPORT EXER, V26, P328
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Galán F, 2015, J INVEST MED HIGH IM, V3, P0, DOI 10.1177/2324709615607908
   Giannoni A, 2017, EUR J HEART FAIL, V19, P1701, DOI 10.1002/ejhf.782
   Gimenes AC, 2011, BRAZ J MED BIOL RES, V44, P354, DOI 10.1590/S0100-879X2011007500023
   GOLDSTEIN I, 1975, J APPL PHYSIOL, V39, P697, DOI 10.1152/jappl.1975.39.5.697
   González-Alonso J, 2006, J PHYSIOL-LONDON, V572, P295, DOI 10.1113/jphysiol.2005.101121
   González-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2
   GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Grassi B, 2019, MED SCI SPORT EXER, V51, P2183, DOI 10.1249/MSS.0000000000002056
   GREGG SG, 1989, J APPL PHYSIOL, V67, P756, DOI 10.1152/jappl.1989.67.2.756
   Haller R G, 1978, TRANS AM NEUROL ASSOC, V103, P6
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395
   HALLER RG, 1984, MED SCI SPORT EXER, V16, P456, DOI 10.1249/00005768-198410000-00006
   HALLER RG, 1985, ANN NEUROL, V17, P196, DOI 10.1002/ana.410170216
   Hammarén E, 2004, EUR NEUROL, V51, P38, DOI 10.1159/000074981
   Hanisch F, 2006, J NEUROL, V253, P417, DOI 10.1007/s00415-006-0987-0
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, PR873, DOI 10.1152/ajpregu.00001.2011
   HOOPER RG, 1995, CHEST, V107, P317, DOI 10.1378/chest.107.2.317
   Hoppeler H, 1998, J EXP BIOL, V201, P1051
   Hunter SK, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a029728
   Ichiwata T, 2010, ADV EXP MED BIOL, V662, P537, DOI 10.1007/978-1-4419-1241-1_78
   Jensen TD, 2002, NEUROLOGY, V58, P1533, DOI 10.1212/WNL.58.10.1533
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Jeppesen TD, 2012, MITOCHONDRION, V12, P414, DOI 10.1016/j.mito.2011.11.003
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jeppesen TD, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-006-0229-5
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Jeppesen TD, 2009, ARCH NEUROL-CHICAGO, V66, P365, DOI 10.1001/archneurol.2009.24
   Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7
   Johnson BD, 1996, MED SCI SPORT EXER, V28, P1129, DOI 10.1097/00005768-199609000-00008
   Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001
   KEMP GJ, 1994, MAGN RESON QUART, V10, P43
   Kim JK, 2007, AM J PHYSIOL-HEART C, V292, PH866, DOI 10.1152/ajpheart.00771.2006
   Kindig AE, 2007, AM J PHYSIOL-HEART C, V293, PH2995, DOI 10.1152/ajpheart.00743.2007
   Kindig AE, 2007, J PHYSIOL-LONDON, V578, P301, DOI 10.1113/jphysiol.2006.119271
   Kleinert M, 2018, MOL METAB, V9, P187, DOI 10.1016/j.molmet.2017.12.016
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Koo P, 2018, CLIN CHEST MED, V39, P401, DOI 10.1016/j.ccm.2018.02.001
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Levine BD, 1997, J APPL PHYSIOL, V83, P102, DOI 10.1152/jappl.1997.83.1.102
   LEWIS SF, 1986, J APPL PHYSIOL, V61, P391, DOI 10.1152/jappl.1986.61.2.391
   LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153
   Lindholm H, 2004, CLIN PHYSIOL FUNCT I, V24, P109, DOI 10.1111/j.1475-097X.2004.00531.x
   LINDINGER MI, 1995, J APPL PHYSIOL, V78, P765, DOI 10.1152/jappl.1995.78.3.765
   Little JP, 2011, AM J PHYSIOL-REG I, V300, PR1303, DOI 10.1152/ajpregu.00538.2010
   Löfberg M, 2001, NEUROMUSCULAR DISORD, V11, P370, DOI 10.1016/S0960-8966(00)00205-4
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   MANCIA G, 1983, CLIN SCI, V65, P227, DOI 10.1042/cs0650227
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   MARTIN BJ, 1979, J APPL PHYSIOL, V46, P322, DOI 10.1152/jappl.1979.46.2.322
   MCARDLE B, 1951, CLIN SCI, V10, P12
   McCoy J, 2017, OPEN HEART, V4, P0, DOI 10.1136/openhrt-2017-000632
   MITCHELL JH, 1958, J CLIN INVEST, V37, P538, DOI 10.1172/JCI103636
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Moosmann P, 2000, J ROY SOC MED, V93, P25, DOI 10.1177/014107680009300108
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Nabben M, 2017, AM J PHYSIOL-REG I, V312, PR689, DOI 10.1152/ajpregu.00264.2016
   Nakagawa E, 1996, BRAIN DEV-JPN, V18, P68, DOI 10.1016/0387-7604(95)00096-8
   NASHEF L, 1989, J NEUROL NEUROSUR PS, V52, P1090, DOI 10.1136/jnnp.52.9.1090
   Newman Jane, 2015, J NEUROMUSCUL DIS, V2, P151
   Ng K, 2010, J NEUROL NEUROSUR PS, V81, P844, DOI 10.1136/jnnp.2009.178921
   PARATI G, 1983, EUR HEART J, V4, P19, DOI 10.1093/eurheartj/4.suppl_D.19
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Park Jane, 1998, BIOFACTORS, V7, P253
   PATERSON DJ, 1992, J APPL PHYSIOL, V72, P811, DOI 10.1152/jappl.1992.72.3.811
   Piepoli M, 1996, CIRCULATION, V93, P940, DOI 10.1161/01.CIR.93.5.940
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   POTTS JT, 1993, AM J PHYSIOL, V265, PH1928, DOI 10.1152/ajpheart.1993.265.6.H1928
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   Radda George K, 1998, BIOFACTORS, V7, P247
   Rasmussen UF, 2001, AM J PHYSIOL-ENDOC M, V280, PE301, DOI 10.1152/ajpendo.2001.280.2.E301
   Reinöhl J, 2003, NEUROSCI LETT, V338, P25, DOI 10.1016/S0304-3940(02)01360-5
   Rodan LH, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0127066
   Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007
   Saltin B, 1993, AM J CLIN NUTR, V57, P752S, DOI 10.1093/ajcn/57.5.752S
   SALTIN B, 1992, MED SCI SPORT EXER, V24, P30
   Saltin B, 2007, J PHYSIOL-LONDON, V583, P819, DOI 10.1113/jphysiol.2007.136309
   SCARLATO G, 1991, REV NEUROL, V147, P542
   Sheel AW, 2011, CURR OPIN PHARMACOL, V11, P195, DOI 10.1016/j.coph.2011.04.004
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 1996, MUSCLE NERVE, V19, P342
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 1999, NEUROMUSCULAR DISORD, V9, P411, DOI 10.1016/S0960-8966(99)00047-4
   Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, PS172, DOI 10.1016/j.nmd.2012.10.005
   Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008
   Steensberg A, 2001, EUR J APPL PHYSIOL, V84, P155, DOI 10.1007/s004210000351
   Stefanetti Renae J, 2020, WELLCOME OPEN RES, V5, P84, DOI 10.12688/wellcomeopenres.15825.1
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky M, 2004, MITOCHONDRION, V4, P529, DOI 10.1016/j.mito.2004.07.011
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Trenell MI, 2007, EUR J APPL PHYSIOL, V99, P541, DOI 10.1007/s00421-006-0372-9
   Uchida K, 2011, J MED ULTRASON, V38, P157, DOI 10.1007/s10396-011-0306-y
   van Beekvelt MCP, 1999, ANN NEUROL, V46, P667, DOI 10.1002/1531-8249(199910)46:4<667::AID-ANA19>3.0.CO;2-D
   van Hall G, 2003, AM J PHYSIOL-ENDOC M, V284, PE193, DOI 10.1152/ajpendo.00273.2002
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Volpi L, 2011, MUSCULOSKELET SURG, V95, P59, DOI 10.1007/s12306-011-0096-9
   Wang HJ, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00398
   WARD SA, 1994, CAN J APPL PHYSIOL, V19, P305, DOI 10.1139/h94-026
   WEBER KT, 1985, J AM COLL CARDIOL, V6, P717, DOI 10.1016/S0735-1097(85)80472-1
   Whitfield KC, 2018, ANN NY ACAD SCI, V1430, P3, DOI 10.1111/nyas.13919
   Xu S, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000008716
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443
NR 159
TC 5
Z9 5
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD APR 15
PY 2021
VL 10
IS 8
BP 
EP 
DI 10.3390/jcm10081796
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA RT4ZI
UT WOS:000644468900001
PM 33924201
DA 2024-11-01
ER

PT J
AU Gayathri, N
   Deepha, S
   Sharma, S
AF Gayathri, Narayanappa
   Deepha, Sekar
   Sharma, Shivani
TI Diagnosis of primary mitochondrial disorders -Emphasis on myopathological aspects
SO MITOCHONDRION
LA English
DT Article
DE COX deficiency; Mitochondrial disorder; Muscle biopsy; OXPHOS; Ragged red fibers; Respiratory chain defect
ID cytochrome-c-oxidase; progressive external ophthalmoplegia; genetically characterized patients; ataxia-neuropathy spectrum; deficient muscle-fibers; inclusion-body myositis; ragged-red fibers; skeletal-muscle; respiratory-chain; dna deletions
AB Mitochondrial disorders are one of the most common neurometabolic disorders affecting all age groups. The phenotype-genotype heterogeneity in these disorders can be attributed to the dual genetic control on mitochondrial functions, posing a challenge for diagnosis. Though the advancement in the high-throughput sequencing and other omics platforms resulted in a "genetics-first" approach, the muscle biopsy remains the benchmark in most of the mitochondrial disorders. This review focuses on the myopathological aspects of primary mitochondrial disorders. The utility of muscle biopsy is not limited to analyse the structural abnormalities; rather it also proves to be a potential tool to understand the deranged sub-cellular functions.
C1 [Gayathri, Narayanappa; Deepha, Sekar; Sharma, Shivani] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore 560029, Karnataka, India.
C3 National Institute of Mental Health & Neurosciences - India
RP Gayathri, N (corresponding author), NIMHANS, Neuromuscular Lab, Neurobiol Res Ctr, Dept Neuropathol, Bangalore, Karnataka, India.
EM gayathri.narayanappa@gmail.com
CR Alfadhel M, 2011, AM J MED GENET A, V155A, P840, DOI 10.1002/ajmg.a.33881
   Alhatou MI, 2004, J MOL HISTOL, V35, P615
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDREETTA F, 1991, J NEUROL SCI, V105, P88, DOI 10.1016/0022-510X(91)90123-O
   Anteneová N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Bindu PS, 2018, MULT SCLER RELAT DIS, V20, P84, DOI 10.1016/j.msard.2018.01.003
   Bindu PS, 2016, MITOCHONDRION, V27, P1, DOI 10.1016/j.mito.2015.12.009
   Bindu PS, 2015, MITOCHONDRION, V25, P6, DOI 10.1016/j.mito.2015.08.002
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Cameron JM, 2004, AM J MED GENET A, V131A, P59, DOI 10.1002/ajmg.a.30287
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2003, J NEUROL SCI, V211, P63, DOI 10.1016/S0022-510X(03)00039-X
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   Chow SL, 2005, ARCH DIS CHILD, V90, P1188, DOI 10.1136/adc.2005.075317
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   Debashree B, 2018, J NEUROCHEM, V145, P323, DOI 10.1111/jnc.14318
   Deepha S, 2021, J MOL NEUROSCI, V71, P2219, DOI 10.1007/s12031-020-01765-8
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   DEVIVO DC, 1993, BRAIN DEV-JPN, V15, P1, DOI 10.1016/0387-7604(93)90002-P
   Parada-Garza JD, 2020, NEUROMUSCULAR DISORD, V30, P590, DOI 10.1016/j.nmd.2020.04.008
   DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DIMAURO S, 1990, NEUROL CLIN, V8, P483, DOI 10.1016/S0733-8619(18)30332-3
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Dubowitz V, 2013, MUCSLE BIOPSY PRACTI, V4th, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Finsterer J, 2019, J NEUROL SCI, V404, P29, DOI 10.1016/j.jns.2019.07.013
   Finsterer J, 2018, NEURORADIOL J, V31, P596, DOI 10.1177/1971400918786054
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gayathri N, 2000, CLIN NEUROPATHOL, V19, P13
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069
   Ghosh S, 2015, MITOCHONDRION, V25, P60, DOI 10.1016/j.mito.2015.09.003
   Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1
   Gonçalves FG, 2020, RADIOGRAPHICS, V40, P2042, DOI 10.1148/rg.2020200052
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   HAMMERSEN F, 1980, ACTA NEUROPATHOL, V49, P35, DOI 10.1007/BF00692217
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   HASEGAWA H, 1993, ACTA NEUROPATHOL, V85, P280
   Hasin Y, 2017, GENOME BIOL, V18, P0, DOI 10.1186/s13059-017-1215-1
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Henao AI, 2016, NEURORADIOL J, V29, P46, DOI 10.1177/1971400915621324
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005
   HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358
   Hu SY, 2019, J ZHEJIANG UNIV-SC B, V20, P449, DOI 10.1631/jzus.B1900196
   Huddar A, 2021, MITOCHONDRION, V60, P170, DOI 10.1016/j.mito.2021.08.011
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kyriacou K, 1999, ULTRASTRUCT PATHOL, V23, P163
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Lu JQ, 2021, MITOCHONDRION, V56, P52, DOI 10.1016/j.mito.2020.11.005
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Machado PM, 2014, CURR OPIN NEUROL, V27, P591, DOI 10.1097/WCO.0000000000000129
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Mastaglia FL, 2012, CURR NEUROL NEUROSCI, V12, P54, DOI 10.1007/s11910-011-0232-9
   MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   McAfee JL, 2017, ANN DIAGN PATHOL, V29, P41, DOI 10.1016/j.anndiagpath.2017.02.010
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   MINKLER PE, 1993, ANAL BIOCHEM, V212, P510, DOI 10.1006/abio.1993.1361
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morava E, 2009, MITOCHONDRION, V9, P438, DOI 10.1016/j.mito.2009.08.003
   Müller T, 2005, ACTA NEUROPATHOL, V110, P426, DOI 10.1007/s00401-005-1063-z
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   Nascimento A, 2016, SEMIN PEDIATR NEUROL, V23, P290, DOI 10.1016/j.spen.2016.11.004
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Phadke R, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6070064
   Pourmand R, 2000, NEUROL CLIN, V18, P1, DOI 10.1016/S0733-8619(05)70176-6
   Quinzii CM, 2007, NEUROCHEM RES, V32, P723, DOI 10.1007/s11064-006-9190-z
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sacconi S, 2006, NEUROLOGY, V67, P1464, DOI 10.1212/01.wnl.0000240071.62540.6f
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sathe G, 2021, MITOCHONDRION, V58, P64, DOI 10.1016/j.mito.2021.02.011
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Siciliano G, 2007, BIOSCIENCE REP, V27, P53, DOI 10.1007/s10540-007-9037-0
   Siegmund SE, 2018, ISCIENCE, V6, P83, DOI 10.1016/j.isci.2018.07.014
   Simard ML, 2018, J PATHOL, V245, P311, DOI 10.1002/path.5084
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Sonam K, 2015, NEUROPEDIATRICS, V46, P277, DOI 10.1055/s-0035-1550149
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Tanji K, 2007, METHOD CELL BIOL, V80, P135, DOI 10.1016/S0091-679X(06)80006-3
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Teraoka M, 1999, HUM GENET, V105, P560, DOI 10.1007/s004390051145
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   van Adel Brian A, 2009, J CLIN NEUROMUSCUL DIS, V10, P97, DOI 10.1097/CND.0b013e3181903126
   Varhaug KN, 2021, BRAIN COMMUN, V3, P0, DOI 10.1093/braincomms/fcaa222
   Vincent AE, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30610
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Vladutiu GD, 2000, ARCH PATHOL LAB MED, V124, P1755
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   Weber K, 1997, AM J HUM GENET, V60, P373
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00031
   YAMAMOTO M, 1988, ACTA NEUROPATHOL, V76, P558, DOI 10.1007/BF00689593
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 153
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2021
VL 61
IS 
BP 69
EP 84
DI 10.1016/j.mito.2021.09.007
EA OCT 2021
PG 16
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA WK9EG
UT WOS:000710021500001
PM 34592422
DA 2024-11-01
ER

PT J
AU Peron, C
   Mauceri, R
   Iannielli, A
   Cavaliere, A
   Legati, A
   Rizzo, A
   Sciacca, FL
   Broccoli, V
   Tiranti, V
AF Peron, Camille
   Mauceri, Roberta
   Iannielli, Angelo
   Cavaliere, Andrea
   Legati, Andrea
   Rizzo, Ambra
   Sciacca, Francesca L.
   Broccoli, Vania
   Tiranti, Valeria
TI Generation of two human iPSC lines, FINCBi002-A and FINCBi003-A, carrying heteroplasmic macrodeletion of mitochondrial DNA causing Pearson's syndrome
SO STEM CELL RESEARCH
LA English
DT Article
AB Pearson marrow pancreas syndrome (PMPS) is a sporadic mitochondrial disease, resulting from the clonal expansion of a mutated mitochondrial DNA (mtDNA) molecule bearing a macro-deletion, and therefore missing essential genetic information. PMPS is characterized by the presence of deleted (A) mtDNA that co-exist with the presence of a variable amount of wild-type mtDNA, a condition termed hetemplasmy. All tissues of the affected individual, including the haemopoietic system and the post-mitotic, highly specialized tissues (brain, skeletal muscle, and heart) contain the large-scale mtDNA deletion in variable amount. We generated human induced pluripotent stem cells (hiPSCs) from two PMPS patients, carrying different type of large-scale deletion.
C1 [Peron, Camille; Mauceri, Roberta; Cavaliere, Andrea; Legati, Andrea; Tiranti, Valeria] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Iannielli, Angelo; Broccoli, Vania] Ist Sci San Raffaele, Milan, Italy.
   [Iannielli, Angelo; Broccoli, Vania] Natl Res Council CNR, Inst Neurosci, Milan, Italy.
   [Rizzo, Ambra; Sciacca, Francesca L.] Fdn IRCCS Ist Neurol Carlo Besta, Lab Clin Invest, Milan, Italy.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Tiranti, V (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
EM valeria.tiranti@istituto-besta.it
FU Associazione Luigi Comini ONLUS -Italy; "Cell line and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks [GTB18001]; Mariani Foundation
CR [Anonymous], 2012, ECA NEWSL, V0, P0
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Mascarello JT, 2011, GENET MED, V13, P667, DOI 10.1097/GIM.0b013e3182227295
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
NR 5
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD JAN 15
PY 2021
VL 50
IS 
BP 
EP 
DI 10.1016/j.scr.2020.102151
EA JAN 2021
PG 5
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA QB6OT
UT WOS:000614260000038
PM 33434818
DA 2024-11-01
ER

PT J
AU Alston, CL
   Stenton, SL
   Hudson, G
   Prokisch, H
   Taylor, RW
AF Alston, Charlotte L.
   Stenton, Sarah L.
   Hudson, Gavin
   Prokisch, Holger
   Taylor, Robert W.
TI The genetics of mitochondrial disease: dissecting mitochondrial pathology using multi-omic pipelines
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE mitochondrial pathology; genetic diagnosis; genomics; proteomics; metabolomics; mitochondrial disease
ID recurrent de-novo; acyl-coa dehydrogenase; complex i deficiency; biallelic mutations; leigh-syndrome; variants; protein; disorders; dna; identification
AB Mitochondria play essential roles in numerous metabolic pathways including the synthesis of adenosine triphosphate through oxidative phosphorylation. Clinically, mitochondrial diseases occur when there is mitochondrial dysfunction - manifesting at any age and affecting any organ system; tissues with high energy requirements, such as muscle and the brain, are often affected. The clinical heterogeneity is parallel to the degree of genetic heterogeneity associated with mitochondrial dysfunction. Around 10% of human genes are predicted to have a mitochondrial function, and defects in over 300 genes are reported to cause mitochondrial disease. Some involve the mitochondrial genome (mtDNA), but the vast majority occur within the nuclear genome. Except for a few specific genetic defects, there remains no cure for mitochondrial diseases, which means that a genetic diagnosis is imperative for genetic counselling and the provision of reproductive options for at-risk families. Next-generation sequencing strategies, particularly exome and whole-genome sequencing, have revolutionised mitochondrial diagnostics such that the traditional muscle biopsy has largely been replaced with a minimally-invasive blood sample for an unbiased approach to genetic diagnosis. Where these genomic approaches have not identified a causative defect, or where there is insufficient support for pathogenicity, additional functional investigations are required. The application of supplementary 'omics' technologies, including transcriptomics, proteomics, and metabolomics, has the potential to greatly improve diagnostic strategies. This review aims to demonstrate that whilst a molecular diagnosis can be achieved for many cases through next-generation sequencing of blood DNA, the use of patient tissues and an integrated, multidisciplinary multi-omics approach is pivotal for the diagnosis of more challenging cases. Moreover, the analysis of clinically relevant tissues from affected individuals remains crucial for understanding the molecular mechanisms underlying mitochondrial pathology. (c) 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.
C1 [Alston, Charlotte L.; Taylor, Robert W.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alston, Charlotte L.; Taylor, Robert W.] Newcastle upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [Stenton, Sarah L.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Stenton, Sarah L.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Hudson, Gavin] Newcastle Univ, Fac Med Sci, Biosci Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Newcastle University - UK
RP Alston, CL (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM charlotte.alston@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; German Bundesministerium fur Bildung und Forschung (BMBF) through the German network for mitochondrial disorders (mitoNET) [01GM1906D]; German BMBF; Horizon2020 through the E-Rare project GENOMIT [01GM1920A]; Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease, Newcastle University Centre for Ageing and Vitality; Biotechnology and Biological Sciences Research Council and Medical Research Council [G016354/1]; MRC/ESPRC Newcastle Molecular Pathology Node; UK National Health Service Highly Specialised Service for Rare Mitochondrial Disorders; Lily Foundation; NIHR Newcastle Biomedical Research Centre (BRC) - National Institute for Health Research (NIHR); National Institute for Health Research (NIHR) [PDF-2018-11-ST2-021]; National Institutes of Health Research (NIHR) [PDF-2018-11-ST2-021] Funding Source: National Institutes of Health Research (NIHR)
CR Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   Aicher JK, 2020, GENET MED, V22, P1181, DOI 10.1038/s41436-020-0780-y
   Alahmad A, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.202012619
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112
   Borna NN, 2019, NEUROGENETICS, V20, P9, DOI 10.1007/s10048-018-0561-9
   Bourchany A, 2017, EUR J MED GENET, V60, P595, DOI 10.1016/j.ejmg.2017.08.011
   Broseus L, 2020, COMPUT STRUCT BIOTEC, V18, P501, DOI 10.1016/j.csbj.2020.02.010
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Coene KLM, 2018, J INHERIT METAB DIS, V41, P337, DOI 10.1007/s10545-017-0131-6
   Cohen BH, 1993, GENEREVIEWS, V0, P0
   Conesa A, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0881-8
   Costa-Silva J, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0190152
   Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   Daniels EG, 2019, CSH MOL CASE STUD, V5, P0, DOI 10.1101/mcs.a004457
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Edhager AV, 2014, MOL GENET METAB, V111, P360, DOI 10.1016/j.ymgme.2014.01.007
   Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600
   Ferraro NM, 2020, SCIENCE, V369, P1334, DOI 10.1126/science.aaz5900
   Ferri L, 2016, CLIN GENET, V90, P461, DOI 10.1111/cge.12756
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033
   Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011
   Frazier AE, 2021, MED-CAMBRIDGE, V2, P49, DOI 10.1016/j.medj.2020.06.004
   Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8
   García-Cazorla A, 2020, ACTA NEUROPATHOL, V140, P971, DOI 10.1007/s00401-020-02223-w
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   González-Quintana A, 2020, MOL GENET METAB, V131, P341, DOI 10.1016/j.ymgme.2020.10.008
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13
   Gunning AC, 2020, AM J HUM GENET, V106, P272, DOI 10.1016/j.ajhg.2020.01.007
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Helman G, 2021, HUM MUTAT, V42, P19, DOI 10.1002/humu.24135
   Helman G, 2016, ANN NEUROL, V79, P379, DOI 10.1002/ana.24572
   Ibrahim AZ, 2020, MOL GENET METAB REP, V25, P0, DOI 10.1016/j.ymgmr.2020.100645
   Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015
   Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206
   Jiang LH, 2020, CELL, V183, P269, DOI 10.1016/j.cell.2020.08.036
   Jimoh IJ, 2020, THER ADV NEUROL DISO, V13, P0, DOI 10.1177/1756286420938972
   de Castro MJ, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9082362
   Karczewski KJ, 2018, NAT REV GENET, V19, P299, DOI 10.1038/nrg.2018.4
   Knottnerus SJG, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165725
   Koh K, 2018, J HUM GENET, V63, P1009, DOI 10.1038/s10038-018-0477-0
   Kohda M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005679
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Kremer LS, 2016, J HEPATOL, V65, P377, DOI 10.1016/j.jhep.2016.04.017
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lee M, 2017, AM J HUM GENET, V100, P751, DOI 10.1016/j.ajhg.2017.04.001
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lunke S, 2020, JAMA-J AM MED ASSOC, V323, P2503, DOI 10.1001/jama.2020.7671
   Maguolo A, 2020, MOL GENET METAB REP, V24, P0, DOI 10.1016/j.ymgmr.2020.100632
   Marchuk DS, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0209185
   Mazzarotto F, 2020, CARDIOVASC DRUG THER, V34, P241, DOI 10.1007/s10557-020-06948-4
   Merritt JL II, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.10.57
   Mertes C, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20573-7
   Mizuguchi T, 2019, J HUM GENET, V64, P359, DOI 10.1038/s10038-019-0569-5
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Mu WB, 2019, GENET MED, V21, P1603, DOI 10.1038/s41436-018-0397-6
   Ng PC, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000160
   Niida Y, 2018, CYTOGENET GENOME RES, V154, P137, DOI 10.1159/000488572
   Nogueira C, 2019, MITOCHONDRION, V47, P309, DOI 10.1016/j.mito.2019.02.006
   Nozaki F, 2016, BRAIN DEV-JPN, V38, P678, DOI 10.1016/j.braindev.2016.01.003
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Papatheodorou I, 2020, NUCLEIC ACIDS RES, V48, PD77, DOI 10.1093/nar/gkz947
   Park E, 2018, AM J HUM GENET, V102, P11, DOI 10.1016/j.ajhg.2017.11.002
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rajagopalan R, 2020, GENOME MED, V12, P0, DOI 10.1186/s13073-020-0712-0
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   ROTIG A, 1989, LANCET, V1, P902
   Rowls C, 2019, BIORXIV, V0, P0, DOI DOI 10.1101/781088
   Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013
   Sánchez-Caballero L, 2020, BBA-BIOENERGETICS, V1861, P0, DOI 10.1016/j.bbabio.2020.148202
   Sánchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Shaikh SS, 2018, EUR J HUM GENET, V26, P1559, DOI 10.1038/s41431-018-0214-3
   Simon MT, 2019, MOL GENET METAB, V126, P53, DOI 10.1016/j.ymgme.2018.11.001
   Soemedi R, 2017, NAT GENET, V49, P848, DOI 10.1038/ng.3837
   Stalke A, 2019, EUR J HUM GENET, V27, P879, DOI 10.1038/s41431-019-0345-1
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taylor K, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21145161
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Tsang MHY, 2020, HUM GENOMICS, V14, P0, DOI 10.1186/s40246-020-00278-0
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhu JH, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28400
   Zytkovicz TH, 2001, CLIN CHEM, V47, P1945
NR 103
TC 32
Z9 32
U1 0
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JUL 15
PY 2021
VL 254
IS 4
BP 430
EP 442
DI 10.1002/path.5641
EA MAR 2021
PG 13
WC Oncology; Pathology
SC Oncology; Pathology
GA SN6TC
UT WOS:000633500600001
PM 33586140
DA 2024-11-01
ER

PT J
AU Povea-Cabello, S
   Villanueva-Paz, M
   Suárez-Rivero, JM
   Alvarez-Córdoba, M
   Villalón-García, I
   Talaverón-Rey, M
   Suárez-Carrillo, A
   Munuera-Cabeza, M
   Sánchez-Alcázar, JA
AF Povea-Cabello, Suleva
   Villanueva-Paz, Marina
   Suarez-Rivero, Juan M.
   alvarez-Cordoba, Monica
   Villalon-Garcia, Irene
   Talaveron-Rey, Marta
   Suarez-Carrillo, Alejandra
   Munuera-Cabeza, Manuel
   Sanchez-Alcazar, Jose A.
TI Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish
SO FRONTIERS IN GENETICS
LA English
DT Review
DE mitochondrial diseases; mtDNA; disease modeling; direct reprogramming; induced neurons
ID pluripotent stem-cells; respiratory-chain supercomplexes; human fibroblasts; direct conversion; drug discovery; mouse models; selective degradation; myoclonic epilepsy; oxidative stress; dna mutation
AB Mitochondrial diseases are a heterogeneous group of rare genetic disorders that can be caused by mutations in nuclear (nDNA) or mitochondrial DNA (mtDNA). Mutations in mtDNA are associated with several maternally inherited genetic diseases, with mitochondrial dysfunction as a main pathological feature. These diseases, although frequently multisystemic, mainly affect organs that require large amounts of energy such as the brain and the skeletal muscle. In contrast to the difficulty of obtaining neuronal and muscle cell models, the development of induced pluripotent stem cells (iPSCs) has shed light on the study of mitochondrial diseases. However, it is still a challenge to obtain an appropriate cellular model in order to find new therapeutic options for people suffering from these diseases. In this review, we deepen the knowledge in the current models for the most studied mt-tRNA mutation-caused mitochondrial diseases, MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonic epilepsy with ragged red fibers) syndromes, and their therapeutic management. In particular, we will discuss the development of a novel model for mitochondrial disease research that consists of induced neurons (iNs) generated by direct reprogramming of fibroblasts derived from patients suffering from MERRF syndrome. We hypothesize that iNs will be helpful for mitochondrial disease modeling, since they could mimic patient's neuron pathophysiology and give us the opportunity to correct the alterations in one of the most affected cellular types in these disorders.
C1 [Povea-Cabello, Suleva; Suarez-Rivero, Juan M.; alvarez-Cordoba, Monica; Villalon-Garcia, Irene; Talaveron-Rey, Marta; Suarez-Carrillo, Alejandra; Munuera-Cabeza, Manuel; Sanchez-Alcazar, Jose A.] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.
   [Povea-Cabello, Suleva; Suarez-Rivero, Juan M.; alvarez-Cordoba, Monica; Villalon-Garcia, Irene; Talaveron-Rey, Marta; Suarez-Carrillo, Alejandra; Munuera-Cabeza, Manuel; Sanchez-Alcazar, Jose A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville, Spain.
   [Villanueva-Paz, Marina] Univ Malaga, Inst Invest Biomed Malaga, Dept Farmacol & Pediat, Fac Med, Malaga, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Malaga
RP Sánchez-Alcázar, JA (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.; Sánchez-Alcázar, JA (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville, Spain.
EM jasanalc@upo.es
FU Instituto de Salud Carlos III, Spain [PI19/00377]; Fondo Europeo de Desarrollo Regional (FEDER-Union Europea); Spanish Ministry of Education, Culture and Sport, "Ayudas para la Formacion de Profesorado Universitario" (FPU); AEPMI (Asociacion de Enfermos de Patologia Mitocondrial)
CR Alberts B, 2007, MOL BIOL CELL, V0, P0
   Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007
   Angelini C, 2014, GENETIC NEUROMUSCULA, V0, P39
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Baile MG, 2013, FRONT BIOSCI-LANDMRK, V18, P241, DOI 10.2741/4098
   Balsa E, 2019, MOL CELL, V74, P877, DOI 10.1016/j.molcel.2019.03.031
   Birtele M, 2019, FEBS LETT, V593, P3370, DOI 10.1002/1873-3468.13612
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   BOURGERON T, 1992, BIOCHEM BIOPH RES CO, V186, P16, DOI 10.1016/S0006-291X(05)80769-7
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Brzezinski P, 2020, TRENDS BIOCHEM SCI, V45, P3, DOI 10.1016/j.tibs.2019.10.011
   Bulthuis EP, 2019, ANTIOXID REDOX SIGN, V30, P2066, DOI 10.1089/ars.2018.7534
   Busch KB, 2020, INT J BIOCHEM CELL B, V120, P0, DOI 10.1016/j.biocel.2020.105694
   Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284
   Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006
   Chang JC, 2013, CYTOTHERAPY, V15, P1580, DOI 10.1016/j.jcyt.2013.06.008
   Chapman J, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10090164
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Chin Randall Marcelo, 2018, BMC RES NOTES, V11, P205, DOI 10.1186/s13104-018-3297-6
   Chou SJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23661
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Crow D, 2019, CELL, V177, P1667, DOI 10.1016/j.cell.2019.05.043
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   DiMauro SHM, 2015, GENEREVIEWS, V0, P0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Drouin-Ouellet J, 2017, FRONT NEUROSCI-SWITZ, V11, P0, DOI 10.3389/fnins.2017.00530
   Drouin-Ouellet J, 2017, EMBO MOL MED, V9, P1117, DOI 10.15252/emmm.201607471
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Falk MJ, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0006607
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2019, EXPERT OPIN PHARMACO, V20, P1289, DOI 10.1080/14656566.2019.1609941
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Garrido-Maraver J, 2015, BBA-MOL BASIS DIS, V1852, P2535, DOI 10.1016/j.bbadis.2015.08.027
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gunnewiek TMK, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107538
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horvath S, 2013, GENOME BIOL, V14, P0, DOI 10.1186/gb-2013-14-10-r115
   Hsu YC, 2016, BBA-GEN SUBJECTS, V1860, P686, DOI 10.1016/j.bbagen.2016.01.009
   Hu SY, 2019, J ZHEJIANG UNIV-SC B, V20, P449, DOI 10.1631/jzus.B1900196
   Huh CJ, 2016, ELIFE, V5, P0, DOI 10.7554/elife.18648
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Inak G, 2017, STEM CELLS, V35, P1655, DOI 10.1002/stem.2637
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008
   Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331
   Jang S, 2020, MITOCHONDRION, V51, P30, DOI 10.1016/j.mito.2019.11.006
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200
   Kirino Yohei, 2005, RNA BIOL, V2, P41, DOI 10.4161/rna.2.2.1610
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543
   Ladewig J, 2012, NAT METHODS, V9, P575, DOI 10.1038/nmeth.1972
   Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Martín-Jiménez R, 2020, DNA CELL BIOL, V39, P1421, DOI 10.1089/dna.2020.5398
   Mast JD, 2008, DEVELOPMENT, V135, P2669, DOI 10.1242/dev.020644
   McGregor A, 2001, MOL GENET GENOMICS, V265, P721, DOI 10.1007/s004380100469
   Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Nakada K, 2001, SEMIN CELL DEV BIOL, V12, P459, DOI 10.1006/scdb.2001.0283
   Napolitano A, 2000, NEUROL SCI, V21, PS981, DOI 10.1007/s100720070015
   Nissanka N, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201949612
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Pacitti D, 2018, NUCLEOS NUCLEOT NUCL, V37, P603, DOI 10.1080/15257770.2018.1492139
   Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009
   Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Parmar M, 2011, CELL RES, V21, P1386, DOI 10.1038/cr.2011.130
   Perales-Clemente E, 2016, EMBO J, V35, P1979, DOI 10.15252/embj.201694892
   Pfisterer U, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep38290
   Pickrell AM, 2013, CURR BIOL, V23, PR1052, DOI 10.1016/j.cub.2013.10.048
   Qin H, 2018, SCI CHINA LIFE SCI, V61, P1151, DOI 10.1007/s11427-018-9359-8
   Reddy P, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11090976
   Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x
   Rusanen H, 2000, BBA-MOL BASIS DIS, V1500, P10, DOI 10.1016/S0925-4439(99)00081-2
   Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Saxena Nishtha, 2018, J HUM REPROD SCI, V11, P3, DOI 10.4103/jhrs.jhrs_54_17
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shrigley S, 2018, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/56904
   Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000
   Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226
   Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014
   Suhr ST, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008124
   Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110
   Torraco A, 2015, MITOCHONDRION, V21, P76, DOI 10.1016/j.mito.2015.01.009
   Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6
   Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Villanueva-Paz M, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165726
   Villanueva-Paz M, 2019, BBA-MOL CELL RES, V1866, P861, DOI 10.1016/j.bbamcr.2019.02.010
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Vithayathil SA, 2012, METHODS MOL BIOL, V837, P219, DOI 10.1007/978-1-61779-504-6_15
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wilkins HM, 2014, REDOX BIOL, V2, P619, DOI 10.1016/j.redox.2014.03.006
   Wollweber F, 2017, BBA-MOL CELL RES, V1864, P1481, DOI 10.1016/j.bbamcr.2017.05.004
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   YONEDA M, 1990, BIOCHEM INT, V21, P789
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhang X, 2016, METHODS MOL BIOL, V1353, P323, DOI 10.1007/7651_2014_195
NR 131
TC 10
Z9 10
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JAN 12
PY 2021
VL 11
IS 
BP 
EP 
DI 10.3389/fgene.2020.610764
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA PX7YT
UT WOS:000611571100001
PM 33510772
DA 2024-11-01
ER

PT J
AU Oncul, U
   Kose, E
   Eminoglu, FT
AF Oncul, Ummuhan
   Kose, Engin
   Eminoglu, Fatma Tuba
TI A Mild Phenotype of Mitochondrial DNA Depletion Syndrome Type 13 with a Novel <i>FBXL4</i> Variant
SO MOLECULAR SYNDROMOLOGY
LA English
DT Article
DE Encephalopathy; FBXL4; Mitochondrial DNA depletion; mtDNA depletion syndrome; Myopathy; MTDPS13
ID mutations
AB Mitochondrial DNA depletion syndromes (MDDS) are a group of rare genetic disorders caused by defects in multiple genes involved in mitochondrial DNA maintenance. Among these, FBXL4 gene variants result in encephalomyopathic mtDNA depletion syndrome 13 (MTDPS13), which commonly presents as a combination of failure to thrive, neurodevelopmental delays, encephalopathy, hypotonia, a pattern of mild facial dysmorphisms, and persistent lactic acidosis. To date, 53 pathogenic FBXL4 variants and 100 cases have been described in the literature. In the present case report, we report on a 4.5-year-old boy with MTDPS13 and a novel variant. The patient had a history of antenatal hydrocephalus, severe developmental delay and mental motor retardation with psychomotor delay, severe hypotonia, mild left ventricular hypertrophic cardiomyopathy, mild facial dysmorphism, and elevated lactate levels. Symptoms suggested mitochondrial myopathy; subsequently, whole-exome sequencing was performed and a novel homozygous variant FBXL4 (NM_012160.4): c.486T>G (p.Tyr162Ter) was identified. While most of the patients with FBLX4 gene mutation have severe clinical manifestation and die at a very young age, clinical progress of our case was milder than previously reported. MDDS are very rare and can present with many different clinical signs and symptoms. In this report, we identified a novel pathogenic variant in the FBXL4 gene. This report shows that patients with FBLX4 gene mutations may present with a milder clinical phenotype than previously reported.
C1 [Oncul, Ummuhan; Kose, Engin; Eminoglu, Fatma Tuba] Ankara Univ, Fac Med, Dept Pediat Metab, Ankara, Turkey.
C3 Ankara University
RP Oncul, U (corresponding author), Ankara Univ, Fac Med, Dept Pediat Metab, Ankara, Turkey.
EM onculummuhan@gmail.com
CR Almannai M, 2017, FBXL4-RELATED ENCEPHALOMYOPATHIC MITOCHONDRIAL DNA DEPLETION SYNDROME, V0, P0
   Baroy T, 2016, EUR J MED GENET, V59, P342, DOI 10.1016/j.ejmg.2016.05.005
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Dai H, 2017, CLIN GENET, V91, P634, DOI 10.1111/cge.12894
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Köse E, 2020, TURKISH J PEDIATR, V62, P652, DOI 10.24953/turkjped.2020.04.016
   Nardi N, 2020, J PEDIATR INTENSIVE, V9, P54, DOI 10.1055/s-0039-1697620
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Suarez-Rivero Juan M, 2016, DISEASES, V5, P0, DOI 10.3390/diseases5010001
   van Rij MC, 2016, CLIN CASE REP, V4, P425, DOI 10.1002/ccr3.511
NR 14
TC 1
Z9 1
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-8769
EI 1661-8777
J9 MOL SYNDROMOL
JI Mol. Syndromol.
PD AUG 15
PY 2021
VL 12
IS 5
BP 294
EP 299
DI 10.1159/000515928
EA JUL 2021
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA UK7MU
UT WOS:000675442100001
PM 34602956
DA 2024-11-01
ER

PT J
AU Suslov, AV
   Afanasyev, MA
   Degtyarev, PA
   Chumachenko, PV
   Ekta, MB
   Sukhorukov, VN
   Khotina, VA
   Yet, SF
   Sobenin, IA
   Postnov, AY
AF Suslov, A. V.
   Afanasyev, M. A.
   Degtyarev, P. A.
   Chumachenko, P. V.
   Ekta, M. Bagheri
   Sukhorukov, V. N.
   Khotina, V. A.
   Yet, S. -F.
   Sobenin, I. A.
   Postnov, A. Yu
TI Molecular Pathogenesis and the Possible Role of Mitochondrial Heteroplasmy in Thoracic Aortic Aneurysm
SO LIFE-BASEL
LA English
DT Article
DE thoracic aortic aneurysm; mitochondrial genome; inflammation; metabolism; aortic dissection; cardiovascular diseases
ID smooth-muscle cells; surgical pathology; mouse model; tgf-beta; circulating fibrocytes; mtdna heteroplasmy; oxidative stress; fibrosis; tissue; mechanisms
AB Thoracic aortic aneurysm (TAA) is a life-threatening condition associated with high mortality, in which the aortic wall is deformed due to congenital or age-associated pathological changes. The mechanisms of TAA development remain to be studied in detail, and are the subject of active research. In this review, we describe the morphological changes of the aortic wall in TAA. We outline the genetic disorders associated with aortic enlargement and discuss the potential role of mitochondrial pathology, in particular mitochondrial DNA heteroplasmy, in the disease pathogenesis.
C1 [Suslov, A. V.; Afanasyev, M. A.; Chumachenko, P. V.; Sukhorukov, V. N.; Sobenin, I. A.; Postnov, A. Yu] Natl Med Res Ctr Cardiol, Moscow 121552, Russia.
   [Suslov, A. V.; Degtyarev, P. A.] Sechenov Univ, Dept Human Anat, First Moscow State Med Univ, Moscow 119435, Russia.
   [Ekta, M. Bagheri; Sukhorukov, V. N.; Khotina, V. A.; Postnov, A. Yu] Res Inst Human Morphol, Moscow 117418, Russia.
   [Khotina, V. A.] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia.
   [Yet, S. -F.] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Taiwan.
C3 National Medical Research Center of Cardiology; Sechenov First Moscow State Medical University; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; National Health Research Institutes - Taiwan
RP Sukhorukov, VN (corresponding author), Natl Med Res Ctr Cardiol, Moscow 121552, Russia.; Sukhorukov, VN (corresponding author), Res Inst Human Morphol, Moscow 117418, Russia.
EM suslov_a_v@staff.sechenov.ru; am-mma@mail.ru; p.degtyarev@mail.ru; chumach7234@mail.ru; ms.bvgheri@gmail.com; vnsukhorukov@gmail.com; nafany905@gmail.com; yetshawfang@gmail.com; igor.sobenin@gmail.com; anton-5@mail.ru
FU Russian Science Foundation [20-45-08002]; Russian Science Foundation [20-45-08002] Funding Source: Russian Science Foundation
CR Akerman AW, 2019, J AM HEART ASSOC, V8, P0, DOI 10.1161/JAHA.118.010332
   ARCINIEGAS E, 1992, J CELL SCI, V103, P521
   Arias M, 2003, BMC GASTROENTEROL, V3, P0, DOI 10.1186/1471-230X-3-29
   Bajwa E, 2019, MEDIAT INFLAMM, V2019, P0, DOI 10.1155/2019/4050796
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   BICKERSTAFF LK, 1982, SURGERY, V92, P1103
   Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58
   BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049
   Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37
   Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619
   Clouse WD, 1999, SURVEY OF ANESTHESIOLOGY, V43, P198, DOI 10.1097/00132586-199908000-00011
   Cook JR, 2015, CLIN GENET, V87, P11, DOI 10.1111/cge.12436
   Creamer TJ, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12020183
   DARE AJ, 1993, HUM PATHOL, V24, P1330, DOI 10.1016/0046-8177(93)90267-K
   Breda CND, 2019, REDOX BIOL, V26, P0, DOI 10.1016/j.redox.2019.101255
   Del Campo JA, 2018, WORLD J HEPATOL, V10, P1, DOI 10.4254/wjh.v10.i1.1
   Dela Cruz CS, 2018, MITOCHONDRION, V41, P37, DOI 10.1016/j.mito.2017.12.001
   Dorn GW, 2019, ANNU REV PHYSIOL, V81, P1, DOI 10.1146/annurev-physiol-020518-114358
   Douillet CD, 2000, AM J PHYSIOL-HEART C, V279, PH2829, DOI 10.1152/ajpheart.2000.279.6.H2829
   Fernandez-García CE, 2017, J THROMB HAEMOST, V15, P575, DOI 10.1111/jth.13608
   Flachskampf Frank A, 2000, CARDIOLOGY CLINICS, V18, P807, DOI 10.1016/S0733-8651(05)70181-8
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091
   Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001
   Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683
   Fritze O, 2012, J VASC RES, V49, P77, DOI 10.1159/000331278
   Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317
   Gao ZJ, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-01919-0
   Garbern JC, 2019, J MOL CELL CARDIOL, V128, P179, DOI 10.1016/j.yjmcc.2019.01.018
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grabenwöger M, 2000, ANN THORAC SURG, V69, P441, DOI 10.1016/S0003-4975(99)01291-6
   Gueguen N, 2021, METHODS MOL BIOL, V2276, P1, DOI 10.1007/978-1-0716-1266-8_1
   Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287
   Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897
   He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018
   Hoey ETD, 2010, AM J ROENTGENOL, V194, PW495, DOI 10.2214/AJR.09.3570
   Homme JL, 2006, AM J SURG PATHOL, V30, P1159, DOI 10.1097/01.pas.0000213270.38091.69
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Jondeau G, 2014, CURR OPIN CARDIOL, V29, P492, DOI 10.1097/HCO.0000000000000114
   Kaarniranta K, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102374
   Kassab S, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.689101
   Kendall RT, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00123
   Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311
   Kim YG, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8111389
   Kong Ping, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6
   Kulek AR, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010214
   Lahera V, 2017, CURR HYPERTENS REP, V19, P0, DOI 10.1007/s11906-017-0710-9
   Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004
   Lederle Frank A, 2009, ANN INTERN MED, V150, P0
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li X, 2020, LIFE SCI, V254, P0, DOI 10.1016/j.lfs.2019.116927
   Liao B, 2020, J ATHEROSCLER THROMB, V27, P545, DOI 10.5551/jat.51102
   Liu X, 2021, OXID MED CELL LONGEV, V2021, P0, DOI 10.1155/2021/5577634
   Lu SZ, 2020, JCI INSIGHT, V5, P0, DOI 10.1172/jci.insight.139445
   Machado TS, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00762
   Mack M, 2018, MATRIX BIOL, V68-69, P106, DOI 10.1016/j.matbio.2017.11.010
   Manea SA, 2015, REDOX BIOL, V5, P358, DOI 10.1016/j.redox.2015.06.012
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   MAYER ED, 1986, ANN THORAC SURG, V42, P81, DOI 10.1016/S0003-4975(10)61842-5
   Mazunin IO, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1418, DOI 10.1134/S0006297915110036
   McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025
   Méndez-Barbero N, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22147284
   Meyer W W, 1980, STRUCTURE AND FUNCTION OF THE CIRCULATION, V0, P95
   Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229
   Miller DV, 2006, AM J SURG PATHOL, V30, P1150, DOI 10.1097/01.pas.0000213293.04026.ec
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Moritz AR, 1932, AM J PATHOL, V8, P717
   Murphy-Marshman H, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0186740
   Nastase MV, 2018, ADV DRUG DELIVER REV, V129, P295, DOI 10.1016/j.addr.2017.12.019
   Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116
   Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715
   Orekhov AN, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9040978
   Pakshir P, 2020, J CELL SCI, V133, P0, DOI 10.1242/jcs.227900
   Parakatselaki ME, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11070633
   Pasta S, 2020, ANN THORAC SURG, V110, P1595, DOI 10.1016/j.athoracsur.2020.03.017
   Peoples JN, 2019, EXP MOL MED, V51, P0, DOI 10.1038/s12276-019-0355-7
   Picca A, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18050933
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Piera-Velazquez S, 2016, J CLIN MED, V5, P0, DOI 10.3390/jcm5040045
   Portelli SS, 2021, REDOX REP, V26, P45, DOI 10.1080/13510002.2021.1899473
   Postnov A, 2021, CURR PHARM DESIGN, V27, P3122, DOI 10.2174/1381612827666210210142200
   Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005
   Richter K, 2016, CELL TISSUE RES, V365, P591, DOI 10.1007/s00441-016-2445-3
   Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Safdar A, 2018, CSH PERSPECT MED, V8, P0, DOI 10.1101/cshperspect.a029827
   Safi HJ, 2001, CIRCULATION, V104, P2938, DOI 10.1161/hc4901.100362
   Sánchez-Infantes D, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10040602
   Schilling JD, 2015, ANTIOXID REDOX SIGN, V22, P1515, DOI 10.1089/ars.2015.6294
   SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P21, DOI 10.1016/S0002-9149(77)80005-2
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f
   Soto ME, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/5392454
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Su SA, 2017, ONCOTARGET, V8, P25700, DOI 10.18632/oncotarget.14878
   Sverdlov AL, 2016, J AM HEART ASSOC, V5, P0, DOI 10.1161/JAHA.115.002555
   Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026
   Thomas TP, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.529075
   Vaamonde-García C, 2019, BIOCHEM PHARMACOL, V165, P181, DOI 10.1016/j.bcp.2019.03.008
   Vaideeswar P, 2008, PATHOLOGY, V40, P505, DOI 10.1080/00313020802198093
   VIRMANI R, 1991, AM J PATHOL, V139, P1119
   Walker EJ, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-56955-1
   Wang HT, 2015, KIDNEY INT, V87, P948, DOI 10.1038/ki.2014.386
   Weiskirchen R, 2019, MOL ASPECTS MED, V65, P2, DOI 10.1016/j.mam.2018.06.003
   Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648
   Wu LY, 2018, INFLAMMATION, V41, P878, DOI 10.1007/s10753-018-0742-6
   Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870
   Yu E, 2018, CARDIOVASC RES, V114, P1696, DOI 10.1093/cvr/cvy180
   Zhang SM, 2021, MOL BIOL REP, V48, P6443, DOI 10.1007/s11033-021-06646-w
   Zhang XL, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21239138
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
   Zhunina OA, 2021, FRONT MOL BIOSCI, V8, P0, DOI 10.3389/fmolb.2021.671908
   Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X
NR 119
TC 2
Z9 2
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD DEC 15
PY 2021
VL 11
IS 12
BP 
EP 
DI 10.3390/life11121395
PG 14
WC Biology; Microbiology
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA YI4RD
UT WOS:000743835700001
PM 34947926
DA 2024-11-01
ER

PT J
AU Lin, Y
   Du, JX
   Wang, W
   Ren, H
   Zhao, DD
   Liu, FC
   Lin, PF
   Ji, KQ
   Zhao, YY
   Yan, CZ
AF Lin, Yan
   Du, Jixiang
   Wang, Wei
   Ren, Hong
   Zhao, Dandan
   Liu, Fuchen
   Lin, Pengfei
   Ji, Kunqian
   Zhao, Yuying
   Yan, Chuanzhu
TI Novel biallelic mutations in <i>POLG</i> gene: large deletion and missense variant associated with PEO
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Mitochondrial disease; POLG; Large deletion; Missense variant; PEO
ID phenotypic spectrum; disease mutations; mitochondrial; defects; replication; fragments; nuclear; ataxia
AB Background Mitochondrial disorders are clinically heterogeneous diseases associated with impaired oxidative phosphorylation (OXPHOS) activity. POLG, which encodes the DNA polymerase-gamma (Pol gamma) catalytic subunit, is the most commonly mutated nuclear gene associated with mitochondrial disorders. Methods We carried out whole-exome sequencing (WES) to identify the gene associated with progressive external ophthalmoplegia (PEO). We then performed histopathological analyses, assessed mitochondrial biology, and executed functional studies to evaluate the potential pathogenicity of the identified genetic mutations. Results Novel biallelic POLG mutations, including a large deletion mutation (exons 7-21) and a missense variant c.1796C>T (p.Thr599Ile) were detected in the proband. Histopathological analysis of a biopsied muscle sample from this patient revealed the presence of approximately 20% COX-negative fibers. Bioinformatics analyses confirmed that the detected mutations were pathogenic. Furthermore, levels of mitochondrial complex I, II, and IV subunit protein expressions were found to be decreased in the proband, and marked impairment of mitochondrial respiration was evident in cells harboring these mutations. Conclusion This study expands the spectrum of known POLG variants associated with PEO and advances current understanding regarding the structural and functional impacts of these mutations.
C1 [Lin, Yan; Du, Jixiang; Wang, Wei; Ren, Hong; Zhao, Dandan; Liu, Fuchen; Lin, Pengfei; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Du, Jixiang; Wang, Wei; Ren, Hong; Zhao, Dandan; Liu, Fuchen; Lin, Pengfei; Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Mitochondrial Med Lab, Qilu Hosp Qingdao, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Res Inst Neuromuscular & Neurodegenerat Dis, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Mitochondrial Med Lab, Qilu Hosp Qingdao, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@qq.com; czyan@sdu.edu.cn
FU National Natural Science Foundation of China [81701237, 81671235]; People's Benefit Project of Science and Technology in Qingdao [16-6-2-1-nsh]; Collaborative Innovation and Achievement Transformation in Universities and Research Institutes of Jinan [2019GXRC050]; Qingdao Key Health Discipline Development Fund; Taishan Scholars Program of Shandong Province
CR Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Craig K, 2007, BRAIN, V130, P0, DOI 10.1093/brain/awm009
   Da Pozzo P, 2017, NEUROL SCI, V38, P563, DOI 10.1007/s10072-016-2734-3
   Da Pozzo P, 2015, NEUROL SCI, V36, P1713, DOI 10.1007/s10072-015-2247-5
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P1, DOI 10.1177/000271623618500112
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Finsterer J, 2018, NEUROL SCI, V39, P571, DOI 10.1007/s10072-017-3116-1
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gaudó P, 2020, NEUROGENETICS, V21, P19, DOI 10.1007/s10048-019-00593-2
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hedberg-Oldfors C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000391
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Ji KQ, 2014, NEUROL SCI, V35, P443, DOI 10.1007/s10072-013-1557-8
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   van der Windt Gerritje J W, 2016, CURR PROTOC IMMUNOL, V113, P0, DOI 10.1002/0471142735.im0316bs113
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, PW296, DOI 10.1093/nar/gky427
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
NR 40
TC 3
Z9 4
U1 0
U2 8
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD OCT 15
PY 2021
VL 42
IS 10
BP 4271
EP 4280
DI 10.1007/s10072-021-05380-2
EA JUN 2021
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA UQ8HB
UT WOS:000668063500006
PM 34189666
DA 2024-11-01
ER

PT J
AU Lopez-Gomez, C
   Sanchez-Quintero, MJ
   Lee, EJ
   Kleiner, G
   Tadesse, S
   Xie, J
   Akman, HO
   Gao, GP
   Hirano, M
AF Lopez-Gomez, Carlos
   Sanchez-Quintero, Maria J.
   Lee, Eung Jeon
   Kleiner, Gulio
   Tadesse, Saba
   Xie, Jun
   Akman, Hasan Orhan
   Gao, Guangping
   Hirano, Michio
TI Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID trial; vector; mice
AB Objective Autosomal recessive human thymidine kinase 2 (TK2) mutations cause TK2 deficiency, which typically manifests as a progressive and fatal mitochondrial myopathy in infants and children. Treatment with pyrimidine deoxynucleosides deoxycytidine and thymidine ameliorates mitochondrial defects and extends the lifespan of Tk2 knock-in mouse (Tk2(KI)) and compassionate use deoxynucleoside therapy in TK2 deficient patients have shown promising indications of efficacy. To augment therapy for Tk2 deficiency, we assessed gene therapy alone and in combination with deoxynucleoside therapy in Tk2(KI) mice. Methods We generated pAAVsc CB6 PI vectors containing human TK2 cDNA (TK2). Adeno-associated virus (AAV)-TK2 was administered to Tk2(KI), which were serially assessed for weight, motor functions, and survival as well as biochemical functions in tissues. AAV-TK2 treated mice were further treated with deoxynucleosides. Results AAV9 delivery of human TK2 cDNA to Tk2(KI) mice efficiently rescued Tk2 activity in all the tissues tested except the kidneys, delayed disease onset, and increased lifespan. Sequential treatment of Tk2(KI) mice with AAV9 first followed by AAV2 at different ages allowed us to reduce the viral dose while further prolonging the lifespan. Furthermore, addition of deoxycytidine and deoxythymidine supplementation to AAV9 + AAV2 treated Tk2(KI) mice dramatically improved mtDNA copy numbers in the liver and kidneys, animal growth, and lifespan. Interpretation Our data indicate that AAV-TK2 gene therapy as well as combination deoxynucleoside and gene therapies is more effective in Tk2(KI) mice than pharmacological alone. Thus, combination of gene therapy with substrate enhancement is a promising therapeutic approach for TK2 deficiency and potentially other metabolic disorders. ANN NEUROL 2021
C1 [Lopez-Gomez, Carlos; Sanchez-Quintero, Maria J.; Lee, Eung Jeon; Kleiner, Gulio; Tadesse, Saba; Akman, Hasan Orhan; Hirano, Michio] Columbia Univ Irving Med Ctr, Dept Neurol, H Houston Merritt Neuromuscular Res Ctr, New York, NY USA.
   [Lopez-Gomez, Carlos] Hosp Univ Virgen de la Victoria, Unidad Gest Clin Aparato Digest, Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
   [Sanchez-Quintero, Maria J.] UMA, Area Corazon, Inst Invest Biomed Malaga IBIMA, CIBERCV,Hosp Clin Univ Virgen de la Victoria, Malaga, Spain.
   [Xie, Jun; Gao, Guangping] Univ Massachusetts, Med Ctr, Microbiol & Physiol Syst, Worcester, MA USA.
   [Xie, Jun; Gao, Guangping] Univ Massachusetts, Med Ctr, Horae Gene Therapy Ctr, Worcester, MA USA.
C3 NewYork-Presbyterian Hospital; Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); Instituto de Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universidad de Malaga; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester
RP Hirano, M (corresponding author), Columbia Univ Irving Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM mh29@columbia.edu
FU National Institutes of Health (NIH) [P01 HD32062]; Department of Defense [W81XWH2010807]; Arturo Estopinan TK2 Research Fund; Nicholas Nunno Foundation; JDM Fund for Mitochondrial Research; Shuman Mitochondrial Disease Fund; Marriott Mitochondrial Disease Clinic Research Fund (MMDCRF) from the J. Willard and Alice S. Marriott Foundation; NINDS [NIH U54 NS078059]; NICHD; U.S. Department of Defense (DOD) [W81XWH2010807] Funding Source: U.S. Department of Defense (DOD)
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Bax BE, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081096
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029
   Cukras C, 2018, MOL THER, V26, P2282, DOI 10.1016/j.ymthe.2018.05.025
   DAvola D, 2016, J HEPATOL, V65, P776, DOI 10.1016/j.jhep.2016.05.012
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Keeler GD, 2018, MOL THER, V26, P173, DOI 10.1016/j.ymthe.2017.09.001
   Kripps KA, 2020, MOL GENET METAB, V130, P58, DOI 10.1016/j.ymgme.2020.03.001
   Krishnan S, 2014, J BIOL CHEM, V289, P0, DOI 10.1074/jbc.M114.588921
   Krishnan S, 2013, J BIOL CHEM, V288, P5072, DOI 10.1074/jbc.M112.437152
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rakoczy EP, 2019, AM J OPHTHALMOL, V204, P113, DOI 10.1016/j.ajo.2019.03.006
   Rashnonejad A, 2016, MOL BIOTECHNOL, V58, P30, DOI 10.1007/s12033-015-9899-5
   Ronzitti G, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.00670
   Takeda S, 2004, NEPHRON EXP NEPHROL, V96, PE119, DOI 10.1159/000077378
   Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Yadak R, 2017, FRONT CELL NEUROSCI, V11, P0, DOI 10.3389/fncel.2017.00031
NR 29
TC 15
Z9 15
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT 15
PY 2021
VL 90
IS 4
BP 640
EP 652
DI 10.1002/ana.26185
EA AUG 2021
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA UW5TE
UT WOS:000684607600001
PM 34338329
DA 2024-11-01
ER

PT J
AU Ng, YS
   Bindoff, LA
   Gorman, GS
   Klopstock, T
   Kornblum, C
   Mancuso, M
   McFarland, R
   Sue, CM
   Suomalainen, A
   Taylor, RW
   Thorburn, DR
   Turnbull, DM
AF Ng, Yi Shiau
   Bindoff, Laurence A.
   Gorman, Grainne S.
   Klopstock, Thomas
   Kornblum, Cornelia
   Mancuso, Michelangelo
   McFarland, Robert
   Sue, Carolyn M.
   Suomalainen, Anu
   Taylor, Robert W.
   Thorburn, David R.
   Turnbull, Doug M.
TI Mitochondrial disease in adults: recent advances and future promise
SO LANCET NEUROLOGY
LA English
DT Review
ID phenotypic heterogeneity; medical genetics; american-college; leigh-syndrome; dna; mutations; diagnosis; patient; prevalence; myopathy
AB Mitochondrial diseases are some of the most common inherited neurometabolic disorders, and major progress has been made in our understanding, diagnosis, and treatment of these conditions in the past 5 years. Development of national mitochondrial disease cohorts and international collaborations has changed our knowledge of the spectrum of clinical phenotypes and natural history of mitochondrial diseases. Advances in high-throughput sequencing technologies have altered the diagnostic algorithm for mitochondrial diseases by increasingly using a genetics-first approach, with more than 350 disease-causing genes identified to date. While the current management strategy for mitochondrial disease focuses on surveillance for multisystem involvement and effective symptomatic treatment, new endeavours are underway to find better treatments, including repurposing current drugs, use of novel small molecules, and gene therapies. Developments made in reproductive technology offer women the opportunity to prevent transmission of DNA-related mitochondrial disease to their children.
C1 [Ng, Yi Shiau; Gorman, Grainne S.; McFarland, Robert; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gorman, Grainne S.; McFarland, Robert; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitodiondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
   [Ng, Yi Shiau; Gorman, Grainne S.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Directorate Neurosci, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, Neuro SysMed, Bergen, Norway.
   [Klopstock, Thomas] Ludwig Max Imilians Univ, LMU Hosp, Friedrich Baur Inst, Dept Neurol, Munich, Germany.
   [Klopstock, Thomas] German Ctr Neurodegenerat Dis, Munich, Germany.
   [Klopstock, Thomas] Munich Cluster Syst Neurol, Munich, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Neuromuscular Dis Sect, Bonn, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis, Bonn, Germany.
   [Mancuso, Michelangelo] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, Pisa, Italy.
   [Sue, Carolyn M.] Univ Sydney, Fac Med & Hlth, Kolling Inst, Dept Neurogenet, Sydney, NSW, Australia.
   [Sue, Carolyn M.] Northern Sydney Local Hlth Dist, Dept Neurol, Royal North Shore Hosp, St Leonards, NSW, Australia.
   [Suomalainen, Anu] Univ Helsinki, Res Program Stem Cells & Metab, Fac Med, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Hilife, Neurosci Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUSlab, Helsinki, Finland.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Bergen; University of Bergen; Haukeland University Hospital; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Bonn; University of Bonn; University of Pisa; University of Sydney; Kolling Institute of Medical Research; Northern Sydney Local Health District; Royal North Shore Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; Royal Children's Hospital Melbourne; University of Melbourne
RP Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council) [G016354/1]; NIHR Biomedical Research Centre for Ageing and Age-Related Disease award; Lily Foundation; UK NHS; German Federal Ministry of Education and Research (Bonn, Germany) [01GM1906A, 01GM1920B]; European Commission; NIHR Clinical Lectureship in Neurology [CL-2016-01-003]; Telethon Grant [GUP09004]; Telethon-MITOCON [GSP16001, RF-2016-02361495]; GENOMIT; NHMRC [APP 1136800]; Mito Foundation; Aligning Science Across Parkinson's Collaborative Research Network; Spastic Paraplegia Foundation; US Department of Defense Congressionally Directed Medical Research Programs; Victorian Government's Operational Infrastructure Support Program; Academy of Finland
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Bax Bridget E, 2020, J TRANSL GENET GENOM, V4, P1, DOI 10.20517/jtgg.2020.08
   Borrelli E, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep37332
   Braz LP, 2021, NEUROL-CLIN PRACT, V11, P97, DOI 10.1212/CPJ.0000000000000795
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Carelli V, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv339
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Catarino CB, 2020, J NEURO-OPHTHALMOL, V40, P558, DOI 10.1097/WNO.0000000000001023
   Corazza G, 2019, GASTROENTEROLOGY, V156, P1525, DOI 10.1053/j.gastro.2018.12.011
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Formichi P, 2020, NEUROL SCI, V41, P3653, DOI 10.1007/s10072-020-04422-5
   Forsström S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Frazier AE, 2020, METHOD CELL BIOL, V155, P121, DOI 10.1016/bs.mcb.2019.11.007
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Hardy SA, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000082
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Kullar PJ, 2016, BRAIN, V139, PE33, DOI 10.1093/brain/aww051
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lehtonen JM, 2021, J INHERIT METAB DIS, V44, P469, DOI 10.1002/jimd.12307
   Lin Y, 2020, ANN CLIN TRANSL NEUR, V7, P1204, DOI 10.1002/acn3.51104
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   Marques-Matos C, 2016, JAMA NEUROL, V73, P604, DOI 10.1001/jamaneurol.2015.5061
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   National Academy of Medicine National Academy of Sciences and the Royal Society, 2020, HER HUM GEN ED, V0, P0
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00024
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Ng YS, 2018, EBIOMEDICINE, V30, P86, DOI 10.1016/j.ebiom.2018.02.010
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Ng YS, 2015, LANCET NEUROL, V14, P1073, DOI 10.1016/S1474-4422(15)00253-7
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Palculict ME, 2016, METHODS MOL BIOL, V1351, P3, DOI 10.1007/978-1-4939-3040-1_1
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Parikh S, 2019, J MED GENET, V56, P123, DOI 10.1136/jmedgenet-2018-105800
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Santarelli R, 2015, BRAIN, V138, P563, DOI 10.1093/brain/awu378
   Shen LS, 2016, HUM MUTAT, V37, P540, DOI 10.1002/humu.22974
   Sinnecker T, 2019, BMC NEUROL, V19, P0, DOI 10.1186/s12883-019-1306-6
   Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Stefanetti Renae J, 2020, WELLCOME OPEN RES, V5, P84, DOI 10.12688/wellcomeopenres.15825.1
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tan J, 2020, EBIOMEDICINE, V54, P0, DOI 10.1016/j.ebiom.2020.102730
   Tankard RM, 2018, AM J HUM GENET, V103, P858, DOI 10.1016/j.ajhg.2018.10.015
   Thauvin-Robinet C, 2019, EUR J HUM GENET, V27, P1197, DOI 10.1038/s41431-019-0384-7
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Ticci C, 2020, NEUROGENETICS, V21, P87, DOI 10.1007/s10048-019-00601-5
   Traschütz A, 2020, ANN NEUROL, V88, P251, DOI 10.1002/ana.25751
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Varhaug KN, 2021, BRAIN COMMUN, V3, P0, DOI 10.1093/braincomms/fcaa222
   Varhaug KN, 2020, ANN CLIN TRANSL NEUR, V7, P1318, DOI 10.1002/acn3.51119
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Warren C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-70885-3
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yokota Y, 2020, BMC NEUROL, V20, P0, DOI 10.1186/s12883-020-01818-w
   Yu-Wai-Man P, 2000, GENEREVIEWS, V0, P1993
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Yu-Wai-Man P, 2013, OPHTHALMOLOGY, V120, P1712, DOI 10.1016/j.ophtha.2013.04.022
NR 113
TC 95
Z9 101
U1 2
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD JUL 15
PY 2021
VL 20
IS 7
BP 573
EP 584
DI 10.1016/S1474-4422(21)00098-3
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA UD5TG
UT WOS:000687268300016
PM 34146515
DA 2024-11-01
ER

PT J
AU Peng, LU
   Bai, GG
   Pang, YX
AF Peng, L. U.
   Bai, Gaigai
   Pang, Yingxin
TI Roles of NPAS2 in circadian rhythm and disease
SO ACTA BIOCHIMICA ET BIOPHYSICA SINICA
LA English
DT Review
DE neuronal PAS domain protein 2 (NPAS2); structure; SNP; function
ID seasonal affective-disorder; night-shift work; pas-a domain; clock genes; breast-cancer; dna-binding; rev-erb; mitochondrial biogenesis; ala394thr polymorphism; protein-2 npas2
AB NPAS2, a circadian rhythm gene encoding the neuronal PAS domain protein 2 (NPAS2), has received widespread attention because of its complex functions in cells and diverse roles in disease progression, especially tumorigenesis. NPAS2 binds with DNA at E-box sequences and forms heterodimers with another circadian protein, brain and muscle ARNT-like protein 1 (BMAL1). Nucleotide variations of the NPAS2 gene have been shown to influence the overall survival and risk of death of cancer patients, and differential expression of NPAS2 has been linked to patient outcomes in breast cancer, lung cancer, non-Hodgkin's lymphoma, and other diseases. Here, we review the latest advances in our understanding of NPAS2 with the aim of drawing attention to its potential clinical applications and prospects.
C1 [Peng, L. U.; Bai, Gaigai; Pang, Yingxin] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250012, Peoples R China.
C3 Shandong University
RP Pang, YX (corresponding author), Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250012, Peoples R China.
EM yingxinpang@126.com
FU National Natural Science Foundation of China [81902657]
CR Akhisaroglu M, 2005, PHARMACOL BIOCHEM BE, V80, P371, DOI 10.1016/j.pbb.2004.11.016
   Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618
   Benna C, 2018, J TRANSL MED, V16, P0, DOI 10.1186/s12967-018-1715-0
   Benna C, 2017, ONCOTARGET, V8, P23978, DOI 10.18632/oncotarget.15074
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Cadenas C, 2014, CELL CYCLE, V13, P3282, DOI 10.4161/15384101.2014.954454
   Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012
   Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075
   Chen YB, 2019, CANCER MED-US, V8, P1919, DOI 10.1002/cam4.2050
   Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024
   Chu LW, 2018, MOL CARCINOGEN, V57, P462, DOI 10.1002/mc.22770
   Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288
   Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557
   DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884
   Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456
   Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795
   Englund Ani, 2009, J CIRCADIAN RHYTHMS, V7, P5, DOI 10.1186/1740-3391-7-5
   Esquifino AI, 1996, BRAIN BEHAV IMMUN, V10, P92, DOI 10.1006/brbi.1996.0010
   Evans DS, 2013, SLEEP, V36, P431, DOI 10.5665/sleep.2466
   Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103
   Fransquet PD, 2018, CLIN BIOCHEM, V58, P5, DOI 10.1016/j.clinbiochem.2018.05.020
   Franzoni A, 2017, EXP BIOL MED, V242, P1553, DOI 10.1177/1535370217724093
   Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3
   Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072
   Gamaleia NF, 2006, EXPERIMENTAL ONCOLOGY, V28, P54
   Gao Q, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep30070
   Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226
   Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564
   Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768
   Grundy A, 2013, CANCER EPIDEMIOL, V37, P606, DOI 10.1016/j.canep.2013.04.006
   Gu FY, 2017, INT J CANCER, V141, P1794, DOI 10.1002/ijc.30883
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Herichová I, 2017, PHYSIOL RES, V66, PS501, DOI 10.33549/physiolres.933799
   Hoffman AE, 2008, MOL CANCER RES, V6, P1461, DOI 10.1158/1541-7786.MCR-07-2094
   Ishida M, 2008, BIOCHEM BIOPH RES CO, V368, P292, DOI 10.1016/j.bbrc.2008.01.053
   Islam H, 2018, METABOLISM, V79, P42, DOI 10.1016/j.metabol.2017.11.001
   Iyyanki T, 2021, GENOME BIOL, V22, P0, DOI 10.1186/s13059-021-02325-y
   Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121
   Jung JS, 2014, CHRONOBIOL INT, V31, P838, DOI 10.3109/07420528.2014.914034
   Kaeffer B, 2005, IN VITRO CELL DEV-AN, V41, P311
   Kim HI, 2015, CHRONOBIOL INT, V32, P785, DOI 10.3109/07420528.2015.1049613
   Kouri VP, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054049
   Kovanen L, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010007
   Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4
   Landgraf D, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005882
   Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021
   Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108
   Lesicka M, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0199622
   Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2
   Logan RW, 2014, BEHAV NEUROSCI, V128, P387, DOI 10.1037/a0036268
   Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y
   Markt SC, 2015, CANCER CAUSE CONTROL, V26, P25, DOI 10.1007/s10552-014-0478-z
   Masood N, 2017, PATHOL ONCOL RES, V23, P707, DOI 10.1007/s12253-016-0184-0
   McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019
   Beaupre LM, 2020, WORLD J BIOL PSYCHIA, V21, P80, DOI 10.1080/15622975.2018.1500028
   Mocellin S, 2018, BMC MED, V16, P0, DOI 10.1186/s12916-018-1010-1
   Mongrain V, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026622
   Monsees GM, 2012, INT J CANCER, V131, P2547, DOI 10.1002/ijc.27564
   Mukaiyama Y, 2006, FEBS J, V273, P2528, DOI 10.1111/j.1742-4658.2006.05259.x
   Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953
   Ozburn AR, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00360
   Parent MÉ, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318
   Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795
   Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5
   Qiu MJ, 2019, CHRONOBIOL INT, V36, P906, DOI 10.1080/07420528.2018.1477792
   Qiu MJ, 2019, CHRONOBIOL INT, V36, P739, DOI 10.1080/07420528.2018.1509080
   Rana S, 2014, ASIAN PAC J CANCER P, V15, P7169, DOI 10.7314/APJCP.2014.15.17.7169
   Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699
   ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72
   Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857
   Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698
   Sancar A, 2021, SCIENCE, V371, P42, DOI 10.1126/science.abb0738
   Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018
   Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825
   Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013
   Song B, 2019, J CELL BIOCHEM, V120, P8731, DOI 10.1002/jcb.28160
   Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230
   Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200
   Uchida T, 2012, J INORG BIOCHEM, V108, P188, DOI 10.1016/j.jinorgbio.2011.12.005
   Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051
   VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325
   Wang B, 2015, INT J CLIN EXP MED, V8, P7176
   Wang FR, 2011, BREAST CANCER RES TR, V127, P769, DOI 10.1007/s10549-010-1157-8
   Wendeu-Foyet MG, 2020, INT J CANCER, V147, P3119, DOI 10.1002/ijc.33139
   Wendeu-Foyet MG, 2019, INT J CANCER, V145, P1745, DOI 10.1002/ijc.32149
   Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595
   Wu YC, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.02451
   Xiang Shulin, 2008, J CIRCADIAN RHYTHMS, V6, P4, DOI 10.1186/1740-3391-6-4
   Xue XF, 2014, BIOCHEM BIOPH RES CO, V450, P1058, DOI 10.1016/j.bbrc.2014.06.104
   Yamamoto T, 2004, BMC MOL BIOL, V5, P0, DOI 10.1186/1471-2199-5-18
   Yang T, 2019, MOL THER-NUCL ACIDS, V18, P1009, DOI 10.1016/j.omtn.2019.10.025
   Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x
   Yi CH, 2009, CANCER LETT, V284, P149, DOI 10.1016/j.canlet.2009.04.017
   Yi CH, 2010, BREAST CANCER RES TR, V120, P663, DOI 10.1007/s10549-009-0484-0
   Yoshino M, 2015, J NUTR BIOCHEM, V26, P1193, DOI 10.1016/j.jnutbio.2015.05.010
   Yu CC, 2019, CANCER CELL INT, V19, P0, DOI 10.1186/s12935-019-0811-4
   Yuan P, 2020, CANCER LETT, V469, P498, DOI 10.1016/j.canlet.2019.11.024
   Yuan P, 2017, CELL DEATH DIS, V8, P0, DOI 10.1038/cddis.2017.131
   Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428
   Zhao FF, 2017, ONCOTARGET, V8, P105873, DOI 10.18632/oncotarget.22411
   Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713
   Zhu Y, 2007, INT J CANCER, V120, P432, DOI 10.1002/ijc.22321
   Zhu Y, 2008, BREAST CANCER RES TR, V107, P421, DOI 10.1007/s10549-007-9565-0
   Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648
   Zienolddiny S, 2013, BREAST CANCER RES, V15, P0, DOI 10.1186/bcr3445
NR 105
TC 11
Z9 12
U1 1
U2 15
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, 100009, PEOPLES R CHINA
SN 1672-9145
EI 1745-7270
J9 ACTA BIOCH BIOPH SIN
JI Acta Biochim. Biophys. Sin.
PD OCT 15
PY 2021
VL 53
IS 10
BP 1257
EP 1265
DI 10.1093/abbs/gmab105
EA AUG 2021
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA WM6SD
UT WOS:000711212200001
PM 34415290
DA 2024-11-01
ER

PT J
AU Cotta, A
   Carvalho, E
   Da-Cunha, A
   Navarro, MM
   Paim, JF
   Valicek, J
   Baptista, S
   da Silveira, EB
   Lima, MI
   Carellos, EVM
   de-La-Rocque-Ferreira, A
   Takata, RI
   Horvath, R
AF Cotta, Ana
   Carvalho, Elmano
   Da-Cunha-Junior, AntonioLopes
   Navarro, Monica Machado
   Paim, Julia Filardi
   Valicek, Jaquelin
   Baptista-Junior, Sidney
   da Silveira, Eni Braga
   Lima, Maria Isabel
   Carellos, Ericka Viana Machado
   De-La-Rocque-Ferreira, Alessandra
   Takata, Reinaldo Issao
   Horvath, Rita
TI Muscle fat replacement and modified ragged red fibers in two patients with reversible infantile respiratory chain deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Reversible infantile respiratory chain deficiency; Digenic inheritance; Mitochondrial myopathy; Imaging; Muscle biopsy; Ragged red fibers
ID mitochondrial encephalomyopathy; diagnosis
AB Reversible infantile respiratory chain deficiency is a severe neonatal mitochondrial myopathy that resolves spontaneously. It is caused by the homoplasmic m.14674T>C mtDNA mutation and additional nuclear variants in genes interacting with mt-tRNAGlu have been detected in some patients. We present detailed clinical, imaging, and muscle biopsy findings in a boy and a girl with neonatal hypotonia, feeding difficulties, lactic acidosis, and ragged red fibers. Both patients show fat replacement on muscle imaging, which was mild in the boy, but severe in the girl, affecting mostly the posterior leg muscles. In addition to the homoplasmic m.14674T>C, both patients carried heterozygous variants in QRSL1 (c. 686T>G; p.Val299Gly) and EARS2 (c.358C>T; p.Arg120Trp), respectively. It is very important to recognize the clinical and morphological signs of reversible infantile respiratory chain deficiency as patients should receive intensive supportive care in the first 6 months of life. Understanding the mechanism of the spontaneous recovery may lead to novel therapeutic perspectives in other mitochondrial diseases. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Cotta, Ana; Paim, Julia Filardi; Baptista-Junior, Sidney] SARAH Network Rehabil Hosp, Pathol Dept, Belo Horizonte, MG, Brazil.
   [Carvalho, Elmano; Valicek, Jaquelin] SARAH Network Rehabil Hosp, Neurophysiol Dept, Belo Horizonte, MG, Brazil.
   [Da-Cunha-Junior, AntonioLopes] SARAH Network Rehabil Hosp, Radiol Dept, Belo Horizonte, MG, Brazil.
   [Navarro, Monica Machado] SARAH Network Rehabil Hosp, Pediat & Genet Dept, Belo Horizonte, MG, Brazil.
   [da Silveira, Eni Braga; Lima, Maria Isabel] SARAH Network Rehabil Hosp, Electron Microscopy Dept, Brasilia, DF, Brazil.
   [Carellos, Ericka Viana Machado] Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Carellos, Ericka Viana Machado] Joao Paulo II Children Hosp, Minas Gerais Hosp Fdn, Belo Horizonte, MG, Brazil.
   [De-La-Rocque-Ferreira, Alessandra; Takata, Reinaldo Issao] SARAH Network Rehabil Hosp, Mol Biol Dept, Brasilia, DF, Brazil.
   [Horvath, Rita] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
C3 Universidade Federal de Minas Gerais; University of Cambridge
RP Cotta, A (corresponding author), SARAH Network Rehabil Hosp, Pathol Dept, Belo Horizonte, MG, Brazil.
EM cotta@sarah.br
FU European Research Council [309548]; Wellcome Investigator Award [109915/Z/15/Z]; Medical Research Council (UK) [MR/N025431/1]; Newton Fund [UK/Turkey] [MR/N027302/1]; Lily Foundation; Evelyn Trust; MRC [MR/S005021/1]; MRC [MR/N010035/1, MR/S005021/1, MR/V009346/1, MR/N025431/2, MR/N025431/1] Funding Source: UKRI; Newton Fund [MR/N027302/1, MR/N027302/2] Funding Source: UKRI; Wellcome Trust [109915/Z/15/Z] Funding Source: Wellcome Trust
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Boczonadi V, 2015, J INHERIT METAB DIS, V38, P427, DOI 10.1007/s10545-014-9784-6
   Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Chen TH, 2013, QJM-INT J MED, V106, P953, DOI 10.1093/qjmed/hct151
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Jungbluth H, 2007, ORPHANET J RARE DIS, V2, P0, DOI 10.1186/1750-1172-2-25
   Kyriacou K, 2005, ULTRASTRUCT PATHOL, V29, P169, DOI 10.1080/01913120590951158
   Kyriacou K, 1999, ULTRASTRUCT PATHOL, V23, P163
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Quijano-Roy S, 2011, SEMIN PEDIATR NEUROL, V18, P221, DOI 10.1016/j.spen.2011.10.003
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Straub Volker, 2012, NEUROMUSCUL DISORD, V22 Suppl 2, PS42, DOI 10.1016/j.nmd.2012.08.002
   Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001
   Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995
NR 17
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN 15
PY 2021
VL 31
IS 6
BP 551
EP 557
DI 10.1016/j.nmd.2021.02.017
EA JUN 2021
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA SU3LB
UT WOS:000663041300011
PM 33832841
DA 2024-11-01
ER

PT J
AU Faria, R
   Vivés, E
   Boisguerin, P
   Sousa, A
   Costa, D
AF Faria, Ruben
   Vives, Eric
   Boisguerin, Prisca
   Sousa, Angela
   Costa, Diana
TI Development of Peptide-Based Nanoparticles for Mitochondrial Plasmid DNA Delivery
SO POLYMERS
LA English
DT Article
DE biocompatibility; cell-penetrating peptides; mitochondrial DNA diseases; mitochondria targeting; nano-delivery systems; plasmid DNA
ID cell-penetrating peptides; gene delivery; co-delivery; cancer; mechanisms; apoptosis; carriers; therapy; system; drug
AB A mitochondrion is a cellular organelle able to produce cellular energy in the form of adenosine triphosphate (ATP). As in the nucleus, mitochondria contain their own genome: the mitochondrial DNA (mtDNA). This genome is particularly susceptible to mutations that are at the basis of a multitude of disorders, especially those affecting the heart, the central nervous system and muscles. Conventional clinical practice applied to mitochondrial diseases is very limited and ineffective; a clear need for innovative therapies is demonstrated. Gene therapy seems to be a promising approach. The use of mitochondrial DNA as a therapeutic, optimized by peptide-based complexes with mitochondrial targeting, can be seen as a powerful tool in the reestablishment of normal mitochondrial function. In line with this requirement, in this work and for the first time, a mitochondrial-targeting sequence (MTS) has been incorporated into previously researched peptides, to confer on them a targeting ability. These peptides were then considered to complex a plasmid DNA (pDNA) which contains the mitochondrial gene ND1 (mitochondrially encoded NADH dehydrogenase 1 protein), aiming at the formation of peptide-based nanoparticles. Currently, the ND1 plasmid is one of the most advanced bioengineered vectors for conducting research on mitochondrial gene expression. The formed complexes were characterized in terms of pDNA complexation capacity, morphology, size, surface charge and cytotoxic profile. These data revealed that the developed carriers possess suitable properties for pDNA delivery. Furthermore, in vitro studies illustrated the mitochondrial targeting ability of the novel peptide/pDNA complexes. A comparison between the different complexes revealed the most promising ones that complex pDNA and target mitochondria. This may contribute to the optimization of peptide-based non-viral systems to target mitochondria, instigating progress in mitochondrial gene therapy.
C1 [Faria, Ruben; Sousa, Angela; Costa, Diana] Univ Beira Interior, UBI, Hlth Sci Res Ctr, CICS, Av Infante D Henrique, P-6200506 Covilha, Portugal.
   [Vives, Eric; Boisguerin, Prisca] Univ Montpellier, CNRS, PhyMedExp, INSERM, F-34295 Montpellier, France.
C3 Universidade da Beira Interior; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)
RP Costa, D (corresponding author), Univ Beira Interior, UBI, Hlth Sci Res Ctr, CICS, Av Infante D Henrique, P-6200506 Covilha, Portugal.
EM ruben_faria95@hotmail.com; eric.vives@umontpellier.fr; prisca.boisguerin@crbm.cnrs.fr; angela@fcsaude.ubi.pt; dcosta@fcsaude.ubi.pt
FU Fundacao para a Ciencia e a Tecnologia (FCT) - European Social Fund (ESF) [IF/01459/2015]; ESF through the Programa Operacional Regional Centro [SFRH/BD/148393/2019]; Fondation ARC pour la Recherche sur le Cancer; "Centre National de la Recherche Scientifique" (CNRS); Programa Operacional Potencial Humano; Fundação para a Ciência e a Tecnologia [SFRH/BD/148393/2019] Funding Source: FCT
CR Ahn J, 2018, J MATER CHEM B, V6, P0, DOI 10.1039/c8tb01358f
   Boguszewska K, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25122857
   Cardoso AM, 2015, MOL PHARMACEUT, V12, P716, DOI 10.1021/mp5005349
   Cerrato CP, 2020, J MATER CHEM B, V8, P10825, DOI 10.1039/d0tb01106a
   Chen WH, 2019, ANGEW CHEM INT EDIT, V58, P6290, DOI 10.1002/anie.201900884
   Chuah JA, 2016, BIOMACROMOLECULES, V17, P3547, DOI 10.1021/acs.biomac.6b01056
   Cohen-Erez I, 2019, POLYM ADVAN TECHNOL, V30, P2506, DOI 10.1002/patA707
   Costa D, 2018, COLLOID SURFACE B, V170, P627, DOI 10.1016/j.colsurfb.2018.06.063
   Costa D, 2017, BIOMACROMOLECULES, V18, P2928, DOI 10.1021/acs.biomac.7b00877
   Coutinho E, 2017, MOL PHARMACEUT, V14, P626, DOI 10.1021/acs.molpharmaceut.6b00823
   Derakhshankhah H, 2018, BIOMED PHARMACOTHER, V108, P1090, DOI 10.1016/j.biopha.2018.09.097
   Deshayes S, 2020, BBA-BIOMEMBRANES, V1862, P0, DOI 10.1016/j.bbamem.2020.183252
   Falanga A, 2020, FUTURE MED CHEM, V12, P1431, DOI 10.4155/fmc-2020-0140
   Faria R, 2020, J MOL LIQ, V316, P0, DOI 10.1016/j.molliq.2020.113873
   Faria R, 2019, J MOL LIQ, V292, P0, DOI 10.1016/j.molliq.2019.111391
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Gessner I, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21072536
   Gómez-Aguado I, 2020, MOLECULES, V25, P0, DOI 10.3390/molecules25245995
   Hertweck KL, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00262
   Jain A, 2016, FEBS LETT, V590, P2896, DOI 10.1002/1873-3468.12329
   Jang YH, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23092316
   Javadov S, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051177
   Jiang WX, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17086-7
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   Khan MM, 2021, J CONTROL RELEASE, V330, P1220, DOI 10.1016/j.jconrel.2020.11.028
   Konate K, 2019, BIOCONJUGATE CHEM, V30, P592, DOI 10.1021/acs.bioconjchem.8b00776
   Leng QX, 2007, DRUG NEWS PERSPECT, V20, P77, DOI 10.1358/dnp.2007.20.2.1083026
   Li Y, 2018, ADV HEALTHC MATER, V7, P0, DOI 10.1002/adhm.201700886
   Martín-Jiménez R, 2020, DNA CELL BIOL, V39, P1421, DOI 10.1089/dna.2020.5398
   McNeil SE, 2011, METHODS MOL BIOL, V697, P1, DOI 10.1007/978-1-60327-198-1
   Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009
   Monlleo-Neila L, 2013, J CHILD NEUROL, V28, P1531, DOI 10.1177/0883073812460580
   Muhammad K, 2020, J MATER CHEM B, V8, P9621, DOI 10.1039/d0tb01675f
   Neves AR, 2020, COLLOID SURFACE B, V185, P0, DOI 10.1016/j.colsurfb.2019.110610
   Ozsvari B, 2018, AGING-US, V10, P229, DOI 10.18632/aging.101384
   Park D, 2020, BMB REP, V53, P3, DOI 10.5483/BMBRep.2020.53.1.272
   Pinti MV, 2019, AM J PHYSIOL-ENDOC M, V316, PE268, DOI 10.1152/ajpendo.00314.2018
   Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194
   Prag HA, 2020, NAT CANCER, V1, P941, DOI 10.1038/s43018-020-00128-x
   Rasmussen MK, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15889-3
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   Ruseska I, 2020, BEILSTEIN J NANOTECH, V11, P101, DOI 10.3762/bjnano.11.10
   Sabourian P, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21218019
   Shang L, 2014, J NANOBIOTECHNOL, V12, P0, DOI 10.1186/1477-3155-12-5
   Slone J, 2020, NPJ GENOM MED, V5, P0, DOI 10.1038/s41525-020-0116-5
   Sousa A, 2019, COLLOID SURFACE B, V183, P0, DOI 10.1016/j.colsurfb.2019.110417
   Su SC, 2021, STAR PROTOC, V2, P0, DOI 10.1016/j.xpro.2020.100275
   Tavassoly I, 2015, CPT-PHARMACOMET SYST, V4, P263, DOI 10.1002/psp4.29
   Tiwari M, 2015, APOPTOSIS, V20, P1019, DOI 10.1007/s10495-015-1136-y
   Wang HL, 2019, J GENE MED, V21, P0, DOI 10.1002/jgm.3101
   Wang WZ, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00376-6
   Zhang XY, 2016, ONCOL LETT, V12, P4887, DOI 10.3892/ol.2016.5302
   Zhu XJ, 2019, SMALL, V15, P0, DOI 10.1002/smll.201803428
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
NR 55
TC 12
Z9 12
U1 2
U2 35
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD JUN 15
PY 2021
VL 13
IS 11
BP 
EP 
DI 10.3390/polym13111836
PG 19
WC Polymer Science
SC Polymer Science
GA SQ7EG
UT WOS:000660514400001
PM 34206125
DA 2024-11-01
ER

PT J
AU Binder, MS
   Roda, RH
   Corse, AM
   Sidhu, S
   Stewart, S
   Barth, AS
AF Scott Binder, M.
   Roda, Ricardo H.
   Corse, Andrea M.
   Sidhu, Sunjeet
   Stewart, Sarah
   Barth, Andreas S.
TI Prevalence of heart disease in patients with mitochondrial abnormalities on skeletal muscle biopsy
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
AB Objective: Mitochondrial DNA mutations are associated with an increased risk of heart disease. Whether an increased prevalence of cardiovascular disease is present in patients presenting with mitochondrial abnormalities on skeletal muscle biopsy remains unknown. This study was designed to determine the prevalence of cardiac conduction disease and structural heart disease in patients presenting with mitochondrial abnormalities on skeletal muscle biopsy. Methods: This is a retrospective cohort study of 103 patients with mitochondrial abnormalities on skeletal muscle biopsy who were referred for evaluation of muscle weakness at a single tertiary care referral center from 2012 to 2018. Of these patients, 59 (57.3%) had an electrocardiogram available and were evaluated for the presence of conduction disease. An echocardiogram was available in 43 patients (42%) who were evaluated for the presence of structural heart disease. The prevalence of cardiac disease was compared to control cohort populations (Framingham and the Atherosclerosis Risk in Communities, ARIC cohorts). Results: Mitochondrial abnormalities associated with cardiac conduction disease (defined as QRS duration >= 120 msec) were present in 8.9%, versus 2.0% (p < 0.001) in the Framingham population and 2.6% (p = 0.003) in the ARIC cohort. LV systolic dysfunction (LVEF <= 50%) was present in 11.6%, versus 3.6% (p < 0.01) in the Framingham and 3% (p < 0.01) in the ARIC populations. Left ventricular hypertrophy was present in 28.6%, versus 13.6% (p < 0.02) in the Framingham and 10.4% (p < 0.001) in the ARIC populations. Interpretation: Given the increased prevalence of cardiovascular disease, patients with mitochondrial abnormalities on skeletal muscle biopsy should undergo routine cardiac screening with physical exam, electrocardiography, and cardiac imaging.
C1 [Scott Binder, M.] Johns Hopkins Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA.
   [Roda, Ricardo H.; Corse, Andrea M.; Stewart, Sarah] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Sidhu, Sunjeet; Barth, Andreas S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University
RP Barth, AS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, 720 Rutland Ave,Ross 871, Baltimore, MD 21287 USA.
EM abarth3@jh.edu
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049
   Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888
   Chong-Nguyen C, 2020, J INHERIT METAB DIS, V43, P478, DOI 10.1002/jimd.12195
   Fernandes-Silva MM, 2017, JACC-HEART FAIL, V5, P157, DOI 10.1016/j.jchf.2016.10.011
   Ho JE, 2016, CIRC-HEART FAIL, V9, P0, DOI 10.1161/CIRCHEARTFAILURE.115.003116
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Konety SH, 2016, CIRC-CARDIOVASC IMAG, V9, P0, DOI 10.1161/CIRCIMAGING.115.004431
   Kouyoumdjian João A, 2018, J. BRAS. PATOL. MED. LAB., V54, P325, DOI 10.5935/1676-2444.20180054
   KREGER BE, 1989, AM HEART J, V117, P903, DOI 10.1016/0002-8703(89)90630-3
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Quadir A, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000339
   SAVAGE DD, 1987, CIRCULATION, V75, P26
   Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Zhang ZM, 2015, J CARD FAIL, V21, P307, DOI 10.1016/j.cardfail.2015.01.001
NR 21
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD APR 15
PY 2021
VL 8
IS 4
BP 825
EP 830
DI 10.1002/acn3.51327
EA FEB 2021
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA RW6JN
UT WOS:000622344900001
PM 33638621
DA 2024-11-01
ER

PT J
AU Becanovic, K
   Muhammad, A
   Gadawska, I
   Sachdeva, S
   Walker, D
   Lazarowski, ER
   Franciosi, S
   Park, KHJ
   Côté, HCF
   Leavitt, BR
AF Becanovic, Kristina
   Muhammad, Asghar
   Gadawska, Izabella
   Sachdeva, Shiny
   Walker, David
   Lazarowski, Eduardo. R.
   Franciosi, Sonia
   Park, Kevin H. J.
   Cote, Helene C. F.
   Leavitt, Blair R.
TI Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease
SO NPJ AGING AND MECHANISMS OF DISEASE
LA English
DT Article
ID dna copy number; mutant huntingtin; mouse model; oxidative damage; energy-metabolism; in-vivo; neurons; abnormality; dysfunction; biogenesis
AB Mitochondrial dysfunction and bioenergetics failure are common pathological hallmarks in Huntington's disease (HD) and aging. In the present study, we used the YAC128 murine model of HD to examine the effects of mutant huntingtin on mitochondrial parameters related to aging in brain and skeletal muscle. We have conducted a cross-sectional natural history study of mitochondrial DNA changes in the YAC128 mouse. Here, we first show that the mitochondrial volume fraction appears to increase in the axons and dendrite regions adjacent to the striatal neuron cell bodies in old mice. Mitochondrial DNA copy number (mtDNAcn) was used as a proxy measure for mitochondrial biogenesis and function. We observed that the mtDNAcn changes significantly with age and genotype in a tissue-specific manner. We found a positive correlation between aging and the mtDNAcn in striatum and skeletal muscle but not in cortex. Notably, the YAC128 mice had lower mtDNAcn in cortex and skeletal muscle. We further show that mtDNA deletions are present in striatal and skeletal muscle tissue in both young and aged YAC128 and WT mice. Tracking gene expression levels cross-sectionally in mice allowed us to identify contributions of age and genotype to transcriptional variance in mitochondria-related genes. These findings provide insights into the role of mitochondrial dynamics in HD pathogenesis in both brain and skeletal muscle, and suggest that mtDNAcn in skeletal muscle tissue may be a potential biomarker that should be investigated further in human HD.
C1 [Becanovic, Kristina; Franciosi, Sonia; Park, Kevin H. J.; Leavitt, Blair R.] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada.
   [Becanovic, Kristina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Muhammad, Asghar] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden.
   [Muhammad, Asghar] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.
   [Gadawska, Izabella; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.
   [Sachdeva, Shiny; Walker, David] St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Dis, Vancouver, BC, Canada.
   [Lazarowski, Eduardo. R.] Univ N Carolina, Cyst Fibrosis Res Ctr, Marsico Lung Inst, Chapel Hill, NC USA.
   [Franciosi, Sonia] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.
   [Park, Kevin H. J.] Cent Michigan Univ, Dept Psychol & Neurosci Program, Mt Pleasant, MI USA.
C3 University of British Columbia; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of British Columbia; St. Paul's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia; Central Michigan University
RP Becanovic, K (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada.; Becanovic, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
EM Kristina.Becanovic@ki.se
FU Karolinska Institute
CR Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004
   Almeida S, 2008, BIOCHEM BIOPH RES CO, V374, P599, DOI 10.1016/j.bbrc.2008.07.009
   Arnold B, 2011, NEUROBIOL DIS, V41, P189, DOI 10.1016/j.nbd.2010.09.006
   ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Bates GP, 2015, NAT REV DIS PRIMERS, V1, P0, DOI 10.1038/nrdp.2015.5
   Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P137, DOI 10.1016/j.brainresbull.2011.05.005
   Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004
   Bozzi M, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21218314
   Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514
   Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x
   Carroll JB, 2011, NEUROBIOL DIS, V43, P257, DOI 10.1016/j.nbd.2011.03.018
   Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004
   Chandra A, 2016, HUM MOL GENET, V25, P2269, DOI 10.1093/hmg/ddw095
   Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   CHEN X, 1995, BBA-MOL BASIS DIS, V1271, P229, DOI 10.1016/0925-4439(95)00032-Y
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cortes CJ, 2014, DRUG DISCOV TODAY, V19, P963, DOI 10.1016/j.drudis.2014.02.014
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Disatnik MH, 2016, J EXP MED, V213, P2655, DOI 10.1084/jem.20160776
   Djoussé L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF
   Dunah AW, 2000, MOL BRAIN RES, V79, P77, DOI 10.1016/S0169-328X(00)00102-9
   DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017
   Flurkey K, 2007, AMERICAN COLLEGE OF LABORATORY ANIMAL MEDICINE, VSecond, P637, DOI 10.1016/B978-012369454-6/50074-1
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Franciosi S, 2012, NEUROBIOL DIS, V45, P438, DOI 10.1016/j.nbd.2011.09.003
   Franco-Iborra S, 2021, AUTOPHAGY, V17, P672, DOI 10.1080/15548627.2020.1728096
   Gan ZJ, 2018, CELL RES, V28, P969, DOI 10.1038/s41422-018-0078-7
   Glaser J, 2018, MUSCLE CELL TISSUE C, V0, P0
   Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317
   Hamilton J, 2015, HUM MOL GENET, V24, P4862, DOI 10.1093/hmg/ddv209
   Hering T, 2017, EXP NEUROL, V288, P167, DOI 10.1016/j.expneurol.2016.10.017
   Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004
   Hodges JL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0101770
   HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879
   Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200
   LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D
   Liu HY, 2017, J BIOENERG BIOMEMBR, V49, P413, DOI 10.1007/s10863-017-9727-7
   Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014
   Lodi R, 2000, ANN NEUROL, V48, P72
   Martin WRW, 2007, J NEUROL SCI, V263, P70, DOI 10.1016/j.jns.2007.05.035
   MARTIN WRW, 1992, NEUROLOGY, V42, P223, DOI 10.1212/WNL.42.1.223
   Martinez-Vicente M, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00064
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   Mielcarek M, 2015, CLIN TRANSL MED, V4, P0, DOI 10.1186/s40169-015-0076-z
   Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Reith A, 1988, STEREOLOGY MORPHOMET, V0, P0
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Saft C, 2005, MOVEMENT DISORD, V20, P674, DOI 10.1002/mds.20373
   Sassone J, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.300
   Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169
   Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313
   Squitieri F, 2010, J NEURAL TRANSM, V117, P77, DOI 10.1007/s00702-009-0328-4
   STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259
   Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E
   TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008
   Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104
   Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004
   Van Laar VS, 2018, J NEUROSCI, V38, P7505, DOI 10.1523/JNEUROSCI.0541-18.2018
   Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407
   Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030
   Yang HM, 2017, FRONT AGING NEUROSCI, V9, P0, DOI 10.3389/fnagi.2017.00193
   Yoshii SR, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18091865
   Zhang JH, 2015, REDOX BIOL, V4, P242, DOI 10.1016/j.redox.2015.01.003
   Zielonka D, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00380
NR 93
TC 14
Z9 14
U1 1
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2056-3973
J9 NPJ AGING MECH DIS
JI npj Aging Mech. Dis.
PD OCT 14
PY 2021
VL 7
IS 1
BP 
EP 
DI 10.1038/s41514-021-00079-2
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA WG9WK
UT WOS:000707341200001
PM 34650085
DA 2024-11-01
ER

PT J
AU Lu, JQ
   Tarnopolsky, MA
AF Lu, Jian-Qiang
   Tarnopolsky, Mark A.
TI Mitochondrial neuropathy and neurogenic features in mitochondrial myopathy
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial disease; Mitochondrial myopathy; Mitochondrial neuropathy; Neuromuscular junction; Neurogenic features; Nerve and muscle pathology
ID progressive external ophthalmoplegia; kearns-sayre syndrome; peripheral neuropathy; neuromuscular-junction; skeletal-muscle; spinocerebellar ataxia; infantile onset; point mutation; leigh-syndrome; dna
AB Mitochondrial diseases (MIDs) involve multiple organs including peripheral nerves and skeletal muscle. Mitochondrial neuropathy (MN) and mitochondrial myopathy (MM) are commonly associated and linked at the neuromuscular junction (NMJ). Herein we review MN in connection with neurogenic features of MM, and pathological evidence for the involvement of the peripheral nerve and NMJ in MID patients traditionally assumed to have predominantly MM. MN is not uncommon, but still likely under-reported, and muscle biopsies of MM commonly exhibit neurogenic features. Pathological examination remains the gold standard to assess the nerve and muscle changes in patients with MIDs. Ultrastructural studies by electron microscopy are often necessary to fully characterize the pathology of mitochondrial cytopathy in MN and MM.
C1 [Lu, Jian-Qiang] McMaster Univ, Dept Pathol & Mol Med Neuropathol, Hamilton, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Dept Med Neurol, Hamilton, ON, Canada.
   [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada.
C3 McMaster University; McMaster University; McMaster University
RP Lu, JQ (corresponding author), Hamilton Gen Hosp, Dept Pathol & Mol Med Neuropathol, 237 Barton St, Hamilton, ON L8L 2X2, Canada.
EM luj85@mcmaster.ca
CR Almutawa W, 2019, EBIOMEDICINE, V45, P379, DOI 10.1016/j.ebiom.2019.06.018
   Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001
   Baumann M, 2019, CLIN GENET, V95, P182, DOI 10.1111/cge.13462
   Bindu PS, 2016, MITOCHONDRION, V27, P1, DOI 10.1016/j.mito.2015.12.009
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Boyd KU, 2011, CLIN PLAST SURG, V38, P643, DOI 10.1016/j.cps.2011.07.008
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   Colomer J, 2000, REV NEUROLOGIA, V30, P1117, DOI 10.33588/rn.3012.2000079
   COQUET M, 1993, NEUROMUSCULAR DISORD, V3, P593, DOI 10.1016/0960-8966(93)90122-Z
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dubowitz V, 2020, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   Dupuis L, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005390
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017
   FUJII T, 1991, J NEUROL SCI, V103, P37, DOI 10.1016/0022-510X(91)90280-K
   Gehrig SM, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0488-x
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   GOEBEL HH, 1986, MUSCLE NERVE, V9, P165, DOI 10.1002/mus.880090210
   Graham LC, 2017, MOL NEURODEGENER, V12, P0, DOI 10.1186/s13024-017-0221-9
   Haas RH, 2014, SEMIN NEUROL, V34, P321, DOI 10.1055/s-0034-1386770
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Higuchi Y, 2018, BRAIN, V141, P1622, DOI 10.1093/brain/awy104
   Hollenbeck PJ, 2005, NEURON, V47, P331, DOI 10.1016/j.neuron.2005.07.017
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Ji KQ, 2020, J NEUROL, V267, P3319, DOI 10.1007/s00415-020-10017-z
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kablar B, 1999, DEV BIOL, V208, P93, DOI 10.1006/dbio.1998.9184
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   KRENDEL DA, 1987, MUSCLE NERVE, V10, P299, DOI 10.1002/mus.880100404
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515
   Lehmann D, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000113
   Lepore E, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8080906
   Lu JQ, 2020, J NEUROL SCI, V413, P0, DOI 10.1016/j.jns.2020.116816
   Lu JQ, 2019, J NEUROPATH EXP NEUR, V78, P508, DOI 10.1093/jnen/nlz029
   Lu JQ, 2016, J NEUROL SCI, V360, P84, DOI 10.1016/j.jns.2015.11.053
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Mitchell WK, 2012, FRONT PHYSIOL, V3, P0, DOI 10.3389/fphys.2012.00260
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   MIZUSAWA H, 1991, REV NEUROL, V147, P501
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   MOLNAR M, 1995, NEUROPATH APPL NEURO, V21, P432, DOI 10.1111/j.1365-2990.1995.tb01080.x
   Mosole S, 2014, J NEUROPATH EXP NEUR, V73, P284, DOI 10.1097/NEN.0000000000000032
   Naumann M, 1997, MUSCLE NERVE, V20, P833, DOI 10.1002/(SICI)1097-4598(199707)20:7<833::AID-MUS7>3.0.CO;2-8
   Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Prada V, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01218
   Rebelo AP, 2018, BRAIN, V141, P662, DOI 10.1093/brain/awx369
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   SAKUTA R, 1989, ANN NEUROL, V25, P594, DOI 10.1002/ana.410250611
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850
   Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   SCHRODER JM, 1991, ACTA NEUROPATHOL, V82, P471, DOI 10.1007/BF00293381
   Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123
   Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156
   SIMON LT, 1990, ANN NEUROL, V28, P349, DOI 10.1002/ana.410280308
   So E, 2018, HUM MOL GENET, V27, P463, DOI 10.1093/hmg/ddx415
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Tryon LD, 2015, AM J PHYSIOL-CELL PH, V309, PC228, DOI 10.1152/ajpcell.00266.2014
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215
   Vannucci B, 2019, MUSCLE NERVE, V60, P604, DOI 10.1002/mus.26654
   Venhoff N, 2012, ARTHRITIS RES THER, V14, P0, DOI 10.1186/ar4076
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Vu TH, 1998, NEUROLOGY, V51, P1190, DOI 10.1212/WNL.51.4.1190
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   WICKS KL, 1991, AM J PHYSIOL, V260, PC841, DOI 10.1152/ajpcell.1991.260.4.C841
   Wilson MH, 2005, INT J NEUROSCI, V115, P803, DOI 10.1080/00207450590882172
   Wilson RJ, 2018, FREE RADICAL BIO MED, V117, P180, DOI 10.1016/j.freeradbiomed.2018.02.006
   Yamadera M, 2019, NEUROPATHOLOGY, V39, P404, DOI 10.1111/neup.12593
   Yasuda K, 2019, J CLIN NEUROSCI, V61, P302, DOI 10.1016/j.jocn.2018.10.054
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Zanssen S, 1998, CLIN NEUROPATHOL, V17, P291
NR 101
TC 10
Z9 10
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2021
VL 56
IS 
BP 52
EP 61
DI 10.1016/j.mito.2020.11.005
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA PQ1TJ
UT WOS:000606333800007
PM 33220502
DA 2024-11-01
ER

PT J
AU Protasoni, M
   Zeviani, M
AF Protasoni, Margherita
   Zeviani, Massimo
TI Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE ATP production; biogenesis of the respiratory chain; mitochondrial disease; mi-tochondrial electrochemical gradient; mitochondrial potential; mitochondrial proton pumping; mitochondrial respiratory chain; oxidative phosphorylation; respiratory complex; respiratory supercomplex
ID cytochrome-c-oxidase; complex-i deficiency; iron-sulfur protein; hereditary optic neuropathy; gastrointestinal stromal tumors; atp synthase deficiency; yeast nuclear gene; respiratory-chain; assembly factor; bc(1) complex
AB Mitochondria are ubiquitous intracellular organelles found in almost all eukaryotes and involved in various aspects of cellular life, with a primary role in energy production. The interest in this organelle has grown stronger with the discovery of their link to various pathologies, including cancer, aging and neurodegenerative diseases. Indeed, dysfunctional mitochondria cannot provide the required energy to tissues with a high-energy demand, such as heart, brain and muscles, leading to a large spectrum of clinical phenotypes. Mitochondrial defects are at the origin of a group of clinically heterogeneous pathologies, called mitochondrial diseases, with an incidence of 1 in 5000 live births. Primary mitochondrial diseases are associated with genetic mutations both in nuclear and mitochondrial DNA (mtDNA), affecting genes involved in every aspect of the organelle function. As a consequence, it is difficult to find a common cause for mitochondrial diseases and, subsequently, to offer a precise clinical definition of the pathology. Moreover, the complexity of this condition makes it challenging to identify possible therapies or drug targets.
C1 [Protasoni, Margherita; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Protasoni, Margherita; Zeviani, Massimo] Univ Cambridge, Cambridge CB2 0XY, England.
   [Zeviani, Massimo] Univ Padua, Dept Neurosci, I-35128 Padua, Italy.
C3 University of Cambridge; University of Padua
RP Zeviani, M (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.; Zeviani, M (corresponding author), Univ Cambridge, Cambridge CB2 0XY, England.; Zeviani, M (corresponding author), Univ Padua, Dept Neurosci, I-35128 Padua, Italy.
EM mp802@mrc-mbu.cam.ac.uk; massimo.zeviani@unipd.it
FU UK Medical Research Council [MC_UU_ 00015/5]; European Research Council [FP7-322424]; NRJ-Institut de France; Fondazione Renato Comini ONLUS; Telethon Italy [GGP19007]; MRC [MC_UU_00015/5] Funding Source: UKRI
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Abu-Libdeh B, 2017, EUR J HUM GENET, V25, P1142, DOI 10.1038/ejhg.2017.112
   Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009
   Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986
   Adeva-Andany MM, 2019, MITOCHONDRION, V46, P73, DOI 10.1016/j.mito.2018.02.009
   Aich A, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.32572
   Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005
   Alahmad A, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.202012619
   Alberts B, 2007, MOL BIOL CELL, V0, P0
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Alston CL, 2018, AM J HUM GENET, V103, P592, DOI 10.1016/j.ajhg.2018.08.013
   Alston CL, 2016, AM J HUM GENET, V99, P217, DOI 10.1016/j.ajhg.2016.05.021
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103
   Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110
   Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030
   Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469
   Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11
   Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793
   Baertling F, 2017, HUM MUTAT, V38, P692, DOI 10.1002/humu.23210
   Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715
   Baker RA, 2019, AM J MED GENET A, V179, P373, DOI 10.1002/ajmg.a.61019
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006
   Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020
   Baysal BE, 2004, J MED GENET, V41, P703, DOI 10.1136/jmg.2004.019224
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   BECKMANN JD, 1987, J BIOL CHEM, V262, P8901
   Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berg JM, 2002, BIOCHEMISTRY, V5th ed., P0
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Berry EA, 1999, J BIOENERG BIOMEMBR, V31, P177, DOI 10.1023/A:1005459426843
   Berry EA, 2013, BBA-BIOENERGETICS, V1827, P1258, DOI 10.1016/j.bbabio.2013.04.006
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111
   Blázques A, 2009, NEUROMUSCULAR DISORD, V19, P143, DOI 10.1016/j.nmd.2008.11.016
   Bode M, 2015, MOL BIOL CELL, V26, P2385, DOI 10.1091/mbc.E14-11-1526
   Bosley TM, 2008, INVEST OPHTH VIS SCI, V49, P5250, DOI 10.1167/iovs.08-2193
   Bottani E, 2017, MOL CELL, V67, P96, DOI 10.1016/j.molcel.2017.06.001
   Bourens M, 2017, J BIOL CHEM, V292, P7774, DOI 10.1074/jbc.M117.778514
   Bourens M, 2017, EMBO REP, V18, P477, DOI 10.15252/embr.201643103
   Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003
   BOUZIDI MF, 1993, NEUROMUSCULAR DISORD, V3, P599
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   BRANDT U, 1994, J BIOL CHEM, V269, P12947
   BRANDT U, 1993, J BIOL CHEM, V268, P8387
   Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041
   BROWN MD, 1992, GENETICS, V130, P163
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206
   Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98
   Cabrera-Orefice A, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06955-y
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033
   Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5
   Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076
   Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200
   Gil-Borlado MC, 2009, MITOCHONDRION, V9, P299, DOI 10.1016/j.mito.2009.04.001
   Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106
   Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531
   Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700
   Cerqua C, 2018, BBA-BIOENERGETICS, V1859, P244, DOI 10.1016/j.bbabio.2018.01.004
   CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0
   Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006
   Chiabrando D, 2014, FRONT PHARMACOL, V5, P0, DOI 10.3389/fphar.2014.00061
   Chinnaiyan Arul M, 1999, NEOPLASIA (NEW YORK), V1, P5
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   CHRISTIANSON T, 1983, P NATL ACAD SCI-BIOL, V80, P5564, DOI 10.1073/pnas.80.18.5564
   Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200
   Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Clemente P, 2013, J BIOL CHEM, V288, P8321, DOI 10.1074/jbc.M112.422220
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Colombini M, 1980, ANN N Y ACAD SCI, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x
   COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   CRIVELLONE MD, 1994, J BIOL CHEM, V269, P21284
   Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226
   Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12
   DAurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dallabona C, 2016, BRAIN, V139, P782, DOI 10.1093/brain/awv392
   Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975
   Davies KM, 2018, P NATL ACAD SCI USA, V115, P3024, DOI 10.1073/pnas.1720702115
   Dawitz H, 2020, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.01555
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Dean DR, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005192
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   DEHAAN M, 1984, EUR J BIOCHEM, V138, P169
   Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y
   Demishtein-Zohary K, 2017, CELL TISSUE RES, V367, P33, DOI 10.1007/s00441-016-2486-7
   Deng K, 2001, J BIOL CHEM, V276, P6499, DOI 10.1074/jbc.M007128200
   Deng KP, 1998, J BIOL CHEM, V273, P20752, DOI 10.1074/jbc.273.33.20752
   Dennerlein S, 2015, CELL REP, V12, P1644, DOI 10.1016/j.celrep.2015.08.009
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05
   Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11
   DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513
   DIECKMANN CL, 1982, P NATL ACAD SCI-BIOL, V79, P1805, DOI 10.1073/pnas.79.6.1805
   Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108
   Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102
   DUMONT ME, 1993, MOL CELL BIOL, V13, P6442, DOI 10.1128/MCB.13.10.6442
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Dwight T, 2017, BMC CANCER, V17, P0, DOI 10.1186/s12885-017-3486-z
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   ERNSTER L, 1981, J CELL BIOL, V91, PS227, DOI 10.1083/jcb.91.3.227s
   FATO R, 1986, BIOCHEMISTRY-US, V25, P3378, DOI 10.1021/bi00359a043
   Fedor JG, 2018, CELL METAB, V28, P525, DOI 10.1016/j.cmet.2018.05.024
   Feichtinger RG, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/7202589
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fernandez-Vizarra E, 2018, CELL CYCLE, V17, P681, DOI 10.1080/15384101.2017.1417707
   Fernández-Vizarra E, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00134
   Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x
   Formosa LE, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107541
   Formosa LE, 2015, HUM MOL GENET, V24, P2952, DOI 10.1093/hmg/ddv058
   Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267
   Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431
   Friedrich T, 2016, BBA-BIOENERGETICS, V1857, P214, DOI 10.1016/j.bbabio.2015.12.004
   FU W, 1990, J BIOL CHEM, V265, P16541
   Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015
   Gerber S, 2017, BRAIN, V140, P2586, DOI 10.1093/brain/awx219
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2018, ESSAYS BIOCHEM, V62, P271, DOI 10.1042/EBC20170099
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378
   Giachin G, 2016, FRONT MOL BIOSCI, V3, P0, DOI 10.3389/fmolb.2016.00043
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1
   Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004
   Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088
   Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504
   Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049
   GRAHAM LA, 1994, BIOCHEM SOC T, V22, P188, DOI 10.1042/bst0220188
   Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004
   Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789
   Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132
   Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359
   Guarani V, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.06265
   Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13
   Guarás A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Gusic M, 2020, AM J HUM GENET, V106, P102, DOI 10.1016/j.ajhg.2019.12.005
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017
   Habibzadeh P, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00944
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   Hällberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001
   Hallmann K, 2016, BRAIN, V139, P338, DOI 10.1093/brain/awv357
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689
   Hartley AM, 2020, P NATL ACAD SCI USA, V117, P9329, DOI 10.1073/pnas.1920612117
   Hartley AM, 2019, NAT STRUCT MOL BIOL, V26, P78, DOI 10.1038/s41594-018-0172-z
   HATEFI Y, 1962, J BIOL CHEM, V237, P2661
   Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0
   Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Hejzlarová K, 2014, PHYSIOL RES, V63, PS57, DOI 10.33549/physiolres.932643
   Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571
   Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530
   Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009
   HILL BC, 1993, J BIOENERG BIOMEMBR, V25, P115, DOI 10.1007/BF00762853
   Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210
   Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262
   Hirst J, 2016, BBA-BIOENERGETICS, V1857, P872, DOI 10.1016/j.bbabio.2015.12.009
   Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619
   HOCHLI M, 1979, P NATL ACAD SCI USA, V76, P1236, DOI 10.1073/pnas.76.3.1236
   Hock DH, 2020, MOL CELL PROTEOMICS, V19, P1145, DOI 10.1074/mcp.RA120.002076
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204
   Hoffmann A, 2018, FRONT BEHAV NEUROSCI, V12, P0, DOI 10.3389/fnbeh.2018.00306
   Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   HOWELL N, 1991, AM J HUM GENET, V49, P939
   Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Huynen MA, 2016, BBA-MOL CELL RES, V1863, P91, DOI 10.1016/j.bbamcr.2015.10.009
   Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776
   Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Inoue M, 2019, ANN NEUROL, V86, P193, DOI 10.1002/ana.25517
   Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441
   Ishigami I, 2017, P NATL ACAD SCI USA, V114, P8011, DOI 10.1073/pnas.1705628114
   Islas-Osuna MA, 2003, CURR GENET, V43, P327, DOI 10.1007/s00294-003-0405-4
   Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008
   Iwata M, 1999, J BIOENERG BIOMEMBR, V31, P169, DOI 10.1023/A:1005407410005
   Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64
   Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Jonckheere An I, 2009, BMJ CASE REP, V2009, P0, DOI 10.1136/bcr.07.2008.0504
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111
   Kater L, 2020, NAT STRUCT MOL BIOL, V27, P142, DOI 10.1038/s41594-019-0364-1
   Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   KEILIN D, 1947, BIOCHEM J, V41, P500, DOI 10.1042/bj0410500
   Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562
   Krause-Buchholz U, 2005, BIOL CHEM, V386, P407, DOI 10.1515/BC.2005.049
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Krüger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563
   Kühlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903
   Kühlbrandt W, 2015, BMC BIOL, V13, P0, DOI 10.1186/s12915-015-0201-x
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197
   Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001
   Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158
   Lenaz G, 1999, BIOFACTORS, V9, P87, DOI 10.1002/biof.5520090202
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022
   Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460
   Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774
   Levitas A, 2010, EUR J HUM GENET, V18, P1160, DOI 10.1038/ejhg.2010.83
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lim SC, 2014, AM J HUM GENET, V94, P209, DOI 10.1016/j.ajhg.2013.12.015
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Llorente-Garcia I, 2014, BBA-BIOENERGETICS, V1837, P811, DOI 10.1016/j.bbabio.2014.01.020
   Lobo-Jarne T, 2018, CELL REP, V25, P1786, DOI 10.1016/j.celrep.2018.10.058
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Lodish HF, 2013, MOLECULAR CELL BIOLOGY, V0, P0
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Lorenzi I, 2018, BBA-MOL CELL RES, V1865, P323, DOI 10.1016/j.bbamcr.2017.11.010
   Lussey-Lepoutre C, 2017, METABOLITES, V7, P0, DOI 10.3390/metabo7020017
   Lyons AM, 2016, J MED GENET, V53, P846, DOI 10.1136/jmedgenet-2016-104194
   Lytovchenko O, 2014, EMBO J, V33, P1624, DOI 10.15252/embj.201488076
   MAARSE AC, 1987, EUR J BIOCHEM, V165, P419, DOI 10.1111/j.1432-1033.1987.tb11455.x
   Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005
   Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009
   Mansilla N, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19030662
   Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845
   Marcet-Houben M, 2009, BMC EVOL BIOL, V9, P0, DOI 10.1186/1471-2148-9-295
   MARGULIS L, 1970, P349, V0, P0
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mathieu L, 2011, MITOCHONDRION, V11, P391, DOI 10.1016/j.mito.2010.12.002
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   MCEWEN JE, 1993, CURR GENET, V23, P9, DOI 10.1007/BF00336742
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012
   McWhinney SR, 2007, NEW ENGL J MED, V357, P1054, DOI 10.1056/NEJMc071191
   Melchionda L, 2014, AM J HUM GENET, V95, P315, DOI 10.1016/j.ajhg.2014.08.003
   Michel H, 1999, NATURE, V402, P602, DOI 10.1038/45133
   Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053
   Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026
   Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009
   Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888
   MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7
   Miyake N, 2013, HUM MUTAT, V34, P446, DOI 10.1002/humu.22257
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   Morán M, 2010, HUM MUTAT, V31, P930, DOI 10.1002/humu.21294
   Mordas A, 2015, ACCOUNTS CHEM RES, V48, P2191, DOI 10.1021/acs.accounts.5b00150
   Mordaunt DA, 2015, AM J MED GENET A, V167, P1330, DOI 10.1002/ajmg.a.36968
   Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015
   Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4
   Morino H, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-5
   Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490
   Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x
   Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x
   Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003
   NOBREGA FG, 1980, J BIOL CHEM, V255, P9828
   NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x
   NOBREGA MP, 1990, J BIOL CHEM, V265, P14220
   Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Nouet C, 2009, J MOL BIOL, V388, P252, DOI 10.1016/j.jmb.2009.03.018
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Ogun ASVM, 2019, BIOCH HEME SYNTHESIS, V0, P0
   Oláhová M, 2019, HUM MOL GENET, V28, P3766, DOI 10.1093/hmg/ddz202
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Oláhová M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214
   Ostergaard E, 2011, J MED GENET, V48, P737, DOI 10.1136/jmg.2011.088856
   OUDSHOORN P, 1987, EUR J BIOCHEM, V163, P97, DOI 10.1111/j.1432-1033.1987.tb10741.x
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188
   Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI 10.1042/BSE0470037
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Pérez-Pérez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Peters JW, 2018, CURR OPIN CHEM BIOL, V47, P32, DOI 10.1016/j.cbpa.2018.07.026
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   PHILLIPS JD, 1990, J BIOL CHEM, V265, P20813
   PHILLIPS JD, 1993, J BIOL CHEM, V268, P11727
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Piekutowska-Abramczuk D, 2018, AM J HUM GENET, V102, P460, DOI 10.1016/j.ajhg.2018.01.008
   Pilet E, 2004, P NATL ACAD SCI USA, V101, P16198, DOI 10.1073/pnas.0405032101
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Pozzan T, 2000, EUR J BIOCHEM, V267, P5269, DOI 10.1046/j.1432-1327.2000.01567.x
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Protasoni M, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019102817
   Protasoni M, 2020, MOL GENET METAB, V129, P26, DOI 10.1016/j.ymgme.2019.11.003
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364
   Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020
   Rathore S, 2019, NAT STRUCT MOL BIOL, V26, P50, DOI 10.1038/s41594-018-0169-7
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Rebelo AP, 2018, BRAIN, V141, P662, DOI 10.1093/brain/awx369
   Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945
   REID RA, 1966, NATURE, V212, P257, DOI 10.1038/212257a0
   Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200
   Reinson K, 2019, EUR J MED GENET, V62, P0, DOI 10.1016/j.ejmg.2018.11.006
   Rendón OZ, 2016, MOL CELL BIOL, V36, P2132, DOI 10.1128/MCB.00066-16
   Renkema GH, 2017, HUM GENET, V136, P759, DOI 10.1007/s00439-017-1794-7
   Rhein VF, 2016, J BIOL CHEM, V291, P14851, DOI 10.1074/jbc.M116.734970
   Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803
   Rieger B, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep46055
   Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010
   RODEL G, 1986, CURR GENET, V11, P47, DOI 10.1007/BF00389425
   Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   SADLER I, 1984, EMBO J, V3, P2137, DOI 10.1002/j.1460-2075.1984.tb02103.x
   Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384
   Salvatori R, 2020, MOL CELL, V77, P887, DOI 10.1016/j.molcel.2019.11.019
   Sánchez E, 2013, BBA-BIOENERGETICS, V1827, P285, DOI 10.1016/j.bbabio.2012.11.003
   Sánchez-Caballero L, 2020, BBA-BIOENERGETICS, V1861, P0, DOI 10.1016/j.bbabio.2020.148202
   Sánchez-Caballero L, 2016, AM J HUM GENET, V99, P208, DOI 10.1016/j.ajhg.2016.05.022
   Sánchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Schäfer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200
   Schägger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Scharwey M, 2013, J CELL SCI, V126, P5317, DOI 10.1242/jcs.134130
   Scheffler IE, 1999, MITOCHONDRIA, V0, P0
   Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706
   Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Siddiqi S, 2013, J HUM GENET, V58, P819, DOI 10.1038/jhg.2013.101
   Signes A, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809582
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Sinkler CA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1534056
   Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0
   Sköldberg F, 1998, CLIN ENDOCRINOL, V48, P11
   Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432
   Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200
   Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009
   Sousa JS, 2018, MITOCHONDRIAL RESP C, V87, P0
   Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898
   SOWERS AE, 1981, P NATL ACAD SCI-BIOL, V78, P6246, DOI 10.1073/pnas.78.10.6246
   Spiegel R, 2009, EUR J HUM GENET, V17, P1200, DOI 10.1038/ejhg.2009.24
   Stephan K, 2020, BBA-BIOENERGETICS, V1861, P0, DOI 10.1016/j.bbabio.2020.148177
   Stoldt S, 2018, NAT CELL BIOL, V20, P528, DOI 10.1038/s41556-018-0090-7
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Strogolova V, 2019, J BIOL CHEM, V294, P4867, DOI 10.1074/jbc.RA118.006888
   Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265
   Stroud DA, 2011, MOL BIOL CELL, V22, P2823, DOI 10.1091/mbc.E11-02-0148
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025
   Szklarczyk R, 2013, HUM MOL GENET, V22, P656, DOI 10.1093/hmg/dds473
   Szklarczyk R, 2012, GENOME BIOL, V13, P0, DOI 10.1186/gb-2012-13-2-r12
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Tait SWG, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a008706
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tang WK, 2020, NAT STRUCT MOL BIOL, V27, P202, DOI 10.1038/s41594-020-0373-0
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   Taylor NG, 2017, J BIOL CHEM, V292, P1815, DOI 10.1074/jbc.M116.766980
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Timón-Gómez A, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107607
   Timón-Gómez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   Trouillard M, 2011, P NATL ACAD SCI USA, V108, PE1027, DOI 10.1073/pnas.1109510108
   TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409
   Tucker EJ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1004034
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x
   TZAGOLOFF A, 1986, J BIOL CHEM, V261, P7163
   URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466
   van Rahden VA, 2015, AM J HUM GENET, V96, P640, DOI 10.1016/j.ajhg.2015.02.002
   Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556
   VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x
   VANLOON APGM, 1984, EMBO J, V3, P1039, DOI 10.1002/j.1460-2075.1984.tb01924.x
   Vartak RS, 2014, J BIOENERG BIOMEMBR, V46, P323, DOI 10.1007/s10863-014-9564-x
   Verkhovsky M, 2012, BBA-BIOENERGETICS, V1817, P1550, DOI 10.1016/j.bbabio.2012.04.013
   Vidoni S, 2017, CELL REP, V18, P1727, DOI 10.1016/j.celrep.2017.01.044
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Visapää I, 1998, AM J HUM GENET, V63, P1396, DOI 10.1086/302123
   Vögtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105
   Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138
   Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x
   Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407
   Vondrackova A, 2012, J HUM GENET, V57, P442, DOI 10.1038/jhg.2012.49
   Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Wanschers BFJ, 2014, HUM MOL GENET, V23, P6356, DOI 10.1093/hmg/ddu357
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107
   Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036
   Wei XJ, 2020, HUM MUTAT, V41, P961, DOI 10.1002/humu.23985
   Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753
   Wikström M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013
   Williams EG, 2016, SCIENCE, V352, P0, DOI 10.1126/science.aad0189
   Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027
   WU M, 1989, J BIOL CHEM, V264, P11122
   Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60
   Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847
   Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469
   Ye Hong, 2010, ADV HEMATOL, V2010, P0, DOI 10.1155/2010/329394
   Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a
   Yu CA, 1996, BBA-BIOENERGETICS, V1275, P47, DOI 10.1016/0005-2728(96)00049-7
   YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017
   Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x
   Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x
   Zara V, 2009, FEBS J, V276, P1900, DOI 10.1111/j.1742-4658.2009.06916.x
   Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011
   Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746
   Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612
   Zheng YR, 2019, CNS NEUROSCI THER, V25, P876, DOI 10.1111/cns.13122
   ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x
   Zong S, 2018, CELL RES, V28, P1026, DOI 10.1038/s41422-018-0071-1
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 484
TC 93
Z9 97
U1 0
U2 70
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 15
PY 2021
VL 22
IS 2
BP 
EP 
DI 10.3390/ijms22020586
PG 53
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA PX4MI
UT WOS:000611330300001
PM 33435522
DA 2024-11-01
ER

PT J
AU Wang, W
   Sun, Y
   Lin, Y
   Xu, XB
   Zhao, DD
   Ji, KQ
   Li, W
   Zhao, YY
   Yan, CZ
AF Wang, Wei
   Sun, Yuan
   Lin, Yan
   Xu, Xuebi
   Zhao, Dandan
   Ji, Kunqian
   Li, Wei
   Zhao, Yuying
   Yan, Chuanzhu
TI A novel nonsense variant in <i>MT</i>-<i>CO3</i> causes MELAS syndrome
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE MELAS; MT-COX3; m.9553G>A; Cytochrome c oxidase; Heteroplasmy
ID cytochrome-c-oxidase; mitochondrial myopathy; frameshift mutation; missense mutation; i gene; deficiency; mtdna; family; microdeletion; patient
AB Both mitochondrial and nuclear gene mutations can cause cytochrome c oxidase (COX, complex.) dysfunction, leading to mitochondrial diseases. Although numerous diseases caused by defects of the COX subunits or COX assembly factors have been documented, clinical cases directly related to mitochondrial cytochrome c oxidase subunit 3 gene (MT-CO3) mutations are relatively rare. Here, we report a 47-year-old female patient presented with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Muscle pathology revealed ragged-red fibres and remarkable COX-deficient muscle fibres. Muscle mitochondrial DNA sequencing analysis identified a novel MT-CO3 variant (m.9553G>A) that changed a highly conserved amino acid to a stop codon (p.Trp116*). This variant was heteroplasmic in multiple tissues, where the mutation load was 13% in oral epithelial cells, 89% in muscle samples, and not detectable in the peripheral blood lymphocytes. Single muscle fiber PCR analysis showed clear segregation of the mutation load with COX deficient fibres. Western blot analysis of the muscle samples revealed a significant decrease in the levels of COX1, COX2, COX3, COX4 and UQCRC2. COX respiration activity was remarkably reduced (58.84%) relative to the controls according to spectrophotometric assays. Taken together, our results indicated that this m.9553G>A variant may be responsible for the MELAS symdrome in the proband by affecting the stability and function of COX. The study expands the clinical and molecular spectrum of COX3-specific mitochondrial diseases. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Wang, Wei; Lin, Yan; Zhao, Dandan; Ji, Kunqian; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Wang, Wei; Lin, Yan; Zhao, Dandan; Ji, Kunqian; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Sun, Yuan; Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Dept Neurol, Cheeloo Coll Med, Qingdao 266035, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250000, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Wenzhou Medical University; Shandong University; Shandong University
RP Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Dept Neurol, Cheeloo Coll Med, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan 250000, Shandong, Peoples R China.
EM jikunqian@qq.com; czyan@sdu.edu.cn
FU National Natural Science Foundation of China [81701237, 81671235]; People's benefit project of science and technology in Qingdao [16-6-2-1-nsh]; Taishan Scholars Program of Shandong Province; projects of collaborative innovation and achievement transformation in universities and research institutes of Jinan [2019GXRC050]
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Bortot B, 2009, MITOCHONDRION, V9, P123, DOI 10.1016/j.mito.2009.01.006
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   Cogliati S, 2016, NATURE, V539, P579, DOI 10.1038/nature20157
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Debray FG, 2014, MITOCHONDRION, V17, P101, DOI 10.1016/j.mito.2014.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Karadimas CL, 2000, NEUROLOGY, V55, P644, DOI 10.1212/WNL.55.5.644
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kytövuori L, 2017, BMC NEUROL, V17, P0, DOI 10.1186/s12883-017-0883-5
   Liu Ching-Hsiung, 2011, ACTA NEUROL TAIWAN, V20, P53
   Lobo-Jarne T, 2018, SEMIN CELL DEV BIOL, V76, P179, DOI 10.1016/j.semcdb.2017.07.021
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Meola G, 2012, J NEUROL, V259, P601, DOI 10.1007/s00415-011-6193-8
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Pérez-Pérez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081
   Poole OV, 2019, MITOCHONDRION, V47, P294, DOI 10.1016/j.mito.2019.02.004
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Roos S, 2019, EUR J HUM GENET, V27, P331, DOI 10.1038/s41431-018-0286-0
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Seneca S, 2015, EUR J HUM GENET, V23, P41, DOI 10.1038/ejhg.2014.49
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Tabebi M, 2015, BIOCHEM BIOPH RES CO, V459, P353, DOI 10.1016/j.bbrc.2015.01.151
   Timón-Gómez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wong LJC, 2001, AM J MED GENET, V102, P95, DOI 10.1002/1096-8628(20010722)102:1<95::AID-AJMG1412>3.0.CO;2-U
NR 40
TC 7
Z9 8
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN 15
PY 2021
VL 31
IS 6
BP 558
EP 565
DI 10.1016/j.nmd.2021.02.020
EA JUN 2021
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA SU3LB
UT WOS:000663041300012
PM 33863631
DA 2024-11-01
ER

PT J
AU ElHefnawi, M
   Hegazy, E
   Elfiky, A
   Jeon, Y
   Jeon, S
   Bhak, J
   Metwally, FM
   Sugano, S
   Horiuchi, T
   Kazumi, A
   Blazyte, A
AF ElHefnawi, Mahmoud
   Hegazy, Elsayed
   Elfiky, Asmaa
   Jeon, Yeonsu
   Jeon, Sungwon
   Bhak, Jong
   Metwally, Fateheya Mohamed
   Sugano, Sumio
   Horiuchi, Terumi
   Kazumi, Abe
   Blazyte, Asta
TI Complete genome sequence and bioinformatics analysis of nine Egyptian females with clinical information from different geographic regions in Egypt
SO GENE
LA English
DT Article
DE Personal genome; Variant analysis
ID progressive external ophthalmoplegia; mitochondrial-dna variant; single nucleotide polymorphisms; read alignment; haplogroup-h; near-eastern; fto gene; association; obesity; mutation
AB Egyptians are at a crossroad between Africa and Eurasia, providing useful genomic resources for analyzing both genetic and environmental factors for future personalized medicine. Two personal Egyptian whole genomes have been published previously by us and here nine female whole genome sequences with clinical information have been added to expand the genomic resource of Egyptian personal genomes. Here we report the analysis of whole genomes of nine Egyptian females from different regions using Illumina short-read sequencers. At 30x sequencing coverage, we identified 12 SNPs that were shared in most of the subjects associated with obesity which are concordant with their clinical diagnosis. Also, we found mtDNA mutation A4282G is common in all the samples and this is associated with chronic progressive external ophthalmoplegia (CPEO). Haplogroup and Admixture analyses revealed that most Egyptian samples are close to the other north Mediterranean, Middle Eastern, and European, respectively, possibly reflecting the into-Africa influx of human migration. In conclusion, we present whole-genome sequences of nine Egyptian females with personal clinical information that cover the diverse regions of Egypt. Although limited in sample size, the whole genomes data provides possible genophenotype candidate markers that are relevant to the region's diseases.
C1 [ElHefnawi, Mahmoud; Hegazy, Elsayed; Blazyte, Asta] Nile Univ, Sch Informat Technol & Comp Sci, Giza 12588, Egypt.
   [ElHefnawi, Mahmoud] Natl Res Ctr, Informat & Syst Dept, Cairo, Egypt.
   [ElHefnawi, Mahmoud] Natl Res Ctr, Ctr Excellence Med Res, Biomed Informat & Chemoinformat Grp, Cairo, Egypt.
   [Elfiky, Asmaa; Metwally, Fateheya Mohamed] Natl Res Ctr, Environm & Occupat Med Dept, Environm Res Div, Cairo, Egypt.
   [Jeon, Yeonsu; Jeon, Sungwon; Bhak, Jong] UNIST, Korean Genom Ctr KOGIC, Ulsan, South Korea.
   [Jeon, Yeonsu; Jeon, Sungwon; Bhak, Jong; Blazyte, Asta] Ulsan Natl Inst Sci & Technol UNIST, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea.
   [Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Osong, South Korea.
   [Sugano, Sumio; Kazumi, Abe] Univ Tokyo, Inst Med Sci, Tokyo, Japan.
   [Horiuchi, Terumi] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan.
C3 Egyptian Knowledge Bank (EKB); Nile University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); University of Tokyo; University of Tokyo
RP ElHefnawi, M (corresponding author), Natl Res Ctr, Informat & Syst Dept, Cairo, Egypt.
EM mahef@aucegypt.edu
FU U-K BRAND Research Fund of UNIST [1.190007.01]; Ulsan City Research Fund of UNIST [1.190033.01]
CR Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590
   Alebshehy R, 2016, EGYPTIAN J HOSP MED, V65, P662, DOI 10.12816/0033779
   Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Allard MW, 2005, FORENSIC SCI INT, V148, P169, DOI 10.1016/j.forsciint.2004.06.001
   Almén MS, 2013, INT J OBESITY, V37, P424, DOI 10.1038/ijo.2012.57
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Austin AM, 2013, MATERN CHILD NUTR, V9, P167, DOI 10.1111/j.1740-8709.2011.00346.x
   Azim MK, 2013, J HUM GENET, V58, P622, DOI 10.1038/jhg.2013.72
   Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Biro FM, 2010, AM J CLIN NUTR, V91, P1499S, DOI 10.3945/ajcn.2010.28701B
   Bonfiglio S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038601
   Brotherton P, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2656
   Busby GBJ, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.15266
   Carter H, 2013, BMC GENOMICS, V14, P0, DOI 10.1186/1471-2164-14-S3-S3
   Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4
   Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Dehghan M, 2005, NUTR J, V4, P0, DOI 10.1186/1475-2891-4-24
   Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017
   ElHefnawi M, 2018, GENE, V668, P129, DOI 10.1016/j.gene.2018.05.048
   Ennafaa H, 2009, BMC GENET, V10, P0, DOI 10.1186/1471-2156-10-8
   Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634
   González AM, 2007, BMC GENOMICS, V8, P0, DOI 10.1186/1471-2164-8-223
   González AM, 2006, BMC GENOMICS, V7, P0, DOI 10.1186/1471-2164-7-124
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grignani P, 2009, FORENSIC SCI INT-GEN, V4, P21, DOI 10.1016/j.fsigen.2009.04.001
   Haber M, 2016, AM J HUM GENET, V99, P1316, DOI 10.1016/j.ajhg.2016.10.012
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Harper MG, 2006, FAM COMMUNITY HEALTH, V29, P288, DOI 10.1097/00003727-200610000-00007
   Hassan NE, 2018, GENES DIS, V5, P150, DOI 10.1016/j.gendis.2017.12.004
   Ilyas M, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1290-1
   Jackson CB, 2014, BRIT J OPHTHALMOL, V98, P1453, DOI 10.1136/bjophthalmol-2014-305300
   Johnson DC, 2015, MITOCHONDR DNA, V26, P445, DOI 10.3109/19401736.2013.840591
   Katsuda I, 2007, EUR J HAEMATOL, V79, P59, DOI 10.1111/j.1600-0609.2007.00871.x
   Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x
   Kleinendorst L, 2018, J MED GENET, V55, P578, DOI 10.1136/jmedgenet-2018-105315
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   Kumari T, 2018, CLIN CHIM ACTA, V482, P136, DOI 10.1016/j.cca.2018.03.041
   Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, PD862, DOI 10.1093/nar/gkv1222
   Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI 10.1093/bioinformatics/btp100
   Licinio J, 2004, MOL PSYCHIATR, V9, P1075, DOI 10.1038/sj.mp.4001587
   Liu ZC, 2007, NEUROSCI LETT, V414, P155, DOI 10.1016/j.neulet.2006.12.013
   Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879
   Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Losleben E, 2003, BEDOUIN MIDDLE E LER, V0, P0
   Lv ZY, 2017, MEDICINE, V96, P0, DOI 10.1097/MD.0000000000008869
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, PD896, DOI 10.1093/nar/gkw1133
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Metspalu E, 1999, GENOMIC DIVERSITY, V0, P121
   Metzker Michael L, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Mohammadnejad L, 2013, CELL J, V15, P152
   Muhsin NIA, 2020, MAMM GENOME, V31, P17, DOI 10.1007/s00335-020-09826-4
   Musaiger AO, 2004, OVERWEIGHT OBESITY E, V0, P0
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nordang GBN, 2017, MOL GENET METAB, V121, P51, DOI 10.1016/j.ymgme.2017.03.007
   Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003
   Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z
   Pennarun E, 2012, BMC EVOL BIOL, V12, P0, DOI 10.1186/1471-2148-12-234
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550
   Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71
   Rask-Andersen M, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-018-08000-4
   Reinehr T, 2004, PEDIATRICS, V114, P1569, DOI 10.1542/peds.2003-0649-F
   Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173
   Rowold DJ, 2007, J HUM GENET, V52, P436, DOI 10.1007/s10038-007-0132-7
   Saunier JL, 2009, FORENSIC SCI INT-GEN, V3, PE97, DOI 10.1016/j.fsigen.2008.09.004
   SEIBEL P, 1994, BIOCHEM BIOPH RES CO, V204, P482, DOI 10.1006/bbrc.1994.2485
   Shohat M, 2011, GENET MED, V13, P487, DOI 10.1097/GIM.0b013e3182060456
   Stevanovitch A, 2004, ANN HUM GENET, V68, P23, DOI 10.1046/j.1529-8817.2003.00057.x
   Sudo Y, 2005, J HUM GENET, V50, P235, DOI 10.1007/s10038-005-0244-x
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Thareja G, 2015, BMC GENOMICS, V16, P0, DOI 10.1186/s12864-015-1233-x
   Treviño RP, 1999, DIABETES CARE, V22, P202, DOI 10.2337/diacare.22.2.202
   Turchi C, 2008, INT J LEGAL MED, V122, P199, DOI 10.1007/s00414-007-0207-1
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, P0, DOI 10.1017/S1462399410001389
   Volckmar AL, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0147904
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Winters C, 2010, EUROPE, V17, P0
NR 87
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD FEB 15
PY 2021
VL 769
IS 
BP 
EP 
DI 10.1016/j.gene.2020.145237
EA JAN 2021
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA PS9KW
UT WOS:000608241600006
PM 33127537
DA 2024-11-01
ER

PT J
AU Orsucci, D
   Ienco, EC
   Rossi, A
   Siciliano, G
   Mancuso, M
AF Orsucci, Daniele
   Ienco, Elena Caldarazzo
   Rossi, Andrea
   Siciliano, Gabriele
   Mancuso, Michelangelo
TI Mitochondrial Syndromes Revisited
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Review
DE CPEO; leber; Leigh syndrome; MELAS; MERRF; mitochondrial myopathy; MNGIE; mtDNA; NARP; PEO
ID progressive external ophthalmoplegia; cardiac involvement; twinkle mutations; cerebellar-ataxia; outcome measures; lactic-acidosis; dna polymerase; large cohort; early-onset; encephalomyopathy
AB In the last ten years, the knowledge of the genetic basis of mitochondrial diseases has significantly advanced. However, the vast phenotypic variability linked to mitochondrial disorders and the peculiar characteristics of their genetics make mitochondrial disorders a complex group of disorders. Although specific genetic alterations have been associated with some syndromic presentations, the genotype-phenotype relationship in mitochondrial disorders is complex (a single mutation can cause several clinical syndromes, while different genetic alterations can cause similar phenotypes). This review will revisit the most common syndromic pictures of mitochondrial disorders, from a clinical rather than a molecular perspective. We believe that the new phenotype definitions implemented by recent large multicenter studies, and revised here, may contribute to a more homogeneous patient categorization, which will be useful in future studies on natural history and clinical trials.
C1 [Orsucci, Daniele; Ienco, Elena Caldarazzo] San Luca Hosp, Unit Neurol, I-55100 Lucca, Italy.
   [Rossi, Andrea] Med Affairs & Sci Commun, CH-1260 Nyon, Switzerland.
   [Siciliano, Gabriele; Mancuso, Michelangelo] Univ Pisa, Dept Clin & Expt Med, Neurol Clin, I-56126 Pisa, Italy.
C3 University of Pisa
RP Orsucci, D (corresponding author), San Luca Hosp, Unit Neurol, I-55100 Lucca, Italy.
EM orsuccid@gmail.com; elenacaldarazzoienco@gmail.com; molezzano.1@libero.it; g.siciliano@unipi.it; m.mancuso@unipi.it
FU Telethon Grant [GUP09004]; Telethon-MITOCON Grant [GSP16001]; GENOMIT [RF-2016-02361495]
CR Alves CAPF, 2020, ANN NEUROL, V88, P218, DOI 10.1002/ana.25789
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   Brambilla A, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01466-w
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Chang XL, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000018634
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Dorn GW, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00782
   El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, P0, DOI 10.3389/fcvm.2016.00025
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995
   Filosto M, 2007, ACTA NEUROL SCAND, V115, P211, DOI 10.1111/j.1600-0404.2006.00777.x
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Friederich MW, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06250-w
   Galetta F, 2014, J NEUROL SCI, V345, P189, DOI 10.1016/j.jns.2014.07.044
   Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008
   Giannoni A, 2017, EUR J HEART FAIL, V19, P1701, DOI 10.1002/ejhf.782
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Hong CM, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00267
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jou C, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8010068
   Kantorovich V, 2010, BEST PRACT RES CL EN, V24, P415, DOI 10.1016/j.beem.2010.04.001
   Kerr M, 2020, MOL GENET METAB, V131, P66, DOI 10.1016/j.ymgme.2020.08.009
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Labory J, 2020, FRONT MOL BIOSCI, V7, P0, DOI 10.3389/fmolb.2020.590842
   Liu XT, 2020, INT J OPHTHALMOL-CHI, V13, P766, DOI 10.18240/ijo.2020.05.11
   Lucas CHG, 2019, ACAD PATHOL, V6, P0, DOI 10.1177/2374289519888732
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, MOVEMENT DISORD, V29, P722, DOI 10.1002/mds.25839
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Marotta R, 2020, MITOCHONDRION, V54, P128, DOI 10.1016/j.mito.2020.08.007
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   McClelland C, 2016, CURR NEUROL NEUROSCI, V16, P0, DOI 10.1007/s11910-016-0652-7
   Montano V, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000519
   Musumeci O, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00160
   Newman NJ, 2020, J NEURO-OPHTHALMOL, V40, P547, DOI 10.1097/WNO.0000000000001045
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Orsucci Daniele, 2019, DRUGS CONTEXT, V8, P212588, DOI 10.7573/dic.212588
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Papadopoulos C, 2020, J INHERIT METAB DIS, V43, P459, DOI 10.1002/jimd.12185
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Quadir A, 2019, NEUROL-GENET, V5, P0, DOI 10.1212/NXG.0000000000000339
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Sanger TD, 2010, MOVEMENT DISORD, V25, P1538, DOI 10.1002/mds.23088
   Schicks J, 2010, MOVEMENT DISORD, V25, P2678, DOI 10.1002/mds.23286
   Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Ticci C, 2020, NEUROGENETICS, V21, P87, DOI 10.1007/s10048-019-00601-5
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wang R, 2020, MITOCHONDRION, V54, P49, DOI 10.1016/j.mito.2020.07.002
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zereg E, 2020, HUM MUTAT, V41, P1394, DOI 10.1002/humu.24037
NR 72
TC 32
Z9 33
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAR 15
PY 2021
VL 10
IS 6
BP 
EP 
DI 10.3390/jcm10061249
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA SE2VR
UT WOS:000651931200001
PM 33802970
DA 2024-11-01
ER

PT J
AU Oláhová, M
   Peter, B
   Szilagyi, Z
   Diaz-Maldonado, H
   Singh, M
   Sommerville, EW
   Blakely, EL
   Collier, JJ
   Hoberg, E
   Stránecky, V
   Hartmannová, H
   Bleyer, AJ
   McBride, KL
   Bowden, SA
   Korandová, Z
   Pecinová, A
   Ropers, HH
   Kahrizi, K
   Najmabadi, H
   Tarnopolsky, MA
   Brady, LI
   Weaver, KN
   Prada, CE
   Ounap, K
   Wojcik, MH
   Pajusalu, S
   Syeda, SB
   Pais, L
   Estrella, EA
   Bruels, CC
   Kunkel, LM
   Kang, PB
   Bonnen, PE
   Mrácek, T
   Kmoch, S
   Gorman, GS
   Falkenberg, M
   Gustafsson, CM
   Taylor, RW
AF Olahova, Monika
   Peter, Bradley
   Szilagyi, Zsolt
   Diaz-Maldonado, Hector
   Singh, Meenakshi
   Sommerville, Ewen W.
   Blakely, Emma L.
   Collier, Jack J.
   Hoberg, Emily
   Stranecky, Viktor
   Hartmannova, Hana
   Bleyer, Anthony J.
   McBride, Kim L.
   Bowden, Sasigarn A.
   Korandova, Zuzana
   Pecinova, Alena
   Ropers, Hans-Hilger
   Kahrizi, Kimia
   Najmabadi, Hossein
   Tarnopolsky, Mark A.
   Brady, Lauren I.
   Weaver, K. Nicole
   Prada, Carlos E.
   Ounap, Katrin
   Wojcik, Monica H.
   Pajusalu, Sander
   Syeda, Safoora B.
   Pais, Lynn
   Estrella, Elicia A.
   Bruels, Christine C.
   Kunkel, Louis M.
   Kang, Peter B.
   Bonnen, Penelope E.
   Mracek, Tomas
   Kmoch, Stanislav
   Gorman, Grainne S.
   Falkenberg, Maria
   Gustafsson, Claes M.
   Taylor, Robert W.
TI <i>POLRMT</i> mutations impair mitochondrial transcription causing neurological disease
SO NATURE COMMUNICATIONS
LA English
DT Article
ID rna-polymerase; structural basis; dna; replication; maintenance; deletions
AB While >300 disease-causing variants have been identified in the mitochondrial DNA (mtDNA) polymerase gamma, no mitochondrial phenotypes have been associated with POLRMT, the RNA polymerase responsible for transcription of the mitochondrial genome. Here, we characterise the clinical and molecular nature of POLRMT variants in eight individuals from seven unrelated families. Patients present with global developmental delay, hypotonia, short stature, and speech/intellectual disability in childhood; one subject displayed an indolent progressive external ophthalmoplegia phenotype. Massive parallel sequencing of all subjects identifies recessive and dominant variants in the POLRMT gene. Patient fibroblasts have a defect in mitochondrial mRNA synthesis, but no mtDNA deletions or copy number abnormalities. The in vitro characterisation of the recombinant POLRMT mutants reveals variable, but deleterious effects on mitochondrial transcription. Together, our in vivo and in vitro functional studies of POLRMT variants establish defective mitochondrial transcription as an important disease mechanism. POLRMT is key for transcription of the mitochondrial genome, yet has not been implicated in mitochondrial disease to date. Here, the authors identify mutations in POLRMT in individuals with mitochondrial disease-related phenotypes and characterise underlying defects in mitochondrial transcription.
C1 [Olahova, Monika; Sommerville, Ewen W.; Blakely, Emma L.; Collier, Jack J.; Gorman, Grainne S.; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Peter, Bradley; Szilagyi, Zsolt; Diaz-Maldonado, Hector; Singh, Meenakshi; Hoberg, Emily; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
   [Stranecky, Viktor; Hartmannova, Hana; Bleyer, Anthony J.; Korandova, Zuzana; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Res Unit Rare Dis, Prague 12000, Czech Republic.
   [Bleyer, Anthony J.] Wake Forest Sch Med, Sect Nephrol, Winston Salem, NC 27101 USA.
   [McBride, Kim L.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Ctr Cardiovasc & Pulm Res,Coll Med, Columbus, OH 43210 USA.
   [Bowden, Sasigarn A.] Ohio State Univ, Nationwide Childrens Hosp, Div Endocrinol, Coll Med, Columbus, OH 43210 USA.
   [Korandova, Zuzana; Pecinova, Alena; Mracek, Tomas] Czech Acad Sci, Inst Physiol, Dept Bioenerget, Prague, Czech Republic.
   [Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.
   [Ropers, Hans-Hilger] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, Mainz, Germany.
   [McBride, Kim L.; Bowden, Sasigarn A.; Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran.
   [Tarnopolsky, Mark A.; Brady, Lauren I.] McMaster Univ, Div Neuromuscular & Neurometab Dis, Dept Pediat & Med, Childrens Hosp, Hamilton, ON, Canada.
   [Weaver, K. Nicole; Prada, Carlos E.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   [Weaver, K. Nicole; Prada, Carlos E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Prada, Carlos E.] Cardiovasc Fdn Colombia, Dept Pediat, Floridablanca, Colombia.
   [Ounap, Katrin; Pajusalu, Sander] Tartu Univ Hosp, Dept Clin Genet, United Labs, Tartu, Estonia.
   [Ounap, Katrin; Pajusalu, Sander] Univ Tartu, Inst Clin Med, Dept Clin Genet, Tartu, Estonia.
   [Ounap, Katrin; Wojcik, Monica H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Wojcik, Monica H.] Boston Childrens Hosp, Dept Pediat, Div Newborn Med & Genet, Boston, MA USA.
   [Wojcik, Monica H.] Boston Childrens Hosp, Dept Pediat, Div Genom, Boston, MA USA.
   [Pajusalu, Sander] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.
   [Syeda, Safoora B.; Bruels, Christine C.; Kang, Peter B.] Univ Florida, Coll Med, Dept Pediat, Div Pediat Neurol, Gainesville, FL USA.
   [Pais, Lynn] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA.
   [Estrella, Elicia A.; Kunkel, Louis M.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA.
   [Kunkel, Louis M.] Harvard Med Sch, Boston, MA 02115 USA.
   [Kang, Peter B.] Univ Florida, Dept Mol Genet & Microbiol, Coll Med, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Genet Inst, Gainesville, FL USA.
   [Kang, Peter B.] Univ Florida, Myol Inst, Gainesville, FL USA.
   [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
C3 Newcastle University - UK; University of Gothenburg; Charles University Prague; Wake Forest University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Max Planck Society; Johannes Gutenberg University of Mainz; McMaster University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Yale University; State University System of Florida; University of Florida; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Baylor College of Medicine
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
EM claes.gustafsson@medkem.gu.se; robert.taylor@ncl.ac.uk
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Mitochondrial Disease Patient Cohort (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; MRC/EPSRC Molecular Pathology Node; Medical Research Council (MRC); Swedish Research Council [2013-3621, 2012-2583]; Swedish Cancer Foundation [2013-3621, 2012-2583]; Knut and Alice Wallenberg foundation; Swedish government; county councils [ALFGBG-727491, ALFGBG-728151]; Ministry of Health of the Czech Republic [NV19-07-00136]; Charles University [UNCE/MED/007, GA UK 772119]; Ministry of Education, Youth and Sports of the Czech Republic [LQ1604 NPU II]; National Center for Medical Genomics [LM2018132]; National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program; National Eye Institute; NIH [R01 NS080929]; Children's Miracle Network; National Human Genome Research Institute; National Heart, Lung and Blood Institute [NIH UM1 HG008900]; NIH NINDS [RO1 NS08372];  [RVO:67985823];  [T32GM007748]
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bowden SA, 2013, CASE REP PEDIAT, V2013, P0, DOI 10.1155/2013/354314
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Farge G, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20112770
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hillen HS, 2018, NAT STRUCT MOL BIOL, V25, P754, DOI 10.1038/s41594-018-0122-9
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035
   HOLT IJ, 1988, LANCET, V1, P1462
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848
   Kühl I, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600963
   Kühl I, 2014, NATURE, V514, PE7, DOI 10.1038/nature13690
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oliveira R, 2017, JIMD REP, V33, P61, DOI 10.1007/8904_2016_581
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Park CB, 2018, BIOCHEM BIOPH RES CO, V507, P148, DOI 10.1016/j.bbrc.2018.10.194
   Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Posse V, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1007781
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajala N, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0116726
   Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003
   Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435
   Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
NR 39
TC 26
Z9 28
U1 0
U2 22
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 18
PY 2021
VL 12
IS 1
BP 
EP 
DI 10.1038/s41467-021-21279-0
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QL9UT
UT WOS:000621426600002
PM 33602924
DA 2024-11-01
ER

PT J
AU Gopan, A
   Sarma, MS
AF Gopan, Amrit
   Sarma, Moinak Sen
TI Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in and out of the liver'
SO WORLD JOURNAL OF HEPATOLOGY
LA English
DT Review
DE Mitochondrial hepatopathy; Respiratory chain defects; Maternal inheritance; Neonatal liver failure; DNA depletion syndrome; Pearson syndrome
ID corrects biochemical derangements; retrospective cohort; dna; disease; transplantation; spectrum; features; mutations; diagnosis; mngie
AB Mitochondria, the powerhouse of a cell, are closely linked to the pathophysiology of various common as well as not so uncommon disorders of the liver and beyond. Evolution supports a prokaryotic descent, and, unsurprisingly, the organelle is worthy of being labeled an organism in itself. Since highly metabolically active organs require a continuous feed of energy, any dysfunction in the structure and function of mitochondria can have variable impact, with the worse end of the spectrum producing catastrophic consequences with a multisystem predisposition. Though categorized a hepatopathy, mitochondrial respiratory chain defects are not limited to the liver in time and space. The liver involvement is also variable in clinical presentation as well as in age of onset, from acute liver failure, cholestasis, or chronic liver disease. Other organs like eye, muscle, central and peripheral nervous system, gastrointestinal tract, hematological, endocrine, and renal systems are also variably involved. Diagnosis hinges on recognition of subtle clinical clues, screening metabolic investigations, evaluation of the extra-hepatic involvement, and role of genetics and tissue diagnosis. Treatment is aimed at both circumventing the acute metabolic crisis and long-term management including nutritional rehabilitation. This review lists and discusses the burden of mitochondrial respiratory chain defects, including various settings when to suspect, their evolution with time, including certain specific disorders, their tiered evaluation with diagnostic algorithms, management dilemmas, role of liver transplantation, and the future research tools.
C1 [Gopan, Amrit] Seth GS Med Coll & KEM Hosp, Dept Gastroenterol, Mumbai 400012, Maharashtra, India.
   [Sarma, Moinak Sen] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Rae Bareilly Rd, Lucknow 226014, Uttar Pradesh, India.
C3 Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Sanjay Gandhi Postgraduate Institute of Medical Sciences
RP Sarma, MS (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Rae Bareilly Rd, Lucknow 226014, Uttar Pradesh, India.
EM moinaksen@gmail.com
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Choi HS, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17256-7
   Clarke C, 2013, MOL GENET METAB, V110, P145, DOI 10.1016/j.ymgme.2013.07.011
   CORMIERDAIRE V, 1994, J PEDIATR-US, V124, P63, DOI 10.1016/S0022-3476(94)70255-1
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   DAngelo R, 2017, MITOCHONDRION, V34, P101, DOI 10.1016/j.mito.2017.02.006
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Dror Y, 2017, HEMATOLOGY BASIC PRI, V0, P350
   Durand P, 2001, J PEDIATR-US, V139, P871, DOI 10.1067/mpd.2001.119989
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Finkenstedt A, 2013, JIMD REP, V10, P41, DOI 10.1007/8904_2012_199
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Lian CX, 2020, BIOCHEM PHARMACOL, V171, P0, DOI 10.1016/j.bcp.2019.113716
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Molleston JP, 2013, J PEDIATR GASTR NUTR, V57, P269, DOI 10.1097/MPG.0b013e31829ef67a
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   NARKEWICZ MR, 1991, J PEDIATR-US, V119, P260, DOI 10.1016/S0022-3476(05)80736-X
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pacitti D, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00669
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pyeritz RE, 2012, GENET MED, V14, P171, DOI 10.1038/gim.2011.48
   Rahman S, 2007, NEUROLOGY, V68, P1872, DOI 10.1212/01.wnl.0000265356.98295.be
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Salsaa M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-68725-5
   Saneto Russell P, 2020, J TRANSL GENET GENOM, V4, P384, DOI 10.20517/jtgg.2020.40
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sitarz KS, 2014, MOL GENET METAB, V112, P57, DOI 10.1016/j.ymgme.2014.03.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sokal EM, 1999, EUR J PEDIATR, V158, PS81, DOI 10.1007/PL00014328
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Taylor SA, 2016, LIVER TRANSPLANT, V22, P677, DOI 10.1002/lt.24433
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
NR 69
TC 4
Z9 4
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1948-5182
EI 
J9 WORLD J HEPATOL
JI World J. Hepatol.
PD NOV 27
PY 2021
VL 13
IS 11
BP 1707
EP 1726
DI 10.4254/wjh.v13.i11.1707
PG 20
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA YY3EI
UT WOS:000754673800017
PM 34904040
DA 2024-11-01
ER

PT J
AU Kaisari, E
   Borruat, FX
AF Kaisari, Eirini
   Borruat, Francois-Xavier
TI The Spectrum of Maculopathy in Mitochondrial DNA A3243G Mutation: A Case Series of Six Patients
SO KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
LA English
DT Article
DE A3243G; MELAS; MIDD; mitochondriopathies; maculopathy
ID deafness; gene
AB Background The mitochondrial DNA (mtDNA) A3243G point mutation encompasses a heterogenous group of disorders including mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), maternally inherited diabetes and deafness (MIDD), and, rarely, chronic progressive external ophthalmoplegia (CPEO). Regardless of the clinical phenotype, a specific retinopathy has been associated with the presence of this mitochondrial DNA mutation. We present six female patients exhibiting retinopathy of the A3243G pointmutation at various stages. History and Signs Six female patients (37-70 years old) with the A3243G point mutation (four MELAS, one MIDD, and one CPEO) exhibited a maculopathy. Visual acuity ranged from 1/60 to 10/10. Visual field abnormalities varied from minimal decreased sensitivity to absolute central scotomas. They all exhibited, at various degrees, a characteristic pattern of perimacular and peripapillary retinal pigment epithelium (RPE) alterations, with mottled dys-autofluorescence and RPE atrophy and deposits on OCT. Therapy and Outcome The level of visual impairment depended on the foveal involvement and the extension of RPE atrophy. The severity of the maculopathy was not related to age. In the only long-term follow-up (15 years), evolution was slowly progressive. Conclusions A single mtDNA point mutation at locus 3243 can result in a variety of clinical presentations (MELAS, MIDD, or CPEO). Ocular involvement may manifest as a perimacular/ peripapillary RPE atrophy/deposit, which can variably impact central visual function (from asymptomatic to legal blindness). The discovery of such a maculopathy should prompt the ophthalmologist to complete the personal and family history, namely, asking for the presence of diabetes mellitus and/ or deafness.
C1 [Kaisari, Eirini; Borruat, Francois-Xavier] Jules Gonin Eye Hosp, Ophthalmol, Ave France 15, CH-1004 Lausanne, Switzerland.
RP Borruat, FX (corresponding author), Jules Gonin Eye Hosp, Ophthalmol, Ave France 15, CH-1004 Lausanne, Switzerland.
EM francois.borruat@fa2.ch
CR Adjadj E, 2008, KLIN MONATSBL AUGENH, V225, P462, DOI 10.1055/s-2008-1027257
   Daruich A, 2014, BMC OPHTHALMOL, V14, P0, DOI 10.1186/1471-2415-14-77
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
NR 7
TC 2
Z9 3
U1 1
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0023-2165
EI 1439-3999
J9 KLIN MONATSBL AUGENH
JI Klinische Monatsblat. Augenheilkunde
PD APR 15
PY 2021
VL 238
IS 04
BP 414
EP 417
DI 10.1055/a-1386-5826
PG 4
WC Ophthalmology
SC Ophthalmology
GA RV2QZ
UT WOS:000645685300022
PM 33930928
DA 2024-11-01
ER

PT J
AU Carreño-Gago, L
   Juárez-Flores, DL
   Grau, JM
   Ramón, J
   Lozano, E
   Vila-Julià, F
   Martí, R
   Garrabou, G
   Garcia-Arumí, E
AF Carreno-Gago, Lidia
   Luz Juarez-Flores, Diana
   Maria Grau, Josep
   Ramon, Javier
   Lozano, Ester
   Vila-Julia, Ferran
   Marti, Ramon
   Garrabou, Gloria
   Garcia-Arumi, Elena
TI Two Novel Variants in <i>YARS2</i> Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial aminocyl-tRNA synthetase; novel pathogenic variant; Pearson's syndrome
ID sideroblastic anemia; lactic-acidosis; mitochondrial myopathy; mutation; sequence
AB Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T>C (p.(Ile464Thr)), that cause a missense variant in amino acid 464. We demonstrate the pathogenicity of these new variants associated with reduced YARS2 mRNA transcript, reduced mitochondrial protein translation and dysfunctional organelle function. These pathogenic variants are responsible for late onset MLASA, herein accompanied by pancreatic insufficiency, observed in both brothers, clinically considered as Pearson's syndrome. Molecular study of YARS2 gene should be considered in patients presenting Pearson's syndrome characteristics and MLASA related phenotypes.
C1 [Carreno-Gago, Lidia; Ramon, Javier; Vila-Julia, Ferran; Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Vall dHebron Inst Recerca VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08035, Spain.
   [Carreno-Gago, Lidia; Luz Juarez-Flores, Diana; Maria Grau, Josep; Ramon, Javier; Vila-Julia, Ferran; Marti, Ramon; Garrabou, Gloria; Garcia-Arumi, Elena] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona 08036, Spain.
   [Luz Juarez-Flores, Diana; Maria Grau, Josep; Garrabou, Gloria] Univ Barcelona, Internal Med Serv, Hosp Clin Barcelona, Fac Med & Hlth Sci,Cellex IDIBAPS,Muscle Res & Mi, Barcelona 08036, Spain.
   [Lozano, Ester] Univ Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona 08028, Spain.
   [Garcia-Arumi, Elena] Vall dHebron Hosp Univ, Dept Clin & Mol Genet, Barcelona 08035, Spain.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona
RP García-Arumí, E (corresponding author), Univ Autonoma Barcelona, Vall dHebron Hosp Univ, Vall dHebron Inst Recerca VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona 08035, Spain.; Grau, JM; García-Arumí, E (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona 08036, Spain.; Grau, JM (corresponding author), Univ Barcelona, Internal Med Serv, Hosp Clin Barcelona, Fac Med & Hlth Sci,Cellex IDIBAPS,Muscle Res & Mi, Barcelona 08036, Spain.; García-Arumí, E (corresponding author), Vall dHebron Hosp Univ, Dept Clin & Mol Genet, Barcelona 08035, Spain.
EM lidiacarre27@gmail.com; dian.juarez@icloud.com; jmgrau@clinic.cat; javier.ramon@vhir.org; elozano@ub.edu; ferran.vila@vhir.org; ramon.marti@vhir.org; garrabou@dinic.cat; e.garcia@vhebron.net
FU Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias; ERDF funds [FIS PI15/01428, FIS PMP15/00025 PI18/00498, PI19/01772]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945
   Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Fleming MD, 2011, HEMATOL-AM SOC HEMAT, V0, PP525, DOI 10.1182/asheducation-2011.1.525
   González-Casacuberta I, 2018, NEUROBIOL AGING, V65, P206, DOI 10.1016/j.neurobiolaging.2018.01.021
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gustafson MA, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221829
   Lazaridis KN, 2016, MAYO CLIN PROC, V91, P297, DOI 10.1016/j.mayocp.2015.12.018
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Long ZB, 2018, GENE, V668, P182, DOI 10.1016/j.gene.2018.05.074
   Meyer-Schuman R, 2017, HUM MOL GENET, V26, PR114, DOI 10.1093/hmg/ddx231
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659
   Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   ROTIG A, 1989, LANCET, V1, P902
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 29
TC 5
Z9 6
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD AUG 15
PY 2021
VL 10
IS 16
BP 
EP 
DI 10.3390/jcm10163471
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA UI2LJ
UT WOS:000690445200001
PM 34441767
DA 2024-11-01
ER

PT J
AU Friederich, MW
   Geddes, GC
   Wortmann, SB
   Punnoose, A
   Wartchow, E
   Knight, KM
   Prokisch, H
   Creadon-Swindell, G
   Mayr, JA
   Van Hove, JLK
AF Friederich, Marisa W.
   Geddes, Gabrielle C.
   Wortmann, Saskia B.
   Punnoose, Ann
   Wartchow, Eric
   Knight, Kaz M.
   Prokisch, Holger
   Creadon-Swindell, Geralyn
   Mayr, Johannes A.
   Van Hove, Johan L. K.
TI Pathogenic variants in <i>MRPL44</i> cause infantile cardiomyopathy due to a mitochondrial translation defect
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Cardiomyopathy; Combined deficiency; Mitochondrial translation; Mitochondrial ribosome; Genetic cause
ID mutations cause; large subunit; ribosome; disease; deficiency
AB Cardiac dysfunction is a common phenotypic manifestation of primary mitochondrial disease with multiple nuclear and mitochondrial DNA pathogenic variants as a cause, including disorders of mitochondrial translation. To date, five patients have been described with pathogenic variants in MRPL44, encoding the ml44 protein which is part of the large subunit of the mitochondrial ribosome (mitoribosome). Three presented as infants with hypertrophic cardiomyopathy, mild lactic acidosis, and easy fatigue and muscle weakness, whereas two presented in adolescence with myopathy and neurological symptoms. We describe two infants who presented with cardiomyopathy from the neonatal period, failure to thrive, hypoglycemia and in one infant lactic acidosis. A decompensation of the cardiac function in the first year resulted in demise. Exome sequencing identified compound heterozygous variants in the MRPL44 gene including the known pathogenic variant c.467 T > G and two novel pathogenic variants. We document a combined respiratory chain enzyme deficiency with emphasis on complex I and IV, affecting heart muscle tissue more than skeletal muscle or fibroblasts. We show this to be caused by reduced mitochondrial DNA encoded protein synthesis affecting all subunits, and resulting in dysfunction of complex I and IV assembly. The degree of oxidative phosphorylation dysfunction correlated with the impairment of mitochondrial protein synthesis due to different pathogenic variants. These functional studies allow for improved understanding of the pathogenesis of MRPL44-associated mitochondrial disorder. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Friederich, Marisa W.; Knight, Kaz M.; Van Hove, Johan L. K.] Univ Colorado, Sect Clin Genet & Metab, Dept Pediat, Aurora, CO USA.
   [Friederich, Marisa W.; Wartchow, Eric; Creadon-Swindell, Geralyn; Van Hove, Johan L. K.] Childrens Hosp Colorado, Dept Pathol & Lab Serv, Aurora, CO USA.
   [Geddes, Gabrielle C.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Geddes, Gabrielle C.] Indiana Univ, Dept Mol & Med Genet, Indianapolis, IN 46204 USA.
   [Wortmann, Saskia B.; Mayr, Johannes A.] Paracelsus Med Univ PMU, Univ Childrens Hosp, Salzburg, Austria.
   [Wortmann, Saskia B.] RadboudUMC, Amalia Childrens Hosp, Nijmegen, Netherlands.
   [Punnoose, Ann] Childrens Hosp Wisconsin, Herma Heart Inst, Milwaukee, WI 53201 USA.
   [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Neuherberg, Germany.
   [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
C3 University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Medical College of Wisconsin; Indiana University System; Indiana University Indianapolis; Paracelsus Private Medical University; Radboud University Nijmegen; Children's Hospital of Wisconsin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich
RP Van Hove, JLK (corresponding author), Mailstop 8400,Educ 2 South L28-4114, Aurora, CO 80045 USA.
FU Children's Hospital Colorado Foundation; National Institutes of Health [NIH U54NS078059]; NCATS; Austrian Science Fund (FWF) [GENOMIT I 4695-B]; German Federal Ministry of Education and Research (BMBF, Bonn, Germany) research grant "German Network for Mitochondrial Disorders" (mitoNET) [01GM1906B]; German BMBF; Horizon2020 through the ERare project GENOMIT [01GM1920A]; Horizon2020 through ERA PerMed project PerMiM [01KU2016A]
CR Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P395, DOI 10.1016/0006-2944(78)90089-3
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chatfield KC, 2015, MITOCHONDRION, V21, P1, DOI 10.1016/j.mito.2014.12.005
   Cheong A, 2020, GENE EXPR PATTERNS, V38, P0, DOI 10.1016/j.gep.2020.119147
   Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049
   De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672
   Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Friederich MW, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06250-w
   Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431
   Gray VE, 2017, GENETICS, V207, P53, DOI 10.1534/genetics.117.300064
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Horga A, 2021, MOL BIOL REP, V48, P2093, DOI 10.1007/s11033-021-06188-1
   Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Pitceathly RDS, 2021, J INHERIT METAB DIS, V44, P22, DOI 10.1002/jimd.12281
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Towbin JA, 2006, MITOCHONDRIAL MEDICINE, V0, P75
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Vasilescu C, 2018, J AM COLL CARDIOL, V72, P2324, DOI 10.1016/j.jacc.2018.08.2171
   Wagner M, 2019, J INHERIT METAB DIS, V42, P909, DOI 10.1002/jimd.12109
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Yeo JHC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0134326
   Zeng R, 2018, CELL METAB, V27, P645, DOI 10.1016/j.cmet.2018.01.012
NR 30
TC 8
Z9 8
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG 15
PY 2021
VL 133
IS 4
BP 362
EP 371
DI 10.1016/j.ymgme.2021.06.001
EA JUL 2021
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA TI5KI
UT WOS:000672841000004
PM 34140213
DA 2024-11-01
ER

PT J
AU Santhoshkumar, R
   Preethish-Kumar, V
   Polavarapu, K
   Reghunathan, D
   Chaudhari, S
   Satyamoorthy, K
   Vengalil, S
   Nashi, S
   Faruq, M
   Joshi, A
   Atchayaram, N
   Narayanappa, G
AF Santhoshkumar, Rashmi
   Preethish-Kumar, Veeramani
   Polavarapu, Kiran
   Reghunathan, Dinesh
   Chaudhari, Sima
   Satyamoorthy, Kapaettu
   Vengalil, Seena
   Nashi, Saraswati
   Faruq, Muhammed
   Joshi, Aditi
   Atchayaram, Nalini
   Narayanappa, Gayathri
TI A Novel L1 Linker Mutation in <i>DES</i> Resulted in Total Absence of Protein
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article
DE Desmin; L1 linker; Dilated cardiomyopathy; Cardio-skeletal phenotype
ID pathology; myopathy; gene
AB Desminopathies (MIM*601419) are clinically heterogeneous, manifesting with myopathy and/or cardiomyopathy and with intra-sarcoplasmic desmin-positive deposits. They have either an autosomal dominant (AD) or recessive (AR) pattern of inheritance. Desmin is a crucial intermediate filament protein regulating various cellular functions in muscle cells. Here, we report a 13-year-old girl, born of second-degree consanguineous parents, with normal developmental milestones, who presented with dilated cardiomyopathy, respiratory insufficiency and predominant distal upper limb weakness. A striking feature on muscle biopsy was the presence of a peripheral chain of nuclei in addition to myopathic features. Immunostaining showed complete lack of desmin expression, further confirmed by western blot analysis. Ultrastructurally, subsarcolemmal granular material, expanded Z-band aggregation, distortion of myofilaments, focal Z-band streaming, lobed and clustered myonuclei were observed. Next-generation sequencing revealed a novel homozygous nonsense mutation c.448C>T, p.R150X in the patient, while the parents were heterozygous carriers. Single mitochondrial DNA deletion and isolated complex IV deficiency were noted. Our findings add to the ever-expanding phenotype and molecular spectrum of desminopathies.
C1 [Santhoshkumar, Rashmi; Narayanappa, Gayathri] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, Karnataka, India.
   [Preethish-Kumar, Veeramani; Polavarapu, Kiran; Vengalil, Seena; Nashi, Saraswati; Atchayaram, Nalini] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru 560029, Karnataka, India.
   [Chaudhari, Sima; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal 576104, Karnataka, India.
   [Faruq, Muhammed; Joshi, Aditi] CSIR Inst Genom & Integrat Biol, New Delhi 110007, India.
C3 National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)
RP Narayanappa, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bengaluru 560029, Karnataka, India.
EM rashuj21@gmail.com; prthshkumar@gmail.com; kinnudreamz@gmail.com; dineshgene89@gmail.com; simachaudhari88@gmail.co; ksatyamoorthy@manipal.edu; seenavengalil@gmail.com; nandanashi@gmail.com; faruq.mohd@igib.in; joshi.aditi21@gmail.com; atchayaramnalini@yahoo.co.in; gayathri.narayanappa@gmail.com
FU Department of Science and Technology [DST], Govt. of India [SO/HS-103/2009/1(G)]
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Muñoz-Mármol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Nalini A, 2013, NEUROL INDIA, V61, P622, DOI 10.4103/0028-3886.125269
   Oldfors A, 2013, MUSCLE BIOPSYA PRACI, V0, P0
   Renjini R, 2012, INDIAN J MED RES, V135, P878
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Thangaraj K, 2002, J ANDROL, V23, P815
   van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
NR 16
TC 6
Z9 6
U1 0
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0895-8696
EI 1559-1166
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD DEC 15
PY 2021
VL 71
IS 12
BP 2468
EP 2473
DI 10.1007/s12031-021-01856-0
EA JUN 2021
PG 6
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA XA2BJ
UT WOS:000659399000003
PM 34106405
DA 2024-11-01
ER

PT J
AU Homma, K
   Toda, E
   Osada, H
   Nagai, N
   Era, T
   Tsubota, K
   Okano, H
   Ozawa, Y
AF Homma, Kohei
   Toda, Eriko
   Osada, Hideto
   Nagai, Norihiro
   Era, Takumi
   Tsubota, Kazuo
   Okano, Hideyuki
   Ozawa, Yoko
TI Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium
SO REDOX BIOLOGY
LA English
DT Article
DE Epithelial mesenchymal transition; Induced pluripotent stem cells; Metabolomics; Mitochondria; Retinal pigment epithelium; Taurine
ID energy-metabolism; oxidative stress; mtdna; differentiation; dysfunction; dystrophy; mutation; mouse; gene; proliferation
AB Mitochondria participate in various metabolic pathways, and their dysregulation results in multiple disorders, including aging-related diseases. However, the metabolic changes and mechanisms of mitochondrial disorders are not fully understood. Here, we found that induced pluripotent stem cells (iPSCs) from a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) showed attenuated proliferation and survival when glycolysis was inhibited. These deficits were rescued by taurine administration. Metabolomic analyses showed that the ratio of the reduced (GSH) to oxidized glutathione (GSSG) was decreased; whereas the levels of cysteine, a substrate of GSH, and oxidative stress markers were upregulated in MELAS iPSCs. Taurine normalized these changes, suggesting that MELAS iPSCs were affected by the oxidative stress and taurine reduced its influence. We also analyzed the retinal pigment epithelium (RPE) differentiated from MELAS iPSCs by using a three-dimensional culture system and found that it showed epithelial mesenchymal transition (EMT), which was suppressed by taurine. Therefore, mitochondrial dysfunction caused metabolic changes, accumulation of oxidative stress that depleted GSH, and EMT in the RPE that could be involved in retinal pathogenesis. Because all these phenomena were sensitive to taurine treatment, we conclude that administration of taurine may be a potential new therapeutic approach for mitochondria-related retinal diseases.
C1 [Homma, Kohei; Toda, Eriko; Osada, Hideto; Nagai, Norihiro; Ozawa, Yoko] Keio Univ, Dept Ophthalmol, Lab Retinal Cell Biol, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
   [Homma, Kohei; Toda, Eriko; Osada, Hideto; Nagai, Norihiro; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
   [Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, Kumamoto 8600811, Japan.
   [Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
   [Ozawa, Yoko] St Lukes Int Hosp, Dept Ophthalmol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
   [Ozawa, Yoko] St Lukes Int Univ, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
C3 Keio University; Keio University; Kumamoto University; Keio University; St. Luke's International Hospital; St. Luke's International Hospital
RP Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Lab Retinal Cell Biol, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
EM ozawa@a5.keio.jp
FU JSR corporation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Keio University Internal Research Funding for the Advancement of Next Generation Research Projects; Japan Society of the Promotion of Science [19K09977, 20K09833, 18K09422]; Keio University Global Research Institute (KGRI) Program for the Advancement of Research in Core Projects; Grants-in-Aid for Scientific Research [20K09833, 19K09977, 18K09422] Funding Source: KAKEN
CR Anton Z, 2020, J CELL SCI, V133, P0
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Barrow JJ, 2016, MOL CELL, V64, P163, DOI 10.1016/j.molcel.2016.08.023
   Bhardwaj V, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21103412
   Bian WP, 2019, ACS SYNTH BIOL, V8, P621, DOI 10.1021/acssynbio.8b00411
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441
   Daruich A, 2014, BMC OPHTHALMOL, V14, P0, DOI 10.1186/1471-2415-14-77
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Ferrington DA, 2016, EXP EYE RES, V145, P269, DOI 10.1016/j.exer.2016.01.018
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gao JY, 2018, J NEUROINFLAMM, V15, P0, DOI 10.1186/s12974-018-1062-3
   Garrido-Maraver J, 2012, BRIT J PHARMACOL, V167, P1311, DOI 10.1111/j.1476-5381.2012.02086.x
   Giannoni E, 2012, ANTIOXID REDOX SIGN, V16, P1248, DOI 10.1089/ars.2011.4280
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GRIERSON I, 1994, EYE, V8, P255, DOI 10.1038/eye.1994.54
   Guerra F, 2017, FRONT ONCOL, V7, P0, DOI 10.3389/fonc.2017.00295
   Gunnewiek TMK, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107538
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221
   Hirasawa M, 2011, MOL VIS, V17, P1222
   Homma K, 2017, GENES CELLS, V22, P250, DOI 10.1111/gtc.12472
   Jeong MH, 2014, BIOCHEM BIOPH RES CO, V454, P417, DOI 10.1016/j.bbrc.2014.10.093
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Kodama M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15136-9
   Kuwahara A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7286
   Lee DS, 2017, ADV EXP MED BIOL, V975, P0
   Lin DS, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8010065
   Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Meseguer S, 2018, BBA-MOL BASIS DIS, V1864, P3022, DOI 10.1016/j.bbadis.2018.06.014
   Miceli MV, 2005, INVEST OPHTH VIS SCI, V46, P1765, DOI 10.1167/iovs.04-1327
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Nagai N, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-01483-2
   Nandhini ATAnitha, 2002, INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, V40, P1016
   Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okamoto T, 2019, TRANSL VIS SCI TECHN, V8, P0, DOI 10.1167/tvst.8.6.20
   Okita K, 2011, NAT METHODS, V8, P409, DOI 10.1038/NMETH.1591
   Oliveira MWS, 2010, PHARMACOL REP, V62, P185, DOI 10.1016/S1734-1140(10)70256-5
   Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384
   Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51
   Ozawa Y, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101779
   Park SY, 2017, ADV EXP MED BIOL, V975, P621, DOI 10.1007/978-94-024-1079-2_48
   Pek NMQ, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-2036-9
   Phillips P H, 1997, J AAPOS, V1, P115, DOI 10.1016/S1091-8531(97)90010-0
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628
   Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI 10.1007/s00726-012-1414-8
   Seidel U, 2019, MOL NUTR FOOD RES, V63, P0, DOI 10.1002/mnfr.201800569
   Shiota M, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03899-1
   Shyh-Chang N, 2011, EMBO J, V30, P4851, DOI 10.1038/emboj.2011.436
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Soga M, 2015, STEM CELLS, V33, P1075, DOI 10.1002/stem.1917
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Sun QR, 2018, NEUROCHEM RES, V43, P276, DOI 10.1007/s11064-017-2419-1
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Takaoka Y, 2019, CANCER SCI, V110, P1331, DOI 10.1111/cas.13980
   Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725
   Tohyama S, 2016, CELL METAB, V23, P663, DOI 10.1016/j.cmet.2016.03.001
   Touret F, 2020, SCIENTIFIC REPORTS, V0, P0
   Tsogtbaatar E, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00087
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Winanto, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2383-6
   Yahata N, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-15871-y
   Yamamoto T, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4480
   Yang WJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1629, DOI 10.1159/000485762
   Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 77
TC 24
Z9 24
U1 3
U2 23
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
EI 
J9 REDOX BIOL
JI Redox Biol.
PD MAY 15
PY 2021
VL 41
IS 
BP 
EP 
DI 10.1016/j.redox.2021.101921
EA MAR 2021
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA RY1SJ
UT WOS:000647697000002
PM 33706170
DA 2024-11-01
ER

PT J
AU Pass, T
   Wiesner, RJ
   Pla-Martín, D
AF Pass, Thomas
   Wiesner, Rudolf J.
   Pla-Martin, David
TI Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Review
DE mitochondria; neurodegeneration; selective vulnerability; mitochondrial DNA maintenance; mitochondrial dynamics; quality control; Ca2+ homeostasis
ID marie-tooth-disease; progressive external ophthalmoplegia; recessive twinkle mutations; targeted antioxidant mitoq; parkin-mediated mitophagy; ventral tegmental area; transgenic mouse model; complex i deficiency; alzheimers-disease; endoplasmic-reticulum
AB Mitochondrial dysfunction is a central feature of neurodegeneration within the central and peripheral nervous system, highlighting a strong dependence on proper mitochondrial function of neurons with especially high energy consumptions. The fitness of mitochondria critically depends on preservation of distinct processes, including the maintenance of their own genome, mitochondrial dynamics, quality control, and Ca2+ handling. These processes appear to be differently affected in common neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as in rare neurological disorders, including Huntington's disease, Amyotrophic Lateral Sclerosis and peripheral neuropathies. Strikingly, particular neuron populations of different morphology and function perish in these diseases, suggesting that cell-type specific factors contribute to the vulnerability to distinct mitochondrial defects. Here we review the disruption of mitochondrial processes in common as well as in rare neurological disorders and its impact on selective neurodegeneration. Understanding discrepancies and commonalities regarding mitochondrial dysfunction as well as individual neuronal demands will help to design new targets and to make use of already established treatments in order to improve treatment of these diseases.
C1 [Pass, Thomas; Wiesner, Rudolf J.; Pla-Martin, David] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
C3 University of Cologne; University of Cologne
RP Pass, T (corresponding author), Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany.
EM thomas.pass@uk-koeln.de
FU German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [73111208-SFB 829, PL 895/1-1]; Koln Fortune [341/2019]
CR Aerts MB, 2016, ANN CLIN TRANSL NEUR, V3, P146, DOI 10.1002/acn3.281
   Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x
   Alberico SL, 2015, BASAL GANGLIA, V5, P51, DOI 10.1016/j.baga.2015.06.001
   ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608
   Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604
   ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562
   Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amo T, 2014, NEUROSCI LETT, V580, P37, DOI 10.1016/j.neulet.2014.07.045
   Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005
   Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006
   Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007
   Area-Gomez E, 2017, FASEB J, V31, P864, DOI 10.1096/fj.201601309
   ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745
   Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103
   Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070
   ATSUMI T, 1981, ACTA NEUROPATHOL, V55, P193, DOI 10.1007/BF00691318
   Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001
   Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833
   Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004
   Baranov SV, 2019, P NATL ACAD SCI USA, V116, P650, DOI 10.1073/pnas.1811021116
   Barneo-Muñoz M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005115
   Barski JJ, 2003, J NEUROSCI, V23, P3469
   Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00254
   Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108
   Bélanger M, 2011, J NEUROSCI, V31, P18338, DOI 10.1523/JNEUROSCI.1249-11.2011
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benkert J, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12834-x
   Berenguer-Escuder C, 2020, HUM MOL GENET, V29, P1353, DOI 10.1093/hmg/ddaa066
   Bernard-Marissal N, 2019, P NATL ACAD SCI USA, V116, P2328, DOI 10.1073/pnas.1810932116
   Bernard-Marissal N, 2015, BRAIN, V138, P875, DOI 10.1093/brain/awv008
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Biglan KM, 2017, ANN CLIN TRANSL NEUR, V4, P360, DOI 10.1002/acn3.412
   Billups B, 2002, J NEUROSCI, V22, P5840
   Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235
   Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Bradshaw TY, 2016, HUM MOL GENET, V25, P3232, DOI 10.1093/hmg/ddw173
   Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Brier MR, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf2362
   Britti E, 2020, CELL CALCIUM, V86, P0, DOI 10.1016/j.ceca.2019.102150
   Burgold J, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-43024-w
   BURKE RE, 1973, J PHYSIOL-LONDON, V234, P749, DOI 10.1113/jphysiol.1973.sp010370
   BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709
   Bursch F, 2019, HUM MOL GENET, V28, P2835, DOI 10.1093/hmg/ddz107
   Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844
   Bussière T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760
   Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005
   Calì T, 2012, J BIOL CHEM, V287, P17914, DOI 10.1074/jbc.M111.302794
   Caligari M, 2013, AMYOTROPH LAT SCL FR, V14, P546, DOI 10.3109/21678421.2013.803576
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Calvo-Rodriguez M, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16074-2
   Calvo-Rodriguez M, 2019, FRONT CELL NEUROSCI, V13, P0, DOI 10.3389/fncel.2019.00022
   Calvo-Rodríguez M, 2016, J ALZHEIMERS DIS, V54, P207, DOI 10.3233/JAD-151189
   Cantarero L, 2020, HUM MOL GENET, V29, P3589, DOI 10.1093/hmg/ddaa243
   Caraveo G, 2014, P NATL ACAD SCI USA, V111, PE3544, DOI 10.1073/pnas.1413201111
   Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X
   Carrion MP, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00064
   Cerminara NL, 2015, NAT REV NEUROSCI, V16, P79, DOI 10.1038/nrn3886
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200
   Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007
   Chang JL, 2018, MOL THER, V26, P1539, DOI 10.1016/j.ymthe.2018.02.029
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen LJ, 2015, NEUROBIOL AGING, V36, P2533, DOI 10.1016/j.neurobiolaging.2015.05.018
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Chrysostomou A, 2016, NEUROPATH APPL NEURO, V42, P477, DOI 10.1111/nan.12282
   Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650
   Civera-Tregón A, 2021, NEUROBIOL DIS, V152, P0, DOI 10.1016/j.nbd.2021.105300
   Combs B, 2019, ADV EXP MED BIOL, V1184, P81, DOI 10.1007/978-981-32-9358-8_7
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Dafinca R, 2020, STEM CELL REP, V14, P892, DOI 10.1016/j.stemcr.2020.03.023
   DALCANTO MC, 1994, AM J PATHOL, V145, P1271
   Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x
   Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421
   Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977
   Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Juan-Sanz J, 2017, NEURON, V93, P867, DOI 10.1016/j.neuron.2017.01.010
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559
   Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526
   Delcambre S, 2016, MITOCHONDRIAL MECH D, V0, PP25, DOI 10.1007/978-3-319-42139-12
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deng ZQ, 2020, AUTOPHAGY, V16, P917, DOI 10.1080/15548627.2019.1644076
   Deng ZQ, 2017, TRENDS CELL BIOL, V27, P491, DOI 10.1016/j.tcb.2017.01.001
   Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314
   DeVos SL, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aag0481
   Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023
   Di Maio R, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aaf3634
   Diepenbroek M, 2014, HUM MOL GENET, V23, P3975, DOI 10.1093/hmg/ddu112
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dopeso-Reyes IG, 2014, FRONT NEUROANAT, V8, P0, DOI 10.3389/fnana.2014.00146
   DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002
   Duda J, 2016, J NEUROCHEM, V139, P156, DOI 10.1111/jnc.13572
   Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   ENOKA RM, 1995, J CLIN NEUROPHYSIOL, V12, P538, DOI 10.1097/00004691-199511000-00002
   Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006
   Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150
   Evans CS, 2019, NEUROBIOL DIS, V122, P35, DOI 10.1016/j.nbd.2018.07.005
   Fahrner JA, 2016, AM J MED GENET A, V170, P2002, DOI 10.1002/ajmg.a.37721
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Feng SM, 2019, ANN CLIN TRANSL NEUR, V6, P2377, DOI 10.1002/acn3.50928
   Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003
   Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X
   Ferri A, 2010, HUM MOL GENET, V19, P4529, DOI 10.1093/hmg/ddq383
   Filadi R, 2016, CELL REP, V15, P2226, DOI 10.1016/j.celrep.2016.05.013
   Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022
   Freer R, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600947
   Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000
   Frey D, 2000, J NEUROSCI, V20, P2534
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   FRIEL DD, 1994, J NEUROSCI, V14, P4007
   Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7
   Fu HJ, 2017, NEURON, V93, P533, DOI 10.1016/j.neuron.2016.12.023
   Fukumitsu K, 2016, MOL CELL NEUROSCI, V71, P56, DOI 10.1016/j.mcn.2015.12.006
   Fukutani Y, 2000, PSYCHIAT CLIN NEUROS, V54, P523, DOI 10.1046/j.1440-1819.2000.00747.x
   Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018
   GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x
   Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008
   Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x
   Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8
   Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008
   Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Göbel J, 2020, CELL METAB, V31, P791, DOI 10.1016/j.cmet.2020.03.005
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655
   GomezIsla T, 1996, J NEUROSCI, V16, P4491
   González-Sánchez P, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep42993
   Goode A, 2016, AUTOPHAGY, V12, P1094, DOI 10.1080/15548627.2016.1170257
   Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006
   Grenier K, 2014, J BIOL CHEM, V289, P29519, DOI 10.1074/jbc.M114.607150
   Grenier K, 2013, FRONT NEUROL, V4, P0, DOI 10.3389/fneur.2013.00100
   Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002
   Grossmann D, 2019, ANTIOXID REDOX SIGN, V31, P1213, DOI 10.1089/ars.2018.7718
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014
   Guatteo E, 2007, NEUROBIOL DIS, V28, P90, DOI 10.1016/j.nbd.2007.07.002
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   Gwon AR, 2012, AGING CELL, V11, P559, DOI 10.1111/j.1474-9726.2012.00817.x
   Haack TB, 2016, AM J HUM GENET, V99, P735, DOI 10.1016/j.ajhg.2016.06.026
   Hadano S, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0009805
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919
   Hanss Z, 2021, MOVEMENT DISORD, V36, P704, DOI 10.1002/mds.28365
   Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1
   Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310
   Higgins CMJ, 2003, BMC NEUROSCI, V4, P0, DOI 10.1186/1471-2202-4-16
   HIGHSTEIN SM, 1982, J COMP NEUROL, V208, P369, DOI 10.1002/cne.902080407
   Hirabayahi Y, 2017, SCIENCE, V358, P623, DOI 10.1126/science.aan6009
   HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E
   Höglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x
   Hong K, 2012, NEUROSCI LETT, V530, P144, DOI 10.1016/j.neulet.2012.10.003
   Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35
   Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002
   Hsu JY, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00196
   Hu D, 2019, ACTA NEUROPATHOL, V137, P939, DOI 10.1007/s00401-019-01993-2
   Huang MZ, 2019, NEUROSCI LETT, V688, P49, DOI 10.1016/j.neulet.2018.02.004
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110
   HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jauhari A, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI150328
   Jenner P, 1996, NEUROLOGY, V47, PS161, DOI 10.1212/WNL.47.6_Suppl_3.161S
   Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672
   Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223
   Kandel ER, 2021, PRINCIPLES OF NEURAL SCIENCE, VSixth, P0
   Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4
   Katsouri L, 2016, P NATL ACAD SCI USA, V113, P12292, DOI 10.1073/pnas.1606171113
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Keeney PM, 2010, MOL NEURODEGENER, V5, P0, DOI 10.1186/1750-1326-5-21
   Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kilarski LL, 2012, MOVEMENT DISORD, V27, P1522, DOI 10.1002/mds.25132
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   König T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020
   Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009
   Kondapalli C, 2012, OPEN BIOL, V2, P0, DOI 10.1098/rsob.120080
   Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088
   Kostic M, 2015, CELL REP, V13, P376, DOI 10.1016/j.celrep.2015.08.079
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kubota M, 2000, DEV MED CHILD NEUROL, V42, P61, DOI 10.1017/S0012162200000116
   Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Kwon SK, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002516
   Ladd AC, 2017, BRAIN RES, V1667, P74, DOI 10.1016/j.brainres.2017.05.010
   LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960
   Lang YK, 2015, PHARMACOEPIDEM DR S, V24, P559, DOI 10.1002/pds.3781
   Langley M, 2017, ANTIOXID REDOX SIGN, V27, P1048, DOI 10.1089/ars.2016.6905
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lavie J, 2017, HUM MOL GENET, V26, P674, DOI 10.1093/hmg/ddw425
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014
   Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849
   Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200
   Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352
   Lemprière S, 2019, NAT REV NEUROL, V15, P435, DOI 10.1038/s41582-019-0211-3
   Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y
   Lieberman OJ, 2017, ENEURO, V4, P0, DOI 10.1523/ENEURO.0167-17.2017
   Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200
   Lin MY, 2017, NEURON, V94, P595, DOI 10.1016/j.neuron.2017.04.004
   Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x
   Liss B, 2001, MOL MEMBR BIOL, V18, P117
   Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570
   Liu J, 2015, FRONT PHYSIOL, V6, P0, DOI 10.3389/fphys.2015.00069
   Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, P0, DOI 10.1186/s11658-016-0031-z
   Liu WT, 2013, CURR NEUROVASC RES, V10, P222, DOI 10.2174/15672026113109990060
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Madruga E, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020740
   Magrané J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528
   Maltecca F, 2015, J CLIN INVEST, V125, P263, DOI 10.1172/JCI74770
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Mao PZ, 2012, HUM MOL GENET, V21, P2973, DOI 10.1093/hmg/dds128
   Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003
   Marland JRK, 2016, J BIOL CHEM, V291, P2080, DOI 10.1074/jbc.M115.686956
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009
   MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533
   McGregor MM, 2019, NEURON, V101, P1042, DOI 10.1016/j.neuron.2019.03.004
   McLelland GL, 2018, AUTOPHAGY, V14, P1658, DOI 10.1080/15548627.2018.1505154
   McLelland GL, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.32866
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011
   Melkov A, 2018, CELL MOL LIFE SCI, V75, P163, DOI 10.1007/s00018-017-2590-1
   Melov S, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000536
   Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Mizuno Y, 2006, J NEUROL SCI, V249, P13, DOI 10.1016/j.jns.2006.05.060
   Mollá B, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00264
   Monaco A, 2020, FRONT MOL NEUROSCI, V13, P0, DOI 10.3389/fnmol.2020.00037
   Montagne A, 2016, ACTA NEUROPATHOL, V131, P687, DOI 10.1007/s00401-016-1570-0
   Moore AS, 2016, P NATL ACAD SCI USA, V113, PE3349, DOI 10.1073/pnas.1523810113
   Mórotz GM, 2012, HUM MOL GENET, V21, P1979, DOI 10.1093/hmg/dds011
   Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685
   Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024
   Muto V, 2018, NEUROLOGY, V91, PE319, DOI 10.1212/WNL.0000000000005869
   Nam T, 2017, MOL CELLS, V40, P897, DOI 10.14348/molcells.2017.0226
   Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503
   Neuhaus JFG, 2014, BRAIN, V137, P354, DOI 10.1093/brain/awt291
   Neuhaus JFG, 2017, NEUROENDOCRINOLOGY, V104, P72, DOI 10.1159/000444680
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nijssen J, 2017, ACTA NEUROPATHOL, V133, P863, DOI 10.1007/s00401-017-1708-8
   Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287
   Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232
   Novak MJU, 2015, HUM BRAIN MAPP, V36, P1728, DOI 10.1002/hbm.22733
   Nozaki Masahisa, 2021, ENEUROLOGICALSCI, V22, P100301, DOI 10.1016/j.ensci.2020.100301
   Obeso JA, 2017, MOVEMENT DISORD, V32, P1264, DOI 10.1002/mds.27115
   Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111
   Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x
   Onesto E, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0316-5
   Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007
   Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008
   Ortner NJ, 2017, J NEUROSCI, V37, P6761, DOI 10.1523/JNEUROSCI.2946-16.2017
   Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050
   Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199
   Padman BS, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08335-6
   Paillusson S, 2017, ACTA NEUROPATHOL, V134, P129, DOI 10.1007/s00401-017-1704-z
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Parkinson Study Group STEADY-PD III Investigators, 2020, ANN INTERN MED, V172, P591, DOI 10.7326/M19-2534
   Pass T, 2020, MOL NEUROBIOL, V57, P3646, DOI 10.1007/s12035-020-01947-w
   Patron M, 2018, CELL RES, V28, P296, DOI 10.1038/cr.2018.17
   Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92
   Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165
   Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102
   Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49
   Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311
   Philippart F, 2016, J NEUROSCI, V36, P7234, DOI 10.1523/JNEUROSCI.0459-16.2016
   Picard M, 2016, CELL METAB, V24, P3, DOI 10.1016/j.cmet.2016.06.024
   Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pla-Martín D, 2015, HUM MOL GENET, V24, P213, DOI 10.1093/hmg/ddu440
   Pla-Martín D, 2013, NEUROBIOL DIS, V55, P140, DOI 10.1016/j.nbd.2013.03.010
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018
   Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996
   Devoto VMP, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-05334-9
   Quintanilla RA, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-45
   Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200
   Ramachandran PS, 2014, MOL THER, V22, P1635, DOI 10.1038/mt.2014.108
   Ramdharry GM, 2010, NEUROMUSCULAR DISORD, V20, PS18, DOI 10.1016/j.nmd.2010.08.001
   Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042
   Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052
   Rcom-Hcheo-Gauthier A, 2014, BIOMOLECULES, V4, P795, DOI 10.3390/biom4030795
   Reddy PH, 2017, HUM MOL GENET, V26, P1597, DOI 10.1093/hmg/ddx129
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Ricke KM, 2020, J NEUROSCI, V40, P1975, DOI 10.1523/JNEUROSCI.1345-19.2019
   Rizzo F, 2016, HUM MOL GENET, V25, P4266, DOI 10.1093/hmg/ddw258
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785
   Rodríguez LR, 2020, REDOX BIOL, V37, P0, DOI 10.1016/j.redox.2020.101762
   Rosencrans WM, 2021, CELL CALCIUM, V95, P0, DOI 10.1016/j.ceca.2021.102355
   Roussarie JP, 2020, NEURON, V107, P821, DOI 10.1016/j.neuron.2020.06.010
   Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101
   Sahu G, 2019, CELL REP, V28, P2427, DOI 10.1016/j.celrep.2019.07.075
   Sanz-Blasco S, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002718
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690
   Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077
   Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Scorziello A, 2013, J CELL SCI, V126, P5566, DOI 10.1242/jcs.129668
   Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440
   Sekine S, 2018, BMC BIOL, V16, P0, DOI 10.1186/s12915-017-0470-7
   Shaltouki A, 2018, ACTA NEUROPATHOL, V136, P607, DOI 10.1007/s00401-018-1873-4
   Sharma M, 2019, J CELL BIOL, V218, P1972, DOI 10.1083/jcb.201807068
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Siklós L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005
   Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210
   Smith GA, 2016, MOL NEUROBIOL, V53, P5161, DOI 10.1007/s12035-015-9435-4
   Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148
   Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004
   Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Sprenger HG, 2021, NAT METAB, V3, P636, DOI 10.1038/s42255-021-00385-9
   Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Stoica R, 2016, EMBO REP, V17, P1326, DOI 10.15252/embr.201541726
   Stoica R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4996
   Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301
   Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Surmeier DJ, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009290
   Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003
   Suzuki M, 2012, BIOCHEM BIOPH RES CO, V429, P18, DOI 10.1016/j.bbrc.2012.10.107
   Swarnkar S, 2015, NEUROBIOL DIS, V82, P66, DOI 10.1016/j.nbd.2015.05.011
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Synofzik M, 2019, INT REV NEUROBIOL, V149, P277, DOI 10.1016/bs.irn.2019.10.019
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tabata Y, 2018, STEM CELL REP, V11, P1171, DOI 10.1016/j.stemcr.2018.09.006
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001
   Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102
   Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0
   Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791
   Thau N, 2012, J NEUROPATH EXP NEUR, V71, P1064, DOI 10.1097/NEN.0b013e318275df4b
   Tian J, 2014, NEUROSCI BULL, V30, P74, DOI 10.1007/s12264-013-1393-0
   Toonen LJA, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35200
   TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104
   Truban D, 2017, J PARKINSON DIS, V7, P13, DOI 10.3233/JPD-160989
   Tsai MF, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.15545
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   ULFHAKE B, 1981, J COMP NEUROL, V202, P585, DOI 10.1002/cne.902020410
   Vaccaro V, 2017, EMBO REP, V18, P231, DOI 10.15252/embr.201642710
   Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Vanstone JR, 2016, EUR J HUM GENET, V24, P1084, DOI 10.1038/ejhg.2015.243
   Vedartham V, 2019, OPHTHALMIC GENET, V40, P376, DOI 10.1080/13816810.2019.1666414
   Velde CV, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022031
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vilariño-Güell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001
   Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004
   Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6
   Wang JQ, 2013, J BIOL CHEM, V288, P3070, DOI 10.1074/jbc.M112.407726
   Wang R, 2017, J ALZHEIMERS DIS, V57, P1041, DOI 10.3233/JAD-160763
   Wang WZ, 2017, HUM MOL GENET, V26, P4118, DOI 10.1093/hmg/ddx299
   Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208
   Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wang XH, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0696-4
   Wang YC, 2011, J BIOL CHEM, V286, P21742, DOI 10.1074/jbc.M110.160697
   Ward JM, 2019, CELL REP, V26, P1189, DOI 10.1016/j.celrep.2019.01.028
   Weber B, 2015, CSH PERSPECT BIOL, V7, P0, DOI 10.1101/cshperspect.a020396
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Wong YC, 2014, P NATL ACAD SCI USA, V111, PE4439, DOI 10.1073/pnas.1405752111
   Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
   Yakubovskaya E, 2014, NUCLEIC ACIDS RES, V42, P4100, DOI 10.1093/nar/gkt1360
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056
   Yilmaz R, 2020, NEUROBIOL AGING, V87, P0, DOI 10.1016/j.neurobiolaging.2019.10.018
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yue M, 2015, NEUROBIOL DIS, V78, P172, DOI 10.1016/j.nbd.2015.02.031
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI 10.1523/JNEUROSCI.1860-14.2014
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105
   Zhou YQ, 2019, J CLIN INVEST, V129, P1756, DOI 10.1172/JCI124194
   Zilocchi M, 2018, NEUROCHEM INT, V118, P61, DOI 10.1016/j.neuint.2018.04.013
   Zimmermann L, 2013, J NEUROSCI, V33, P2784, DOI 10.1523/JNEUROSCI.4116-12.2013
   Zimón M, 2011, NEUROLOGY, V77, P540, DOI 10.1212/WNL.0b013e318228fc70
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
   Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008
   Zou ZY, 2017, J NEUROL NEUROSUR PS, V88, P540, DOI 10.1136/jnnp-2016-315018
   Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 441
TC 17
Z9 17
U1 1
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD JUN 30
PY 2021
VL 8
IS 
BP 
EP 
DI 10.3389/fmolb.2021.676187
PG 30
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA TL3CZ
UT WOS:000674734600001
PM 34295920
DA 2024-11-01
ER

PT J
AU Zweers, H
   van Wegberg, AMJ
   Janssen, MCH
   Wortmann, SB
AF Zweers, Heidi
   van Wegberg, Annemiek M. J.
   Janssen, Mirian C. H.
   Wortmann, Saskia B.
TI Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Epilepsy; Complex I; Treatment; Management; Mitochondrial myopathy; OXPHOS; Mitochondrial DNA deletion; Adverse event; Modified Atkins diet; High fat diet
ID triacylglycerol infusion; prisma statement; agc1 deficiency; myopathy; metaanalyses; children; health; muscle; fat
AB BackgroundNo curative therapy for mitochondrial disease (MD) exists, prioritizing supportive treatment for symptom relief. In animal and cell models ketones decrease oxidative stress, increase antioxidants and scavenge free radicals, putting ketogenic diets (KDs) on the list of management options for MD. Furthermore, KDs are well-known, safe and effective treatments for epilepsy, a frequent symptom of MD. This systematic review evaluates efficacy and safety of KD for MD.MethodsWe searched Pubmed, Cochrane, Embase and Cinahl (November 2020) with search terms linked to MD and KD. From the identified records, we excluded studies on Pyruvate Dehydrogenase Complex deficiency. From these eligible reports, cases without a genetically confirmed diagnosis and cases without sufficient data on KD and clinical course were excluded. The remaining studies were included in the qualitative analysis.ResultsOnly 20 cases (14 pediatric) from the 694 papers identified met the inclusion criteria (one controlled trial (n=5), 15 case reports). KD led to seizure control in 7 out of 8 cases and improved muscular symptoms in 3 of 10 individuals. In 4 of 20 cases KD reversed the clinical phenotype (e.g. cardiomyopathy, movement disorder). In 5 adults with mitochondrial DNA deletion(s) related myopathy rhabdomyolysis led to cessation of KD. Three individuals with POLG mutations died while being on KD, however, their survival was not different compared to individuals with POLG mutations without KD.ConclusionData on efficacy and safety of KD for MD is too scarce for general recommendations. KD should be considered in individuals with MD and therapy refractory epilepsy, while KD is contraindicated in mitochondrial DNA deletion(s) related myopathy. When considering KD for MD the high rate of adverse effects should be taken into account, but also spectacular improvements in individual cases. KD is a highly individual management option in this fragile patient group and requires an experienced team. To increase knowledge on this-individually-promising management option more (prospective) studies using adequate outcome measures are crucial.
C1 [Zweers, Heidi; van Wegberg, Annemiek M. J.] Radboudumc, Dept Gastroenterol & Hepatol Dietet, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.
   [Zweers, Heidi; van Wegberg, Annemiek M. J.; Janssen, Mirian C. H.; Wortmann, Saskia B.] Radboudumc, Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
   [Wortmann, Saskia B.] Paracelsus Med Univ, Univ Childrens Hosp, Salzburg, Austria.
   [Janssen, Mirian C. H.] Radboudumc, Dept Internal Med, Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Paracelsus Private Medical University; Radboud University Nijmegen
RP Zweers, H (corresponding author), Radboudumc, Dept Gastroenterol & Hepatol Dietet, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.; Zweers, H (corresponding author), Radboudumc, Amalia Childrens Hosp, Radboud Ctr Mitochondrial Med RCMM, Nijmegen, Netherlands.
EM Heidi.Zweers-vanEssen@radboudumc.nl
CR Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899
   Dahlin M, 2015, EPILEPSIA, V56, Pe176, DOI 10.1111/epi.13193
   Danial NN, 2013, J CHILD NEUROL, V28, P1027, DOI 10.1177/0883073813487598
   de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8
   Deberles E, 2020, CAN J CARDIOL, V36, P0, DOI 10.1016/j.cjca.2020.04.024
   Della Marina Adela, 2020, JIMD REP, V53, P10, DOI 10.1002/jmd2.12109
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Emperador S, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1128-z
   Fraser JL, 2014, MOLEC GENET METAB RE, V1, P66, DOI 10.1016/j.ymgmr.2013.12.007
   Guzmán M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001
   Hasan-Olive MM, 2019, NEUROCHEM RES, V44, P22, DOI 10.1007/s11064-018-2588-6
   Hikmat O, 2017, J INHERIT METAB DIS, V40, P861, DOI 10.1007/s10545-017-0084-9
   Huang X, 2017, SUCCINYL COA SYNTHET, V0, P0
   Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646
   Illsinger S, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2020.104046
   Jeremy Howick ICJLL, 2011, THE OXFORD LEVELS OF EVIDENCE 2OCEBM LEVELS OF EVIDENCE WORKING GROUP, V0, P0
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Koessler Miriam, 2021, JIMD REP, V57, P3, DOI 10.1002/jmd2.12169
   Köse E, 2020, TURKISH J PEDIATR, V62, P652, DOI 10.24953/turkjped.2020.04.016
   Kossoff Eric H, 2018, EPILEPSIA OPEN, V3, P175, DOI 10.1002/epi4.12225
   Kossoff EH, 2012, CURR OPIN NEUROL, V25, P173, DOI 10.1097/WCO.0b013e3283515e4a
   Kotecha S, 2019, BMJ CASE REP, V12, P0, DOI 10.1136/bcr-2019-229668
   Laugel V, 2007, PEDIATR NEUROL, V36, P54, DOI 10.1016/j.pediatrneurol.2006.08.007
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Martin-McGill KJ, 2018, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001903.pub4
   Masino SA, 2016, KETOGENIC DIET AND METABOLIC THERAPIES: EXPANDED ROLES IN HEALTH AND DISEASE, V0, P0
   Moher D, 2015, SYST REV-LONDON, V4, P0, DOI 10.1371/journal.pmed.1000097
   Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873
   Na JH, 2020, THER ADV NEUROL DISO, V13, P0, DOI 10.1177/1756286419897813
   OByrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Ouzzani M, 2016, SYST REV-LONDON, V5, P0, DOI 10.1186/s13643-016-0384-4
   Pfeiffer B, 2020, NEUROPEDIATRICS, V51, P160, DOI 10.1055/s-0039-3400976
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Repp BM, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0784-8
   Rho JM, 2017, NEUROSCI LETT, V637, P4, DOI 10.1016/j.neulet.2015.07.034
   Roef MJ, 2002, AM J CLIN NUTR, V75, P228, DOI 10.1093/ajcn/75.2.228
   Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237
   Schiff M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028823
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Seo JH, 2010, BRAIN DEV-JPN, V32, P253, DOI 10.1016/j.braindev.2008.12.020
   Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5
   Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926
   Spiegler J, 2011, NEUROPEDIATRICS, V42, P194, DOI 10.1055/s-0031-1287812
   Stafford P, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-74
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Sterne JAC, 2016, BMJ-BRIT MED J, V355, P0, DOI 10.1136/bmj.i4919
   Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062
   Takahara S, 2022, CARDIOVASC RES, V118, P977, DOI 10.1093/cvr/cvab068
   Theunissen TEJ, 2017, FRONT MOL NEUROSCI, V10, P0, DOI 10.3389/fnmol.2017.00336
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Vehmeijer FOL, 2015, EUR J PAEDIATR NEURO, V19, P701, DOI 10.1016/j.ejpn.2015.06.004
   Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
   Zweers H, 2020, NUTRITION, V69, P0, DOI 10.1016/j.nut.2019.06.025
NR 59
TC 30
Z9 33
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUL 3
PY 2021
VL 16
IS 1
BP 
EP 
DI 10.1186/s13023-021-01927-w
PG 15
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA TH1PC
UT WOS:000671865800001
PM 34217336
DA 2024-11-01
ER

PT J
AU Müller-Nedebock, AC
   van der Westhuizen, FH
   Koks, S
   Bardien, S
AF Muller-Nedebock, Amica C.
   van Der Westhuizen, Francois H.
   Koks, Sulev
   Bardien, Soraya
TI Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk
SO MOVEMENT DISORDERS
LA English
DT Review
DE Parkinson&apos; s disease; parkinsonism; mitochondrial DNA; mtDNA maintenance; mtDNA transcription and translation
ID progressive external ophthalmoplegia; polymerase-gamma mutation; early-onset parkinsonism; transcription factors b1; genome-wide association; dominant optic atrophy; factor-a tfam; substantia-nigra; autosomal-dominant; 1-methyl-4-phenylpyridinium ion
AB Over the past four decades, mitochondrial dysfunction has been a recurring theme in Parkinson's disease (PD) and is hypothesized to play a central role in its disease pathogenesis. Given the instrumental role of mitochondria in cellular energy production, their dysfunction can be detrimental to highly energy-dependent dopaminergic neurons, known to degenerate in PD. Mitochondria harbor multiple copies of their own genomes (mtDNA), encoding critical respiratory chain complexes required for energy production. Consequently, mtDNA has been investigated as a source of mitochondrial dysfunction in PD. As seen in multiple mitochondrial diseases, deleterious mtDNA variation and mtDNA copy number depletion can impede mtDNA protein synthesis, leading to inadequate energy production in affected cells and the onset of a disease phenotype. As such, high burdens of mtDNA defects but also mtDNA depletion, previously identified in the substantia nigra of PD patients, have been suggested to play a role in PD. Genetic variation in nuclear DNA encoding factors required for replicating, transcribing, and translating mtDNA, could underlie these observed mtDNA changes. Herein we examine this possibility and provide an overview of studies that have investigated whether nuclear-encoded genes associated with mtDNA processes may influence PD risk. Overall, pathway-based analysis studies, mice models, and case reports of mitochondrial disease patients manifesting with parkinsonism all implicate genes encoding factors related to mtDNA processes in neurodegeneration and PD. Most notably, cumulative genetic variation in these genes likely contributes to neurodegeneration and PD risk by acting together in common pathways to disrupt mtDNA processes or impair their regulation. (c) 2021 International Parkinson and Movement Disorder Society (c) 2021 International Parkinson and Movement Disorder Society
C1 [Muller-Nedebock, Amica C.; Bardien, Soraya] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, Cape Town, South Africa.
   [van Der Westhuizen, Francois H.] North West Univ, Human Metabol, Potchefstroom, South Africa.
   [Koks, Sulev] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia.
   [Koks, Sulev] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia.
C3 Stellenbosch University; North West University - South Africa; Perron Institute for Neurological & Translational Science; Murdoch University
RP Müller-Nedebock, AC; Bardien, S (corresponding author), Stellenbosch Univ, Div Mol Biol & Human Genet, Dept Biomed Sci, POB 241, ZA-8000 Cape Town, South Africa.
EM amicamuller@sun.ac.za; sbardien@sun.ac.za
FU National Research Foundation of South Africa
CR Abahuni N, 2007, NEUROSCI LETT, V414, P126, DOI 10.1016/j.neulet.2006.12.053
   Alvarez V, 2008, NEUROSCI LETT, V432, P79, DOI 10.1016/j.neulet.2007.12.010
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Balafkan N, 2012, MITOCHONDRION, V12, P640, DOI 10.1016/j.mito.2012.08.004
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bandres-Ciga S, 2019, MOVEMENT DISORD, V34, P460, DOI 10.1002/mds.27614
   Barchiesi A, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20092221
   Behrouz B, 2010, NEUROSCI LETT, V486, P228, DOI 10.1016/j.neulet.2010.09.059
   Belin AC, 2007, NEUROSCI LETT, V420, P257, DOI 10.1016/j.neulet.2007.05.010
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bentley SR, 2014, MITOCHONDRION, V15, P65, DOI 10.1016/j.mito.2014.01.004
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Billingsley KJ, 2018, CELL TISSUE RES, V373, P9, DOI 10.1007/s00441-018-2817-y
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, P0, DOI 10.1038/s41531-019-0080-x
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7
   Chen C, 2020, NEUROBIOL DIS, V134, P0, DOI 10.1016/j.nbd.2019.104631
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Coxhead J, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.036
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   di Poggio MB, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-105
   Dolhun R, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-92
   Dölle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fasullo M, 2015, INT J MOL SCI, V16, P9431, DOI 10.3390/ijms16059431
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gatt AP, 2013, NEUROSCI LETT, V557, P177, DOI 10.1016/j.neulet.2013.10.045
   Gaweda-Walerych K, 2010, NEUROSCI LETT, V469, P24, DOI 10.1016/j.neulet.2009.11.037
   Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Güldner M, 2016, PARKINSONISM RELAT D, V31, P148, DOI 10.1016/j.parkreldis.2016.07.005
   Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030
   Gui YX, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0050086
   Gurgel-Giannetti J, 2012, MUSCLE NERVE, V45, P453, DOI 10.1002/mus.22330
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   HEIKKILA RE, 1985, NEUROSCI LETT, V62, P389, DOI 10.1016/0304-3940(85)90580-4
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310
   Hughes K, 2013, BRENNERS ENCY GENETI, V0, PP352
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Jang S, 2020, MITOCHONDRION, V51, P30, DOI 10.1016/j.mito.2019.11.006
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kammenga JE, 2017, FEBS J, V284, P3362, DOI 10.1111/febs.14080
   Keener AM, 2016, SEMIN NEUROL, V36, P330, DOI 10.1055/s-0036-1585097
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kim SJ, 2017, J PHYSIOL-LONDON, V595, P6613, DOI 10.1113/JP274472
   Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005
   Lefaivre Shannon C, 2016, CEREBELLUM ATAXIAS, V3, P13, DOI 10.1186/s40673-016-0051-5
   Lezza Angela M S, 2012, FRONTIERS IN BIOLOGY 生物学前沿, V7, P30
   Li X, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0059064
   Lieberman AP, 2019, ANNU REV PATHOL-MECH, V14, P1, DOI 10.1146/annurev-pathmechdis-012418-012857
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   Liu ZR, 2008, MOL VIS, V14, P1995
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Lynch DS, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000188
   Ma L, 2018, PARKINSONISM RELAT D, V46, P0
   Machado A, 2006, MOVEMENT DISORD, V21, PS247, DOI 10.1002/mds.20959
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   MIZUNO Y, 1987, NEUROSCI LETT, V81, P204, DOI 10.1016/0304-3940(87)90366-1
   Müller-Nedebock AC, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104495
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Ohnmacht J, 2020, J NEURAL TRANSM, V127, P729, DOI 10.1007/s00702-020-02184-0
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Podlesniy P, 2019, EBIOMEDICINE, V48, P554, DOI 10.1016/j.ebiom.2019.09.015
   Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Reeve A, 2013, J NEUROSCI, V33, P10790, DOI 10.1523/JNEUROSCI.3525-12.2013
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Rempe T, 2016, PARKINSONISM RELAT D, V29, P135, DOI 10.1016/j.parkreldis.2016.04.020
   Ro S, 2013, CELL RES, V23, P759, DOI 10.1038/cr.2013.37
   Robak LA, 2017, BRAIN, V140, P3191, DOI 10.1093/brain/awx285
   Rosa ID, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005779
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Sánchez-Ferrero E, 2009, PARKINSONISM RELAT D, V15, P468, DOI 10.1016/j.parkreldis.2008.09.004
   Sato K, 2011, J NEUROL, V258, P1327, DOI 10.1007/s00415-011-5936-x
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   Smith AC, 2016, NUCLEIC ACIDS RES, V44, PD1258, DOI 10.1093/nar/gkv1001
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Synofzik M, 2010, MOVEMENT DISORD, V25, P243, DOI 10.1002/mds.22865
   Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023
   Tiangyou W, 2006, NEUROLOGY, V67, P1698, DOI 10.1212/01.wnl.0000238963.07425.d5
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Zheng L, 2017, HUM MOL GENET, V26, P582, DOI 10.1093/hmg/ddw418
   Zhou XS, 2019, HUM MOL GENET, V28, P2874, DOI 10.1093/hmg/ddz103
NR 172
TC 13
Z9 13
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD APR 15
PY 2021
VL 36
IS 4
BP 815
EP 831
DI 10.1002/mds.28475
EA JAN 2021
PG 17
WC Clinical Neurology
SC Neurosciences & Neurology
GA RM8LT
UT WOS:000612831100001
PM 33513296
DA 2024-11-01
ER

PT J
AU Laine-Menéndez, S
   Domínguez-González, C
   Blázquez, A
   Delmiro, A
   García-Consuegra, I
   Fernández-de la Torre, M
   Hernández-Laín, A
   Sayas, J
   Martín, MA
   Morán, M
AF Laine-Menendez, Sara
   Dominguez-Gonzalez, Cristina
   Blazquez, Alberto
   Delmiro, Aitor
   Garcia-Consuegra, Ines
   Fernandez-de la Torre, Miguel
   Hernandez-Lain, Aurelio
   Sayas, Javier
   Martin, Miguel Angel
   Moran, Maria
TI Preferent Diaphragmatic Involvement in TK2 Deficiency: An Autopsy Case Study
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondrial diseases; diaphragm; thymidine kinase 2; respiratory failure
ID thymidine kinase 2; mitochondrial-dna depletion; mechanical ventilation; oxidative stress; dysfunction; proteolysis; deoxycytidine; degradation; activation; expression
AB Our goal was to analyze post mortem tissues of an adult patient with late-onset thymidine kinase 2 (TK2) deficiency who died of respiratory failure. Compared with control tissues, we found a low mtDNA content in the patient's skeletal muscle, liver, kidney, small intestine, and particularly in the diaphragm, whereas heart and brain tissue showed normal mtDNA levels. mtDNA deletions were present in skeletal muscle and diaphragm. All tissues showed a low content of OXPHOS subunits, and this was especially evident in diaphragm, which also exhibited an abnormal protein profile, expression of non-muscular beta-actin and loss of GAPDH and alpha-actin. MALDI-TOF/TOF mass spectrometry analysis demonstrated the loss of the enzyme fructose-bisphosphate aldolase, and enrichment for serum albumin in the patient's diaphragm tissue. The TK2-deficient patient's diaphragm showed a more profound loss of OXPHOS proteins, with lower levels of catalase, peroxiredoxin 6, cytosolic superoxide dismutase, p62 and the catalytic subunits of proteasome than diaphragms of ventilated controls. Strong overexpression of TK1 was observed in all tissues of the patient with diaphragm showing the highest levels. TK2 deficiency induces a more profound dysfunction of the diaphragm than of other tissues, which manifests as loss of OXPHOS and glycolytic proteins, sarcomeric components, antioxidants and overactivation of the TK1 salvage pathway that is not attributed to mechanical ventilation.
C1 [Laine-Menendez, Sara; Dominguez-Gonzalez, Cristina; Blazquez, Alberto; Delmiro, Aitor; Garcia-Consuegra, Ines; Fernandez-de la Torre, Miguel; Martin, Miguel Angel; Moran, Maria] Hosp 12 Octubre Imas12, Mitochondrial & Neuromuscular Dis Lab, Inst Invest Sanitaria, Madrid 28041, Spain.
   [Dominguez-Gonzalez, Cristina; Martin, Miguel Angel; Moran, Maria] Spanish Network Biomed Res Rare Dis CIBERER, U723, Madrid 28029, Spain.
   [Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Neuromuscular Unit, Deparment Neurol, Madrid 28041, Spain.
   [Hernandez-Lain, Aurelio] Hosp 12 Octubre, Dept Pathol Neuropathol, Madrid 28041, Spain.
   [Sayas, Javier] Hosp 12 Octubre, Dept Pneumol, Ventilat Unit, Madrid 28041, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre
RP Morán, M (corresponding author), Hosp 12 Octubre Imas12, Mitochondrial & Neuromuscular Dis Lab, Inst Invest Sanitaria, Madrid 28041, Spain.; Morán, M (corresponding author), Spanish Network Biomed Res Rare Dis CIBERER, U723, Madrid 28029, Spain.
EM slaine.imas12@h12o.es; cdgonzalez@salud.madrid.org; abencinar@hotmail.com; adelmiro@h12o.es; inesgcg@hotmail.com; Miguel.fnandezt.imas12@h12o.es; aurelio.hlain@salud.madrid.org; jsayascat@gmail.com; mamcasanueva.imas12@h12o.es; mmoran@h12o.es
FU Spanish Instituto de Salud Carlos III (ISCIII) [PMP15/00025, PI17/00093, PI18/01374]; European Regional Development fund from the European Union
CR Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004
   Barcia G, 2020, NEUROMUSCULAR DISORD, V30, P593, DOI 10.1016/j.nmd.2020.06.002
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Corpeno R, 2014, J PHYSIOL-LONDON, V592, P3859, DOI 10.1113/jphysiol.2014.277962
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, P0, DOI 10.1016/j.ymgmr.2020.100701
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453
   Drummond MC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003743
   Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330
   Duiverman ML, 2017, INT J CHRONIC OBSTR, V12, P243, DOI 10.2147/COPD.S119959
   DupontVersteegden EE, 1996, P SOC EXP BIOL MED, V213, P281
   Fredriksson K, 2005, ACTA ANAESTH SCAND, V49, P1101, DOI 10.1111/j.1399-6576.2005.00718.x
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   GREAVES DS, 1991, MUSCLE NERVE, V14, P543, DOI 10.1002/mus.880140609
   HAN JW, 1992, BIOCHEMISTRY-US, V31, P377, DOI 10.1021/bi00117a010
   HEILIG A, 1988, EUR J BIOCHEM, V171, P503, DOI 10.1111/j.1432-1033.1988.tb13818.x
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, P0, DOI 10.1136/bmjresp-2020-000774
   Hudson MB, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0137693
   Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   KARLSTROM AR, 1990, MOL CELL BIOCHEM, V92, P23
   Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002
   Kockskämper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782
   Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223
   Lavie J, 2018, CELL REP, V23, P2852, DOI 10.1016/j.celrep.2018.05.013
   Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447
   Levine S, 2011, AM J RESP CRIT CARE, V183, P483, DOI 10.1164/rccm.200910-1487OC
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876
   Morán M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Orsucci Daniele, 2019, DRUGS CONTEXT, V8, P212588, DOI 10.7573/dic.212588
   Picard M, 2015, J APPL PHYSIOL, V118, P1161, DOI 10.1152/japplphysiol.00873.2014
   Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC
   Powers SK, 2020, ANTIOXID REDOX SIGN, V33, P559, DOI 10.1089/ars.2019.8000
   Powers SK, 2019, PFLUG ARCH EUR J PHY, V471, P441, DOI 10.1007/s00424-018-2227-8
   Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62
   Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200
   Ravanelli S, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00270
   Rivera H, 2010, MITOCHONDRION, V10, P362, DOI 10.1016/j.mito.2010.03.003
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Seo IR, 2006, BIOCHEM J, V399, P325, DOI 10.1042/BJ20060701
   Shin WH, 2020, BMB REP, V53, P56, DOI 10.5483/BMBRep.2020.53.1.283
   Smuder AJ, 2018, FREE RADICAL BIO MED, V115, P179, DOI 10.1016/j.freeradbiomed.2017.11.025
   Sollanek KJ, 2015, J APPL PHYSIOL, V118, P849, DOI 10.1152/japplphysiol.00797.2014
   Sun R, 2020, NUCLEOS NUCLEOT NUCL, V39, P1347, DOI 10.1080/15257770.2020.1720234
   Tang HB, 2011, FASEB J, V25, P2921, DOI 10.1096/fj.11-183798
   van den Berg M, 2017, AM J RESP CRIT CARE, V196, P1544, DOI 10.1164/rccm.201703-0501OC
   Wagatsuma A, 2001, ACTA NEUROPATHOL, V101, P540
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang LY, 2020, BMC MOL CELL BIOL, V21, P0, DOI 10.1186/s12860-020-00272-3
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
   Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476
NR 59
TC 4
Z9 5
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN 15
PY 2021
VL 22
IS 11
BP 
EP 
DI 10.3390/ijms22115598
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA SQ2OB
UT WOS:000660195900001
PM 34070501
DA 2024-11-01
ER

PT J
AU Stewart, JB
   Chinnery, PF
AF Stewart, James B.
   Chinnery, Patrick F.
TI Extreme heterogeneity of human mitochondrial DNA from organelles to populations
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID mtdna heteroplasmy; natural-selection; point mutations; genetic bottleneck; rapid segregation; substantia-nigra; skeletal-muscle; in-vivo; genome; evolution
AB Contrary to the long-held view that most humans harbour only identical mitochondrial genomes, deep resequencing has uncovered unanticipated extreme genetic variation within mitochondrial DNA (mtDNA). Most, if not all, humans contain multiple mtDNA genotypes (heteroplasmy); specific patterns of variants accumulate in different tissues, including cancers, over time; and some variants are preferentially passed down or suppressed in the maternal germ line. These findings cast light on the origin and spread of mtDNA mutations at multiple scales, from the organelle to the human population, and challenge the conventional view that high percentages of a mutation are required before a new variant has functional consequences. Deep resequencing has revealed extreme genetic variation in mitochondrial genomes at multiple levels. This heterogeneity has implications for the origins of human mitochondrial DNA mutations as well as their impact on rare and common human diseases, including cancer.
C1 [Stewart, James B.] Max Planck Inst Biol Ageing, Cologne, Germany.
   [Stewart, James B.] Newcastle Univ, Fac Med Sci, Biosci Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Chinnery, Patrick F.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
C3 Max Planck Society; Newcastle University - UK; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge
RP Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Chinnery, PF (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.
EM pfc25@cam.ac.uk
FU Max Planck Society; United Mitochondrial Disease Foundation; UK Medical Research Council Mitochondrial Biology Unit [MC_UU_00015/9]; Medical Research Council International Centre for Genomic Medicine in Neuromuscular Disease; Leverhulme Trust [RPG-2018-408]; NIHR Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; NIHR Biomedical Research Centre based at University of Cambridge
CR Albayrak L, 2016, BMC GENOMICS, V17, P0, DOI 10.1186/s12864-016-3375-x
   Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Antonicka H, 2020, CELL METAB, V32, P479, DOI 10.1016/j.cmet.2020.07.017
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barrett A, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0175
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   Bendall KE, 1996, AM J HUM GENET, V59, P1276
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BEZIAT F, 1993, NUCLEIC ACIDS RES, V21, P387, DOI 10.1093/nar/21.3.387
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Cai N, 2015, CURR BIOL, V25, P3170, DOI 10.1016/j.cub.2015.10.065
   Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   CANN RL, 1984, GENETICS, V106, P479
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013
   Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   De Stordeur E, 1997, HEREDITY, V79, P615, DOI 10.1038/sj.hdy.6882760
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Dou XY, 2019, GENOME RES, V29, P1622, DOI 10.1101/gr.234021.117
   Douvlataniotis K, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aay3335
   Ellison CK, 2008, J EVOLUTION BIOL, V21, P1844, DOI 10.1111/j.1420-9101.2008.01608.x
   Faith JJ, 2003, GENETICS, V165, P735
   Fan L, 2019, PREPRINT, V0, P0, DOI DOI 10.1101/715870
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Fonseca MM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106654
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661
   Gómez-Durán A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grandhi S, 2017, HUM MOL GENET, V26, P2912, DOI 10.1093/hmg/ddx172
   Gray MW, 2015, P NATL ACAD SCI USA, V112, P10133, DOI 10.1073/pnas.1421379112
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Guyatt AL, 2019, HUM GENOMICS, V13, P0, DOI 10.1186/s40246-018-0190-2
   Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Hauswith WW, 1985, ACHIEVEMENTS PERSPEC, VII, P49
   Hazkani-Covo E, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1000834
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264
   Hudson G, 2019, NATURE, V574, PE8, DOI 10.1038/s41586-019-1623-3
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   Hübner A, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-47570-1
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   James AC, 2003, GENETICS, V164, P187
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109
   Johnston IG, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07464
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Just RS, 2014, P NATL ACAD SCI USA, V111, PE4546, DOI 10.1073/pnas.1413478111
   Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901
   Klucnika A, 2019, OPEN BIOL, V9, P0, DOI 10.1098/rsob.180267
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Kühl I, 2014, NATURE, V514, PE7, DOI 10.1038/nature13690
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li MK, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks499
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lorente L, 2016, J CRIT CARE, V33, P95, DOI 10.1016/j.jcrc.2016.02.003
   Lorente L, 2012, CRIT CARE, V16, P0, DOI 10.1186/cc11150
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Ma HS, 2016, NAT GENET, V48, P798, DOI 10.1038/ng.3587
   Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5
   Maude H, 2019, FRONT CELL DEV BIOL, V7, P0, DOI 10.3389/fcell.2019.00201
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Mechta M, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00166
   Meirelles FV, 1997, GENETICS, V145, P445
   Milot E, 2017, NAT ECOL EVOL, V1, P1400, DOI 10.1038/s41559-017-0276-6
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Mossman JA, 2019, G3-GENES GENOM GENET, V9, P1175, DOI 10.1534/g3.119.400067
   Nagarajan-Radha V, 2019, J GERONTOL A-BIOL, V74, P1573, DOI 10.1093/gerona/glz104
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Otten ABC, 2016, CELL REP, V16, P622, DOI 10.1016/j.celrep.2016.06.023
   Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863
   Persson Ö, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0
   Phillips WS, 2015, GENOME BIOL EVOL, V7, P2023, DOI 10.1093/gbe/evv116
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Purhonen J, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-14201-2
   Rand DM, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0188
   Ratel D, 2006, FEBS LETT, V580, P3179, DOI 10.1016/j.febslet.2006.04.074
   Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727
   Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Saini SK, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-01743-y
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, P0, DOI 10.1016/j.fsigen.2020.102274
   Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682
   Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003
   Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005333
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI 10.1139/O02-135
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   van der Wijst MGP, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-00263-z
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vaught RC, 2020, J EVOLUTION BIOL, V33, P694, DOI 10.1111/jeb.13605
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067
   Wei W, 2020, J INTERN MED, V287, P634, DOI 10.1111/joim.13047
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Wei W, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1007126
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Yamamoto K, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-0812-9
   Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343
   Yasukawa T, 2018, J BIOCHEM, V164, P183, DOI 10.1093/jb/mvy058
   Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zaidi AA, 2019, NAT ECOL EVOL, V3, P213, DOI 10.1038/s41559-018-0766-1
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang Y, 2019, MOL CELL, V73, P1127, DOI 10.1016/j.molcel.2019.01.013
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 168
TC 130
Z9 145
U1 1
U2 56
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD FEB 15
PY 2021
VL 22
IS 2
BP 106
EP 118
DI 10.1038/s41576-020-00284-x
EA SEP 2020
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA PU3AH
UT WOS:000573441200001
PM 32989265
DA 2024-11-01
ER

PT J
AU Klein, IL
   van de Loo, KFE
   Smeitink, JAM
   Janssen, MCH
   Kessels, RPC
   van Karnebeek, CD
   van der Veer, E
   Custers, JAE
   Verhaak, CM
AF Klein, Inge-Lot
   van de Loo, Kim F. E.
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
   Kessels, Roy P. C.
   van Karnebeek, Clara D.
   van der Veer, Elja
   Custers, Jose A. E.
   Verhaak, Christianne M.
TI Cognitive functioning and mental health in mitochondrial disease: A systematic scoping review
SO NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
LA English
DT Review
DE Mitochondrial disease; Cognitive functioning; Mental health; Psychology; Psychiatry; Fatigue; Scoping review
ID progressive external ophthalmoplegia; quality-of-life; psychiatric comorbidity; diagnostic-criteria; outcome measures; adult patients; dna mutations; follow-up; disorders; children
AB Mitochondrial diseases (MDs) are rare, heterogeneous, hereditary and progressive in nature. In addition to the serious somatic symptoms, patients with MD also experience problems regarding their cognitive functioning and mental health. We provide an overview of all published studies reporting on any aspect of cognitive functioning and/or mental health in patients with MD and their relatives. A total of 58 research articles and 45 case studies were included and critically reviewed. Cognitive impairments in multiple domains were reported. Mental disorders were frequently reported, especially depression and anxiety. Furthermore, most studies showed impairments in self-reported psychological functioning and high prevalence of mental health problems in (matrilineal) relatives. The included studies showed heterogeneity regarding patient samples, measurement instruments and reference groups, making comparisons cautious. Results highlight a high prevalence of cognitive impairments and mental disorders in patients with MD. Recommendations for further research as well as tailored patientcare with standardized follow-up are provided. Key gaps in the literature are identified, of which studies on natural history are of highest importance.
C1 [Klein, Inge-Lot; van de Loo, Kim F. E.; Custers, Jose A. E.; Verhaak, Christianne M.] Radboud Univ Nijmegen Med Ctr, Amalia Childrens Hosp, Radboud Inst Hlth Sci, Radboud Ctr Mitochondrial Med,Dept Med Psychol, Geert Grootepl Zuid 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Smeitink, Jan A. M.; van Karnebeek, Clara D.] Radboud Univ Nijmegen Med Ctr, Amalia Childrens Hosp, Radboud Inst Mol Life Sci, Radboud Ctr Mitochondrial Med,Dept Pediat, Geert Grootepl Zuid 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Smeitink, Jan A. M.] Khondrion BV, Philips van Leydenlaan 15,POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Radboud Ctr Mitochondrial Med, Dept Internal Med, Geert Grootepl Zuid 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Kessels, Roy P. C.] Radboud Univ Nijmegen Med Ctr, Dept Med Psychol, Geert Grootepl Zuid 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Thomas van Aquinostr 4,Postbus 9104, NL-6500 HE Nijmegen, Netherlands.
   [Kessels, Roy P. C.] Vincent van Gogh Inst Psychiat, d n Herk 90, NL-5803 DN Venray, Netherlands.
   [van der Veer, Elja] Int Mito Patients Assoc, NL-2861 AD Bergambacht, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Philips; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen
RP van de Loo, KFE (corresponding author), Radboud Univ Nijmegen Med Ctr, Amalia Childrens Hosp, Radboud Inst Hlth Sci, Radboud Ctr Mitochondrial Med,Dept Med Psychol, Geert Grootepl Zuid 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM Kim.vandeLoo@radboudumc.nl
FU 'Prinses Beatrix Spierfonds', the Dutch foundation for muscular diseases [W.OK17-06]
CR Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221
   Allen J, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00386
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Anglin RE, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.107
   Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345
   Anglin RE, 2012, J CLIN PSYCHIAT, V73, P506, DOI 10.4088/JCP.11r07237
   Babinská K, 2017, ACT NERV SUPER REDIV, V59, P39
   Bansal Y, 2016, CURR NEUROPHARMACOL, V14, P610, DOI 10.2174/1570159X14666160229114755
   Barbour KA, 2005, NEUROBIOL AGING, V26, PS119, DOI 10.1016/j.neurobiolaging.2005.09.007
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bernardo TC, 2016, BRAIN PATHOL, V26, P648, DOI 10.1111/bpa.12403
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003
   Boles RG, 2005, AM J MED GENET B, V137B, P20, DOI 10.1002/ajmg.b.30199
   Born AP, 2015, EUR J PAEDIATR NEURO, V19, P69, DOI 10.1016/j.ejpn.2014.10.006
   Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Brown Bradley D, 2015, INNOV CLIN NEUROSCI, V12, P29
   Burnett BB, 2005, J AFFECT DISORDERS, V88, P109, DOI 10.1016/j.jad.2005.05.009
   Campos Y, 2001, J INHERIT METAB DIS, V24, P685, DOI 10.1023/A:1012719211505
   Clarke DM, 2009, MED J AUSTRALIA, V190, P0
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Cozart B, 2018, CLIN NEUROPHARMACOL, V41, P103, DOI 10.1097/WNF.0000000000000277
   Cui SL, 2019, J NEURO-OPHTHALMOL, V39, P56, DOI 10.1097/WNO.0000000000000644
   Custers JAE, 2018, ORPHANET J RARE DIS, V13, P0, DOI 10.1186/s13023-018-0951-y
   De Luca R, 2016, APPL NEUROPSYCH-ADUL, V23, P61, DOI 10.1080/23279095.2014.960522
   Dinas PC, 2011, IRISH J MED SCI, V180, P319, DOI 10.1007/s11845-010-0633-9
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Ellaway RH, 2018, MED TEACH, V40, P219, DOI 10.1080/0142159X.2017.1406662
   Eom S, 2017, PEDIATR NEUROL, V71, P43, DOI 10.1016/j.pediatrneurol.2017.01.019
   Fattal O, 2006, PSYCHOSOMATICS, V47, P1, DOI 10.1176/appi.psy.47.1.1
   Fattal O, 2007, CNS SPECTRUMS, V12, P429, DOI 10.1017/S1092852900015303
   Ferguson J, 2016, BRIT J VISUAL IMPA, V34, P111, DOI 10.1177/0264619615616260
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   Fiuza-Luces C, 2018, MED SCI SPORT EXER, V50, P1142, DOI 10.1249/MSS.0000000000001546
   Fromont I, 2009, J NEUROL, V256, P1696, DOI 10.1007/s00415-009-5185-4
   Frye RE, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.51
   Galán F, 2015, J INVEST MED HIGH IM, V3, P0, DOI 10.1177/2324709615607908
   Garcia GA, 2017, CLIN OPHTHALMOL, V11, P417, DOI 10.2147/OPTH.S113414
   Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601
   Gramstad A, 2009, EPILEPSY BEHAV, V16, P172, DOI 10.1016/j.yebeh.2009.01.014
   Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037
   Guevara-Campos J, 2013, METAB BRAIN DIS, V28, P605, DOI 10.1007/s11011-013-9419-x
   Harris Juan-Diego, 2008, CURR OPIN SUPPORT PALLIAT CARE, V2, P180, DOI 10.1097/SPC.0b013e32830baed0
   Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298
   Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1
   Inczedy-Farkas G, 2014, ARCH CLIN NEUROPSYCH, V29, P315, DOI 10.1093/arclin/acu016
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, P0, DOI 10.1186/1744-9081-8-9
   Irwin MH, 2016, DRUG DEVELOP RES, V77, P109, DOI 10.1002/ddr.21294
   Iwata K, 2019, ADV EXP MED BIOL, V1118, P63, DOI 10.1007/978-3-030-05542-4_3
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Ju Seok Ryu, 2009, J CHILD NEUROL, V24, P1307, DOI 10.1177/0883073809334380
   Kannan K, 2006, HONG KONG J PSYCHIAT, V16, P150
   KARTSOUNIS LD, 1992, ARCH NEUROL-CHICAGO, V49, P158, DOI 10.1001/archneur.1992.00530260058020
   Kasamo K, 2020, NEUROSCI RES, V157, P58, DOI 10.1016/j.neures.2019.07.006
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Khacho M, 2019, NAT REV NEUROSCI, V20, P34, DOI 10.1038/s41583-018-0091-3
   Kim KR, 2010, PEDIATR NEUROL, V42, P271, DOI 10.1016/j.pediatrneurol.2009.11.012
   Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166
   Knapen J, 2015, DISABIL REHABIL, V37, P1490, DOI 10.3109/09638288.2014.972579
   Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023
   Koene S, 2013, MITOCHONDRION, V13, P15, DOI 10.1016/j.mito.2012.11.002
   Kraya T, 2019, MITOCHONDRION, V44, P53, DOI 10.1016/j.mito.2017.12.012
   Krieg E, 2016, MITOCHONDRION, V28, P60, DOI 10.1016/j.mito.2016.03.008
   Lacey CJ, 2008, PSYCHOSOMATICS, V49, P540, DOI 10.1176/appi.psy.49.6.540
   LANG CJG, 1995, EUR J NEUROL, V2, P171, DOI 10.1111/j.1468-1331.1995.tb00112.x
   Levac D, 2010, IMPLEMENT SCI, V5, P0, DOI 10.1186/1748-5908-5-69
   Lindenschot M, 2018, OCCUP THER INT, V0, P0, DOI DOI 10.1155/2018/5716947
   Magner M, 2014, PSYCHIATR POL, V48, P1035, DOI 10.12740/PP/24062
   Majamaa-Voltti KAM, 2006, NEUROLOGY, V66, P1470, DOI 10.1212/01.wnl.0000216136.61640.79
   Mancuso M, 2006, J NEUROL SCI, V243, P97, DOI 10.1016/j.jns.2005.11.021
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Marin SE, 2016, NEUROL CLIN, V34, P247, DOI 10.1016/j.ncl.2015.08.011
   Marrie RA, 2015, NEUROLOGY, V85, P1972, DOI 10.1212/WNL.0000000000002174
   Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487
   Martens AM, 2014, PEDIATR PHYS THER, V26, P19, DOI 10.1097/PEP.0000000000000016
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Montirosso R, 2002, J NEUROL SCI, V194, P3, DOI 10.1016/S0022-510X(01)00664-5
   Moore HL, 2020, EUR J NEUROL, V27, P3, DOI 10.1111/ene.14068
   Moore HL, 2019, ANN CLIN TRANSL NEUR, V6, P826, DOI 10.1002/acn3.736
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2010, MITOCHONDRION, V10, P528, DOI 10.1016/j.mito.2010.05.011
   Morris G, 2015, BMC MED, V13, P0, DOI 10.1186/s12916-015-0310-y
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Neargarder SA, 2007, COGN BEHAV NEUROL, V20, P193, DOI 10.1097/WNN.0b013e318051808c
   Niyazov DM, 2016, MOL SYNDROMOL, V7, P122, DOI 10.1159/000446586
   Noorda G, 2012, JIMD REP, V6, P85, DOI 10.1007/8904_2011_121
   Pangalila RF, 2015, ARCH PHYS MED REHAB, V96, P1242, DOI 10.1016/j.apmr.2015.02.012
   Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Peters MDJ, 2020, JBI MANUAL FOR EVIDENCE SYNTHESIS, V0, PP407, DOI 10.46658/JBIMES-20-12
   Petschner P, 2018, NEUROSCIENCE, V370, P207, DOI 10.1016/j.neuroscience.2017.09.049
   Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123
   Poole OV, 2019, EUR J NEUROL, V26, P1111, DOI 10.1111/ene.13952
   Quittner AL, 2014, THORAX, V69, P1090, DOI 10.1136/thoraxjnl-2014-205983
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Rapinesi C, 2015, GEN HOSP PSYCHIAT, V37, P0, DOI 10.1016/j.genhosppsych.2015.03.002
   Read Catherine Yetter, 2003, J PEDIATR NURS, V18, P181, DOI 10.1053/jpdn.2003.36
   Rogac M, 2011, PEDIATR NEUROL, V44, P340, DOI 10.1016/j.pediatrneurol.2010.12.004
   Rosebush PI, 2017, SCHIZOPHR RES, V187, P33, DOI 10.1016/j.schres.2017.05.010
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Sartor H, 2002, ACTA NEUROL SCAND, V106, P309, DOI 10.1034/j.1600-0404.2002.01089.x
   Schreiber H, 2012, J CHILD NEUROL, V27, P1506, DOI 10.1177/0883073812442589
   Senger BA, 2016, APPL NURS RES, V29, P195, DOI 10.1016/j.apnr.2015.03.010
   Senger BA, 2016, J PEDIATR NURS, V31, P32, DOI 10.1016/j.pedn.2015.08.007
   Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753
   Shurtleff H, 2018, EPILEPSY BEHAV, V88, P235, DOI 10.1016/j.yebeh.2018.09.013
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smits BW, 2012, EUR J NEUROL, V19, P176, DOI 10.1111/j.1468-1331.2011.03496.x
   Smits BW, 2011, NEUROMUSCULAR DISORD, V21, P272, DOI 10.1016/j.nmd.2010.12.008
   Streck EL, 2014, REV BRAS PSIQUIATR, V36, P156, DOI 10.1590/1516-4446-2013-1224
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
   Tsao CY, 2007, J CHILD NEUROL, V22, P1121, DOI 10.1177/0883073807306266
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Varvogli L, 1999, J INHERIT METAB DIS, V22, P615, DOI 10.1023/A:1005521828360
   Verhaak C, 2016, ORPHANET J RARE DIS, V11, P0, DOI 10.1186/s13023-016-0403-5
   Verhoeven WMA, 2011, NEUROPSYCH DIS TREAT, V7, P293, DOI 10.2147/NDT.S20153
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Zverová M, 2019, NEUROPSYCH DIS TREAT, V15, P233, DOI 10.2147/NDT.S188964
   Zweers H, 2020, NUTRITION, V69, P0, DOI 10.1016/j.nut.2019.06.025
NR 134
TC 10
Z9 10
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0149-7634
EI 1873-7528
J9 NEUROSCI BIOBEHAV R
JI Neurosci. Biobehav. Rev.
PD JUN 15
PY 2021
VL 125
IS 
BP 57
EP 77
DI 10.1016/j.neubiorev.2021.02.004
EA FEB 2021
PG 21
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA RW8AI
UT WOS:000646741600005
PM 33582231
DA 2024-11-01
ER

PT J
AU Gomes, TMB
   Ng, YS
   Pickett, SJ
   Turnbull, DM
   Vincent, AE
AF Gomes, Tiago M. Bernardino
   Ng, Yi Shiau
   Pickett, Sarah J.
   Turnbull, Doug M.
   Vincent, Amy E.
TI Mitochondrial DNA disorders: from pathogenic variants to preventing transmission
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID cytochrome-c-oxidase; preimplantation genetic diagnosis; hereditary optic neuropathy; muscle-fiber analysis; ragged-red fibers; external ophthalmoplegia; myoclonic epilepsy; pearson-syndrome; mutation; disease
AB Mitochondrial DNA (mtDNA) disorders are recognized as one of the most common causes of inherited metabolic disorders. The mitochondrial genome occurs in multiple copies resulting in both homoplasmic and heteroplasmic pathogenic mtDNA variants. A biochemical defect arises when the pathogenic variant level reaches a threshold, which differs between variants. Moreover, variants can segregate, clonally expand, or be lost from cellular populations resulting in a dynamic and tissue-specific mosaic pattern of oxidative deficiency. MtDNA is maternally inherited but transmission patterns of heteroplasmic pathogenic variants are complex. During oogenesis, a mitochondrial bottleneck results in offspring with widely differing variant levels to their mother, whilst highly deleterious variants, such as deletions, are not transmitted. Complemented by a complex interplay between mitochondrial and nuclear genomes, these peculiar genetics produce marked phenotypic variation, posing challenges to the diagnosis and clinical management of patients. Novel therapeutic compounds and several genetic therapies are currently under investigation, but proven disease-modifying therapies remain elusive. Women who carry pathogenic mtDNA variants require bespoke genetic counselling to determine their reproductive options. Recent advances in in vitro fertilization techniques, have greatly improved reproductive choices, but are not without their challenges. Since the first pathogenic mtDNA variants were identified over 30 years ago, there has been remarkable progress in our understanding of these diseases. However, many questions remain unanswered and future studies are required to investigate the mechanisms of disease progression and to identify new disease-specific therapeutic targets.
C1 [Gomes, Tiago M. Bernardino; Ng, Yi Shiau; Pickett, Sarah J.; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Gomes, Tiago M. Bernardino; Ng, Yi Shiau] Newcastle upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Wellcome Ctr Mitochondrial Res, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU National Institute for Health Research [CL-2016-01-003]; Wellcome [204709/Z/16/Z, 215888/Z/19/Z, 203105/Z/16/Z]; United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease award; Lily Foundation; United Kingdom National Health Service; Newcastle University Centre for Ageing and Vitality; Biotechnology and Biological Sciences Research Council; Medical Research Council [G016354/1]; Wellcome Trust [203105/Z/16/Z, 204709/Z/16/Z, 215888/Z/19/Z] Funding Source: Wellcome Trust
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bredenoord AL, 2008, HUM REPROD UPDATE, V14, P83, DOI 10.1093/humupd/dmm037
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Craven L, 2016, STEM CELLS, V34, P265, DOI 10.1002/stem.2221
   Craven L, 2011, HUM MOL GENET, V20, PR168, DOI 10.1093/hmg/ddr373
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Feeney CL, 2019, BJOG-INT J OBSTET GY, V126, P1380, DOI 10.1111/1471-0528.15667
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Jankauskaite E, 2020, J APPL GENET, V61, P195, DOI 10.1007/s13353-020-00550-y
   JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kawamura E, 2020, MOL THER-NUCL ACIDS, V20, P687, DOI 10.1016/j.omtn.2020.04.004
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Lee HF, 2007, EUR J PAEDIATR NEURO, V11, P208, DOI 10.1016/j.ejpn.2006.12.008
   Lim AZ, 2020, NEUROMUSCULAR DISORD, V30, P661, DOI 10.1016/j.nmd.2020.06.008
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Otten ABC, 2018, HUM REPROD, V33, P1331, DOI 10.1093/humrep/dey114
   Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X
   PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Poincenot L, 2020, OPHTHALMOLOGY, V127, P679, DOI 10.1016/j.ophtha.2019.11.014
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Puomila A, 2007, EUR J HUM GENET, V15, P1079, DOI 10.1038/sj.ejhg.5201828
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   ROTIG A, 1989, LANCET, V1, P902
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Salas A, 2020, FORENSIC SCI INT-GEN, V47, P0, DOI 10.1016/j.fsigen.2020.102274
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   The Royal Society; National Academy of Sciences; National Academy of Medicine; International Commission on the Clinical Use of Human Germline Genome Editing, 2020, HER HUM GEN ED, V0, P0, DOI DOI 10.17226/25665
   TOKUNAGA M, 1994, ANN NEUROL, V35, P413, DOI 10.1002/ana.410350407
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wei W, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-15336-3
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zierz CM, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8060789
NR 80
TC 15
Z9 16
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD OCT 15
PY 2021
VL 30
IS R2
BP R245
EP R253
DI 10.1093/hmg/ddab156
EA JUN 2021
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA WJ1JG
UT WOS:000708804800011
PM 34169319
DA 2024-11-01
ER

PT J
AU Bruhn, H
   Samuelsson, K
   Schober, FA
   Engvall, M
   Lesko, N
   Wibom, R
   Nennesmo, I
   Calvo-Garrido, J
   Press, R
   Stranneheim, H
   Freyer, C
   Wedell, A
   Wredenberg, A
AF Bruhn, Helene
   Samuelsson, Kristin
   Schober, Florian A.
   Engvall, Martin
   Lesko, Nicole
   Wibom, Rolf
   Nennesmo, Inger
   Calvo-Garrido, Javier
   Press, Rayomand
   Stranneheim, Henrik
   Freyer, Christoph
   Wedell, Anna
   Wredenberg, Anna
TI Novel Mutation m.10372A&gt;G in <i>MT-ND3</i> Causing Sensorimotor Axonal Polyneuropathy
SO NEUROLOGY-GENETICS
LA English
DT Article
ID mitochondrial-dna mutation; muscle; gene; encephalopathy; transition; phenotypes; neuropathy; narp
AB Objective To investigate the pathogenicity of a novel MT-ND3 mutation identified in a patient with adult-onset sensorimotor axonal polyneuropathy and report the clinical, morphologic, and biochemical findings. Methods Clinical assessments and morphologic and biochemical investigations of skeletal muscle and cultured myoblasts from the patient were performed. Whole-genome sequencing (WGS) of DNA from skeletal muscle and Sanger sequencing of mitochondrial DNA (mtDNA) from both skeletal muscle and cultured myoblasts were performed. Heteroplasmic levels of mutated mtDNA in different tissues were quantified by last-cycle hot PCR. Results Muscle showed ragged red fibers, paracrystalline inclusions, a significant reduction in complex I (CI) respiratory chain (RC) activity, and decreased adenosine triphosphate (ATP) production for all substrates used by CI. Sanger sequencing of DNA from skeletal muscle detected a unique previously unreported heteroplasmic mutation in mtDNA encoded MT-ND3, coding for a subunit in CI. WGS confirmed the mtDNA mutation but did not detect any other mutation explaining the disease. Cultured myoblasts, however, did not carry the mutation, and RC activity measurements in myoblasts were normal. Conclusions We report a case with adult-onset sensorimotor axonal polyneuropathy caused by a novel mtDNAmutation in MT-ND3. Loss of heteroplasmy in blood, cultured fibroblasts and myoblasts from the patient, and normal measurement of RC activity of the myoblasts support pathogenicity of the mutation. These findings highlight the importance of mitochondrial investigations in patients presenting with seemingly idiopathic polyneuropathy, especially if muscle also is affected.
C1 [Bruhn, Helene; Wibom, Rolf; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Bruhn, Helene; Engvall, Martin; Lesko, Nicole; Wibom, Rolf; Stranneheim, Henrik; Freyer, Christoph; Wedell, Anna; Wredenberg, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Samuelsson, Kristin; Press, Rayomand] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Samuelsson, Kristin; Press, Rayomand] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden.
   [Schober, Florian A.; Engvall, Martin; Lesko, Nicole; Calvo-Garrido, Javier; Stranneheim, Henrik; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Nennesmo, Inger] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden.
   [Stranneheim, Henrik] Karolinska Inst, Sci Life Lab, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet
RP Bruhn, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.; Bruhn, H (corresponding author), Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
EM helene.bruhn@sll.se
FU Swedish Research Council [2019-01154, VR2016-02179]; Stockholm County Council [20170022]; Swedish Research Council [2019-01154] Funding Source: Swedish Research Council
CR Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Cabrera-Orefice A, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06955-y
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Di Luca A, 2017, P NATL ACAD SCI USA, V114, PE6314, DOI 10.1073/pnas.1706278114
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gilhuis HJ, 2006, NEUROMUSCULAR DISORD, V16, P394, DOI 10.1016/j.nmd.2006.03.006
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Haapanen O, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-07930-1
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MITOMAP, 2018, HUM MIT GEN DAT, V0, P0
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Sciacco M, 2003, J NEUROL, V250, P1498, DOI 10.1007/s00415-003-0246-6
   Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, PW296, DOI 10.1093/nar/gky427
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 38
TC 4
Z9 5
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD APR 15
PY 2021
VL 7
IS 2
BP 
EP 
DI 10.1212/NXG.0000000000000566
PG 10
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA SO2TR
UT WOS:000658830100008
PM 33732874
DA 2024-11-01
ER

PT J
AU Bérat, CM
   Montealegre, S
   Wiedemann, A
   Nuzum, ML
   Blondel, A
   Debruge, H
   Cano, A
   Chabrol, B
   Hoebeke, C
   Polak, M
   Stoupa, A
   Feillet, F
   Torre, S
   Boddaert, N
   Bruel, H
   Barth, M
   Damaj, L
   Abi-Wardé, MT
   Afenjar, A
   Benoist, JF
   Madrange, M
   Caccavelli, L
   Renard, P
   Hubas, A
   Nusbaum, P
   Pontoizeau, C
   Gobin, S
   van Endert, P
   Ottolenghi, C
   Maltret, A
   de Lonlay, P
AF Berat, Claire-Marine
   Montealegre, Sebastian
   Wiedemann, Arnaud
   Nuzum, Malou Le Corronc
   Blondel, Amelie
   Debruge, Hugo
   Cano, Aline
   Chabrol, Brigitte
   Hoebeke, Celia
   Polak, Michel
   Stoupa, Athanasia
   Feillet, Francois
   Torre, Stephanie
   Boddaert, Nathalie
   Bruel, Henri
   Barth, Magalie
   Damaj, Lena
   Abi-Warde, Marie-Therese
   Afenjar, Alexandra
   Benoist, Jean-Francois
   Madrange, Marine
   Caccavelli, Laure
   Renard, Perrine
   Hubas, Arnaud
   Nusbaum, Patrick
   Pontoizeau, Clement
   Gobin, Stephanie
   van Endert, Peter
   Ottolenghi, Chris
   Maltret, Alice
   de Lonlay, Pascale
TI Clinical and biological characterization of 20 patients withTANGO2deficiency indicates novel triggers of metabolic crises and no primary energetic defect
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE Brugada pattern; glutamate oxidation; long-QT; palmitate oxidation; TANGO2; triggers
ID mitochondrial; mutations
AB TANGO2 disease is a severe inherited disorder associating multiple symptoms such as metabolic crises, encephalopathy, cardiac arrhythmias, and hypothyroidism. The mechanism of action of TANGO2 is currently unknown. Here, we describe a cohort of 20 French patients bearing mutations in theTANGO2gene. We found that the main clinical presentation was the association of neurodevelopmental delay (n = 17), acute metabolic crises (n = 17) and hypothyroidism (n = 12), with a large intrafamilial clinical variability. Metabolic crises included rhabdomyolysis (15/17), neurological symptoms (14/17), and cardiac features (12/17; long QT (n = 10), Brugada pattern (n = 2), cardiac arrhythmia (n = 6)) that required intensive care. We show previously uncharacterized triggers of metabolic crises in TANGO2 patients, such as some anesthetics and possiblyl-carnitine. Unexpectedly, plasma acylcarnitines, plasma FGF-21, muscle histology, and mitochondrial spectrometry were mostly normal. Moreover, in patients' primary myoblasts, palmitate and glutamine oxidation rates, and the mitochondrial network were also normal. Finally, we found variable mitochondrial respiration and defective clearance of oxidized DNA upon cycles of starvation and refeeding. We conclude that TANGO2 disease is a life-threatening disease that needs specific cardiac management and anesthesia protocol. Mechanistically, TANGO2 disease is unlikely to originate from a primary mitochondrial defect. Rather, we suggest that mitochondrial defects are secondary to strong extrinsic triggers in TANGO2 deficient patients.
C1 [Berat, Claire-Marine; Montealegre, Sebastian; Nuzum, Malou Le Corronc; Debruge, Hugo; Madrange, Marine; Caccavelli, Laure; Renard, Perrine; van Endert, Peter; de Lonlay, Pascale] Inst Necker Enfants Malad, INSERM, U1151, Paris, France.
   [Berat, Claire-Marine; Polak, Michel; Stoupa, Athanasia; Boddaert, Nathalie; van Endert, Peter; de Lonlay, Pascale] Univ Paris, Paris, France.
   [Berat, Claire-Marine; Montealegre, Sebastian; Madrange, Marine; Caccavelli, Laure; de Lonlay, Pascale] Necker Enfants Malad Univ Hosp, APHP, Imagine Inst, Filiere G2M,Reference Ctr Inherited Metab Dis, Paris, France.
   [Wiedemann, Arnaud; Feillet, Francois] Nancy Hosp, Reference Ctr Inherited Metab Disorders, Dept Pediat Intens Care, INSERM,U1256, Nancy, France.
   [Blondel, Amelie; Benoist, Jean-Francois; Pontoizeau, Clement; Ottolenghi, Chris] Necker Enfants Malad Univ Hosp, APHP, Dept Biochem, Filiere G2M, Paris, France.
   [Cano, Aline; Chabrol, Brigitte; Hoebeke, Celia] La Timone Hosp, Reference Ctr Inherited Metab Disorders, Filiere G2M, Marseille, France.
   [Polak, Michel; Stoupa, Athanasia] Univ Hosp, APHP, Reference Ctr Rare Endocrine Dis Growth & Dev, Necker Enfants Malad,Imagine Inst,Endocrinol Unit, Paris, France.
   [Torre, Stephanie] Rouen Hosp, Competence Ctr Inherited Metab Disorders, Filiere G2M, Rouen, France.
   [Boddaert, Nathalie] Necker Enfants Malad Univ Hosp, APHP, Paediat Radiol Dept, Paris, France.
   [Boddaert, Nathalie] INSERM, U1163, Imagine Inst, Paris, France.
   [Bruel, Henri] Le Havre Hosp, Pediat Dept, Le Havre, France.
   [Barth, Magalie] Angers Hosp, Pediat Dept, Angers, France.
   [Damaj, Lena] Rennes Hosp, Pediat Dept, Rennes, France.
   [Abi-Warde, Marie-Therese] Strasbourg Hosp, Pediat Dept, Strasbourg, France.
   [Afenjar, Alexandra] Trousseau Hosp, APHP, Reference Ctr Cerebellar Malformat & Congenital D, Paris, France.
   [Hubas, Arnaud; Nusbaum, Patrick] Hop Cochin, Lab Culture Cellulaire, Genet & Mol Biol, Paris, France.
   [Gobin, Stephanie] Necker Enfants Malad Univ Hosp, APHP, Genet Dept, Paris, France.
   [Maltret, Alice] Necker Enfants Malad Univ Hosp, APHP, Cardiol Unit, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Universite de Rouen Normandie; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Cochin - APHP; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Rennes; CHU Rennes; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Sorbonne Universite; Hopital Universitaire Armand-Trousseau - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP
RP de Lonlay, P (corresponding author), Hop Necker Enfants Malad, Metab Unit, 149 Rue Sevres, F-75015 Paris, France.
EM pdelonlay@neuf.fr
FU Agence Nationale de la Recherche [ANR - AAPG 2018 CE17 MetabInf]; Association Francaise contre les Myopathies [19773]; Erreurs Innees du Metabolisme (SFEIM); Societe Francaise de Pediatrie (SFP); Fondation Jerome Lejeune; Fondation maladies rares; Nos Anges; No Myolyse; AMMI; OPPH; TANGO2 family associations; TANGO2 fundation; Hyperinsulinisme; Noa Luu
CR Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377
   Dines JN, 2019, GENET MED, V21, P601, DOI 10.1038/s41436-018-0137-y
   DING ZF, 2013, SCI REP UK, V3, P0
   Habarou F, 2017, AM J HUM GENET, V101, P283, DOI 10.1016/j.ajhg.2017.07.001
   Hume-Smith HV, 2008, ANESTH ANALG, V107, P806, DOI 10.1213/ane.0b013e3181815ce3
   Jennions E, 2019, J INHERIT METAB DIS, V42, P898, DOI 10.1002/jimd.12149
   Kloesel B, 2011, CAN J ANESTH, V58, P824, DOI 10.1007/s12630-011-9546-y
   Kremer LS, 2016, AM J HUM GENET, V98, P358, DOI 10.1016/j.ajhg.2015.12.009
   Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008
   Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027
   Meisner JK, 2020, CIRC-GENOM PRECIS ME, V13, P0, DOI 10.1161/CIRCGEN.120.002928
   Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021
   Mingirulli N, 2020, J INHERIT METAB DIS, V43, P297, DOI 10.1002/jimd.12156
   Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scuotto Frederico, 2020, HEARTRHYTHM CASE REP, V6, P256, DOI 10.1016/j.hrcr.2020.01.007
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
NR 18
TC 29
Z9 29
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAR 15
PY 2021
VL 44
IS 2
BP 415
EP 425
DI 10.1002/jimd.12314
EA SEP 2020
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA RF6NN
UT WOS:000574439900001
PM 32929747
DA 2024-11-01
ER

PT J
AU Govers, LP
   Toka, HR
   Hariri, A
   Walsh, SB
   Bockenhauer, D
AF Govers, Larissa P.
   Toka, Hakan R.
   Hariri, Ali
   Walsh, Stephen B.
   Bockenhauer, Detlef
TI Mitochondrial DNA mutations in renal disease: an overview
SO PEDIATRIC NEPHROLOGY
LA English
DT Review
DE Mitochondrial DNA; Renal disease; Renal Fanconi syndrome; Distal tubulopathies; Nephrotic syndrome; Tubulointerstitial nephritis
ID kearns-sayre-syndrome; fanconi-debre syndrome; respiratory-chain; complex-iii; lactic acidemia; deletion; hypoparathyroidism; transcription; myopathy; patient
AB Kidneys have a high energy demand to facilitate the reabsorption of the glomerular filtrate. For this reason, renal cells have a high density of mitochondria. Mitochondrial cytopathies can be the result of a mutation in both mitochondrial and nuclear DNA. Mitochondrial dysfunction can lead to a variety of renal manifestations. Examples of tubular manifestations are renal Fanconi Syndrome, which is often found in patients diagnosed with Kearns-Sayre and Pearson's marrow-pancreas syndrome, and distal tubulopathies, which result in electrolyte disturbances such as hypomagnesemia. Nephrotic syndrome can be a glomerular manifestation of mitochondrial dysfunction and is typically associated with focal segmental glomerular sclerosis on histology. Tubulointerstitial nephritis can also be seen in mitochondrial cytopathies and may lead to end-stage renal disease. The underlying mechanisms of these cytopathies remain incompletely understood; therefore, current therapies focus mainly on symptom relief. A better understanding of the molecular disease mechanisms is critical in order to improve treatments.
C1 [Govers, Larissa P.; Walsh, Stephen B.; Bockenhauer, Detlef] UCL, Dept Renal Med, London, England.
   [Toka, Hakan R.] Manatee Kidney Dis Consultants, Bradenton, FL USA.
   [Hariri, Ali] Sanofi Rare Dis, Clin Dev, Boston, MA USA.
   [Bockenhauer, Detlef] Great Ormond St Hosp Children NHS Fdn Trust, Renal Unit, Great Ormond St, London, England.
C3 University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Bockenhauer, D (corresponding author), UCL, Dept Renal Med, London, England.; Bockenhauer, D (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Renal Unit, Great Ormond St, London, England.
EM d.bockenhauer@ucl.ac.uk
CR ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Astor MC, 2015, ENDOCR CONNECT, V4, P215, DOI 10.1530/EC-15-0066
   Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Au KM, 2007, PEDIATR NEPHROL, V22, P136, DOI 10.1007/s00467-006-0288-y
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Becher MW, 1999, HUM PATHOL, V30, P577, DOI 10.1016/S0046-8177(99)90204-6
   Bénit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Burke DG, 2003, INT J SPORT NUTR EXE, V13, P294, DOI 10.1123/ijsnem.13.3.294
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700
   Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, PF145, DOI 10.1152/ajprenal.00164.2016
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Connor TM, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006620
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   DAco KE, 2013, PEDIATR NEPHROL, V28, P515, DOI 10.1007/s00467-012-2354-y
   DAS AM, 1994, EUR J PEDIATR, V153, P267, DOI 10.1007/s004310050134
   DEWHURST AG, 1986, J NEUROL NEUROSUR PS, V49, P1323, DOI 10.1136/jnnp.49.11.1323
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emma F, 2006, PEDIATR NEPHROL, V21, P355, DOI 10.1007/s00467-005-2092-5
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fazzini F, 2019, KIDNEY INT, V96, P480, DOI 10.1016/j.kint.2019.04.021
   Ganetzky RD, 2018, MOL GENET METAB, V123, P301, DOI 10.1016/j.ymgme.2018.01.010
   Gilbert RD, 1996, ULTRASTRUCT PATHOL, V20, P473, DOI 10.3109/01913129609016351
   GOTO Y, 1990, J PEDIATR-US, V116, P904, DOI 10.1016/S0022-3476(05)80648-1
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Isotani H, 1996, CLIN ENDOCRINOL, V45, P637, DOI 10.1046/j.1365-2265.1996.00856.x
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Joyce E, 2017, PEDIATR NEPHROL, V32, P577, DOI 10.1007/s00467-016-3394-5
   Katsanos KH, 2001, AM J NEPHROL, V21, P150, DOI 10.1159/000046239
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134
   Kim KM, 2017, BMB REP, V50, P164, DOI 10.5483/BMBRep.2017.50.4.013
   Kleta R, 2018, J AM SOC NEPHROL, V29, P727, DOI 10.1681/ASN.2017060600
   Klootwijk ED, 2015, NEPHROL DIAL TRANSPL, V30, P1456, DOI 10.1093/ndt/gfu377
   Kodner CM, 2003, AM FAM PHYSICIAN, V67, P2527
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kuwertz-Bröking E, 2000, PEDIATR NEPHROL, V14, P495, DOI 10.1007/s004670050802
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Lee YS, 2001, PEDIATR NEPHROL, V16, P710, DOI 10.1007/s004670100637
   Lim Kenneth, 2017, CLIN NEPHROL CASE STUD, V5, P20, DOI 10.5414/CNCS109083
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Marlow FL, 2017, STEM CELL RES, V21, P178, DOI 10.1016/j.scr.2017.03.004
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mihai Cristina Maria, 2009, J MED CASE REP, V3, P101, DOI 10.1186/1752-1947-3-101
   Mima A, 2011, RENAL FAILURE, V33, P622, DOI 10.3109/0886022X.2011.585730
   MORI K, 1991, AM J MED GENET, V38, P583, DOI 10.1002/ajmg.1320380417
   MORRIS AAM, 1995, PEDIATR NEPHROL, V9, P407, DOI 10.1007/BF00866711
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   NIAUDET P, 1994, PEDIATR NEPHROL, V8, P164, DOI 10.1007/BF00865468
   OGIER H, 1988, J PEDIATR-US, V112, P734, DOI 10.1016/S0022-3476(88)80690-5
   Ormazabal A, 2015, DRUG DISCOV TODAY, V20, P1349, DOI 10.1016/j.drudis.2015.07.002
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PELLOCK JM, 1978, ANN NEUROL, V3, P455, DOI 10.1002/ana.410030519
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157
   Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277
   RHEUBAN KS, 1983, CLIN PEDIATR, V22, P822, DOI 10.1177/000992288302201208
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   SARASTE M, 1983, TRENDS BIOCHEM SCI, V8, P139, DOI 10.1016/0968-0004(83)90239-6
   Sato M, 2012, AUTOPHAGY, V8, P424, DOI 10.4161/auto.19243
   Scaglia F, 2003, AM J MED GENET A, V123A, P172, DOI 10.1002/ajmg.a.20315
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   SHOFFNER JM, 1995, KIDNEY INT, V47, P1101, DOI 10.1038/ki.1995.157
   SIMOPOULOS AP, 1971, J PEDIATR-US, V79, P633, DOI 10.1016/S0022-3476(71)80312-8
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Solano A, 2004, PEDIATR NEPHROL, V19, P790, DOI 10.1007/s00467-004-1473-5
   SPERL W, 1988, EUR J PEDIATR, V147, P418, DOI 10.1007/BF00496424
   Starr MC, 2018, PEDIATR NEPHROL, V33, P1257, DOI 10.1007/s00467-018-3937-z
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   THORNER P S, 1985, PEDIATRIC PATHOLOGY, V4, P25
   TOPPET M, 1977, AM J DIS CHILD, V131, P437, DOI 10.1001/archpedi.1977.02120170063012
   Tzen CY, 2001, KIDNEY INT, V59, P846, DOI 10.1046/j.1523-1755.2001.00567.x
   van den Ouweland JMW, 2000, EUR J HUM GENET, V8, P195, DOI 10.1038/sj.ejhg.5200444
   VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wilichowski E, 1997, PEDIATR RES, V41, P193, DOI 10.1203/00006450-199702000-00007
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Yubero D, 2015, EXPERT REV MOL DIAGN, V15, P1049, DOI 10.1586/14737159.2015.1062727
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zsurka G, 1997, HUM GENET, V99, P484, DOI 10.1007/s004390050393
NR 95
TC 36
Z9 40
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD JAN 15
PY 2021
VL 36
IS 1
BP 9
EP 17
DI 10.1007/s00467-019-04404-6
EA JAN 2020
PG 9
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA OZ4NF
UT WOS:000574055100001
PM 31925537
DA 2024-11-01
ER

PT J
AU Hussain, M
   Mohammed, A
   Saifi, S
   Khan, A
   Kaur, E
   Priya, S
   Agarwal, H
   Sengupta, S
AF Hussain, Mansoor
   Mohammed, Aftab
   Saifi, Shabnam
   Khan, Aamir
   Kaur, Ekjot
   Priya, Swati
   Agarwal, Himanshi
   Sengupta, Sagar
TI MITOL-dependent ubiquitylation negatively regulates the entry of PolγA into mitochondria
SO PLOS BIOLOGY
LA English
DT Article
AB Mutations in mitochondrial replicative polymerase Pol gamma A lead to progressive external ophthalmoplegia (PEO). While Pol gamma A is the known central player in mitochondrial DNA (mtDNA) replication, it is unknown whether a regulatory process exists on the mitochondrial outer membrane which controlled its entry into the mitochondria. We now demonstrate that Pol gamma A is ubiquitylated by mitochondrial E3 ligase, MITOL (or MARCH5, RNF153). Ubiquitylation in wild-type (WT) Pol gamma A occurs at Lysine 1060 residue via K6 linkage. Ubiquitylation of Pol gamma A negatively regulates its binding to Tom20 and thereby its mitochondrial entry. While screening different PEO patients for mitochondrial entry, we found that a subset of the Pol gamma A mutants is hyperubiquitylated by MITOL and interact less with Tom20. These Pol gamma A variants cannot enter into mitochondria, instead becomes enriched in the insoluble fraction and undergo enhanced degradation. Hence, mtDNA replication, as observed via BrdU incorporation into the mtDNA, was compromised in these PEO mutants. However, by manipulating their ubiquitylation status by 2 independent techniques, these PEO mutants were reactivated, which allowed the incorporation of BrdU into mtDNA. Thus, regulated entry of non-ubiquitylated Pol gamma A may have beneficial consequences for certain PEO patients.
C1 [Hussain, Mansoor; Mohammed, Aftab; Saifi, Shabnam; Khan, Aamir; Kaur, Ekjot; Priya, Swati; Agarwal, Himanshi; Sengupta, Sagar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi, India.
C3 Department of Biotechnology (DBT) India; National Institute of Immunology (NII)
RP Sengupta, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi, India.
EM sagar@nii.ac.in
FU National Institute of Immunology (NII); Department of Biotechnology (DBT), India [BT/MED/30/SP11263/2015, BT/PR23545/BRB/10/1593/2017, BT/PR27681/GET/119/269/2018]; Council of Scientific and Industrial Research (CSIR), India [37(1699)/17/EMR-11]; Science & Engineering Research Board (SERB), India [EMR/2017/000541]; J C Bose Fellowship [JCB/2018/000013]; DBT-RA Fellowship [35/July 2019/10]; DST Inspire Faculty Fellowship [DST/INSPIRE/04/2017/000088]
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678
   Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004
   Bragoszewski P, 2017, OPEN BIOL, V7, P0, DOI 10.1098/rsob.170007
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309
   Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Gupta S, 2014, CARCINOGENESIS, V35, P34, DOI 10.1093/carcin/bgt315
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064
   Kasahara T, 2017, PSYCHIAT CLIN NEUROS, V71, P518, DOI 10.1111/pcn.12496
   Kim SH, 2016, FEBS J, V283, P294, DOI 10.1111/febs.13568
   Kowalski L, 2018, BMC BIOL, V16, P0, DOI 10.1186/s12915-018-0536-1
   Kumari J, 2016, J CELL SCI, V129, P1312, DOI 10.1242/jcs.181297
   Lee BH, 2016, NATURE, V532, P398, DOI 10.1038/nature17433
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005
   Margineantu DH, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0001066
   Metzger MB, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.51065
   Michel MA, 2017, MOL CELL, V68, P233, DOI 10.1016/j.molcel.2017.08.020
   Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790
   Ordureau A, 2020, MOL CELL, V77, P1124, DOI 10.1016/j.molcel.2019.11.013
   Park YY, 2012, CELL DIV, V7, P0, DOI 10.1186/1747-1028-7-25
   Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927
   Phu L, 2020, MOL CELL, V77, P1107, DOI 10.1016/j.molcel.2020.02.012
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200
   Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rusilowicz-Jones EV, 2020, LIFE SCI ALLIANCE, V3, P0, DOI 10.26508/lsa.202000768
   Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128
   Shi HX, 2011, PLOS PATHOG, V7, P0, DOI 10.1371/journal.ppat.1002057
   Shiiba I, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113781
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023
   Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109
   Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112
   Yoo YS, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8910
NR 51
TC 11
Z9 11
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR 15
PY 2021
VL 19
IS 3
BP 
EP 
DI 10.1371/journal.pbio.3001139
PG 28
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics
GA QS5WB
UT WOS:000625969200001
PM 33657094
DA 2024-11-01
ER

PT J
AU de la Hoz, CPDF
   Morís, G
   Jiménez-Mallebrera, C
   Badosa, C
   Hernández-Laín, A
   Encinar, AB
   Martín, MA
   Domínguez-González, C
AF de Fuenmayor-Fernandez de la Hoz, Carlos Pablo
   Moris, German
   Jimenez-Mallebrera, Cecilia
   Badosa, Carmen
   Hernandez-Lain, Aurelio
   Blazquez Encinar, Alberto
   Angel Martin, Miguel
   Dominguez-Gonzalez, Cristina
TI Recurrent rhabdomyolysis and exercise intolerance: A new phenotype of late-onset thymidine kinase 2 deficiency
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
AB A 29-year-old man developed, since the age of 18, exercise intolerance and exercise-induced rhabdomyolysis, with myoglobinuria. Muscle biopsy showed ragged-red fibers. Multiple mitochondrial DNA deletions were detected. The previously reported pathogenic homozygous mutation c.323C>T (p.Thr108Met) in TK2 was identified. This case expands the phenotypic spectrum of TK2 deficiency and indicates that it should be considered in the differential diagnosis of episodic rhabdomyolysis and exercise intolerance, along with other metabolic and mitochondrial myopathies. Since a new treatment is under development, it is essential improving knowledge of the natural history of TK2 deficiency.
C1 [de Fuenmayor-Fernandez de la Hoz, Carlos Pablo; Dominguez-Gonzalez, Cristina] Hosp 12 Octubre, Dept Neurol, Neuromuscular Unit, Madrid, Spain.
   [Moris, German] Hosp Cent Asturias, Dept Neurol, Neuromuscular Unit, Oviedo, Spain.
   [Jimenez-Mallebrera, Cecilia; Badosa, Carmen] Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Neuropediat Dept, Neuromuscular Unit, Barcelona, Spain.
   [Jimenez-Mallebrera, Cecilia; Blazquez Encinar, Alberto; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.
   [Hernandez-Lain, Aurelio] Hosp 12 Octubre, Dept Pathol Neuropathol, Neuromuscular Unit, Madrid, Spain.
   [Blazquez Encinar, Alberto; Angel Martin, Miguel; Dominguez-Gonzalez, Cristina] Hosp 12 Octubre Res Inst Imas12, Madrid, Spain.
   [Blazquez Encinar, Alberto; Angel Martin, Miguel] Hosp 12 Octubre, Dept Clin Biochem, Mitochondrial Dis Lab, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; Central University Hospital Asturias; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre
RP Domínguez-González, C (corresponding author), Hosp Univ 12 Octubre, Serv Neurol, Unidad Enfermedades Neuromusculares, Ave Cordoba Sin Numero, Madrid 28041, Spain.
EM edgonzalez@salud.madrid.org
FU Spanish Instituto de Salud Carlos III (ISCIII) [PMP15-00025]
CR Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
NR 7
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR 15
PY 2021
VL 26
IS 
BP 
EP 
DI 10.1016/j.ymgmr.2020.100701
EA JAN 2021
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA QI2PD
UT WOS:000618816000007
PM 33457207
DA 2024-11-01
ER

PT J
AU Tinker, RJ
   Lim, AZ
   Stefanetti, RJ
   McFarland, R
AF Tinker, Rory J.
   Lim, Albert Z.
   Stefanetti, Renae J.
   McFarland, Robert
TI Current and Emerging Clinical Treatment in Mitochondrial Disease
SO MOLECULAR DIAGNOSIS & THERAPY
LA English
DT Review
ID nitric-oxide production; melas syndrome; mutation; arginine; encephalomyopathy; restoration; myopathy; deficiency; metabolism; citrulline
AB Primary mitochondrial disease (PMD) is a group of complex genetic disorders that arise due to pathogenic variants in nuclear or mitochondrial genomes. Although PMD is one of the most prevalent inborn errors of metabolism, it often exhibits marked phenotypic variation and can therefore be difficult to recognise. Current treatment for PMD revolves around supportive and preventive approaches, with few disease-specific therapies available. However, over the last decade there has been considerable progress in our understanding of both the genetics and pathophysiology of PMD. This has resulted in the development of a plethora of new pharmacological and non-pharmacological therapies at varying stages of development. Many of these therapies are currently undergoing clinical trials. This review summarises the latest emerging therapies that may become mainstream treatment in the coming years. It is distinct from other recent reviews in the field by comprehensively addressing both pharmacological non-pharmacological therapy from both a bench and a bedside perspective. We highlight the current and developing therapeutic landscape in novel pharmacological treatment, dietary supplementation, exercise training, device use, mitochondrial donation, tissue replacement gene therapy, hypoxic therapy and mitochondrial base editing.
C1 [Tinker, Rory J.; Lim, Albert Z.; Stefanetti, Renae J.; McFarland, Robert] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Tinker, Rory J.; Lim, Albert Z.; Stefanetti, Renae J.; McFarland, Robert] Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McFarland, Robert] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP McFarland, R (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; McFarland, R (corresponding author), Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; McFarland, R (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Di, Newcastle Upon Tyne, Tyne & Wear, England.
EM robert.mcfarland@newcastle.ac.uk
FU Wellcome; Medical Research Council (UK); Lily Foundation; UMDF; Ryan Stanford Appeal
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592
   Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Anderson L, 2016, NEURON, V92, P943, DOI 10.1016/j.neuron.2016.10.036
   APABHAI S, 2011, BRAIN, V6, P0
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Ariceta G, 2019, PEDIATR NEPHROL, V34, P571, DOI 10.1007/s00467-017-3856-4
   Artuch R, 1998, J INHERIT METAB DIS, V21, P837, DOI 10.1023/A:1005470702369
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bax BE, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081096
   BERNSEN PLJA, 1991, ARCH NEUROL-CHICAGO, V48, P334, DOI 10.1001/archneur.1991.00530150106028
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Beyrath J, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-24900-3
   Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   CAMPOS Y, 1993, MUSCLE NERVE, V16, P150, DOI 10.1002/mus.880160205
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Castro RJ, 2016, J LAW BIOSCI, V3, P726, DOI 10.1093/jlb/lsw051
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chan A, 1998, J NEUROL, V245, P681, DOI 10.1007/s004150050267
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chiba M, 2014, DIGEST DIS SCI, V59, P3129, DOI 10.1007/s10620-014-3399-5
   Christie AW, 1996, DIABETOLOGIA, V39, P45
   Civiletto G, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708799
   Cree L, 2015, MOL HUM REPROD, V21, P3, DOI 10.1093/molehr/gau082
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   de Laat P, 2015, NETH J MED, V73, P30
   Dhamne SC, 2015, ANN CLIN TRANSL NEUR, V2, P843, DOI 10.1002/acn3.226
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Distelmaier F, 2017, BRAIN, V140, P0, DOI 10.1093/brain/aww303
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Enns GM, 2017, J INBORN ERRORS META, V0, P0
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Frey S, 2017, BBA-MOL BASIS DIS, V1863, P284, DOI 10.1016/j.bbadis.2016.10.028
   Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835
   Garagnani P, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/560340
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012
   Gold R, 1996, EUR NEUROL, V36, P191, DOI 10.1159/000117246
   Goldstein A, 2013, NEUROTHERAPEUTICS, V10, P320, DOI 10.1007/s13311-012-0175-0
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guha S, 2019, HUM MOL GENET, V28, P1837, DOI 10.1093/hmg/ddz023
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kanabus M, 2014, BRIT J PHARMACOL, V171, P1798, DOI 10.1111/bph.12456
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   KARAA A, 2018, BRIT J PHARMACOL, V90, P0
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene, 2017, ORPHANET J RARE DIS, V0, P0
   KOEV D, 1993, DIABETES CARE, V16, P1285, DOI 10.2337/diacare.16.9.1285
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Komura K, 2003, PEDIATR NEUROL, V28, P53, DOI 10.1016/S0887-8994(02)00469-1
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Leonardi A, 2015, PHARM DEV TECHNOL, V20, P716, DOI 10.3109/10837450.2014.915572
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lightowlers RN, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050964
   Lindvall Olle, 2004, NEURORX, V1, P379, DOI 10.1602/neurorx.1.4.379
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   LOU HC, 1981, ARCH NEUROL-CHICAGO, V38, P469, DOI 10.1001/archneur.1981.00510070103027
   Ludwig DS, 2020, J NUTR, V150, P1354, DOI 10.1093/jn/nxz308
   Majamaa K, 1996, LIFE SCI, V58, P691, DOI 10.1016/0024-3205(95)02338-0
   Mancuso M, 2012, EXPERT OPIN PHARMACO, V13, P527, DOI 10.1517/14656566.2012.657177
   Marquardt L, 2019, EPILEPSY BEHAV REP, V12, P0, DOI 10.1016/j.ebr.2019.100339
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Martin-McGill KJ, 2018, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001903.pub4
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Melegh B, 1997, NEUROPEDIATRICS, V28, P257, DOI 10.1055/s-2007-973710
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Newman Jane, 2015, J NEUROMUSCUL DIS, V2, P151
   Ng Yi Shiau, 2018, EPILEPSIA OPEN, V3, P103, DOI 10.1002/epi4.12094
   Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   OKANE MJ, 1992, BRIT J CLIN PHARMACO, V33, P451, DOI 10.1111/j.1365-2125.1992.tb04067.x
   Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198
   Parikh S, 2017, GENET MED, V0, P19
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PETERSON PL, 1995, BBA-MOL BASIS DIS, V1271, P275, DOI 10.1016/0925-4439(95)00039-7
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pike NB, 2005, J CLIN INVEST, V115, P3400, DOI 10.1172/JCI27160
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Posey JE, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1127-0
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0217-2
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Reisman SA, 2019, DRUG DES DEV THER, V13, P1259, DOI 10.2147/DDDT.S193889
   Reznik M, 2020, NEUROLOGY, V94, P0
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Romero-Moya D, 2017, STEM CELLS, V35, P1687, DOI 10.1002/stem.2634
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21
   Seo KS, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00552
   Sharma A, 2010, J PHARM BIOALLIED SC, V2, P290, DOI 10.4103/0975-7406.72128
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Siciliano G, 2000, NEUROMUSCULAR DISORD, V10, P40, DOI 10.1016/S0960-8966(99)00068-1
   Siciliano G, 2012, NEUROMUSCULAR DISORD, V22, PS172, DOI 10.1016/j.nmd.2012.10.005
   Slone J, 2020, NPJ GENOM MED, V5, P0, DOI 10.1038/s41525-020-0116-5
   Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014
   Starr RR, 2015, AM J PUBLIC HEALTH, V105, P478, DOI 10.2105/AJPH.2014.302348
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Stefanetti RJ, 2020, WELLCOME OPEN RES, V0, P0
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 1999, HUM MOL GENET, V8, P1047, DOI 10.1093/hmg/8.6.1047
   Taivassalo T, 1999, MUSCLE NERVE, V22, P1239, DOI 10.1002/(SICI)1097-4598(199909)22:9<1239::AID-MUS11>3.0.CO;2-W
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   TOSCANO A, 1995, J NEUROL, V242, P203, DOI 10.1007/BF00919592
   Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484
   Vignal C, 2018, OPHTHALMOLOGY, V125, P945, DOI 10.1016/j.ophtha.2017.12.036
   Vitale, 2020, HUM MUTAT, V2, P2
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   WANG YX, 2004, P NATL ACAD SCI USA, V2, P0
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Yang DJ, 2020, BRAIN STIMUL, V13, P109, DOI 10.1016/j.brs.2019.09.006
   Zhang, 2020, ANN TRANSL MED, V0, P0
   Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
   Zweers H, 2018, JPEN-PARENTER ENTER, V42, P581, DOI 10.1177/0148607117699792
NR 167
TC 38
Z9 42
U1 1
U2 7
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1177-1062
EI 1179-2000
J9 MOL DIAGN THER
JI Mol. Diagn. Ther.
PD MAR 15
PY 2021
VL 25
IS 2
BP 181
EP 206
DI 10.1007/s40291-020-00510-6
EA MAR 2021
PG 26
WC Genetics & Heredity; Pharmacology & Pharmacy
SC Genetics & Heredity; Pharmacology & Pharmacy
GA QW5WN
UT WOS:000623706000002
PM 33646563
DA 2024-11-01
ER

PT J
AU Esterhuizen, K
   Lindeque, JZ
   Mason, S
   van der Westhuizen, FH
   Rodenburg, RJ
   de Laat, P
   Smeitink, JAM
   Janssen, MCH
   Louw, R
AF Esterhuizen, Karien
   Lindeque, J. Zander
   Mason, Shayne
   van der Westhuizen, Francois H.
   Rodenburg, Richard J.
   de Laat, Paul
   Smeitink, Jan A. M.
   Janssen, Mirian C. H.
   Louw, Roan
TI One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A &gt; G mutation
SO METABOLOMICS
LA English
DT Article
DE MELAS; MIDD; Myopathy; Metabolomics; m.3243A > G; Mitochondrial disease
ID stroke-like-episodes; ragged-red fibers; mitochondrial-myopathy; lactic-acidosis; lipoic acid; diagnosis; encephalopathy; features; insulin; synthase
AB Introduction The m.3243A > G mitochondrial DNA mutation is one of the most common mitochondrial disease-causing mutations, with a carrier rate as high as 1:400. This point mutation affects the MT-TL1 gene, ultimately affecting the oxidative phosphorylation system and the cell's energy production. Strikingly, the m.3243A > G mutation is associated with different phenotypes, including mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), maternally inherited diabetes and deafness (MIDD) and myopathy. Objectives We investigated urine metabolomes of MELAS, MIDD and myopathy patients in order to identify affected metabolic pathways and possible treatment options. Methods A multiplatform metabolomics approach was used to comprehensively analyze the metabolome and compare metabolic profiles of different phenotypes caused by the m.3243A > G mutation. Our analytical array consisted of NMR spectroscopy, LC-MS/MS and GC-TOF-MS. Results The investigation revealed phenotypic specific metabolic perturbations, as well as metabolic similarities between the different phenotypes. We show that glucose metabolism is highly disturbed in the MIDD phenotype, but not in MELAS or myopathy, remodeled fatty acid oxidation is characteristic of the MELAS patients, while one-carbon metabolism is strongly modified in both MELAS and MIDD, but not in the myopathy group. Lastly we identified increased creatine in the urine of the myopathy patients, but not in MELAS or MIDD. Conclusion We conclude by giving novel insight on the phenotypes of the m.3243A > G mutation from a metabolomics point of view. Directives are also given for future investigations that could lead to better treatment options for patients suffering from this debilitating disease.
C1 [Esterhuizen, Karien; Lindeque, J. Zander; Mason, Shayne; van der Westhuizen, Francois H.; Louw, Roan] North West Univ, Mitochondria Res Lab, Human Metabol, Potchefstroom, South Africa.
   [Rodenburg, Richard J.; de Laat, Paul; Smeitink, Jan A. M.; Janssen, Mirian C. H.] Radboud Univ Nijmegen, Dept Pediat, Radboud Ctr Mitochondrial Med, Med Ctr, Nijmegen, Netherlands.
   [Janssen, Mirian C. H.] Radboud Univ Nijmegen, Dept Internal Med, Radboud Ctr Mitochondrial Med, Med Ctr, Nijmegen, Netherlands.
   [Louw, Roan] North West Univ, Fac Nat & Agr Sci, Human Metabol, Potchefstroom Campus,Private Bag X6001, Potchefstroom, South Africa.
C3 North West University - South Africa; Radboud University Nijmegen; Radboud University Nijmegen; North West University - South Africa
RP Louw, R (corresponding author), North West Univ, Mitochondria Res Lab, Human Metabol, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
FU Technology Innovation Agency (TIA), South Africa [Metabol. 01]
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Brière JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Carbonneau M, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12700
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Hernández-Luis C, 2007, REV ESP CARDIOL, V60, P89, DOI 10.1016/S0300-8932(07)74995-3
   Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200
   HOLM S, 1979, SCAND J STAT, V6, P65
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kami K, 2012, MITOCHONDRION, V12, P644, DOI 10.1016/j.mito.2012.07.113
   KASSEL DB, 1986, BIOMED ENVIRON MASS, V13, P535, DOI 10.1002/bms.1200131004
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Kennedy AD, 2016, GENET TEST MOL BIOMA, V20, P485, DOI 10.1089/gtmb.2015.0291
   Khamis MM, 2018, METABOLOMICS, V14, P0, DOI 10.1007/s11306-018-1418-9
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Lorenzoni PJ, 2014, ARQ NEURO-PSIQUIAT, V72, P803, DOI 10.1590/0004-282X20140124
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marshall DD, 2017, PROG NUCL MAG RES SP, V100, P1, DOI 10.1016/j.pnmrs.2017.01.001
   McLaughlin MJ, 2014, PM&R, V6, P544, DOI 10.1016/j.pmrj.2014.04.006
   Mignarri A, 2015, J NEUROL SCI, V349, P254, DOI 10.1016/j.jns.2014.12.040
   Muoio DM, 2008, DIABETES, V57, P1455, DOI 10.2337/db08-0281
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473
   Park SY, 2017, FRONT NEUROL, V8, P0, DOI 10.3389/fneur.2017.00520
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   PISTERS PWT, 1992, SURGERY, V111, P301
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Rowland LP, 1993, HDB CLIN NEUROLOGY, V22, P177
   Sage-Schwaede A, 2019, ANN CLIN TRANSL NEUR, V6, P1877, DOI 10.1002/acn3.50846
   Santa KM, 2010, PHARMACOTHERAPY, V30, P1179, DOI 10.1592/phco.30.11.1179
   Scaglia F, 2006, CNS DRUGS, V20, P443, DOI 10.2165/00023210-200620060-00002
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Vollmar AKR, 2019, METABOLITES, V9, P0, DOI 10.3390/metabo9100198
   Xia Jianguo, 2016, CURR PROTOC BIOINFORMATICS, V55, P0, DOI 10.1002/cpbi.11
   Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131
   Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005
   Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e
NR 52
TC 9
Z9 9
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD JAN 12
PY 2021
VL 17
IS 1
BP 
EP 
DI 10.1007/s11306-020-01769-w
PG 16
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA PW3DV
UT WOS:000610554300001
PM 33438095
DA 2024-11-01
ER

PT J
AU Xu, MT
   Kopajtich, R
   Elstner, M
   Wang, ZX
   Liu, ZM
   Wang, JL
   Prokisch, H
   Fang, F
AF Xu, Manting
   Kopajtich, Robert
   Elstner, Matthias
   Wang, Zhaoxia
   Liu, Zhimei
   Wang, Junling
   Prokisch, Holger
   Fang, Fang
TI Identification of a Novel Variant in <i>MT-CO3</i> Causing MELAS
SO FRONTIERS IN GENETICS
LA English
DT Article
DE MELAS; novel mitochondrial DNA variant; MT-CO3 gene; complex IV of respiratory chain; mitochondrial diseases
ID stroke-like-episodes; mitochondrial; encephalopathy; mutations; disease; family; gene
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited mitochondrial disease. Most cases of MELAS are caused by the m.3243A > G variant in the MT-TL1 gene encoding tRNALeu((UUR)). However, the genetic cause in 10% of patients with MELAS is unknown. We investigated the pathogenicity of the novel mtDNA variant m.9396G > A/MT-CO3 (p.E64K), which affects an extremely conserved amino acid in the CO3 subunit of mitochondrial respiratory chain (MRC) complex IV (CIV) in a patient with MELAS. Biochemical assays of a muscle biopsy confirmed remarkable CIV deficiency, and pathological examination showed ragged red fibers and generalized COX non-reactive muscle fibers. Transfer of the mutant mtDNA into cybrids impaired CIV assembly, followed by remarkable mitochondrial dysfunction and ROS production. Our findings highlight the pathogenicity of a novel m.9396G > A variant and extend the spectrum of pathogenic mtDNA variants.
C1 [Xu, Manting; Liu, Zhimei; Wang, Junling; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing, Peoples R China.
   [Xu, Manting; Kopajtich, Robert; Prokisch, Holger] Tech Univ Munich, Sch Med, Inst Human Genet, Munich, Germany.
   [Xu, Manting; Kopajtich, Robert; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogen, Munich, Germany.
   [Elstner, Matthias] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany.
   [Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China.
C3 Capital Medical University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Peking University
RP Fang, F (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, Beijing, Peoples R China.
EM fangfang@bch.com.cn
FU Capital Health Research and Development Fund [2018-2-2096]; National Natural Science Foundation of China [81541115]; German BMBF through the ERA PerMed project PerMiM [01KU2016A]; Horizon 2020 through the ERA PerMed project PerMiM [01KU2016A]; European Joint Programme on Rare Diseases project GENOMIT [01GM1920A]
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Cheldi A, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-8
   Choi BO, 2008, EXP MOL MED, V40, P354, DOI 10.3858/emm.2008.40.3.354
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Chomyn A, 1996, METHODS ENZYMOL, V264, P334, DOI 10.1016/S0076-6879(96)64031-2
   Delmiro A, 2013, HUM MUTAT, V34, P1623, DOI 10.1002/humu.22445
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jha Pooja, 2016, CURR PROTOC MOUSE BIOL, V6, P1, DOI 10.1002/9780470942390.mo150182
   Ji KQ, 2020, ANN CLIN TRANSL NEUR, V7, P980, DOI 10.1002/acn3.51069
   Ji KQ, 2014, NEUROMOL MED, V16, P119, DOI 10.1007/s12017-013-8264-8
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 20
TC 5
Z9 6
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 12
PY 2021
VL 12
IS 
BP 
EP 
DI 10.3389/fgene.2021.638749
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA SI0HE
UT WOS:000654508500001
PM 34054915
DA 2024-11-01
ER

PT J
AU Zuccolotto-dos-Reis, FH
   Escarso, SHA
   Araujo, JS
   Espreafico, EM
   Alberici, LC
   Sobreira, CFD
AF Zuccolotto-dos-Reis, Felippe Henrique
   Andriao Escarso, Silvia Helena
   Araujo, Jackeline Souza
   Espreafico, Enilza Maria
   Alberici, Luciane Carla
   da Rosa Sobreira, Claudia Ferreira
TI Acetyl-CoA-driven respiration in frozen muscle contributes to the diagnosis of mitochondrial disease
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
DE acetyl&#8208; CoA&#8208; driven respiration; electron transport chain; frozen skeletal muscle biopsy; high&#8208; resolution respirometry; mitochondrial diseases; oxygen consumption rate
ID chain; fibers; disorders; tissue
AB Background Freezing human biopsies is common in clinical practice for storage. However, this technique disrupts mitochondrial membranes, hampering further analyses of respiratory function. To contribute to laboratorial diagnosis of mitochondrial diseases, this study sought to develop a respirometry approach using O2k (Oroboros Ins.) to measure the whole electron transport chain (ETC) activity in homogenates of frozen skeletal muscle biopsies. Patients and Methods We enrolled 16 patients submitted to muscle biopsy in the process of routine diagnostic investigation: four with mitochondrial disease and severe mitochondrial dysfunction; seven with exercise intolerance and multiple deletions of mitochondrial DNA, presenting mild to moderate mitochondrial dysfunction; five without mitochondrial disease, as controls. Whole homogenates of muscle fragments were prepared using grinder-type equipment. O-2 consumption rates were normalized using citrate synthase activity. Results Transmission electron microscopy confirmed mitochondrial membrane discontinuation, indicating increased permeability of mitochondrial membranes in homogenates from frozen biopsies. O-2 consumption rates in the presence of acetyl-CoA lead to maximum respiratory rates sensitive to rotenone, malonate and antimycin. This protocol of acetyl-CoA-driven respiration (ACoAR), applied in whole homogenates of frozen muscle, was sensitive enough to identify ETC abnormality, even in patients with mild to moderate mitochondrial dysfunction. We demonstrated adequate repeatability of ACoAR and found significant correlation between O-2 consumption rates and enzyme activity assays of individual ETC complexes. Conclusions We present preliminary data on a simple, low cost and reliable procedure to measure respiratory function in whole homogenates of frozen skeletal muscle biopsies, contributing to diagnosis of mitochondrial diseases in humans.
C1 [Zuccolotto-dos-Reis, Felippe Henrique; Andriao Escarso, Silvia Helena; da Rosa Sobreira, Claudia Ferreira] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci, Div Neurol, Sao Paulo, Brazil.
   [Araujo, Jackeline Souza; Espreafico, Enilza Maria] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Sao Paulo, Brazil.
   [Alberici, Luciane Carla] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept BioMol Sci, Ribeirao Preto, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo
RP Sobreira, CFD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci, Av Bandeirantes 3900, Ribeirao Preto, SP, Brazil.
EM csobreira@fmrp.usp.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]; FAPESP [2017/04372-0, 2016/23509-4, 2016/10862-8]; CNPq Research Fellowship
CR Acin-Perez R, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2019104073
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   García-Roche M, 2018, REDOX BIOL, V17, P207, DOI 10.1016/j.redox.2018.03.008
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Kuznetsov AV, 2003, ANAL BIOCHEM, V319, P296, DOI 10.1016/S0003-2697(03)00326-9
   Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4
   Larsen S, 2014, ANAL BIOCHEM, V446, P64, DOI 10.1016/j.ab.2013.10.023
   Larsen S, 2012, CRYOLETTERS, V33, P170
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Picard M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018317
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Ziak J, 2015, MITOCHONDRION, V21, P106, DOI 10.1016/j.mito.2015.02.002
NR 29
TC 3
Z9 3
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2972
EI 1365-2362
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD SEP 15
PY 2021
VL 51
IS 9
BP 
EP 
DI 10.1111/eci.13574
EA MAY 2021
PG 10
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA TX9PY
UT WOS:000646167900001
PM 33937992
DA 2024-11-01
ER

PT J
AU Klein, HU
   Trumpff, C
   Yang, HS
   Lee, AJ
   Picard, M
   Bennett, DA
   De Jager, PL
AF Klein, Hans-Ulrich
   Trumpff, Caroline
   Yang, Hyun-Sik
   Lee, Annie J.
   Picard, Martin
   Bennett, David A.
   De Jager, Philip L.
TI Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain
SO MOLECULAR NEURODEGENERATION
LA English
DT Article
DE Mitochondria; Neurodegeneration; Alzheimer's disease; Mitochondrial DNA copy number; Mitochondrial heteroplasmy; Tau; Amyloid; TDP-43
ID tdp-43 pathology; skeletal-muscle; copy number; mutations; neurons; memory; transcription; accumulation; impairment; level
AB Background Mitochondrial dysfunction is a feature of neurodegenerative diseases, including Alzheimer's disease (AD). Changes in the mitochondrial DNA copy number (mtDNAcn) and increased mitochondrial DNA mutation burden have both been associated with neurodegenerative diseases and cognitive decline. This study aims to systematically identify which common brain pathologies in the aged human brain are associated with mitochondrial recalibrations and to disentangle the relationship between these pathologies, mtDNAcn, mtDNA heteroplasmy, aging, neuronal loss, and cognitive function. Methods Whole-genome sequencing data from n = 1361 human brain samples from 5 different regions were used to quantify mtDNAcn as well as heteroplasmic mtDNA point mutations and small indels. Brain samples were assessed for 10 common pathologies. Annual cognitive test results were used to assess cognitive function proximal to death. For a subset of samples, neuronal proportions were estimated from RNA-seq profiles, and mass spectrometry was used to quantify the mitochondrial protein content of the tissue. Results mtDNAcn was 7-14% lower in AD relative to control participants. When accounting for all 10 common neuropathologies, only tau was significantly associated with lower mtDNAcn in the dorsolateral prefrontal cortex. In the posterior cingulate cortex, TDP-43 pathology demonstrated a distinct association with mtDNAcn. No changes were observed in the cerebellum, which is affected late by pathologies. Neither age nor gender was associated with mtDNAcn in the studied brain regions when adjusting for pathologies. Mitochondrial content and mtDNAcn independently explained variance in cognitive function unaccounted by pathologies, implicating complex mitochondrial recalibrations in cognitive decline. In contrast, mtDNA heteroplasmy levels increased by 1.5% per year of life in the cortical regions, but displayed no association with any of the pathologies or cognitive function. Conclusions We studied mtDNA quantity and quality in relation to mixed pathologies of aging and showed that tau and not amyloid-beta is primarily associated with reduced mtDNAcn. In the posterior cingulate cortex, the association of TDP-43 with low mtDNAcn points to a vulnerability of this region in limbic-predominant age-related TDP-43 encephalopathy. While we found low mtDNAcn in brain regions affected by pathologies, the absence of associations with mtDNA heteroplasmy burden indicates that mtDNA point mutations and small indels are unlikely to be involved in the pathogenesis of late-onset neurodegenerative diseases.
C1 [Klein, Hans-Ulrich; De Jager, Philip L.] Columbia Univ, Ctr Translat & Computat Neuroimmunol, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.
   [Klein, Hans-Ulrich; Lee, Annie J.; De Jager, Philip L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA.
   [Trumpff, Caroline; Picard, Martin] Columbia Univ, Div Behav Med, Dept Psychiat, Irving Med Ctr, New York, NY 10032 USA.
   [Yang, Hyun-Sik] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA.
   [Picard, Martin] Columbia Univ, Merritt Ctr, Irving Med Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Columbia Translat Neurosci Initiat, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.
   [Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.
C3 Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Harvard University; Brigham & Women's Hospital; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Rush University
RP Klein, HU; De Jager, PL (corresponding author), Columbia Univ, Ctr Translat & Computat Neuroimmunol, Dept Neurol, Irving Med Ctr, New York, NY 10032 USA.; Klein, HU; De Jager, PL (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Irving Med Ctr, New York, NY 10032 USA.
EM hk2948@cumc.columbia.edu; pld2115@cumc.columbia.edu
FU NIH [U01AG046152, U01AG061356, P30AG010161, R01AG015819, R01AG017917]
CR Allen M, 2016, SCI DATA, V3, P0, DOI 10.1038/sdata.2016.89
   Area-Gomez E, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-61142-8
   Area-Gomez E, 2019, J CLIN INVEST, V129, P34, DOI 10.1172/JCI120848
   Arvanitakis Z, 2017, BRAIN PATHOL, V27, P77, DOI 10.1111/bpa.12365
   Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378
   Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3
   Bennett DA, 2018, J ALZHEIMERS DIS, V64, PS161, DOI 10.3233/JAD-179939
   Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031
   Botha H, 2018, BRAIN, V141, P1201, DOI 10.1093/brain/awy049
   Boyle PA, 2015, NEUROLOGY, V85, P1930, DOI 10.1212/WNL.0000000000002175
   Brinckmann A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013513
   Buchman AS, 2011, STROKE, V42, P3183, DOI 10.1161/STROKEAHA.111.623462
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   De Jager PL, 2018, SCI DATA, V5, P0, DOI 10.1038/sdata.2018.142
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Ding J, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005306
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Fries GR, 2017, TRANSL PSYCHIAT, V7, P0, DOI 10.1038/s41398-017-0048-8
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hägg S, 2021, HUM GENET, V140, P849, DOI 10.1007/s00439-020-02249-w
   Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004
   Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321
   Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1
   Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li XC, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24756
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263
   Longchamps R, 1900, V2021, V0, P0, DOI DOI 10.1101/2021.01.25.428086
   Longchamps RJ, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0228166
   Love Seth, 2014, AM J NEURODEGENER DIS, V3, P19
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Moore AZ, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12683
   Murray ME, 2014, ALZHEIMERS RES THER, V6, P0, DOI 10.1186/alzrt254
   Nacheva E, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0180467
   Nag S, 2018, ACTA NEUROPATHOL COM, V6, P0, DOI 10.1186/s40478-018-0531-3
   Nag S, 2017, NEUROLOGY, V88, P653, DOI 10.1212/WNL.0000000000003610
   Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388
   Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Patrick E, 2020, PLOS COMPUT BIOL, V16, P0, DOI 10.1371/journal.pcbi.1008120
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rausser S, 1900, V2021, V0, PP2020, DOI 10.16.342923
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Rodríguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234
   Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24
   Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012
   Shim HB, 2020, MITOCHONDRION, V52, P108, DOI 10.1016/j.mito.2020.03.001
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Thul PJ, 2017, SCIENCE, V356, P0, DOI 10.1126/science.aal3321
   Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Wang MH, 2018, SCI DATA, V5, P0, DOI 10.1038/sdata.2018.185
   Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Wang X, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00392-6
   Wei W, 2017, ACTA NEUROPATHOL COM, V5, P0, DOI 10.1186/s40478-016-0404-6
   Weidling IW, 2020, J ALZHEIMERS DIS, V77, P149, DOI 10.3233/JAD-200286
   Wingo AP, 2020, NAT NEUROSCI, V23, P696, DOI 10.1038/s41593-020-0635-5
   Yang SY, 2021, GENOME RES, V31, P349, DOI 10.1101/gr.269381.120
   Yin JX, 2020, NEUROLOGY, V94, PE2404, DOI 10.1212/WNL.0000000000009582
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zhong Y, 2013, BMC BIOINFORMATICS, V14, P0, DOI 10.1186/1471-2105-14-89
NR 80
TC 53
Z9 55
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD NOV 6
PY 2021
VL 16
IS 1
BP 
EP 
DI 10.1186/s13024-021-00495-8
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA WS2OZ
UT WOS:000715027900001
PM 34742335
DA 2024-11-01
ER

PT J
AU Nasca, A
   Di Meo, I
   Fellig, Y
   Saada, A
   Elpeleg, O
   Ghezzi, D
   Edvardson, S
AF Nasca, Alessia
   Di Meo, Ivano
   Fellig, Yakov
   Saada, Ann
   Elpeleg, Orly
   Ghezzi, Daniele
   Edvardson, Shimon
TI A novel homozygous <i>MSTO1</i> mutation in Ashkenazi Jewish siblings with ataxia and myopathy
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
AB MSTO1 is a cytoplasmic protein that modulates mitochondrial dynamics by promoting mitochondrial fusion. Mutations in the MSTO1 gene are responsible for an extremely rare condition characterized by early-onset myopathy and cerebellar ataxia. We report here two siblings from a large Ashkenazi Jewish family, presenting with a progressive neuromuscular disease characterized by ataxia and myopathy. By whole exome sequencing, we found a novel homozygous missense mutation (c.1403T>A, p.Leu468Gln) in MSTO1. Studies performed on fibroblasts from the index patient demonstrated the pathogenic role of the identified variant; we found that MSTO1 protein level was reduced and that mitochondrial network was fragmented or formed enlarged structures. Moreover, patient's cells showed reduced mitochondrial DNA amount. Our report confirms that MSTO1 mutations are typically recessive, and associated with clinical phenotypes characterized by early-onset muscle impairment and ataxia, often with upper motor neuron signs and varied cognitive impairment.
C1 [Nasca, Alessia; Di Meo, Ivano; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.
   [Fellig, Yakov] Hadassah Hebrew Univ Jerusalem, Dept Pathol, IL-91120 Jerusalem, Israel.
   [Saada, Ann; Elpeleg, Orly] Hadassah Hebrew Univ Jerusalem, Dept Genet, IL-91120 Jerusalem, Israel.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Edvardson, Shimon] Hadassah Hebrew Univ Jerusalem, Pediat Neurol Unit, IL-91240 Jerusalem, Israel.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Milan; Hebrew University of Jerusalem; Hadassah University Medical Center
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, I-20126 Milan, Italy.; Ghezzi, D (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.; Edvardson, S (corresponding author), Hadassah Hebrew Univ Jerusalem, Pediat Neurol Unit, IL-91240 Jerusalem, Israel.
EM daniele.ghezzi@istituto-besta.it; simon@hadassah.org.il
FU Mariani Foundation
CR Ardicli D, 2019, NEUROMUSCULAR DISORD, V29, P448, DOI 10.1016/j.nmd.2019.03.011
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Iwama K, 2018, J HUM GENET, V63, P263, DOI 10.1038/s10038-017-0405-8
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Li K, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.01.013
   Nasca A, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00625
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   Nasca A, 2016, HUM MUTAT, V37, P898, DOI 10.1002/humu.23033
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Schultz-Rogers L, 2019, CSH MOL CASE STUD, V5, P0, DOI 10.1101/mcs.a004309
   Shahrour MA, 2017, CLIN GENET, V91, P690, DOI 10.1111/cge.12855
   Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800
NR 14
TC 3
Z9 3
U1 0
U2 9
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD AUG 15
PY 2021
VL 66
IS 8
BP 835
EP 840
DI 10.1038/s10038-020-00897-4
EA FEB 2021
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA TP7KF
UT WOS:000620106700001
PM 33612823
DA 2024-11-01
ER

PT J
AU Sharma, A
   Schaefer, ST
   Sae-Lee, C
   Byun, HM
   Wüllner, U
AF Sharma, Amit
   Schaefer, Simon T.
   Sae-Lee, Chanachai
   Byun, Hyang-Min
   Wuellner, Ullrich
TI Elevated serum mitochondrial DNA in females and lack of altered platelet mitochondrial methylation in patients with Parkinson′s disease
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Parkinson ' s diseases; mitochondrial; DNA methylation; biomarkers; Platelets
ID complex-i
AB Purpose: Mitochondrial dysfunction has long been considered in the pathogenesis of Parkinson's disease (PD). This is evident from the presence of mitochondrial DNA deletions in substantia nigra neurons and respiratory chain abnormalities in the skeletal muscle of PD patients. However, the contributing factors that potentially cause oxidative stress in PD are still elusive. To a certain extent, the identification of acquired changes in circulating mitochondrial DNA (mtDNA) content in blood samples may mirror the mitochondrial (dys-) function. Therefore, herein, we investigated the mtDNA concentrations in serum and cerebrospinal fluid (CSF) of PD patients. Materials and methods: We performed quantitative analysis (qPCR) at two mitochondrial regions (D-Loop; ATPase6) and evaluated the platelet mtDNA methylation levels (MT-TL1 ,MT-CO1, MT-CO2 and MT-CO3) by bisulfite-PCR pyrosequencing. Results: Our quantitative analysis at two mitochondrial regions (D-Loop; ATPase6) revealed an increase in mtDNA serum concentrations in PD females compared to healthy females. Of particular interest, these altered concentrations were restricted to females serum only. Thus, in males as well as CSF of PD patients no increase was detected. Additionally, mtDNA methylation in platelets isolated from the plasma of PD patients showed no altered methylation levels in the mitochondrial MT-TL1 and MT-CO1 regions. Besides, a complete lack of platelet mtDNA methylation was observed at MT-CO2 and MT-CO3 mitochondrial sites. Conclusions: Taken together, we found an increased mtDNA serum concentration exclusively in PD females. As of yet, it is unclear whether this might reflect specific changes or characteristics of female PD pathobiology. However, in context to the ongoing debate about mtDNA methylation, we could show that the mitochondrial epigenome does harbor detectable CpG methylation sites in platelets-derived DNA.
C1 [Sharma, Amit; Wuellner, Ullrich] Univ Clin Bonn, Dept Neurol, Bonn, Germany.
   [Sharma, Amit] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany.
   [Schaefer, Simon T.] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Anesthesiol, Munich, Germany.
   [Sae-Lee, Chanachai; Byun, Hyang-Min] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sae-Lee, Chanachai] Mahidol Univ, Siriraj Hosp, Res Div, Fac Med, Bangkok, Thailand.
   [Wuellner, Ullrich] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Munich; Newcastle University - UK; Mahidol University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)
RP Wüllner, U (corresponding author), Univ Hosp Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.
EM ullrich.wuellner@ukbonn.de
FU German Federal Ministry of Education and Research (BMBF/ANR) through the EpiPD (Epigenomics of Parkinson's disease) project, under bilateral Epigenomics of Common and Agerelated Diseases Programme [01KU1403B]
CR Baccarelli AA, 2015, CLIN EPIGENETICS, V7, P0, DOI 10.1186/s13148-015-0078-0
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Kaut O, 2017, NEUROL RES, V39, P281, DOI 10.1080/01616412.2017.1279424
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Mechta M, 2017, FRONT GENET, V8, P0, DOI 10.3389/fgene.2017.00166
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Schäfer ST, 2016, ANESTHESIOLOGY, V124, P923, DOI 10.1097/ALN.0000000000001008
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   Sharma A, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-54865-w
   Sharma A, 2017, NEUROBIOL AGING, V57, P0, DOI 10.1016/j.neurobiolaging.2017.05.021
   Wüllner U, 2016, J NEUROCHEM, V139, P108, DOI 10.1111/jnc.13646
NR 14
TC 25
Z9 28
U1 0
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD MAR 4
PY 2021
VL 131
IS 3
BP 279
EP 282
DI 10.1080/00207454.2020.1738433
EA MAR 2020
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA QJ4JP
UT WOS:000519454200001
PM 32125208
DA 2024-11-01
ER

